<SEC-DOCUMENT>0000790526-22-000010.txt : 20220510
<SEC-HEADER>0000790526-22-000010.hdr.sgml : 20220510
<ACCEPTANCE-DATETIME>20220510171956
ACCESSION NUMBER:		0000790526-22-000010
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		61
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220510
DATE AS OF CHANGE:		20220510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		22911076

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>rdnt-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:24636b67-e396-4152-b274-3287e4e6d5f6,g:fb9713cf-faca-444a-b4d8-252fbad89deb,d:cf50c354d3d14f9eaeb683bc15ad4328--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:rdnt="http://www.radnet.com/20220331" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rdnt-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80L2ZyYWc6OWM4MTJhNDc3ZWU4NDAxNzljZDYzZmFkZDMzNzBjZTMvdGFibGU6MzMyMjkxYjkzM2ZlNDA0OGJiMjEyYzY2NmE0OTQ5NTEvdGFibGVyYW5nZTozMzIyOTFiOTMzZmU0MDQ4YmIyMTJjNjY2YTQ5NDk1MV8xLTEtMS0xLTE0Mjc5_bff61dc2-0e03-45ce-8503-5248048e6447">0000790526</ix:nonNumeric><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80L2ZyYWc6OWM4MTJhNDc3ZWU4NDAxNzljZDYzZmFkZDMzNzBjZTMvdGFibGU6MzMyMjkxYjkzM2ZlNDA0OGJiMjEyYzY2NmE0OTQ5NTEvdGFibGVyYW5nZTozMzIyOTFiOTMzZmU0MDQ4YmIyMTJjNjY2YTQ5NDk1MV8yLTEtMS0xLTE0Mjc5_67d882ce-7816-486b-8f80-c9fa30a7a395">false</ix:nonNumeric><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80L2ZyYWc6OWM4MTJhNDc3ZWU4NDAxNzljZDYzZmFkZDMzNzBjZTMvdGFibGU6MzMyMjkxYjkzM2ZlNDA0OGJiMjEyYzY2NmE0OTQ5NTEvdGFibGVyYW5nZTozMzIyOTFiOTMzZmU0MDQ4YmIyMTJjNjY2YTQ5NDk1MV8zLTEtMS0xLTE0Mjc5_90099f11-bace-4b90-b162-bafa79a80b31">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80L2ZyYWc6OWM4MTJhNDc3ZWU4NDAxNzljZDYzZmFkZDMzNzBjZTMvdGFibGU6MzMyMjkxYjkzM2ZlNDA0OGJiMjEyYzY2NmE0OTQ5NTEvdGFibGVyYW5nZTozMzIyOTFiOTMzZmU0MDQ4YmIyMTJjNjY2YTQ5NDk1MV80LTEtMS0xLTE0Mjc5_9a7c6e00-109a-425f-adce-17ad7775d158">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80L2ZyYWc6OWM4MTJhNDc3ZWU4NDAxNzljZDYzZmFkZDMzNzBjZTMvdGFibGU6MzMyMjkxYjkzM2ZlNDA0OGJiMjEyYzY2NmE0OTQ5NTEvdGFibGVyYW5nZTozMzIyOTFiOTMzZmU0MDQ4YmIyMTJjNjY2YTQ5NDk1MV81LTEtMS0xLTE0Mjc5_7b3394d6-e896-43d1-80c3-d92bb28a9cb1">2022</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rdnt-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib54bc4806e7a4e68808598eddfb79202_I20220505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i2d51580d4825469e821595335785ef53_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i149f4a7d4caa402e82e20e079677076d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2605b786cda241819a617675d3a16552_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i285d42025a684eea9d37aef0f1d14159_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61b4276af6d44d32ad20efcc3c5b920b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1edab43086bf43f4838cf141ce134cfb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6c326d52eb544be8bd9b419b21bf661_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92a159e91d424561b526e4f4e0f77d49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a062644b1a463b95d9488efe1f1e9d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9902151192a44beaa1c9350219e3f13_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bb0ae88cb924707aa34148fe232e546_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i520ee3069e394d228388f671ea45af80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53a301eed9394031a8f0503c15c07855_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ca7e0851947420686d239632088b156_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9029d82f8c0a4ca992f906e0be3c5858_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib19dc048664d4c4fa328399747a3ccfa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4622b4997a4a4eccb0c0fb0915a887af_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia31e62681d3c4358b16ca1844ba3f0b1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb193f06c3a44c5a8335f469b106c368_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadec43eade70409e9d0da25233b1dfde_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6075cb3a8ec8490d9a77109346158e64_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4832576a7844a8596613f578d05549d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefc7c8c1bcd0401d8a5c82be7e8fe00f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa990aa527e1441eb4aa259e7c4a4311_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70baa850fe584a93b43499065527584c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i068b30b1e9cb45efbe0395c727f3bb66_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia524ae0349d841c5bea7e971fafb1f2f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3ea365926174da78fafa3edf281157f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bd41347893b42dda87f2f49f1d20d77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i729694f595eb4900a9bbee1a57c1c865_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80d5947f62c845b3b04f76fc1a749fe1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i776431f5daf3445a96806322961098ce_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6c1a53cb7ec4f729af5315153b1f9ab_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia07ad7db2a1a4923864a30fe3533a635_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3d203a14a9649c5b4159c9895f003d2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c8654171884445c860af370f5bfea70_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a645db31d194b07afc404edff2224fc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib15b4952b11a47fb9236321bd4319708_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice4eb83abe1d4023b624f59e96214964_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9923e7aecddc4104b04852156ffa40cd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i072529ea3a664abaa7cfed01aee70693_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08eccb87eff3426d8baf820a26ef8096_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87a8e19419ba4657b804a6671424a127_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d4c12a55344278a60a16915110bed1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193b2936e56f4e0cbc28405f53112fa5_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa15adcb65e94d769e97b210362a1702_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4779c75d3584b92a138261c6841bda4_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id03c7545762c4f66b0e58615ce5345db_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92e430343aa64146a7eda3b1524bc877_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4b3b1411401444f9e1598514c6e4f34_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10368330403342cab4b72f7c8a363d0b_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="center"><xbrli:measure>rdnt:center</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>rdnt:segment</xbrli:measure></xbrli:unit><xbrli:context id="i408288df014b467c9d35d6c84ed0afd4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4121846437d46c897233bae9c9a6bbd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe76a6a063624942b6870c14878eb85b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i36c0e21c63724ab3a7cb8109c29fb186_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f9c76414c854366adacd1025313a311_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0814f8295094f73a07b17a0ea048a22_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if18b633eea03421b8f0beb791427de6a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f90bdc631743c984922bdc1021a382_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a26be7fa427465ea07552ca86911792_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bd4c2145a8a4cd3863fd3617fbfa90e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5620bbf4e4f84b4c910f4cc3a6fd3e4b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia71163553a4f410787a124d8d66b0e24_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id872fda809f94d66911bf9bed7f149bc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaf803a00a874891b5809498d753bd6c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92d49bb958ff4b4c812a88416ba02fa6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41646490802644a5945209bcc69d3f40_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie16c2fada5f146a28cfdc71179dea43e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9ebdad869674354bf27b7a86e43d9e3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie38a0f605d3e4c68b25430e65285e3e7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6e867081801442288b3623055f9b0d6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i041ea1457ed044bcaa322ae1adc5cf1d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97333ecfd0244f90905767929fe29b00_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad6312f903a74fa5a463cec7c3aeeef9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb6fe52c39e2437d8016fabb3cae733e_D20200101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3550ac82c3f40c19d6f03a23e217852_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b6de56811c743baa555eba8f903a54d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75d923098e5d4a0ba8b3f7ac2c2de141_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82ee386e6eb4838b2bc73fbbed35685_D20200101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3be9b88ce86c4744bf9e653fbfd94c90_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7a4a64a35034275b1c621fed996e4d6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i942d9cebffbb4273877f3ac67a45462f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b445489971a44ef8c84f8ed64c4e83e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee8582ac6274cbd9efd095c7d1133b3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12c3a8c867b34ac68810453b838a2512_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe80e0841a2748468587fe41fa4e816d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6c679f4cdfd406189d36613f3477385_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia604fcc12d02444abd767ce04feff86e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fefd7d7be254ff5afc618390afc8022_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVAndQuantibBVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="incentiveplan"><xbrli:measure>rdnt:incentivePlan</xbrli:measure></xbrli:unit><xbrli:context id="i8c5258f2864b4b36a115d030fd6f6f0c_I20210415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f6c8dad5f1a47f795469ebccd173f1a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i096002072adf4d33b28c2551f1673e8d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>rdnt:agreement</xbrli:measure></xbrli:unit><xbrli:context id="i3ca7aedbfe5d492cbf2c8002a3274c68_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic89c652d406f400bb6ace78022bdeb15_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ca7b8d957854f59aa72e2303bda7c43_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e159b506e24f2ba312631b9d16e313_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a953bd9d4fa4594b4bec67ab351df4a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3c38d0041d84df692e1f844842547ab_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ad404b13b9e47818c995000abcc2af9_D20200701-20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd1aeae2536a41608c3ca6a90e5f158e_D20200701-20231031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81fba56dea454c119ee7cf826d420c68_D20231101-20251030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2025-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5a821e65c2544d5a2b4b289ae3296fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a2b41962224ca58c77ef230e603ac4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed6eb6d787b4fb6b3d5fbfd38cd9917_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if95355fe5a3242819fcb7d0e02be7ec3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf2ec2ce1cae4a43bed55d993eadf539_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f460fdf9f124cfaa19c7b7e51eaf2f2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c9a983e6ab54175b3a01c54d524c7a8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i753a81b55a9f4fb484fadfcdc315c4e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc1c497245b149e284139819564e0884_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf6e35695eaa4dd8b7dd11f4cabb0ea7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b37a6d0909f429ea7e69dfe397ea84b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1c72c1dc48746639ec661fa2dcd2090_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie348136a7ee3486ca5466e8c06a98ee0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1b6d8c2e1034d85aab248128f367e1b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia18b8469f0344621a9fe57a2fdd8b537_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2943452c6ebb4be889c458dfb30e5334_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id14ca2ee887945609d66115bf804422c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if42b9c9a847043829b014731da1e39d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9157a041f574895a708682c8fc778d8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id469797c65cf443da10faec1b3088beb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2158c83bdd5247bcb8c21b6f9c1ab650_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib324770e341c43deb03d6adaf27aeb3b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fb86495a1f749bea1502c1e616f2590_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2cdca6cf3344e588f5fd3a61929ec4a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65afeb72c5874b7dabc692b4b7060cf4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7628b2fb529f4c519168b280f905d875_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fc944cf5d8b4854b25485eed3739509_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i087e463165f046e8819239d70522c4bb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6e199c650d745829d22ac92ce902098_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992fabbabab44df7b3b1693d7cbf856c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7037863c1e3e41be9812230db93860cc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>rdnt:security</xbrli:measure></xbrli:unit><xbrli:context id="id0849868ae3c4ceb92bbeb7de548fba8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f1f9da235cc407c9377b1b4199f2c94_D20191105-20191105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-05</xbrli:startDate><xbrli:endDate>2019-11-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="jointventure"><xbrli:measure>rdnt:jointVenture</xbrli:measure></xbrli:unit><xbrli:context id="i6eae8a7d772041fd90c955f920bc9ae8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec48a9056e99437fbf2864df26de0803_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie110fb96d5d244519c0c1cf9826af837_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i729756c7eae9463bb7f2dc97e4f51489_D20220101-20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic67563cef4c9491d9d0dc503a64601b6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie90163b29ad64822a65cf592dbd711ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id06cc52a0f9944378c61c46c035f80f6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2588fa1944547388e26c3a6dc631651_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i636dd2048c8c4f80b50c95a50ddf044d_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLC1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideac6fdbbd604859beff580d11ae84b3_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLC2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib261e6ac493749b8b10541441e853944_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0bf43006b8e4c76b133b1590044e764_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87b26de1e4b243908f72f164ff3c9086_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2031463f67164712a74de886e34783a3_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d27827222204849a68e073722e8fc1d_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:CertainSellerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c67e44f3fc456cab260a3b8f274e7e_D20220331-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeafd6bcebca4a6683a7ac275f256f43_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae865f3f81124444953fdc68855c5377_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6603de1c39843a99a8e725c3ba62d5d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i733096088bfb4e4593a3c6893d07f184_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfb1d71aa2ad40129d22f67c28e34718_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17d341f477874224896da30df2514be5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b2021e8693c43efb8f3683e1a35b4df_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c9e01d6493f43e299012d6df312e4bf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i306b15aed8664de6a18898691aeec87c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45d5c9e3d43546498d2a26f35f8668b2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f7f03f2987a4c7fb79e4440534fa07b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53f75acbd56447d2a0b5536e5817ebbb_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808acf82ba384ff191da9c1c7c61d43a_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c887837d9ef4909b82fa07c516cbe5f_D20210423-20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-23</xbrli:startDate><xbrli:endDate>2021-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia71e051856e14e40b66eb9309af46b02_D20210423-20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-23</xbrli:startDate><xbrli:endDate>2021-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb3b9b1ec109454b8176b9068a603457_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9078e720809546d6aaf957bdefc7dbd7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf7f88c678b74b4b886228218a5301cd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a411712fae44141898b470479a1a692_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bc8bed1e3c54b7ba889d6e0b9d215c5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b94146cc90742289e03e41f9581f179_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fb8a36da6224876bbbbb9c7b1e0d449_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a2d0c6e90f04f8082784ea469840870_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a4c35b6f71f4affa5768a0f639d4a2e_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib94c9abf453248efa63db38b503a8c1f_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14767b8798514b70a2a6a74b9bfa6102_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6498b4b0455a4c30a9f141fc0c149aa5_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77287fbd0d0a43c186ef244cf589e396_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21e6a5f9bcb0473b911a70e52c9e9944_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0203d30cd0df4077a62703e30f8c9f72_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66fff8293b844dbb838b2a1631a77770_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7197db62c8b045d3873fabec7ae0b9bb_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0748b4650f54d66b1525c3d3fd5f155_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f32cd9d031641319a66833f52dcf90b_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e79888671f849d681c9ca4dc7cbaa90_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d79a719943a464f8d6d78268821d707_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a23d776eb16471e8f49c42bb87a1e64_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i284b87cc02134d23929b19658a998ad3_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64766f8ffc80490290a08bed27b2773e_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i788b4cad69a643e098e52cb02eb7e58d_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i216ae89339844560bddb88a4bcab64fb_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bdf68a9ef0548fb84d159aeddab27f9_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c6b1f79048e42b0884571c09c623080_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib450abcacaa5468ca7b49d50d7ed31f4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12925f11ce794cee9ffd477add1fac2e_D20181231-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3adb88ce1adf406397b79615c8b29bf7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5edfcb6761487ba2db12d147e1a78a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i944cc9d161d74ab4a23982b4cd8bdde3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifab2cc344a8d437a8e02749427a7acff_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55945c769c1d4cb2adf73dd4dd33aeb1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b949300d1bf4eb787b7017dba8800a8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f737acdac8048f2957feb692e3d8687_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if714085c7d9d491f9c016de58ac30e20_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f29d5fa82f04e0896fcba4d15e506de_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf21c52bd3f345188e62a53c44636392_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c069f2e05fb4ade941f4557b949f231_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ba7bf841c994912865be36c75e38317_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69b9eb94e2114856a02bf051af39e645_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c4dd403dd9e4ae1818b1ff441f9d0fd_I20200828"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dde26745a6044629a509a83ba660edb_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i173683f5805b4c458be4a416f552f961_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice280dd4e241422aad4acecf0b4651de_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d0fe3c768bd4ce39293d761c41ecb34_D20190418-20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-18</xbrli:startDate><xbrli:endDate>2019-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11e3573789424e659f1797ec670783df_I20210415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fe72543c2724817acf22b92b9937440_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9212727f374b4ce7870dbc05eb4d8aab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if325d72e03184e4ea6e238d77b34f487_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf3ba225c36c476084469d9c6670a07a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bb501a256514bab8c456345170a164f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e2634a74afe41adab0fab66686d695b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia330bf2f544847c6ba7b2723fd73ac98_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5e7a1236cb84c87a209ab1daf15ec5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e5cdfa72e1f434c8006a75f7440ddfa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9638ca6566474cefbd8968ed4929434f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2d96663c67244b8aed2634eec524266_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02c8a2af4cae4e6e846dbb7f3b47fdb3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id651533cf9634a93ac70355625b736ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5c138bc3875441b941c772784e63633_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc2a40dd49e04ddfaf6d85ae95da2eff_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i097c50f9108e4084a44c52e4dd246bee_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34139941895f4c2b87454e78288b6292_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id250c206c9c1458d9f1fbcfcdf5640d7_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id200edd7b27544e283a49fdc5f16ae77_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6fa67c017444c96a4b8dc187d33a734_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05688edf21f347e59b6c396261cdb342_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="location"><xbrli:measure>rdnt:location</xbrli:measure></xbrli:unit><xbrli:context id="i5b489515e2944df5827ad37c4f4ac39a_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf0e02f07fbc478f873c7b8dd2a24f2d_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjM5_2cbcf70a-ec94-42ec-93e2-ac0e9ba20196">10-Q</ix:nonNumeric> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjM1_55fbade5-e73b-433b-bcc4-052b1cd6f421">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQ_c1894b9b-34d1-4cb6-9f51-3217f7dedfaa">March 31, 2022</ix:nonNumeric> </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="margin-bottom:10pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjM2_90595e2b-a27e-487e-9cd5-c861ce1fdb25">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:10pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQ0_618091fb-d4db-4e66-b164-a61d3a536872">001-33307</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQw_9bfdb962-073c-48b9-83d1-5337de9323d8">RadNet, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.865%"><tr><td style="width:1.0%"></td><td style="width:26.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF8wLTAtMS0xLTE0Mjc5_13ed9f23-cb66-4cd2-946f-5bd41555f059">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF8wLTItMS0xLTE0Mjc5_fcebab3b-b2cb-44d8-978b-301eb46a860c">13-3326724</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:5pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF8zLTAtMS0xLTE0Mjc5_3eb791c7-cee7-4803-90e4-6e0c4e5b4a6b">1510 Cotner Avenue</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF80LTAtMS0xLTE0Mjc5_e75b0df8-87dc-4fd4-8851-95da0bcb8218">Los Angeles,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF80LTEtMS0xLTE0Mjc5_47786280-22ac-4286-9592-b2045c928664">California</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF80LTItMS0xLTE0Mjc5_9702910d-f12d-4f07-9211-11d2367032f4">90025</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQx_e9ef9563-578d-4b9e-9219-4777e0dbb2be">310</ix:nonNumeric>) <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjM3_d080afc7-3737-4d21-8443-9bbf09c87905">478-7808</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.166%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registered Exchange</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZjFjYjFhMmZiOWQxNDEyOWJjM2FhNGZhOWYxNjg5MDQvdGFibGVyYW5nZTpmMWNiMWEyZmI5ZDE0MTI5YmMzYWE0ZmE5ZjE2ODkwNF8xLTAtMS0xLTE0Mjc5_ef6e0ff1-3f90-4cf3-b8d7-47f8f5c097bb">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZjFjYjFhMmZiOWQxNDEyOWJjM2FhNGZhOWYxNjg5MDQvdGFibGVyYW5nZTpmMWNiMWEyZmI5ZDE0MTI5YmMzYWE0ZmE5ZjE2ODkwNF8xLTItMS0xLTE0Mjc5_cb439d47-7cdf-4463-959d-33adf3086960">RDNT</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZjFjYjFhMmZiOWQxNDEyOWJjM2FhNGZhOWYxNjg5MDQvdGFibGVyYW5nZTpmMWNiMWEyZmI5ZDE0MTI5YmMzYWE0ZmE5ZjE2ODkwNF8xLTQtMS0xLTE0Mjc5_521b21f6-b83e-4fce-8af9-0648973369d6">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjM4_44f8d900-d391-4e9c-8194-69bfd4742423">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;<ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQy_dc67fd7c-8039-47de-af81-4e8040d14a8e">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.218%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6MTk5ZDJhZDYwZmE1NGNkNjhhNmUyZGE2NjA0YmQ0MTgvdGFibGVyYW5nZToxOTlkMmFkNjBmYTU0Y2Q2OGE2ZTJkYTY2MDRiZDQxOF8wLTAtMS0xLTM1NDg0_a9264edf-e76f-4f95-928d-d89414c8b868">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6MTk5ZDJhZDYwZmE1NGNkNjhhNmUyZGE2NjA0YmQ0MTgvdGFibGVyYW5nZToxOTlkMmFkNjBmYTU0Y2Q2OGE2ZTJkYTY2MDRiZDQxOF8xLTMtMS0xLTE0Mjc5_2a55de5f-0a81-4657-bc63-7a5f12208fcb">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6MTk5ZDJhZDYwZmE1NGNkNjhhNmUyZGE2NjA0YmQ0MTgvdGFibGVyYW5nZToxOTlkMmFkNjBmYTU0Y2Q2OGE2ZTJkYTY2MDRiZDQxOF8yLTMtMS0xLTE0Mjc5_9c9b5df8-f51c-4a7e-a55f-ca8bec2b2a53">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#9744;</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQz_75d3fb24-99d6-4df7-8a68-9b3377e65c45">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding on May&#160;5, 2022 was <ix:nonFraction unitRef="shares" contextRef="ib54bc4806e7a4e68808598eddfb79202_I20220505" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjI2_3e140ec3-b7b1-4286-9f55-e0dda96c8a8c">56,219,473</ix:nonFraction> shares.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC.</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:91.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_10">PART I &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_10">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_13">ITEM 1. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_13">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_16">Condensed Consolidated Balance Sheets at March 31, 2022 and December 31, 2021 </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_16">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_19">Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2022 and 2021 </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_19">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">3</a></span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_25">Condensed Consolidated Statement of Stockholders' Equity for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_25">4</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_31">Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_31">5</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_34">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_34">7</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_58">ITEM 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_58">24</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_85">ITEM 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_85">38</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_88">ITEM 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_88">39</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_91">PART II &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_91">40</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_94">ITEM 1.&#160;&#160;Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_94">40</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_97">ITEM 1A.&#160;&#160;Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_100">40</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_100">ITEM 2.&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_103">40</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_103">ITEM 3.&#160;&#160;Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_103">40</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_106">ITEM 4.&#160;&#160;Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_106">40</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_109">ITEM 5.&#160;&#160;Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_109">40</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ITEM 6.&#160;&#160;Exhibits</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_112">41</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_115">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_115">42</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1 &#8211; Financial Statements</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNC0xLTEtMS0xNDI3OQ_03e9a56b-2d38-428b-b835-d1b8934404e9">70,713</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNC0zLTEtMS0xNDI3OQ_a0fecf5a-507c-4012-ac74-218bf017baa8">134,606</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNS0xLTEtMS0xNDI3OQ_5f8e22dd-8595-42c2-b854-3760b571c7b3">159,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNS0zLTEtMS0xNDI3OQ_d1ade471-fdf7-4c99-a307-2bfc816a9672">135,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Due from affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNi0xLTEtMS0xNDI3OQ_ed65408d-2044-477f-81f4-20a5a5c7a9ce">5,783</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNi0zLTEtMS0xNDI3OQ_89d81a46-2c5e-4f24-bc9f-1a8dca04003e">5,384</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNy0xLTEtMS0xNDI3OQ_b48689ea-ce72-4c96-8331-b699471ea67b">52,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNy0zLTEtMS0xNDI3OQ_2fd93870-99e3-4e5e-8c36-f1ada6204ad8">49,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets </span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfOS0xLTEtMS0xNDI3OQ_12b40bcf-63d1-4875-9128-7fe00a6635d6">288,696</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfOS0zLTEtMS0xNDI3OQ_a9b2c2e5-e286-47ff-9d87-901d47547475">324,264</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, net</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTEtMS0xLTEtMTQyNzk_1c81b476-68d7-487e-a54d-aa0782529433">488,958</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTEtMy0xLTEtMTQyNzk_e47c0d64-1a1e-4f18-b076-948e4b7ad450">484,247</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTItMS0xLTEtMTQyNzk_95ee0aa4-9f07-49e6-94bb-392897578ed0">595,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTItMy0xLTEtMTQyNzk_297aed39-129b-462d-bca1-fdd9b7f12430">584,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total property, equipment and right-of-use assets</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTMtMS0xLTEtMTQyNzk_b3094687-a0e9-42f7-ac3e-6d74e4495033">1,084,750</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTMtMy0xLTEtMTQyNzk_9e805ebe-af25-4d28-addb-584c1804ac4f">1,068,538</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTUtMS0xLTEtMTQyNzk_74e5f79d-93d4-427a-bd5c-5e76448cff59">570,188</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTUtMy0xLTEtMTQyNzk_1b996130-7eae-49b0-b753-5b31db4c6754">513,820</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTYtMS0xLTEtMTQyNzk_a0186e4b-4b94-4e4b-8e53-11300a4e8b14">99,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTYtMy0xLTEtMTQyNzk_af68411c-7b7a-471d-aab2-5e9b4eb6d8a3">56,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred financing costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTctMS0xLTEtMTQyNzk_c609c8ed-3831-4b52-9afd-dcf9346ec70e">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTctMy0xLTEtMTQyNzk_d9e82954-0621-456e-86ec-3b471f00ca7a">2,135</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Investment in joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTgtMS0xLTEtMTQyNzk_663d6e34-74cf-4fd9-a2e5-9a33046db9b7">44,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTgtMy0xLTEtMTQyNzk_92f60fc2-ffc0-443a-bb18-dadbc4410ade">42,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTktMS0xLTEtMTQyNzk_7e063da3-eeba-4fec-8b68-5ff98ec3dfee">12,800</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTktMy0xLTEtMTQyNzk_8ee2f20c-be46-4ea7-acbd-7c17eafe8319">14,853</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deposits and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:DepositsAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjAtMS0xLTEtMTQyNzk_8e894f1f-4d58-4517-a917-24923a110e5d">38,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:DepositsAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjAtMy0xLTEtMTQyNzk_84a845ab-74d9-4f68-b50a-73e47439fcf5">36,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjEtMS0xLTEtMTQyNzk_d09bf0b9-a12b-49c1-861e-c8107bc87293">2,141,521</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjEtMy0xLTEtMTQyNzk_12a8f3fa-5d51-4b6c-ae75-d4b7dc1be9f3">2,058,474</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accounts payable, accrued expenses and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjQtMS0xLTEtMTQyNzk_ba98cc97-cc9e-4f5b-8a0d-10b4abe50f22">276,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjQtMy0xLTEtMTQyNzk_c1260a90-f32b-46f6-812a-285f9b69f69e">263,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Due to affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjUtMS0xLTEtMTQyNzk_5843d51a-4988-4c69-861d-45d5e8dccde4">21,985</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjUtMy0xLTEtMTQyNzk_1354a784-83b1-4e04-b48c-45bd250992d8">23,530</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:DeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjYtMS0xLTEtMTQyNzk_ee3cf539-8068-4f65-9735-6e13a922932a">6,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:DeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjYtMy0xLTEtMTQyNzk_226344f7-0df6-4694-9766-7300a893e223">10,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Current operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjgtMS0xLTEtMTQyNzk_d494d2f0-f713-45a2-b7ad-14b4a4c21c8e">64,906</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjgtMy0xLTEtMTQyNzk_fe5bd60d-5563-436e-a44d-2cb43ef291b4">65,452</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Current portion of notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjktMS0xLTEtMTQyNzk_e58e43a0-8a7f-4232-bb60-c99fa28bab7a">11,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjktMy0xLTEtMTQyNzk_9c6c85f9-48a3-4dc2-9740-886c857be078">11,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzAtMS0xLTEtMTQyNzk_f1fecbbf-4267-4f6e-a814-7d9b7a14d848">381,298</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzAtMy0xLTEtMTQyNzk_71790eac-db68-4093-948e-68e19b498c04">374,784</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM LIABILITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Long-term operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzMtMS0xLTEtMTQyNzk_a398b9eb-c035-41f5-b026-2c71fdc49271">590,665</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzMtMy0xLTEtMTQyNzk_a8e4dc4f-3461-4635-8b41-9823ffd0c19d">577,675</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Notes payable, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzQtMS0xLTEtMTQyNzk_396057ec-2766-462a-9a11-64977effcca2">740,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzQtMy0xLTEtMTQyNzk_b442fdb0-06ef-4ed7-8072-eb969a9a42ff">743,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other non-current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzUtMS0xLTEtMTQyNzk_787d673d-a00b-4328-b067-bdb8e9c3f274">7,401</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzUtMy0xLTEtMTQyNzk_cda9a198-47f3-4ee2-87fc-75370ce5e28c">16,360</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzYtMS0xLTEtMTQyNzk_7a64c68b-188c-4c5d-ac69-716b9b84f91a">1,720,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzYtMy0xLTEtMTQyNzk_f57b8ae9-3210-4a2f-9522-f674a10eae15">1,712,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV8xOQ_406b5ec6-a5fa-4662-9db6-5353707806ea"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV8xOQ_f5b86d27-ada6-4313-bbd2-e349418e0650">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV8zMw_60c8d945-93eb-4f13-b146-cfd27f4e158d"><ix:nonFraction unitRef="shares" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV8zMw_a5c24e22-eee5-47a0-b895-f808cb069063">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV81NQ_6aed3357-15bb-42b5-9dea-48702acad63e"><ix:nonFraction unitRef="shares" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV81NQ_c840d738-fffa-4c4f-b65e-fa912992b08d">56,197,826</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV82Mg_b4daad65-dcee-408c-a46b-2c7d4e7f8c84"><ix:nonFraction unitRef="shares" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV82Mg_cb74376b-9d1f-4f5e-9c17-9e042e5bcf1b">53,548,227</ix:nonFraction></ix:nonFraction> shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMS0xLTEtMTQyNzk_1655081f-d7d2-4786-8f06-e54c65bffeeb">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMy0xLTEtMTQyNzk_6a16bccb-e12d-480e-9e84-8443e38b0c77">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Additional paid-in-capital</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzktMS0xLTEtMTQyNzk_36df3923-a6e4-4c35-8441-a32e1d1a19a3">409,863</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzktMy0xLTEtMTQyNzk_6f8b358b-f730-4b88-901c-fa5a9b49baeb">342,592</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDAtMS0xLTEtMTQyNzk_e3d731e9-f11d-46f3-a0ec-8d80684644af">20,761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDAtMy0xLTEtMTQyNzk_1e2a890a-218b-41ae-a5e1-c8f61d47f6b8">20,421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accumulated deficit</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDEtMS0xLTEtMTQyNzk_c30ab2bf-b0dc-42ce-a2ec-c6d5ba450d3b">90,260</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDEtMy0xLTEtMTQyNzk_52ce09c6-670f-4a88-9414-cbcd93561359">93,272</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total RadNet, Inc.'s stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDItMS0xLTEtMTQyNzk_e26fb8fb-8a92-44fb-b81e-f47663d5df96">298,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDItMy0xLTEtMTQyNzk_cddbc60f-0e6f-4938-9a46-018d20dd5ef1">228,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDMtMS0xLTEtMTQyNzk_3e8f584b-1186-44af-b02d-06dd560497c4">122,603</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDMtMy0xLTEtMTQyNzk_fe6e4428-50e0-4bfe-a281-fc274f1e4771">117,253</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDQtMS0xLTEtMTQyNzk_21ab7623-47de-41f6-bc0f-0e5c6b6a20f7">421,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDQtMy0xLTEtMTQyNzk_0e7351f7-faa0-4355-99e6-f411f31bbdd3">346,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and equity</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDUtMS0xLTEtMTQyNzk_6cbc27d5-b4b3-477f-96b1-820d5eefc125">2,141,521</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDUtMy0xLTEtMTQyNzk_0bb0a813-eab2-4e4b-a633-40a91b20fbe1">2,058,474</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_19"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"></td><td style="width:66.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service fee revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2605b786cda241819a617675d3a16552_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMy0xLTEtMS0xNDI3OQ_6743fe6b-048d-4cd1-a3f8-8f3ecc604091">303,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285d42025a684eea9d37aef0f1d14159_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMy0zLTEtMS0xNDI3OQ_d645c49f-02bb-4790-bb4a-cc9df9063779">279,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b4276af6d44d32ad20efcc3c5b920b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNC0xLTEtMS0xNDI3OQ_37dc0d0d-acf5-43ee-bd77-6a9c865b0a61">38,491</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edab43086bf43f4838cf141ce134cfb_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNC0zLTEtMS0xNDI3OQ_009a11f8-4b5a-430e-85b4-8323bb2ab8da">35,742</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNS0xLTEtMS0xNDI3OQ_ac548f13-56dc-460b-8e01-cf17d2e500cd">341,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNS0zLTEtMS0xNDI3OQ_00ec7af8-242b-4875-bc25-d3b074997de6">315,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNi0xLTEtMS0xNDI3OQ_e3f495e8-cfb0-435a-be95-f327db014c95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNi0zLTEtMS0xNDI3OQ_cbb56b6a-2bdb-46e0-8d07-174f97f89363">6,248</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfOC0xLTEtMS0xNDI3OQ_81deff8c-1abf-4516-a552-352cd4da0bfb">315,039</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfOC0zLTEtMS0xNDI3OQ_09286c08-f4ab-474c-9855-ebe27fdd74c2">282,280</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfOS0xLTEtMS0xNDI3OQ_42d0ff66-9be8-41e7-8aaf-7f0a100a6a3d">27,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfOS0zLTEtMS0xNDI3OQ_e4543706-6351-4d05-a2f3-60e82063dea3">22,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss (gain) on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTAtMS0xLTEtMTQyNzk_e1446f35-4eea-4462-ae93-ab43da60fbbd">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTAtMy0xLTEtMTQyNzk_6fa9ad07-60b0-4ade-8118-3612a8e2d3ea">1,307</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTEtMS0xLTEtMTQyNzk_5a39a621-42dd-43e2-84da-39602c94f8bc">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTEtMy0xLTEtMTQyNzk_388f3da8-d7aa-4341-bd92-553c81c7758c">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTItMS0xLTEtMTQyNzk_a4af68f0-8d59-487c-b9a3-90309ab3021b">343,486</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTItMy0xLTEtMTQyNzk_ecf5bc9f-9c54-4db9-bb96-9a9173267a6f">303,914</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(LOSS) INCOME  FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTMtMS0xLTEtMTQyNzk_e517b55f-add1-4ed0-a093-08cc5509902c">1,719</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTMtMy0xLTEtMTQyNzk_557688bd-8640-4c1f-a7c1-648148886675">17,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTYtMS0xLTEtMTQyNzk_d7bc2cb5-335c-43b5-8481-71f650967821">11,593</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTYtMy0xLTEtMTQyNzk_1220af2b-6712-4f92-a3c0-4150dc7c42aa">12,826</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTctMS0xLTEtMTQyNzk_60027d05-5d17-4fb4-8f97-4d8d529f9d62">2,517</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTctMy0xLTEtMTQyNzk_1b61da85-6d31-4d53-96f4-de29c5ce952a">2,285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTgtMS0xLTEtMTQyNzk_5a96f45d-7ede-495b-bd6e-1202d6087578">20,819</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTgtMy0xLTEtMTQyNzk_210fdfed-cf4f-4ec1-8c97-08c9fe314c05">11,245</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjAtMS0xLTEtMTQyNzk_69758f31-c104-4921-a6e7-72a395943cb6">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjAtMy0xLTEtMTQyNzk_c2518227-d584-4aab-a01d-98205c29a1ac">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjEtMS0xLTEtMTQyNzk_a7046e53-82bd-464a-833a-d54664350df5">11,578</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjEtMy0xLTEtMTQyNzk_8f91beed-58d1-4c02-80aa-3400e921ef89">498</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjItMS0xLTEtMTQyNzk_7f54abf8-af31-4e8e-b2ce-09bcc8f6352f">9,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjItMy0xLTEtMTQyNzk_f2087d16-579f-4720-af86-6914112a03bd">18,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Provision for income taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjMtMS0xLTEtMTQyNzk_505d17e4-0749-4523-817f-387fbaffd0f9">1,496</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjMtMy0xLTEtMTQyNzk_042ae99b-07ca-44e1-b67b-125df5f304dc">4,376</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjQtMS0xLTEtMTQyNzk_4198d68a-5739-4c32-8047-015112651df7">8,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjQtMy0xLTEtMTQyNzk_30dd6cb7-381b-46ad-b5eb-cc6f04377e05">13,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjUtMS0xLTEtMTQyNzk_c7be1cd9-a146-4f81-868a-e825f925decb">5,350</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjUtMy0xLTEtMTQyNzk_0e7cfd2b-9530-4585-bd55-8a769143708d">4,317</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjYtMS0xLTEtMTQyNzk_dfc6bc12-7356-4096-8729-fc2b86734a72">3,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjYtMy0xLTEtMTQyNzk_84900985-6ee1-4fd4-8400-ee11ea06fbd2">9,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjgtMS0xLTEtMTQyNzk_51891c3a-ef15-44d7-af4f-47cd50204dca">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjgtMy0xLTEtMTQyNzk_9086a115-d101-48d5-bbd0-2414c27dba9b">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzAtMS0xLTEtMTQyNzk_d183191b-7d1e-4258-b435-4c1a3eb03752">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzAtMy0xLTEtMTQyNzk_9c4d4aa2-81df-4676-a8f9-68c371721195">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WEIGHTED AVERAGE SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzItMS0xLTEtMTQyNzk_5c302461-30c3-4215-8445-b41f41e08a93">55,303,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzItMy0xLTEtMTQyNzk_f26ba4db-8e44-4a57-9983-93ff4b1338fd">51,951,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzMtMS0xLTEtMTQyNzk_a647d542-e9f6-4459-8d45-21e1f11bc4f9">56,362,193</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzMtMy0xLTEtMTQyNzk_36418344-aeae-400d-b55c-c5c5a011ab19">52,828,941</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"></td><td style="width:69.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.243%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfMi0xLTEtMS0xNDI3OQ_f494f733-354f-49f5-ad26-609dae716f8e">8,363</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfMi0zLTEtMS0xNDI3OQ_40697341-3c75-4c85-835c-c2e03157ac90">13,775</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfMy0xLTEtMS0xNDI3OQ_fc6aed5d-190d-48f2-949f-6518f864f68e">1,264</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfMy0zLTEtMS0xNDI3OQ_fd14780e-df3a-4606-9176-6df9c9c2825e">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNS0xLTEtMS0xNDI3OQ_1338fb7a-0043-4785-8114-68ab9925039f">923</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNS0zLTEtMS0xNDI3OQ_b92f90cf-6a43-4831-846d-f015e47cd26c">925</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNi0xLTEtMS0xNDI3OQ_77d4187b-7428-4390-a511-f6180a34fd71">8,022</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNi0zLTEtMS0xNDI3OQ_de5eed07-d878-4b48-a484-9c319f013928">14,688</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Less comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNy0xLTEtMS0xNDI3OQ_553f4fda-eed4-4a77-b182-dbf30e078b7e">5,350</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNy0zLTEtMS0xNDI3OQ_98a7a9d6-2b2a-4a42-85d7-6e63a4c2d45b">4,317</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME ATTRIBUTABLE TO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfOS0xLTEtMS0xNDI3OQ_cfcb3935-24d7-4a75-a9ba-7963304c9a13">2,672</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfOS0zLTEtMS0xNDI3OQ_2df7f3c5-ce22-4371-b838-3ce304dc4cd8">10,371</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in the Company&#8217;s consolidated stockholders' equity, including noncontrolling interest, during the three months ended March&#160;31, 2022 and March&#160;31, 2021.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.458%"><tr><td style="width:1.0%"></td><td style="width:28.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.454%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.888%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>&#160;Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Radnet, Inc.'s<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE - JANUARY 1, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6c326d52eb544be8bd9b419b21bf661_I20211231" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi0xLTEtMS0xNDI3OQ_d282360a-6e75-4921-8ccc-8c0bb8ce4cfa">53,548,227</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c326d52eb544be8bd9b419b21bf661_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi0zLTEtMS0xNDI3OQ_c90f0df3-e944-4bf9-9884-8b1fd18bc86c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a159e91d424561b526e4f4e0f77d49_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi01LTEtMS0xNDI3OQ_9129ddd9-36a3-4b47-82ab-31abe5bbea26">342,592</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0a062644b1a463b95d9488efe1f1e9d_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi03LTEtMS0xNDI3OQ_d7f2f55d-a778-42cc-a7a0-abb89f354d49">20,421</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9902151192a44beaa1c9350219e3f13_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi05LTEtMS0xNDI3OQ_41a3563a-2d23-4cbd-aedc-18efbeb82553">93,272</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb0ae88cb924707aa34148fe232e546_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi0xMS0xLTEtMTQyNzk_005f2163-0e87-43d3-bd09-0b308fbe253b">228,904</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i520ee3069e394d228388f671ea45af80_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi0xMy0xLTEtMTQyNzk_c06e5e98-aea9-49c0-a209-f1dd667b7ffe">117,253</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi0xNS0xLTEtMTQyNzk_e02e8966-5013-42ed-9772-840aa6ab6fb0">346,157</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53a301eed9394031a8f0503c15c07855_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNS0xLTEtMS0xNDI3OQ_e81eb2ca-1fff-4051-8fb0-8a23288c2c7b">530,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ca7e0851947420686d239632088b156_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNi0xLTEtMS0xNDI3OQ_abf74015-452b-4d89-a99c-9d965c97ea41">13,119</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9029d82f8c0a4ca992f906e0be3c5858_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNy01LTEtMS0xNDI3OQ_80bf79c5-2768-426d-97cb-f7db7cb6d943">10,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNy0xMS0xLTEtMTQyNzk_17826665-0334-4e52-9178-de9e770c3e22">10,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNy0xNS0xLTEtMTQyNzk_345f47bd-5c48-4eed-b7b1-359552e68d16">10,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with acquisitions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53a301eed9394031a8f0503c15c07855_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfOS0xLTEtMS0xNDI3OQ_4e3b63f6-d0ab-41b8-94d5-6393b986603b">2,106,292</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9029d82f8c0a4ca992f906e0be3c5858_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfOS01LTEtMS0xNDI3OQ_d1b5ab4d-7c89-4ddf-8267-e428676f1c95">56,470</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfOS0xMS0xLTEtMTQyNzk_7204145f-280a-4f18-8d9d-142b2e1bd816">56,470</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfOS0xNS0xLTEtMTQyNzk_d2e8e453-2b0c-474a-b8e5-1c55aff97357">56,470</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19dc048664d4c4fa328399747a3ccfa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTctNy0xLTEtMTQyNzk_1fa2f07e-0c4d-4e7e-8171-fe08a8953314">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTctMTEtMS0xLTE0Mjc5_2ea29e36-1946-4a80-9b98-da278a17bc8c">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTctMTUtMS0xLTE0Mjc5_a55a2e26-528f-477d-bbbb-13afd04378e2">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19dc048664d4c4fa328399747a3ccfa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTktNy0xLTEtMTQyNzk_19b85285-50bc-41a0-9c5a-0c75a617e057">923</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTktMTEtMS0xLTE0Mjc5_c63882f4-0ca9-4372-960a-8957f4ed4a06">923</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTktMTUtMS0xLTE0Mjc5_0772e1fa-91fb-40d3-b895-8eeac4a3c909">923</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19dc048664d4c4fa328399747a3ccfa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjAtNy0xLTEtMTQyNzk_e0b0550e-805d-4322-8479-e521a88c4c00">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4622b4997a4a4eccb0c0fb0915a887af_D20220101-20220331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjAtOS0xLTEtMTQyNzk_f9c2a6df-dfd7-4d22-8f39-886c8aa12034">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjAtMTUtMS0xLTE0Mjc5_ffa490cf-8db8-4cad-82ee-f049ed916c3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4622b4997a4a4eccb0c0fb0915a887af_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjEtOS0xLTEtMTQyNzk_74068177-f587-4970-96df-b4b5d29a134a">3,013</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjEtMTEtMS0xLTE0Mjc5_e457ecdc-cbc7-4d19-b421-273dc8cc7f4d">3,013</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e62681d3c4358b16ca1844ba3f0b1_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjEtMTMtMS0xLTE0Mjc5_dd33b432-5482-4f45-838b-dfd9f8571c09">5,350</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjEtMTUtMS0xLTE0Mjc5_7ed156ec-ee5f-4f8f-bf9a-8075e1d1a539">8,363</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE-MARCH 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb193f06c3a44c5a8335f469b106c368_I20220331" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItMS0xLTEtMTQyNzk_1430ebfb-3bda-4706-9387-954cac7012e9">56,197,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb193f06c3a44c5a8335f469b106c368_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItMy0xLTEtMTQyNzk_fe8b9f0a-1ea8-4ee9-b2ac-4ac119dc95d9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadec43eade70409e9d0da25233b1dfde_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItNS0xLTEtMTQyNzk_e40c116b-3fa2-4e07-9642-e3ef14eccb5d">409,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6075cb3a8ec8490d9a77109346158e64_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItNy0xLTEtMTQyNzk_8ee5b4b9-134c-4c98-bdf1-2e03abfc65bb">20,761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4832576a7844a8596613f578d05549d_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItOS0xLTEtMTQyNzk_5bc07254-00ab-4621-a076-a7b35f1b9c44">90,260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc7c8c1bcd0401d8a5c82be7e8fe00f_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItMTEtMS0xLTE0Mjc5_e89312e7-cdfe-4155-91eb-333696b18be8">298,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa990aa527e1441eb4aa259e7c4a4311_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItMTMtMS0xLTE0Mjc5_fd832291-e307-4267-8f14-570247adc050">122,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItMTUtMS0xLTE0Mjc5_809b44a0-277c-4374-bac9-5144ab079cb5">421,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE - JANUARY 1, 2021</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70baa850fe584a93b43499065527584c_I20201231" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtMS0xLTEtMTQyNzk_bbdea9ff-beaf-4cd4-be79-50dfec469014">51,640,537</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70baa850fe584a93b43499065527584c_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtMy0xLTEtMTQyNzk_82762a22-bede-4741-858a-441da11246e5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i068b30b1e9cb45efbe0395c727f3bb66_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtNS0xLTEtMTQyNzk_ea43e862-ddc6-4b02-b673-b93ad0904109">307,788</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia524ae0349d841c5bea7e971fafb1f2f_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtNy0xLTEtMTQyNzk_1b82e8f8-491c-4b59-81c3-ef9e520d6700">24,051</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3ea365926174da78fafa3edf281157f_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtOS0xLTEtMTQyNzk_e67e14fe-d8b0-45b1-8700-255209de9abe">117,999</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd41347893b42dda87f2f49f1d20d77_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtMTEtMS0xLTE0Mjc5_4b82b150-074f-4cef-86ba-f0d986284371">165,743</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i729694f595eb4900a9bbee1a57c1c865_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtMTMtMS0xLTE0Mjc5_6b6b339a-29e4-4d45-8b3a-8c96a1a66ac8">92,560</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80d5947f62c845b3b04f76fc1a749fe1_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtMTUtMS0xLTE0Mjc5_ae3659fc-d849-4797-b80b-c0f73d14d604">258,303</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i776431f5daf3445a96806322961098ce_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjYtMS0xLTEtMTQyNzk_29315a62-2929-40b9-bbbd-bf7346b22f36">699,825</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6c1a53cb7ec4f729af5315153b1f9ab_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjctMS0xLTEtMTQyNzk_63d5ff0c-0c24-4e6f-a70e-e55a264ac5ad">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07ad7db2a1a4923864a30fe3533a635_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjgtNS0xLTEtMTQyNzk_bee48d86-6136-4ebd-8618-f450451a9f7b">8,248</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjgtMTEtMS0xLTE0Mjc5_4324d120-3672-4104-b7e9-7e44b04c175f">8,248</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjgtMTUtMS0xLTE0Mjc5_a91f64d3-248d-4ed7-9f87-7bc89998266b">8,248</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of noncontorlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07ad7db2a1a4923864a30fe3533a635_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjktNS0xLTEtMTQyNzk_869a9500-ac74-4ae1-a8d1-a7f6b2767fa9">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjktMTEtMS0xLTE0Mjc5_ac005b2c-ca37-48f8-a074-3e67ffe9f262">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjktMTUtMS0xLTE0Mjc5_be0095e9-8833-4d30-baa2-e1796bce73d8">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions from noncontrolling partner</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3d203a14a9649c5b4159c9895f003d2_D20210101-20210331" decimals="-3" name="rdnt:ContributionsFromNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzMtMTMtMS0xLTE0Mjc5_93407a75-65e2-4db9-8038-69883e9e4cbf">123</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="rdnt:ContributionsFromNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzMtMTUtMS0xLTE0Mjc5_28e7dae7-0d26-47db-a817-9e824597595f">123</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c8654171884445c860af370f5bfea70_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzUtNy0xLTEtMTQyNzk_3c1a7c12-e2b7-4fd6-9fca-ca05d39960a1">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzUtMTEtMS0xLTE0Mjc5_ec56cb49-64a6-477f-bacf-eb8de0b328bc">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzUtMTUtMS0xLTE0Mjc5_a8c59d6a-ba61-4b37-b260-1af9675c90f2">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c8654171884445c860af370f5bfea70_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzctNy0xLTEtMTQyNzk_267cbd15-e3be-4752-9a2a-17f6511e556f">925</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzctMTEtMS0xLTE0Mjc5_215b9ad4-28eb-45f3-9f13-b1bfcfe65f30">925</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzctMTUtMS0xLTE0Mjc5_3812ed11-6ec3-4659-b8c8-ff4119934099">925</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a645db31d194b07afc404edff2224fc_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzktOS0xLTEtMTQyNzk_280d6c26-46c4-4578-903c-96d89dcae2ea">9,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzktMTEtMS0xLTE0Mjc5_b75fe1db-d372-4c99-8326-c1b95e2a7d0f">9,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3d203a14a9649c5b4159c9895f003d2_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzktMTMtMS0xLTE0Mjc5_05403efb-35a8-45f4-b08d-803dbb829e52">4,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzktMTUtMS0xLTE0Mjc5_0a669a43-5205-4642-b03f-26754f93afcf">13,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE-MARCH 31, 2021</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib15b4952b11a47fb9236321bd4319708_I20210331" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtMS0xLTEtMTQyNzk_d65396e3-a74f-4eb5-aa0c-a1858d75f392">52,340,856</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib15b4952b11a47fb9236321bd4319708_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtMy0xLTEtMTQyNzk_07df5d32-2516-40fc-957f-51bf9b27b9f4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4eb83abe1d4023b624f59e96214964_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtNS0xLTEtMTQyNzk_344ab2f2-2ecf-4e7f-9f4a-ee659578a87b">316,032</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9923e7aecddc4104b04852156ffa40cd_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtNy0xLTEtMTQyNzk_8fe3c3ba-edd8-4925-a42f-2ea59c5b5bd2">23,138</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i072529ea3a664abaa7cfed01aee70693_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtOS0xLTEtMTQyNzk_94b9555c-2004-4fdf-be69-b70d50267946">108,541</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08eccb87eff3426d8baf820a26ef8096_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtMTEtMS0xLTE0Mjc5_aad82afc-7d04-4547-a394-cdbd0e41a755">184,358</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87a8e19419ba4657b804a6671424a127_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtMTMtMS0xLTE0Mjc5_ef2cc74a-3303-40e0-972f-80919f13e982">97,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d4c12a55344278a60a16915110bed1_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtMTUtMS0xLTE0Mjc5_a5ee69cd-9e25-40c9-93ac-8e746496c1db">281,358</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_31"></div><hr style="page-break-after:always"/><div style="min-height:24.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMy0xLTEtMS0xNDI3OQ_d87ed036-1462-4c1f-9f6e-9c7f3bcf1e44">8,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMy0zLTEtMS0xNDI3OQ_5c166588-1f01-4e52-97a4-45f2479997a2">13,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNS0xLTEtMS0xNDI3OQ_bd2344a9-9c4e-4656-a402-266a9e8b2be6">27,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNS0zLTEtMS0xNDI3OQ_a5d2596e-2242-4106-813b-0625aeb68e75">22,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNi0xLTEtMS0xNDI3OQ_a1275876-eb0b-4c71-80c4-5554612b7b44">16,802</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNi0zLTEtMS0xNDI3OQ_ab19276b-b9b1-450c-b49c-b6cb28f2195a">17,863</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures, net of dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNy0xLTEtMS0xNDI3OQ_7d2ea010-0071-4f58-8cb1-cf1260f92053">2,517</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNy0zLTEtMS0xNDI3OQ_2499aee2-dec5-4106-8c61-aee353dcd123">2,285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of deferred financing costs and loan discount</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfOS0xLTEtMS0xNDI3OQ_b8520c2d-b10b-430c-a6ce-660fa755d7be">648</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfOS0zLTEtMS0xNDI3OQ_9837c0a3-942d-4501-b324-212fd207476e">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTAtMS0xLTEtMTQyNzk_9154711d-e368-4b8b-b08a-783bf4163474">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTAtMy0xLTEtMTQyNzk_51d1d622-1dcc-4382-ad91-fc1fef4f7a38">1,307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTItMS0xLTEtMTQyNzk_2bef196b-e1f3-42d0-89a8-8b6ae2e43c90">923</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTItMy0xLTEtMTQyNzk_27f2a177-5501-4782-8a58-f9aacd065012">925</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTMtMS0xLTEtMTQyNzk_c3bdc80c-1cd1-48e4-b62c-db5aacd7a432">20,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTMtMy0xLTEtMTQyNzk_5f4294e0-0aae-4ae2-993a-b3f9c1d4f10c">11,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTQtMS0xLTEtMTQyNzk_6d4e0d0d-bc1d-4ada-bbd1-aebb0eb7ceb2">11,102</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTQtMy0xLTEtMTQyNzk_d173fa20-f014-43dd-b10f-24fa44d77d7c">8,248</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTYtMS0xLTEtMTQyNzk_84e52d26-91e1-4e7b-9502-c7af4ed9004a">501</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTYtMy0xLTEtMTQyNzk_c85e17fc-1015-42cc-a533-05c21d053102">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</span></div></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTgtMS0xLTEtMTQyNzk_b6eefeaa-bdd2-4287-b2b5-002830ad1235">23,904</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTgtMy0xLTEtMTQyNzk_17b20653-44c2-4e74-a60f-baeb20a607bc">17,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTktMS0xLTEtMTQyNzk_baf7eb8f-d54a-494e-ad78-aa486f59569b">4,065</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTktMy0xLTEtMTQyNzk_223a9fd1-2459-4bdf-9afb-8e812c617f93">4,308</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjAtMS0xLTEtMTQyNzk_ce3e3221-750e-47aa-a7bf-69fc189d406f">1,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjAtMy0xLTEtMTQyNzk_fb025881-487a-44aa-8242-5b3779f9b6f2">3,507</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjEtMS0xLTEtMTQyNzk_a0e83d02-0f79-4a11-8d0c-1a6df76b0ebf">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjEtMy0xLTEtMTQyNzk_7d30f70b-ff0c-4ddd-a47b-06d8b9af90f2">3,133</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjItMS0xLTEtMTQyNzk_6650a127-fe98-4e50-85ab-00f184ffe8dd">15,859</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjItMy0xLTEtMTQyNzk_773b4927-c377-4ccd-a4fd-7bd8365cf7e2">18,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjMtMS0xLTEtMTQyNzk_7acccd4d-a190-4d67-bedd-814994af5ff7">4,519</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjMtMy0xLTEtMTQyNzk_9d3a7dd6-059e-42b1-88d3-843170743a6a">1,416</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjQtMS0xLTEtMTQyNzk_a0caafa9-b75d-4d7b-b7c1-2c79e9896af7">7,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjQtMy0xLTEtMTQyNzk_5776dc39-e1b4-48d4-8281-bc9e4bff87d8">17,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by operating activities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjUtMS0xLTEtMTQyNzk_9e84368a-360d-4dbe-be42-f7e791fbec7e">901</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjUtMy0xLTEtMTQyNzk_282cdc41-9981-41cb-a7dc-78f7f73abcd2">28,084</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of imaging centers and other acquisitions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjctMS0xLTEtMTQyNzk_1fa060a1-da8c-4bd6-a385-adc0fac401ba">25,123</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjctMy0xLTEtMTQyNzk_9f7ea63b-e916-40f4-9d39-d3842fa0e46b">57,075</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjktMS0xLTEtMTQyNzk_eac8edf2-a640-4a91-b2f8-4bc55b34fee9">36,558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjktMy0xLTEtMTQyNzk_49a7f404-9b26-4ede-85e8-6e6948043d5a">30,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzAtMS0xLTEtMTQyNzk_437b332b-9c83-40f3-b0d9-3dd9df343650">117</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzAtMy0xLTEtMTQyNzk_d0a11c5f-a6fe-40a3-a3af-457f29133aee">151</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzQtMS0xLTEtMTQyNzk_7d238300-a369-4169-ad7a-d852b83a0c23">61,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzQtMy0xLTEtMTQyNzk_d18c53a9-dc89-4dc2-86b1-a94a89264438">87,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal payments on notes and leases payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzYtMS0xLTEtMTQyNzk_3b582842-f79b-4e34-906e-2d694798c31d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzYtMy0xLTEtMTQyNzk_bdb7b5ab-4062-431c-b79b-7740708be779">827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on term loan debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzctMS0xLTEtMTQyNzk_d1258ecc-d835-40df-856a-6457d6fdf9bf">3,313</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzctMy0xLTEtMTQyNzk_bbfebf3f-24ba-47a6-b1e5-dcf28de341fb">10,824</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDUtMS0xLTEtMTQyNzk_e850853e-0805-4bbd-bbed-ee73713edaf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDUtMy0xLTEtMTQyNzk_cd43c40b-333a-467a-80c2-1c221174397e">87,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on revolving credit facility</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDYtMS0xLTEtMTQyNzk_75d3a3c1-0724-4b7d-8016-233b1b612bef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDYtMy0xLTEtMTQyNzk_c493f145-afb7-4b95-9afa-624f81531b57">87,100</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDgtMS0xLTEtMTQyNzk_dcb13be8-65b8-4362-ba51-419d7db3da80">3,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDgtMy0xLTEtMTQyNzk_c71dc11e-ad26-4415-90cd-e0ae14858769">11,651</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EFFECT OF EXCHANGE RATE CHANGES ON CASH</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDktMS0xLTEtMTQyNzk_8bd20e14-8179-4baf-bd76-198278aba2c5">83</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDktMy0xLTEtMTQyNzk_b31e3a15-97fe-4813-bdde-16ea4b4986d7">12</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET DECREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTAtMS0xLTEtMTQyNzk_67821609-f967-4f8a-8f2e-6c704f88c9f7">63,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTAtMy0xLTEtMTQyNzk_f3934019-910b-4211-b1c3-5043cfea88da">70,927</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTEtMS0xLTEtMTQyNzk_c4dd6149-7719-4712-bbf4-27260f72e3ca">134,606</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80d5947f62c845b3b04f76fc1a749fe1_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTEtMy0xLTEtMTQyNzk_0a3a0a4a-1764-42f6-a58c-b3fb3b33868b">102,018</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTItMS0xLTEtMTQyNzk_2d2c6a76-bf1f-41e0-9365-62d28b1c6e30">70,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d4c12a55344278a60a16915110bed1_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTItMy0xLTEtMTQyNzk_6b7112ff-6aaf-4405-9be8-cf344f813440">31,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTUtMS0xLTEtMTQyNzk_d3ae0ed8-5bab-40de-8385-5a1707725cbc">7,448</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTUtMy0xLTEtMTQyNzk_882bfe6f-df3f-4608-8cea-3f7923631d9a">8,267</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTYtMS0xLTEtMTQyNzk_89a3b5f7-06c6-4a4b-aa9f-b572dec6049d">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTYtMy0xLTEtMTQyNzk_ed52621b-0cf2-422e-a8f6-7234d2d523c2">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:24.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Schedule of Non-Cash Investing and Financing Activities</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired equipment and certain leasehold improvements for approximately $<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfNDMz_d8aa1727-b6b6-4d2d-a428-bc6a9f139a86">42.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfNDQw_344e5ea3-9aaa-435e-ad06-df7588073f15">28.8</ix:nonFraction> million during the three months ended March&#160;31, 2022 and 2021, respectively, which were not paid for as of March&#160;31, 2022 and 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> respectively. The offsetting amounts due were recorded in our condensed consolidated balance sheet under accounts payable, accrued expenses and other.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="i193b2936e56f4e0cbc28405f53112fa5_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTcwNQ_7ad48ca9-997f-49c2-8163-a5f011bc54e9">1,141,234</ix:nonFraction> shares of our common stock to complete our purchase of Aidence Holding B.V..The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTcyMQ_4f7cd3bb-9839-4fbf-bb7f-57b35cb57672">30.6</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTc1Ng_bfff0d9c-a21f-4980-85c6-e2e8e2e627c2">965,058</ix:nonFraction> shares to complete our purchase of Quantib B.V..  The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTc0Mw_4d7653b7-cffb-4a62-9436-184d809cfdff">25.9</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, partnership agreement with Simi Valley Hospital and Health Services ("Simi Adventist").  Of the total combined assets of $<ix:nonFraction unitRef="usd" contextRef="i92e430343aa64146a7eda3b1524bc877_I20210101" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTExMw_aa213311-deed-4bce-9879-23de8fadc707">0.4</ix:nonFraction> million, RadNet transferred $<ix:nonFraction unitRef="usd" contextRef="ie4b3b1411401444f9e1598514c6e4f34_D20210101-20210101" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTEzNw_f27a8639-fef3-430f-b1d7-4526ebf96b40">0.3</ix:nonFraction> million and Simi Adventist contributed the remaining $<ix:nonFraction unitRef="usd" contextRef="i10368330403342cab4b72f7c8a363d0b_I20210101" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTE4Ng_5030f077-ed34-4fbe-b803-3408519a6811">0.1</ix:nonFraction> million.</span></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1 &#8211; <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfODk2NQ_9aae7568-d124-4a74-9501-d3a7d4929cef" continuedAt="ica5ccee3a75e42adb59afa542c35fe17" escape="true">NATURE OF BUSINESS AND BASIS OF PRESENTATION</ix:nonNumeric></span></div><ix:continuation id="ica5ccee3a75e42adb59afa542c35fe17" continuedAt="i4236d3c5a4de422ea3750134a99a3212"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At March&#160;31, 2022, we operated directly or indirectly through joint ventures with hospitals, <ix:nonFraction unitRef="center" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="INF" name="rdnt:NumberOfCenters" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfMTA5OTUxMTY1MzY5Nw_2c5cb528-6c18-46e4-933a-d6220dfb2acb">351</ix:nonFraction> centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise <ix:nonFraction unitRef="segment" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfMTA5OTUxMTY1ODk2OQ_86ca50c9-50c9-4c0f-9775-d5c96b792a26">two</ix:nonFraction> segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group ("the Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDc1Mw_acb791df-aea7-4d27-a653-7b5969e7a393">45.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDc2MA_8a2d674c-7b38-4233-bfe3-0e25afbb78d9">46.1</ix:nonFraction> million of revenue, net of management services fees to RadNet, for the three months ended March&#160;31, 2022 and 2021, respectively and $<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDg3Mw_11d29d63-8452-4262-908d-2d68e73abe1d">45.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDg4MA_3556c250-16eb-4ae8-b240-59f40f6eec95">46.1</ix:nonFraction> million of operating expenses for the three months ended March&#160;31, 2022 and 2021, respectively.  RadNet recognized $<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDk3Ng_20ae9ffa-13cb-4a55-b89a-878420856273">191.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDk4Mw_9caeda5e-6a7e-4b33-a726-2d285a4aee73">179.0</ix:nonFraction> million of total billed net service fee revenue for the three months ended March&#160;31, 2022, and 2021, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying condensed consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our condensed consolidated balance sheets at March&#160;31, 2022 and December&#160;31, 2021, we have included approximately $<ix:nonFraction unitRef="usd" contextRef="i408288df014b467c9d35d6c84ed0afd4_I20220331" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNTg5MQ_d003cb0a-15d9-4220-94fa-ab680e712fae">100.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia4121846437d46c897233bae9c9a6bbd_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNTg5OA_981199bc-3b2c-483d-bcfe-db39b06e26e9">89.2</ix:nonFraction> million, respectively, of accounts receivable and approximately $<ix:nonFraction unitRef="usd" contextRef="i408288df014b467c9d35d6c84ed0afd4_I20220331" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNTk1Nw_2bbcc8af-526c-477d-aa01-b220a1a9de0a">16.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia4121846437d46c897233bae9c9a6bbd_I20211231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNTk2NA_fbb92c45-fe04-401a-8926-bb138b3a6857">14.4</ix:nonFraction> million of accounts payable and accrued liabilities related to the Group, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i4236d3c5a4de422ea3750134a99a3212"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also own a <ix:nonFraction unitRef="number" contextRef="ibe76a6a063624942b6870c14878eb85b_I20220331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNjMzOQ_b88f2ec1-2ed1-4fa8-a3f0-55e2621feaa6">49</ix:nonFraction>% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender, LLC is dependent on RadNet to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $<ix:nonFraction unitRef="usd" contextRef="ibe76a6a063624942b6870c14878eb85b_I20220331" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfMTA5OTUxMTY1NTczNg_8005e086-0841-48a7-aeb4-e4d73fe429c5">3.9</ix:nonFraction>&#160;million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $<ix:nonFraction unitRef="usd" contextRef="i36c0e21c63724ab3a7cb8109c29fb186_D20220101-20220331" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfMTA5OTUxMTY1NTk0Mw_28694ba1-077f-4a8e-b2f5-8a6b89fc0e09">0.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i0f9c76414c854366adacd1025313a311_D20210101-20210331" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfMTA5OTUxMTY1NTkzNQ_93bcac4f-c20c-4116-bc2c-13fc42841f37">0.6</ix:nonFraction>&#160;million for the three months ended March 31, 2022, and March&#160;31, 2021, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended March&#160;31, 2022 and 2021 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December&#160;31, 2021.</span></div></ix:continuation><div id="icf50c354d3d14f9eaeb683bc15ad4328_40"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyODQ_fc9303c6-0166-40f1-a837-d93ef97344b3" continuedAt="ie80a3a65159f4bcd84f98056e946f642" escape="true">SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="ie80a3a65159f4bcd84f98056e946f642" continuedAt="if0a59e4c522a41e9b77f647e0713813f"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period covered in this report, there have been no material changes to the significant accounting policies we use and have explained, in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2021. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2021.</span></div><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNTc_a3203be2-7978-444c-bb11-2e98276bc707" continuedAt="i4f6dbade1cb946aea817c198a2f7154d" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="if0a59e4c522a41e9b77f647e0713813f" continuedAt="i8df1114b5a4f4f2aa016c2c9e837adde"><ix:continuation id="i4f6dbade1cb946aea817c198a2f7154d"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div></ix:continuation><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyMzM_d3eec6d9-cdb3-4a2a-b621-83dc101c3726" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenues during the three months ended March&#160;31, 2022 and 2021 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.707%"><tr><td style="width:1.0%"></td><td style="width:65.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.781%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0814f8295094f73a07b17a0ea048a22_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMi0xLTEtMS0xNDI3OQ_0a941d2b-a4ec-48d8-84e7-99cce3162584">188,465</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18b633eea03421b8f0beb791427de6a_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMi0zLTEtMS0xNDI3OQ_033fb4fa-c7b3-4d0f-8eda-741669f3a38d">182,096</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f90bdc631743c984922bdc1021a382_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMy0xLTEtMS0xNDI3OQ_66517092-21d7-44c6-a020-791cc4fee9e6">70,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a26be7fa427465ea07552ca86911792_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMy0zLTEtMS0xNDI3OQ_89f8050d-740b-4a0a-9cc8-dd5d02096fe0">63,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bd4c2145a8a4cd3863fd3617fbfa90e_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNC0xLTEtMS0xNDI3OQ_1f41d90a-d59a-4d54-b1bd-d9ea5cea9a10">9,087</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5620bbf4e4f84b4c910f4cc3a6fd3e4b_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNC0zLTEtMS0xNDI3OQ_d6d31753-6d00-4e74-a4bc-11419e861a1f">8,451</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71163553a4f410787a124d8d66b0e24_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNS0xLTEtMS0xNDI3OQ_5d19766c-e606-475b-be83-02b72885e9ed">12,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id872fda809f94d66911bf9bed7f149bc_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNS0zLTEtMS0xNDI3OQ_d75277b9-832c-471a-9085-b67731f835ff">10,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf803a00a874891b5809498d753bd6c_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNi0xLTEtMS0xNDI3OQ_7a0d7f3d-2541-4aea-8da6-d51642e87ae7">7,123</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d49bb958ff4b4c812a88416ba02fa6_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNi0zLTEtMS0xNDI3OQ_b489e7f0-8dde-4ad3-a0d6-e0d269bbad1a">4,775</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41646490802644a5945209bcc69d3f40_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNy0xLTEtMS0xNDI3OQ_70e7a744-9174-4203-b659-245b95689d59">5,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie16c2fada5f146a28cfdc71179dea43e_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNy0zLTEtMS0xNDI3OQ_167230ca-8fea-424c-a587-f31dcdf6aa92">5,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ebdad869674354bf27b7a86e43d9e3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOC0xLTEtMS0zODIxMA_ef45050c-3a83-4dfa-b883-d0aef15e9d03">3,399</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38a0f605d3e4c68b25430e65285e3e7_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOC0zLTEtMS0zODIyMg_b1f7049f-49cd-4456-b93d-d88c78bdbeb8">2,426</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6e867081801442288b3623055f9b0d6_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOC0xLTEtMS0xNDI3OQ_c9bea4c0-3197-49d6-b439-4a9d6604bbcb">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i041ea1457ed044bcaa322ae1adc5cf1d_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOC0zLTEtMS0xNDI3OQ_0487221b-5567-4225-8cc0-a204033a88f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97333ecfd0244f90905767929fe29b00_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOS0xLTEtMS0xNDI3OQ_d2523360-4afb-4b27-a188-248c61dd3247">5,647</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad6312f903a74fa5a463cec7c3aeeef9_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOS0zLTEtMS0xNDI3OQ_675891cb-ddf9-4ccf-a3eb-03580b918f54">2,622</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2605b786cda241819a617675d3a16552_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTAtMS0xLTEtMTQyNzk_f4133d0b-a9de-4732-8ad3-24ebf5461f6c">303,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285d42025a684eea9d37aef0f1d14159_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTAtMy0xLTEtMTQyNzk_41963681-e7b5-4979-bd29-3fa4417a7469">279,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b4276af6d44d32ad20efcc3c5b920b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTEtMS0xLTEtMTQyNzk_4f96f6e0-5832-48b8-ae95-066852efba81">38,491</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edab43086bf43f4838cf141ce134cfb_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTEtMy0xLTEtMTQyNzk_9bed5862-bc99-475e-a5cc-9f8ea1ab4d94">35,742</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTItMS0xLTEtMTQyNzk_fa9b569f-8750-4f86-8ec1-ae9270e93f63">341,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTItMy0xLTEtMTQyNzk_42ec45f4-78b4-402f-97e9-9f75b18c9901">315,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Beginning in the second quarter of 2020 and through the three months ended March 31, 2022, we received funding from the various programs established by the CARES Act as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$<ix:nonFraction unitRef="usd" contextRef="ifb6fe52c39e2437d8016fabb3cae733e_D20200101-20220331" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NjEyNg_0201c080-06ea-4568-aa52-b07cad6b1f71">39.6</ix:nonFraction> million total of accelerated Medicare payments received, $<ix:nonFraction unitRef="usd" contextRef="if3550ac82c3f40c19d6f03a23e217852_D20200101-20201231" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NzYyMQ_44f14ea1-2776-49c3-8795-d6bcaf96b384">39.5</ix:nonFraction> million for the twelve months ended December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i8b6de56811c743baa555eba8f903a54d_D20210101-20211231" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NzYyOA_ba05c87a-db1d-4273-8ac9-126e33b57582">0.1</ix:nonFraction> million for the twelve months ended December&#160;31, 2021.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$<ix:nonFraction unitRef="usd" contextRef="i75d923098e5d4a0ba8b3f7ac2c2de141_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NzI4Ng_61744820-b715-479b-bbc0-eb5cb3fcab78">4.0</ix:nonFraction> million from the Paycheck Protection Program through the twelve months ended December 31, 2020.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$<ix:nonFraction unitRef="usd" contextRef="ie82ee386e6eb4838b2bc73fbbed35685_D20200101-20211231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODA4Ng_aeca735b-552a-4a89-bec1-870d70cc479c">35.4</ix:nonFraction> million total Provider Relief Funding, $<ix:nonFraction unitRef="usd" contextRef="if3550ac82c3f40c19d6f03a23e217852_D20200101-20201231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODA5MA_ed5ea287-5c85-4e71-8dd0-a8bcc21b34fd">26.3</ix:nonFraction> million received for the twelve months ended December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i8b6de56811c743baa555eba8f903a54d_D20210101-20211231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODA5NA_2b45bde9-e4fe-4329-89d6-02a502d3b4ff">9.1</ix:nonFraction> million received for the twelve months ended December 31, 2021, with $<ix:nonFraction unitRef="usd" contextRef="i3be9b88ce86c4744bf9e653fbfd94c90_D20210101-20210331" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODMwMQ_85110032-3a0d-43fd-b577-44a71f0ed49d">6.2</ix:nonFraction> million of it received during the three months ended March 31, 2021.  <ix:nonFraction unitRef="usd" contextRef="if7a4a64a35034275b1c621fed996e4d6_D20220101-20220331" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODM5MA_8069aabc-1410-432b-859c-ed54cc93d3ef">No</ix:nonFraction> Provider Relief Funding was received for the three months ended March 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accelerated Medicare and Blue Shield payments were recorded to Deferred Revenue in our consolidated balance sheet and are being applied to revenue as services are performed beginning in 2021. Through the three months ended March 31, 2022, $<ix:nonFraction unitRef="usd" contextRef="if7a4a64a35034275b1c621fed996e4d6_D20220101-20220331" decimals="-5" name="rdnt:RepaymentOfAdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODE4Mw_53b88f4c-85cb-4027-9666-8dd39492cb01">36.0</ix:nonFraction> million of the accelerated Medicare payments has been applied to revenue. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The $<ix:nonFraction unitRef="usd" contextRef="i75d923098e5d4a0ba8b3f7ac2c2de141_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NzI5Mg_61744820-b715-479b-bbc0-eb5cb3fcab78">4.0</ix:nonFraction> million secured from the Paycheck Protection Program was accounted for as debt and in December 2020 we met the eligibility requirements under the government guidelines for forgiveness and the loans were written off to gain on extinguishment of debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Provider Relief Funding from 2021 is displayed as such on our condensed consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The CARES Act also provides for the deferral of the employer-paid portion of the social security payroll tax with 50% due by December 31, 2021 and 50% due December 31, 2022. We elected to defer $<ix:nonFraction unitRef="usd" contextRef="i942d9cebffbb4273877f3ac67a45462f_I20201231" decimals="-5" name="rdnt:SocialSecurityTaxEmployerDeferralCARESAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NTAxMA_fc18eaae-262c-4d3c-8e89-48a62b075fa1">16.3</ix:nonFraction> million of this tax through December 31, 2020. Additionally, The CARES Act provided a refundable employer tax credit equal to <ix:nonFraction unitRef="number" contextRef="i942d9cebffbb4273877f3ac67a45462f_I20201231" decimals="INF" name="rdnt:CaresActRefundableClaimPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NTAyMg_e9e27ac8-846c-4b88-819c-3548edbc5c5b">50</ix:nonFraction>% of qualified wages, including </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="i8df1114b5a4f4f2aa016c2c9e837adde" continuedAt="id7325335182142dfa19d63a9f7f5ecaa"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">certain health insurance costs, that can be used to offset payroll tax liabilities.  In 2021 we qualified for a portion of the credit and recorded a benefit of $<ix:nonFraction unitRef="usd" contextRef="i8b6de56811c743baa555eba8f903a54d_D20210101-20211231" decimals="-5" name="rdnt:IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NTAyNg_54b79f1e-a8df-4a1c-996e-0856c554a176">7.7</ix:nonFraction>&#160;million through a reduction of payroll tax expense.  Our remaining deferred tax liability balance of approximately $<ix:nonFraction unitRef="usd" contextRef="i9b445489971a44ef8c84f8ed64c4e83e_I20220331" decimals="-5" name="rdnt:SocialSecurityTaxEmployerDeferralCARESAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NTAzMw_e19651b4-4aae-4e3b-a61c-c43d385f2807">8.1</ix:nonFraction>&#160;million at March 31, 2022, will be paid by December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNTA_ccb424a3-fc47-4a8a-91d0-f50ec8440ea5" continuedAt="i9776e14798de474788837619f388e20a" escape="true">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9776e14798de474788837619f388e20a" continuedAt="i52223c0a0d524c19839129c3266de34a">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. </ix:continuation> Amounts remaining to be collected on these agreement were $<ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-5" name="rdnt:ContractsReceivableFactoringReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfNzM3Ng_c7b5d5b4-166a-4855-8d66-91f6771ec30b">17.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-5" name="rdnt:ContractsReceivableFactoringReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfNzM4Mw_967314e3-eeb1-4586-94e8-c13e280c2986">17.7</ix:nonFraction> million at March&#160;31, 2022 and December&#160;31, 2021, respectively. <ix:continuation id="i52223c0a0d524c19839129c3266de34a">We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:DeferredChargesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyODU_673ed42c-335b-42bc-9807-20561f9aa404" escape="true">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method.</ix:nonNumeric> Deferred financing costs, net of accumulated amortization, were $<ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfNzkwMQ_865cac27-5cc8-498c-aa84-79c105daaa66">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfNzkwOA_b94b68c1-ad72-40b8-a511-b7704b0f9f2f">2.1</ix:nonFraction> million, as of March&#160;31, 2022 and December&#160;31, 2021, respectively and related to our Barclays Revolving Credit Facility.  See Note 5, Credit Facilities and Notes Payable for more information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNjQ_cab837e8-d9d9-4668-a404-9d6534186c3d" escape="true">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from <ix:nonNumeric contextRef="i5ee8582ac6274cbd9efd095c7d1133b3_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfODM0MA_1c06b7a1-2db4-48a6-9e99-8f6a28fd2b95">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i12c3a8c867b34ac68810453b838a2512_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfODM0Ng_6cd57b06-b606-4936-8490-9b754820923e">15</ix:nonNumeric> years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from <ix:nonNumeric contextRef="ibe80e0841a2748468587fe41fa4e816d_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfODQ2NQ_129bf4f3-ec0e-42d3-b185-e7b1210379b5">3</ix:nonNumeric> to <ix:nonNumeric contextRef="id6c679f4cdfd406189d36613f3477385_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfODQ3MQ_531f501f-8bb8-4d6f-9a7d-39a116b787b1">15</ix:nonNumeric> years. Maintenance and repairs are charged to expense as incurred.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyMzc_a84599c4-cb14-40b9-8a5b-64d9d53843b1" escape="true">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyMzQ_0afb67aa-cfc2-412d-98bf-56c4496b3c64" continuedAt="idd3fb28f22354129a2077fb3b0bf81d8" escape="true">GOODWILL AND INDEFINITE LIVED INTANGIBLES</ix:nonNumeric> - Goodwill at March&#160;31, 2022 totaled $<ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfOTY4Mw_1c82d49b-6931-4b3f-b443-3332e7c09a32">570.2</ix:nonFraction> million.  Indefinite lived intangible assets at March&#160;31, 2022 were $<ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfOTczNA_1fb3157a-4512-4ccb-b006-564865b277b6">13.2</ix:nonFraction> million.  <ix:continuation id="idd3fb28f22354129a2077fb3b0bf81d8">Goodwill and Indefinite Lived Intangibles are recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2021, noting no impairment.  We considered the current and expected future economic and market conditions surrounding COVID-19 pandemic and did not identify an indication of goodwill impairment being more likely than not through March&#160;31, 2022</ix:continuation>.  <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNzg_f2aeeeb3-33df-4361-925f-54089f5ed45b" continuedAt="id3be65e356d0431681d0cfccb4adb694" escape="true">Activity in goodwill for the three months ended March&#160;31, 2022 is provided below (in thousands):</ix:nonNumeric></span></div><ix:continuation id="id3be65e356d0431681d0cfccb4adb694"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmI3OTc1ZTNlMGFkYTQxYjY5NDdjMDA5Y2Y2ZDFkYmMzL3RhYmxlcmFuZ2U6Yjc5NzVlM2UwYWRhNDFiNjk0N2MwMDljZjZkMWRiYzNfMC0xLTEtMS0xNDI3OQ_34917ab6-5ae8-4dd1-a9fb-accc9f0fdcdb">513,820</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia604fcc12d02444abd767ce04feff86e_D20220101-20220331" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmI3OTc1ZTNlMGFkYTQxYjY5NDdjMDA5Y2Y2ZDFkYmMzL3RhYmxlcmFuZ2U6Yjc5NzVlM2UwYWRhNDFiNjk0N2MwMDljZjZkMWRiYzNfMS0xLTEtMS0xNDI3OQ_bcae721e-5ee9-490f-adf0-d440565c6aa4">57,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmI3OTc1ZTNlMGFkYTQxYjY5NDdjMDA5Y2Y2ZDFkYmMzL3RhYmxlcmFuZ2U6Yjc5NzVlM2UwYWRhNDFiNjk0N2MwMDljZjZkMWRiYzNfMi0xLTEtMS0xNDI3OQ_1196e1e8-45d7-4755-8187-329cd1a95110">296</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmI3OTc1ZTNlMGFkYTQxYjY5NDdjMDA5Y2Y2ZDFkYmMzL3RhYmxlcmFuZ2U6Yjc5NzVlM2UwYWRhNDFiNjk0N2MwMDljZjZkMWRiYzNfMy0xLTEtMS0xNDI3OQ_eefa6612-2c13-4a81-b38f-c1229223affa">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmI3OTc1ZTNlMGFkYTQxYjY5NDdjMDA5Y2Y2ZDFkYmMzL3RhYmxlcmFuZ2U6Yjc5NzVlM2UwYWRhNDFiNjk0N2MwMDljZjZkMWRiYzNfMTQtMS0xLTEtMTQyNzk_3ad58288-c19e-422d-92e1-b71ab89760ae">570,188</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill balances at March 31, 2022 reflect additional goodwill arising from deferred tax liabilities recorded on our acquisitions of Aidence Holding B.V. and Quantib B.V. of $<ix:nonFraction unitRef="usd" contextRef="i6fefd7d7be254ff5afc618390afc8022_D20220101-20220331" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjE5OTAyMzMxMDg1NQ_aa5005e8-7b56-4a02-8b1e-864c963aef1c">7.3</ix:nonFraction> million.  See Note 4, Business Combinations and Related Activity for more information.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="id7325335182142dfa19d63a9f7f5ecaa" continuedAt="id41ffcc1bac14bc08438fe1c5b9a8a99"><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNTE_a11fc5bb-f2ba-4a87-a32d-ec9ce6076b9b" continuedAt="i726df587cad3441ea83dfe3b3f6264ae" escape="true">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. </ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTE1ODE_4c9e957f-826a-41f5-8a86-ef0768df7d26">1.5</ix:nonFraction> million, or an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTE2MTM_83e85c86-753c-4ce9-a1eb-0193e26b67bf">15.2</ix:nonFraction>%, for the three months ended March 31, 2022 compared to income tax expense of $<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTE2NjI_b12704b0-0bd5-4a67-879d-77a8fe66fd12">4.4</ix:nonFraction> million, or an effective tax rate of <ix:nonFraction unitRef="number" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTE2OTQ_76103854-ae11-4045-b398-ba4c56df90cf">24.1</ix:nonFraction>% for the three months ended March 31, 2021.  The income tax rates for the three months ended March&#160;31, 2022 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes (iii) effects of foreign income taxes; and (iv) excess tax benefits attributable to share-based compensation.  <ix:continuation id="i726df587cad3441ea83dfe3b3f6264ae">We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNjE_2893dee6-17a0-4362-8468-528f26d11773" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of March&#160;31, 2022.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyMzg_db815701-01ba-423c-98c8-a37e74f4425e" escape="true">EQUITY BASED COMPENSATION &#8211; We have <ix:nonFraction unitRef="incentiveplan" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTQ5MjY_f79458dc-7df6-4fe2-91a9-8a4d87d1e7d4">one</ix:nonFraction> long-term incentive plan that we adopted in 2006 and which we have amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved <ix:nonFraction unitRef="shares" contextRef="i8c5258f2864b4b36a115d030fd6f6f0c_I20210415" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTUyNzM_649c7662-d399-47d8-81df-9ce8359099b3">16,500,000</ix:nonFraction> shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric.  We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period.  Stock options generally vest over <ix:nonNumeric contextRef="i1f6c8dad5f1a47f795469ebccd173f1a_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTU1MzM_e1683e8d-b6a6-4297-893e-f9db2e812307">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTU1Mzk_0d1e5826-7fd9-41b9-bba1-855cf9c13010">five years</ix:nonNumeric> and expire <ix:nonNumeric contextRef="i1f6c8dad5f1a47f795469ebccd173f1a_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTU1NTM_a4bf8c2d-8523-4dd8-899c-6b01dea79e65">five years</ix:nonNumeric> to <ix:nonNumeric contextRef="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTU1NTk_b56f4002-f1bb-4f37-a4e2-790b6617fcde">ten years</ix:nonNumeric> from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 7, Stock-Based Compensation, for more information.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNjU_cfebca64-8409-4f53-9640-0c2df3708364" escape="true">COMPREHENSIVE INCOME (LOSS) - Accounting guidance establishes rules for reporting and displaying comprehensive income or loss and its components. Our unrealized gains or losses on foreign currency translation adjustments, interest rate cap and swap agreements are included in comprehensive loss and are included in the consolidated statements of comprehensive income (loss) for the three months ended March&#160;31, 2022 and 2021</ix:nonNumeric>.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="id41ffcc1bac14bc08438fe1c5b9a8a99" continuedAt="i78156e4805064064b479350790143890"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNjI_27a96608-1da5-49f8-89be-b76c3609de75" escape="true">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNDA_8c0d9700-8287-4e6a-aee7-6ccbb53ca272" continuedAt="ie3ec8100c4904c4aace4b0b550b179ad" escape="true">DERIVATIVE INSTRUMENTS</ix:nonNumeric> - In the second quarter of 2019, we entered into <ix:nonFraction unitRef="agreement" contextRef="i096002072adf4d33b28c2551f1673e8d_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTc5ODQ_287b4317-1b9e-412b-9714-21c3a5e41a5f">four</ix:nonFraction> forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i096002072adf4d33b28c2551f1673e8d_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTgwODM_a553584a-e791-403f-bca7-9ed0f2ebe1cb">500,000,000</ix:nonFraction>, consisting of <ix:nonFraction unitRef="agreement" contextRef="i3ca7aedbfe5d492cbf2c8002a3274c68_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTgxMDE_d0553068-47fb-4a7a-a520-0094b369150c">two</ix:nonFraction> agreements of $<ix:nonFraction unitRef="usd" contextRef="i3ca7aedbfe5d492cbf2c8002a3274c68_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTgxMTg_31ee4541-6724-4247-95d7-a5a159140c2a">50,000,000</ix:nonFraction> each and <ix:nonFraction unitRef="agreement" contextRef="i3ca7aedbfe5d492cbf2c8002a3274c68_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTgxMzA_a751e40c-cdb2-4eba-96da-8a357ca8f333">two</ix:nonFraction> agreements of  $<ix:nonFraction unitRef="usd" contextRef="ic89c652d406f400bb6ace78022bdeb15_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTgxNDg_37601643-9a3f-41aa-988c-89ff7a8aa83d">200,000,000</ix:nonFraction> each.  <ix:continuation id="ie3ec8100c4904c4aace4b0b550b179ad" continuedAt="i64cb4a84c45d4db1b1d404b8c1da5213">The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional.</ix:continuation> Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at <ix:nonFraction unitRef="number" contextRef="i6ca7b8d957854f59aa72e2303bda7c43_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTg1MDU_b7572978-0e95-466d-a955-eee705c7a343">1.96</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="i94e159b506e24f2ba312631b9d16e313_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTg1MTY_e7e0c0eb-68a3-4524-8213-90844bb14c1d">100,000,000</ix:nonFraction> notional and at <ix:nonFraction unitRef="number" contextRef="i4a953bd9d4fa4594b4bec67ab351df4a_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTg1MzU_3dfc546b-aab4-4cbc-8a5f-5011ea19e6ae">2.05</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="ib3c38d0041d84df692e1f844842547ab_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTg1NDY_2c0194df-c6a2-4ed0-96b5-b74d6d6db522">400,000,000</ix:nonFraction> notional.  <ix:continuation id="i64cb4a84c45d4db1b1d404b8c1da5213" continuedAt="idbffdab335334a87929126bf012aa728">As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates are above the arranged rates.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idbffdab335334a87929126bf012aa728">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.</ix:continuation>  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $<ix:nonFraction unitRef="usd" contextRef="ib3c38d0041d84df692e1f844842547ab_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTkyNjY_2c0194df-c6a2-4ed0-96b5-b74d6d6db522">400,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="i4a953bd9d4fa4594b4bec67ab351df4a_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTkzMTk_3dfc546b-aab4-4cbc-8a5f-5011ea19e6ae">2.05</ix:nonFraction>% due October 2025 and our $<ix:nonFraction unitRef="usd" contextRef="i94e159b506e24f2ba312631b9d16e313_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTkzNDc_e7e0c0eb-68a3-4524-8213-90844bb14c1d">100,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="i6ca7b8d957854f59aa72e2303bda7c43_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk0MDA_b7572978-0e95-466d-a955-eee705c7a343">1.96</ix:nonFraction>% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="ib3c38d0041d84df692e1f844842547ab_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk2MTk_2c0194df-c6a2-4ed0-96b5-b74d6d6db522">400,000,000</ix:nonFraction> notional and after July 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="i94e159b506e24f2ba312631b9d16e313_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk2NjI_e7e0c0eb-68a3-4524-8213-90844bb14c1d">100,000,000</ix:nonFraction> notional are being recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $<ix:nonFraction unitRef="usd" contextRef="i1ad404b13b9e47818c995000abcc2af9_D20200701-20200701" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk4MzQ_6ac2a587-54e4-4b75-997f-034bfd50790a">24.4</ix:nonFraction> million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $<ix:nonFraction unitRef="usd" contextRef="idd1aeae2536a41608c3ca6a90e5f158e_D20200701-20231031" decimals="-5" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk5NDE_f674be67-44f1-4679-ae5c-3b7e5f87f801">0.4</ix:nonFraction> million per month and continuing at approximately $<ix:nonFraction unitRef="usd" contextRef="i81fba56dea454c119ee7cf826d420c68_D20231101-20251030" decimals="-5" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk5ODY_fde7361b-3ac3-4f5e-98c8-6a2464129ca6">0.3</ix:nonFraction> million through October 2025.</span></div><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyODg_a642bab2-8314-4a7a-b28b-45305d62cd56" continuedAt="ie8d8f00749c343e188254ece38c6bca5" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:36.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.229%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.217%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5a821e65c2544d5a2b4b289ae3296fa_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmIwMTRkMjQ3NGFkMzQxYTJiM2ZkOTc2NDVmODE4OTdkL3RhYmxlcmFuZ2U6YjAxNGQyNDc0YWQzNDFhMmIzZmQ5NzY0NWY4MTg5N2RfMi0yLTEtMS0xNDI3OQ_8d52e7bf-305a-4c30-b466-b7b2e3bcdb9d">18,886</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a2b41962224ca58c77ef230e603ac4_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmIwMTRkMjQ3NGFkMzQxYTJiM2ZkOTc2NDVmODE4OTdkL3RhYmxlcmFuZ2U6YjAxNGQyNDc0YWQzNDFhMmIzZmQ5NzY0NWY4MTg5N2RfMi00LTEtMS0xNDI3OQ_bd3f3618-4c39-43a6-9d55-ec732b0c2396">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a2b41962224ca58c77ef230e603ac4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmIwMTRkMjQ3NGFkMzQxYTJiM2ZkOTc2NDVmODE4OTdkL3RhYmxlcmFuZ2U6YjAxNGQyNDc0YWQzNDFhMmIzZmQ5NzY0NWY4MTg5N2RfMi02LTEtMS0xNDI3OQ_d7223baf-2afa-4f62-b5a1-0bba00634ef1">923</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ed6eb6d787b4fb6b3d5fbfd38cd9917_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmIwMTRkMjQ3NGFkMzQxYTJiM2ZkOTc2NDVmODE4OTdkL3RhYmxlcmFuZ2U6YjAxNGQyNDc0YWQzNDFhMmIzZmQ5NzY0NWY4MTg5N2RfMi04LTEtMS0xNDI3OQ_cf3cd70e-cb66-4255-accf-04fc8c2c8135">17,963</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"></td><td style="width:35.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if95355fe5a3242819fcb7d0e02be7ec3_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjgwMzRiY2Y4ODM1NDQ1OTFiOGU5YWFhNjc2YzU5NzZjL3RhYmxlcmFuZ2U6ODAzNGJjZjg4MzU0NDU5MWI4ZTlhYWE2NzZjNTk3NmNfMi0yLTEtMS0xNDI3OQ_e42d2a7e-897a-43cf-879d-8ef1c5bd1f42">22,581</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2ec2ce1cae4a43bed55d993eadf539_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjgwMzRiY2Y4ODM1NDQ1OTFiOGU5YWFhNjc2YzU5NzZjL3RhYmxlcmFuZ2U6ODAzNGJjZjg4MzU0NDU5MWI4ZTlhYWE2NzZjNTk3NmNfMi00LTEtMS0xNDI3OQ_b8df3ed0-381c-4dd4-acf0-9896ee3c8a52">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2ec2ce1cae4a43bed55d993eadf539_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjgwMzRiY2Y4ODM1NDQ1OTFiOGU5YWFhNjc2YzU5NzZjL3RhYmxlcmFuZ2U6ODAzNGJjZjg4MzU0NDU5MWI4ZTlhYWE2NzZjNTk3NmNfMi02LTEtMS0xNDI3OQ_46b06173-0a2e-45f0-95a8-bff7f2b1f237">3,695</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5a821e65c2544d5a2b4b289ae3296fa_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjgwMzRiY2Y4ODM1NDQ1OTFiOGU5YWFhNjc2YzU5NzZjL3RhYmxlcmFuZ2U6ODAzNGJjZjg4MzU0NDU5MWI4ZTlhYWE2NzZjNTk3NmNfMi04LTEtMS0xNDI3OQ_faaffee0-42bb-43be-83dd-6198bdc19f31">18,886</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><ix:continuation id="i78156e4805064064b479350790143890" continuedAt="i53fc3c748bc8431aadabf2a482af8b40"><ix:continuation id="ie8d8f00749c343e188254ece38c6bca5"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:23.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f460fdf9f124cfaa19c7b7e51eaf2f2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJmZDlkNTZiMzk3ZDRiMzE5NDVhYzJkNDRmMDE4NDMwL3RhYmxlcmFuZ2U6MmZkOWQ1NmIzOTdkNGIzMTk0NWFjMmQ0NGYwMTg0MzBfMi0yLTEtMS0xNDI3OQ_7b426209-e85c-4b58-9e81-9b4a5948718b">20,819</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c9a983e6ab54175b3a01c54d524c7a8_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJmZDlkNTZiMzk3ZDRiMzE5NDVhYzJkNDRmMDE4NDMwL3RhYmxlcmFuZ2U6MmZkOWQ1NmIzOTdkNGIzMTk0NWFjMmQ0NGYwMTg0MzBfMi02LTEtMS0xNDI3OQ_de121cf4-bafe-4d12-9d8a-6559b946e832">923</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of the 2019 Swaps at March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONTINGENT CONSIDERATION - On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening, in a combination stock and cash purchase.  As part of the purchase agreement, we will issue <ix:nonNumeric contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMzI5ODUzNDkzNzE2Mg_8376e9a1-38cc-444b-8e78-2a283c0bb1fd">18</ix:nonNumeric> months after acquisition, <ix:nonFraction unitRef="shares" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY4MTUyMQ_505466ba-784b-4666-92c4-f87134e2380c">113,303</ix:nonFraction> shares with an initial fair value at the date of close of $<ix:nonFraction unitRef="usd" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="-5" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY4MTUzOQ_397dc9d2-934d-4e3f-ae4b-e78750e8cc00">3.0</ix:nonFraction> million subject to adjustment for any indemnification claims and will be marked to market in subsequent periods.  See Note 4, Business Combinations and Related Activity for more information on the Quantib acquisition.</span></div><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMzI5ODUzNDkzNzE2Mw_339ddbf7-8752-4acf-8ff0-a1009a0e56da" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of contingent consideration on our condensed consolidated balance sheet is as follows (amounts in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"></td><td style="width:24.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.132%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.899%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 20, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of other non operating income recognized on contingent consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i753a81b55a9f4fb484fadfcdc315c4e5_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjA3NGJiMjhiN2RkYjQ2YzA5MWQ2ZDEwMTZmMjZhOTVkL3RhYmxlcmFuZ2U6MDc0YmIyOGI3ZGRiNDZjMDkxZDZkMTAxNmYyNmE5NWRfMi0yLTEtMS0zOTI5OA_ba45eecb-5250-4143-a51a-83c15e31462a">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc1c497245b149e284139819564e0884_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjA3NGJiMjhiN2RkYjQ2YzA5MWQ2ZDEwMTZmMjZhOTVkL3RhYmxlcmFuZ2U6MDc0YmIyOGI3ZGRiNDZjMDkxZDZkMTAxNmYyNmE5NWRfMi00LTEtMS0zOTI5OA_7914d20a-1076-4497-a7dc-5e635c68fe0c">501</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf6e35695eaa4dd8b7dd11f4cabb0ea7_I20220331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjA3NGJiMjhiN2RkYjQ2YzA5MWQ2ZDEwMTZmMjZhOTVkL3RhYmxlcmFuZ2U6MDc0YmIyOGI3ZGRiNDZjMDkxZDZkMTAxNmYyNmE5NWRfMi04LTEtMS0zOTI5OA_69da8cdd-241a-483f-ae03-e453c2f506c9">501</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Non Operating Income</span></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of contingent consideration at March&#160;31, 2022.</span></div><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNzM_1703cc95-f3a5-416b-80ed-c69158ee4de6" continuedAt="icb3a58a715ac4ace8a6a3516e53319cd" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNjM_64c9774e-07ff-4da5-8bc6-916923e9f0ba" continuedAt="ib83a1daacd6549e9bca3209e6a031f71" escape="true">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="i53fc3c748bc8431aadabf2a482af8b40" continuedAt="i414a36e0a09843dc8a5191b55731555f"><ix:continuation id="ib83a1daacd6549e9bca3209e6a031f71" continuedAt="i347350b7a6754bbc9408738029d00b73"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term assets</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b37a6d0909f429ea7e69dfe397ea84b_I20220331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjYzZTQ3NDQzODVhODQ2ODM5MGUxMTBlNzBmZDMzMTQ5L3RhYmxlcmFuZ2U6NjNlNDc0NDM4NWE4NDY4MzkwZTExMGU3MGZkMzMxNDlfNC0xLTEtMS0xNDI3OQ_90bc3f99-7747-4aad-b425-3478d6345d9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1c72c1dc48746639ec661fa2dcd2090_I20220331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjYzZTQ3NDQzODVhODQ2ODM5MGUxMTBlNzBmZDMzMTQ5L3RhYmxlcmFuZ2U6NjNlNDc0NDM4NWE4NDY4MzkwZTExMGU3MGZkMzMxNDlfNC0zLTEtMS0xNDI3OQ_379465a3-df94-46a2-aff1-764369a8ca0f">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie348136a7ee3486ca5466e8c06a98ee0_I20220331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjYzZTQ3NDQzODVhODQ2ODM5MGUxMTBlNzBmZDMzMTQ5L3RhYmxlcmFuZ2U6NjNlNDc0NDM4NWE4NDY4MzkwZTExMGU3MGZkMzMxNDlfNC01LTEtMS0xNDI3OQ_94819936-c79b-47c4-b71e-50b531b4f158">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1b6d8c2e1034d85aab248128f367e1b_I20220331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjYzZTQ3NDQzODVhODQ2ODM5MGUxMTBlNzBmZDMzMTQ5L3RhYmxlcmFuZ2U6NjNlNDc0NDM4NWE4NDY4MzkwZTExMGU3MGZkMzMxNDlfNC03LTEtMS0xNDI3OQ_56298835-6776-4634-98f7-b5d8ec549e91">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18b8469f0344621a9fe57a2fdd8b537_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjZmNTRkMDEyNjYzMDQ0N2E4ZjM3ZjA2Yzg4NTU4ZDIwL3RhYmxlcmFuZ2U6NmY1NGQwMTI2NjMwNDQ3YThmMzdmMDZjODg1NThkMjBfNC0xLTEtMS0xNDI3OQ_9e905569-667d-4da2-aeb7-a00fe37cbc0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2943452c6ebb4be889c458dfb30e5334_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjZmNTRkMDEyNjYzMDQ0N2E4ZjM3ZjA2Yzg4NTU4ZDIwL3RhYmxlcmFuZ2U6NmY1NGQwMTI2NjMwNDQ3YThmMzdmMDZjODg1NThkMjBfNC0zLTEtMS0xNDI3OQ_fc48d67b-5084-46fe-b637-5dffd4ffa2fb">16,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id14ca2ee887945609d66115bf804422c_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjZmNTRkMDEyNjYzMDQ0N2E4ZjM3ZjA2Yzg4NTU4ZDIwL3RhYmxlcmFuZ2U6NmY1NGQwMTI2NjMwNDQ3YThmMzdmMDZjODg1NThkMjBfNC01LTEtMS0xNDI3OQ_ed40b7db-3651-41ad-b6e6-5402518f9674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42b9c9a847043829b014731da1e39d0_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjZmNTRkMDEyNjYzMDQ0N2E4ZjM3ZjA2Yzg4NTU4ZDIwL3RhYmxlcmFuZ2U6NmY1NGQwMTI2NjMwNDQ3YThmMzdmMDZjODg1NThkMjBfNC03LTEtMS0xNDI3OQ_f18a418f-becd-4f4d-b98b-d9c6050b21a8">16,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icb3a58a715ac4ace8a6a3516e53319cd" continuedAt="i2c1c402b109d4f82aec7e2a646bafb9d">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration:</span></div><ix:continuation id="i347350b7a6754bbc9408738029d00b73" continuedAt="i2944a2bfec4148968631f6900ea183b6"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarize the estimated fair values of certain of our shares of common stock issued in our Quantib B.V. acquisition on January 20, 2022, and held back for indemnification purposes that are subject to fair value measurements and the classification of these liabilities on our condensed consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmE5MmZlNzc5NjJiZjRiMWU4MmQzOTZiMzBlNjVkNDYyL3RhYmxlcmFuZ2U6YTkyZmU3Nzk2MmJmNGIxZTgyZDM5NmIzMGU2NWQ0NjJfNC0wLTEtMS0zOTYxNC90ZXh0cmVnaW9uOjFlOTg0MDY1NmQ1ZDQxMTg4YmYxNDE1NjYxOGQ2ZDY3XzE2NDkyNjc0NDE3MTM_505466ba-784b-4666-92c4-f87134e2380c">113,303</ix:nonFraction> shares of RadNet common stock</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9157a041f574895a708682c8fc778d8_I20220331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmE5MmZlNzc5NjJiZjRiMWU4MmQzOTZiMzBlNjVkNDYyL3RhYmxlcmFuZ2U6YTkyZmU3Nzk2MmJmNGIxZTgyZDM5NmIzMGU2NWQ0NjJfNC0xLTEtMS0zOTA5NQ_27c68808-98b5-4f78-946b-95386b0e5af4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id469797c65cf443da10faec1b3088beb_I20220331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmE5MmZlNzc5NjJiZjRiMWU4MmQzOTZiMzBlNjVkNDYyL3RhYmxlcmFuZ2U6YTkyZmU3Nzk2MmJmNGIxZTgyZDM5NmIzMGU2NWQ0NjJfNC0zLTEtMS0zOTA5NQ_18c7ec9a-7ab7-450d-960e-ee978be45010">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2158c83bdd5247bcb8c21b6f9c1ab650_I20220331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmE5MmZlNzc5NjJiZjRiMWU4MmQzOTZiMzBlNjVkNDYyL3RhYmxlcmFuZ2U6YTkyZmU3Nzk2MmJmNGIxZTgyZDM5NmIzMGU2NWQ0NjJfNC01LTEtMS0zOTA5NQ_81c6493d-fb03-4837-b651-0e87d5812c51">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib324770e341c43deb03d6adaf27aeb3b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmE5MmZlNzc5NjJiZjRiMWU4MmQzOTZiMzBlNjVkNDYyL3RhYmxlcmFuZ2U6YTkyZmU3Nzk2MmJmNGIxZTgyZDM5NmIzMGU2NWQ0NjJfNC03LTEtMS0zOTA5NQ_1ac46b6b-bf6e-48b7-992d-c8179c72461b">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 3 inputs. More specifically, the fair value was determined by calculating the value estimated shares issuable as of the reporting date (which was $<ix:nonFraction unitRef="usdPerShare" contextRef="i9fb86495a1f749bea1502c1e616f2590_I20220120" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY4MzMyNw_8994963f-fc07-40b2-8df2-9befd02c8eca">22.37</ix:nonFraction>), the time period related to the contractual settlement term, and the probability of issuing the shares.  As all the inputs are not observable (excluding our closing share price) and cannot be corroborated by observable market data, we employ a Level 3 category.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt:</span></div><ix:continuation id="i2944a2bfec4148968631f6900ea183b6"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9157a041f574895a708682c8fc778d8_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjk5Yzk2ZmVjMThlNDRjZmM5NmVkMzBiOTY0NDU0OTlmL3RhYmxlcmFuZ2U6OTljOTZmZWMxOGU0NGNmYzk2ZWQzMGI5NjQ0NTQ5OWZfMi0xLTEtMS0xNDI3OQ_beda4210-4aab-4c51-b5e1-37961339f967">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id469797c65cf443da10faec1b3088beb_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjk5Yzk2ZmVjMThlNDRjZmM5NmVkMzBiOTY0NDU0OTlmL3RhYmxlcmFuZ2U6OTljOTZmZWMxOGU0NGNmYzk2ZWQzMGI5NjQ0NTQ5OWZfMi0zLTEtMS0xNDI3OQ_022db19d-d296-4a7e-bb25-073e22e2f048">753,769</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2158c83bdd5247bcb8c21b6f9c1ab650_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjk5Yzk2ZmVjMThlNDRjZmM5NmVkMzBiOTY0NDU0OTlmL3RhYmxlcmFuZ2U6OTljOTZmZWMxOGU0NGNmYzk2ZWQzMGI5NjQ0NTQ5OWZfMi01LTEtMS0xNDI3OQ_6cf572c5-d8ba-46bc-8c5f-8b6a4cb0c50b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib324770e341c43deb03d6adaf27aeb3b_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjk5Yzk2ZmVjMThlNDRjZmM5NmVkMzBiOTY0NDU0OTlmL3RhYmxlcmFuZ2U6OTljOTZmZWMxOGU0NGNmYzk2ZWQzMGI5NjQ0NTQ5OWZfMi03LTEtMS0xNDI3OQ_160f240d-82f9-4a44-9362-b20952b58c1e">753,769</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjk5Yzk2ZmVjMThlNDRjZmM5NmVkMzBiOTY0NDU0OTlmL3RhYmxlcmFuZ2U6OTljOTZmZWMxOGU0NGNmYzk2ZWQzMGI5NjQ0NTQ5OWZfMi05LTEtMS0xNDI3OQ_80890b8d-7346-40c5-9947-6d09ab7d58c4">764,563</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2cdca6cf3344e588f5fd3a61929ec4a_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJiYmNlYjY3NjNiZTRhOGY5NGRlMjdlZDNjOWQzNTk2L3RhYmxlcmFuZ2U6MmJiY2ViNjc2M2JlNGE4Zjk0ZGUyN2VkM2M5ZDM1OTZfMi0xLTEtMS0xNDI3OQ_428db72c-7ed8-47ac-9bcc-1d4e3943d2ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65afeb72c5874b7dabc692b4b7060cf4_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJiYmNlYjY3NjNiZTRhOGY5NGRlMjdlZDNjOWQzNTk2L3RhYmxlcmFuZ2U6MmJiY2ViNjc2M2JlNGE4Zjk0ZGUyN2VkM2M5ZDM1OTZfMi0zLTEtMS0xNDI3OQ_823cd004-3b72-48d5-a660-0762a383fcd8">766,973</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7628b2fb529f4c519168b280f905d875_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJiYmNlYjY3NjNiZTRhOGY5NGRlMjdlZDNjOWQzNTk2L3RhYmxlcmFuZ2U6MmJiY2ViNjc2M2JlNGE4Zjk0ZGUyN2VkM2M5ZDM1OTZfMi01LTEtMS0xNDI3OQ_ec449e8d-2e93-476c-8e72-e7b10473bfc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc944cf5d8b4854b25485eed3739509_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJiYmNlYjY3NjNiZTRhOGY5NGRlMjdlZDNjOWQzNTk2L3RhYmxlcmFuZ2U6MmJiY2ViNjc2M2JlNGE4Zjk0ZGUyN2VkM2M5ZDM1OTZfMi03LTEtMS0xNDI3OQ_4024dbbe-4387-428e-bdba-8108ca40e007">766,973</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJiYmNlYjY3NjNiZTRhOGY5NGRlMjdlZDNjOWQzNTk2L3RhYmxlcmFuZ2U6MmJiY2ViNjc2M2JlNGE4Zjk0ZGUyN2VkM2M5ZDM1OTZfMi05LTEtMS0xNDI3OQ_9ef1df05-738b-4dff-a02b-fb54f5a792f6">767,875</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and at December&#160;31, 2021 our Barclays revolving credit facility had <ix:nonFraction unitRef="usd" contextRef="i087e463165f046e8819239d70522c4bb_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjI2MzA_40b0875a-d4d1-43a5-a79f-aa8652f3e672"><ix:nonFraction unitRef="usd" contextRef="ia6e199c650d745829d22ac92ce902098_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjI2MzA_c3fa8075-c212-4967-8582-562d03d093c2">no</ix:nonFraction></ix:nonFraction> balance outstanding. Our SunTrust revolving credit facility relating to our consolidated subsidiary The New Jersey Imaging Network ("NJIN"), had <ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjI3Nzg_751bc152-cfc2-4c21-9f8e-1cfc046a9996"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjI3Nzg_b2725c9b-0946-4a76-a2e5-5ea677d6b481">no</ix:nonFraction></ix:nonFraction> principal amount outstanding at March&#160;31, 2022 and at December&#160;31, 2021.</span></div><ix:continuation id="i2c1c402b109d4f82aec7e2a646bafb9d"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt, which is discussed in Note 6, Credit Facilities and Notes Payable, was determined using Level 2 inputs primarily related to comparable market prices.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="i414a36e0a09843dc8a5191b55731555f" continuedAt="i2d7c1f9bd64c4e15ae92e34bf75e28e7"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNTU_d2864375-2505-4b1b-bccd-1d11827f43e7" escape="true">EARNINGS PER SHARE - <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyODI_65e9366b-eccc-4108-b7fa-c1793c1fd015" continuedAt="i46b3d396916b4cf88e86bfb9756c16c3" escape="true">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i46b3d396916b4cf88e86bfb9756c16c3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"></td><td style="width:67.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.768%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income  attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMi0xLTEtMS0xNDI3OQ_dd15cd64-da20-495a-9462-51c015956b7f">3,013</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMi0zLTEtMS0xNDI3OQ_d9c5414d-6517-45d1-bdf1-440226e33b4d">9,458</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfNS0xLTEtMS0xNDI3OQ_da1a683b-ae38-4a66-b4cc-965645188363">55,303,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfNS0zLTEtMS0xNDI3OQ_3493ba89-6d53-478e-842c-f92033c9162a">51,951,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfNi0xLTEtMS0xNDI3OQ_295e8c84-33a1-4cad-976d-f3119db1d15e">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfNi0zLTEtMS0xNDI3OQ_89f1d033-6635-4f78-acac-474d49ff6c51">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfOS0xLTEtMS0xNDI3OQ_63e98820-2c92-494f-89b7-cff2113d2613">55,303,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfOS0zLTEtMS0xNDI3OQ_136de271-a66e-47a4-afc2-199f9f083073">51,951,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTAtMS0xLTEtMTQyNzk_eb7ab237-2199-4857-b50d-47b8972a7a57">197,911</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTAtMy0xLTEtMTQyNzk_5767e399-253a-425d-ba55-519a4afdfe05">253,265</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and contingently issuable shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTEtMS0xLTEtMTQyNzk_775bf995-bc76-46c3-84ee-c53721c9f2af">861,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTEtMy0xLTEtMTQyNzk_575948df-f20b-41e9-975b-158ff3028389">624,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTItMS0xLTEtMTQyNzk_adf9bf68-a8f4-455f-9e21-1cd77f056002">56,362,193</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTItMy0xLTEtMTQyNzk_4f9b3a0d-868f-4a72-8134-26fce0a7a8dd">52,828,941</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTMtMS0xLTEtMTQyNzk_82c548e5-0c56-4ead-9a96-a620a511f45a">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTMtMy0xLTEtMTQyNzk_b051bbb9-efc7-4955-b6e5-18815a38da9e">0.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options:</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i992fabbabab44df7b3b1693d7cbf856c_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTctMS0xLTEtMTQyNzk_2b3c0db7-6c63-4ba4-b4a9-013b46bba064">46,912</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7037863c1e3e41be9812230db93860cc_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTctMy0xLTEtMTQyNzk_ce292ffb-7adf-4f00-ab10-04fe5fef50e6">82,595</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNzU_cb385a56-2776-4fcb-ba88-63d48de39af9" escape="true">EQUITY INVESTMENTS AT FAIR VALUE&#8211;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we have <ix:nonFraction unitRef="security" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="INF" name="rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjQyMjA_830cf82c-97a6-47e8-ba94-37add25c17bd">three</ix:nonFraction> equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision Imaging Solutions Ltd., based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $<ix:nonFraction unitRef="usd" contextRef="id0849868ae3c4ceb92bbeb7de548fba8_I20220331" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjQ1ODI_54270d60-f071-4a6b-8172-8ff0defdc6b5">1.2</ix:nonFraction> million  represents a <ix:nonFraction unitRef="number" contextRef="id0849868ae3c4ceb92bbeb7de548fba8_I20220331" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjQ1OTk_47640089-2181-4b5b-aa4f-f28b78b667e8">14.21</ix:nonFraction>% equity interest in the company.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $<ix:nonFraction unitRef="usd" contextRef="i4f1f9da235cc407c9377b1b4199f2c94_D20191105-20191105" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjU1MDY_e3785ff0-7265-4f27-96c3-15da2dad7ac0">1.0</ix:nonFraction> million and also loaned the company $<ix:nonFraction unitRef="usd" contextRef="i4f1f9da235cc407c9377b1b4199f2c94_D20191105-20191105" decimals="-5" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjU1Mzc_34481872-d16c-4c61-8ece-7e3d239fbef6">2.5</ix:nonFraction> million in support of its operations.  No observable price changes, impairment in our investment or impairment of the loan receivable was identified as of March&#160;31, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="i2d7c1f9bd64c4e15ae92e34bf75e28e7"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyODM_a36b997a-42c3-40e2-afcd-1961d7475dcc" escape="true">INVESTMENT IN JOINT VENTURES &#8211; We have <ix:nonFraction unitRef="jointventure" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="INF" name="rdnt:NumberofUnconsolidatedJointVentures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjU3MzA_889a55f8-c291-4b07-8687-3105c8d37a60">13</ix:nonFraction> unconsolidated joint ventures with ownership interests ranging from <ix:nonFraction unitRef="number" contextRef="i6eae8a7d772041fd90c955f920bc9ae8_D20220101-20220331" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjU4MDE_bc0d4fd0-3398-470c-a522-7f6539812e04">35</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="iec48a9056e99437fbf2864df26de0803_D20220101-20220331" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjU4MDc_98482a17-1910-44a1-9041-d81038bec166">55</ix:nonFraction>%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of March&#160;31, 2022.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition by Equity Method Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, our joint venture with Calvert Medical Imaging Center, LLC, completed the acquisition of certain assets to strengthen our presence in the Maryland market.  <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfNDM5ODA0NjUzOTg4Nw_0becb54e-5683-4dd3-89db-3a154c3f5ad4" continuedAt="ic2fdfcdeed654d939e7b23e013229d61" escape="true">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="ic2fdfcdeed654d939e7b23e013229d61" continuedAt="ibc0361be4d284803bdcc59ecdf37c8eb"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:17.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.974%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC *&#94;</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie110fb96d5d244519c0c1cf9826af837_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjQ5OTg2ZDIzMmUwYzQ0ODE5NGJhOTc5ZTUxMDdkZjQxL3RhYmxlcmFuZ2U6NDk5ODZkMjMyZTBjNDQ4MTk0YmE5NzllNTEwN2RmNDFfMS0yLTEtMS0zMDQzMw_2b04a46c-42e7-451d-a1ad-6cf90c2b3299">3,922</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie110fb96d5d244519c0c1cf9826af837_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjQ5OTg2ZDIzMmUwYzQ0ODE5NGJhOTc5ZTUxMDdkZjQxL3RhYmxlcmFuZ2U6NDk5ODZkMjMyZTBjNDQ4MTk0YmE5NzllNTEwN2RmNDFfMS0zLTEtMS0zMDQzMw_85b6cc74-c0d3-474a-8e12-806333c7dea1">2,121</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie110fb96d5d244519c0c1cf9826af837_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjQ5OTg2ZDIzMmUwYzQ0ODE5NGJhOTc5ZTUxMDdkZjQxL3RhYmxlcmFuZ2U6NDk5ODZkMjMyZTBjNDQ4MTk0YmE5NzllNTEwN2RmNDFfMS00LTEtMS0zMDQzMw_6d65b723-3c5d-44e5-965c-bd12a15e712c">1,295</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie110fb96d5d244519c0c1cf9826af837_I20220101" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjQ5OTg2ZDIzMmUwYzQ0ODE5NGJhOTc5ZTUxMDdkZjQxL3RhYmxlcmFuZ2U6NDk5ODZkMjMyZTBjNDQ4MTk0YmE5NzllNTEwN2RmNDFfMS01LTEtMS0zMDQzMw_f9d6a993-26df-4969-87fc-db024b451562">1,801</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie110fb96d5d244519c0c1cf9826af837_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjQ5OTg2ZDIzMmUwYzQ0ODE5NGJhOTc5ZTUxMDdkZjQxL3RhYmxlcmFuZ2U6NDk5ODZkMjMyZTBjNDQ4MTk0YmE5NzllNTEwN2RmNDFfMS04LTEtMS0zMDQzMw_d4da1c5e-16a6-4816-a433-d20d2ef4758f">1,295</ix:nonFraction>)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94; IFRC LLC acquisitions consisted of <ix:nonFraction unitRef="center" contextRef="i729756c7eae9463bb7f2dc97e4f51489_D20220101-20220101" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODQ1Nw_30322cfc-0dd5-436c-b86e-d54236e2f2be">three</ix:nonFraction> subsidiaries of IFRC, two of which were purchased separately by wholly owned RadNet subsidiaries.</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNDk_cfe01ffc-950f-422d-b0ca-2bf477d582f6" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the three months ended March 31, 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmNmMjFkYzUzNmViYTQ5YTJhZGQ0MDk3OTE4NDIyNzI1L3RhYmxlcmFuZ2U6Y2YyMWRjNTM2ZWJhNDlhMmFkZDQwOTc5MTg0MjI3MjVfMC0xLTEtMS0xNDI3OQ_751474af-687d-4c34-9ee5-b56cb3ed88c2">42,229</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmNmMjFkYzUzNmViYTQ5YTJhZGQ0MDk3OTE4NDIyNzI1L3RhYmxlcmFuZ2U6Y2YyMWRjNTM2ZWJhNDlhMmFkZDQwOTc5MTg0MjI3MjVfMS0xLTEtMS0xNDI3OQ_c821536b-91b8-4142-9968-da7b26748d3b">2,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmNmMjFkYzUzNmViYTQ5YTJhZGQ0MDk3OTE4NDIyNzI1L3RhYmxlcmFuZ2U6Y2YyMWRjNTM2ZWJhNDlhMmFkZDQwOTc5MTg0MjI3MjVfNy0xLTEtMS0xNDI3OQ_2cd18a7a-d066-4c9f-be6d-9a1b4b8d6c48">44,746</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately $<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjY4MDA_be3c108f-01ba-4e8e-a6e3-1ce07b8294ae">5.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjY4MDc_240d99be-6c5f-4f22-bc9e-eb0802e0434c">5.2</ix:nonFraction> million for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNDM_f9771e7a-a58d-4e2a-bf4b-1f1f74eddb7f" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2022 and December&#160;31, 2021 and income statement data for the three months ended March 31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMS0xLTEtMS0xNDI3OQ_b295c706-9646-49f1-9d1d-252ce628a271">37,119</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMS0zLTEtMS0xNDI3OQ_fecf3b06-8170-4f55-a0fd-b4d7623f59e0">37,186</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMi0xLTEtMS0xNDI3OQ_4981cd39-9aa6-493b-a061-ee97d7542ed4">83,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMi0zLTEtMS0xNDI3OQ_0f98256d-6134-490d-b1a3-9bbf7456224e">73,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMy0xLTEtMS0xNDI3OQ_24a3db8c-84ee-4fff-afa0-0ec9ab822a87">12,722</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMy0zLTEtMS0xNDI3OQ_78e4524f-26df-439b-b5ae-273e7a84f556">12,919</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNC0xLTEtMS0xNDI3OQ_0cc2d1d7-74a2-4f6a-b19b-1fd0339a496f">27,298</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNC0zLTEtMS0xNDI3OQ_f58c263f-b9fe-4183-a0e5-65d468594840">22,370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNS0xLTEtMS0xNDI3OQ_dd52e07b-ff8c-4670-8654-217129819e40">80,506</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNS0zLTEtMS0xNDI3OQ_d789ab1c-d4d2-463a-bd55-93f07a5ef26f">75,489</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNy0xLTEtMS0xNDI3OQ_5b424380-b716-4f45-ba5e-ed6d053121a1">37,214</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNy0zLTEtMS0xNDI3OQ_f45200b6-c86c-4b70-8b97-feea918382b5">34,930</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331" decimals="-3" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfOC0xLTEtMS0xNDI3OQ_ef600a51-eb50-49e4-9314-da7b58307f21">7,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfOC0zLTEtMS0xNDI3OQ_ddb6e503-2d14-4c79-bfcf-38b521977ad9">7,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfOS0xLTEtMS0xNDI3OQ_4a393b59-bb2f-4540-9707-b202b6c9d0cd">44,746</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfOS0zLTEtMS0xNDI3OQ_6e493e60-9af1-4a02-ba71-c81cc21560f6">42,229</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id06cc52a0f9944378c61c46c035f80f6_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjEyNTQ3ZWQzYTM2NTRiMmY4OGQyODE3ZTg0YjU3NzYzL3RhYmxlcmFuZ2U6MTI1NDdlZDNhMzY1NGIyZjg4ZDI4MTdlODRiNTc3NjNfMS0xLTEtMS0xNDI3OQ_676a14be-38a3-4cca-8086-75c5780924ab">34,411</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2588fa1944547388e26c3a6dc631651_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjEyNTQ3ZWQzYTM2NTRiMmY4OGQyODE3ZTg0YjU3NzYzL3RhYmxlcmFuZ2U6MTI1NDdlZDNhMzY1NGIyZjg4ZDI4MTdlODRiNTc3NjNfMS0zLTEtMS0xNDI3OQ_f6477fde-c4d5-464e-be03-95c50347f8bb">31,718</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id06cc52a0f9944378c61c46c035f80f6_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjEyNTQ3ZWQzYTM2NTRiMmY4OGQyODE3ZTg0YjU3NzYzL3RhYmxlcmFuZ2U6MTI1NDdlZDNhMzY1NGIyZjg4ZDI4MTdlODRiNTc3NjNfMi0xLTEtMS0xNDI3OQ_1bc148ad-5f1d-4e31-84ae-3437f8caeae0">5,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2588fa1944547388e26c3a6dc631651_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjEyNTQ3ZWQzYTM2NTRiMmY4OGQyODE3ZTg0YjU3NzYzL3RhYmxlcmFuZ2U6MTI1NDdlZDNhMzY1NGIyZjg4ZDI4MTdlODRiNTc3NjNfMi0zLTEtMS0xNDI3OQ_2416f2da-5467-4d90-8ccd-926d1425a1cf">4,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_43"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3 &#8211; <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80My9mcmFnOjc1N2Q0OTViMGNhMzRmZjhiYjk3ZDBlY2E5NjY3N2Q4L3RleHRyZWdpb246NzU3ZDQ5NWIwY2EzNGZmOGJiOTdkMGVjYTk2Njc3ZDhfMjIzMQ_92ce3bfe-bb33-43d7-883b-60dd87d66ca2" continuedAt="i4a22e07c544249d392768256982aa06d" escape="true"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80My9mcmFnOjc1N2Q0OTViMGNhMzRmZjhiYjk3ZDBlY2E5NjY3N2Q4L3RleHRyZWdpb246NzU3ZDQ5NWIwY2EzNGZmOGJiOTdkMGVjYTk2Njc3ZDhfMjIzNA_3c356eed-ddb7-4b31-b0b6-b8a089c02287" continuedAt="i4d4b0cd510674a78b2c36ee000edc5fe" escape="true">RECENT ACCOUNTING AND REPORTING STANDARD</ix:nonNumeric></ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span><br/></span></div><ix:continuation id="i4a22e07c544249d392768256982aa06d"><ix:continuation id="i4d4b0cd510674a78b2c36ee000edc5fe"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#8217;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard was effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-01 clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  The adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  The adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. We do not expect ASU 2021-08 to have a material effect, if any, on our consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="icf50c354d3d14f9eaeb683bc15ad4328_46"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 4 &#8211; <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTgxOQ_f8504ed1-7fe2-4553-8714-9bc6d5e6c384" continuedAt="i3b75b5e3f0f14aa3a4f211032d88f1fe" escape="true">BUSINESS COMBINATIONS AND RELATED ACTIVITY</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i3b75b5e3f0f14aa3a4f211032d88f1fe" continuedAt="i2a7c05a061b04c22a264a3bc09e20c8b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Maryland market.  These acquisitions are reported as part of our Imaging Center segment.  <ix:continuation id="ibc0361be4d284803bdcc59ecdf37c8eb" continuedAt="i8c246208b5d74818a3ad82672f067452">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i8c246208b5d74818a3ad82672f067452"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"><tr><td style="width:1.0%"></td><td style="width:16.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#94;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS0yLTEtMS0xNDI3OQ_e8b5b262-2fad-4753-ab44-eef326da1c33">4,800</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS0zLTEtMS0xNDI3OQ_58c1f77e-e06e-414b-aac6-4ddcfe2dab22">2,103</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS00LTEtMS0xNDI3OQ_cac5d17f-cd6b-488a-973f-f77826879031">857</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS01LTEtMS0xNDI3OQ_274ac6d2-8097-42b0-89aa-9db8de4e2971">2,697</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS03LTEtMS0xNDI3OQ_cec36195-dee5-4691-b416-98de93e62c32">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS04LTEtMS0xNDI3OQ_8cb01583-1b37-44a9-9645-1540812a41b6">857</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi0yLTEtMS0xNDI3OQ_a0c49be4-1e51-4aa5-accb-8e1ef1b84116">8,200</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi0zLTEtMS0xNDI3OQ_5fad21d4-1aec-419b-8bd7-b8c7a93d97d9">2,910</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi00LTEtMS0xNDI3OQ_99ceb28d-ab25-49f1-893f-3f3c8e50308b">1,703</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi01LTEtMS0xNDI3OQ_4cf9d5a0-ce9a-40fa-a180-23360bd53ede">5,271</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi03LTEtMS0xNDI3OQ_eb05f1fc-70b4-4d9a-960e-9e7e89220a90">19</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi04LTEtMS0xNDI3OQ_ab3d55c9-f8cd-4983-b6ec-e1a27d090e63">1,703</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib261e6ac493749b8b10541441e853944_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctMi0xLTEtMTQyNzk_8b5db959-8c12-4e58-80c6-6378fcd93e33">13,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib261e6ac493749b8b10541441e853944_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctMy0xLTEtMTQyNzk_982d96ff-9822-4a76-85c5-806862194cb0">5,013</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib261e6ac493749b8b10541441e853944_I20220331" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctNC0xLTEtMTQyNzk_0cea6562-f7ea-4554-9f6d-01de57ffeb4b">2,560</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib261e6ac493749b8b10541441e853944_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctNS0xLTEtMTQyNzk_6466da4b-a2c9-492e-9323-45cf8a5d34b2">7,968</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib261e6ac493749b8b10541441e853944_I20220331" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctNy0xLTEtMTQyNzk_dc9852c3-f285-4e9d-a177-482b085ae4bf">19</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib261e6ac493749b8b10541441e853944_I20220331" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctOC0xLTEtMTQyNzk_a37e183e-4c4e-46e1-8241-830370cbf283">2,560</ix:nonFraction>)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94; IFRC LLC acquisitions consisted of <ix:nonFraction unitRef="center" contextRef="i729756c7eae9463bb7f2dc97e4f51489_D20220101-20220101" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTYzNDgwNg_8b4b41f2-ff56-4b5e-9fea-21d2608ce09e">three</ix:nonFraction> subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="i2a7c05a061b04c22a264a3bc09e20c8b"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening, in an combination stock and cash purchase.  Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $<ix:nonFraction unitRef="usd" contextRef="i193b2936e56f4e0cbc28405f53112fa5_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjE3Nw_2e3f0b21-c3b1-47eb-8cce-952459b20da4">45.2</ix:nonFraction> million including i) <ix:nonFraction unitRef="shares" contextRef="id0bf43006b8e4c76b133b1590044e764_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjQ2NA_c11128e2-ff78-4880-b73c-477cd9cba4a4">1,117,872</ix:nonFraction> shares issued at $<ix:nonFraction unitRef="usdPerShare" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjIxNg_4797db09-4426-4246-9986-f37607c181c9"><ix:nonFraction unitRef="usdPerShare" contextRef="i87b26de1e4b243908f72f164ff3c9086_I20220120" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjIxNg_aab5bcb0-b683-44fe-9de3-4a8f8d56d1ee">26.80</ix:nonFraction></ix:nonFraction> per share with a fair value of $<ix:nonFraction unitRef="usd" contextRef="id0bf43006b8e4c76b133b1590044e764_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjQ2OA_d09502af-b839-41d8-a3cb-a0c3850e6b5f">30.0</ix:nonFraction> million ii) cash of $<ix:nonFraction unitRef="usd" contextRef="i193b2936e56f4e0cbc28405f53112fa5_D20220120-20220120" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjI2Nw_4bff6b0a-1716-45bb-a6ed-9a3f4a00c0aa">1.8</ix:nonFraction> million and iii) assuming liabilities of $<ix:nonFraction unitRef="usd" contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjI5NQ_b7035510-654d-4270-980e-2e19d2698269">11.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjMwMA_b802d2d7-7cc2-458a-8f63-27b8fa5ca694">7.4</ix:nonFraction> million in milestone contingent consideration and cash holdback of $<ix:nonFraction unitRef="usd" contextRef="i2031463f67164712a74de886e34783a3_I20220120" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjM4NA_67d01419-c11a-406d-b214-f7bed35e76f7">4.5</ix:nonFraction> million and iv) a settlement of a loan from RadNet of $<ix:nonFraction unitRef="usd" contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjQzOA_10b80234-1c01-4107-b426-cad191537e43">1.5</ix:nonFraction> million.  In addition we paid certain seller closing costs through the issuance of <ix:nonFraction unitRef="shares" contextRef="i3d27827222204849a68e073722e8fc1d_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1Mjk3MA_900fbc29-4141-4791-a9bc-067ccc0e6de8">23,362</ix:nonFraction> shares at a fair value of $<ix:nonFraction unitRef="usd" contextRef="i3d27827222204849a68e073722e8fc1d_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MzA4NA_0b0106d2-e24c-4074-9af7-1104e8467c45">0.6</ix:nonFraction> million.  We preliminarily recorded $<ix:nonFraction unitRef="usd" contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MTAyMw_8f3041f6-83bb-4b6a-969c-613095575d22">1.0</ix:nonFraction> million in current assets, $<ix:nonFraction unitRef="usd" contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MTAzOQ_510eaecb-2a12-47fe-a620-f9e6f5b60bec">0.2</ix:nonFraction> million in property plant and equipment, $<ix:nonFraction unitRef="usd" contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MTA1MQ_886f45f8-d6b0-4d02-b076-1103a3cd1561">27.5</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MTMwNw_d5ac2591-5576-4c56-b1a9-bf391fea2dfd">3.2</ix:nonFraction> million in liabilities and $<ix:nonFraction unitRef="usd" contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MTA0NQ_1f965840-e5be-44ed-b819-e53c140dfa75">19.2</ix:nonFraction> million in goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening, in a combination stock and cash purchase.  Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $<ix:nonFraction unitRef="usd" contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0MzIxMA_f39ba270-71a5-4acb-8b93-f820881d0564">42.3</ix:nonFraction> million including i) <ix:nonFraction unitRef="shares" contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTc5NQ_0574c655-d1f0-4bf0-bf9a-b4753162831e">965,058</ix:nonFraction> shares issued at $<ix:nonFraction unitRef="usdPerShare" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NDM1OA_4797db09-4426-4246-9986-f37607c181c9"><ix:nonFraction unitRef="usdPerShare" contextRef="i87b26de1e4b243908f72f164ff3c9086_I20220120" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NDM1OA_aab5bcb0-b683-44fe-9de3-4a8f8d56d1ee">26.80</ix:nonFraction></ix:nonFraction> per share with a fair value of $<ix:nonFraction unitRef="usd" contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0MzIzNQ_574f4886-d385-4ceb-b1eb-167d1e9d3c61">25.9</ix:nonFraction> million ii) cash of $<ix:nonFraction unitRef="usd" contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NDk2NQ_1fad84b7-cd58-450d-b6fb-0040c39f7cfa">11.8</ix:nonFraction> million and iii)  <ix:nonFraction unitRef="shares" contextRef="i15c67e44f3fc456cab260a3b8f274e7e_D20220331-20220331" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0MzI1OA_df51bea4-1f5e-445c-ac12-f0e36cd4f24c">113,303</ix:nonFraction> shares with a fair value at the date of close of $<ix:nonFraction unitRef="usd" contextRef="i15c67e44f3fc456cab260a3b8f274e7e_D20220331-20220331" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0MzI3Mw_fc08b1c8-2730-481b-8e3f-a5e8bbbfdf34">3.0</ix:nonFraction> million and cash holdback of $<ix:nonFraction unitRef="usd" contextRef="ieeafd6bcebca4a6683a7ac275f256f43_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTAwNA_3a17f478-46a6-4dd0-966f-dfb6804e3717">1.6</ix:nonFraction> million to be issued <ix:nonNumeric contextRef="ibc1c497245b149e284139819564e0884_D20220101-20220331" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMzI5ODUzNDkxMDEyNw_c9444196-860a-4657-8692-9c5bf374f5b5">18</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods. We preliminarily recorded $<ix:nonFraction unitRef="usd" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTMzOQ_342c3831-d4df-4a46-a36b-620a68010e62">2.4</ix:nonFraction> million in current assets, $<ix:nonFraction unitRef="usd" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTM0Mg_dad8f1ca-5350-42d8-ace9-022d9e85b2c4">0.1</ix:nonFraction> million in property plant and equipment, $<ix:nonFraction unitRef="usd" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTM4Mw_ef2c3fe6-1774-4e3c-86d6-307ccb30ba29">21.3</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTQwOQ_a52aa5bd-8dee-4236-8490-60f6212ab00f">3.7</ix:nonFraction> million in liabilities and $<ix:nonFraction unitRef="usd" contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTQzMg_4ae0127e-6321-4e1f-a04c-7763bedf44a4">22.2</ix:nonFraction> million in goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, our acquisitions of Aidence and Quantib are preliminary.  As we finalize our estimation of the fair value of the assets acquired and liabilities assumed, additional adjustments may be recorded during the measurement period (a period not to exceed 12 months). The initial accounting is preliminary as of March 31, 2022 for the acquired assets and liabilities as we are currently in the process of completing the assessment of valuation inputs and assumptions as well as completing the assessment of the tax attributes of the business combination. The finalization of the acquisition accounting valuation assessment may result in a change in the valuation of the deferred tax assets and liabilities and intangible assets, along with the opening working capital accounts, which could have a material impact on our results of operations and financial position.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_1099511628810"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 5 &#8211; <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGV4dHJlZ2lvbjo0ZTEyOWUwYTE1MTc0YThkODhiYTNhOTA5MDBmM2RjMV8zMjk4NTM0OTA1MTQ3_54a4c7c7-5a90-4388-9669-64c6ad093876" continuedAt="iab6dd8c1cdfb407faff197fb88cafc78" escape="true">SEGMENT REPORTING</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iab6dd8c1cdfb407faff197fb88cafc78" continuedAt="if5df9785dcd54a30853a5729bc01dd5f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reportable segments are described below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence ("AI")</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGV4dHJlZ2lvbjo0ZTEyOWUwYTE1MTc0YThkODhiYTNhOTA5MDBmM2RjMV8zMjk4NTM0OTA1MTQ4_937e7e27-f0b0-4be6-8b61-f1327eb6759c" continuedAt="i30d3d74270114d9a833ef0a5a2ac4efd" escape="true">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="if5df9785dcd54a30853a5729bc01dd5f"><div style="text-indent:36pt"><ix:continuation id="i30d3d74270114d9a833ef0a5a2ac4efd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.198%"><tr><td style="width:1.0%"></td><td style="width:51.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.103%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.104%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8zLTEtMS0xLTMwNDg3_4f81c467-8268-4586-908f-cf80f8435645">341,168</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8zLTMtMS0xLTMwNDg3_3b5137ce-cb9f-4bf7-a8d9-39b5ed92d91a">315,319</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV80LTEtMS0xLTMwNDg3_6819768f-9ba8-45b7-9f44-82e55c631823">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV80LTMtMS0xLTMwNDg3_175d9fe2-76c8-4ba5-92da-7e9a88936e43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV81LTEtMS0xLTMwNDg3_1c428699-7bba-448c-b58b-9d42ef0969db">341,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV81LTMtMS0xLTMwNDg3_c9837f80-807c-49f4-979b-4d20f90d16ac">315,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV84LTEtMS0xLTMwNDg3_d7aa9608-6333-4f83-b7aa-faff7a3d1848">310,110</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV84LTMtMS0xLTMwNDg3_2f42f908-a6a1-4d28-ae56-115c207c4709">281,013</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV85LTEtMS0xLTMwNDg3_17467aa6-9889-4045-9f37-e75086f7ed2b">4,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV85LTMtMS0xLTMwNDg3_bb0903fb-421e-454c-81fc-7a3b0e024ce3">1,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xMC0xLTEtMS0zMDQ4Nw_7a871762-e65d-400f-badb-02d954fcd16d">315,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xMC0zLTEtMS0zMDQ4Nw_1f678462-c744-4051-8d47-4c91cf343300">282,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xMy0xLTEtMS0zMDQ4Nw_7f4933d0-80b0-41c0-8dba-17667800d4f4">25,805</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xMy0zLTEtMS0zMDQ4Nw_a279fb13-5f27-4b28-9879-99178dd32f08">22,569</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xNC0xLTEtMS0zMDQ4Nw_e664c277-cbc6-4d79-8985-032ef0194142">1,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xNC0zLTEtMS0zMDQ4Nw_d8630146-c1ef-4f80-ab69-e9badaa9dcad">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xNS0xLTEtMS0zMDQ4Nw_0dc44c7f-4513-4181-86f9-d7520cb50ba9">27,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xNS0zLTEtMS0zMDQ4Nw_b5ac55bb-466a-4d05-be3a-7ae42bdc5f2f">22,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss (Gain) on Disposal of Equipment:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xOC0xLTEtMS0zMDQ4Nw_70748690-5f7c-4cef-ab78-647a9e3c7ef2">1,154</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xOC0zLTEtMS0zMDQ4Nw_c3bde0a9-af54-4684-955b-547ce8992629">1,307</ix:nonFraction>)</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xOS0xLTEtMS0zMDQ4Nw_e9f51ea6-11d7-4e80-8dde-1e789f33a5e5">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xOS0zLTEtMS0zMDQ4Nw_6cad91df-c640-4ced-ad7e-cca9827fec54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss (gain)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yMC0xLTEtMS0zMDQ4Nw_e6b10979-724e-4eb2-ab1a-eb0ca9e3cb02">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yMC0zLTEtMS0zMDQ4Nw_abc24239-8f9d-486e-b2ab-901a232e9a0d">1,307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yMy0xLTEtMS0zMDQ4Nw_9a9b13a5-bbdd-4526-bca2-5fa94e9cc416">201</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yMy0zLTEtMS0zMDQ4Nw_346294df-66bf-4028-a703-85604b6620fc">285</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yNC0xLTEtMS0zMDQ4Nw_c6f65cb4-9777-4a51-9cf6-789f57b04d30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yNC0zLTEtMS0zMDQ4Nw_7290d7d1-02d9-43a5-90f7-6eefef4c3567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yNS0xLTEtMS0zMDQ4Nw_dace7161-8c70-49fb-adf7-05f8035ffe63">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yNS0zLTEtMS0zMDQ4Nw_c0aecdd7-4389-4fc9-81ef-61de6fb9593d">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(Loss) Income from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yOC0xLTEtMS0zMDQ4Nw_712a1d66-5a82-4ecd-9c02-4a3a28c84774">3,898</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yOC0zLTEtMS0zMDQ4Nw_361b895a-4767-4f1b-a461-b0b8a49225bc">12,759</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yOS0xLTEtMS0zMDQ4Nw_5c3c805c-3569-43d2-a5f9-b1183e4242f5">5,617</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yOS0zLTEtMS0zMDQ4Nw_4bb4757f-5cb7-4a7b-a4c7-57360e83b9c3">1,354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total (loss) income from operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8zMC0xLTEtMS0zMDQ4Nw_71f15b80-f5a1-4e27-b30b-876a32f5ed46">1,719</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8zMC0zLTEtMS0zMDQ4Nw_236d62b2-aa69-40ea-81ca-1e47e12b8377">11,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For proper comparative purposes, Imaging Center segment revenue in 2021 excludes $<ix:nonFraction unitRef="usd" contextRef="i3be9b88ce86c4744bf9e653fbfd94c90_D20210101-20210331" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGV4dHJlZ2lvbjo0ZTEyOWUwYTE1MTc0YThkODhiYTNhOTA5MDBmM2RjMV8xNjQ5MjY3NDY5NzE0_85110032-3a0d-43fd-b577-44a71f0ed49d">6.2</ix:nonFraction> million in Provider Relief Funding, as it represents a form of direct Government stimulus.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6 &#8211; <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfODE0OA_92d6747e-c756-4875-89fc-1de5119211fe" continuedAt="ie4647649b57d4714817660b060d42967" escape="true">CREDIT FACILITIES AND NOTES PAYABLE</ix:nonNumeric></span></div><ix:continuation id="ie4647649b57d4714817660b060d42967" continuedAt="i6119ac4bd85e44e9959243796666a7b1"><ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfODE0OQ_c6323d09-97d6-4f76-b29e-124e64137cc3" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and December&#160;31, 2021 our term loan debt obligations are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:74.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.841%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6603de1c39843a99a8e725c3ba62d5d_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMi0xLTEtMS0xNDI3OQ_9121669e-14ba-4796-a732-c03857182997">719,563</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i733096088bfb4e4593a3c6893d07f184_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMi0zLTEtMS0xNDI3OQ_c1a88288-6f93-4817-8474-8133f1ba8838">721,375</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6603de1c39843a99a8e725c3ba62d5d_I20220331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMy0xLTEtMS0xNDI3OQ_adce833b-93aa-467f-8a17-4b54b3811fc8">12,692</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i733096088bfb4e4593a3c6893d07f184_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMy0zLTEtMS0xNDI3OQ_137b991b-48c5-4fbe-926d-d8b3bd16dbea">13,213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb1d71aa2ad40129d22f67c28e34718_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfNC0xLTEtMS0xNDI3OQ_70779f3f-d265-40c9-a729-17fdfe130b51">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d341f477874224896da30df2514be5_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfNC0zLTEtMS0xNDI3OQ_07e64140-da3b-47f0-af2a-2c52b47faf3b">46,500</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfOC0xLTEtMS0xNDI3OQ_24835c36-e206-41f4-a361-fd3f17fa385f">751,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfOC0zLTEtMS0xNDI3OQ_bfc28c52-1b62-4be6-b173-a06350807780">754,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfOS0xLTEtMS0xNDI3OQ_0dff8170-f7cd-4e72-8769-f6391dae6290">11,164</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfOS0zLTEtMS0xNDI3OQ_4f9d35ce-dd6d-442c-ac8d-d29fcf46ef29">11,164</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMTAtMS0xLTEtMTQyNzk_99d0e24b-050b-4cc2-867c-8f747fe73df4">740,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMTAtMy0xLTEtMTQyNzk_975ac29f-c8b9-4299-bbed-9f3862d5b276">743,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="i087e463165f046e8819239d70522c4bb_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTM3_40b0875a-d4d1-43a5-a79f-aa8652f3e672"><ix:nonFraction unitRef="usd" contextRef="ia6e199c650d745829d22ac92ce902098_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTM3_c3fa8075-c212-4967-8582-562d03d093c2">no</ix:nonFraction></ix:nonFraction> outstanding balance under our $<ix:nonFraction unitRef="usd" contextRef="i4b2021e8693c43efb8f3683e1a35b4df_I20210423" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTcw_806bb614-a15f-4bba-911b-89786b2b44d4">195.0</ix:nonFraction> million Barclays Revolving Credit Facility at March&#160;31, 2022 and have reserved $<ix:nonFraction unitRef="usd" contextRef="i4c9e01d6493f43e299012d6df312e4bf_I20220331" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjMy_8cac2f52-e71c-473f-b281-bfa481d9553f">7.8</ix:nonFraction> million for certain letters of credit. The remaining $<ix:nonFraction unitRef="usd" contextRef="i306b15aed8664de6a18898691aeec87c_I20220331" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjgw_d971c0b1-cd1b-4c97-b043-658b69f420bc">187.2</ix:nonFraction> million of our Barclays Revolving Credit Facility was available to draw upon as of March&#160;31, 2022.  We had <ix:nonFraction unitRef="usd" contextRef="i45d5c9e3d43546498d2a26f35f8668b2_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMzcw_227322bd-89f1-47aa-b08e-8a03cacee279">no</ix:nonFraction> outstanding balance under our $<ix:nonFraction unitRef="usd" contextRef="i2f7f03f2987a4c7fb79e4440534fa07b_I20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNDAz_da19a20d-7c79-4fa3-ae2e-68fcdc0ae4da">30.0</ix:nonFraction> million SunTrust Revolving Credit Facility at March&#160;31, 2022.  As of March&#160;31, 2022, we were in compliance with all covenants under our credit facilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $<ix:nonFraction unitRef="usd" contextRef="i53f75acbd56447d2a0b5536e5817ebbb_I20210423" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNzYw_ec4cd18c-3ea3-4ee3-aea6-deaebd557d8b">725.0</ix:nonFraction> million of senior secured first lien term loans (the "First Lien Term Loans") and a $<ix:nonFraction unitRef="usd" contextRef="i4b2021e8693c43efb8f3683e1a35b4df_I20210423" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfODM5_806bb614-a15f-4bba-911b-89786b2b44d4">195.0</ix:nonFraction> million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i808acf82ba384ff191da9c1c7c61d43a_I20210423" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTE4MA_e358e6d9-1f54-4ca2-8374-3d661059d320">14.9</ix:nonFraction> million segregated as follows: $<ix:nonFraction unitRef="usd" contextRef="i808acf82ba384ff191da9c1c7c61d43a_I20210423" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTIwNg_701749f1-620c-48ed-aa00-4fac6cedd679">8.8</ix:nonFraction> million capitalized to discount and deferred finance cost, $<ix:nonFraction unitRef="usd" contextRef="i808acf82ba384ff191da9c1c7c61d43a_I20210423" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTI2MA_3fa237a5-66a6-416c-8a1b-1b10813b28fb">4.5</ix:nonFraction> million expensed to debt restructuring costs,  $<ix:nonFraction unitRef="usd" contextRef="i7c887837d9ef4909b82fa07c516cbe5f_D20210423-20210423" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTMwMg_fa03d0a0-c4ce-4468-b5bd-d6e6a092e31c">1.5</ix:nonFraction> million charged to loss on early extinguishment of debt and $<ix:nonFraction unitRef="usd" contextRef="ia71e051856e14e40b66eb9309af46b02_D20210423-20210423" decimals="-5" name="us-gaap:AmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTM1Nw_7cb30f19-c00e-468d-940c-ce5169a5c7e6">0.1</ix:nonFraction> million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Secured Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">First Lien Term Loans:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Lien Term Loans under the Restated Credit Agreement bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable margin for Eurodollar Rate term loans under the Restated Credit Agreement is <ix:nonFraction unitRef="number" contextRef="ieb3b9b1ec109454b8176b9068a603457_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTg5OA_19e1292d-b5f6-4c0c-919e-9a44ee38b438">3.25</ix:nonFraction>% per annum, with a reduction to <ix:nonFraction unitRef="number" contextRef="i9078e720809546d6aaf957bdefc7dbd7_D20210101-20210331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTkzMg_72d2dc99-68fc-428c-b314-f91dc4f98065">3.00</ix:nonFraction>% per annum upon delivery by us of financial statements for the period ending March 31, 2021 evidencing a first lien net leverage ratio of <ix:nonFraction unitRef="number" contextRef="iaf7f88c678b74b4b886228218a5301cd_I20210331" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjA3Mg_0f70ecb7-7598-4d6e-b634-e5deb0e0abbb">3.50</ix:nonFraction> to 1.00 or less.  Such statements were delivered by us on May 27, 2021. At March&#160;31, 2022 the effective Eurodollar Rate and the Alternate Base Rate for the First Lien Term Loans under the Restated Credit Agreement was <ix:nonFraction unitRef="number" contextRef="i3a411712fae44141898b470479a1a692_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjI3OQ_ba460654-82d2-4d2a-9a3d-34c428e781e9">0.75</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4bc8bed1e3c54b7ba889d6e0b9d215c5_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjI4Ng_37a762a6-8258-46d2-86bb-3386012be8b4">3.50</ix:nonFraction>%, respectively and the applicable margin for the Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was <ix:nonFraction unitRef="number" contextRef="i7b94146cc90742289e03e41f9581f179_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjQzOQ_6bf92397-713a-4503-b02b-7431a7de1bfd">3.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1fb8a36da6224876bbbbb9c7b1e0d449_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjQ0Ng_1b65aa8a-1fa8-4ae0-bcab-279a33e6b9de">2.00</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="i2a2d0c6e90f04f8082784ea469840870_D20220101-20220331" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjYwMA_57ccc2cd-dc01-419e-84e4-a0ce80ee307b">1.8</ix:nonFraction> million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, our SunTrust credit facilities, which relate to our consolidated subsidiary The New Jersey Imaging Network, L.L.C.("NJIN"), were comprised of one term loan in the principal amount described in the table above (the "SunTrust Term Loan") and a revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="i2f7f03f2987a4c7fb79e4440534fa07b_I20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMzA0Ng_da19a20d-7c79-4fa3-ae2e-68fcdc0ae4da">30.0</ix:nonFraction> million (the "SunTrust Revolving Credit Facility") both of which are provided pursuant to the Amended and Restated Revolving Credit and Term Loan Agreement dated August 31, 2018, among NJIN, as borrower, with SunTrust Bank, as administrative agent, and the lenders identified therein (as amended, the "SunTrust Credit Agreement").  <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="rdnt:ScheduleOfLeverageRatioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfODE1MQ_13798acf-f268-4640-91c0-9e9b33e2ed3e" continuedAt="i363fa7470272482cbe12210ca6120a97" escape="true">Our SunTrust Term Loan bears interest at either an Adjusted LIBOR or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="i6119ac4bd85e44e9959243796666a7b1" continuedAt="ifbb0db1f7f0d4fd5b5a125683f43ab15"><div style="text-align:justify;text-indent:36pt"><ix:continuation id="i363fa7470272482cbe12210ca6120a97" continuedAt="ic417844239764fdc81839eab6cab2524"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to <ix:nonFraction unitRef="number" contextRef="i6a4c35b6f71f4affa5768a0f639d4a2e_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMS0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjgwNTZjYTQ0NWU4MjQ2MWE4ZjNiMmYxNmVhNGM0NzE1XzI5_5932e248-d623-406d-87ef-68f595c6ec85">3.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib94c9abf453248efa63db38b503a8c1f_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMS0yLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjVmYWZkMmYxYzY3YzQ2NWI5NTg1MjdlYzJlMTRkOGE2XzU_aef539f0-d905-4713-8613-22df37c39128">2.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14767b8798514b70a2a6a74b9bfa6102_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMS0zLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjViMTNlYWRlZTk0MjQ0ZjBiZTNhZDA2OTQ1NDcyODBmXzU_510b4ee0-9e6b-4c5f-86b7-a89cfc7c18cd">1.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6498b4b0455a4c30a9f141fc0c149aa5_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMS00LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjQ2MTgzMmE4MGMyYjQyMGE4M2E2YTZkNjIyYTA0NGFiXzU_f9f8bc6c-323d-4ef9-b019-e380bfa54869">2.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6498b4b0455a4c30a9f141fc0c149aa5_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMS01LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjcwMzA4YTE0YzM1YzQyNDI5MTQ2MzQzZGUwMGQ1YTY5XzU_b1184bb7-e1ba-49e5-bb75-336eeba4297d">0.45</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i77287fbd0d0a43c186ef244cf589e396_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjU1OTJlM2NkMTU4ZTRlMmNhMzc5ZDIwMjc4YjJlMzZiXzE0_ea39a0d2-76e0-4fd0-9f1e-e494019ae5b8">3.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="i77287fbd0d0a43c186ef244cf589e396_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjU1OTJlM2NkMTU4ZTRlMmNhMzc5ZDIwMjc4YjJlMzZiXzUx_cb978cb5-b3a6-44f9-aca7-ee5cc93ea6cd">2.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i21e6a5f9bcb0473b911a70e52c9e9944_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi0yLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmVhNGU1YzQ5MmI3MDRjMDZiOTRkZjY5N2VhMjFlZTNjXzU_b08fc110-c15a-4e39-8f09-7f99a27409e0">2.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0203d30cd0df4077a62703e30f8c9f72_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi0zLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjllZjMzZmIwZmY5YzQxMDRiY2E1YTk0MzI5YzYyMTg1XzU_0f92e885-8c9b-4a1e-bd0c-4438b43d4c6f">1.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i66fff8293b844dbb838b2a1631a77770_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi00LTEtMS0xNDI3OS90ZXh0cmVnaW9uOmMyYTcxYzE4NDE1OTQ5NjI5ZmYwNDg1NTFjNzJiYWUyXzU_a3486d1c-dbe7-4ce3-ae89-6f1fd7c1454b">2.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i66fff8293b844dbb838b2a1631a77770_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi01LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjhjNzY2MjhlZjM2MjQzMGE5M2FmZGExY2RhNTdiMTFiXzU_f47e3aa0-fbdb-4b4a-9d28-146d52b6faa0">0.40</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i7197db62c8b045d3873fabec7ae0b9bb_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmZkMmEzNzBiZDc5MDQwMzg5NGFjMDNmODE5ZDQ0OGUzXzE1_31a6acab-bc69-4052-a460-75ac5171c71d">2.50</ix:nonFraction>:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7197db62c8b045d3873fabec7ae0b9bb_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmZkMmEzNzBiZDc5MDQwMzg5NGFjMDNmODE5ZDQ0OGUzXzUy_d51579a0-8716-4461-b549-07d5ada7aec2">2.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib0748b4650f54d66b1525c3d3fd5f155_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy0yLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmNiYmI4ZmI3Yjg0YzRmZTI4Nzc4ZjFjODU1YTNmMTAzXzU_7a79bb0a-e45a-41bc-b72d-2017f3c1a12b">2.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f32cd9d031641319a66833f52dcf90b_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy0zLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjBlNjhjNTI3MjZlYTRkNzM5YmJlNDliNDZiYTg4YWI3XzU_2cbc21c1-7069-484c-981e-afff973cf5f6">1.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e79888671f849d681c9ca4dc7cbaa90_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy00LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjc3Y2VkNmU2M2Y5NjRiNDJiM2UyMzIxZWFlZDBjYzNiXzU_341c6c45-80b3-4299-b968-0c002df4c105">2.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e79888671f849d681c9ca4dc7cbaa90_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy01LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjMxMDRhYmNjNzQzOTRmMjZhZmU1MWYwMTIzYmI2MDM1XzU_2693a8ea-c43b-445d-94c4-f2b478508170">0.35</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i2d79a719943a464f8d6d78268821d707_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjQ4YTdjYTU4MTIyZjQ3NWI4ZDIwOWIyNTA0Y2FmMzkwXzE0_411b4889-0983-4352-b0fc-df43f203cd14">2.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="i2d79a719943a464f8d6d78268821d707_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjQ4YTdjYTU4MTIyZjQ3NWI4ZDIwOWIyNTA0Y2FmMzkwXzUx_4610a5fe-2e58-455e-9683-7c63cc34a643">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a23d776eb16471e8f49c42bb87a1e64_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC0yLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjg2ODk3ZjNhYjZlNjQwZjg5ZWU5MTZhMzAwODc0NjRhXzU_3609be58-fd2f-4722-b5fb-dc00bd4e3a5c">1.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i284b87cc02134d23929b19658a998ad3_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC0zLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmU2ZTY1ZmU5MmJhNTQzZDM5ZWUzMWEyNzEzMmVlNTljXzU_cd6709fa-a743-488b-b868-ea17820d408a">0.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64766f8ffc80490290a08bed27b2773e_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC00LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjhmMTI2YjhmMjNkYTRjZDJhMzI4N2IyZDE3NDcyOTVjXzU_78f9b19a-ca72-4097-895a-c6955d6c55c6">1.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64766f8ffc80490290a08bed27b2773e_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC01LTEtMS0xNDI3OS90ZXh0cmVnaW9uOmE3ZjcxYjRiNjRkZTRhMTJiYjY0MmFiNmNmMGEyY2E5XzU_9882dcb9-d9e9-4430-8804-cfd4ed6bf640">0.30</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i788b4cad69a643e098e52cb02eb7e58d_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNS0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjEwMmE3YmViZDZkMzQzMzViZTE0NzY4NTQ3ZTljZjhjXzE0_e9256885-1e87-4b3b-9de0-3b3acd81008c">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i216ae89339844560bddb88a4bcab64fb_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNS0yLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmY4NzIwNzU2Mzc0OTQwNDdiNDI1OWZmNjAxMmJjMDZmXzU_80a7ff73-60ef-454a-8afe-5fe1fa6a0610">1.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdf68a9ef0548fb84d159aeddab27f9_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNS0zLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjBjMzNhMjMzODhiNTRiNjk4ZDM4MWExYTIzYTgzN2MxXzU_0dd74bb2-17ab-4511-b132-124f4ec86989">0.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c6b1f79048e42b0884571c09c623080_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNS00LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjE0MTJmODlhYmMwMjRjNTViYjg4NThjN2ExM2MzODQ0XzU_243dbd2c-d8ce-43b4-bee4-eef232fa34ee">1.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c6b1f79048e42b0884571c09c623080_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNS01LTEtMS0xNDI3OS90ZXh0cmVnaW9uOmJlM2U2MTM0ZWFlZDQ0NDdhNDc2ZGRiNzQ5OWYxOGRlXzU_52781483-d9d2-48bd-8f71-ea8e32fe5acb">0.30</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans and other obligations outstanding under the SunTrust Credit Agreement currently bear interest at a three month LIBOR election at <ix:nonFraction unitRef="number" contextRef="ib450abcacaa5468ca7b49d50d7ed31f4_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMzcxMg_ee94925e-85ce-47f5-bf1c-0681a4218a69">0.22</ix:nonFraction>% plus an applicable margin and fees based on Pricing Level V described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $<ix:nonFraction unitRef="usd" contextRef="i12925f11ce794cee9ffd477add1fac2e_D20181231-20181231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMzg5Nw_92ce7a81-7e5a-4fce-baae-56ffc34a9798">0.8</ix:nonFraction> million, representing annual amortization equal to <ix:nonFraction unitRef="number" contextRef="i12925f11ce794cee9ffd477add1fac2e_D20181231-20181231" decimals="INF" name="rdnt:DebtInstrumentPeriodicPaymentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMzk0Mw_f412e665-db95-48ba-8acd-70c56eb96a80">5.0</ix:nonFraction>% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $<ix:nonFraction unitRef="usd" contextRef="i3adb88ce1adf406397b79615c8b29bf7_I20181231" decimals="-5" name="rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNDA3MA_1393b313-e501-45c8-8d79-3d41c9abf41d">0.4</ix:nonFraction> million, with the remaining balance to be paid at maturity.  The SunTrust Term Loan will mature on August 31, 2023 unless otherwise accelerated under the terms of the SunTrust Credit Agreement.</span></div><div><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $<ix:nonFraction unitRef="usd" contextRef="i4b2021e8693c43efb8f3683e1a35b4df_I20210423" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNDQwNA_806bb614-a15f-4bba-911b-89786b2b44d4">195.0</ix:nonFraction> million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $<ix:nonFraction unitRef="usd" contextRef="i4c9e01d6493f43e299012d6df312e4bf_I20220331" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNDU3MA_34b2bd3f-2a87-4314-8682-6a70a849a959">2.0</ix:nonFraction> million at March&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic417844239764fdc81839eab6cab2524" continuedAt="i88141fd142cf4ee69690bcfb2afb7f97">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="i88141fd142cf4ee69690bcfb2afb7f97"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"></td><td style="width:31.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Net Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alternate Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; <ix:nonFraction unitRef="number" contextRef="i6e5edfcb6761487ba2db12d147e1a78a_I20220331" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMS0wLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjhlNjExZTJiZjk4MjQ5MmE5MDIwZjA5NjU2Y2Q4OTdjXzY_ee1c03a1-22a2-4e04-b03c-b3871a4fbc8e">3.50</ix:nonFraction>x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i944cc9d161d74ab4a23982b4cd8bdde3_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMS0xLTEtMS0xNDI3OQ_35707668-31c3-4b3f-83f3-97ede0d7db47">3.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifab2cc344a8d437a8e02749427a7acff_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMS0yLTEtMS0xNDI3OQ_6a0536b1-ae76-4e7f-ba08-35d89e66ca07">2.25</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; <ix:nonFraction unitRef="number" contextRef="i55945c769c1d4cb2adf73dd4dd33aeb1_I20220331" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMi0wLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmUyYjUwYjZlM2I2OTQ3OTI5M2RmMzFjNGUzOTljMDhlXzY_d5117274-43fc-43b0-93df-0ed7340f3f69">3.00</ix:nonFraction>x but &#8804; <ix:nonFraction unitRef="number" contextRef="i5b949300d1bf4eb787b7017dba8800a8_I20220331" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMi0wLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmUyYjUwYjZlM2I2OTQ3OTI5M2RmMzFjNGUzOTljMDhlXzE2_4aaaafa6-eca4-4cc5-92de-23768e63c354">3.50</ix:nonFraction>x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f737acdac8048f2957feb692e3d8687_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMi0xLTEtMS0xNDI3OQ_509d7451-0f32-4021-9440-77a2bdd8b345">3.00</ix:nonFraction>%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if714085c7d9d491f9c016de58ac30e20_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMi0yLTEtMS0xNDI3OQ_a8480453-71a4-4863-8960-dbeac0f7b588">2.00</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; <ix:nonFraction unitRef="number" contextRef="i6f29d5fa82f04e0896fcba4d15e506de_I20220331" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMy0wLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmNjZWQxNzFjOWYxYTRjNWJhNWU5ZDFjMzRmNjU3NmQ1XzY_8ec7ab32-6f11-4217-be58-43887099ed4e">3.00</ix:nonFraction>x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf21c52bd3f345188e62a53c44636392_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMy0xLTEtMS0xNDI3OQ_7aee6163-6108-462b-a372-b5de76489509">2.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c069f2e05fb4ade941f4557b949f231_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMy0yLTEtMS0xNDI3OQ_1a63a9a6-360e-4a95-9d2d-f953456bc2ff">1.75</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was <ix:nonFraction unitRef="number" contextRef="i4c9e01d6493f43e299012d6df312e4bf_I20220331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNTAyMg_3075c3d0-d1ff-4612-9ef4-ba23037799c7">5.25</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently <ix:nonFraction unitRef="number" contextRef="i9ba7bf841c994912865be36c75e38317_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNTIxMQ_f68ac3ac-ea45-4e48-945b-88aed78b1abb">2.75</ix:nonFraction>% and fronting fees accrue at <ix:nonFraction unitRef="number" contextRef="i69b9eb94e2114856a02bf051af39e645_D20220101-20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNTI0Mg_94faa2de-1f68-4e30-87ac-4ae4887f7a74">0.125</ix:nonFraction>% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of <ix:nonFraction unitRef="number" contextRef="i69b9eb94e2114856a02bf051af39e645_D20220101-20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNTQ0Mg_f6735989-3822-4912-9cf4-bce9a5e499aa">0.50</ix:nonFraction>% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="ifbb0db1f7f0d4fd5b5a125683f43ab15"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SunTrust Credit Agreement established a $<ix:nonFraction unitRef="usd" contextRef="i2f7f03f2987a4c7fb79e4440534fa07b_I20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNTc5Mg_fcd7dd84-bf4d-4f49-984e-b661755ed6c9">30.0</ix:nonFraction> million revolving credit facility available to NJIN for funding requirements. The SunTrust Revolving Credit Facility terminates on the earliest of (i) August 31, 2023, (ii) the voluntary termination thereof by NJIN pursuant to Section 2.8 of the SunTrust Credit Agreement, or (iii) the date on which all amounts outstanding under the SunTrust Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  As of March&#160;31, 2022, NJIN had no borrowings under the SunTrust Revolving Credit Facility. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent prior amendments to prior credit facilities:</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the "Eighth Amendment").  The Eighth Amendment amended the prior first lien credit agreement to add $<ix:nonFraction unitRef="usd" contextRef="i2c4dd403dd9e4ae1818b1ff441f9d0fd_I20200828" decimals="INF" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNjY4Mg_f3495d1d-c24c-4aba-82a7-942379d4942c">57.5</ix:nonFraction> million of revolving commitments to the prior Barclays revolving credit facility increasing the maximum borrowing capacity under the prior Barclays revolving credit facility to $<ix:nonFraction unitRef="usd" contextRef="i4b2021e8693c43efb8f3683e1a35b4df_I20210423" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNjg1NA_806bb614-a15f-4bba-911b-89786b2b44d4">195.0</ix:nonFraction> million while leaving the maturity date of July 1, 2023 unchanged.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019 we entered into the following <ix:nonFraction unitRef="center" contextRef="i0dde26745a6044629a509a83ba660edb_I20190418" decimals="INF" name="rdnt:NumberOfAmendments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNjk2NQ_81344636-6d6e-4334-8e58-76edfd268832">two</ix:nonFraction> amendments to the prior first lien credit agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#8220;Sixth Amendment&#8221;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#8220;Seventh Amendment&#8221;).  Among other things, the Sixth Amendment amended the prior first lien credit agreement to issue $<ix:nonFraction unitRef="usd" contextRef="i173683f5805b4c458be4a416f552f961_I20190418" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNzMyMw_650b1920-8dd7-4de9-a85f-2badcdbdf302">100.0</ix:nonFraction> million in incremental first lien term loans and to add an additional $<ix:nonFraction unitRef="usd" contextRef="ice280dd4e241422aad4acecf0b4651de_I20190418" decimals="INF" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNzM4OA_187fa84a-cfb0-4435-b233-b117b75a01d5">20.0</ix:nonFraction> million of revolving commitments to the prior Barclays revolving credit facility.  The Seventh Amendment amended the prior first lien credit agreement to extend the maturity date of the prior Barclays revolving credit facility by an additional <ix:nonNumeric contextRef="i6d0fe3c768bd4ce39293d761c41ecb34_D20190418-20190418" name="rdnt:DebtInstrumentExtensionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNzYyNw_99448021-ab0f-42d5-84e6-d102ced40b63">two years</ix:nonNumeric> to July 1, 2023, unless sooner terminated in accordance with the terms of the prior first lien credit agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The prior first lien credit agreement was amended and restated by the Restated Credit Agreement described above, and the prior first lien term loans and prior Barclays revolving credit facility under the prior first lien credit agreement were refinanced and replaced by the First Lien Term Loans and the Barclays Revolving Credit Facility provided under the Restated Credit Agreement described above.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_52"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7 &#8211; <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMzcxOQ_049a44ee-88e4-4a09-9cd7-793ccfcf25b1" continuedAt="if01c4245967b4d67a13adcb7195039c3" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="if01c4245967b4d67a13adcb7195039c3" continuedAt="ibd4a443f57034df1bbc34984c0aa5633"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="incentiveplan" contextRef="i11e3573789424e659f1797ec670783df_I20210415" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNjk_26ad1308-c3e3-4bb4-a1e9-d21d27103691">one</ix:nonFraction> long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021  (the "Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan <ix:nonFraction unitRef="shares" contextRef="i11e3573789424e659f1797ec670783df_I20210415" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNDUx_d4eb6a5e-edf8-4360-91e0-705654f7d480">16,500,000</ix:nonFraction> shares of common stock. We can issue options (incentive and nonstatutory), performance based options, stock awards (restricted or unrestricted), stock units, performance based stock units, and stock appreciation rights under the Restated Plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option grants, whether incentive or nonstatutory, generally vest over <ix:nonNumeric contextRef="i1f6c8dad5f1a47f795469ebccd173f1a_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNzI0_db37cde9-aff9-4574-9a80-71b5f02be6b3">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNzMw_ae8c0c63-1461-42cf-8fc0-2f3fbd288cd8">5</ix:nonNumeric> years and expire <ix:nonNumeric contextRef="i1f6c8dad5f1a47f795469ebccd173f1a_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNzUw_b99b60e4-a65f-4319-abcc-f3bbe0389526">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNzU2_2b773c42-067f-426e-8abc-aa8a4f7d5789">10</ix:nonNumeric> years from the date of grant.  Under the Restated Plan, stock options may not be granted at a per share exercise price below the fair market value of a share of our common stock on the date of grant, may not be repriced or exchanged without stockholder approval, and the maximum exercisable term of the option may not exceed <ix:nonNumeric contextRef="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA4NA_7d1e9ae4-0764-4e14-9cc8-4c70510e97f1">10</ix:nonNumeric> years.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="ibd4a443f57034df1bbc34984c0aa5633" continuedAt="i2e86f340ed154954bbf0b20e4f7cafa0"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had outstanding options to acquire <ix:nonFraction unitRef="shares" contextRef="i5fe72543c2724817acf22b92b9937440_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTE0Mg_8f4bebb1-cdda-40ff-9ae5-d70bf8cbd9f8">683,914</ix:nonFraction> shares of our common stock, of which options to acquire <ix:nonFraction unitRef="shares" contextRef="i5fe72543c2724817acf22b92b9937440_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTIwMQ_48641de6-1966-49e1-90c0-318015378434">508,969</ix:nonFraction> shares were exercisable. <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMzcyMQ_0885bba8-bf46-42b4-9e54-dc48220fcbc3" continuedAt="ic1a198f1f516422f9e79ccbe8134dcc6" escape="true">The following summarizes all of our option transactions for the three months ended March&#160;31, 2022:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ic1a198f1f516422f9e79ccbe8134dcc6" continuedAt="if5a7dc42998b48a1bb26ad1495438ebe"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9212727f374b4ce7870dbc05eb4d8aab_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfMS0yLTEtMS0xNDI3OQ_fbc5943f-32b5-42c2-b10a-38d28e620cbc">473,939</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9212727f374b4ce7870dbc05eb4d8aab_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfMS00LTEtMS0xNDI3OQ_d217e871-f399-4ada-98f0-eb633fb0eaef">9.38</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if325d72e03184e4ea6e238d77b34f487_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfMi0yLTEtMS0xNDI3OQ_feb2df58-05e4-463c-871f-45cab696c9ad">209,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if325d72e03184e4ea6e238d77b34f487_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfMi00LTEtMS0xNDI3OQ_3396ef88-f466-4ae0-aebe-05abfbc4e822">29.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fe72543c2724817acf22b92b9937440_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNS0yLTEtMS0xNDI3OQ_ed7fbdba-cfaf-4a7b-87bf-2df241399dcc">683,914</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fe72543c2724817acf22b92b9937440_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNS00LTEtMS0xNDI3OQ_e45bca62-a5da-44fc-b538-17747438786d">15.54</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if325d72e03184e4ea6e238d77b34f487_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNS02LTEtMS0xNDI3OQ_9c5e0095-c617-45e7-b148-21d18c212efd">6.49</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe72543c2724817acf22b92b9937440_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNS04LTEtMS0xNDI3OQ_88938eab-b58c-43df-802b-3c537d42b01c">6,157,802</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fe72543c2724817acf22b92b9937440_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNi0yLTEtMS0xNDI3OQ_db159cf7-075d-4e26-ad76-f0ac2b364a48">508,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fe72543c2724817acf22b92b9937440_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNi00LTEtMS0xNDI3OQ_98e35efb-4758-4f60-b489-c80995df785e">11.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if325d72e03184e4ea6e238d77b34f487_D20220101-20220331" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNi02LTEtMS0xNDI3OQ_b19148c2-0d1f-4467-bed2-16cdeb5e441b">5.43</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe72543c2724817acf22b92b9937440_I20220331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNi04LTEtMS0xNDI3OQ_15ca3f05-9042-4d5b-8ba1-71e40cce2989">6,126,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on March&#160;31, 2022 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on March&#160;31, 2022.  As of March&#160;31, 2022, total unrecognized stock-based compensation expense related to non-vested employee awards was $<ix:nonFraction unitRef="usd" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzMjYwOA_a4f4ffe2-8a62-4d8b-8f54-9b86ad790215">2.6</ix:nonFraction> million, which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTkxNw_14c5d4aa-332d-4935-bed6-7f03bfb10d96">2.24</ix:nonNumeric> years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted options to acquire&#160;<ix:nonFraction unitRef="shares" contextRef="icf3ba225c36c476084469d9c6670a07a_D20200401-20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjA3Nw_35dfad2e-ed0a-4a17-9b57-4eede73940f1">412,434</ix:nonFraction>&#160;shares at a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6bb501a256514bab8c456345170a164f_D20200401-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjExNw_c7ed90f2-b6ad-432b-a0c6-260a72316d4b">16.93</ix:nonFraction>&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of March&#160;31, 2022, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $<ix:nonFraction unitRef="usd" contextRef="i8e2634a74afe41adab0fab66686d695b_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjM2NQ_3fb29d89-34a5-43fe-bdb0-b0f2a7ff12fb">1.6</ix:nonFraction> million, which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="ia330bf2f544847c6ba7b2723fd73ac98_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjQ1Mg_33bbbd86-0b80-4f90-b294-1ba5da11a232">1.23</ix:nonNumeric> years</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><ix:continuation id="if5a7dc42998b48a1bb26ad1495438ebe"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:48.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5e7a1236cb84c87a209ab1daf15ec5d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfMS0yLTEtMS0xNDI3OQ_1761a507-d29c-41be-915e-c7e5308802db">320,660</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5e5cdfa72e1f434c8006a75f7440ddfa_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfMi0yLTEtMS0xNDI3OQ_20192704-86ce-4b1b-825d-21ec89309198">12,637</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9638ca6566474cefbd8968ed4929434f_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfMy0yLTEtMS0xNDI3OQ_e0cd33f1-2190-4f3f-bfd8-083bc163a5b5">308,023</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e5cdfa72e1f434c8006a75f7440ddfa_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfMy02LTEtMS0xNDI3OQ_a0fbf8ab-562e-45be-bdd5-5e02f2c6c38e">7.18</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9638ca6566474cefbd8968ed4929434f_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfMy04LTEtMS0xNDI3OQ_8ece2a87-a6ac-4bbb-b84b-b75fa0f45c36">6,890,475</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9638ca6566474cefbd8968ed4929434f_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfNC0yLTEtMS0xNDI3OQ_696248fa-3596-4492-b695-a60c0480c6e3">46,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e5cdfa72e1f434c8006a75f7440ddfa_D20220101-20220331" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfNC02LTEtMS0xNDI3OQ_8df234c2-ebe3-4d3e-ac17-1f6f008a1278">7.18</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9638ca6566474cefbd8968ed4929434f_I20220331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfNC04LTEtMS0xNDI3OQ_d7b389f3-402f-4261-896a-e743163c3765">1,049,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options issued in replacement of original DeepHealth options as a result of our acquisition are not included in the share count under the Restated Plan.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of March&#160;31, 2022, we have issued a total of <ix:nonFraction unitRef="shares" contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjc0NA_2258ed5d-803b-485e-8c73-a10b07f633d6">7,743,651</ix:nonFraction> RSA&#8217;s of which <ix:nonFraction unitRef="shares" contextRef="i02c8a2af4cae4e6e846dbb7f3b47fdb3_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjc2Mg_a646c2cd-8bf1-4290-b2ae-56d830d7e715">438,786</ix:nonFraction> were unvested at March&#160;31, 2022. <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMzcxNw_39cf7d59-4737-4404-9112-a770516af0a9" continuedAt="i37f92506a4f7426cb8927b67c17c78fc" escape="true">The following summarizes all unvested RSA&#8217;s activities during the three months ended March&#160;31, 2022:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i37f92506a4f7426cb8927b67c17c78fc"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id651533cf9634a93ac70355625b736ef_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfMS0xLTEtMS0xNDI3OQ_ec803e09-eac1-4ec7-97ea-feccd1662ff0">456,075</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id651533cf9634a93ac70355625b736ef_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfMS01LTEtMS0xNDI3OQ_7bba8ff7-611e-4adc-a69b-6164f6887604">20.06</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfMy0xLTEtMS0xNDI3OQ_c50b2499-77c5-4759-8765-19b5088f3148">500,622</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfMy01LTEtMS0xNDI3OQ_c3bd500e-2fa3-40f9-964f-b69ca1c75843">28.72</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfNC0xLTEtMS0xNDI3OQ_4112d3b7-a651-4cd3-8be7-552dd1475dca">517,911</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfNC01LTEtMS0xNDI3OQ_fc467c85-6704-411b-b1e0-e50a92894dd4">21.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at March 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02c8a2af4cae4e6e846dbb7f3b47fdb3_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfNi0xLTEtMS0xNDI3OQ_5741743a-2348-4bd0-8f76-5f20c53ad90b">438,786</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfNi0zLTEtMS0xNDI3OQ_1808b9dd-142c-420d-a06d-9ec7f7ca89ff">1.16</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02c8a2af4cae4e6e846dbb7f3b47fdb3_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfNi01LTEtMS0xNDI3OQ_ad8492e2-0634-49bb-b333-bde4fe8b68c0">25.96</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based on the closing price of our common stock on the award date.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><ix:continuation id="i2e86f340ed154954bbf0b20e4f7cafa0"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits share awards not subject to any future service period. These are valued and expensed based on the closing price of our common stock on the date of award. During the three months ended March&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="ia5c138bc3875441b941c772784e63633_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNjU5NzA2OTc3MTQ5Mw_b83c7e39-fa74-4ea8-998f-96bfc4667b6d">no</ix:nonFraction> such awards were granted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock units ("PSUs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the company granted certain employees PSUs with a target award of <ix:nonFraction unitRef="shares" contextRef="ibc2a40dd49e04ddfaf6d85ae95da2eff_D20220101-20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNjk5OQ_6fb06a46-a34a-4417-901d-29df5616c420">25,683</ix:nonFraction> shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="number" contextRef="i097c50f9108e4084a44c52e4dd246bee_D20220101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNzAwMw_394b1ee3-d668-488d-9632-43590f10fbbe">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i34139941895f4c2b87454e78288b6292_D20220101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNzAwOA_3390dc50-2ced-4b23-8271-ef1e7adc5a30">200</ix:nonFraction>% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock options ("PSOs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the company granted certain employees PSOs with a potential to option a maximum of <ix:nonFraction unitRef="shares" contextRef="id250c206c9c1458d9f1fbcfcdf5640d7_D20220101-20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNzA0Nw_7f0543db-2d96-4b9f-9e07-442208c86c04">111,925</ix:nonFraction> shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="shares" contextRef="id200edd7b27544e283a49fdc5f16ae77_I20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNzA1MQ_bda63507-24e1-4533-ac65-a823318e1f15">0</ix:nonFraction> shares to <ix:nonFraction unitRef="shares" contextRef="ie6fa67c017444c96a4b8dc187d33a734_I20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNzA1NQ_72eda54b-ea1e-4d06-bc27-4fb0bd672158">111,925</ix:nonFraction> shares) depending upon the extent to which we achieve a performance condition as determined the board of directors over the period from January 1, 2022 through December 31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restated Plan summary</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the <ix:nonFraction unitRef="shares" contextRef="i11e3573789424e659f1797ec670783df_I20210415" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMzM5NA_d4eb6a5e-edf8-4360-91e0-705654f7d480">16,500,000</ix:nonFraction> shares of common stock reserved for issuance under the Restated Plan, at March&#160;31, 2022, there remain <ix:nonFraction unitRef="shares" contextRef="i2d51580d4825469e821595335785ef53_I20220331" decimals="INF" name="us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMzY1MQ_c1ff5a37-1ae6-4a06-b869-029ef7fa74a9">2,380,364</ix:nonFraction> shares available under the Restated Plan for future issuance.</span></div></ix:continuation><div id="icf50c354d3d14f9eaeb683bc15ad4328_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8 &#8211; <ix:nonNumeric contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81NS9mcmFnOjY0NzczMzQzZThkMTQyZTI5ZmZhZjg3OTc5MjE5ZDU5L3RleHRyZWdpb246NjQ3NzMzNDNlOGQxNDJlMjlmZmFmODc5NzkyMTlkNTlfMzM_5d165f5d-a7fb-4012-a505-d8914b861641" continuedAt="i24518dc9be604561b7c4f6dd166ab787" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i24518dc9be604561b7c4f6dd166ab787" continuedAt="i8f5501360c2c4d7e8d8539a0b185d42b">Formation of majority owned subsidiary</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8f5501360c2c4d7e8d8539a0b185d42b">On April 1, 2022 we entered into Frederick County Radiology, LLC, a partnership with Frederick Health Hospital, Inc. ("Hospital").  The operation will offer multi-modality services out of <ix:nonFraction unitRef="location" contextRef="i05688edf21f347e59b6c396261cdb342_I20220401" decimals="INF" name="rdnt:NumberOfLocationOfferingMultiModalityServices" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81NS9mcmFnOjY0NzczMzQzZThkMTQyZTI5ZmZhZjg3OTc5MjE5ZDU5L3RleHRyZWdpb246NjQ3NzMzNDNlOGQxNDJlMjlmZmFmODc5NzkyMTlkNTlfMTY0OTI2NzQ0NDIxMA_29d4c3eb-b1b0-469a-8988-72fe2cefc970">six</ix:nonFraction> locations in Frederick, Maryland.  RadNet will have a <ix:nonFraction unitRef="number" contextRef="i5b489515e2944df5827ad37c4f4ac39a_D20220401-20220401" decimals="INF" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81NS9mcmFnOjY0NzczMzQzZThkMTQyZTI5ZmZhZjg3OTc5MjE5ZDU5L3RleHRyZWdpb246NjQ3NzMzNDNlOGQxNDJlMjlmZmFmODc5NzkyMTlkNTlfMTA5OTUxMTYzMDMxNA_c7a64c6d-67bf-42c5-913f-b1cc35eabf21">65</ix:nonFraction>% economic interest and Hospital will have a <ix:nonFraction unitRef="number" contextRef="ibf0e02f07fbc478f873c7b8dd2a24f2d_D20220401-20220401" decimals="INF" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81NS9mcmFnOjY0NzczMzQzZThkMTQyZTI5ZmZhZjg3OTc5MjE5ZDU5L3RleHRyZWdpb246NjQ3NzMzNDNlOGQxNDJlMjlmZmFmODc5NzkyMTlkNTlfMTA5OTUxMTYzMDMxOA_9629b765-d748-4ba7-8774-f6ab69764d78">35</ix:nonFraction>% economic interest</ix:continuation>.</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_58"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q and with our audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the U.S. Securities and Exchange Commission (SEC) on March 1, 2022.</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_61"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views about future events and are based on our currently available financial, economic and competitive data and on current business plans. Actual events or results may differ materially depending on risks and uncertainties that may affect our operations, markets, services, prices and other factors.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;assumption&#8221; or the negative of these terms or other comparable terminology. Forward-looking statements in this quarterly report include, among others, statements we make regarding:</span></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">anticipated trends in our revenues, operating expenses or capital expenditures, and our financial guidance;</span></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">expected future market acceptance for our products or services, and the anticipated protection afforded by our competitive strengths in the markets we serve;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">potential timing and impact of changes in regulations impacting our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the ongoing impact on our business, suppliers, payors, customers, referral sources, partners, patients and employees of the COVID-19 pandemic; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the anticipated effect of the measures we are taking to respond to the COVID-19 pandemic</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to successfully acquire and integrate new imaging operations; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">cost savings, efficiencies and improvements anticipated from our investments in artificial intelligence and machine learning products and services; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our future liquidity and our continuing ability to service and remain in compliance with applicable debt covenants or refinance our current indebtedness.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are neither historical facts nor assurances of future performance.  Because forward-looking statements relate to the future, they are inherently subject to known and unknown risks, uncertainties and other factors that are difficult to predict and our of our control.  Our actual results, level of activity, performance or achievements may be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forwards-looking statements.  Important factors that could cause our actual results to differ materially from those indicated or implied in our forward-looking statements include the factors included in &#8220;Risk Factors,&#8221; in our annual report on Form 10-K for the fiscal year ended December 31, 2021 or supplemented by the information in Part II&#8211; Item 1A below. You should consider the inherent limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of predictions contained in such forward-looking statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any forward-looking statement in this quarterly report is based on information currently available to us and speaks only as of the date of this report.  We do not undertake any responsibility to release publicly any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of this quarterly report or any unanticipated events which may cause actual results to differ from those expressed or implied by the forward-looking statements contained in this quarterly report, except as required by law.</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_64"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States based on number of locations and annual imaging revenue. At March&#160;31, 2022, we operated, directly or indirectly through joint ventures with hospitals, 351 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.  Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Artificial Intelligence ("AI") segment that has been established through our acquisitions of  DeepHealth, Nulogix Aidence Holding B.V. and Quantib B.V..  Our current AI focus is to develop solutions that employ machine learning to assist radiologists and other clinicians in interpreting images and improving patient care, initially in the fields of brain, breast, prostate, and pulmonary diagnostics..</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive substantially all of our revenue, directly or indirectly, from fees charged for the diagnostic imaging services performed at our centers. The following table shows our centers in operation and revenues for the three months ended March&#160;31, 2022 and March&#160;31, 2021:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"></td><td style="width:64.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers in operation</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues (millions)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including private, managed care capitated and government payors. We believe our payor diversity mitigates our exposure to possible unfavorable reimbursement trends within any one payor class. In addition, our experience with capitation arrangements over the last several years has provided us with the expertise to manage utilization and pricing effectively, resulting in a predictable stream of revenue. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenue during the three months ended March&#160;31, 2022 and 2021 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,465&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,096&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,087&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,451&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,775&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,647&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,622&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,491&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,742&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,767&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As 2022 begins, our procedure volumes remain strong.  Our acquisitions of Aidence Holding B.V. and Quantib B.V. have expanded our AI initiatives to encompass imaging diagnostics solutions for the most prevalent cancers.  We have also opened five centers through a combination of acquisition and internal development.</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_67"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Investments, Acquisitions and Dispositions, and Joint Venture Activity</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed our medical imaging business through a combination of organic growth, equity investments, acquisitions and joint venture formations. The information below updates our activity of such matters contained in our annual report on Form 10-K for the year ended December 31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we have three equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision Imaging Solutions Ltd., based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $1.2 million  represents a 14.21% equity interest in the company.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million. On January 1, 2019 we funded a convertible promissory note in the amount of $0.1 million that converted into an additional 80,000 shares effective December 21, 2019.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of it operations.  No observable price changes,  impairment in our investment or impairment of the loan receivable was identified as of March&#160;31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-top:10pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Maryland market.  These acquisitions are reported as part of our Imaging Center segment..  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"></td><td style="width:18.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.519%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.061%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#94;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,000</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,013</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,560</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,968</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,560)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94; IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening, in an combination stock and cash purchase.  Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $45.2 million including i) 1,117,872 shares issued at $26.80 per share with a fair value of $30.0 million ii) cash of $1.8 million and iii) assuming liabilities of $11.9 million, $7.4 million in milestone contingent consideration and cash holdback of $4.5 million and iv) a settlement of a loan from RadNet of $1.5 million.  In addition we paid certain seller closing costs through the issuance of 23,362 shares at a fair value of $0.6 million.  We preliminarily recorded $1.0 million in current assets, $0.2 million in property plant and equipment, $27.5 million in intangible assets, $3.2 million in liabilities and $19.2 million in goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening, in a combination stock and cash purchase.  Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $42.3 million including i) 965,058 shares issued at $26.80 per share with a fair value of $25.9 million ii) cash of $11.8 million and iii)  113,303 shares with a fair value at the date of close of $3.0 million and cash holdback of $1.6 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims. We preliminarily recorded $2.4 million million in current assets, $0.1 million in property plant and equipment, $21.3 million in intangible assets, $3.7 million in liabilities and $22.2 million in goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we finalize our estimation of the fair value of the assets acquired and liabilities assumed, additional adjustments may be recorded during the measurement period (a period not to exceed 12 months). The initial accounting is incomplete as of March 31, 2022 for the acquired assets and liabilities as we are currently in the process of completing the assessment of valuation inputs and assumptions as well as completing the assessment of the tax attributes of the business combination. The finalization of the acquisition accounting valuation assessment may result in a change in the valuation of the deferred tax assets and liabilities and intangible assets, along with the opening working capital accounts, which could have a material impact on our results of operations and financial position.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint Venture Activity</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, our joint venture with Calvert Medical Imaging Center, LLC, completed the acquisition of certain assets to strengthen our presence in the Maryland market.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"></td><td style="width:18.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.519%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.061%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC *&#94;</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,922</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,295</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,295)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94; IFRC LLC acquisitions consisted of three subsidiaries of IFRC, two of which were purchased separately by wholly owned RadNet subsidiaries.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the three months ended March 31, 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,746&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately $5.5 million and $5.2 million for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2022 and December&#160;31, 2021 and income statement data for the three months ended March 31, 2022 and 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,119&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,186&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,407&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,722)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,919)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,298)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,370)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,506&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,489&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,214&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,930&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,532&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,746&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,411&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,718&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_70"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a company&#8217;s financial condition and results of operations and require management&#8217;s most difficult, subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods.&#160;In Note 2 to our consolidated financial statements in this quarterly report and in our annual report on Form 10-K for the year ended December&#160;31, 2021, we discuss our significant accounting policies, including those that do not require management to make difficult, subjective or complex judgments or estimates. The most significant areas involving management&#8217;s judgments and estimates are described below.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements were prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues generally relate to net patient fees received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations, changes in business and economic conditions, and the frequent changes in managed care contractual terms resulting from contract re-negotiations and renewals.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon our management's estimate of amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements. Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.  Our estimates and assumptions related to revenue recognition did not change materially for the quarter ended March&#160;31, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provider Relief Fund (COVID-19 Stimulus Funding)</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Provider Relief Fund offers government assistance to eligible providers throughout the healthcare system in support of certain expenses or lost revenue attributable to the coronavirus pandemic. We have recorded provider relief funding in our condensed Consolidated Statements of Operations in the amount of $6.2 million for the three months ended March 31, 2021. No provider relief funding was received for the three months ended March 31, 2022.  Generally, the department of Health and Human Services ("HHS") does not intend to recoup funds as long as a provider's lost revenue and increased expenses exceed the amount of provider relief funding one has received. HHS reserves the right to audit Relief Fund recipients in the future to ensure that this requirement is met and collect any Relief Fund amounts that were made in error or exceed lost revenue or increased expenses due to the pandemic. Failure to comply with the terms and conditions may be grounds for recoupment.  In recognizing revenue associated with provider relief funding our management is required to assess whether our operations have meet the applicable requirements for the funding received.  During the quarter ended March&#160;31, 2022, we continued to evaluate our operating results in light of the most recent government guidance and based on our assessment, the amount of revenue recognized is appropriate.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients.&#160;Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors.&#160;We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.  Our estimates and assumptions for allowances on our account receivable did not change materially during the quarter ended March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combination</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate all acquisitions under the framework Clarifying the Definition of a Business in the accounting guidance. Once a purchase has been determined to be the acquisition of a business, we are required to recognize the assets acquired and the liabilities assumed at their acquisition date fair values. Any portion of the purchase consideration transferred in excess of the net of the acquisition date fair values of the assets acquired and the liabilities assumed, is allocated to goodwill.  The allocation requires our management to make estimates of the value of various assets acquired and liabilities assumed.  While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Indefinite Lived Intangibles</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill at March&#160;31, 2022 totaled $570.2 million.  Indefinite Lived Intangible Assets at March&#160;31, 2022 were $13.2 million and are associated with the value of certain trade name intangibles.  Our management reviews the fair value of our reporting units on an annual basis to determine if an event has occurred which suggest that the fair value of a reporting unit may be impaired.  When we determine the carrying value of a reporting unit exceeds its fair value, an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  The review of fair value requires our management to make assessments of the business and financial prospects for a particular reporting unit.  We tested goodwill for impairment on October 1, 2021.  We also continue at regular intervals to consider the current and expected future economic and market conditions surrounding the COVID-19 pandemic and to date have not had an indication of goodwill impairment being more likely than not through March&#160;31, 2022.</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_73"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Standards</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3, Recent Accounting and Reporting Standards to the financial statements included in this report for further information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the three months ended March&#160;31, 2022 and 2021, the percentage that certain items in the statements of operations bears to total service revenue, inclusive of revenue under capitation contracts.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.853%"><tr><td style="width:1.0%"></td><td style="width:66.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.526%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss (gain) on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(LOSS) INCOME  FROM OPERATIONS</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div style="margin-top:1pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed our medical imaging centers segment through a combination of organic growth, equity investments, acquisitions and joint venture formations.  We have segregated some of our information to demonstrate which is attributable to centers that were in operation through the entirety of the comparison period, and which is attributable to those that were acquired or disposed of during the period.  The discussion below shows a breakdown and analysis of revenue and expenses for the three months ended March&#160;31, 2022 and 2021. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2022 Compared to the Three Months Ended March 31, 2021 </span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenue inclusive of Provider Relief funding where applicable for 2022 and 2021</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$341,167</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$321,567</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19,600</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$314,705</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$305,892</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8,813</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26,462</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15,675</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upswing in revenue reflects an overall same center 6.2% growth in total procedure volumes over the same period in the prior year as business continues to return to pre-COVID-19 levels.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On a same center basis, with routine imaging procedures rising 5.6%, and advanced radiology procedures of MRI, PET and CT, expanding at a combined 7.9%, revenue increased over the same period in the prior year.  Total Provider Relief funding used to offset lost revenue due to the pandemic and included in the above amounts was $6.2 million for the three months ended March 31, 2021.  Excluded amounts refer to revenue contributions for the three month periods ending March 31, 2022 and March 31, 2021, respectively, from centers that were acquired or divested between January 1, 2021 through March 31, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses for the three months ended March 31, 2022 increased approximately $34.7 million, or 11.5%, from $302.6 million for the three months ended March 31, 2021 to $337.3 million for the three months ended March 31, 2022. The following table sets forth a breakdown of our cost of operations and total operating expenses for the three months ended March&#160;31, 2022 and 2021 (in thousands):&#160;</span></div><div style="margin-top:5pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:74.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and professional reading fees, excluding stock-based compensation</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,962&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,204&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and equipment rental</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,623&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,711&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,611&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,337&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,013&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,307)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,271&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,560&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, telecom, utilities, marketing, travel and other expenses.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below provides additional information and analysis on changes in our various operating expenses for the three months ended March&#160;31, 2022 and 2021 (in thousands): </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Salaries and professional reading fees, excluding stock-based compensation and severance</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and Professional Fees</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Salaries</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$196,962</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$177,204</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19,758</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Salaries</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$182,278</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$168,535</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,743</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,684</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8,669</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stemming from the higher procedure volumes noted above, our staffing levels were adjusted to support the influx of patients seeking radiology procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we face inflation in employee cost similar to the general economy as demand returns to pre-Covid levels.  Excluded amounts refer to salaries and professional reading fees for the three month </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">periods ending March 31, 2022 and March 31, 2021, respectively, from centers that were acquired or divested between January 1, 2021 through March 31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation increased $2.6 million, or 32.9% to approximately $10.4 million for the three months ended March 31, 2022 compared to $7.8 million for three months ended March 31, 2021. This increase was driven by the higher fair value of RSA&#8217;s awarded and vested in the first quarter of 2022 as compared to RSA&#8217;s awarded and vested in the prior year&#8217;s first quarter.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Building and equipment rental</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building &amp; Equipment Rental</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,623</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,711</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$912</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,425</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,462</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(1,037)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded Sites</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,198</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,249</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in building and rental expense relates to reduced equipment rental expenses relating to operating lease contracts which ended or were bought out during 2021. Excluded amounts refer to building and equipment rental for the three month periods ending March 31, 2022 and March 31, 2021, respectively, from centers that were acquired or divested between January 1, 2021 through March 31, 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical supplies</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Supplies Expense</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15,557</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,970</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,587</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,505</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,229</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,276</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded Sites</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,052</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$741</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rise in Medical supplies expense corresponds to higher patient volume combined with price increases for contrasting agents used in advanced radiology procedures.  Excluded amounts refer to medical supplies expense for the three month periods ending March 31, 2022 and March 31, 2021, respectively, from centers that were acquired or divested between January 1, 2021 through March 31, 2022. . </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other operating expenses</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Expenses</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$57,611</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$53,337</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,274</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$52,326</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50,521</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,805</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded Sites</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,285</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,816</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expenses increase relates to one time settlement charge for telecom contracts being phased out as part of a change in service provider.  Excluded amounts refer to other operating expenses for the three month periods ending March 31, 2022 and March 31, 2021, respectively, from centers that were acquired or divested between January 1, 2021 through March 31, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional segment operating and non operating expenses:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:48.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,806</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22,569</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,238</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on disposal of equipment and other</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,154</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($1,307)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,461</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($20,819)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($11,245)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,575)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$661</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$654</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$201</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$285</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.6)%</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nm= not meaningful</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.684%"><tr><td style="width:1.0%"></td><td style="width:41.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interest Expense</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11,601</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,826</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(1,224)</span></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#eeeeee;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to derivatives*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,671</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,650</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to amortization**</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$647</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,147</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Interest Expense***</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,283</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8,029</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(745)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*    Includes interest on current and prior derivative instruments not related to debt obligations.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**  Includes combined noncash amortization of deferred loan costs and discount on issuance of debt.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***Includes interest related to our term loans, revolving credit line,notes, finance leases and other.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Excluding the effect of interest expense related to derivatives and amortization for the three months ended March 31, 2022 compared to the three months ended March 31, 2021, interest expense decreased $0.7 million, or 9.3%. </span><span style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%">The reduction in interest expense is attributable to a lower base rate that that was negotiated as part of an amendment to our senior credit facilities which reduced the effective interest rates on our term loan and revolving credit facilities as compared to the same period last year.  Based on recent increases in global interests rates, we expect the effective interest rates on our senior credit facilities, and our related interest expense, to rise in the near term.  See &#8220;Liquidity and Capital Resources&#8221; below for more details on our credit facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To mitigate our future interest expense exposure we have entered into certain interest rate swap agreements.  See the Derivative Instruments section of Note 2, Significant Accounting Policies, to the condensed consolidated financial statements included in this report for more details on our derivative transactions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in earnings from unconsolidated joint ventures</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022 we recognized equity in earnings from unconsolidated joint ventures in the amount of $2.5 million and for three months ended March 31, 2021 we recognized equity in earnings from unconsolidated joint ventures of $2.3 million, an increase of $0.2 million or 10.2%.  The increase was mainly related to the equity in earnings received from our venture operations in Maryland.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AI Segment</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.  We are developing our AI segment initially through acquisition activity.  Our acquisitions of Nulogix and Deephealth comprise the results for 2021.  Our 2022 results now include our recent additions of Aidence Holding B.V and Quantib B.V.  The  breakdown of revenue and expenses of the segment for the three months ended March&#160;31, 2022 and 2021 are as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.514%"><tr><td style="width:1.0%"></td><td style="width:55.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.417%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="9" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$599</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$599</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from Operations</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($5,617)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($1,354)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($4,263)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($504)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$200</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment loss</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($5,113)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($1,554)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($3,559)</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_1063"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use both GAAP and non-GAAP metrics to measure our financial results.  We believe that, in addition to GAAP metrics, certain non-GAAP metrics, such as Adjusted EBITDA assist us in measuring our business performance, cash generated from operations, leverage capacity and ability to service our debt obligations. We believe this information is useful to investors and other interested parties because we are highly leveraged and our non-GAAP metrics remove non-cash and certain other charges that occur in the affected period and provide a basis for measuring the Company's financial condition against other quarters.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and excluding losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishment, bargain purchase gains and non-cash equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to noncontrolling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taking place during the period.  We have not made specific adjustments to our calculation of Adjusted EBITDA in response to COVID 19.  Our net income reflected below includes the effect of revenue received under the Provider Relief Fund of $6.2 million for the three months ended March 31, 2021.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity.  Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is most comparable to the GAAP financial measure, net income attributable to RadNet, Inc. common stockholders. The following is a reconciliation of GAAP net income attributable to RadNet, Inc. common stockholders to Adjusted EBITDA for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"></td><td style="width:58.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.831%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,458&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,593&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,826&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,118&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,656&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash employee stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,307)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non operational rent expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of equipment attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA including losses from AI Segment &amp; Provider Relief Funding</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38,132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45,503</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,248)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA including losses from AI Segment and excluding benefit from Provider Relief Funding</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38,132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses from AI Segment</span></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA excluding losses from AI Segment &amp; Provider Relief Funding</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,717</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,066</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_82"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key balance sheet data related to our liquidity as of March&#160;31, 2022 and December&#160;31, 2021 and income statement data for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:68.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.676%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,713&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,606&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,725&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,062&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital (exclusive of current operating lease liabilities)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,696)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,932&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:68.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.950%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.410%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,767&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,319&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income  attributable to RadNet common stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,458&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations.&#160;In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging centers, the acquisition of additional centers and new diagnostic imaging equipment.&#160;Because our cash </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have credit available from our current credit facilities and borrowing under those facilities is subject to continued compliance with lending covenants.  We currently meet those requirements, and expect that we will continue to do so for the foreseeable future, but substantial and sustained operating losses could impact our ability to borrow under those facilities.  If we are not able to meet such requirements, we may be required to seek additional financing and there can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our subsidiaries or affiliates may from time to time, in our sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sources and Uses of Cash</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key components of our sources and uses of cash for the three months ended:</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.497%"><tr><td style="width:1.0%"></td><td style="width:66.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by operating activities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,084&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,564)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,348)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in financing activities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,313)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,651)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in operating activities for the three  months ended March&#160;31, 2022 was $0.9 million and cash provided by operation activities was  $28.1 million for the three months ended March 31, 2021. Our cash provided by operating activities for the three months ended March&#160;31, 2022 was affected by the non-cash change in fair value of our interest rate hedge of $20.8 million.  Our cash provided by operating activities for the period ended March&#160;31, 2021 was benefited by the receipt of $39.6 million in CMS advances recorded as deferred revenue.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities for the three months ended March&#160;31, 2022, included purchases of property and equipment for approximately $36.6 million and the acquisition of imaging business and other assets for $25.1 million.  As part of our business operations we continually evaluate investment opportunities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities of $3.3 million  for the three months ended March&#160;31, 2022, was due to payment on our term loan obligations. Please see Note 6, Credit Facilities and Notes Payable in the notes to consolidated financials statements for more information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Payments on the associated notes receivables will be reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. At March&#160;31, 2022 we have&#160;$17.0 million, net of discount, remaining to be collected on these agreements. We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain secured credit facilities with Barclays Bank PLC and with SunTrust Bank.  The Barclays credit facilities are comprised of first lien term loans and a revolving credit facility of $195.0 million.  The SunTrust credit facilities are comprised of a term loan and a revolving credit facility of $30.0 million. As of March&#160;31, 2022, we were in compliance with all covenants under our credit facilities.  Deferred financing costs at March&#160;31, 2022, net of accumulated amortization, was $2.0 million and is specifically related to our Barclays revolving credit facility.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our condensed consolidated balance sheets at March&#160;31, 2022 are $764.6 million of total term loan debt (exclusive of unamortized discounts of  $12.7 million) in thousands: </span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:58.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719,563&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,692)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706,871&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,563&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,692)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751,871&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we had no borrowings under our Barclays or SunTrust revolving credit facilities.  After reserves for outstanding letters of credit of $7.8 million on our Barclays Revolving Credit Facility, we have $187.2 million available for borrowing and $30.0 million available under our SunTrust Revolving Credit Facility.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our existing capital resources, anticipated cash from operations and our borrowing capacity under our credit facilities will be sufficient to sustain our operations for the next twelve months and the foreseeable future.  Please see Note 6, Credit Facilities and Notes Payable in the notes to consolidated financials statements for more information on our secured credit facilities and refinancing activity of April 23, 2021.</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_85"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We receive payment for our imaging services exclusively in United States dollars. As a result, our financial results are unlikely to be affected by factors such as changes in foreign currency, exchange rates or weak economic conditions in foreign markets.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign exchange risk with respect to revenues and expenses denominated in the Euro, Canadian Dollar and Hungarian Forint. We have Artificial Intelligence operations in the Netherlands and maintain research and development centers in Canada and Hungary.  At the present time, we do not have any foreign currency exchange contracts to mitigate this risk. At March&#160;31, 2022, a hypothetical 1% decline in the currency exchange rates between the U.S. dollar against these currencies, would have resulted in an annual increase of approximately $0.2 million in operating expenses.&#160;</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Sensitivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We pay interest on various types of debt instruments to our suppliers and lending institutions. The agreements entail either fixed or variable interest rates.&#160; Instruments which have fixed rates are mainly leases on radiology equipment. Variable rate interest obligations relate primarily to amounts borrowed under our outstanding credit facilities.&#160;Accordingly, our interest expense and consequently, our earnings, are affected by changes in short term interest rates. However due to our purchase of caps, described below, the effects of interest rate changes are limited.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We can elect Eurodollar or Base Rate (Prime) interest rate options on amounts outstanding under the First Lien Term Loans.  At March&#160;31, 2022, we had $719.6 million outstanding subject to a Eurodollar election on First Lien Term Loans and our effective 3 month LIBOR rate plus applicable margin was 3.75%. A hypothetical 1% increase in the adjusted Eurodollar rates under the Restated Credit Agreement over the current Eurodollar rate would result in an increase of $7.2 million in annual interest expense and a corresponding decrease in income before taxes. At March&#160;31, 2022, we had $1.8 million loan amount principal outstanding subject to an alternate base rate election on First Lien Term Loans with an effective rate of 5.50%.  A hypothetical 1% increase in the alternative base rate under the First Lien Credit Agreement over the current alternative base rate would result in an increase of $18.1 thousand in annual interest expense and a corresponding decrease in income before taxes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we had $45.0 million outstanding subject to an adjusted Eurodollar election on the SunTrust Restated Credit Agreement. We can elect Eurodollar or Base Rate (Prime) interest rate options on amounts outstanding under the SunTrust Restated Credit Agreement.  At March&#160;31, 2022, our effective LIBOR rate plus applicable margin was 2.51%.  A hypothetical 1% increase in the adjusted Eurodollar rates under the SunTrust Restated Credit Agreement would result in an increase of approximately $0.5 million in annual interest expense and a corresponding decrease in income before taxes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05%  for the $400,000,000 notional.  As of the effective date, we will be liable for premium </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments if interest rates decline below arranged rates, but will receive payments under the 2019 Swaps if interest rates rise above the arranged rates.</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_88"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controls and Procedures</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain controls and procedures designed to ensure that we are able to collect the information we are required to disclose in the reports we file with the SEC, and to process, summarize and disclose this information within the time periods specified in the rules of the SEC. Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has conducted an evaluation of the design and operation of our &#8220;disclosure controls and procedures&#8221; as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report  for the purposes set forth above.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> been no change in our internal control over financial reporting during three months ended March 31, 2022 that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_94"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;Legal Proceedings</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged from time to time in the defense of lawsuits arising out of the ordinary course and conduct of our business. We do not believe that the outcome of any of our current litigation will have a material adverse impact on our business, financial condition and results of operations. However, we could be subsequently named as a defendant in other lawsuits that could adversely affect us.</span></div><div><span><br/></span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_97"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;Risk Factors</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information about the risks and uncertainties related to our business, please see the risk factors described in our annual report on Form 10-K for the year ended December 31, 2021. The risks described in our Form 10-K and Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_100"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we issued 1,141,234 shares of our common stock to complete our purchase of Aidence Holding B.V..The shares were ascribed a value of $30.6 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on January 20, 2022, we issued 965,058 shares of our common stock to complete our purchase of Quantib B.V..  These shares were ascribed a value of $25.7 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All shares were issued pursuant to the private placement exemption contained in Section 4(a)(2) of the Securities Act.</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_103"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;Defaults Upon Senior Securities</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_106"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_109"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;Other Information</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. Exhibits</span></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.974%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000079052622000006/radnet-rwilsonamendedandre.htm">Amended and Restated Severance Agreement dated January 26, 2022 with Ruth Wilson (incorporated by reference to Exhibit 10.20 to the registrant's Annual Report on Form 10-K filed with the SEC on March 1, 2022)**</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000079052622000006/radnet-cgordonamendedandre.htm">Amended and Restated Severance Agreement dated February 24, 2022 with Christine Gordon (incorporated by reference to Exhibit 10.21 to the registrant's Annual Report on Form 10-K filed with the SEC on March 1, 2022)**</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12022exhibit311.htm">Certification of Howard G. Berger, M.D. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12022exhibit312.htm">Certification of Mark D. Stolper pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12022exhibit321.htm">Certification of Howard G. Berger, M.D. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12022exhibit322.htm">Certification of Mark D. Stolper pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from RadNet, Inc.'s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 formatted in Inline XBRL (Extensible Business Reporting Language) includes: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Loss, (iv) the Condensed Consolidated Statements of Changes in Stockholders Equity, (v) the Condensed Consolidated Statements of Cash Flows, and (vi) Notes to the Condensed Consolidated Financial Statements.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** &#160;&#160;&#160;&#160;Indicates management contract or compensatory plan.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="icf50c354d3d14f9eaeb683bc15ad4328_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf50c354d3d14f9eaeb683bc15ad4328_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RADNET, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 10, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Howard G. Berger, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Howard G. Berger, M.D., President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 10, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark D. Stolper</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark D. Stolper, Chief Financial Officer<br/>(Principal Financial and Accounting Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>q12022exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic91312c845964150a3dcedacc381b86d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Howard G. Berger, M.D., certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-Q of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; May&#160;10, 2022 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President, Chief Executive Officer and Chairman of the Board of Directors</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>q12022exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i08209d2fba5248558cf5c1256ee77677_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark D. Stolper, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this report on Form 10-Q of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.    The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; May&#160;10, 2022 </font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>q12022exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4a0e0081ceb846d09fab8a6374fd03b6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended March 31, 2022, as filed with the Securities and Exchange Commission on May 10, 2022 (the &#8220;Report&#8221;), I, Howard G. Berger, M.D., Chairman of the Board of Directors and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2022</font></td></tr></table></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>q12022exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="if40dd22ca9cc4877aada4c4a9ee51cb0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended March 31, 2022, as filed with the Securities and Exchange Commission on May 10, 2022 (the &#8220;Report&#8221;), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 10, 2022</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>rdnt-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:24636b67-e396-4152-b274-3287e4e6d5f6,g:fb9713cf-faca-444a-b4d8-252fbad89deb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rdnt="http://www.radnet.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.radnet.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.radnet.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical">
        <link:definition>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSANDBASISOFPRESENTATION" roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION">
        <link:definition>2101101 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative" roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative">
        <link:definition>2402401 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue">
        <link:definition>2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative">
        <link:definition>2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill">
        <link:definition>2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative">
        <link:definition>2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration">
        <link:definition>2410406 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details- Contingent Consideration)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements">
        <link:definition>2411407 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare">
        <link:definition>2412408 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition">
        <link:definition>2413409 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details- Schedule of Acquisition)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures">
        <link:definition>2414410 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures">
        <link:definition>2415411 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGANDREPORTINGSTANDARD" roleURI="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD">
        <link:definition>2116103 - Disclosure - RECENT ACCOUNTING AND REPORTING STANDARD</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITY" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY">
        <link:definition>2117104 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables">
        <link:definition>2318302 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed">
        <link:definition>2419412 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets Acquired and Liabilities Assumed)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative">
        <link:definition>2420413 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTING" roleURI="http://www.radnet.com/role/SEGMENTREPORTING">
        <link:definition>2121105 - Disclosure - SEGMENT REPORTING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTINGTables" roleURI="http://www.radnet.com/role/SEGMENTREPORTINGTables">
        <link:definition>2322303 - Disclosure - SEGMENT REPORTING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTINGDetails" roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails">
        <link:definition>2423414 - Disclosure - SEGMENT REPORTING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLE" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE">
        <link:definition>2124106 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLETables" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables">
        <link:definition>2325304 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt">
        <link:definition>2426415 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative">
        <link:definition>2427416 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument">
        <link:definition>2428417 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio">
        <link:definition>2429418 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>2130107 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>2331305 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsNarrative" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative">
        <link:definition>2432419 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants">
        <link:definition>2433420 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsRSUs" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs">
        <link:definition>2434421 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS">
        <link:definition>2135108 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>2436422 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rdnt_ScheduleOfLeverageRatioTableTextBlock" abstract="false" name="ScheduleOfLeverageRatioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_IFRCLLCMember" abstract="true" name="IFRCLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSeventhAmendmentMember" abstract="true" name="FirstLienCreditAgreementSeventhAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AdvanceMedicarePayments" abstract="false" name="AdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ImagingCentersMember" abstract="true" name="ImagingCentersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" abstract="false" name="PropertyPlantandEquipmentNetIncludingRightofUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BarclaysMember" abstract="true" name="BarclaysMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AggregateIntrinsicValue" abstract="true" name="AggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_SoftwareMember" abstract="true" name="SoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_OtherSellersMember" abstract="true" name="OtherSellersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_October2023Member" abstract="true" name="October2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_HealthCareManagementServiceMember" abstract="true" name="HealthCareManagementServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NumberofUnconsolidatedJointVentures" abstract="false" name="NumberofUnconsolidatedJointVentures" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_MonthlyAmortizationOfDeferredHedgeGains" abstract="false" name="MonthlyAmortizationOfDeferredHedgeGains" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" abstract="false" name="DebtInstrumentCovenantLiquidityRatioRequiredMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_PerformanceBasedStockUnitsMember" abstract="true" name="PerformanceBasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_COVID19PandemicMember" abstract="true" name="COVID19PandemicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SimiAdventistMember" abstract="true" name="SimiAdventistMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RestatedPlanMember" abstract="false" name="RestatedPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIMember" abstract="true" name="PricingLevelIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioFourMember" abstract="true" name="LeverageRatioFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SocialSecurityTaxEmployerDeferralCARESAct" abstract="false" name="SocialSecurityTaxEmployerDeferralCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_IFRCLLC2Member" abstract="true" name="IFRCLLC2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" abstract="false" name="LineofCreditFacilityIncreaseBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" abstract="true" name="InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_IFRCLLCAcquisitionsMember" abstract="true" name="IFRCLLCAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ContributionsFromNoncontrollingInterests" abstract="false" name="ContributionsFromNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NumberOfAmendments" abstract="false" name="NumberOfAmendments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_AidenceMember" abstract="true" name="AidenceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelVMember" abstract="true" name="PricingLevelVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingContractualLife" abstract="true" name="WeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_LeverageRatioDomain" abstract="true" name="LeverageRatioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FutureServiceMember" abstract="true" name="FutureServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" abstract="false" name="IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PerformanceBasedStockOptionsMember" abstract="true" name="PerformanceBasedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ProceedsFromProviderReliefFunding" abstract="false" name="ProceedsFromProviderReliefFunding" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" abstract="true" name="BusinessCombinationContingentConsiderationLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_ContractsReceivableFactoringReceivable" abstract="false" name="ContractsReceivableFactoringReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CashHoldbackMember" abstract="true" name="CashHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ManagementServiceFees" abstract="false" name="ManagementServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_WorkersCompensationPersonalInjury1Member" abstract="true" name="WorkersCompensationPersonalInjury1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SunTrustMember" abstract="true" name="SunTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_NumberOfLocationOfferingMultiModalityServices" abstract="false" name="NumberOfLocationOfferingMultiModalityServices" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_CertainSellerMember" abstract="true" name="CertainSellerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" abstract="false" name="DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_GlendaleAdvancedImagingMember" abstract="true" name="GlendaleAdvancedImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" abstract="false" name="JointVentureInvestmentAndFinancialInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_OperatingIncomeLossExcludingReliefFunding" abstract="false" name="OperatingIncomeLossExcludingReliefFunding" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LeverageRatioThreeMember" abstract="true" name="LeverageRatioThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementEighthAmendmentMember" abstract="true" name="FirstLienCreditAgreementEighthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioFiveMember" abstract="true" name="LeverageRatioFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DeepHealthIncMember" abstract="true" name="DeepHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentLeverageRatio" abstract="false" name="DebtInstrumentLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_SimiValleyImagingGroupLLCMember" abstract="true" name="SimiValleyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIMember" abstract="true" name="PricingLevelIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CaresActRefundableClaimPercentage" abstract="false" name="CaresActRefundableClaimPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_WhiteRabbit.aiInc.Member" abstract="true" name="WhiteRabbit.aiInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_IFRCLLC1Member" abstract="true" name="IFRCLLC1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSixthAmendmentMember" abstract="true" name="FirstLienCreditAgreementSixthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DignityHealthMember" abstract="true" name="DignityHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentPercent" abstract="false" name="DebtInstrumentPeriodicPaymentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_CapitationArrangementsMember" abstract="true" name="CapitationArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioOneMember" abstract="true" name="LeverageRatioOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_A2019SWAPSMember" abstract="true" name="A2019SWAPSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RepaymentOfAdvanceMedicarePayments" abstract="false" name="RepaymentOfAdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_A2019SWAPS1Member" abstract="true" name="A2019SWAPS1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_October2025Member" abstract="true" name="October2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AIMember" abstract="true" name="AIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_CommercialInsurance1Member" abstract="true" name="CommercialInsurance1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ScriptSenderLlcMember" abstract="false" name="ScriptSenderLlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DeepHealthInc.Member" abstract="true" name="DeepHealthInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquipmentAcquiredAndLeaseholdImprovements" abstract="false" name="EquipmentAcquiredAndLeaseholdImprovements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_Medicaid1Member" abstract="true" name="Medicaid1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_QuantibMember" abstract="true" name="QuantibMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_Medicare1Member" abstract="true" name="Medicare1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIVMember" abstract="true" name="PricingLevelIVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_DebtInstrumentExtensionPeriod" abstract="false" name="DebtInstrumentExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_RestatedAgreementMember" abstract="true" name="RestatedAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FrederickCountyRadiologyLLCMember" abstract="true" name="FrederickCountyRadiologyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionsMember" abstract="true" name="BusinessAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_HealthCarePatientServiceOtherMember" abstract="true" name="HealthCarePatientServiceOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_JointVentureMember" abstract="true" name="JointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIIMember" abstract="true" name="PricingLevelIIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MedicVisionMember" abstract="false" name="MedicVisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NumberOfCenters" abstract="false" name="NumberOfCenters" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_FirstLienTermLoanMember" abstract="false" name="FirstLienTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ProperyAndEquipmentNetMember" abstract="false" name="ProperyAndEquipmentNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementMember" abstract="true" name="FirstLienCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioAxis" abstract="true" name="LeverageRatioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_FrederickHealthHospitalIncMember" abstract="true" name="FrederickHealthHospitalIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PaycheckProtectionProgramLoansMember" abstract="true" name="PaycheckProtectionProgramLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioTwoMember" abstract="true" name="LeverageRatioTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AidenceHoldingBVAndQuantibBVMember" abstract="true" name="AidenceHoldingBVAndQuantibBVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>rdnt-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:24636b67-e396-4152-b274-3287e4e6d5f6,g:fb9713cf-faca-444a-b4d8-252fbad89deb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2e655276-e5b4-4d17-8121-f09f6092581b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_52607e41-b06f-40a9-825d-aef2742891a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2e655276-e5b4-4d17-8121-f09f6092581b" xlink:to="loc_us-gaap_StockholdersEquity_52607e41-b06f-40a9-825d-aef2742891a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a57c371e-18e5-47c7-9a68-97760ec4d3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2e655276-e5b4-4d17-8121-f09f6092581b" xlink:to="loc_us-gaap_MinorityInterest_a57c371e-18e5-47c7-9a68-97760ec4d3ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d1e0cf0f-6b8d-4aa9-ab5d-9b90fdcdc741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2c6d0d1c-cab4-46c9-b013-9d3559ca9d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d1e0cf0f-6b8d-4aa9-ab5d-9b90fdcdc741" xlink:to="loc_us-gaap_Liabilities_2c6d0d1c-cab4-46c9-b013-9d3559ca9d64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a868e16-476a-448d-92bf-6e0c314c7436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d1e0cf0f-6b8d-4aa9-ab5d-9b90fdcdc741" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a868e16-476a-448d-92bf-6e0c314c7436" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b9fada60-269f-4c23-aa79-0e726415585d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_94150921-ad4e-4bdf-8216-4fe3f3c265c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9fada60-269f-4c23-aa79-0e726415585d" xlink:to="loc_us-gaap_CommonStockValue_94150921-ad4e-4bdf-8216-4fe3f3c265c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5af63197-916c-4c98-9689-118802fb2f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9fada60-269f-4c23-aa79-0e726415585d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5af63197-916c-4c98-9689-118802fb2f4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_048b4a83-9abb-4470-b719-274a8c332427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9fada60-269f-4c23-aa79-0e726415585d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_048b4a83-9abb-4470-b719-274a8c332427" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_24ef2255-395d-4557-8c10-82e75c3b50bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9fada60-269f-4c23-aa79-0e726415585d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_24ef2255-395d-4557-8c10-82e75c3b50bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_eac21b77-23e7-42a4-85d6-18d9c66a8bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ae9e0205-6c8d-4f5d-9ec3-e219a986b10a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eac21b77-23e7-42a4-85d6-18d9c66a8bcc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ae9e0205-6c8d-4f5d-9ec3-e219a986b10a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b35b8a6d-0098-463a-92c7-fc72b29d5b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eac21b77-23e7-42a4-85d6-18d9c66a8bcc" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b35b8a6d-0098-463a-92c7-fc72b29d5b5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_85ac2c78-2ee8-406a-8b9b-4e8011b2a19f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eac21b77-23e7-42a4-85d6-18d9c66a8bcc" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_85ac2c78-2ee8-406a-8b9b-4e8011b2a19f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3aba13bd-aeaa-453d-b9c7-71b90b34bb40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eac21b77-23e7-42a4-85d6-18d9c66a8bcc" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3aba13bd-aeaa-453d-b9c7-71b90b34bb40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bb35648e-2cad-489e-81f0-7475359fa67d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2f5c9a66-7ac7-45fc-9f3e-cd2981e35095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb35648e-2cad-489e-81f0-7475359fa67d" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2f5c9a66-7ac7-45fc-9f3e-cd2981e35095" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_867aaa5e-e844-4312-9527-5807ad1b7d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb35648e-2cad-489e-81f0-7475359fa67d" xlink:to="loc_us-gaap_DueToAffiliateCurrent_867aaa5e-e844-4312-9527-5807ad1b7d0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_ced9bfcb-b140-4ca6-8caa-1bbe65f40283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb35648e-2cad-489e-81f0-7475359fa67d" xlink:to="loc_us-gaap_DeferredRevenue_ced9bfcb-b140-4ca6-8caa-1bbe65f40283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_88daeadf-e72d-4de3-90de-e5371f31ade7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb35648e-2cad-489e-81f0-7475359fa67d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_88daeadf-e72d-4de3-90de-e5371f31ade7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_56421a79-f5e7-49f8-b0a4-b18675b02774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb35648e-2cad-489e-81f0-7475359fa67d" xlink:to="loc_us-gaap_NotesPayableCurrent_56421a79-f5e7-49f8-b0a4-b18675b02774" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_bd0e8bd0-1c88-4a13-8f6c-38932cd7424c" xlink:href="rdnt-20220331.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d8f43323-4cfa-4643-a5c6-7d27fd16c9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_bd0e8bd0-1c88-4a13-8f6c-38932cd7424c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d8f43323-4cfa-4643-a5c6-7d27fd16c9f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_dcf14c78-c59f-41dd-8d18-7e1f3edffd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_bd0e8bd0-1c88-4a13-8f6c-38932cd7424c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_dcf14c78-c59f-41dd-8d18-7e1f3edffd6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1ca9b1da-69b3-4b69-be4f-676ae54c2525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5bfcfc99-9efb-4ade-a888-2672666e7fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ca9b1da-69b3-4b69-be4f-676ae54c2525" xlink:to="loc_us-gaap_LiabilitiesCurrent_5bfcfc99-9efb-4ade-a888-2672666e7fd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8c5e34d9-8cf3-49e7-99f1-e4c7ecaab641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ca9b1da-69b3-4b69-be4f-676ae54c2525" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8c5e34d9-8cf3-49e7-99f1-e4c7ecaab641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_4046dc00-2bc1-4968-b683-91c71db3f2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ca9b1da-69b3-4b69-be4f-676ae54c2525" xlink:to="loc_us-gaap_LongTermNotesPayable_4046dc00-2bc1-4968-b683-91c71db3f2d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_37c91a4c-87b3-4842-899c-30000487536f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ca9b1da-69b3-4b69-be4f-676ae54c2525" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_37c91a4c-87b3-4842-899c-30000487536f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_01031656-cd1e-457a-a2ba-5913e71f91dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d4a848ed-2fda-49db-9d57-57e819748228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01031656-cd1e-457a-a2ba-5913e71f91dd" xlink:to="loc_us-gaap_Goodwill_d4a848ed-2fda-49db-9d57-57e819748228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ffc7ad95-3331-428e-9b0a-ab74e6a78b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01031656-cd1e-457a-a2ba-5913e71f91dd" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ffc7ad95-3331-428e-9b0a-ab74e6a78b10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_440fc75d-061a-4304-8ae9-22c29b88b4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01031656-cd1e-457a-a2ba-5913e71f91dd" xlink:to="loc_us-gaap_DepositsAssets_440fc75d-061a-4304-8ae9-22c29b88b4a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_6449efd7-58c4-4ca4-9135-dfc95f1842fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01031656-cd1e-457a-a2ba-5913e71f91dd" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_6449efd7-58c4-4ca4-9135-dfc95f1842fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_3be44468-0547-4936-af83-04a7c57c1887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01031656-cd1e-457a-a2ba-5913e71f91dd" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_3be44468-0547-4936-af83-04a7c57c1887" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c94a6a6b-d5a4-4e43-a501-f5c8f066a5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01031656-cd1e-457a-a2ba-5913e71f91dd" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c94a6a6b-d5a4-4e43-a501-f5c8f066a5f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_ba0b12a4-5c1c-4917-9982-e6af9e9dc1ee" xlink:href="rdnt-20220331.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01031656-cd1e-457a-a2ba-5913e71f91dd" xlink:to="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_ba0b12a4-5c1c-4917-9982-e6af9e9dc1ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_12c9e76a-e006-4704-bf56-1fe7ef8a68d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01031656-cd1e-457a-a2ba-5913e71f91dd" xlink:to="loc_us-gaap_AssetsCurrent_12c9e76a-e006-4704-bf56-1fe7ef8a68d5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ade674d0-4148-4dc4-a695-af8c2633a38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_152731a3-bbbc-47dc-a7ce-a7c7910c577a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ade674d0-4148-4dc4-a695-af8c2633a38a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_152731a3-bbbc-47dc-a7ce-a7c7910c577a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2e4b34af-0d1f-4205-b533-7e143c68dce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ade674d0-4148-4dc4-a695-af8c2633a38a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2e4b34af-0d1f-4205-b533-7e143c68dce4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_75bee431-e3a3-4a4c-9cd3-41b8b32a6e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_8dd06baa-cb67-4d92-8809-de865c82a1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_75bee431-e3a3-4a4c-9cd3-41b8b32a6e88" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_8dd06baa-cb67-4d92-8809-de865c82a1cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_16c4587c-f120-4866-b66d-5218ed554eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_75bee431-e3a3-4a4c-9cd3-41b8b32a6e88" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_16c4587c-f120-4866-b66d-5218ed554eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_6e4d0d6c-6577-4dfb-b212-d101abf0e019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_75bee431-e3a3-4a4c-9cd3-41b8b32a6e88" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_6e4d0d6c-6577-4dfb-b212-d101abf0e019" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_6f903352-66ab-4b8a-9a8f-a62f78d48c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_75bee431-e3a3-4a4c-9cd3-41b8b32a6e88" xlink:to="loc_us-gaap_SeveranceCosts1_6f903352-66ab-4b8a-9a8f-a62f78d48c07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f5f4d5ee-531d-4fd6-a2b2-73f58dee1c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_86f89957-1f71-409f-a50b-1fc8fe6ca5af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f5f4d5ee-531d-4fd6-a2b2-73f58dee1c10" xlink:to="loc_us-gaap_InterestExpenseDebt_86f89957-1f71-409f-a50b-1fc8fe6ca5af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_74e5527a-fe4b-42ad-a6eb-0ef50c9cca8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f5f4d5ee-531d-4fd6-a2b2-73f58dee1c10" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_74e5527a-fe4b-42ad-a6eb-0ef50c9cca8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b34fa01c-c313-45ac-ab65-0742a52141fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f5f4d5ee-531d-4fd6-a2b2-73f58dee1c10" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b34fa01c-c313-45ac-ab65-0742a52141fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_abb0b76b-ea25-49ec-bdf0-9484a082d971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f5f4d5ee-531d-4fd6-a2b2-73f58dee1c10" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_abb0b76b-ea25-49ec-bdf0-9484a082d971" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e680824a-46aa-4833-a002-3519c3e70995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_483851e0-a7d3-4ff7-8ef6-4c523edf185e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e680824a-46aa-4833-a002-3519c3e70995" xlink:to="loc_us-gaap_ProfitLoss_483851e0-a7d3-4ff7-8ef6-4c523edf185e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8fbdbb8c-d56d-40ed-acc3-1846c6538a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e680824a-46aa-4833-a002-3519c3e70995" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8fbdbb8c-d56d-40ed-acc3-1846c6538a4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d56ebd1-65a8-4ffe-b379-644c94482d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f23d939a-06ad-4f3b-af09-4eda38b5b730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d56ebd1-65a8-4ffe-b379-644c94482d7a" xlink:to="loc_us-gaap_OperatingIncomeLoss_f23d939a-06ad-4f3b-af09-4eda38b5b730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ac3520ff-0ad6-4656-a9c1-7daf69b945cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d56ebd1-65a8-4ffe-b379-644c94482d7a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ac3520ff-0ad6-4656-a9c1-7daf69b945cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a30b7ee3-65b3-4d3c-a540-c6cded6081cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2f8bcd13-a18f-4931-814e-2b12d1cc8ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a30b7ee3-65b3-4d3c-a540-c6cded6081cf" xlink:to="loc_us-gaap_OperatingExpenses_2f8bcd13-a18f-4931-814e-2b12d1cc8ee7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_2c0ea405-1ee6-42cc-aabf-b96b303c22d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a30b7ee3-65b3-4d3c-a540-c6cded6081cf" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_2c0ea405-1ee6-42cc-aabf-b96b303c22d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b1639e8a-6c5b-4d75-bd65-7979e0cb1312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a30b7ee3-65b3-4d3c-a540-c6cded6081cf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b1639e8a-6c5b-4d75-bd65-7979e0cb1312" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d4c02b43-dc23-46b4-be6c-972db871ede2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_592d403d-70fd-4053-b466-1c2c39c37f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d4c02b43-dc23-46b4-be6c-972db871ede2" xlink:to="loc_us-gaap_ProfitLoss_592d403d-70fd-4053-b466-1c2c39c37f0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6c03ef97-c6c2-4030-8d56-81cdf39b43fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d4c02b43-dc23-46b4-be6c-972db871ede2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6c03ef97-c6c2-4030-8d56-81cdf39b43fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6594c256-4486-4bbc-8054-5c82c55e377a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d4c02b43-dc23-46b4-be6c-972db871ede2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6594c256-4486-4bbc-8054-5c82c55e377a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e581b1fd-364e-40a8-980a-5e320e8f3d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_751cba46-a614-4e91-a9f7-28760b52895e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e581b1fd-364e-40a8-980a-5e320e8f3d8e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_751cba46-a614-4e91-a9f7-28760b52895e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ceddc1c8-8979-45e1-aed4-28cf34e84643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e581b1fd-364e-40a8-980a-5e320e8f3d8e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ceddc1c8-8979-45e1-aed4-28cf34e84643" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d9a8cf3-7c68-4a94-ad62-b69053e4d37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_b8da0117-bbe3-48fc-b574-8a6d663255cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d9a8cf3-7c68-4a94-ad62-b69053e4d37f" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_b8da0117-bbe3-48fc-b574-8a6d663255cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_f25412e8-911b-4ca1-ba34-6bff5839a3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d9a8cf3-7c68-4a94-ad62-b69053e4d37f" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_f25412e8-911b-4ca1-ba34-6bff5839a3ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ce59b3e9-6a6f-46f7-b088-1a9ea8bfa256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d9a8cf3-7c68-4a94-ad62-b69053e4d37f" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ce59b3e9-6a6f-46f7-b088-1a9ea8bfa256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd442d45-c04a-424d-943a-3c040d6ed361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3624319d-2617-4b5e-82de-90b36bf9b579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd442d45-c04a-424d-943a-3c040d6ed361" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3624319d-2617-4b5e-82de-90b36bf9b579" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2406c96b-73c3-4573-8e7a-7a4bb278c389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd442d45-c04a-424d-943a-3c040d6ed361" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2406c96b-73c3-4573-8e7a-7a4bb278c389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcae0783-d5d2-46d9-8874-db5232489c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd442d45-c04a-424d-943a-3c040d6ed361" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcae0783-d5d2-46d9-8874-db5232489c41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_124b7816-f116-4455-bb39-ad5059c9431c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd442d45-c04a-424d-943a-3c040d6ed361" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_124b7816-f116-4455-bb39-ad5059c9431c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_937326b7-f24f-4ba5-be13-3c4d2cc3f261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_ProfitLoss_937326b7-f24f-4ba5-be13-3c4d2cc3f261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2ac13771-8bf6-4497-9b4c-9b875cf7a394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2ac13771-8bf6-4497-9b4c-9b875cf7a394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5973001b-1fe7-4a0f-a96c-008ec82ff880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5973001b-1fe7-4a0f-a96c-008ec82ff880" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_06c28cee-06df-446f-be96-a66e1e94b9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_06c28cee-06df-446f-be96-a66e1e94b9c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_5b7b3b1b-f5c7-40d7-ba17-bc73172a7aee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_5b7b3b1b-f5c7-40d7-ba17-bc73172a7aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_12df14f6-58c8-4845-a7aa-23f3cf5470fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_12df14f6-58c8-4845-a7aa-23f3cf5470fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_4e1d7cee-b62b-4d0b-a144-2b7b159d3472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_4e1d7cee-b62b-4d0b-a144-2b7b159d3472" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8de61051-fb32-4fb0-84eb-d4bb733bced7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_ShareBasedCompensation_8de61051-fb32-4fb0-84eb-d4bb733bced7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8a8cbd4d-cf3a-4ce1-8b0d-865cd04d139b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8a8cbd4d-cf3a-4ce1-8b0d-865cd04d139b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_51dd56a5-5a19-43e2-b691-b7b4ab05c41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_51dd56a5-5a19-43e2-b691-b7b4ab05c41a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_c36d7d7e-31cf-4f2a-9ca1-cf0844c0640c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_c36d7d7e-31cf-4f2a-9ca1-cf0844c0640c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_fe16a0ea-3051-4f77-b180-3834387385e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_fe16a0ea-3051-4f77-b180-3834387385e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a2350c5a-e8ab-4303-9070-6b19890078bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a2350c5a-e8ab-4303-9070-6b19890078bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_bcb820c7-16c0-47f5-bda3-126a1319a444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_bcb820c7-16c0-47f5-bda3-126a1319a444" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_20a4fdbb-2d59-4cf6-bcb4-b3b7d5f1d8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_20a4fdbb-2d59-4cf6-bcb4-b3b7d5f1d8e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_23e7b70c-5a56-4bba-a1bc-4b4344e8afb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_23e7b70c-5a56-4bba-a1bc-4b4344e8afb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_466b2343-5616-494f-9f92-c53eeb9b1001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb0b458b-7e7a-4fc1-8716-6c793a7e81f2" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_466b2343-5616-494f-9f92-c53eeb9b1001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_68d3ae64-17b2-46bb-a994-2b6b0008b0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_31578976-3953-40cd-8cd9-06ef4ca029c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_68d3ae64-17b2-46bb-a994-2b6b0008b0c9" xlink:to="loc_us-gaap_RepaymentsOfDebt_31578976-3953-40cd-8cd9-06ef4ca029c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_c7431406-0226-43ae-aa0a-85357882b123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_68d3ae64-17b2-46bb-a994-2b6b0008b0c9" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_c7431406-0226-43ae-aa0a-85357882b123" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_8ef07268-a9dc-4662-976b-2a820cec70f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_68d3ae64-17b2-46bb-a994-2b6b0008b0c9" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_8ef07268-a9dc-4662-976b-2a820cec70f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_dbfa6ccb-5955-41aa-bd2a-d93de450a3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_68d3ae64-17b2-46bb-a994-2b6b0008b0c9" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_dbfa6ccb-5955-41aa-bd2a-d93de450a3b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_68b78f40-d32f-432c-a7a2-91bfb3bd3997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_68d3ae64-17b2-46bb-a994-2b6b0008b0c9" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_68b78f40-d32f-432c-a7a2-91bfb3bd3997" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f2773567-f0fb-4064-bb15-370166624f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_005e9c37-8c2c-4892-8f62-c647657d69ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f2773567-f0fb-4064-bb15-370166624f0b" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_005e9c37-8c2c-4892-8f62-c647657d69ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_e664767d-5682-42bf-836b-f4add636f9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f2773567-f0fb-4064-bb15-370166624f0b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_e664767d-5682-42bf-836b-f4add636f9fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_42f94ec3-3b8b-490c-802c-a920802924fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f2773567-f0fb-4064-bb15-370166624f0b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_42f94ec3-3b8b-490c-802c-a920802924fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7443b629-06d8-45ca-9ef7-d7bc68d40bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_7aaf5171-6495-49ca-98bf-830477955f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7443b629-06d8-45ca-9ef7-d7bc68d40bc7" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_7aaf5171-6495-49ca-98bf-830477955f3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_32618fbe-fa9a-4d8d-86ca-757d12e48cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7443b629-06d8-45ca-9ef7-d7bc68d40bc7" xlink:to="loc_us-gaap_EquityMethodInvestments_32618fbe-fa9a-4d8d-86ca-757d12e48cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_bada4148-116c-41d4-bd59-de4cb3aaa001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_830ce412-3b00-4aa4-9094-c210c27cd72a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_bada4148-116c-41d4-bd59-de4cb3aaa001" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_830ce412-3b00-4aa4-9094-c210c27cd72a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c139aa09-7a0b-4103-ba89-dfe056ecdde1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_bada4148-116c-41d4-bd59-de4cb3aaa001" xlink:to="loc_us-gaap_LiabilitiesCurrent_c139aa09-7a0b-4103-ba89-dfe056ecdde1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0fa4a557-875d-4796-8bb2-b56aa9a98294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_bada4148-116c-41d4-bd59-de4cb3aaa001" xlink:to="loc_us-gaap_AssetsCurrent_0fa4a557-875d-4796-8bb2-b56aa9a98294" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_6bc0f00e-c9f6-44a7-ab2a-9907e62aa4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_bada4148-116c-41d4-bd59-de4cb3aaa001" xlink:to="loc_us-gaap_AssetsNoncurrent_6bc0f00e-c9f6-44a7-ab2a-9907e62aa4f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20220331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_02c92310-f0d1-4f1f-b668-5c93dec0d668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_e66f9f7f-4585-4fd0-88b1-7e211b50dcd7" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_02c92310-f0d1-4f1f-b668-5c93dec0d668" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_e66f9f7f-4585-4fd0-88b1-7e211b50dcd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_3f3c2a40-7f66-477d-b39d-59762f46a2f0" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_02c92310-f0d1-4f1f-b668-5c93dec0d668" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_3f3c2a40-7f66-477d-b39d-59762f46a2f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_de3d9a06-6b37-496d-aaaf-58e26250e22f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_02c92310-f0d1-4f1f-b668-5c93dec0d668" xlink:to="loc_us-gaap_Goodwill_de3d9a06-6b37-496d-aaaf-58e26250e22f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_d08d4ad1-0915-469b-992b-1b5181451f57" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_02c92310-f0d1-4f1f-b668-5c93dec0d668" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_d08d4ad1-0915-469b-992b-1b5181451f57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b8d3c5ac-293d-4499-a327-baf4b8ab6560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_02c92310-f0d1-4f1f-b668-5c93dec0d668" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b8d3c5ac-293d-4499-a327-baf4b8ab6560" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_78f3b481-5421-43d4-80b8-47d819bcf2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ac66de20-b8cf-4770-b8a1-57609fa87f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_78f3b481-5421-43d4-80b8-47d819bcf2f5" xlink:to="loc_us-gaap_LongTermDebtCurrent_ac66de20-b8cf-4770-b8a1-57609fa87f49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f8809e10-28e0-46ce-88c3-d4cf69e6a463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_78f3b481-5421-43d4-80b8-47d819bcf2f5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f8809e10-28e0-46ce-88c3-d4cf69e6a463" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>rdnt-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:24636b67-e396-4152-b274-3287e4e6d5f6,g:fb9713cf-faca-444a-b4d8-252fbad89deb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="if7ebcc14843b4abe8202aa0bd2beb75b_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_35bfc0ac-8b34-4819-9b06-bcb40f049a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_RevenuesAbstract_35bfc0ac-8b34-4819-9b06-bcb40f049a03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6f3f9fde-fe93-4915-8a6f-a1211fc2d518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_35bfc0ac-8b34-4819-9b06-bcb40f049a03" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6f3f9fde-fe93-4915-8a6f-a1211fc2d518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_02b9d10d-2542-4c07-9cb8-c68b88b6ca21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_35bfc0ac-8b34-4819-9b06-bcb40f049a03" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_02b9d10d-2542-4c07-9cb8-c68b88b6ca21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_9682f116-d91f-41f1-aa7b-ceae62f84661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_9682f116-d91f-41f1-aa7b-ceae62f84661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9518398d-c987-418d-b223-6b1458836b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9518398d-c987-418d-b223-6b1458836b37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_1025fda9-e09a-4e7c-9ffd-dc4e8e8ea32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_1025fda9-e09a-4e7c-9ffd-dc4e8e8ea32a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_ef8b1c8d-0edf-4f7b-8a35-5b7596aad4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:to="loc_us-gaap_SeveranceCosts1_ef8b1c8d-0edf-4f7b-8a35-5b7596aad4e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_fb6714b5-e846-4606-ad69-38bde76f2509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:to="loc_us-gaap_OperatingExpenses_fb6714b5-e846-4606-ad69-38bde76f2509" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b26309fc-bfe2-4e3d-8f3e-fbd6c76f5289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_OperatingIncomeLoss_b26309fc-bfe2-4e3d-8f3e-fbd6c76f5289" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_769f1735-b000-4439-b19c-42276ce0ea49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:to="loc_us-gaap_InterestExpenseDebt_769f1735-b000-4439-b19c-42276ce0ea49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d4f3385a-0fab-4940-a97e-e7c94779f498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d4f3385a-0fab-4940-a97e-e7c94779f498" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_dbb3cb13-58b0-411f-a31f-f6148989b091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_dbb3cb13-58b0-411f-a31f-f6148989b091" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e88658c9-2ee6-4ea3-818d-cd4d1eff2507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e88658c9-2ee6-4ea3-818d-cd4d1eff2507" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d675e511-25f6-400e-aad3-6d63e69970b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d675e511-25f6-400e-aad3-6d63e69970b8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_45b84726-ad00-4b55-8838-889af2628300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_45b84726-ad00-4b55-8838-889af2628300" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b0880b1a-02ee-4505-884d-d006da43e29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b0880b1a-02ee-4505-884d-d006da43e29b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_58344038-2a58-4b89-805d-55c7fb7cb9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_ProfitLoss_58344038-2a58-4b89-805d-55c7fb7cb9bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e267efb7-7bb5-4dbb-9232-7a47e8271beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e267efb7-7bb5-4dbb-9232-7a47e8271beb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5f7f7745-3a6e-48f0-a829-a8fe14c32b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_NetIncomeLoss_5f7f7745-3a6e-48f0-a829-a8fe14c32b36" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6c19fb70-c5eb-4147-b8d6-33d6200564f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_EarningsPerShareBasic_6c19fb70-c5eb-4147-b8d6-33d6200564f8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_287e62e2-ae26-4d44-969d-0d88df7d32e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_287e62e2-ae26-4d44-969d-0d88df7d32e3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00064da9-6e43-453b-9233-c9a58b712470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00064da9-6e43-453b-9233-c9a58b712470" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02c22fd2-a946-4f21-9ec9-d39eaa881914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00064da9-6e43-453b-9233-c9a58b712470" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02c22fd2-a946-4f21-9ec9-d39eaa881914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4163e169-399c-4bbd-9655-f9bae9dafeab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00064da9-6e43-453b-9233-c9a58b712470" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4163e169-399c-4bbd-9655-f9bae9dafeab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f99fa4bc-d23d-421c-83e8-c33d591601fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_StatementTable_f99fa4bc-d23d-421c-83e8-c33d591601fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0ea662ff-ac70-470a-8fd7-1053a6f08495" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f99fa4bc-d23d-421c-83e8-c33d591601fc" xlink:to="loc_srt_ProductOrServiceAxis_0ea662ff-ac70-470a-8fd7-1053a6f08495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0ea662ff-ac70-470a-8fd7-1053a6f08495_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0ea662ff-ac70-470a-8fd7-1053a6f08495" xlink:to="loc_srt_ProductsAndServicesDomain_0ea662ff-ac70-470a-8fd7-1053a6f08495_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_40acc0eb-9f9b-4cf9-afa3-65e93cc2cd0e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0ea662ff-ac70-470a-8fd7-1053a6f08495" xlink:to="loc_srt_ProductsAndServicesDomain_40acc0eb-9f9b-4cf9-afa3-65e93cc2cd0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_4bf7f5fc-5e08-46b1-a5a6-12290d786e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_40acc0eb-9f9b-4cf9-afa3-65e93cc2cd0e" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_4bf7f5fc-5e08-46b1-a5a6-12290d786e7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_6a5e1e07-9958-4d6d-9879-70bea568a181" xlink:href="rdnt-20220331.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_40acc0eb-9f9b-4cf9-afa3-65e93cc2cd0e" xlink:to="loc_rdnt_CapitationArrangementsMember_6a5e1e07-9958-4d6d-9879-70bea568a181" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="if57b5db01e6447eda6781ef32c93dab1_CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cccbf66a-8d68-4e6b-b197-b8686c9128d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cccbf66a-8d68-4e6b-b197-b8686c9128d2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1c18dcc9-786d-413f-9cfa-108691ee77e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_SharesOutstanding_1c18dcc9-786d-413f-9cfa-108691ee77e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5d3bdaf-2ceb-4d8a-923e-07c7ec1ced17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5d3bdaf-2ceb-4d8a-923e-07c7ec1ced17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a44b6824-05d3-44f2-9313-0f59be7c577a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a44b6824-05d3-44f2-9313-0f59be7c577a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_866415c8-6b33-4eac-b62b-0bbaeac4bece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_866415c8-6b33-4eac-b62b-0bbaeac4bece" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_c99ac0db-611e-4793-89f9-f7652ca4e8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_c99ac0db-611e-4793-89f9-f7652ca4e8b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_79f79720-948e-452d-8d45-8bff1bd4a7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_79f79720-948e-452d-8d45-8bff1bd4a7ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_79461a6e-eaf6-42fb-89a6-cd24dfbc65b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_79461a6e-eaf6-42fb-89a6-cd24dfbc65b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests_ed2bf835-c01a-4b50-b80c-4661d1196776" xlink:href="rdnt-20220331.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_rdnt_ContributionsFromNoncontrollingInterests_ed2bf835-c01a-4b50-b80c-4661d1196776" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_28032968-4f7f-4927-a525-aee060d19cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_28032968-4f7f-4927-a525-aee060d19cf7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6521fec8-f8e5-4c8f-91b5-2e03c0e965af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6521fec8-f8e5-4c8f-91b5-2e03c0e965af" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_a55c5ef5-b4e6-4db3-8315-a29491501c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockholdersEquityOther_a55c5ef5-b4e6-4db3-8315-a29491501c18" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6ac23167-60f1-4b30-bdba-4bb6d5708239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_ProfitLoss_6ac23167-60f1-4b30-bdba-4bb6d5708239" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_83eb497b-d55c-435b-8ef4-b63bcfbc1844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b81916bf-4282-419f-a4e5-a81735ee6af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6f24b149-294a-4c27-bfec-85e8f516303e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_cccbf66a-8d68-4e6b-b197-b8686c9128d2" xlink:to="loc_us-gaap_StatementTable_6f24b149-294a-4c27-bfec-85e8f516303e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_25bf38ef-42bc-475e-ad21-2e22ac2d5b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6f24b149-294a-4c27-bfec-85e8f516303e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_25bf38ef-42bc-475e-ad21-2e22ac2d5b08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_25bf38ef-42bc-475e-ad21-2e22ac2d5b08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25bf38ef-42bc-475e-ad21-2e22ac2d5b08" xlink:to="loc_us-gaap_EquityComponentDomain_25bf38ef-42bc-475e-ad21-2e22ac2d5b08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9918e186-5dab-4d21-abf7-410e96433dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25bf38ef-42bc-475e-ad21-2e22ac2d5b08" xlink:to="loc_us-gaap_EquityComponentDomain_9918e186-5dab-4d21-abf7-410e96433dac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9918e186-5dab-4d21-abf7-410e96433dac" xlink:to="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5b2a3589-08cd-408e-9d65-7f09e83bf715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:to="loc_us-gaap_CommonStockMember_5b2a3589-08cd-408e-9d65-7f09e83bf715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_36180c57-9ef9-45f6-9adf-c87f4e214cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_36180c57-9ef9-45f6-9adf-c87f4e214cd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_358ef6e3-2d7a-4017-9746-c5dbe611e4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_358ef6e3-2d7a-4017-9746-c5dbe611e4b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_517ec737-cff1-491f-8e7c-504c389c948c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:to="loc_us-gaap_RetainedEarningsMember_517ec737-cff1-491f-8e7c-504c389c948c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9992076c-f48b-4cce-b5e7-5d787cc0945f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9918e186-5dab-4d21-abf7-410e96433dac" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9992076c-f48b-4cce-b5e7-5d787cc0945f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bab60446-13ea-4351-bea6-83d118abddf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6f24b149-294a-4c27-bfec-85e8f516303e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bab60446-13ea-4351-bea6-83d118abddf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bab60446-13ea-4351-bea6-83d118abddf2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bab60446-13ea-4351-bea6-83d118abddf2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bab60446-13ea-4351-bea6-83d118abddf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57040d81-ba00-44d6-8fd2-ef63e3577e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bab60446-13ea-4351-bea6-83d118abddf2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57040d81-ba00-44d6-8fd2-ef63e3577e4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_105ab3c6-6f86-4407-9591-e2505fa07d1b" xlink:href="rdnt-20220331.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57040d81-ba00-44d6-8fd2-ef63e3577e4b" xlink:to="loc_rdnt_DeepHealthInc.Member_105ab3c6-6f86-4407-9591-e2505fa07d1b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="extended" id="ib28b5d9fff9343a190437e11298e4150_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_90a8c765-5124-4c34-b624-78e17cb36991" xlink:href="rdnt-20220331.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_90a8c765-5124-4c34-b624-78e17cb36991" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_58fdab7c-0f05-48ae-b554-90a8afd86a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_58fdab7c-0f05-48ae-b554-90a8afd86a67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_2b6104b5-a520-46d7-b602-6ed8f1be6a49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_2b6104b5-a520-46d7-b602-6ed8f1be6a49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_69105774-376c-4bcc-8a4e-f130a22bd657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_69105774-376c-4bcc-8a4e-f130a22bd657" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_1e16065b-71e7-4190-b5af-b16fe6a5de66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_1e16065b-71e7-4190-b5af-b16fe6a5de66" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3b18c2de-54bc-447d-9184-64335f1dae53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_us-gaap_StatementTable_3b18c2de-54bc-447d-9184-64335f1dae53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_01b4981a-dab8-4c04-9fe2-5131b5046f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3b18c2de-54bc-447d-9184-64335f1dae53" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_01b4981a-dab8-4c04-9fe2-5131b5046f8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_01b4981a-dab8-4c04-9fe2-5131b5046f8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_01b4981a-dab8-4c04-9fe2-5131b5046f8f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_01b4981a-dab8-4c04-9fe2-5131b5046f8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f592cdf1-9a9d-4660-8033-14c890c8b53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_01b4981a-dab8-4c04-9fe2-5131b5046f8f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f592cdf1-9a9d-4660-8033-14c890c8b53f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_88c8f46e-89d8-4b73-9e5a-53afee3adb6b" xlink:href="rdnt-20220331.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f592cdf1-9a9d-4660-8033-14c890c8b53f" xlink:to="loc_rdnt_AidenceMember_88c8f46e-89d8-4b73-9e5a-53afee3adb6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_4c7654bc-222f-4757-b986-f87cadf1e3e9" xlink:href="rdnt-20220331.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f592cdf1-9a9d-4660-8033-14c890c8b53f" xlink:to="loc_rdnt_QuantibMember_4c7654bc-222f-4757-b986-f87cadf1e3e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_32548eb2-69b7-444e-9df9-9ce7e072d6ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3b18c2de-54bc-447d-9184-64335f1dae53" xlink:to="loc_dei_LegalEntityAxis_32548eb2-69b7-444e-9df9-9ce7e072d6ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_32548eb2-69b7-444e-9df9-9ce7e072d6ac_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_32548eb2-69b7-444e-9df9-9ce7e072d6ac" xlink:to="loc_dei_EntityDomain_32548eb2-69b7-444e-9df9-9ce7e072d6ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3815a56b-2254-4f99-bf11-9b70af13bf95" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_32548eb2-69b7-444e-9df9-9ce7e072d6ac" xlink:to="loc_dei_EntityDomain_3815a56b-2254-4f99-bf11-9b70af13bf95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_5866b0a9-5dac-4ee4-b759-eadf6721c744" xlink:href="rdnt-20220331.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3815a56b-2254-4f99-bf11-9b70af13bf95" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_5866b0a9-5dac-4ee4-b759-eadf6721c744" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_af70cf5a-e42b-473a-92fb-d623ac67e990" xlink:href="rdnt-20220331.xsd#rdnt_SimiAdventistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3815a56b-2254-4f99-bf11-9b70af13bf95" xlink:to="loc_rdnt_SimiAdventistMember_af70cf5a-e42b-473a-92fb-d623ac67e990" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative" xlink:type="extended" id="iff338683754244968cddd579244ca3f0_NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_dc8d13c9-8ee9-42fb-91e3-920512f2f137" xlink:href="rdnt-20220331.xsd#rdnt_NumberOfCenters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_rdnt_NumberOfCenters_dc8d13c9-8ee9-42fb-91e3-920512f2f137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_4bd5cf45-ef69-41f0-9f6b-1a1bb6f82250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_NumberOfReportableSegments_4bd5cf45-ef69-41f0-9f6b-1a1bb6f82250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_3630f918-3ad0-4745-9c35-64d647114d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_3630f918-3ad0-4745-9c35-64d647114d7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_9797a7e8-23dd-42f0-986f-b461c6ae3407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_9797a7e8-23dd-42f0-986f-b461c6ae3407" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_b5356632-29f5-4e0f-9d2a-c6c516d43f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_b5356632-29f5-4e0f-9d2a-c6c516d43f23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e7415022-0efd-4426-8208-c854526d2b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_Assets_e7415022-0efd-4426-8208-c854526d2b6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_90e73d01-ea9b-4fe8-8fa6-a3621cadc7de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_Liabilities_90e73d01-ea9b-4fe8-8fa6-a3621cadc7de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_05b8a4bf-1c34-474f-82c4-16c1666beb71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_05b8a4bf-1c34-474f-82c4-16c1666beb71" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_db05a12a-db5d-490d-8360-a839500aa2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_EquityMethodInvestments_db05a12a-db5d-490d-8360-a839500aa2d6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_61758de2-ff55-494e-bc9e-af58f3087244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_61758de2-ff55-494e-bc9e-af58f3087244" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_59484ea4-03c1-4264-a13e-fc1b498d6ee8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_59484ea4-03c1-4264-a13e-fc1b498d6ee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_59484ea4-03c1-4264-a13e-fc1b498d6ee8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_59484ea4-03c1-4264-a13e-fc1b498d6ee8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_59484ea4-03c1-4264-a13e-fc1b498d6ee8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b90a7157-8b55-478e-aedf-a3f07eccdc4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_59484ea4-03c1-4264-a13e-fc1b498d6ee8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b90a7157-8b55-478e-aedf-a3f07eccdc4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_13e48a16-dfb7-4434-8267-3cfb036cb797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b90a7157-8b55-478e-aedf-a3f07eccdc4d" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_13e48a16-dfb7-4434-8267-3cfb036cb797" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_15e7b2ad-3fbf-4ee8-944c-7718994efe14" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_15e7b2ad-3fbf-4ee8-944c-7718994efe14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_15e7b2ad-3fbf-4ee8-944c-7718994efe14_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_15e7b2ad-3fbf-4ee8-944c-7718994efe14" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_15e7b2ad-3fbf-4ee8-944c-7718994efe14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1402a872-941a-4940-87f7-c1ad53905f64" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_15e7b2ad-3fbf-4ee8-944c-7718994efe14" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1402a872-941a-4940-87f7-c1ad53905f64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLlcMember_199076ec-23fe-4d39-ba6f-64cac11f9c73" xlink:href="rdnt-20220331.xsd#rdnt_ScriptSenderLlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1402a872-941a-4940-87f7-c1ad53905f64" xlink:to="loc_rdnt_ScriptSenderLlcMember_199076ec-23fe-4d39-ba6f-64cac11f9c73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_e7564535-434e-4e67-b626-0355d897333e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_e7564535-434e-4e67-b626-0355d897333e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_e7564535-434e-4e67-b626-0355d897333e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_e7564535-434e-4e67-b626-0355d897333e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_e7564535-434e-4e67-b626-0355d897333e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_905bc40d-61e5-4b4f-802b-8107f77f448d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_e7564535-434e-4e67-b626-0355d897333e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_905bc40d-61e5-4b4f-802b-8107f77f448d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_fbec9ffd-42b7-492f-ae5d-70d4cb91584f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_905bc40d-61e5-4b4f-802b-8107f77f448d" xlink:to="loc_us-gaap_OperatingExpenseMember_fbec9ffd-42b7-492f-ae5d-70d4cb91584f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6046805e-d93f-44b9-bcb5-bb3ef02617c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6046805e-d93f-44b9-bcb5-bb3ef02617c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6046805e-d93f-44b9-bcb5-bb3ef02617c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6046805e-d93f-44b9-bcb5-bb3ef02617c2" xlink:to="loc_us-gaap_RelatedPartyDomain_6046805e-d93f-44b9-bcb5-bb3ef02617c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2866834b-0a10-465d-aff2-b66354cb11f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6046805e-d93f-44b9-bcb5-bb3ef02617c2" xlink:to="loc_us-gaap_RelatedPartyDomain_2866834b-0a10-465d-aff2-b66354cb11f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_2495cdd7-bc91-4191-9380-71f5f68e84a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_2866834b-0a10-465d-aff2-b66354cb11f9" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_2495cdd7-bc91-4191-9380-71f5f68e84a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" xlink:type="extended" id="i31072eecea9e483580454b8c122c2aab_SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ba81732e-78b2-41d3-8f12-c66d147e7b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ed5f7886-fe55-4b01-86e6-b1aea18fb258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ba81732e-78b2-41d3-8f12-c66d147e7b26" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ed5f7886-fe55-4b01-86e6-b1aea18fb258" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ed8dc71a-5f0e-4d7f-8f18-fc2b03f9bd80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ba81732e-78b2-41d3-8f12-c66d147e7b26" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ed8dc71a-5f0e-4d7f-8f18-fc2b03f9bd80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c7037f2c-93f2-4a56-8464-201750db5438" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ed8dc71a-5f0e-4d7f-8f18-fc2b03f9bd80" xlink:to="loc_srt_ProductOrServiceAxis_c7037f2c-93f2-4a56-8464-201750db5438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c7037f2c-93f2-4a56-8464-201750db5438_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c7037f2c-93f2-4a56-8464-201750db5438" xlink:to="loc_srt_ProductsAndServicesDomain_c7037f2c-93f2-4a56-8464-201750db5438_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fdbd9936-4358-45ca-9bb1-6baedb092ee5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c7037f2c-93f2-4a56-8464-201750db5438" xlink:to="loc_srt_ProductsAndServicesDomain_fdbd9936-4358-45ca-9bb1-6baedb092ee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fdbd9936-4358-45ca-9bb1-6baedb092ee5" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_dbd0a201-5b9f-4b81-b7aa-0fb038bf0b81" xlink:href="rdnt-20220331.xsd#rdnt_CommercialInsurance1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_CommercialInsurance1Member_dbd0a201-5b9f-4b81-b7aa-0fb038bf0b81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_7dd3f46e-91fa-46c9-af0b-b67c1a8af7fb" xlink:href="rdnt-20220331.xsd#rdnt_Medicare1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_Medicare1Member_7dd3f46e-91fa-46c9-af0b-b67c1a8af7fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_0b1bb17d-1f8a-4f1c-be2f-d7663bcf97c4" xlink:href="rdnt-20220331.xsd#rdnt_Medicaid1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_Medicaid1Member_0b1bb17d-1f8a-4f1c-be2f-d7663bcf97c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_9d0c89fb-4af1-4006-86c1-0409932b6653" xlink:href="rdnt-20220331.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_9d0c89fb-4af1-4006-86c1-0409932b6653" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_f923ba52-858d-4dfa-8874-21fcb1f42bc9" xlink:href="rdnt-20220331.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_f923ba52-858d-4dfa-8874-21fcb1f42bc9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_33a3ad24-367b-45e2-8ffd-f657bc7bcdba" xlink:href="rdnt-20220331.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_HealthCareManagementServiceMember_33a3ad24-367b-45e2-8ffd-f657bc7bcdba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SoftwareMember_6fbbf994-f294-4926-8cfc-88bd5fe00b3f" xlink:href="rdnt-20220331.xsd#rdnt_SoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_SoftwareMember_6fbbf994-f294-4926-8cfc-88bd5fe00b3f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_ecc8b749-f690-44a9-b26a-54c9c27a631b" xlink:href="rdnt-20220331.xsd#rdnt_AIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_AIMember_ecc8b749-f690-44a9-b26a-54c9c27a631b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_efad2e67-dfb2-4d89-806d-288694981228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_us-gaap_HealthCareOtherMember_efad2e67-dfb2-4d89-806d-288694981228" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_def0b508-15bd-4f67-8fba-eb497bd6f231" xlink:href="rdnt-20220331.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fdbd9936-4358-45ca-9bb1-6baedb092ee5" xlink:to="loc_rdnt_CapitationArrangementsMember_def0b508-15bd-4f67-8fba-eb497bd6f231" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended" id="i6b83342a789449a8bfeeca6ab6cc0508_SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_ca6256e3-79a6-4fdf-96d9-1a0dd1bd46a4" xlink:href="rdnt-20220331.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_AdvanceMedicarePayments_ca6256e3-79a6-4fdf-96d9-1a0dd1bd46a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans_b2fa0911-4349-4460-93f9-33654adc84bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_ProceedsFromLoans_b2fa0911-4349-4460-93f9-33654adc84bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_eb32b243-7cb9-4d2f-bbbd-10ef9030b524" xlink:href="rdnt-20220331.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_eb32b243-7cb9-4d2f-bbbd-10ef9030b524" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments_22d65d96-1f36-4a3d-995b-2f2cd1ee4700" xlink:href="rdnt-20220331.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_RepaymentOfAdvanceMedicarePayments_22d65d96-1f36-4a3d-995b-2f2cd1ee4700" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_7e8a089b-1e80-4569-9472-ddd884725d12" xlink:href="rdnt-20220331.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_7e8a089b-1e80-4569-9472-ddd884725d12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage_87464db1-4e66-42fc-beca-32a3cefec3a8" xlink:href="rdnt-20220331.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_CaresActRefundableClaimPercentage_87464db1-4e66-42fc-beca-32a3cefec3a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_71b29435-fa42-4067-9446-dfc8cb047bf8" xlink:href="rdnt-20220331.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_71b29435-fa42-4067-9446-dfc8cb047bf8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_1267ab95-f933-4946-b411-5078a43e4cff" xlink:href="rdnt-20220331.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_1267ab95-f933-4946-b411-5078a43e4cff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_a917aaeb-1702-48f9-932a-2c86a30e5bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_a917aaeb-1702-48f9-932a-2c86a30e5bfb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e921fcd8-ee00-4d6a-8c36-4fdf62cc34f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e921fcd8-ee00-4d6a-8c36-4fdf62cc34f2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_acc01d14-6383-4607-a37b-dbe0f1e940d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_Goodwill_acc01d14-6383-4607-a37b-dbe0f1e940d6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_87c30b29-efa2-4495-9564-2e5f0934b92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_87c30b29-efa2-4495-9564-2e5f0934b92a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b0110c10-f74e-45d8-9f5d-fc53e76b1153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b0110c10-f74e-45d8-9f5d-fc53e76b1153" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9b0223d1-d54f-49bb-8d31-bda7ec44191c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9b0223d1-d54f-49bb-8d31-bda7ec44191c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_745e934c-308a-4eca-8a40-df22d736233c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_745e934c-308a-4eca-8a40-df22d736233c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_029c9fe2-8f24-47b0-ba14-7546329538d4" xlink:href="rdnt-20220331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_029c9fe2-8f24-47b0-ba14-7546329538d4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_d95164bb-ff55-4e09-aa9d-083b7315cd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_d95164bb-ff55-4e09-aa9d-083b7315cd21" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_410b78bc-bc88-4152-af83-25f1625742a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_410b78bc-bc88-4152-af83-25f1625742a5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_11ef8905-d3c1-466f-85a1-baa9cc6d4bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_11ef8905-d3c1-466f-85a1-baa9cc6d4bfa" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_bf516d91-82eb-4449-a6b8-78c7e679fbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_bf516d91-82eb-4449-a6b8-78c7e679fbd3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_dd936aab-d2c3-4803-930a-9ab215a39567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_dd936aab-d2c3-4803-930a-9ab215a39567" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_64ec9d7b-fe19-45e1-a6a7-f1591726e85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_64ec9d7b-fe19-45e1-a6a7-f1591726e85a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_1addb169-7083-42fb-8dfb-62b669585b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_1addb169-7083-42fb-8dfb-62b669585b09" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_9b520694-4c95-4f23-953d-16bbee3caa51" xlink:href="rdnt-20220331.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_9b520694-4c95-4f23-953d-16bbee3caa51" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_1d27644d-2aa2-4e3c-84a4-ffe8a1c4e59a" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_1d27644d-2aa2-4e3c-84a4-ffe8a1c4e59a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_88c80b6b-e7bf-4509-8869-372a5f1c1030" xlink:href="rdnt-20220331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_88c80b6b-e7bf-4509-8869-372a5f1c1030" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_bb8634f0-e8c4-450e-9bcf-405378471ed4" xlink:href="rdnt-20220331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_bb8634f0-e8c4-450e-9bcf-405378471ed4" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_6a6133b2-f31c-4049-828f-8e47cfb1abaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_SharePrice_6a6133b2-f31c-4049-828f-8e47cfb1abaa" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e1fbfea8-2572-441c-8305-fd6bce07606e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_LineOfCredit_e1fbfea8-2572-441c-8305-fd6bce07606e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_5b8fe284-4ab6-4790-83f5-73cb5a016c5d" xlink:href="rdnt-20220331.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_5b8fe284-4ab6-4790-83f5-73cb5a016c5d" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_65d8aeab-6d47-449d-942b-41f74f3020e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_65d8aeab-6d47-449d-942b-41f74f3020e7" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1ecd1bf2-351c-4b77-9014-c956cdb1d3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1ecd1bf2-351c-4b77-9014-c956cdb1d3e7" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_66785405-f6cb-4698-aa05-48b1bbfff0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_66785405-f6cb-4698-aa05-48b1bbfff0a2" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_3c172394-178a-43d1-81bd-d1cdce474079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_3c172394-178a-43d1-81bd-d1cdce474079" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_d24713cb-336b-4878-bd5e-bfbba698add3" xlink:href="rdnt-20220331.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_d24713cb-336b-4878-bd5e-bfbba698add3" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_67c062e0-9add-42c9-88c9-34d8a5556802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_67c062e0-9add-42c9-88c9-34d8a5556802" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_bc483d42-d2ac-488b-afcb-4f9b518215be" xlink:href="rdnt-20220331.xsd#rdnt_ManagementServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_ManagementServiceFees_bc483d42-d2ac-488b-afcb-4f9b518215be" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_b988b25c-555a-4f4d-9f95-ef4e4a53a3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_b988b25c-555a-4f4d-9f95-ef4e4a53a3c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_b988b25c-555a-4f4d-9f95-ef4e4a53a3c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_b988b25c-555a-4f4d-9f95-ef4e4a53a3c6" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_b988b25c-555a-4f4d-9f95-ef4e4a53a3c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_1f81f706-2acd-4c20-b76b-6c560c89bd33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_b988b25c-555a-4f4d-9f95-ef4e4a53a3c6" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_1f81f706-2acd-4c20-b76b-6c560c89bd33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_d5e7d6b2-7ff0-4790-8fe9-72f2d55e5f33" xlink:href="rdnt-20220331.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_1f81f706-2acd-4c20-b76b-6c560c89bd33" xlink:to="loc_rdnt_COVID19PandemicMember_d5e7d6b2-7ff0-4790-8fe9-72f2d55e5f33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b3008d0b-066a-4dc8-9a23-478738a91c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_DebtInstrumentAxis_b3008d0b-066a-4dc8-9a23-478738a91c9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b3008d0b-066a-4dc8-9a23-478738a91c9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b3008d0b-066a-4dc8-9a23-478738a91c9b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b3008d0b-066a-4dc8-9a23-478738a91c9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1969f011-37b8-443e-aa6a-34e29bd8b866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b3008d0b-066a-4dc8-9a23-478738a91c9b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1969f011-37b8-443e-aa6a-34e29bd8b866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_a7be3d82-0c62-4355-9acf-708f08897331" xlink:href="rdnt-20220331.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1969f011-37b8-443e-aa6a-34e29bd8b866" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_a7be3d82-0c62-4355-9acf-708f08897331" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_ce575a56-a9a0-43ae-946e-6af2cd305a3e" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1969f011-37b8-443e-aa6a-34e29bd8b866" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_ce575a56-a9a0-43ae-946e-6af2cd305a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bf8b13bf-b8ea-47c1-8773-3395d9a4d58d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_srt_RangeAxis_bf8b13bf-b8ea-47c1-8773-3395d9a4d58d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf8b13bf-b8ea-47c1-8773-3395d9a4d58d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bf8b13bf-b8ea-47c1-8773-3395d9a4d58d" xlink:to="loc_srt_RangeMember_bf8b13bf-b8ea-47c1-8773-3395d9a4d58d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc1119e8-a7a8-402f-b00f-bca619bbbb31" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bf8b13bf-b8ea-47c1-8773-3395d9a4d58d" xlink:to="loc_srt_RangeMember_cc1119e8-a7a8-402f-b00f-bca619bbbb31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d707b531-3395-46eb-a2f4-970bda14dd60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cc1119e8-a7a8-402f-b00f-bca619bbbb31" xlink:to="loc_srt_MinimumMember_d707b531-3395-46eb-a2f4-970bda14dd60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_36507e78-e2f8-4654-bf93-ba11632c8551" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cc1119e8-a7a8-402f-b00f-bca619bbbb31" xlink:to="loc_srt_MaximumMember_36507e78-e2f8-4654-bf93-ba11632c8551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3161b45e-1fa3-4b1d-af8d-c22ecd8bc706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3161b45e-1fa3-4b1d-af8d-c22ecd8bc706" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3161b45e-1fa3-4b1d-af8d-c22ecd8bc706_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3161b45e-1fa3-4b1d-af8d-c22ecd8bc706" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3161b45e-1fa3-4b1d-af8d-c22ecd8bc706_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47e98f12-ce9c-4972-8979-9e46e22adadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3161b45e-1fa3-4b1d-af8d-c22ecd8bc706" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47e98f12-ce9c-4972-8979-9e46e22adadd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember_b83949c9-6c3e-4cfe-9b09-3c388f4099b4" xlink:href="rdnt-20220331.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47e98f12-ce9c-4972-8979-9e46e22adadd" xlink:to="loc_rdnt_ProperyAndEquipmentNetMember_b83949c9-6c3e-4cfe-9b09-3c388f4099b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_fd3f534d-2537-4982-925a-cf0d891a99bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47e98f12-ce9c-4972-8979-9e46e22adadd" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_fd3f534d-2537-4982-925a-cf0d891a99bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4b3ef0b3-235c-46ea-813f-634b0b6e402a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_PlanNameAxis_4b3ef0b3-235c-46ea-813f-634b0b6e402a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4b3ef0b3-235c-46ea-813f-634b0b6e402a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_4b3ef0b3-235c-46ea-813f-634b0b6e402a" xlink:to="loc_us-gaap_PlanNameDomain_4b3ef0b3-235c-46ea-813f-634b0b6e402a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6fd070b4-b92e-440f-a482-b93389b8fa34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_4b3ef0b3-235c-46ea-813f-634b0b6e402a" xlink:to="loc_us-gaap_PlanNameDomain_6fd070b4-b92e-440f-a482-b93389b8fa34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_8d90a727-4435-4f97-ba3c-1be742b5cbea" xlink:href="rdnt-20220331.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6fd070b4-b92e-440f-a482-b93389b8fa34" xlink:to="loc_rdnt_RestatedPlanMember_8d90a727-4435-4f97-ba3c-1be742b5cbea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_68ddb746-922c-4ed2-9fe1-db022f178534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_68ddb746-922c-4ed2-9fe1-db022f178534" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_68ddb746-922c-4ed2-9fe1-db022f178534_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_68ddb746-922c-4ed2-9fe1-db022f178534" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_68ddb746-922c-4ed2-9fe1-db022f178534_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_6dfa53d1-8c18-4ead-bb37-61506fe8d1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_68ddb746-922c-4ed2-9fe1-db022f178534" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_6dfa53d1-8c18-4ead-bb37-61506fe8d1ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_7e7ee4ec-2753-482b-9895-914cef0fd959" xlink:href="rdnt-20220331.xsd#rdnt_A2019SWAPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_6dfa53d1-8c18-4ead-bb37-61506fe8d1ff" xlink:to="loc_rdnt_A2019SWAPSMember_7e7ee4ec-2753-482b-9895-914cef0fd959" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_4687c2f0-3e6d-4dd0-8c97-ab0051224b10" xlink:href="rdnt-20220331.xsd#rdnt_A2019SWAPS1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_6dfa53d1-8c18-4ead-bb37-61506fe8d1ff" xlink:to="loc_rdnt_A2019SWAPS1Member_4687c2f0-3e6d-4dd0-8c97-ab0051224b10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_80dab679-45ed-47c6-8b88-337316f660ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_80dab679-45ed-47c6-8b88-337316f660ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_80dab679-45ed-47c6-8b88-337316f660ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_80dab679-45ed-47c6-8b88-337316f660ba" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_80dab679-45ed-47c6-8b88-337316f660ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_bca07b64-6a15-4651-9894-3291e4bb8e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_80dab679-45ed-47c6-8b88-337316f660ba" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_bca07b64-6a15-4651-9894-3291e4bb8e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_5674a9c8-050a-4b49-a416-305d1d3c83aa" xlink:href="rdnt-20220331.xsd#rdnt_October2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_bca07b64-6a15-4651-9894-3291e4bb8e47" xlink:to="loc_rdnt_October2023Member_5674a9c8-050a-4b49-a416-305d1d3c83aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_99e8cc84-15a5-4943-8b45-2229bb6004c4" xlink:href="rdnt-20220331.xsd#rdnt_October2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_bca07b64-6a15-4651-9894-3291e4bb8e47" xlink:to="loc_rdnt_October2025Member_99e8cc84-15a5-4943-8b45-2229bb6004c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fa60426a-2905-4d7a-81e2-d0133772acc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fa60426a-2905-4d7a-81e2-d0133772acc6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fa60426a-2905-4d7a-81e2-d0133772acc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fa60426a-2905-4d7a-81e2-d0133772acc6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fa60426a-2905-4d7a-81e2-d0133772acc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_07c0a416-7cce-4c57-bc19-9c37ecd0f801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fa60426a-2905-4d7a-81e2-d0133772acc6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_07c0a416-7cce-4c57-bc19-9c37ecd0f801" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_01eed272-e4a5-49bc-8921-27dd49bf1a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_07c0a416-7cce-4c57-bc19-9c37ecd0f801" xlink:to="loc_us-gaap_InterestRateSwapMember_01eed272-e4a5-49bc-8921-27dd49bf1a37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_01e0854e-2687-4461-b433-82dd53c74188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_VariableRateAxis_01e0854e-2687-4461-b433-82dd53c74188" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_01e0854e-2687-4461-b433-82dd53c74188_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_01e0854e-2687-4461-b433-82dd53c74188" xlink:to="loc_us-gaap_VariableRateDomain_01e0854e-2687-4461-b433-82dd53c74188_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c65fdecd-fde4-47b3-b465-5ec656a40492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_01e0854e-2687-4461-b433-82dd53c74188" xlink:to="loc_us-gaap_VariableRateDomain_c65fdecd-fde4-47b3-b465-5ec656a40492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_5e2409e8-26bc-4957-b1b5-13b18c68db40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c65fdecd-fde4-47b3-b465-5ec656a40492" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_5e2409e8-26bc-4957-b1b5-13b18c68db40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ffb1e653-a823-47e0-8f1e-bb00a20da01c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_srt_StatementScenarioAxis_ffb1e653-a823-47e0-8f1e-bb00a20da01c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ffb1e653-a823-47e0-8f1e-bb00a20da01c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_ffb1e653-a823-47e0-8f1e-bb00a20da01c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ffb1e653-a823-47e0-8f1e-bb00a20da01c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_da8b43d9-4779-4c43-be8d-16be02fec9ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_ffb1e653-a823-47e0-8f1e-bb00a20da01c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_da8b43d9-4779-4c43-be8d-16be02fec9ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_879ea67c-e7ff-43f8-b160-334c9eef684f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_da8b43d9-4779-4c43-be8d-16be02fec9ea" xlink:to="loc_srt_ScenarioForecastMember_879ea67c-e7ff-43f8-b160-334c9eef684f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4a122d4f-79dc-4f4e-bad5-8c194a31ba13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_CreditFacilityAxis_4a122d4f-79dc-4f4e-bad5-8c194a31ba13" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4a122d4f-79dc-4f4e-bad5-8c194a31ba13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4a122d4f-79dc-4f4e-bad5-8c194a31ba13" xlink:to="loc_us-gaap_CreditFacilityDomain_4a122d4f-79dc-4f4e-bad5-8c194a31ba13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6298937-b2ce-4b9d-916a-a7303b6b0cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4a122d4f-79dc-4f4e-bad5-8c194a31ba13" xlink:to="loc_us-gaap_CreditFacilityDomain_d6298937-b2ce-4b9d-916a-a7303b6b0cae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d25f827e-01b9-43a1-9d55-f3e74b195dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d6298937-b2ce-4b9d-916a-a7303b6b0cae" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d25f827e-01b9-43a1-9d55-f3e74b195dc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_4787df01-4bf5-4a3e-a017-f9786ac0aa68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_4787df01-4bf5-4a3e-a017-f9786ac0aa68" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_4787df01-4bf5-4a3e-a017-f9786ac0aa68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_4787df01-4bf5-4a3e-a017-f9786ac0aa68" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_4787df01-4bf5-4a3e-a017-f9786ac0aa68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_782f8c93-f913-4d0e-9a04-b48b2b29a39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_4787df01-4bf5-4a3e-a017-f9786ac0aa68" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_782f8c93-f913-4d0e-9a04-b48b2b29a39e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_584d6a24-2867-43d6-87f6-1ddab7e23865" xlink:href="rdnt-20220331.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_782f8c93-f913-4d0e-9a04-b48b2b29a39e" xlink:to="loc_rdnt_BarclaysMember_584d6a24-2867-43d6-87f6-1ddab7e23865" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6eefd33f-4e36-4359-a369-d2f0e2fa4207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6eefd33f-4e36-4359-a369-d2f0e2fa4207" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6eefd33f-4e36-4359-a369-d2f0e2fa4207_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6eefd33f-4e36-4359-a369-d2f0e2fa4207" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6eefd33f-4e36-4359-a369-d2f0e2fa4207_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8f9676ea-de88-4306-a2d7-d79cb27a937a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6eefd33f-4e36-4359-a369-d2f0e2fa4207" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8f9676ea-de88-4306-a2d7-d79cb27a937a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d089dd2f-9d8b-40fa-8911-7573c6429f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8f9676ea-de88-4306-a2d7-d79cb27a937a" xlink:to="loc_us-gaap_LineOfCreditMember_d089dd2f-9d8b-40fa-8911-7573c6429f31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1c3d6f48-3b0e-4cd8-bf88-045f8e61e440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1c3d6f48-3b0e-4cd8-bf88-045f8e61e440" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c3d6f48-3b0e-4cd8-bf88-045f8e61e440_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1c3d6f48-3b0e-4cd8-bf88-045f8e61e440" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c3d6f48-3b0e-4cd8-bf88-045f8e61e440_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06f0334b-df5e-4180-bdf7-883ad5fcf44f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1c3d6f48-3b0e-4cd8-bf88-045f8e61e440" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06f0334b-df5e-4180-bdf7-883ad5fcf44f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_a960b7a5-d8ae-48af-a335-791d2ec21782" xlink:href="rdnt-20220331.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06f0334b-df5e-4180-bdf7-883ad5fcf44f" xlink:to="loc_rdnt_QuantibMember_a960b7a5-d8ae-48af-a335-791d2ec21782" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_412c2ab2-7bce-44d3-9798-6ce7442abb66" xlink:href="rdnt-20220331.xsd#rdnt_AidenceHoldingBVAndQuantibBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06f0334b-df5e-4180-bdf7-883ad5fcf44f" xlink:to="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_412c2ab2-7bce-44d3-9798-6ce7442abb66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_658d9540-3af9-4ef5-9d14-d957512ff357" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_658d9540-3af9-4ef5-9d14-d957512ff357" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_658d9540-3af9-4ef5-9d14-d957512ff357_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_658d9540-3af9-4ef5-9d14-d957512ff357" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_658d9540-3af9-4ef5-9d14-d957512ff357_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_91e46695-83d7-44ec-b1f6-a82db52b76c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_658d9540-3af9-4ef5-9d14-d957512ff357" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_91e46695-83d7-44ec-b1f6-a82db52b76c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_11d9cbd5-d12d-4c8d-9b8c-e96b4e273be1" xlink:href="rdnt-20220331.xsd#rdnt_MedicVisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_91e46695-83d7-44ec-b1f6-a82db52b76c0" xlink:to="loc_rdnt_MedicVisionMember_11d9cbd5-d12d-4c8d-9b8c-e96b4e273be1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_a3642115-f2cb-46d8-8772-5e97f45c2663" xlink:href="rdnt-20220331.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_91e46695-83d7-44ec-b1f6-a82db52b76c0" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_a3642115-f2cb-46d8-8772-5e97f45c2663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c34c029d-9859-4271-9fd9-ac43c3b9b4d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_srt_CounterpartyNameAxis_c34c029d-9859-4271-9fd9-ac43c3b9b4d9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c34c029d-9859-4271-9fd9-ac43c3b9b4d9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_c34c029d-9859-4271-9fd9-ac43c3b9b4d9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c34c029d-9859-4271-9fd9-ac43c3b9b4d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e8b4e0b0-93c7-4259-ade3-5b0543af11df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_c34c029d-9859-4271-9fd9-ac43c3b9b4d9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e8b4e0b0-93c7-4259-ade3-5b0543af11df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_4dde5ac1-81e7-4fb6-a8db-de5b7deefd23" xlink:href="rdnt-20220331.xsd#rdnt_DignityHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e8b4e0b0-93c7-4259-ade3-5b0543af11df" xlink:to="loc_rdnt_DignityHealthMember_4dde5ac1-81e7-4fb6-a8db-de5b7deefd23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dd14d4c8-c448-4b4a-b45d-e136eeeb1491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dd14d4c8-c448-4b4a-b45d-e136eeeb1491" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_dd14d4c8-c448-4b4a-b45d-e136eeeb1491_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dd14d4c8-c448-4b4a-b45d-e136eeeb1491" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_dd14d4c8-c448-4b4a-b45d-e136eeeb1491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_64cf8f81-8c36-4898-a2d9-77ab111569e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dd14d4c8-c448-4b4a-b45d-e136eeeb1491" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_64cf8f81-8c36-4898-a2d9-77ab111569e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_4764c3e8-7c57-46c6-bfe2-f85355c2ddc6" xlink:href="rdnt-20220331.xsd#rdnt_JointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_64cf8f81-8c36-4898-a2d9-77ab111569e5" xlink:to="loc_rdnt_JointVentureMember_4764c3e8-7c57-46c6-bfe2-f85355c2ddc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8e6731dd-eb5d-49ee-9e68-b58ed5df85ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_dei_LegalEntityAxis_8e6731dd-eb5d-49ee-9e68-b58ed5df85ae" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8e6731dd-eb5d-49ee-9e68-b58ed5df85ae_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8e6731dd-eb5d-49ee-9e68-b58ed5df85ae" xlink:to="loc_dei_EntityDomain_8e6731dd-eb5d-49ee-9e68-b58ed5df85ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_05abf13c-8599-4a89-b0e9-5fab242a0ee4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8e6731dd-eb5d-49ee-9e68-b58ed5df85ae" xlink:to="loc_dei_EntityDomain_05abf13c-8599-4a89-b0e9-5fab242a0ee4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_e0781990-4e99-4c49-ae64-1156901f71b8" xlink:href="rdnt-20220331.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_05abf13c-8599-4a89-b0e9-5fab242a0ee4" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_e0781990-4e99-4c49-ae64-1156901f71b8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" xlink:type="extended" id="i00883666778245da8260d435486bb34f_SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_1e6bcecf-7fce-4b16-b128-6952088f5994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1e6bcecf-7fce-4b16-b128-6952088f5994" xlink:to="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3563f806-d410-4750-8286-23ac9f7ae1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:to="loc_us-gaap_Goodwill_3563f806-d410-4750-8286-23ac9f7ae1ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_957afadb-48ae-4f6a-9a55-ced84b66fda8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_957afadb-48ae-4f6a-9a55-ced84b66fda8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_cfa37406-82e0-4bce-839a-e11c757b5e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_cfa37406-82e0-4bce-839a-e11c757b5e88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_891f390f-999c-49f9-afad-4207682508a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_891f390f-999c-49f9-afad-4207682508a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0f345c6b-f336-4054-a482-e42e80c69a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_fbea7e1c-1da6-4a07-8c2f-63450a7a986b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_1e6bcecf-7fce-4b16-b128-6952088f5994" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_fbea7e1c-1da6-4a07-8c2f-63450a7a986b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_20f42278-a466-422d-b7c3-ad45c2624aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_fbea7e1c-1da6-4a07-8c2f-63450a7a986b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_20f42278-a466-422d-b7c3-ad45c2624aca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_20f42278-a466-422d-b7c3-ad45c2624aca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_20f42278-a466-422d-b7c3-ad45c2624aca" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_20f42278-a466-422d-b7c3-ad45c2624aca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12e3b2d9-5d97-409b-8735-0aa0254ae7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_20f42278-a466-422d-b7c3-ad45c2624aca" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12e3b2d9-5d97-409b-8735-0aa0254ae7ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember_e2ff8cc5-a42d-4f8d-af71-ecfa3070c1c3" xlink:href="rdnt-20220331.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12e3b2d9-5d97-409b-8735-0aa0254ae7ce" xlink:to="loc_rdnt_BusinessAcquisitionsMember_e2ff8cc5-a42d-4f8d-af71-ecfa3070c1c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_c4db84a2-ca7d-4bce-ba5e-f8874b945325" xlink:href="rdnt-20220331.xsd#rdnt_AidenceHoldingBVAndQuantibBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12e3b2d9-5d97-409b-8735-0aa0254ae7ce" xlink:to="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_c4db84a2-ca7d-4bce-ba5e-f8874b945325" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" xlink:type="extended" id="i63df2fc81a784039aa6808d23f16024a_SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58ef43a5-abaf-4591-8e54-b601b69dbeed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58ef43a5-abaf-4591-8e54-b601b69dbeed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_23c90ae0-4bdf-4d5f-903c-fc96aa5bf165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_23c90ae0-4bdf-4d5f-903c-fc96aa5bf165" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_69c299fa-eda1-417f-89a0-ee5bae5a9b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_69c299fa-eda1-417f-89a0-ee5bae5a9b7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6f439622-421e-44d5-aeef-217eff007a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2e0cdb36-be50-45e7-9718-23444fccc2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2e0cdb36-be50-45e7-9718-23444fccc2e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:to="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0a927420-5aa1-4e45-b363-d2c6c59fe2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0a927420-5aa1-4e45-b363-d2c6c59fe2fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0a927420-5aa1-4e45-b363-d2c6c59fe2fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0a927420-5aa1-4e45-b363-d2c6c59fe2fe" xlink:to="loc_us-gaap_EquityComponentDomain_0a927420-5aa1-4e45-b363-d2c6c59fe2fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_99189698-3a8d-436c-ae58-3b767e3a1b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0a927420-5aa1-4e45-b363-d2c6c59fe2fe" xlink:to="loc_us-gaap_EquityComponentDomain_99189698-3a8d-436c-ae58-3b767e3a1b3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f1f37d4a-88f2-4fc5-a45c-6f2471c57fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_99189698-3a8d-436c-ae58-3b767e3a1b3d" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f1f37d4a-88f2-4fc5-a45c-6f2471c57fb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_884e38f0-4ca6-49e7-8a62-7c3834c25e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_884e38f0-4ca6-49e7-8a62-7c3834c25e9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_884e38f0-4ca6-49e7-8a62-7c3834c25e9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_884e38f0-4ca6-49e7-8a62-7c3834c25e9f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_884e38f0-4ca6-49e7-8a62-7c3834c25e9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ff3e3e78-f636-4952-8933-008dc1d717b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_884e38f0-4ca6-49e7-8a62-7c3834c25e9f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ff3e3e78-f636-4952-8933-008dc1d717b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_e955d70d-9eb4-4349-a641-16967c4c2493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff3e3e78-f636-4952-8933-008dc1d717b8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_e955d70d-9eb4-4349-a641-16967c4c2493" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_22c81242-dd00-4b5f-b84d-97307ee8a5de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff3e3e78-f636-4952-8933-008dc1d717b8" xlink:to="loc_us-gaap_InterestExpenseMember_22c81242-dd00-4b5f-b84d-97307ee8a5de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_469beb6f-9972-4a03-8ce9-8395de679625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_469beb6f-9972-4a03-8ce9-8395de679625" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_469beb6f-9972-4a03-8ce9-8395de679625_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_469beb6f-9972-4a03-8ce9-8395de679625" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_469beb6f-9972-4a03-8ce9-8395de679625_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_23f88e08-e7f7-4256-9743-216a4c219372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_469beb6f-9972-4a03-8ce9-8395de679625" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_23f88e08-e7f7-4256-9743-216a4c219372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c3f1b6ba-b071-43f3-8e4d-8bf1bb011553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_23f88e08-e7f7-4256-9743-216a4c219372" xlink:to="loc_us-gaap_InterestRateSwapMember_c3f1b6ba-b071-43f3-8e4d-8bf1bb011553" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration" xlink:type="extended" id="i6d8651f32bb941e28d57dfe98f4ffe4e_SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3e984d24-5f7b-4c0f-9173-4fdf287f0019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_da88a623-026a-49da-9021-ef4c16e3ca35" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e984d24-5f7b-4c0f-9173-4fdf287f0019" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_da88a623-026a-49da-9021-ef4c16e3ca35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7f7274da-3b8e-4535-bbc8-2e45c633025a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_da88a623-026a-49da-9021-ef4c16e3ca35" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7f7274da-3b8e-4535-bbc8-2e45c633025a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_31b25c06-fe78-4fa2-be2a-0a765b6ed4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_da88a623-026a-49da-9021-ef4c16e3ca35" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_31b25c06-fe78-4fa2-be2a-0a765b6ed4d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b0c62f57-780f-4ed9-a9e8-d9af2b769008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c53bf5f3-0ffe-47fd-930f-bae0d4979ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e984d24-5f7b-4c0f-9173-4fdf287f0019" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c53bf5f3-0ffe-47fd-930f-bae0d4979ab9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cf0939bc-fab5-43c5-9bb3-7482771b49a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c53bf5f3-0ffe-47fd-930f-bae0d4979ab9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cf0939bc-fab5-43c5-9bb3-7482771b49a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf0939bc-fab5-43c5-9bb3-7482771b49a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cf0939bc-fab5-43c5-9bb3-7482771b49a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf0939bc-fab5-43c5-9bb3-7482771b49a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecb3f70b-c925-4099-8eb8-8322c627933b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cf0939bc-fab5-43c5-9bb3-7482771b49a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecb3f70b-c925-4099-8eb8-8322c627933b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_d14996e5-1eb6-44fe-8724-96029eab2837" xlink:href="rdnt-20220331.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecb3f70b-c925-4099-8eb8-8322c627933b" xlink:to="loc_rdnt_QuantibMember_d14996e5-1eb6-44fe-8724-96029eab2837" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended" id="idf6cf68d555343bea9b0e9e8b7e37862_SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c8f4cee6-0eaf-4c15-9ef4-06c7e3964f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_e5ab3ef7-5de4-49ac-9e82-c5d11e2088fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c8f4cee6-0eaf-4c15-9ef4-06c7e3964f98" xlink:to="loc_us-gaap_DerivativeAssets_e5ab3ef7-5de4-49ac-9e82-c5d11e2088fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2d9cdb30-6b5f-4b2f-bfd1-9513711527b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c8f4cee6-0eaf-4c15-9ef4-06c7e3964f98" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2d9cdb30-6b5f-4b2f-bfd1-9513711527b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_c979159f-b47d-4241-bf84-e02802ba9f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c8f4cee6-0eaf-4c15-9ef4-06c7e3964f98" xlink:to="loc_us-gaap_DebtInstrumentFairValue_c979159f-b47d-4241-bf84-e02802ba9f41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c8f4cee6-0eaf-4c15-9ef4-06c7e3964f98" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5f17527e-989e-4ce4-a7ac-484b60ff2cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5f17527e-989e-4ce4-a7ac-484b60ff2cff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5f17527e-989e-4ce4-a7ac-484b60ff2cff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5f17527e-989e-4ce4-a7ac-484b60ff2cff" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5f17527e-989e-4ce4-a7ac-484b60ff2cff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c1e3ea55-6bbe-4e27-9d36-378aa66d3849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5f17527e-989e-4ce4-a7ac-484b60ff2cff" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c1e3ea55-6bbe-4e27-9d36-378aa66d3849" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c51cd6b0-5730-4a90-9c38-87b2170fa296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c1e3ea55-6bbe-4e27-9d36-378aa66d3849" xlink:to="loc_us-gaap_InterestRateSwapMember_c51cd6b0-5730-4a90-9c38-87b2170fa296" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_25c58ff1-d06c-45eb-8f4d-359721c66d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_25c58ff1-d06c-45eb-8f4d-359721c66d56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_25c58ff1-d06c-45eb-8f4d-359721c66d56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_25c58ff1-d06c-45eb-8f4d-359721c66d56" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_25c58ff1-d06c-45eb-8f4d-359721c66d56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_10f6254c-2a08-4d5b-9c2c-758ff086e125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_25c58ff1-d06c-45eb-8f4d-359721c66d56" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_10f6254c-2a08-4d5b-9c2c-758ff086e125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_2b56f605-a6ea-4737-9e09-92b00e734db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_10f6254c-2a08-4d5b-9c2c-758ff086e125" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_2b56f605-a6ea-4737-9e09-92b00e734db3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f6d5eddb-1d17-4c41-9c09-0bcef8441cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_2b56f605-a6ea-4737-9e09-92b00e734db3" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f6d5eddb-1d17-4c41-9c09-0bcef8441cbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fd01fe05-478f-4e3e-8486-f692287b8799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fd01fe05-478f-4e3e-8486-f692287b8799" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fd01fe05-478f-4e3e-8486-f692287b8799_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fd01fe05-478f-4e3e-8486-f692287b8799" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fd01fe05-478f-4e3e-8486-f692287b8799_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61c022f3-c508-4e08-bdad-7ea123297c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fd01fe05-478f-4e3e-8486-f692287b8799" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61c022f3-c508-4e08-bdad-7ea123297c6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7fa6ed4b-66dd-4aa4-9018-d672cb4df9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61c022f3-c508-4e08-bdad-7ea123297c6c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7fa6ed4b-66dd-4aa4-9018-d672cb4df9f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f91e509a-ca4c-443b-a3b4-e922cf84020f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61c022f3-c508-4e08-bdad-7ea123297c6c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f91e509a-ca4c-443b-a3b4-e922cf84020f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_87837744-12e5-41e7-adaf-47c973168069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61c022f3-c508-4e08-bdad-7ea123297c6c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_87837744-12e5-41e7-adaf-47c973168069" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_67bfb462-f9b6-4701-b4f4-e39d8dddbd83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_67bfb462-f9b6-4701-b4f4-e39d8dddbd83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_67bfb462-f9b6-4701-b4f4-e39d8dddbd83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67bfb462-f9b6-4701-b4f4-e39d8dddbd83" xlink:to="loc_us-gaap_EquityComponentDomain_67bfb462-f9b6-4701-b4f4-e39d8dddbd83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0027a946-3421-4cb2-9bac-25f1baddd350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67bfb462-f9b6-4701-b4f4-e39d8dddbd83" xlink:to="loc_us-gaap_EquityComponentDomain_0027a946-3421-4cb2-9bac-25f1baddd350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2c086b5e-db00-40a4-b9e6-631bd88f34aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0027a946-3421-4cb2-9bac-25f1baddd350" xlink:to="loc_us-gaap_CommonStockMember_2c086b5e-db00-40a4-b9e6-631bd88f34aa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended" id="ic5ff83c60ce54d7b90004f6f53acf60e_SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_601856f9-ca2a-46ba-a295-0d8001e7988b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d0a401a8-1924-4191-a063-4df95446cdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_601856f9-ca2a-46ba-a295-0d8001e7988b" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d0a401a8-1924-4191-a063-4df95446cdbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40185192-9473-4bba-b859-940d90e44ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d0a401a8-1924-4191-a063-4df95446cdbd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40185192-9473-4bba-b859-940d90e44ec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3e1fabda-bfa5-46f1-a03b-16c02fbd8958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_601856f9-ca2a-46ba-a295-0d8001e7988b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3e1fabda-bfa5-46f1-a03b-16c02fbd8958" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_de797b1f-12f5-44c5-a4f4-5a3d06c5db07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3e1fabda-bfa5-46f1-a03b-16c02fbd8958" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_de797b1f-12f5-44c5-a4f4-5a3d06c5db07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_de797b1f-12f5-44c5-a4f4-5a3d06c5db07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_de797b1f-12f5-44c5-a4f4-5a3d06c5db07" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_de797b1f-12f5-44c5-a4f4-5a3d06c5db07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0379c1f9-b659-4898-9492-5eca1c848e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_de797b1f-12f5-44c5-a4f4-5a3d06c5db07" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0379c1f9-b659-4898-9492-5eca1c848e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8893c193-dbd0-4442-b0de-bc65b1168be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0379c1f9-b659-4898-9492-5eca1c848e63" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8893c193-dbd0-4442-b0de-bc65b1168be2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition" xlink:type="extended" id="i92565b626863468592aaeb2d07d16a0e_SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d1c6d47-d98d-4bc1-85ab-d43a0f90207a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d1c6d47-d98d-4bc1-85ab-d43a0f90207a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4dd37faa-4581-4590-a1d9-04c56d9e3126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4dd37faa-4581-4590-a1d9-04c56d9e3126" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_86a26c62-b5ab-40da-b3ff-e28353f01c32" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_86a26c62-b5ab-40da-b3ff-e28353f01c32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_39f05eff-fa53-469f-ac2d-c567604efdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_us-gaap_Goodwill_39f05eff-fa53-469f-ac2d-c567604efdbd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_59953e76-b7a6-4403-8d5e-95c24e034964" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_59953e76-b7a6-4403-8d5e-95c24e034964" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_a58fcabd-bbae-4f95-876b-4f5f7130dee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_a58fcabd-bbae-4f95-876b-4f5f7130dee7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50a92d26-ae8b-4184-baad-4da93ff3efcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50a92d26-ae8b-4184-baad-4da93ff3efcc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_750508b7-414d-4bc2-b8ea-3d326774b6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50a92d26-ae8b-4184-baad-4da93ff3efcc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_750508b7-414d-4bc2-b8ea-3d326774b6fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_750508b7-414d-4bc2-b8ea-3d326774b6fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_750508b7-414d-4bc2-b8ea-3d326774b6fc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_750508b7-414d-4bc2-b8ea-3d326774b6fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4bbcf22-3c37-4521-8cf9-e227a976994e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_750508b7-414d-4bc2-b8ea-3d326774b6fc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4bbcf22-3c37-4521-8cf9-e227a976994e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCMember_58a80032-b67e-40ea-b460-1f3ab6e98123" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4bbcf22-3c37-4521-8cf9-e227a976994e" xlink:to="loc_rdnt_IFRCLLCMember_58a80032-b67e-40ea-b460-1f3ab6e98123" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCAcquisitionsMember_0e171a16-7717-4eb0-b87b-d044add231cb" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLCAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4bbcf22-3c37-4521-8cf9-e227a976994e" xlink:to="loc_rdnt_IFRCLLCAcquisitionsMember_0e171a16-7717-4eb0-b87b-d044add231cb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended" id="i30683b81566b45b085495cfa403133bd_SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fbfbcd00-6785-4d17-886e-a2b00a844200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_AssetsCurrent_fbfbcd00-6785-4d17-886e-a2b00a844200" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_5f18d99e-7e9f-4f17-8a80-d83f15e81bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_AssetsNoncurrent_5f18d99e-7e9f-4f17-8a80-d83f15e81bc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_651207f9-c55f-4e1c-8ea7-f2d6b384f7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_LiabilitiesCurrent_651207f9-c55f-4e1c-8ea7-f2d6b384f7e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_9c99603f-6d89-4bda-a91d-23e8c22be16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_9c99603f-6d89-4bda-a91d-23e8c22be16f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_7fd63306-db6b-4171-a700-58134f923d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_7fd63306-db6b-4171-a700-58134f923d1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_54df15e0-c5ce-4f14-8c1a-7991bae47654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_EquityMethodInvestments_54df15e0-c5ce-4f14-8c1a-7991bae47654" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_79c62385-ca03-4f4e-be89-c05457a08a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_79c62385-ca03-4f4e-be89-c05457a08a9d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_3088283c-7b42-4f8b-a740-8b6a22a0ecf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_3088283c-7b42-4f8b-a740-8b6a22a0ecf3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_193e4723-d11a-44cf-87f5-2bda01124b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_Revenues_193e4723-d11a-44cf-87f5-2bda01124b07" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6d916c24-7d38-46a7-a7c1-435a8841a303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_ProfitLoss_6d916c24-7d38-46a7-a7c1-435a8841a303" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_24e3f5e5-f85c-4bd7-b3a4-2e7eb46e862e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_24e3f5e5-f85c-4bd7-b3a4-2e7eb46e862e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0f47839b-3fed-4bf5-9ad4-f00d1d77031e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_24e3f5e5-f85c-4bd7-b3a4-2e7eb46e862e" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0f47839b-3fed-4bf5-9ad4-f00d1d77031e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0f47839b-3fed-4bf5-9ad4-f00d1d77031e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0f47839b-3fed-4bf5-9ad4-f00d1d77031e" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0f47839b-3fed-4bf5-9ad4-f00d1d77031e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_6cf95a20-1368-411b-8586-06c575827b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0f47839b-3fed-4bf5-9ad4-f00d1d77031e" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_6cf95a20-1368-411b-8586-06c575827b66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_fd0ca2e0-b8fc-445a-8b17-06e5ed9a5be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_6cf95a20-1368-411b-8586-06c575827b66" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_fd0ca2e0-b8fc-445a-8b17-06e5ed9a5be0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20220331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed" xlink:type="extended" id="i573a8f7c85ac47c898967c9e98c918e5_BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fa9098c0-82ff-4753-ae62-6495d7082f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fa9098c0-82ff-4753-ae62-6495d7082f25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cc5d10d9-d2e2-40cb-aff5-20337e414fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cc5d10d9-d2e2-40cb-aff5-20337e414fd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_7fcd6413-8db7-4336-af28-bd2affe4eeb8" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_7fcd6413-8db7-4336-af28-bd2affe4eeb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ca91e80e-0505-4c54-8942-c500a4cb4ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_us-gaap_Goodwill_ca91e80e-0505-4c54-8942-c500a4cb4ee5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_0c62e606-c91c-4d9d-9235-1f90679a4983" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_0c62e606-c91c-4d9d-9235-1f90679a4983" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_2d132a4c-3303-4093-8d06-b71cf47a9b09" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_2d132a4c-3303-4093-8d06-b71cf47a9b09" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_1d73fa73-1793-4fd0-a325-d224291f1f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_1d73fa73-1793-4fd0-a325-d224291f1f9e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85df6b4c-65cf-4df8-b1b1-6e871cbc14f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85df6b4c-65cf-4df8-b1b1-6e871cbc14f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8082a522-5be6-4db5-b5dc-2b966544df3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85df6b4c-65cf-4df8-b1b1-6e871cbc14f1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8082a522-5be6-4db5-b5dc-2b966544df3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8082a522-5be6-4db5-b5dc-2b966544df3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8082a522-5be6-4db5-b5dc-2b966544df3c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8082a522-5be6-4db5-b5dc-2b966544df3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14607d17-fd0e-40f9-a93b-a7602dca5aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8082a522-5be6-4db5-b5dc-2b966544df3c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14607d17-fd0e-40f9-a93b-a7602dca5aa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCAcquisitionsMember_56b8485e-31b9-4072-a95f-2403cab443c2" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLCAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14607d17-fd0e-40f9-a93b-a7602dca5aa4" xlink:to="loc_rdnt_IFRCLLCAcquisitionsMember_56b8485e-31b9-4072-a95f-2403cab443c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLC1Member_8c5a63d6-c785-45d7-af91-59bbda1c27ce" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLC1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_IFRCLLCAcquisitionsMember_56b8485e-31b9-4072-a95f-2403cab443c2" xlink:to="loc_rdnt_IFRCLLC1Member_8c5a63d6-c785-45d7-af91-59bbda1c27ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLC2Member_1f5d5b96-f8a5-4676-8641-76b9ec1d950c" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLC2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_IFRCLLCAcquisitionsMember_56b8485e-31b9-4072-a95f-2403cab443c2" xlink:to="loc_rdnt_IFRCLLC2Member_1f5d5b96-f8a5-4676-8641-76b9ec1d950c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative" xlink:type="extended" id="if21e2fe5aff04ba4ac84c45e58e249f4_BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2e0d767a-63df-4a65-b07c-18710f81c14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2e0d767a-63df-4a65-b07c-18710f81c14a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_12b05854-502a-46bf-bf62-13108f655db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_12b05854-502a-46bf-bf62-13108f655db9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_9378e558-c04f-4a87-afc9-52c55b142825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_9378e558-c04f-4a87-afc9-52c55b142825" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_906158b6-9286-448a-b111-b0b9766e64f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_906158b6-9286-448a-b111-b0b9766e64f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c0847a21-62a3-4405-80e0-0fc568c84e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c0847a21-62a3-4405-80e0-0fc568c84e16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_04f9096c-026a-49f8-acc0-ad2ab69a5aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_04f9096c-026a-49f8-acc0-ad2ab69a5aef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c9dfbd1e-2f22-4017-a38d-340fa16ee23a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c9dfbd1e-2f22-4017-a38d-340fa16ee23a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_6ef73a15-a9d5-4ec2-968b-c0d2f95f0bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_6ef73a15-a9d5-4ec2-968b-c0d2f95f0bbe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_22aea4d1-3208-4e84-a08d-8caa4fa839aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_22aea4d1-3208-4e84-a08d-8caa4fa839aa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_73ad71fb-9565-4b8b-b3d3-9dd16085529a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_73ad71fb-9565-4b8b-b3d3-9dd16085529a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eca3f16b-6215-4b68-aa9f-43e39f832707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eca3f16b-6215-4b68-aa9f-43e39f832707" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_f5392a89-e23e-4043-8d95-4f49988f0fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_f5392a89-e23e-4043-8d95-4f49988f0fc6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_79e7cde7-84dd-46fb-8896-73c4505b2ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_Goodwill_79e7cde7-84dd-46fb-8896-73c4505b2ee1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_c1a4808f-b020-441d-b18f-b8f401e0e846" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_c1a4808f-b020-441d-b18f-b8f401e0e846" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b494f2c0-0c00-4242-ba2b-b9cdd27e2e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b494f2c0-0c00-4242-ba2b-b9cdd27e2e16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b494f2c0-0c00-4242-ba2b-b9cdd27e2e16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b494f2c0-0c00-4242-ba2b-b9cdd27e2e16" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b494f2c0-0c00-4242-ba2b-b9cdd27e2e16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50d6b7dc-d4c6-4c45-896e-b32e9c126e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b494f2c0-0c00-4242-ba2b-b9cdd27e2e16" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50d6b7dc-d4c6-4c45-896e-b32e9c126e43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_e0b018e6-bc33-498a-93af-b0b1dd54a51d" xlink:href="rdnt-20220331.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50d6b7dc-d4c6-4c45-896e-b32e9c126e43" xlink:to="loc_rdnt_AidenceMember_e0b018e6-bc33-498a-93af-b0b1dd54a51d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_e2264fb2-7f4e-4b7b-8dcd-ebb6802c328c" xlink:href="rdnt-20220331.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50d6b7dc-d4c6-4c45-896e-b32e9c126e43" xlink:to="loc_rdnt_QuantibMember_e2264fb2-7f4e-4b7b-8dcd-ebb6802c328c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_bf92a9d9-c570-4467-b3ee-6401453786d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:to="loc_srt_CounterpartyNameAxis_bf92a9d9-c570-4467-b3ee-6401453786d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf92a9d9-c570-4467-b3ee-6401453786d4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_bf92a9d9-c570-4467-b3ee-6401453786d4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf92a9d9-c570-4467-b3ee-6401453786d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8038c35b-b45d-48d5-a823-a2661dc57310" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_bf92a9d9-c570-4467-b3ee-6401453786d4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8038c35b-b45d-48d5-a823-a2661dc57310" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CertainSellerMember_282d4e32-c9b5-48cf-a34c-4a27233a4040" xlink:href="rdnt-20220331.xsd#rdnt_CertainSellerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8038c35b-b45d-48d5-a823-a2661dc57310" xlink:to="loc_rdnt_CertainSellerMember_282d4e32-c9b5-48cf-a34c-4a27233a4040" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OtherSellersMember_0947b3a4-3165-4197-9d3f-a0a446b0c7c0" xlink:href="rdnt-20220331.xsd#rdnt_OtherSellersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8038c35b-b45d-48d5-a823-a2661dc57310" xlink:to="loc_rdnt_OtherSellersMember_0947b3a4-3165-4197-9d3f-a0a446b0c7c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_deb3476b-a50f-4ab7-8d87-21d87e1c8897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_deb3476b-a50f-4ab7-8d87-21d87e1c8897" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_deb3476b-a50f-4ab7-8d87-21d87e1c8897_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_deb3476b-a50f-4ab7-8d87-21d87e1c8897" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_deb3476b-a50f-4ab7-8d87-21d87e1c8897_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a4546f63-1401-4a2a-9a17-4b077ec25e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_deb3476b-a50f-4ab7-8d87-21d87e1c8897" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a4546f63-1401-4a2a-9a17-4b077ec25e4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_f4e6f3e9-1496-4f09-b3c8-688503b41c96" xlink:href="rdnt-20220331.xsd#rdnt_CashHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_a4546f63-1401-4a2a-9a17-4b077ec25e4b" xlink:to="loc_rdnt_CashHoldbackMember_f4e6f3e9-1496-4f09-b3c8-688503b41c96" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SEGMENTREPORTINGDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="extended" id="i9c372ec27bfb4416893a8ae83e892823_SEGMENTREPORTINGDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_16492983-2052-45ce-bd96-388a2c380ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_Revenues_16492983-2052-45ce-bd96-388a2c380ba0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_f4c3c4fa-1d65-4c04-951e-348181b0d6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_f4c3c4fa-1d65-4c04-951e-348181b0d6f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e0c5ec93-b7f9-4634-8995-8be73f36f39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e0c5ec93-b7f9-4634-8995-8be73f36f39e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_e58f251c-3a51-448c-8a29-c61373a0a401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_e58f251c-3a51-448c-8a29-c61373a0a401" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_f5bced7e-4258-43d2-8e59-afef5d16e990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_SeveranceCosts1_f5bced7e-4258-43d2-8e59-afef5d16e990" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_a872991d-0abb-4d67-a0c5-44165e053337" xlink:href="rdnt-20220331.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_a872991d-0abb-4d67-a0c5-44165e053337" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_a7001da0-fc66-4c59-b5f4-59efd66a0133" xlink:href="rdnt-20220331.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_a7001da0-fc66-4c59-b5f4-59efd66a0133" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d081c3fc-108a-4026-a603-754ddb5ca59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d081c3fc-108a-4026-a603-754ddb5ca59d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_abb18ca6-8cdf-4979-8f0e-b0449ec2c0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d081c3fc-108a-4026-a603-754ddb5ca59d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_abb18ca6-8cdf-4979-8f0e-b0449ec2c0d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_abb18ca6-8cdf-4979-8f0e-b0449ec2c0d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_abb18ca6-8cdf-4979-8f0e-b0449ec2c0d5" xlink:to="loc_us-gaap_SegmentDomain_abb18ca6-8cdf-4979-8f0e-b0449ec2c0d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3c830565-b007-4137-baa0-b92184023775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_abb18ca6-8cdf-4979-8f0e-b0449ec2c0d5" xlink:to="loc_us-gaap_SegmentDomain_3c830565-b007-4137-baa0-b92184023775" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_0baac765-e865-4e6a-8898-ae5fee066056" xlink:href="rdnt-20220331.xsd#rdnt_ImagingCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3c830565-b007-4137-baa0-b92184023775" xlink:to="loc_rdnt_ImagingCentersMember_0baac765-e865-4e6a-8898-ae5fee066056" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_ebb95030-17ae-4010-938a-4269a6948dc5" xlink:href="rdnt-20220331.xsd#rdnt_AIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3c830565-b007-4137-baa0-b92184023775" xlink:to="loc_rdnt_AIMember_ebb95030-17ae-4010-938a-4269a6948dc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_029d8459-f95d-4e8f-a646-2bc74df3198f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d081c3fc-108a-4026-a603-754ddb5ca59d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_029d8459-f95d-4e8f-a646-2bc74df3198f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_029d8459-f95d-4e8f-a646-2bc74df3198f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_029d8459-f95d-4e8f-a646-2bc74df3198f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_029d8459-f95d-4e8f-a646-2bc74df3198f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_22198f26-9606-4cf3-b84a-f8a47b1d1d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_029d8459-f95d-4e8f-a646-2bc74df3198f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_22198f26-9606-4cf3-b84a-f8a47b1d1d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_c2651d03-9997-4b85-b644-82b594d0caa0" xlink:href="rdnt-20220331.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_22198f26-9606-4cf3-b84a-f8a47b1d1d96" xlink:to="loc_rdnt_COVID19PandemicMember_c2651d03-9997-4b85-b644-82b594d0caa0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="extended" id="i8780cfb84b404ddb8b733c0eab062d30_CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_41089ab1-5559-4f6b-8c45-c7f0837f1aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:to="loc_us-gaap_LongTermDebt_41089ab1-5559-4f6b-8c45-c7f0837f1aa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_bffab436-a5e6-4378-9eec-6192dd3fed86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_bffab436-a5e6-4378-9eec-6192dd3fed86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8ef8aa1d-b7af-40d4-a1f7-8e6a9ebd1e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3a961337-6f83-4509-9763-e8f962e0bae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:to="loc_us-gaap_LongTermDebtCurrent_3a961337-6f83-4509-9763-e8f962e0bae4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b8f26e9d-9056-4ad7-ad6d-908d505d4735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b8f26e9d-9056-4ad7-ad6d-908d505d4735" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2a39e8e3-83d3-4051-9170-37e56dfc575b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:to="loc_us-gaap_DebtInstrumentTable_2a39e8e3-83d3-4051-9170-37e56dfc575b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fac26bae-53b6-4913-a4af-f8a3b62fdaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2a39e8e3-83d3-4051-9170-37e56dfc575b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fac26bae-53b6-4913-a4af-f8a3b62fdaa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fac26bae-53b6-4913-a4af-f8a3b62fdaa3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fac26bae-53b6-4913-a4af-f8a3b62fdaa3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fac26bae-53b6-4913-a4af-f8a3b62fdaa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1705876b-ddc6-4bf2-81ee-ce8220f7bd09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fac26bae-53b6-4913-a4af-f8a3b62fdaa3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1705876b-ddc6-4bf2-81ee-ce8220f7bd09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_4eb134b1-aeab-426a-b4b1-cebe39a75b42" xlink:href="rdnt-20220331.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1705876b-ddc6-4bf2-81ee-ce8220f7bd09" xlink:to="loc_rdnt_TermLoanMember_4eb134b1-aeab-426a-b4b1-cebe39a75b42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9a441ea6-ff67-4a1c-bec1-03d3d79e8b12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2a39e8e3-83d3-4051-9170-37e56dfc575b" xlink:to="loc_us-gaap_DebtInstrumentAxis_9a441ea6-ff67-4a1c-bec1-03d3d79e8b12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9a441ea6-ff67-4a1c-bec1-03d3d79e8b12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a441ea6-ff67-4a1c-bec1-03d3d79e8b12" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9a441ea6-ff67-4a1c-bec1-03d3d79e8b12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95ff090f-0742-40cb-8f7c-dabb60212e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a441ea6-ff67-4a1c-bec1-03d3d79e8b12" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95ff090f-0742-40cb-8f7c-dabb60212e14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_af04b4ef-8618-4e85-897f-c98a6dc94477" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95ff090f-0742-40cb-8f7c-dabb60212e14" xlink:to="loc_rdnt_FirstLienTermLoanMember_af04b4ef-8618-4e85-897f-c98a6dc94477" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_f725b364-cd1b-4886-a558-21ca21b6c369" xlink:href="rdnt-20220331.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95ff090f-0742-40cb-8f7c-dabb60212e14" xlink:to="loc_rdnt_RestatedAgreementMember_f725b364-cd1b-4886-a558-21ca21b6c369" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="extended" id="i17b0ff5e378841f1b8a93a2215501c25_CREDITFACILITYANDNOTESPAYABLEDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ea384bf8-65d1-4d9a-8a12-4344a7d876d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LineOfCredit_ea384bf8-65d1-4d9a-8a12-4344a7d876d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c2ddb9e2-4344-4058-8736-291af6bbff6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c2ddb9e2-4344-4058-8736-291af6bbff6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_38ff15bd-1d43-47ee-8831-308b756ee011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_38ff15bd-1d43-47ee-8831-308b756ee011" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0fd8f22c-b3ce-46d9-bb19-cd92d50a050e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0fd8f22c-b3ce-46d9-bb19-cd92d50a050e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_638be7db-fd93-4dc0-80e1-f9c171f6a8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_638be7db-fd93-4dc0-80e1-f9c171f6a8a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_f67e63e0-5362-4d44-866d-ebc9512e65df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_f67e63e0-5362-4d44-866d-ebc9512e65df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_d1b91c89-e9ba-4eb9-8c75-160ce62e813e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_d1b91c89-e9ba-4eb9-8c75-160ce62e813e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_75de4ca6-81b8-4eca-8d5b-9f53c1ac33af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_75de4ca6-81b8-4eca-8d5b-9f53c1ac33af" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_6994b9d1-5da2-4d83-80ee-196ba50fa33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_6994b9d1-5da2-4d83-80ee-196ba50fa33f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_14398520-4bff-4b13-b9db-0a8ab39c1a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_14398520-4bff-4b13-b9db-0a8ab39c1a9a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_efa7367c-a96b-4d43-984f-c37f9a2500ff" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_efa7367c-a96b-4d43-984f-c37f9a2500ff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c28feb1b-5170-4d46-b6a0-30bfdb1ac4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c28feb1b-5170-4d46-b6a0-30bfdb1ac4ae" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1d3b8176-b238-408d-abb6-ee2a308739cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1d3b8176-b238-408d-abb6-ee2a308739cd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_43066008-397b-4e19-b92a-9af52ea0fb9d" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_43066008-397b-4e19-b92a-9af52ea0fb9d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_ef0e784a-9a5d-4cf4-94f8-7f667bb86026" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_ef0e784a-9a5d-4cf4-94f8-7f667bb86026" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_cafccd1f-bbb0-457d-a2f6-cdb233103c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_cafccd1f-bbb0-457d-a2f6-cdb233103c0f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_d9fbf57b-b60b-46a9-a0ba-570253282f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_d9fbf57b-b60b-46a9-a0ba-570253282f89" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_333f4a35-67b9-4131-88ce-d2053b6c20a1" xlink:href="rdnt-20220331.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_333f4a35-67b9-4131-88ce-d2053b6c20a1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAmendments_d935aaf3-6c43-435b-a78c-12c0d4754123" xlink:href="rdnt-20220331.xsd#rdnt_NumberOfAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_NumberOfAmendments_d935aaf3-6c43-435b-a78c-12c0d4754123" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentExtensionPeriod_8868017a-18cb-4459-a06d-e2b173371e40" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_DebtInstrumentExtensionPeriod_8868017a-18cb-4459-a06d-e2b173371e40" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_79a1c075-54b1-49ca-af6e-9ca8911e8335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_CreditFacilityAxis_79a1c075-54b1-49ca-af6e-9ca8911e8335" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_79a1c075-54b1-49ca-af6e-9ca8911e8335_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_79a1c075-54b1-49ca-af6e-9ca8911e8335" xlink:to="loc_us-gaap_CreditFacilityDomain_79a1c075-54b1-49ca-af6e-9ca8911e8335_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8267301c-58fc-409e-babf-e9fb03600bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_79a1c075-54b1-49ca-af6e-9ca8911e8335" xlink:to="loc_us-gaap_CreditFacilityDomain_8267301c-58fc-409e-babf-e9fb03600bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e61f3255-731a-4027-bb55-9dc40248f166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8267301c-58fc-409e-babf-e9fb03600bb1" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e61f3255-731a-4027-bb55-9dc40248f166" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_7fed1fe4-afc1-428a-94fc-f98d3041f870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8267301c-58fc-409e-babf-e9fb03600bb1" xlink:to="loc_us-gaap_LetterOfCreditMember_7fed1fe4-afc1-428a-94fc-f98d3041f870" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ccec444f-f819-4844-bd66-f89883b50af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_DebtInstrumentAxis_ccec444f-f819-4844-bd66-f89883b50af9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ccec444f-f819-4844-bd66-f89883b50af9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ccec444f-f819-4844-bd66-f89883b50af9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ccec444f-f819-4844-bd66-f89883b50af9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ccec444f-f819-4844-bd66-f89883b50af9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_30fcf78e-794b-44a4-8bdb-602c5b927688" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_30fcf78e-794b-44a4-8bdb-602c5b927688" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_879d5a91-560b-40c9-8153-542a9b014469" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_879d5a91-560b-40c9-8153-542a9b014469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_3311bfdc-1e0b-43d0-94bd-137226d8af09" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_3311bfdc-1e0b-43d0-94bd-137226d8af09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_bd4df2c5-8ec9-4329-98d3-560bb2b1b356" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:to="loc_rdnt_FirstLienTermLoanMember_bd4df2c5-8ec9-4329-98d3-560bb2b1b356" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_870d5351-3481-4d03-8e14-4005378c864d" xlink:href="rdnt-20220331.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:to="loc_rdnt_RestatedAgreementMember_870d5351-3481-4d03-8e14-4005378c864d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_9d293cd9-5199-4125-9682-8d70d3579a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_9d293cd9-5199-4125-9682-8d70d3579a08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_9d293cd9-5199-4125-9682-8d70d3579a08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_9d293cd9-5199-4125-9682-8d70d3579a08" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_9d293cd9-5199-4125-9682-8d70d3579a08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_38356050-a513-4998-9e83-96f1a403e8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_9d293cd9-5199-4125-9682-8d70d3579a08" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_38356050-a513-4998-9e83-96f1a403e8b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_ab320b23-30a5-42ee-a9c3-df004234c0f0" xlink:href="rdnt-20220331.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_38356050-a513-4998-9e83-96f1a403e8b1" xlink:to="loc_rdnt_BarclaysMember_ab320b23-30a5-42ee-a9c3-df004234c0f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_6fcec59d-dee1-4811-a510-cb245963c60c" xlink:href="rdnt-20220331.xsd#rdnt_SunTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_38356050-a513-4998-9e83-96f1a403e8b1" xlink:to="loc_rdnt_SunTrustMember_6fcec59d-dee1-4811-a510-cb245963c60c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0d12a072-9d89-41df-b362-6c80757c97b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0d12a072-9d89-41df-b362-6c80757c97b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0d12a072-9d89-41df-b362-6c80757c97b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0d12a072-9d89-41df-b362-6c80757c97b9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0d12a072-9d89-41df-b362-6c80757c97b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0d12a072-9d89-41df-b362-6c80757c97b9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_04aec08d-8a92-400c-a5db-dc6e92b9ff5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:to="loc_us-gaap_LineOfCreditMember_04aec08d-8a92-400c-a5db-dc6e92b9ff5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_3589d062-37e6-430f-a64e-35f76d196593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:to="loc_us-gaap_MediumTermNotesMember_3589d062-37e6-430f-a64e-35f76d196593" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_cce0096e-b1ae-459d-b93a-a08bc2633e3e" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_cce0096e-b1ae-459d-b93a-a08bc2633e3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_e9a4dbc3-c543-4de7-9c12-fb167b953180" xlink:href="rdnt-20220331.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:to="loc_rdnt_TermLoanMember_e9a4dbc3-c543-4de7-9c12-fb167b953180" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a0daa255-fca9-44fd-86a1-757088bed38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:to="loc_us-gaap_LetterOfCreditMember_a0daa255-fca9-44fd-86a1-757088bed38a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9edccd2b-979a-43fa-8407-09ca27c24d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_VariableRateAxis_9edccd2b-979a-43fa-8407-09ca27c24d2c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9edccd2b-979a-43fa-8407-09ca27c24d2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_9edccd2b-979a-43fa-8407-09ca27c24d2c" xlink:to="loc_us-gaap_VariableRateDomain_9edccd2b-979a-43fa-8407-09ca27c24d2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8de3c52c-6bc9-4288-8783-2dc04a974288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_9edccd2b-979a-43fa-8407-09ca27c24d2c" xlink:to="loc_us-gaap_VariableRateDomain_8de3c52c-6bc9-4288-8783-2dc04a974288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_fadac3db-8aa3-4ab2-8c81-7f11b3b39eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8de3c52c-6bc9-4288-8783-2dc04a974288" xlink:to="loc_us-gaap_EurodollarMember_fadac3db-8aa3-4ab2-8c81-7f11b3b39eee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4b1f38e1-07c3-4150-8ce1-d215c0dd3b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8de3c52c-6bc9-4288-8783-2dc04a974288" xlink:to="loc_us-gaap_BaseRateMember_4b1f38e1-07c3-4150-8ce1-d215c0dd3b7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_13965a9d-4c4c-4efd-a02c-0546301779b2" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_rdnt_LeverageRatioAxis_13965a9d-4c4c-4efd-a02c-0546301779b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_13965a9d-4c4c-4efd-a02c-0546301779b2_default" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_13965a9d-4c4c-4efd-a02c-0546301779b2" xlink:to="loc_rdnt_LeverageRatioDomain_13965a9d-4c4c-4efd-a02c-0546301779b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_2be56c80-391b-40ab-ab4a-e71987708e94" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_13965a9d-4c4c-4efd-a02c-0546301779b2" xlink:to="loc_rdnt_LeverageRatioDomain_2be56c80-391b-40ab-ab4a-e71987708e94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFiveMember_a8d2b587-f963-4f44-8952-348a5a408f78" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_2be56c80-391b-40ab-ab4a-e71987708e94" xlink:to="loc_rdnt_LeverageRatioFiveMember_a8d2b587-f963-4f44-8952-348a5a408f78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_5457dfe1-5f27-4567-9b05-e3503510bc23" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_2be56c80-391b-40ab-ab4a-e71987708e94" xlink:to="loc_rdnt_LeverageRatioThreeMember_5457dfe1-5f27-4567-9b05-e3503510bc23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_ab58a93e-0128-44b2-bc0f-7471d272d6ab" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_2be56c80-391b-40ab-ab4a-e71987708e94" xlink:to="loc_rdnt_PricingLevelIIIMember_ab58a93e-0128-44b2-bc0f-7471d272d6ab" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" xlink:type="extended" id="i353681a837294e8a9a058993df0728b2_CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_368379a5-acab-44c6-9019-219639746ea8" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_368379a5-acab-44c6-9019-219639746ea8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_fc3fcc30-7aab-40b8-946b-f72e9ace77ed" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_fc3fcc30-7aab-40b8-946b-f72e9ace77ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2f043059-10a1-4bbc-98c7-3c0aa18a3bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2f043059-10a1-4bbc-98c7-3c0aa18a3bba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_ce411710-51a9-4270-b99a-4aae9f6d8a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_ce411710-51a9-4270-b99a-4aae9f6d8a47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_9daf8fb8-519b-4a2e-84fc-72f04e558f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_9daf8fb8-519b-4a2e-84fc-72f04e558f32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_fca15705-3a69-49d4-8c6e-a0c655d58632" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_rdnt_LeverageRatioAxis_fca15705-3a69-49d4-8c6e-a0c655d58632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_fca15705-3a69-49d4-8c6e-a0c655d58632_default" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_fca15705-3a69-49d4-8c6e-a0c655d58632" xlink:to="loc_rdnt_LeverageRatioDomain_fca15705-3a69-49d4-8c6e-a0c655d58632_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_fca15705-3a69-49d4-8c6e-a0c655d58632" xlink:to="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_6f9c5bec-32c1-4980-9edc-c672ab18cc69" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:to="loc_rdnt_PricingLevelIMember_6f9c5bec-32c1-4980-9edc-c672ab18cc69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_b0650abb-87e1-4cb1-99dc-768bf5f6f767" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:to="loc_rdnt_PricingLevelIIMember_b0650abb-87e1-4cb1-99dc-768bf5f6f767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_7ffc7775-478e-4bcc-a12c-7fa3f9865978" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:to="loc_rdnt_PricingLevelIIIMember_7ffc7775-478e-4bcc-a12c-7fa3f9865978" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_b886d671-00b4-48e4-9f16-96cda52edce0" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:to="loc_rdnt_PricingLevelIVMember_b886d671-00b4-48e4-9f16-96cda52edce0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_51c23e55-5d98-4276-82ed-63215d90516b" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:to="loc_rdnt_PricingLevelVMember_51c23e55-5d98-4276-82ed-63215d90516b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d3a859e6-1509-4c2f-80f9-aefe2cf43434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_us-gaap_VariableRateAxis_d3a859e6-1509-4c2f-80f9-aefe2cf43434" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d3a859e6-1509-4c2f-80f9-aefe2cf43434_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_d3a859e6-1509-4c2f-80f9-aefe2cf43434" xlink:to="loc_us-gaap_VariableRateDomain_d3a859e6-1509-4c2f-80f9-aefe2cf43434_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d2905496-033c-45ed-8a90-af07a76458c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_d3a859e6-1509-4c2f-80f9-aefe2cf43434" xlink:to="loc_us-gaap_VariableRateDomain_d2905496-033c-45ed-8a90-af07a76458c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_94c1844b-fb44-4ae1-8e6c-78235e267917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d2905496-033c-45ed-8a90-af07a76458c5" xlink:to="loc_us-gaap_EurodollarMember_94c1844b-fb44-4ae1-8e6c-78235e267917" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_b385d263-f042-49a1-ad92-49212d22bec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d2905496-033c-45ed-8a90-af07a76458c5" xlink:to="loc_us-gaap_BaseRateMember_b385d263-f042-49a1-ad92-49212d22bec9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_35371ded-fce9-499b-98c9-1697577f239d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_us-gaap_DebtInstrumentAxis_35371ded-fce9-499b-98c9-1697577f239d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35371ded-fce9-499b-98c9-1697577f239d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_35371ded-fce9-499b-98c9-1697577f239d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35371ded-fce9-499b-98c9-1697577f239d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a0f6aaba-3783-41f1-a6fc-085767084b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_35371ded-fce9-499b-98c9-1697577f239d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a0f6aaba-3783-41f1-a6fc-085767084b1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_c4c9e54f-e71c-4dbe-bfe4-adf8f900b443" xlink:href="rdnt-20220331.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a0f6aaba-3783-41f1-a6fc-085767084b1e" xlink:to="loc_rdnt_RestatedAgreementMember_c4c9e54f-e71c-4dbe-bfe4-adf8f900b443" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b30161fe-4707-4333-83c6-fd32c4a88961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_us-gaap_CreditFacilityAxis_b30161fe-4707-4333-83c6-fd32c4a88961" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b30161fe-4707-4333-83c6-fd32c4a88961_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b30161fe-4707-4333-83c6-fd32c4a88961" xlink:to="loc_us-gaap_CreditFacilityDomain_b30161fe-4707-4333-83c6-fd32c4a88961_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_241d27f1-30a2-4a4c-8096-f6c297c8655c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b30161fe-4707-4333-83c6-fd32c4a88961" xlink:to="loc_us-gaap_CreditFacilityDomain_241d27f1-30a2-4a4c-8096-f6c297c8655c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_25bfce3e-5a07-4d88-a2fd-f82b96a5d043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_241d27f1-30a2-4a4c-8096-f6c297c8655c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_25bfce3e-5a07-4d88-a2fd-f82b96a5d043" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_17775467-e28e-4ce3-9f22-af9b207d8f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_17775467-e28e-4ce3-9f22-af9b207d8f4b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_17775467-e28e-4ce3-9f22-af9b207d8f4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17775467-e28e-4ce3-9f22-af9b207d8f4b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_17775467-e28e-4ce3-9f22-af9b207d8f4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9dc77752-4e02-4cb5-b4d9-e9b169a3fd15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17775467-e28e-4ce3-9f22-af9b207d8f4b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9dc77752-4e02-4cb5-b4d9-e9b169a3fd15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_b66cf742-9d75-42ec-bed7-018ce9294960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9dc77752-4e02-4cb5-b4d9-e9b169a3fd15" xlink:to="loc_us-gaap_LineOfCreditMember_b66cf742-9d75-42ec-bed7-018ce9294960" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended" id="i1bd9ca72f16e4b53b25a9bc2472a64c7_CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_18f0efa7-9964-47a3-94eb-1fab47ef98e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_78c1c773-ff9f-4fbf-be95-f1e616871a47" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_18f0efa7-9964-47a3-94eb-1fab47ef98e8" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_78c1c773-ff9f-4fbf-be95-f1e616871a47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c4e8d277-4cda-44d5-a11b-f5fe90c006a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_18f0efa7-9964-47a3-94eb-1fab47ef98e8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c4e8d277-4cda-44d5-a11b-f5fe90c006a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_18f0efa7-9964-47a3-94eb-1fab47ef98e8" xlink:to="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_dab8c1d7-2e9d-47d2-893f-c9ef10b791e3" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_rdnt_LeverageRatioAxis_dab8c1d7-2e9d-47d2-893f-c9ef10b791e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_dab8c1d7-2e9d-47d2-893f-c9ef10b791e3_default" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_dab8c1d7-2e9d-47d2-893f-c9ef10b791e3" xlink:to="loc_rdnt_LeverageRatioDomain_dab8c1d7-2e9d-47d2-893f-c9ef10b791e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_a7d303b2-a9de-4d9a-9c27-48a5a1db4cbc" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_dab8c1d7-2e9d-47d2-893f-c9ef10b791e3" xlink:to="loc_rdnt_LeverageRatioDomain_a7d303b2-a9de-4d9a-9c27-48a5a1db4cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_582e09fe-7e80-425b-b9a6-e7640218d47e" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_a7d303b2-a9de-4d9a-9c27-48a5a1db4cbc" xlink:to="loc_rdnt_LeverageRatioOneMember_582e09fe-7e80-425b-b9a6-e7640218d47e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_451e081b-4c49-43c2-bfb8-7ec73023c4ed" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_a7d303b2-a9de-4d9a-9c27-48a5a1db4cbc" xlink:to="loc_rdnt_LeverageRatioTwoMember_451e081b-4c49-43c2-bfb8-7ec73023c4ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember_3eec2362-9475-4abc-b572-897df0b0f46b" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_a7d303b2-a9de-4d9a-9c27-48a5a1db4cbc" xlink:to="loc_rdnt_LeverageRatioFourMember_3eec2362-9475-4abc-b572-897df0b0f46b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0937ec47-914c-43c1-bfa3-95b59ab92910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_us-gaap_CreditFacilityAxis_0937ec47-914c-43c1-bfa3-95b59ab92910" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0937ec47-914c-43c1-bfa3-95b59ab92910_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_0937ec47-914c-43c1-bfa3-95b59ab92910" xlink:to="loc_us-gaap_CreditFacilityDomain_0937ec47-914c-43c1-bfa3-95b59ab92910_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ebbf773e-a7eb-47f5-989c-266ec5b15364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_0937ec47-914c-43c1-bfa3-95b59ab92910" xlink:to="loc_us-gaap_CreditFacilityDomain_ebbf773e-a7eb-47f5-989c-266ec5b15364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9b0e0213-f008-49d7-b877-10efe36c7ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ebbf773e-a7eb-47f5-989c-266ec5b15364" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9b0e0213-f008-49d7-b877-10efe36c7ed2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f4a2740f-6941-48b8-badb-42d92d8b7894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_us-gaap_DebtInstrumentAxis_f4a2740f-6941-48b8-badb-42d92d8b7894" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f4a2740f-6941-48b8-badb-42d92d8b7894_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f4a2740f-6941-48b8-badb-42d92d8b7894" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f4a2740f-6941-48b8-badb-42d92d8b7894_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c4fffe31-7bfb-4a07-aecd-e5c33e2b3ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f4a2740f-6941-48b8-badb-42d92d8b7894" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c4fffe31-7bfb-4a07-aecd-e5c33e2b3ae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_135f6890-8466-4dc3-815f-a6e583090de5" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c4fffe31-7bfb-4a07-aecd-e5c33e2b3ae5" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_135f6890-8466-4dc3-815f-a6e583090de5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_207756e2-3ddf-4bfb-9c8f-79038a3ed39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_207756e2-3ddf-4bfb-9c8f-79038a3ed39d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_207756e2-3ddf-4bfb-9c8f-79038a3ed39d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_207756e2-3ddf-4bfb-9c8f-79038a3ed39d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_207756e2-3ddf-4bfb-9c8f-79038a3ed39d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ec444684-95cf-4385-a561-4ba8adc7efbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_207756e2-3ddf-4bfb-9c8f-79038a3ed39d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ec444684-95cf-4385-a561-4ba8adc7efbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_cf364f1b-bb12-4039-bd1a-79cf2f85ef37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ec444684-95cf-4385-a561-4ba8adc7efbe" xlink:to="loc_us-gaap_LineOfCreditMember_cf364f1b-bb12-4039-bd1a-79cf2f85ef37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f9a4f381-f13f-465c-83e7-fbad41b0a0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_us-gaap_VariableRateAxis_f9a4f381-f13f-465c-83e7-fbad41b0a0ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f9a4f381-f13f-465c-83e7-fbad41b0a0ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f9a4f381-f13f-465c-83e7-fbad41b0a0ba" xlink:to="loc_us-gaap_VariableRateDomain_f9a4f381-f13f-465c-83e7-fbad41b0a0ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b0927d63-3adc-4fa6-8958-2ee4331b0935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f9a4f381-f13f-465c-83e7-fbad41b0a0ba" xlink:to="loc_us-gaap_VariableRateDomain_b0927d63-3adc-4fa6-8958-2ee4331b0935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_da70e34b-b1d4-49a4-8d90-bc8fef034546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b0927d63-3adc-4fa6-8958-2ee4331b0935" xlink:to="loc_us-gaap_EurodollarMember_da70e34b-b1d4-49a4-8d90-bc8fef034546" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_247d3550-cc45-46ba-b560-0cf6fac20739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b0927d63-3adc-4fa6-8958-2ee4331b0935" xlink:to="loc_us-gaap_BaseRateMember_247d3550-cc45-46ba-b560-0cf6fac20739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_65bbb55e-da8e-4024-943a-2246b782deb9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_srt_RangeAxis_65bbb55e-da8e-4024-943a-2246b782deb9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_65bbb55e-da8e-4024-943a-2246b782deb9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_65bbb55e-da8e-4024-943a-2246b782deb9" xlink:to="loc_srt_RangeMember_65bbb55e-da8e-4024-943a-2246b782deb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f850901-d04e-4e2e-ab42-edef195fe146" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_65bbb55e-da8e-4024-943a-2246b782deb9" xlink:to="loc_srt_RangeMember_6f850901-d04e-4e2e-ab42-edef195fe146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c712498-ae72-4f1c-a6e0-fb9a83bce076" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f850901-d04e-4e2e-ab42-edef195fe146" xlink:to="loc_srt_MaximumMember_0c712498-ae72-4f1c-a6e0-fb9a83bce076" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4ecb7c88-0167-4153-8a13-c55b10c4d848" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f850901-d04e-4e2e-ab42-edef195fe146" xlink:to="loc_srt_MinimumMember_4ecb7c88-0167-4153-8a13-c55b10c4d848" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended" id="i2893787a6e8f49cc978ee130bde980af_STOCKBASEDCOMPENSATIONDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_e179b3fd-58c0-43c7-b3e5-19e3449ffa15" xlink:href="rdnt-20220331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_e179b3fd-58c0-43c7-b3e5-19e3449ffa15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_67e46d12-48fb-454f-a296-c298139f014c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_67e46d12-48fb-454f-a296-c298139f014c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_05da8765-12b5-4088-b55b-0aac0328fbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_05da8765-12b5-4088-b55b-0aac0328fbc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_af639ce7-c985-436c-8f2f-b46fe76cd6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_af639ce7-c985-436c-8f2f-b46fe76cd6d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8f844acb-e249-44df-a870-f084d4467405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8f844acb-e249-44df-a870-f084d4467405" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_53989260-f639-4684-be44-72df3bae78ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_53989260-f639-4684-be44-72df3bae78ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_137b730c-bb1f-4677-b7e1-8c8b449e10b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_137b730c-bb1f-4677-b7e1-8c8b449e10b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d8e3f45-674a-41ef-a7ee-972ae3590f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d8e3f45-674a-41ef-a7ee-972ae3590f07" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d1c8c06b-5a52-4a6e-8a70-fc67f226fd57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d1c8c06b-5a52-4a6e-8a70-fc67f226fd57" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0063dae0-8bfc-427c-b6c8-fb63de7c090c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0063dae0-8bfc-427c-b6c8-fb63de7c090c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1e50c94b-befa-43d7-b45a-d5064d5df375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1e50c94b-befa-43d7-b45a-d5064d5df375" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dc17a4b0-59d0-4a1b-8ce6-5c9bd4654f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dc17a4b0-59d0-4a1b-8ce6-5c9bd4654f3f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2c2a95d8-8247-4d17-910a-dd4e86b0f099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2c2a95d8-8247-4d17-910a-dd4e86b0f099" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_354d3030-c3ca-489d-8db6-0866fb5c1d63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_354d3030-c3ca-489d-8db6-0866fb5c1d63" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_207650ee-eb58-45aa-a48c-3e552f6768fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_207650ee-eb58-45aa-a48c-3e552f6768fb" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d3241c40-f797-4139-800f-8734d39db303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d3241c40-f797-4139-800f-8734d39db303" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_5f1868f3-a83c-48b2-a19b-6372639299de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_5f1868f3-a83c-48b2-a19b-6372639299de" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d2b90150-b80b-4f73-908c-ce515a8abc20" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:to="loc_srt_RangeAxis_d2b90150-b80b-4f73-908c-ce515a8abc20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d2b90150-b80b-4f73-908c-ce515a8abc20_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d2b90150-b80b-4f73-908c-ce515a8abc20" xlink:to="loc_srt_RangeMember_d2b90150-b80b-4f73-908c-ce515a8abc20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8fbcac11-8ad2-4b42-a381-6d7a7d1b601b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d2b90150-b80b-4f73-908c-ce515a8abc20" xlink:to="loc_srt_RangeMember_8fbcac11-8ad2-4b42-a381-6d7a7d1b601b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b2495929-8b49-496d-ac94-2f8c77605338" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8fbcac11-8ad2-4b42-a381-6d7a7d1b601b" xlink:to="loc_srt_MinimumMember_b2495929-8b49-496d-ac94-2f8c77605338" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f1d47b2d-676f-4d6e-897e-2329f5684ef8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8fbcac11-8ad2-4b42-a381-6d7a7d1b601b" xlink:to="loc_srt_MaximumMember_f1d47b2d-676f-4d6e-897e-2329f5684ef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f5d49d2d-4225-40cf-97ea-bd06d2ff7436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:to="loc_us-gaap_AwardTypeAxis_f5d49d2d-4225-40cf-97ea-bd06d2ff7436" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5d49d2d-4225-40cf-97ea-bd06d2ff7436_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f5d49d2d-4225-40cf-97ea-bd06d2ff7436" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5d49d2d-4225-40cf-97ea-bd06d2ff7436_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f5d49d2d-4225-40cf-97ea-bd06d2ff7436" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_19942fa3-c95c-4aab-a4b3-ba4d118f237e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:to="loc_us-gaap_StockOptionMember_19942fa3-c95c-4aab-a4b3-ba4d118f237e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e341517f-f841-4571-a5da-57379df71b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:to="loc_us-gaap_RestrictedStockMember_e341517f-f841-4571-a5da-57379df71b3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_9f1f79ad-022a-468b-8f21-bc4b752dea48" xlink:href="rdnt-20220331.xsd#rdnt_FutureServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:to="loc_rdnt_FutureServiceMember_9f1f79ad-022a-468b-8f21-bc4b752dea48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_7567be1d-df3c-4686-aa84-78c9904310ab" xlink:href="rdnt-20220331.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_7567be1d-df3c-4686-aa84-78c9904310ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_d545d25c-f4a4-483f-a811-ee637676db2f" xlink:href="rdnt-20220331.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_d545d25c-f4a4-483f-a811-ee637676db2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_83f12ca9-976c-4253-b0d6-da6a91e315ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_83f12ca9-976c-4253-b0d6-da6a91e315ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83f12ca9-976c-4253-b0d6-da6a91e315ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_83f12ca9-976c-4253-b0d6-da6a91e315ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83f12ca9-976c-4253-b0d6-da6a91e315ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc5aaf9e-d927-4e4a-afd4-a8e04ddbb36e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_83f12ca9-976c-4253-b0d6-da6a91e315ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc5aaf9e-d927-4e4a-afd4-a8e04ddbb36e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_dd55db1b-c8f0-49d1-91a6-6e5824795b23" xlink:href="rdnt-20220331.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc5aaf9e-d927-4e4a-afd4-a8e04ddbb36e" xlink:to="loc_rdnt_DeepHealthIncMember_dd55db1b-c8f0-49d1-91a6-6e5824795b23" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20220331.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended" id="i0c3e391bc38a46e8b581daee6f6e52e7_STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_878729de-a3b7-489e-8ec8-e346c357c9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_878729de-a3b7-489e-8ec8-e346c357c9fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_76ad2498-997e-4428-8650-7704fb8758a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_76ad2498-997e-4428-8650-7704fb8758a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cb6cfcb9-5187-4906-91e9-9df013299d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cb6cfcb9-5187-4906-91e9-9df013299d5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_46bc877c-49b7-4b4a-ab13-eb57e5a0e02b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2b19180d-42a2-40ef-ad62-b9a5720ab612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2b19180d-42a2-40ef-ad62-b9a5720ab612" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d7dd96a3-a0c9-4bfa-83f2-28d7f0655325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d7dd96a3-a0c9-4bfa-83f2-28d7f0655325" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_feb2369b-8e1c-4695-9ecc-980591fce7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d7dd96a3-a0c9-4bfa-83f2-28d7f0655325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_feb2369b-8e1c-4695-9ecc-980591fce7f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1a744f92-aa92-46c5-a5f5-10127626ed32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d7dd96a3-a0c9-4bfa-83f2-28d7f0655325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1a744f92-aa92-46c5-a5f5-10127626ed32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_04253071-7c3e-4162-8264-a472ee3109ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d9d165b3-e0d5-4c26-b458-d4a6c388cf15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d9d165b3-e0d5-4c26-b458-d4a6c388cf15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_88de5c15-f504-42cc-9a6b-9693a6422950" xlink:href="rdnt-20220331.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_88de5c15-f504-42cc-9a6b-9693a6422950" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_22316704-5125-4eec-a543-6d4350c48678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_88de5c15-f504-42cc-9a6b-9693a6422950" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_22316704-5125-4eec-a543-6d4350c48678" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7cd54807-b980-4589-9ca3-72b29af6b595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_88de5c15-f504-42cc-9a6b-9693a6422950" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7cd54807-b980-4589-9ca3-72b29af6b595" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_8a83d7a1-f73d-4803-9462-e3f4849d6563" xlink:href="rdnt-20220331.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_rdnt_AggregateIntrinsicValue_8a83d7a1-f73d-4803-9462-e3f4849d6563" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5364c0d1-a90c-4c91-b00b-02469653f089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_8a83d7a1-f73d-4803-9462-e3f4849d6563" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5364c0d1-a90c-4c91-b00b-02469653f089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_823c307b-52cb-462a-b83a-4fa66cef7cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_8a83d7a1-f73d-4803-9462-e3f4849d6563" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_823c307b-52cb-462a-b83a-4fa66cef7cf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac1ff9e-f184-4ed2-80d5-e0c167da6799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac1ff9e-f184-4ed2-80d5-e0c167da6799" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_142e1b8e-9410-4e1e-b364-55436ab11613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac1ff9e-f184-4ed2-80d5-e0c167da6799" xlink:to="loc_us-gaap_AwardTypeAxis_142e1b8e-9410-4e1e-b364-55436ab11613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_142e1b8e-9410-4e1e-b364-55436ab11613_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_142e1b8e-9410-4e1e-b364-55436ab11613" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_142e1b8e-9410-4e1e-b364-55436ab11613_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb9813b7-39bc-4691-901e-56a1658fc599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_142e1b8e-9410-4e1e-b364-55436ab11613" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb9813b7-39bc-4691-901e-56a1658fc599" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_2a6e633e-0d82-4e21-938b-22fd5d980397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb9813b7-39bc-4691-901e-56a1658fc599" xlink:to="loc_us-gaap_StockOptionMember_2a6e633e-0d82-4e21-938b-22fd5d980397" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_197d21db-aa16-44ab-be96-afc79c5e71a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac1ff9e-f184-4ed2-80d5-e0c167da6799" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_197d21db-aa16-44ab-be96-afc79c5e71a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_197d21db-aa16-44ab-be96-afc79c5e71a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_197d21db-aa16-44ab-be96-afc79c5e71a8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_197d21db-aa16-44ab-be96-afc79c5e71a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b4bba07-75d0-433d-aa27-422f67533648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_197d21db-aa16-44ab-be96-afc79c5e71a8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b4bba07-75d0-433d-aa27-422f67533648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_fb31e163-1377-439f-b276-f07fe31682ab" xlink:href="rdnt-20220331.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b4bba07-75d0-433d-aa27-422f67533648" xlink:to="loc_rdnt_DeepHealthInc.Member_fb31e163-1377-439f-b276-f07fe31682ab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="simple" xlink:href="rdnt-20220331.xsd#STOCKBASEDCOMPENSATIONDetailsRSUs"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="extended" id="i0a794c76610244a78fcb8f32153f4a9d_STOCKBASEDCOMPENSATIONDetailsRSUs">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0923cebe-f9b6-4a06-bc7c-baa85a3d19f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0923cebe-f9b6-4a06-bc7c-baa85a3d19f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51cbe86d-a8fe-484c-b3ea-6afbb3358789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51cbe86d-a8fe-484c-b3ea-6afbb3358789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8e4a9436-fe3e-40aa-aece-6c52a56e89f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8e4a9436-fe3e-40aa-aece-6c52a56e89f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_19b9aaee-344d-45e7-ad09-8c0f67a57839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_19b9aaee-344d-45e7-ad09-8c0f67a57839" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0da1aea2-b946-4943-8617-01c073d240e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_02a15805-739a-4d42-ab86-a4ed635a1156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0923cebe-f9b6-4a06-bc7c-baa85a3d19f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_02a15805-739a-4d42-ab86-a4ed635a1156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0923cebe-f9b6-4a06-bc7c-baa85a3d19f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d799be6b-57d4-4b87-b978-e81577af2ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d799be6b-57d4-4b87-b978-e81577af2ac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bcc3de1f-c024-4a45-875b-0fcb85676c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bcc3de1f-c024-4a45-875b-0fcb85676c7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d67ae66a-8dc9-4f0e-ab4d-2326ce1f67b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d67ae66a-8dc9-4f0e-ab4d-2326ce1f67b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1176e04a-603a-4500-be5a-17d79ded2967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a226620-8f2a-43be-b60d-4c8942659098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0923cebe-f9b6-4a06-bc7c-baa85a3d19f1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a226620-8f2a-43be-b60d-4c8942659098" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e7e1cb72-fa75-4bc6-8beb-a089e1aab739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a226620-8f2a-43be-b60d-4c8942659098" xlink:to="loc_us-gaap_AwardTypeAxis_e7e1cb72-fa75-4bc6-8beb-a089e1aab739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7e1cb72-fa75-4bc6-8beb-a089e1aab739_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e7e1cb72-fa75-4bc6-8beb-a089e1aab739" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7e1cb72-fa75-4bc6-8beb-a089e1aab739_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f2dfd4-8cf3-4a70-8a8c-c3adffc9e0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e7e1cb72-fa75-4bc6-8beb-a089e1aab739" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f2dfd4-8cf3-4a70-8a8c-c3adffc9e0f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_572c1cdd-a34f-4b71-a9f3-b87b61f8cfae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f2dfd4-8cf3-4a70-8a8c-c3adffc9e0f9" xlink:to="loc_us-gaap_RestrictedStockMember_572c1cdd-a34f-4b71-a9f3-b87b61f8cfae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended" id="id4121020b0f14603a7c4e766c897bb22_SUBSEQUENTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_0d970e32-205d-4ab1-b711-f4adb01d9a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_99f7460e-c32a-44c0-9899-42dbb0398af3" xlink:href="rdnt-20220331.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0d970e32-205d-4ab1-b711-f4adb01d9a08" xlink:to="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_99f7460e-c32a-44c0-9899-42dbb0398af3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_8814756d-046c-4acc-8bbe-0efb6ec3de34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0d970e32-205d-4ab1-b711-f4adb01d9a08" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_8814756d-046c-4acc-8bbe-0efb6ec3de34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_0d970e32-205d-4ab1-b711-f4adb01d9a08" xlink:to="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_aaf5bf9b-a0e6-4e24-ae16-7fc1fa61b7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_aaf5bf9b-a0e6-4e24-ae16-7fc1fa61b7aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aaf5bf9b-a0e6-4e24-ae16-7fc1fa61b7aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_aaf5bf9b-a0e6-4e24-ae16-7fc1fa61b7aa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aaf5bf9b-a0e6-4e24-ae16-7fc1fa61b7aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_64494676-645a-4c70-86c7-bd3b2f7faeef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_aaf5bf9b-a0e6-4e24-ae16-7fc1fa61b7aa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_64494676-645a-4c70-86c7-bd3b2f7faeef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6dbda06b-5f7c-42a7-bb8a-41707ddf1d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_64494676-645a-4c70-86c7-bd3b2f7faeef" xlink:to="loc_us-gaap_SubsequentEventMember_6dbda06b-5f7c-42a7-bb8a-41707ddf1d60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_636fc50b-79d9-4666-9012-0d6d41b65a5a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:to="loc_dei_LegalEntityAxis_636fc50b-79d9-4666-9012-0d6d41b65a5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_636fc50b-79d9-4666-9012-0d6d41b65a5a_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_636fc50b-79d9-4666-9012-0d6d41b65a5a" xlink:to="loc_dei_EntityDomain_636fc50b-79d9-4666-9012-0d6d41b65a5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_46720b2a-29d0-469d-a1d7-c5a94c5908cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_636fc50b-79d9-4666-9012-0d6d41b65a5a" xlink:to="loc_dei_EntityDomain_46720b2a-29d0-469d-a1d7-c5a94c5908cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_1271105d-6604-49d1-9694-4c9dc028d6c5" xlink:href="rdnt-20220331.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_46720b2a-29d0-469d-a1d7-c5a94c5908cd" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_1271105d-6604-49d1-9694-4c9dc028d6c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember_98a9ac7b-b288-4255-93f7-71a20ca40870" xlink:href="rdnt-20220331.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_46720b2a-29d0-469d-a1d7-c5a94c5908cd" xlink:to="loc_rdnt_FrederickHealthHospitalIncMember_98a9ac7b-b288-4255-93f7-71a20ca40870" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_ae718554-2e00-4d2d-9454-31be894e6759" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:to="loc_srt_OwnershipAxis_ae718554-2e00-4d2d-9454-31be894e6759" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ae718554-2e00-4d2d-9454-31be894e6759_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_ae718554-2e00-4d2d-9454-31be894e6759" xlink:to="loc_srt_OwnershipDomain_ae718554-2e00-4d2d-9454-31be894e6759_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_cbc8f4f6-2576-4c14-9e1d-fdd2601fa3d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_ae718554-2e00-4d2d-9454-31be894e6759" xlink:to="loc_srt_OwnershipDomain_cbc8f4f6-2576-4c14-9e1d-fdd2601fa3d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_6d2f5283-be78-4c71-a986-084331ca5bc0" xlink:href="rdnt-20220331.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_cbc8f4f6-2576-4c14-9e1d-fdd2601fa3d0" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_6d2f5283-be78-4c71-a986-084331ca5bc0" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>rdnt-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:24636b67-e396-4152-b274-3287e4e6d5f6,g:fb9713cf-faca-444a-b4d8-252fbad89deb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_744a005f-0be8-4081-99ba-0fe7902a2917_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_73579af5-fb4f-4ffb-978a-d31407bd8e8a_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIMember_056414c0-ca62-4a86-9f46-d172490f06a3_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIMember" xlink:to="lab_rdnt_PricingLevelIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_9fd3d950-7597-448c-84ba-28d4b8579c54_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, liability, period</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Period</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_1ec0f262-3137-4d44-a983-f6a1222049ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_0080e70d-8ec6-442b-a08d-23288fd1ec51_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_131ce7bf-8042-4b3d-8f99-436149672fc6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_d8e17770-a05a-4cdc-9521-c97bac211c27_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4ae2d75c-79d0-4601-a14a-6d1993b6d3a0_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c757f430-7953-456d-925a-8063532c7530_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_e4573ae9-b668-417c-9c2d-e514a862760b_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_17f78d02-242d-44d5-9573-41e7badb0e7d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_40f4fd55-3140-4403-b079-02611b54b15d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to RadNet, Inc.'s common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_61a18c22-d936-4df9-8323-6d4f81ba8468_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS RECEIVABLE</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_ed9501e9-df27-4762-9ed6-97952f1b6bd4_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6fe896c2-56bd-42f0-8e0c-602e95b40124_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_3ed1f00f-6231-4d44-8ade-f426c1fa86a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_6ad7990a-e3f7-408e-b9b8-fb3f794ab5cb_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of additional shares issued after execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:href="rdnt-20220331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_3aea82dc-93f5-45bc-a311-c05fb93ac955_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_bd977c78-416b-42d4-a9a3-5ab20d5de2ee_terseLabel_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_label_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_documentation_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:href="rdnt-20220331.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:to="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_2f908a29-9834-44d6-a2bc-77dc8a057aff_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssets_7c398a92-d0e4-494b-9c6a-4db9bc3ac480_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits and other</link:label>
    <link:label id="lab_us-gaap_DepositsAssets_label_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssets" xlink:to="lab_us-gaap_DepositsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_f7a0256c-ce8f-4c34-9884-157cfeff91c8_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability [Roll Forward]</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability [Roll Forward]</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_df5b5624-f3f7-4f1e-91f6-af7ce289e577_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0c167707-388a-405a-93e3-67494e3ccffa_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a46b242b-d637-43fb-a66f-53ab0dbc53cd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_2e649bbd-d6b7-4a9e-afd0-8c4a4836e1d5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c65f4bd6-7426-45f1-a24f-9cdc2de4a6f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e2bddc9-8b9e-4457-a8d8-bd585c684455_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_6d6bd762-8e1d-4214-9b7c-7530a689a3dc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_59c77a54-6271-4acd-858e-ffc7e84ed3a3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0ce7ab35-984c-43c4-8183-a80458fff351_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available in grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06165f32-4223-4a87-81bc-14dce833b9fc_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET DECREASE IN CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e9646825-c9e4-4be6-bcbe-5e670d257038_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bfb9494c-38f8-47d5-8cc5-42123ffeab8d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b3fe7caa-6c2f-4c07-9fbe-78b426c391ab_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_edc81bf4-b607-491c-a64f-62d9c4e7cef1_terseLabel_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_label_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options [Member]</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_documentation_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember" xlink:href="rdnt-20220331.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PerformanceBasedStockOptionsMember" xlink:to="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_ea992b8d-e010-4723-b96f-1ff2f061875a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation adjustment</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_e3b86dcf-40c0-41e5-aeba-12727f255599_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of cash flow hedge, net of taxes</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:to="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_1cfc65e8-f92c-4746-bc7e-63f5f49096fb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Service Fee Revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Transactions Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:to="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_9566bdac-9a2d-4484-b9e2-cadd2b779163_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60dfb45b-0432-4684-a6bc-77d9959c5371_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_4a43840a-6c3f-482f-bd3e-daffbf3e8933_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:to="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9080c311-9a99-45dd-9d2d-c5648c1c7f07_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLoans_9f47fce2-ff90-4a23-9a8c-e0b74e3d10d6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from PPP loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLoans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLoans" xlink:to="lab_us-gaap_ProceedsFromLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_dc95f4eb-14ba-49cd-9517-dad823626e1d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ef1cd4f1-44f5-4417-959c-739af23e4170_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_43b9e3cf-0582-40b0-be8e-37830cad410f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_957e3fdf-1f84-43f6-b0d2-cd2243baa28b_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin for Letter of Credit Fees</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_fceada68-0a64-40cf-ba15-3b2197ac4bb2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4238626b-2b2f-4054-83d2-3d1e3099d848_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TermLoanMember_afa38896-0a67-4dd1-a958-9f54e255e853_terseLabel_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans</link:label>
    <link:label id="lab_rdnt_TermLoanMember_label_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember" xlink:href="rdnt-20220331.xsd#rdnt_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TermLoanMember" xlink:to="lab_rdnt_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d7fc59f0-448c-46a4-ad6a-be9d34b9f559_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_86be7a71-2194-47c8-9b38-b8f977e8dd8e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_83973311-8237-4b33-a041-0689041220c9_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicaid1Member_36475732-7f3a-46b3-8406-0ef791df42e7_terseLabel_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_label_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_documentation_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member" xlink:href="rdnt-20220331.xsd#rdnt_Medicaid1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicaid1Member" xlink:to="lab_rdnt_Medicaid1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_5bb04b22-d13c-442a-a8f4-3314baa4c293_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_d9fe31bf-5902-48a6-964d-20a31a77d50d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_c5aa2be7-f0ef-42f0-9e92-250c6c198c72_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_51e84de2-7906-43b1-a6aa-c5e1990f9b8d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_328277a5-04d7-445e-8ee9-b7e24e66920a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_55b18479-aba9-407e-9f8e-276b9932e4ac_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable Shares at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthInc.Member_5378ffff-db1c-4ec2-be88-97663c8ab26a_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthInc.Member_label_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthInc.Member_documentation_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member" xlink:href="rdnt-20220331.xsd#rdnt_DeepHealthInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthInc.Member" xlink:to="lab_rdnt_DeepHealthInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedAgreementMember_f0fb99b7-99ea-4c8d-94fb-918b39e91045_terseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust Term Loan collateralized by NJIN's tangible and intangible assets</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_77375d00-3b23-4e7a-93ea-34cc72c0b1fe_verboseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust Term Loan</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_label_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_documentation_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember" xlink:href="rdnt-20220331.xsd#rdnt_RestatedAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedAgreementMember" xlink:to="lab_rdnt_RestatedAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2401b8f5-282c-458d-ad12-336906464405_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3ee791c8-2894-4639-918b-c568914b4980_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d78576ab-48a7-4163-947f-81064b3f26eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f2c13778-7b97-45c2-a538-55ea9edae0e1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_27a9a40f-06bf-4172-8cd5-5e6c76967208_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_42513e41-b7a3-4246-a334-39897f6c053d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2b4b616a-2fd9-458e-8629-bbac60b3c3c7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_d7371b04-2675-44fb-b6a6-a3472d9192aa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loans and SunTrust Term Loan</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_4f841608-5d13-482c-8a25-ad7667f9f0f9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management services provided to BRMG and NY Groups</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Income or Loss before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_3ce810c7-c807-4624-b625-823c2c41cd8b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_2b50e186-6511-44d1-b5a9-53494f59d475_terseLabel_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly amortization of deferred hedge gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_documentation_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:href="rdnt-20220331.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:to="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_46e0a68c-674d-46ad-a27a-b191b667364d_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 3.00x but &#8804; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioTwoMember" xlink:to="lab_rdnt_LeverageRatioTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IFRCLLC2Member_028dbda1-c4d9-43a5-b73b-d3ba9edc53a7_terseLabel_en-US" xlink:label="lab_rdnt_IFRCLLC2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC</link:label>
    <link:label id="lab_rdnt_IFRCLLC2Member_label_en-US" xlink:label="lab_rdnt_IFRCLLC2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC2 [Member]</link:label>
    <link:label id="lab_rdnt_IFRCLLC2Member_documentation_en-US" xlink:label="lab_rdnt_IFRCLLC2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLC2Member" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLC2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IFRCLLC2Member" xlink:to="lab_rdnt_IFRCLLC2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a2ffd884-b6a7-4fac-9650-5d86262b3c69_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_30b2d173-1076-4b17-bb36-306da054c8ff_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entity, ownership percentage</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_769edb31-3f4d-4324-8fb8-8fb984cce5f1_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment amortization increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_db4b5d8e-cb27-4c9d-a63d-f442b2859864_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPSMember_89ac0d63-4100-434f-83fe-361d05bea511_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_label_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember" xlink:href="rdnt-20220331.xsd#rdnt_A2019SWAPSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPSMember" xlink:to="lab_rdnt_A2019SWAPSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_340ef6b6-7da5-4439-92f1-b0c4e3449c0c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_ac1cf1ac-11db-4748-b612-9b893bd76b05_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INDEFINITE LIVED INTANGIBLES</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_a044e6d3-f2bc-4745-a12e-894b92a8ffbd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_3b6535aa-47a0-4658-8fb9-06f751a5fdce_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioAxis_b3332487-2c4d-4a41-a360-088c72be4e8a_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_label_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioAxis" xlink:to="lab_rdnt_LeverageRatioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3b616f02-c396-4d3d-93a1-1b656bf9f6c2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_353a517f-848e-42f2-aed0-5e4b1997a268_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_d2050d92-4005-4412-a185-a50f741f28d8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_55fd025e-76ef-482a-a073-d0cb504e0403_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CaresActRefundableClaimPercentage_7c598759-d9f2-4999-88c9-3ed303e9e778_terseLabel_en-US" xlink:label="lab_rdnt_CaresActRefundableClaimPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable claim percentage</link:label>
    <link:label id="lab_rdnt_CaresActRefundableClaimPercentage_label_en-US" xlink:label="lab_rdnt_CaresActRefundableClaimPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cares Act, Refundable Claim Percentage</link:label>
    <link:label id="lab_rdnt_CaresActRefundableClaimPercentage_documentation_en-US" xlink:label="lab_rdnt_CaresActRefundableClaimPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cares Act, Refundable Claim Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage" xlink:href="rdnt-20220331.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CaresActRefundableClaimPercentage" xlink:to="lab_rdnt_CaresActRefundableClaimPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_67308dd8-fa3d-4ce4-8543-bedcc7f3abae_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_7b3f184b-8254-4015-9dcb-c77eab7cd102_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenseMember_61cb797c-3421-4a37-b80e-84996a6b99c3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense</link:label>
    <link:label id="lab_us-gaap_OperatingExpenseMember_label_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenseMember" xlink:to="lab_us-gaap_OperatingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_c4bf9ab5-f805-4500-914e-f13f295547d6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_874b162e-23cc-4a07-ab70-25e63cbc1dfb_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_889d93ba-ccd6-4caf-b19e-9c3ee45ba2c1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AIMember_9238ae59-5056-4091-b533-80b7d36e0272_verboseLabel_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI revenue</link:label>
    <link:label id="lab_rdnt_AIMember_1b655140-9cf2-4566-b713-5a4bbfb844c3_terseLabel_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI</link:label>
    <link:label id="lab_rdnt_AIMember_label_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI [Member]</link:label>
    <link:label id="lab_rdnt_AIMember_documentation_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember" xlink:href="rdnt-20220331.xsd#rdnt_AIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AIMember" xlink:to="lab_rdnt_AIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_be7ac6dd-ee69-46a5-ab1e-45b57195d904_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7ceb1645-c2e1-4763-ba8d-b755f24dd087_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3c3b37b8-8f87-4e93-be29-a82ff1ae4a20_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_50763234-a9d5-49c7-878a-a2ad9642d40d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_ec602458-6d0a-4d38-8751-7864ccaab516_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiAdventistMember_75fab871-153f-40d4-a179-9d7b96a2fdc8_terseLabel_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist</link:label>
    <link:label id="lab_rdnt_SimiAdventistMember_label_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist [Member]</link:label>
    <link:label id="lab_rdnt_SimiAdventistMember_documentation_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember" xlink:href="rdnt-20220331.xsd#rdnt_SimiAdventistMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiAdventistMember" xlink:to="lab_rdnt_SimiAdventistMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_507390e0-5628-4123-b656-99ec1284165f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_b66ae874-df82-438f-b52b-8824ba7f2ee6_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_77a3c00e-5fa9-4462-ba5f-066dc5c650cb_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FrederickCountyRadiologyLLCMember_bf20949a-237f-4d24-8a48-473a42e52cc4_terseLabel_en-US" xlink:label="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick County Radiology, LLC</link:label>
    <link:label id="lab_rdnt_FrederickCountyRadiologyLLCMember_label_en-US" xlink:label="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick County Radiology, LLC [Member]</link:label>
    <link:label id="lab_rdnt_FrederickCountyRadiologyLLCMember_documentation_en-US" xlink:label="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick County Radiology, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember" xlink:href="rdnt-20220331.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FrederickCountyRadiologyLLCMember" xlink:to="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_8325811a-53af-4f94-b7c0-4c396a6cf39f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_62bca9c7-cfbe-4905-a763-b39c35b77c71_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_89a2cc5a-db74-4c68-a335-bb38f536bf07_terseLabel_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts receivable, factoring receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_label_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_documentation_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:href="rdnt-20220331.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:to="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_7119b4a4-4e1e-460a-b754-d2629baa5988_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_1c1b7fca-89a8-4bb5-9389-1811f80517ad_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsLineItems" xlink:to="lab_us-gaap_OffsettingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2023Member_3e8e2ab0-5248-44c5-9f17-d1897e460bd0_terseLabel_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023</link:label>
    <link:label id="lab_rdnt_October2023Member_label_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:label id="lab_rdnt_October2023Member_documentation_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member" xlink:href="rdnt-20220331.xsd#rdnt_October2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2023Member" xlink:to="lab_rdnt_October2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_cb11ced2-f14a-489e-9969-ebf204159f2e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_6d61fbe0-1706-4687-826c-f33166ac5af2_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_c2f07f01-5bc6-4d5b-b271-ed32bfff326d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_1e6d2377-4ba5-4f59-948f-3cced976030f_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_456974b8-fed8-48a9-921d-9d4289745f07_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_af5b6d48-eab6-4777-b7bd-ed23b5814f15_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_407c6eac-4325-4983-be98-4726e1ed5754_terseLabel_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in deferred social security taxes</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_label_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_documentation_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:href="rdnt-20220331.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:to="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_fe8caa46-7a99-4d96-b615-794522a9fce9_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScriptSenderLlcMember_34714cc2-dc46-415c-8205-ec5b0a697e8d_terseLabel_en-US" xlink:label="lab_rdnt_ScriptSenderLlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC</link:label>
    <link:label id="lab_rdnt_ScriptSenderLlcMember_label_en-US" xlink:label="lab_rdnt_ScriptSenderLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLlcMember" xlink:href="rdnt-20220331.xsd#rdnt_ScriptSenderLlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScriptSenderLlcMember" xlink:to="lab_rdnt_ScriptSenderLlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_f0c7184b-be1b-48df-b0b0-c1cc8c4e2cf7_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternate Base Rate Spread</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FutureServiceMember_992e9fab-d331-400e-8bc2-0d15060395f7_terseLabel_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_label_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service [Member]</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_documentation_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember" xlink:href="rdnt-20220331.xsd#rdnt_FutureServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FutureServiceMember" xlink:to="lab_rdnt_FutureServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_30fff309-ae93-4b85-a46f-f29c37096388_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_5b3bd02c-94e6-42bc-83a5-be46c98a4cc7_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIIMember_74568def-544d-4a4a-a193-555ed1101c2d_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIIMember" xlink:to="lab_rdnt_PricingLevelIIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_19b55769-f54f-4143-80a9-92ad0c0baf46_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_QuantibMember_92b61ace-9250-46c4-bdf3-ae42a7252ddc_terseLabel_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib B.V</link:label>
    <link:label id="lab_rdnt_QuantibMember_label_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib [Member]</link:label>
    <link:label id="lab_rdnt_QuantibMember_documentation_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember" xlink:href="rdnt-20220331.xsd#rdnt_QuantibMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_QuantibMember" xlink:to="lab_rdnt_QuantibMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_3e062d1c-0ac9-465c-9233-52a06386a5df_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a103aa07-da66-49e1-9ce6-324eef50d69b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_af7c238a-2948-43ca-932f-b37e0b543799_terseLabel_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, increase borrowing capacity</link:label>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_label_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase Borrowing Capacity</link:label>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_documentation_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:href="rdnt-20220331.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:to="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_17241cf1-8db6-4bf2-b131-6feb302a63b1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Swaps - Interest Rate Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_89985a64-97e8-49a1-b81b-ca61ce69c8cd_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_e489a0ea-7223-44d4-8488-18aebb14100d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NATURE OF BUSINESS AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_91de2661-261b-4695-8b31-3d6e0f6fadcc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_3d4711a9-6b51-49ea-88f4-b28e465c4968_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTable" xlink:to="lab_us-gaap_OffsettingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_573081b2-af99-4416-aedc-9acc1647c96a_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on notes and leases payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_dfcdec26-5eea-4530-a109-6ce6ba62d21a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_9e3dd512-4363-49e5-9fbe-d53f60eed62d_terseLabel_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leverage Ratio</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_label_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:href="rdnt-20220331.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:to="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_56a8d318-2341-4c30-866e-1723e60c1c1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivative Instruments on Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_67f2e47b-c666-492e-8f98-6232bf6b8a93_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_cdfc0956-d3d2-46a8-9ef5-a28ebf364034_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d2298536-7fb5-4575-8614-c77089fed022_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f825047e-2017-45ff-9291-10a970494882_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5e3621df-39f7-45ee-86dd-e2ea309999eb_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of other non operating income recognized on contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_d1500ec0-4279-499e-bed0-2bb5559e7400_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total credit facilities outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f264e2c-da2f-4945-9c4a-a774e84cf582_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EFFECT OF EXCHANGE RATE CHANGES ON CASH</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IFRCLLCAcquisitionsMember_c4753f28-0967-4dd3-ab5a-6865fcdaa739_terseLabel_en-US" xlink:label="lab_rdnt_IFRCLLCAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC Acquisitions</link:label>
    <link:label id="lab_rdnt_IFRCLLCAcquisitionsMember_label_en-US" xlink:label="lab_rdnt_IFRCLLCAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC Acquisitions [Member]</link:label>
    <link:label id="lab_rdnt_IFRCLLCAcquisitionsMember_documentation_en-US" xlink:label="lab_rdnt_IFRCLLCAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCAcquisitionsMember" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLCAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IFRCLLCAcquisitionsMember" xlink:to="lab_rdnt_IFRCLLCAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4cdc6663-7aee-4b7e-ac56-c5e75dcd315c_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OtherSellersMember_dae9dab0-baf5-415d-8ef5-992210522ab9_terseLabel_en-US" xlink:label="lab_rdnt_OtherSellersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sellers</link:label>
    <link:label id="lab_rdnt_OtherSellersMember_label_en-US" xlink:label="lab_rdnt_OtherSellersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sellers [Member]</link:label>
    <link:label id="lab_rdnt_OtherSellersMember_documentation_en-US" xlink:label="lab_rdnt_OtherSellersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sellers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OtherSellersMember" xlink:href="rdnt-20220331.xsd#rdnt_OtherSellersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OtherSellersMember" xlink:to="lab_rdnt_OtherSellersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_365e2222-ff79-47c4-9022-e5466c5eb023_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs, net of accumulated amortization</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ed65dc08-a881-4921-9e48-86dc2e5a0c89_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e8ee6cf5-43a2-4ba2-87a1-a822f98552f6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureMember_d0a392cc-7cf8-4ae5-975b-092f48a0827c_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture</link:label>
    <link:label id="lab_rdnt_JointVentureMember_label_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember" xlink:href="rdnt-20220331.xsd#rdnt_JointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureMember" xlink:to="lab_rdnt_JointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_ddaa0f9b-b439-472e-9b3a-a2d73d6f377c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock subject to service vesting</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_87565904-da9e-4d6a-accc-26be87623ea8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_9f37d43f-e79b-4cee-8992-0a5dbedbe6f9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9370cda6-0861-4958-84a9-50396cd1b3d6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SunTrustMember_8b8b4194-a437-4139-bcff-c2932e536df2_terseLabel_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust</link:label>
    <link:label id="lab_rdnt_SunTrustMember_label_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:label id="lab_rdnt_SunTrustMember_documentation_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember" xlink:href="rdnt-20220331.xsd#rdnt_SunTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SunTrustMember" xlink:to="lab_rdnt_SunTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_58ea9045-ea05-494a-8ae7-171bd36046cf_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_7e53ed7f-997c-4a72-b540-d0f04016bb7e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_1df02337-d018-4a87-8f14-843c05cb42a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CREDIT FACILITIES AND NOTES PAYABLE</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_46a932b6-e53d-466f-9af3-f70627c8ef32_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_a880ec63-f5ec-4cd7-8a94-fbba4287aa90_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_fbb1dd21-dc67-46bb-aa39-58467c38090a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price Per Common Share, Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_5d7685d8-7e89-40f5-b09c-bebdd90fa3b7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_62398200-3b79-454a-9de4-fd8155a5f005_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_21b7416f-5e6a-4047-b343-6bd8c89c2a56_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioDomain_b72e644f-0ba3-4278-a03b-3ab673b09d8a_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_label_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioDomain" xlink:to="lab_rdnt_LeverageRatioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_8e59fcdb-5460-4134-957d-ccc2332ca5a5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_80db01c9-213c-4c18-90c5-c219796da003_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost in excess of book value of acquired joint venture interests and other</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_1c00c657-6208-4893-8d25-39c1fd72a19c_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions [Member]</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember" xlink:href="rdnt-20220331.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionsMember" xlink:to="lab_rdnt_BusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_cbf955ce-94be-4e91-8a41-7c999eaaf0fd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioFourMember_f5f16eb0-c1c1-43ac-8e08-67e8139e8f2a_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#8804; 3.00x</link:label>
    <link:label id="lab_rdnt_LeverageRatioFourMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Four [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioFourMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioFourMember" xlink:to="lab_rdnt_LeverageRatioFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_9ac900b8-86e6-493c-8e6d-86bafd26091c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_2be6ede3-a60f-466d-8243-55d3b6fcb435_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_e49052be-f9ad-42d8-bce0-fbc7e987ecaa_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_d9bd58eb-2a0f-4436-b52d-374fb9f583fc_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_631b8ba5-946a-434b-adb7-2fae83e752b4_terseLabel_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging</link:label>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_label_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember" xlink:href="rdnt-20220331.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GlendaleAdvancedImagingMember" xlink:to="lab_rdnt_GlendaleAdvancedImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5afb1c6e-a5e6-45d1-9e75-9125a363e128_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_df665654-55c0-4368-aa5d-9e1e6ce3f9cd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - $0.0001 par value, 200,000,000 shares authorized; 56,197,826 and 53,548,227 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5891949b-cba0-47f2-9007-f73833c8dffd_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3b28b5dd-c088-4e32-ad91-50fa102dfcad_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized expense weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_94f00511-5c49-4bbf-9db6-943ea2b61778_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a1bef843-b739-47ba-b99f-940d3eae73ee_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_fef5aa03-7a42-41bd-8edc-1abc8698466f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill from acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_6972fb2c-7dbb-4a53-a4b5-a801313b52e8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_77febe46-f14e-4cd6-99c3-a01dd152df73_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_04b72e7f-f0f5-476e-9f33-740473272e84_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life (in years)</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life abstract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:href="rdnt-20220331.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:to="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_f357865f-43f9-4719-9b5b-f0aafbad67f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_453227b0-cf77-4215-8784-da8508a6d472_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_9454ef2f-3b0a-44a8-ae8c-45f72e3cef83_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d57ed8ee-717f-4e31-9940-07bf47c41ccb_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_1eee1b40-bb1e-4421-a7b4-79cc34609e50_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_8b786303-1b09-46a5-ab36-5016298e69c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATIONS AND RELATED ACTIVITY</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_4c8e4d6b-4351-4532-86b7-e2ae327e61e1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_4e6f3c65-6245-4372-ad9a-4abd53f7a7dc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_714d5daf-0379-4860-8c83-bd2156c69f1e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional deferred finance costs on revolving loan amendment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_1308876d-560e-4314-ac16-0d6e2a64ec4b_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_23671537-1a0e-42ae-8aac-857287825ec6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_25744387-ee19-40c9-96c4-2ca4c119edc4_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:to="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_18e9c37c-038d-4847-9961-2e36b1f7e1af_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_266e3c4e-e6c7-4c8e-affc-4597f4a6b4f8_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d19e0fc9-6659-4988-9882-2304b901ae32_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_3fa02718-2c62-48ed-aadc-6ff4a76e4e49_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_c8fb60ef-3c3a-4e77-bb03-d6482d4b330f_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from affiliates</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_3378987c-80cd-4706-af8d-50134487c85a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_6835c8d4-597e-4892-82e5-ababbce7a6ca_terseLabel_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) Income from Operations</link:label>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_label_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Excluding Relief Funding</link:label>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_documentation_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Excluding Relief Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:href="rdnt-20220331.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:to="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_352fd4b0-723d-4031-88c3-56c4674081f0_verboseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_4a9d012d-5b01-458c-8b30-536a8d392116_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePatientServiceMember" xlink:to="lab_us-gaap_HealthCarePatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_da584c71-694b-4abf-b91b-938bb55794f3_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_ee4e7bbf-5603-435f-a5ff-bd9277ef6920_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans settled</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0b1a1cb9-0b3c-4de8-a3b3-1b283e541d70_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_2124d360-80ab-4d21-b47d-3e9f835af5c0_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_76b51722-ff67-4d9f-b6f1-061a727a725f_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total service revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_09a1f22e-f239-4bdc-95af-5814c7a6368d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SoftwareMember_7c4197f9-dac0-4ebe-91ab-8cd7b869dd15_terseLabel_en-US" xlink:label="lab_rdnt_SoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue</link:label>
    <link:label id="lab_rdnt_SoftwareMember_label_en-US" xlink:label="lab_rdnt_SoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software [Member]</link:label>
    <link:label id="lab_rdnt_SoftwareMember_documentation_en-US" xlink:label="lab_rdnt_SoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SoftwareMember" xlink:href="rdnt-20220331.xsd#rdnt_SoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SoftwareMember" xlink:to="lab_rdnt_SoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_df808e9e-319b-40c3-a623-00f7ebec82ec_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_f70a6978-557c-43ad-98fb-ef15e2896d7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_4dbe6a51-524f-419d-b800-c10b0b31ace3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_f33a5af8-f483-40e5-a755-9526b329b74b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider relief funding</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_6ce03360-c0b2-47c0-9c02-cb3097112441_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_ed56136d-fbba-44d6-b16d-c3b9a41ee51c_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_96344f1b-bab2-4971-b85d-cddc43c59a1d_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_1d8f64b1-1c62-428f-ba74-09537c700997_terseLabel_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember" xlink:href="rdnt-20220331.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiValleyImagingGroupLLCMember" xlink:to="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_dab38fc7-0cb3-4864-82df-925062486a73_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_e91704f4-410b-4ed9-8bea-bfd99743d4b4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_e8a0a7d1-ad20-4bf4-b57c-c838795a61b2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT REPORTING</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CashHoldbackMember_4d312eea-7f1a-4274-b8fe-d0716040be60_terseLabel_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback</link:label>
    <link:label id="lab_rdnt_CashHoldbackMember_label_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback [Member]</link:label>
    <link:label id="lab_rdnt_CashHoldbackMember_documentation_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember" xlink:href="rdnt-20220331.xsd#rdnt_CashHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CashHoldbackMember" xlink:to="lab_rdnt_CashHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_eefa10ce-91c2-4b46-a8f8-f5fad4c4e3e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontorlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_07cc1166-2e0e-44ee-a75f-2346e15d2859_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(LOSS) INCOME FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_532748ba-b932-446b-89d5-40672440c31f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_27740dea-ea9c-49d8-b185-6ce7ce7ce7aa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AidenceHoldingBVAndQuantibBVMember_ff95c1eb-ab0a-46db-89ee-c3321ae71000_terseLabel_en-US" xlink:label="lab_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V. and Quantib B.V</link:label>
    <link:label id="lab_rdnt_AidenceHoldingBVAndQuantibBVMember_label_en-US" xlink:label="lab_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V. and Quantib B.V [Member]</link:label>
    <link:label id="lab_rdnt_AidenceHoldingBVAndQuantibBVMember_documentation_en-US" xlink:label="lab_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V. and Quantib B.V</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:href="rdnt-20220331.xsd#rdnt_AidenceHoldingBVAndQuantibBVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:to="lab_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_6ede9c85-60c5-4907-b9ed-9498de0a532f_terseLabel_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_label_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_documentation_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue" xlink:href="rdnt-20220331.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AggregateIntrinsicValue" xlink:to="lab_rdnt_AggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6609252e-448e-4bf7-b8ab-5a37dcdf5746_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_65f4dd87-5aa5-4c3b-b0c3-8dbb8f13f59f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_48eab3e1-436c-4b97-8a9d-76e82b937295_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to fund loan to related parties</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_20a29b7c-913e-4289-8b5e-696443f3c884_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_63379eb5-014c-4dea-808e-7f8a0b7d5908_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of operations, excluding depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_b17d0fc0-64d8-4cb0-8fa5-814a34c9dec7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Operations</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ImagingCentersMember_009709d9-7d52-43a3-b8c2-25c3b1dfabb4_terseLabel_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers</link:label>
    <link:label id="lab_rdnt_ImagingCentersMember_label_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers [Member]</link:label>
    <link:label id="lab_rdnt_ImagingCentersMember_documentation_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember" xlink:href="rdnt-20220331.xsd#rdnt_ImagingCentersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ImagingCentersMember" xlink:to="lab_rdnt_ImagingCentersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_fac7b37a-f345-4983-a303-ee50ed96914b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfCenters_98af8692-e16d-4a3c-8355-6435913f790d_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_label_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_documentation_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters" xlink:href="rdnt-20220331.xsd#rdnt_NumberOfCenters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfCenters" xlink:to="lab_rdnt_NumberOfCenters" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c3259de6-a68b-4e5b-9b9a-ee1eebdd08cf_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_08ea3061-123c-423d-bdbd-03385ce9e84d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_610f4250-78d4-489d-99ac-05c34c603512_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loan debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_7b295262-cbb1-48a8-95d1-1795172b7b1f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a55059db-d06f-4957-8db0-25e27ee9225e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_8e394918-f93e-409b-836c-6ad5292fc154_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_2b7dd791-8b33-480b-a9ff-8818f4c88582_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY INVESTMENTS AT FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_359cb4ae-06be-4e9a-8a67-dd7bb13baaf6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_6db616af-fdb2-4dae-b056-20529168625a_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIMember_7e2531c7-c0f3-405a-b410-9e31f99e99c4_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIMember" xlink:to="lab_rdnt_PricingLevelIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_1f3134b2-7971-40a9-b5ec-a3aeee3efec7_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_03665607-4e3b-4425-811a-bf6bf8c52e72_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c4aba2d3-dc3c-4723-b167-37409fd743c6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cumulative foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86b8b063-1b9b-48f3-8478-f56926fa19b7_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_47b325a6-512c-42dc-86c8-8ce53b655933_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_62e3c820-d7ed-4cb4-8199-df97cc0437cf_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts payable</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_12140a1a-4dff-429e-93bf-81f75d1a50a2_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loan</link:label>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_label_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienTermLoanMember" xlink:to="lab_rdnt_FirstLienTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceFees_8a894a0e-25df-4d71-8637-89fa5a46cbc1_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_label_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_documentation_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees" xlink:href="rdnt-20220331.xsd#rdnt_ManagementServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceFees" xlink:to="lab_rdnt_ManagementServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_84cd1726-e1ca-4065-8fb7-e842f2a3a9db_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_184357bb-b5bb-4ad9-973c-c4a2fe3ffdff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_30c34bfe-2c0b-4e87-b75e-36c82cea7f0d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6411b4c5-1331-44d1-a2e2-49bf226c8eba_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_4d5601dc-0c9b-4ccd-83dc-e6d648523885_negatedTerseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_589d43b3-31b4-4c6e-9f9f-79a9094f92f5_terseLabel_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unconsolidated joint ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_label_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:href="rdnt-20220331.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:to="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_ad235cd7-8ffc-4a5b-b6af-d78fdc341c25_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total RadNet, Inc.'s stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_04719e34-44c0-4633-82a3-965818c6749b_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:to="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b6aa035f-ef5e-4954-b413-2a985c7bdf3f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a61a758f-5ded-4426-a5a9-e710ca6a4e91_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a71ec037-4a23-46d2-b657-8600a88cf361_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_0d52f586-6957-4199-ba0e-4bfb3822f81a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of imaging centers and other acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBuildings" xlink:to="lab_us-gaap_PaymentsToAcquireBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_a2641eb9-5131-4cbb-b304-efa78d165119_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_30862141-96e5-413c-bc4c-d166d357c587_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_66a8c5ec-cae6-48b4-ab44-6759cde5988b_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt restructuring and extinguishment expenses</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_1814bca6-de48-4614-89dd-56705ad46229_terseLabel_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of advance medicare payments</link:label>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:href="rdnt-20220331.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:to="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_756b4bc2-2bbd-4f04-b21e-83d6ef9c5313_terseLabel_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired and leasehold improvements</link:label>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_label_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Acquired and Leasehold Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:href="rdnt-20220331.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:to="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_b853c3d9-c049-443a-aae8-5d33b2acf8b2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPE estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_a723ce66-94a9-44d6-a80b-b99bd1b66f6c_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar Rate Spread</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_5227d776-63ef-45d3-85a9-85917416f6fa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per share (dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_3efaace4-40c1-4b4f-a5fb-deb5948dbab7_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_ca63b9db-7d53-4961-b2b3-fe7977d3ba60_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BarclaysMember_48627abb-ad44-43da-b7f4-aebcf0222d02_terseLabel_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays</link:label>
    <link:label id="lab_rdnt_BarclaysMember_label_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:label id="lab_rdnt_BarclaysMember_documentation_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember" xlink:href="rdnt-20220331.xsd#rdnt_BarclaysMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BarclaysMember" xlink:to="lab_rdnt_BarclaysMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_cf0c47cc-2fb4-462c-97e2-8f5aba6c5fd9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e9349e06-4399-4b74-b825-23f5487550be_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContributionsFromNoncontrollingInterests_fa769202-63d6-4398-9238-99d2a47bd604_terseLabel_en-US" xlink:label="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution from noncontrolling partner</link:label>
    <link:label id="lab_rdnt_ContributionsFromNoncontrollingInterests_label_en-US" xlink:label="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions From Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests" xlink:href="rdnt-20220331.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContributionsFromNoncontrollingInterests" xlink:to="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5557704f-2322-4463-b8cb-aae2ae7b9a01_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_0c1075d3-b909-476a-8d4e-b8371cccdd98_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_55d483a3-6b6b-490e-a9ef-f0392a4fd560_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0e9581c1-7209-4d1a-869c-41120acdd476_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_9cb7dc27-7c31-4796-8fd7-58bd93e2abb6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_d3eaf35c-bc7c-485e-b3a3-b895c45d5d97_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Percentage for Commitment Fee</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_53ed7a22-ef69-4dbd-b2b4-9c11276a8e39_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_44e565c0-1453-4801-853c-136f84394661_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment in Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_cd4520f2-188f-40e5-8806-c6f8a3a499c7_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_077197f5-1db6-41f4-a3d2-025aece6e5d9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_ab3b7c2a-ecb0-4403-abf4-0e30f0082f7f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_ef4a53d8-1728-4a01-bd6a-6a6d9a9b49a5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_9b7dc954-5ce5-4914-a4ce-2bbc20b6923a_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_4d90f015-75ce-474c-aba6-65163bb9eaab_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_aa0672c1-83fe-4208-adb8-8b8ebd07b383_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_6eea9983-012b-4962-b44b-7858cf8999d8_terseLabel_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities without readily determinable fair value</link:label>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_label_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Securities</link:label>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_documentation_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:href="rdnt-20220331.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:to="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_f1601e7c-b2d6-4743-a3e0-b842522656af_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INCOME AND EXPENSES</link:label>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpensesAbstract" xlink:to="lab_us-gaap_OtherExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthIncMember_99a7b802-80ba-4317-8189-78dbddecdbc5_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_label_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deep Health Inc [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_documentation_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deep Health, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember" xlink:href="rdnt-20220331.xsd#rdnt_DeepHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthIncMember" xlink:to="lab_rdnt_DeepHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_7c3de755-1fc9-46eb-8add-765767a0734c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING AND REPORTING STANDARD</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_20890c24-7943-4d74-9264-8b64ced6615c_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_18ae777f-80cd-42d0-9f7c-48e54065cbd2_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio, greater than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:to="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_10d34627-70ab-4b83-81fc-c156159ad77d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_947d5b17-8858-4488-b2de-4606efe468ab_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e3524965-15d7-48af-83c8-df1d13d2af7c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_961d3da3-094b-4440-b742-4fa5819f3fe5_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0625805e-7939-43e0-8c5e-1f0a308250dc_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7de8b118-2581-45b3-83cd-51426fedeb5d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_1a4fc741-6aae-43e6-ac0d-720d665a2b30_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7e33d1ab-6995-4cf4-a4a7-11903d50d7e4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b6bd1ffd-4415-47ea-9a51-a766bb91fca8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_813a9b4a-d2b1-4a53-a6b3-342141b7081b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOtherMember_13ae7f6e-1164-4d84-87c6-06961f31b309_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_HealthCareOtherMember_label_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOtherMember" xlink:to="lab_us-gaap_HealthCareOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5f7889ad-de83-4e75-addc-0a7c843db4ab_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_1065c5a4-aa51-4cd0-a954-7f5e1d96b26c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_91685ac0-2846-4ff8-b84e-82a85d98131f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_26d0a8f3-d861-4f27-86da-c26951977cb9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_73344393-a84a-4b10-a8fb-98fbab9e5a09_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE SHARES OUTSTANDING</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_bea6906c-c350-4f58-a65b-77d764b918d8_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_228ff828-9761-4fa3-85a2-d7682a82fcf6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8f9b0d20-3fc9-434d-99cb-9e2a05bc173e_negatedNetLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_cbe55a2b-9697-4d51-8942-2902ad815ec3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicare1Member_6f1cc45c-dc69-4d92-9485-f1bb3b483c68_terseLabel_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_rdnt_Medicare1Member_label_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicare1Member_documentation_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member" xlink:href="rdnt-20220331.xsd#rdnt_Medicare1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicare1Member" xlink:to="lab_rdnt_Medicare1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_e0809a24-3f83-406a-8ac7-d566113cda85_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_1c6c003c-09b7-44a9-a9b1-34f9d1ce45d0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_1a3631cb-ee17-42e4-baed-c673f521e654_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_55e0126b-d769-4574-aa50-06195f8a6b7b_totalLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_c2313586-fb52-4311-938a-566e8dc81a37_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0e9aae7c-94f6-4fef-95f1-5e289fdb7b66_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_6934b17b-491e-4ff1-86a9-6df180d0e4b0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_e4657856-34f0-4a60-b19a-09a3c7b6976a_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_5e3c25b8-23f2-4b5e-8aa9-1222c76b9722_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementMember" xlink:to="lab_rdnt_FirstLienCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_d82dc39a-e391-4295-aa86-d8a7d13c480c_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_6aa0dd78-d93b-4dde-b5f3-215d63aa30d9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_383ca89a-7938-4fbf-922f-7853b805b45c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_90a226d6-8e61-4771-971e-42f5a9949eac_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredCharges" xlink:to="lab_us-gaap_AmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_303072e7-877d-4458-9e83-61e2a9711493_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f71eacf1-e22f-485c-8a93-aa63436ad92f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_7ef7622d-c18f-4ea7-854b-09919cc8e257_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioOneMember_44c86e38-a78b-4c50-8184-23d07e702190_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioOneMember" xlink:to="lab_rdnt_LeverageRatioOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9608e854-e203-4196-b855-5ee27803a89b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under the equity compensation plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_f9d0d508-e430-433c-84f4-5e8cc032c3f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9a51e2e8-ff9a-4068-a025-c830ca013963_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_f1496779-6c0f-45c7-932b-ac1a85c351f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total issued up to date (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_2a587d5d-2549-43d7-98ef-a3a1effc307e_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, percent</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_324a1928-233b-4d05-b107-586441db9901_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_ec0da737-e09c-4c3c-abb9-c38751866b6b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_c0baca57-b4f4-42b4-b761-648214af64fe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity issued or issuable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_98bf187e-fd57-4e97-b529-b498d87daa1b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a6477a80-3215-41cf-816a-1e5e0667846e_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of comprehensive loss recognized on derivative net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_bd1b5576-e4d6-4501-9ac5-9b240b2f6261_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_c9262736-038c-4366-acd1-4b73c31254f5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for sale of unregistered securities for acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a6c6373b-bd34-442b-aa32-1837b81c6221_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_02c03272-a529-43f8-9d76-a792d3c1ca05_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_5876b5fa-cde6-43a7-b050-aa4042a679b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_COVID19PandemicMember_bcbc1a8b-875b-4568-bdb7-810e789c0064_terseLabel_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_label_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic [Member]</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_documentation_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember" xlink:href="rdnt-20220331.xsd#rdnt_COVID19PandemicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_COVID19PandemicMember" xlink:to="lab_rdnt_COVID19PandemicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ab5d3af1-7703-4fcc-b309-3f9f5715a4d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise price Per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfAmendments_0ba948dd-36a0-403b-bd48-d4cabaa3c4d5_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of amendments</link:label>
    <link:label id="lab_rdnt_NumberOfAmendments_label_en-US" xlink:label="lab_rdnt_NumberOfAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Amendments</link:label>
    <link:label id="lab_rdnt_NumberOfAmendments_documentation_en-US" xlink:label="lab_rdnt_NumberOfAmendments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Amendments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAmendments" xlink:href="rdnt-20220331.xsd#rdnt_NumberOfAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfAmendments" xlink:to="lab_rdnt_NumberOfAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_ca6db149-cb4d-4b00-9f9e-788433f43154_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_c7114b1e-aa6c-49a3-b798-b283c1264eb9_terseLabel_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program loans at 1% due April 2022</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_label_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans [Member]</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_documentation_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember" xlink:href="rdnt-20220331.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PaycheckProtectionProgramLoansMember" xlink:to="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_eb171b00-a1b8-4fe0-a3e9-262a3be914bc_terseLabel_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_label_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units [Member]</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_documentation_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember" xlink:href="rdnt-20220331.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PerformanceBasedStockUnitsMember" xlink:to="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_71745c5c-cddf-4cd0-9200-3ccd808dbe77_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_ec4659da-b806-42bf-bc6a-0c7aa02225c6_terseLabel_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation/personal injury</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_label_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_documentation_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:href="rdnt-20220331.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:to="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_652ec0e9-9fc4-4f6e-81eb-b260ba7c1b1c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_42607e24-6ab9-4cb1-bfdf-168930d69be7_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:href="rdnt-20220331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_9ca98c22-a6b8-4c76-84ef-2b004e27414d_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to affiliates</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_09dd4cc0-deee-4190-b379-57f3c4e06bd1_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME BEFORE INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_70b849b7-5ca9-44e0-a680-d20533ab0d9a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b6afe4ee-205c-4945-8f3d-f1e366795a6e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_00566e0f-5ba7-4f17-ae37-17086bcdc1c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_11c94b30-a793-4537-8f00-8d7ec73eb558_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_bea68b47-ec29-4103-bbae-9d1da2598c96_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0f32eda1-a806-4785-b254-e93f8aaba020_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8b5889b8-6ffe-4b18-be9d-373be58a9627_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c3ee371a-ebed-4c67-b29e-e111707aad90_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_d9a688e1-76b9-407a-829d-7ebad7626f66_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_06e2305c-38fc-483b-a29a-ebe8cd002de7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_d85dbba4-b1ed-46aa-b2ee-a83d70ed562b_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2025Member_3e6641bd-14ff-4df6-a4b3-932cd59af580_terseLabel_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025</link:label>
    <link:label id="lab_rdnt_October2025Member_label_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:label id="lab_rdnt_October2025Member_documentation_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member" xlink:href="rdnt-20220331.xsd#rdnt_October2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2025Member" xlink:to="lab_rdnt_October2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9e4522a9-10e8-4704-8d65-4da0bec3bc30_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d05cea1c-a2c8-47f3-bd26-4881925d9a3c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e70e4d8c-7f0b-4b21-a902-2e6bdbc6f22b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_a75d69f2-8530-4237-9925-933032f75233_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts receivable</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_479561c7-30cd-4b17-a47c-44d820b4acf8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock subject only to service vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_95f71c96-fb03-4475-87e8-8cf3c1490706_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_bbcfbcd7-2287-4a0a-a558-cfc73c59e5d6_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2306c2e2-6067-44cd-af14-83aabeaa48bd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_73c7907a-fceb-41fb-8db2-06980515fc4f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_cdc7ab3b-a518-4a0f-8b7d-756f2542a74f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups operating expenses</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_cae7b81c-5c7f-457e-a3f7-2748722714be_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_4701f17e-7fb9-4c06-a5ac-6daf097631b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of RSA Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_13755705-d0ef-471f-8b24-810d9dcf8737_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plans</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:href="rdnt-20220331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_64a60109-2df2-4bea-b7b1-6b64ea68c6bf_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_514b5ad8-0639-44d7-8fa6-24e8a8cbc883_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_cc2be9e7-a932-45ee-975d-6e8d58f74714_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicVisionMember_ac35cce0-fcc8-49b0-b7fc-de67ebd80d24_terseLabel_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision</link:label>
    <link:label id="lab_rdnt_MedicVisionMember_label_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember" xlink:href="rdnt-20220331.xsd#rdnt_MedicVisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicVisionMember" xlink:to="lab_rdnt_MedicVisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9030f0f9-75fd-4e49-85e4-a68baff9a473_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_3aace81e-dd2d-4af7-a5cc-bdd1a416e7c0_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_a1e69fb5-efea-4934-9ade-e379796631ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses at the beginning</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_ba04c912-bbbd-402f-8cd1-65ad19484b2e_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses at the end</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_e8a0261c-1f39-428d-afd8-d0c1ece13f23_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3294d5a7-ce1b-452c-9ad9-b477620e0f96_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_6dd7409c-2e09-4a57-93bf-2458d3eb441a_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_5e358ea6-e203-4331-8675-ed1dcec60276_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_20ed5ef4-5f73-417a-a918-c892f4848e88_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_3b541726-7cf2-42d5-95e1-fa3a84256a7d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_6f9c1f69-527a-40d0-9f0f-4797bb7388e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notes Payable, Line of Credit and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_fa394b5a-c13d-42b2-a3b0-24383d5c86ff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_dc307772-8351-4a30-bcbf-7fa33a207f60_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Assets</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_90202ca7-eb0b-45d5-b15d-5910a68f2d1b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED FINANCING COSTS</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_39f24db0-77a5-452c-b39a-4066187d3b7c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_6d286ad7-ec53-4c41-bfbc-fc26bda474af_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CertainSellerMember_d37a3baf-3597-4738-9833-f7998d3b016e_terseLabel_en-US" xlink:label="lab_rdnt_CertainSellerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Seller</link:label>
    <link:label id="lab_rdnt_CertainSellerMember_label_en-US" xlink:label="lab_rdnt_CertainSellerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Seller [Member]</link:label>
    <link:label id="lab_rdnt_CertainSellerMember_documentation_en-US" xlink:label="lab_rdnt_CertainSellerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Seller</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CertainSellerMember" xlink:href="rdnt-20220331.xsd#rdnt_CertainSellerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CertainSellerMember" xlink:to="lab_rdnt_CertainSellerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_bfbe5ba4-af67-46db-9e7d-d5595931dddb_terseLabel_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee revenue</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_label_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_documentation_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember" xlink:href="rdnt-20220331.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCareManagementServiceMember" xlink:to="lab_rdnt_HealthCareManagementServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6f90633-c562-4c7b-af61-1cb30732f07f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_389d4b23-0bca-47c4-9587-cf334dda1a80_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_3ead76ce-1791-44e8-acbc-5a29ca8dd3d4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_bf68a5a8-b076-4974-a6e8-469395c9a0fc_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_ea0620fa-0e06-44c5-bda0-5da178edb791_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_dad4d32a-870b-4c17-9cf1-53e322e1fd69_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5d2c9162-4b5e-4da9-8327-3dd2c12a9e41_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_3ab6eb7e-a18f-4b1e-9e0c-9ec20eb19a91_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c4a746d8-8f22-48c5-91d5-53e562f3fae9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_f638d0be-38bb-48a5-945f-365e689d3aae_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_43b05985-8f91-483b-9fe8-66af485e8dab_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1152e9f5-b65c-4759-b149-1a026cd1b40e_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IFRCLLC1Member_14fa9910-0eee-4370-84aa-aa28489776f9_terseLabel_en-US" xlink:label="lab_rdnt_IFRCLLC1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC</link:label>
    <link:label id="lab_rdnt_IFRCLLC1Member_label_en-US" xlink:label="lab_rdnt_IFRCLLC1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC 1 [Member]</link:label>
    <link:label id="lab_rdnt_IFRCLLC1Member_documentation_en-US" xlink:label="lab_rdnt_IFRCLLC1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLC1Member" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLC1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IFRCLLC1Member" xlink:to="lab_rdnt_IFRCLLC1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_12ab1baa-da15-46b9-b42d-39270076ab47_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_8293f99d-94bd-4dca-85a3-60d8b0b12d1b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_b1ce9955-2922-4657-9e94-808732ce3889_totalLabel_en-US" xlink:label="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, equipment and right-of-use assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_label_en-US" xlink:label="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Net Including Right of Use Assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_documentation_en-US" xlink:label="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Net Including Right of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:href="rdnt-20220331.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:to="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_3a966dcb-ece9-479a-a59f-0e040ffb162d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f50b0f3f-f7a6-4f64-bda1-63dc259c19a1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_cfc65418-3449-4bc7-a4b0-fdc8b1cf8f28_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENTS IN JOINT VENTURES</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c422f2cf-5d7c-4b14-a146-8e97a848cd1c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_507a287c-c91c-4ad9-9613-78f3b07cd19e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9c0cf6a7-b5a3-4f84-a5a9-1457aa33e00c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_99045a89-644c-4c94-9cf4-6ed31a2035f3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_dbacd972-dd88-485a-9061-08f1ecad2486_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings in these joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentExtensionPeriod_d37271b9-c44d-4db1-922a-3e0b1bd2d51f_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension period</link:label>
    <link:label id="lab_rdnt_DebtInstrumentExtensionPeriod_label_en-US" xlink:label="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period</link:label>
    <link:label id="lab_rdnt_DebtInstrumentExtensionPeriod_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentExtensionPeriod" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentExtensionPeriod" xlink:to="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_695cb5e1-33b0-4ab4-a5f9-5e8112720ca2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_dd87218f-4fb2-4800-b061-791c8f8118a6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property &amp; Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1f636bf3-0492-4fdf-abdf-8dbe1adb54e1_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_eedd0f5b-5173-4fdc-9ff7-ad1bc6234d25_terseLabel_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred social security taxes</link:label>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_label_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_documentation_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:href="rdnt-20220331.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:to="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_42cffd20-6046-4a30-9821-2a67b3be083f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_89810cae-03a1-485b-bf0d-a9857805bab0_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Radnet, Inc.'s Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_f0420731-83e7-4933-bab0-373f9cc08720_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_6ee993db-1fdd-4c34-8def-26b5c09c8f65_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_8bf988cc-8adf-4c96-9708-07b512d19ba1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_20a606bb-980c-461d-812b-6f04551eb9e5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromProviderReliefFunding_9b7c17a4-1b9e-4d8f-9353-aaeaa0187ebe_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from provider relief funding</link:label>
    <link:label id="lab_rdnt_ProceedsFromProviderReliefFunding_label_en-US" xlink:label="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Provider Relief Funding</link:label>
    <link:label id="lab_rdnt_ProceedsFromProviderReliefFunding_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Provider Relief Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding" xlink:href="rdnt-20220331.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromProviderReliefFunding" xlink:to="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_e46c2ba6-0de9-4e2e-8a12-97a1eebb394f_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares issuable upon exercise of stock options and warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6a4273a7-c555-4dea-9ed4-e9d43bd8e76c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_bc4ca536-cba7-44a3-9649-8925b29638ff_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest issued, value assigned</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b9783360-b359-4c09-8a51-1f30dc359f48_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_085d6ea1-e3e5-4b58-9c8a-5aef1fa60f88_terseLabel_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other patient revenue</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_label_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_documentation_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:href="rdnt-20220331.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:to="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedPlanMember_06d63428-3057-4882-a509-5c1d7087e44a_terseLabel_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan</link:label>
    <link:label id="lab_rdnt_RestatedPlanMember_label_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember" xlink:href="rdnt-20220331.xsd#rdnt_RestatedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedPlanMember" xlink:to="lab_rdnt_RestatedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3b652b5a-fc99-4071-af45-6b32bde1cb1e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_2feccebb-4a5c-4bb4-90e5-8f02ffc7c0cd_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_757a3505-97ca-4b60-8d1f-a160369c275a_terseLabel_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc.</link:label>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_label_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_documentation_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member" xlink:href="rdnt-20220331.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WhiteRabbit.aiInc.Member" xlink:to="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_8256ac23-71b1-4856-af1b-e073a6b843ec_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_66e25737-77f9-44b2-b276-41e211199402_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio</link:label>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_label_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio</link:label>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentLeverageRatio" xlink:to="lab_rdnt_DebtInstrumentLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_10030b93-d07d-4f14-9e0e-06d4e36c54b9_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio, less than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a57ea34f-da02-4bf3-83b4-9f281471f0d1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_e08a32cf-fb67-4a53-89ae-f158c8226bb0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fda3ff04-5d30-414b-a8ca-93507a546e09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_6f9408c7-0bc5-4eb9-b713-788ae95858e8_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FrederickHealthHospitalIncMember_af77cdef-7c7c-4971-bfb5-db87a8423f14_terseLabel_en-US" xlink:label="lab_rdnt_FrederickHealthHospitalIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick Health Hospital, Inc.</link:label>
    <link:label id="lab_rdnt_FrederickHealthHospitalIncMember_label_en-US" xlink:label="lab_rdnt_FrederickHealthHospitalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick Health Hospital, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_FrederickHealthHospitalIncMember_documentation_en-US" xlink:label="lab_rdnt_FrederickHealthHospitalIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick Health Hospital, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember" xlink:href="rdnt-20220331.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FrederickHealthHospitalIncMember" xlink:to="lab_rdnt_FrederickHealthHospitalIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3d867896-e89e-41b9-9ebb-ef7c43f893ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_5656fbc7-7ec9-4c33-b564-f57cddbc6abf_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_38a2571e-8ec8-4c37-8b85-5549cb7612d3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_fe9db179-566c-42ca-9ebc-88183488e9f6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_af960af6-61af-42d7-9d8d-cdc625b5ca6d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DignityHealthMember_7f2161be-06c3-4d12-a67d-d5297f4a0818_terseLabel_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health</link:label>
    <link:label id="lab_rdnt_DignityHealthMember_label_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember" xlink:href="rdnt-20220331.xsd#rdnt_DignityHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DignityHealthMember" xlink:to="lab_rdnt_DignityHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_d5fe108b-76e6-418a-96b7-919427ad4d35_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_c112b98e-7cd1-4338-8e3f-2020fb55ecb6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_16981068-abc6-4426-ab34-5f058a3989d6_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_59b8ca5d-4082-4659-861e-9ad3de7fab18_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_c99d6bd3-61cf-4a42-b961-fc4473730d69_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Swaps - Interest Rate Contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_8ff89f2d-8af4-46f3-b274-f133690a7284_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_a8b48973-60e2-4af7-82f8-815bcffe93bc_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_5b4c52af-2061-48a1-9481-5505d3cbec81_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_b46d93e4-f601-42b8-8c16-565c24256496_netLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_e28b76cc-d1c3-4730-a884-5bf8138fd72a_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_7e9da2fe-86ba-42ed-8097-43e010c76303_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AidenceMember_f3d9150d-e694-4b07-938d-ca4cce946203_terseLabel_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence B.V</link:label>
    <link:label id="lab_rdnt_AidenceMember_label_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence [Member]</link:label>
    <link:label id="lab_rdnt_AidenceMember_documentation_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember" xlink:href="rdnt-20220331.xsd#rdnt_AidenceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AidenceMember" xlink:to="lab_rdnt_AidenceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0f79edbb-e103-4f18-bdcd-da03e006bb00_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2a1e2424-6e35-474a-9031-ac22ba296d4f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_dbb936a2-23b4-47a1-a67f-9f93ec2e4f0d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term portion debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_c302e1ab-79ef-4165-aa6a-f2ff7f1c4f8e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioFiveMember_353c0bd2-f6e9-42ef-965f-effceeb353a9_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Five</link:label>
    <link:label id="lab_rdnt_LeverageRatioFiveMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Five [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioFiveMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFiveMember" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioFiveMember" xlink:to="lab_rdnt_LeverageRatioFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_f8080fd4-6a36-4a85-914b-249ee4da4a8b_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5d7907d5-832e-42a4-bcee-7f92e88a34f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_414c45e2-2be7-4cf1-a149-532f30ecb311_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Current</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_07521a46-da9c-4dc4-97e7-8a40b34acf7b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIVMember_4346737b-807f-421b-9abe-97d9a6f9fc69_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIVMember" xlink:to="lab_rdnt_PricingLevelIVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8aa5dd8e-5a05-4f10-b3f2-e7bd4ec48f72_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_93bd0372-06e0-411d-a252-672ea41b01ff_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_29bc0e41-2a3e-4086-89c5-fe30c8170c82_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_7c9d68cf-a71b-4fba-8470-2825def304a0_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_2f0e1d26-ae9c-4789-b5ab-c1fdcc5a0350_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_30069bc3-0a52-468e-b0ca-800388b92a7d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs and loan discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProperyAndEquipmentNetMember_e849f0fd-bb67-42a3-8c4c-6aad543db6c8_terseLabel_en-US" xlink:label="lab_rdnt_ProperyAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts returned to property and equipment</link:label>
    <link:label id="lab_rdnt_ProperyAndEquipmentNetMember_label_en-US" xlink:label="lab_rdnt_ProperyAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and Equipment, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember" xlink:href="rdnt-20220331.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProperyAndEquipmentNetMember" xlink:to="lab_rdnt_ProperyAndEquipmentNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_b2e4ac93-0164-40ad-b0cb-40a67584b363_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_dcd21fff-ee2d-44d9-bf97-5c58fa9e05f2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_a09d0466-2261-4c2a-a776-3b97709c0617_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of forward interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f0f052d2-87ee-4c7a-9f8c-b5a77c1fc7f0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83dfb593-bbac-4fe7-810d-b5df23b7f1b4_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_4cf8ff6c-0f63-44a3-a81c-dee38528fb32_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a0742d06-c7c5-4f98-837a-e2157ec438ad_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_56a48d98-a90a-42a3-ad11-5e59031cb292_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_e63df073-ae01-449a-bc08-e67132632dc7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_94c598f3-51ae-493f-ac6d-aa07ca8f72eb_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7475e62d-3fd8-4540-993b-2e2b49a0a08b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c067cad6-1e7f-4462-8290-b9f0e1063f31_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CommercialInsurance1Member_87027604-186c-432a-b44d-b060d0c2d555_terseLabel_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial insurance</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_label_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_documentation_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member" xlink:href="rdnt-20220331.xsd#rdnt_CommercialInsurance1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CommercialInsurance1Member" xlink:to="lab_rdnt_CommercialInsurance1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0acbc7b9-d563-473b-90cb-21ed3f420909_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0d1f984e-6025-46de-a717-8d5b1778905b_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares used in calculating diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_fb6a8640-7b02-426b-9afd-3d52f0e95bc6_terseLabel_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance medicare payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments" xlink:href="rdnt-20220331.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdvanceMedicarePayments" xlink:to="lab_rdnt_AdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_d2f34f8a-b854-4fb8-a2cb-4065e9b2374f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_57f25d2f-2982-427f-a7ff-3de18127d352_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_a6e22a11-1835-42c5-9bb7-2d47c5d94619_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4980df2e-7e80-4aea-acd6-d523b88aa241_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1b938ff4-b39f-480d-b9f4-7e9eeb93e337_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c829d4e2-41ff-4ec9-97e9-484f53109ed5_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin For Loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_4ec19916-1f2c-41d9-acb7-eb8ddb9a4f3d_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_b5d6ff12-c33e-4f2d-b92c-0f15089e6153_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_791bd920-2b08-4f58-9eef-bf3fe13e37cd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_01a6ce21-b05b-4c19-bbee-165fd0871908_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, net of taxes</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_7b23b692-21d6-4d80-98e6-96628c0dca80_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_b0926112-e65a-4c62-b31f-c399b1ade142_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioThreeMember" xlink:to="lab_rdnt_LeverageRatioThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_bb94ed9f-de2f-43a2-8bd8-7138a8290b55_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement, Sixth Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_e62e6d5f-a648-43bc-a9b2-c72d8bff8994_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_96e672a6-531c-4484-8aa1-d737a7b3fe15_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2765290c-1ed3-4839-894a-a03c29c2b970_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_99f187e4-1c3f-48f5-a32d-84b4178fab36_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_068e6854-b3b4-486a-b40f-7ed5e2a4bfe6_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_dd19683b-87c2-4d59-ba90-e37b647aeac9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_2a8e5971-e0be-41f6-865b-5e97df42b0e9_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Joint Venture Investment and Financial Information</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment And Financial Information [Table Text Block]</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment And Financial Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:href="rdnt-20220331.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:to="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21c39356-9e72-46a6-9904-5ac02045f3de_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7f4aa410-dc57-4e53-b0f6-dcfa1d12bf37_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_00acab8d-74ad-4cc8-8001-5493a9b847a4_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_de44cc85-cd8e-4b3d-a65f-1bbf35d6c637_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_49ac4dd7-a12b-48c2-a4f3-d47afed87d07_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_7582ecdb-3a35-4779-9524-40183dc7dda3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payment to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f019c8af-4e45-4e87-afe1-9505f9e84bbc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0c8df9dd-c7a1-4007-9ea1-28d854178b38_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_0b369880-498b-4c27-a05f-b4c7949b4953_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_d30ecef3-4bfc-4468-840b-b136921f3119_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_acd2b973-7bff-428e-9656-755c409b1f64_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_76a07e56-c774-4960-8396-9c6aaf840869_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1ab6f5e5-246b-46ee-be09-b3c5d9a16478_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_8d1b1d65-2a84-4e52-9751-00ae59cf6f84_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups revenues</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_425ceb75-b44d-4f8f-9d3d-cd08c3586965_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_706533b4-3ac6-45b1-8d5c-76c65d62c2da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ecdb90d7-b6b6-4363-a64d-8105347e204d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING AND REPORTING STANDARDS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IFRCLLCMember_73d95b19-2d88-4484-9fcf-ffe52dec598e_terseLabel_en-US" xlink:label="lab_rdnt_IFRCLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC</link:label>
    <link:label id="lab_rdnt_IFRCLLCMember_label_en-US" xlink:label="lab_rdnt_IFRCLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC [Member]</link:label>
    <link:label id="lab_rdnt_IFRCLLCMember_documentation_en-US" xlink:label="lab_rdnt_IFRCLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IFRC LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCMember" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IFRCLLCMember" xlink:to="lab_rdnt_IFRCLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_6c377cf6-fcf0-433e-b6e6-0e2194524740_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelVMember_42967cca-3850-4b57-b66c-a234d9d82f8f_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelVMember" xlink:to="lab_rdnt_PricingLevelVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_fd496896-f7e5-4a75-ab55-f3b1636c8510_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_da4f909a-716a-4a2f-9a70-ba2e78b9cb54_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_80004eab-1beb-423f-bd7c-13c1926dff30_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CapitationArrangementsMember_30527eb4-b336-4766-a595-e98d7b914abc_verboseLabel_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue under capitation arrangements</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_72e318d9-0641-4096-ab42-dbaf4242b191_terseLabel_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue under capitation arrangements</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_label_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_documentation_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember" xlink:href="rdnt-20220331.xsd#rdnt_CapitationArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CapitationArrangementsMember" xlink:to="lab_rdnt_CapitationArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_46072bdf-4234-4cb4-9f65-d1ecda6e205b_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_3d5bf05f-aa7f-41eb-811f-f0cad1c00687_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_72d8671f-aae5-413c-a624-2dea63a66d2e_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_f6dd9438-4bad-434f-a9f1-a7d5c9aa66c6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_dda0c101-7a1b-4811-a38b-703dc6da052b_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPS1Member_7a751181-2dd7-477f-be80-91064b618c84_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_label_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member" xlink:href="rdnt-20220331.xsd#rdnt_A2019SWAPS1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPS1Member" xlink:to="lab_rdnt_A2019SWAPS1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_e1124395-81c0-4776-95c4-d4373c9eb71c_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f62a4a8e-b6cd-4b87-bce8-2aa3d598aef3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_702e6958-94ee-437d-a90e-eafb71795515_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_6a60afd9-5943-4d2c-8ac3-fecef985ec8a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures, net of dividends</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfLocationOfferingMultiModalityServices_b6c8b255-f7e8-4605-a62a-705db1e80b72_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of location offering multi-modality services</link:label>
    <link:label id="lab_rdnt_NumberOfLocationOfferingMultiModalityServices_label_en-US" xlink:label="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Location Offering Multi-Modality Services</link:label>
    <link:label id="lab_rdnt_NumberOfLocationOfferingMultiModalityServices_documentation_en-US" xlink:label="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Location Offering Multi-Modality Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:href="rdnt-20220331.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:to="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_725bd60f-d2a5-45ee-9f7a-feda2f7eff8a_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on First Lien Term Loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>rdnt-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:24636b67-e396-4152-b274-3287e4e6d5f6,g:fb9713cf-faca-444a-b4d8-252fbad89deb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CoverPage" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_efbead7a-baa3-42ec-8857-e822a9904293" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_DocumentType_efbead7a-baa3-42ec-8857-e822a9904293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_70502d15-dca7-4323-a1b4-1e7bf207b317" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_DocumentQuarterlyReport_70502d15-dca7-4323-a1b4-1e7bf207b317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b1b1e039-c19d-495a-b223-d1efb9788578" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_DocumentPeriodEndDate_b1b1e039-c19d-495a-b223-d1efb9788578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_be46fa14-90e1-4b38-b1a6-2786ec3dd127" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_DocumentTransitionReport_be46fa14-90e1-4b38-b1a6-2786ec3dd127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b6ed0554-c30f-4fd3-a28e-82239fae5ed2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityFileNumber_b6ed0554-c30f-4fd3-a28e-82239fae5ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f0f7eb11-3a8f-40f1-9442-e6b37f1795a3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityRegistrantName_f0f7eb11-3a8f-40f1-9442-e6b37f1795a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_baa14cc5-3149-4cc9-82b9-58669d5d7982" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_baa14cc5-3149-4cc9-82b9-58669d5d7982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2465ae0b-5d38-4285-8958-a48151966e95" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityTaxIdentificationNumber_2465ae0b-5d38-4285-8958-a48151966e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_4b932822-a439-4e2c-b75d-12f943d349d6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityAddressAddressLine1_4b932822-a439-4e2c-b75d-12f943d349d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8cc191d8-5e57-4794-98ec-22f558cfde9d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityAddressCityOrTown_8cc191d8-5e57-4794-98ec-22f558cfde9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_77ee0592-c690-444e-8717-c93ac3ed822a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityAddressStateOrProvince_77ee0592-c690-444e-8717-c93ac3ed822a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5c4496c7-d76d-4f28-bb75-162028962a4d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityAddressPostalZipCode_5c4496c7-d76d-4f28-bb75-162028962a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a42b9cf2-615a-495c-a6da-116b373b04b5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_CityAreaCode_a42b9cf2-615a-495c-a6da-116b373b04b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ae09b983-b59f-41b1-a9b9-797285365119" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_LocalPhoneNumber_ae09b983-b59f-41b1-a9b9-797285365119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_88118d4a-d828-44b1-b099-ff0781ad3253" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_Security12bTitle_88118d4a-d828-44b1-b099-ff0781ad3253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c11d7b48-d26b-44e5-ac00-449751dca418" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_TradingSymbol_c11d7b48-d26b-44e5-ac00-449751dca418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_df3ea1da-9eb1-4005-9e7f-a249f1a16ac5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_SecurityExchangeName_df3ea1da-9eb1-4005-9e7f-a249f1a16ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c35147e1-49cf-42ad-9f98-1b4809d0f303" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityCurrentReportingStatus_c35147e1-49cf-42ad-9f98-1b4809d0f303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b454a62d-850c-45a6-8c76-5ffd896327eb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityInteractiveDataCurrent_b454a62d-850c-45a6-8c76-5ffd896327eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_8ec4ad52-62b8-49fd-905d-4a306d01ea8d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityFilerCategory_8ec4ad52-62b8-49fd-905d-4a306d01ea8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_ece17c61-b68a-4cf5-be85-c4bf639d4491" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntitySmallBusiness_ece17c61-b68a-4cf5-be85-c4bf639d4491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ca32b935-b579-45cd-8f92-636e781e7cce" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityEmergingGrowthCompany_ca32b935-b579-45cd-8f92-636e781e7cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8b85ce24-aef9-4209-9bf6-a1d6613024ad" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityShellCompany_8b85ce24-aef9-4209-9bf6-a1d6613024ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2fe68cde-1228-412b-8761-a819e692ed46" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2fe68cde-1228-412b-8761-a819e692ed46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1f1ae5fd-fb88-4399-b783-5b2f8f8384c8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_EntityCentralIndexKey_1f1ae5fd-fb88-4399-b783-5b2f8f8384c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9cf60aa8-25c1-4e65-9332-899b922895bc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_AmendmentFlag_9cf60aa8-25c1-4e65-9332-899b922895bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_1db63f05-be37-492c-95a3-b0245def1b72" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_CurrentFiscalYearEndDate_1db63f05-be37-492c-95a3-b0245def1b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_323545be-2f92-4e32-8cf7-3d225afcc537" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_323545be-2f92-4e32-8cf7-3d225afcc537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_866b14b9-f195-4a59-88d9-2e338adfd952" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78fd70d6-ba54-4c53-9a02-e0e964cf87a6" xlink:to="loc_dei_DocumentFiscalYearFocus_866b14b9-f195-4a59-88d9-2e338adfd952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_17699cec-d792-4882-abf6-f7b55c831ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ff341408-f9a6-42a2-a4bb-370c51f6f741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17699cec-d792-4882-abf6-f7b55c831ae9" xlink:to="loc_us-gaap_AssetsAbstract_ff341408-f9a6-42a2-a4bb-370c51f6f741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_fc000e7e-aeb6-42aa-8369-8fbf908cc853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ff341408-f9a6-42a2-a4bb-370c51f6f741" xlink:to="loc_us-gaap_AssetsCurrentAbstract_fc000e7e-aeb6-42aa-8369-8fbf908cc853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3f162997-f16b-4c1b-bef3-9b135b195286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fc000e7e-aeb6-42aa-8369-8fbf908cc853" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3f162997-f16b-4c1b-bef3-9b135b195286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5fb768f1-909c-4e74-89cb-bcade2c62d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fc000e7e-aeb6-42aa-8369-8fbf908cc853" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5fb768f1-909c-4e74-89cb-bcade2c62d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_bc57ab52-fab2-4dda-91a5-d1f198b64d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fc000e7e-aeb6-42aa-8369-8fbf908cc853" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_bc57ab52-fab2-4dda-91a5-d1f198b64d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9d37b74b-5bd1-48d9-8346-9596a6e6ad2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fc000e7e-aeb6-42aa-8369-8fbf908cc853" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9d37b74b-5bd1-48d9-8346-9596a6e6ad2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b38f0767-0c46-4d8d-a7ba-bd128540dd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fc000e7e-aeb6-42aa-8369-8fbf908cc853" xlink:to="loc_us-gaap_AssetsCurrent_b38f0767-0c46-4d8d-a7ba-bd128540dd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_434c7e4b-a058-4732-9eac-6da18c0b3db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ff341408-f9a6-42a2-a4bb-370c51f6f741" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_434c7e4b-a058-4732-9eac-6da18c0b3db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_52a3d3bf-5676-4616-bcfa-1ec49ad7144b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_434c7e4b-a058-4732-9eac-6da18c0b3db1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_52a3d3bf-5676-4616-bcfa-1ec49ad7144b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0346024c-befa-42c8-8540-84b79980d84e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_434c7e4b-a058-4732-9eac-6da18c0b3db1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0346024c-befa-42c8-8540-84b79980d84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_b81f2eb0-ff4e-4dd7-8724-8b6da1698a57" xlink:href="rdnt-20220331.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_434c7e4b-a058-4732-9eac-6da18c0b3db1" xlink:to="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_b81f2eb0-ff4e-4dd7-8724-8b6da1698a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_235c3944-0a67-4866-b28c-27cedec5a239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ff341408-f9a6-42a2-a4bb-370c51f6f741" xlink:to="loc_us-gaap_OtherAssetsAbstract_235c3944-0a67-4866-b28c-27cedec5a239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3700520a-0604-4a0e-bb0f-47ee4e1f0269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_235c3944-0a67-4866-b28c-27cedec5a239" xlink:to="loc_us-gaap_Goodwill_3700520a-0604-4a0e-bb0f-47ee4e1f0269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ba8e9695-a434-4b59-bacb-99136538777e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_235c3944-0a67-4866-b28c-27cedec5a239" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ba8e9695-a434-4b59-bacb-99136538777e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_c8cbca43-3a0f-42f6-a5ee-7b57a243de1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_235c3944-0a67-4866-b28c-27cedec5a239" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_c8cbca43-3a0f-42f6-a5ee-7b57a243de1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ba3c5854-8031-463f-a06a-00584ec019e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_235c3944-0a67-4866-b28c-27cedec5a239" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ba3c5854-8031-463f-a06a-00584ec019e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_40dc86b0-8da2-42f4-aae2-10141fd85ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_235c3944-0a67-4866-b28c-27cedec5a239" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_40dc86b0-8da2-42f4-aae2-10141fd85ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_22dd8fe4-3440-4fd6-a7c5-6b883b99e4f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_235c3944-0a67-4866-b28c-27cedec5a239" xlink:to="loc_us-gaap_DepositsAssets_22dd8fe4-3440-4fd6-a7c5-6b883b99e4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_23225d28-8c04-4af5-a935-40039990a483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ff341408-f9a6-42a2-a4bb-370c51f6f741" xlink:to="loc_us-gaap_Assets_23225d28-8c04-4af5-a935-40039990a483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_730a973b-5397-464e-9dd8-2a2e589fb32c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17699cec-d792-4882-abf6-f7b55c831ae9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_730a973b-5397-464e-9dd8-2a2e589fb32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_385c74b1-7375-46a6-8e6f-4045a389fe76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_730a973b-5397-464e-9dd8-2a2e589fb32c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_385c74b1-7375-46a6-8e6f-4045a389fe76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1589328e-93b7-413f-83e3-3b5aed0428e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_385c74b1-7375-46a6-8e6f-4045a389fe76" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1589328e-93b7-413f-83e3-3b5aed0428e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_d899ea51-0db7-40db-a63c-d1f7f85b64c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_385c74b1-7375-46a6-8e6f-4045a389fe76" xlink:to="loc_us-gaap_DueToAffiliateCurrent_d899ea51-0db7-40db-a63c-d1f7f85b64c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_6ec806db-3b32-4d49-a23f-2be3db8e375d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_385c74b1-7375-46a6-8e6f-4045a389fe76" xlink:to="loc_us-gaap_DeferredRevenue_6ec806db-3b32-4d49-a23f-2be3db8e375d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_cf9fcda1-9bca-4a2f-8d1c-22f055fcd5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_385c74b1-7375-46a6-8e6f-4045a389fe76" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_cf9fcda1-9bca-4a2f-8d1c-22f055fcd5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_3038f2ab-fedc-424b-b11e-9f4a14895ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_385c74b1-7375-46a6-8e6f-4045a389fe76" xlink:to="loc_us-gaap_NotesPayableCurrent_3038f2ab-fedc-424b-b11e-9f4a14895ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fcad0a05-2bd9-439c-ac40-263d913ffa6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_385c74b1-7375-46a6-8e6f-4045a389fe76" xlink:to="loc_us-gaap_LiabilitiesCurrent_fcad0a05-2bd9-439c-ac40-263d913ffa6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_06d5e901-36f4-422c-93b8-c844c123e330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_730a973b-5397-464e-9dd8-2a2e589fb32c" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_06d5e901-36f4-422c-93b8-c844c123e330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_24be8cf4-03d3-4375-8cee-5daca9abe219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_06d5e901-36f4-422c-93b8-c844c123e330" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_24be8cf4-03d3-4375-8cee-5daca9abe219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_698e7cad-a47f-486d-a29c-b5f1b3ac2a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_06d5e901-36f4-422c-93b8-c844c123e330" xlink:to="loc_us-gaap_LongTermNotesPayable_698e7cad-a47f-486d-a29c-b5f1b3ac2a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8be01cf2-bc25-4cec-ac5a-ef86ebdaabb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_06d5e901-36f4-422c-93b8-c844c123e330" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_8be01cf2-bc25-4cec-ac5a-ef86ebdaabb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b326159e-dbc6-4e76-bf84-1b44b3ab717a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_06d5e901-36f4-422c-93b8-c844c123e330" xlink:to="loc_us-gaap_Liabilities_b326159e-dbc6-4e76-bf84-1b44b3ab717a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_fb682424-dd31-4045-acb1-9970d9a063e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_730a973b-5397-464e-9dd8-2a2e589fb32c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_fb682424-dd31-4045-acb1-9970d9a063e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_38ee992a-8177-4558-8c88-f470a75657e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb682424-dd31-4045-acb1-9970d9a063e6" xlink:to="loc_us-gaap_CommonStockValue_38ee992a-8177-4558-8c88-f470a75657e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b52e0f25-285c-4244-b58e-f0425b57aa05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb682424-dd31-4045-acb1-9970d9a063e6" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b52e0f25-285c-4244-b58e-f0425b57aa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b07d80e0-7232-4a23-891b-4eb7c025eab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb682424-dd31-4045-acb1-9970d9a063e6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b07d80e0-7232-4a23-891b-4eb7c025eab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c3ca5632-1df1-4eef-a7e2-6604d77c634b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb682424-dd31-4045-acb1-9970d9a063e6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c3ca5632-1df1-4eef-a7e2-6604d77c634b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_217e732b-7f41-4d68-8771-a54dc890a3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb682424-dd31-4045-acb1-9970d9a063e6" xlink:to="loc_us-gaap_StockholdersEquity_217e732b-7f41-4d68-8771-a54dc890a3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ae8f5793-7db0-4b24-baea-6cb56ec7133a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb682424-dd31-4045-acb1-9970d9a063e6" xlink:to="loc_us-gaap_MinorityInterest_ae8f5793-7db0-4b24-baea-6cb56ec7133a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ea6fe23-7bc5-4014-96ae-b8241a14493f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fb682424-dd31-4045-acb1-9970d9a063e6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ea6fe23-7bc5-4014-96ae-b8241a14493f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddcc52e1-2add-4181-805f-5497e582ae4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_730a973b-5397-464e-9dd8-2a2e589fb32c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddcc52e1-2add-4181-805f-5497e582ae4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_aaea51be-a53f-46bb-814b-685410fb985d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5e43aee9-1f62-41d1-8809-2ce07aa81887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aaea51be-a53f-46bb-814b-685410fb985d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5e43aee9-1f62-41d1-8809-2ce07aa81887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_87d0f0f9-6a78-4eb7-b2f0-1a98afd1ef34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aaea51be-a53f-46bb-814b-685410fb985d" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_87d0f0f9-6a78-4eb7-b2f0-1a98afd1ef34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_094bcd07-e3fc-42df-b8cb-9cc6600176c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aaea51be-a53f-46bb-814b-685410fb985d" xlink:to="loc_us-gaap_CommonStockSharesIssued_094bcd07-e3fc-42df-b8cb-9cc6600176c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_eed93626-4b71-45a4-92b6-36957aa94282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aaea51be-a53f-46bb-814b-685410fb985d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_eed93626-4b71-45a4-92b6-36957aa94282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7920313f-0e0e-40a9-8fea-c4c96cabd495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f99fa4bc-d23d-421c-83e8-c33d591601fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7920313f-0e0e-40a9-8fea-c4c96cabd495" xlink:to="loc_us-gaap_StatementTable_f99fa4bc-d23d-421c-83e8-c33d591601fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0ea662ff-ac70-470a-8fd7-1053a6f08495" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f99fa4bc-d23d-421c-83e8-c33d591601fc" xlink:to="loc_srt_ProductOrServiceAxis_0ea662ff-ac70-470a-8fd7-1053a6f08495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_40acc0eb-9f9b-4cf9-afa3-65e93cc2cd0e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0ea662ff-ac70-470a-8fd7-1053a6f08495" xlink:to="loc_srt_ProductsAndServicesDomain_40acc0eb-9f9b-4cf9-afa3-65e93cc2cd0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_4bf7f5fc-5e08-46b1-a5a6-12290d786e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_40acc0eb-9f9b-4cf9-afa3-65e93cc2cd0e" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_4bf7f5fc-5e08-46b1-a5a6-12290d786e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_6a5e1e07-9958-4d6d-9879-70bea568a181" xlink:href="rdnt-20220331.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_40acc0eb-9f9b-4cf9-afa3-65e93cc2cd0e" xlink:to="loc_rdnt_CapitationArrangementsMember_6a5e1e07-9958-4d6d-9879-70bea568a181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f99fa4bc-d23d-421c-83e8-c33d591601fc" xlink:to="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_35bfc0ac-8b34-4819-9b06-bcb40f049a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_RevenuesAbstract_35bfc0ac-8b34-4819-9b06-bcb40f049a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6f3f9fde-fe93-4915-8a6f-a1211fc2d518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_35bfc0ac-8b34-4819-9b06-bcb40f049a03" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6f3f9fde-fe93-4915-8a6f-a1211fc2d518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_02b9d10d-2542-4c07-9cb8-c68b88b6ca21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_35bfc0ac-8b34-4819-9b06-bcb40f049a03" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_02b9d10d-2542-4c07-9cb8-c68b88b6ca21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_9682f116-d91f-41f1-aa7b-ceae62f84661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_9682f116-d91f-41f1-aa7b-ceae62f84661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9518398d-c987-418d-b223-6b1458836b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9518398d-c987-418d-b223-6b1458836b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_1025fda9-e09a-4e7c-9ffd-dc4e8e8ea32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_1025fda9-e09a-4e7c-9ffd-dc4e8e8ea32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_ef8b1c8d-0edf-4f7b-8a35-5b7596aad4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:to="loc_us-gaap_SeveranceCosts1_ef8b1c8d-0edf-4f7b-8a35-5b7596aad4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_fb6714b5-e846-4606-ad69-38bde76f2509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e5ce641f-08f2-40cb-82cb-896b0482f992" xlink:to="loc_us-gaap_OperatingExpenses_fb6714b5-e846-4606-ad69-38bde76f2509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b26309fc-bfe2-4e3d-8f3e-fbd6c76f5289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_OperatingIncomeLoss_b26309fc-bfe2-4e3d-8f3e-fbd6c76f5289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_769f1735-b000-4439-b19c-42276ce0ea49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:to="loc_us-gaap_InterestExpenseDebt_769f1735-b000-4439-b19c-42276ce0ea49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d4f3385a-0fab-4940-a97e-e7c94779f498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d4f3385a-0fab-4940-a97e-e7c94779f498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_dbb3cb13-58b0-411f-a31f-f6148989b091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_dbb3cb13-58b0-411f-a31f-f6148989b091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e88658c9-2ee6-4ea3-818d-cd4d1eff2507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e88658c9-2ee6-4ea3-818d-cd4d1eff2507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d675e511-25f6-400e-aad3-6d63e69970b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_e39cc2e8-60a9-48a3-acac-20343341bb9c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d675e511-25f6-400e-aad3-6d63e69970b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_45b84726-ad00-4b55-8838-889af2628300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_45b84726-ad00-4b55-8838-889af2628300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b0880b1a-02ee-4505-884d-d006da43e29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b0880b1a-02ee-4505-884d-d006da43e29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_58344038-2a58-4b89-805d-55c7fb7cb9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_ProfitLoss_58344038-2a58-4b89-805d-55c7fb7cb9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e267efb7-7bb5-4dbb-9232-7a47e8271beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e267efb7-7bb5-4dbb-9232-7a47e8271beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5f7f7745-3a6e-48f0-a829-a8fe14c32b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_NetIncomeLoss_5f7f7745-3a6e-48f0-a829-a8fe14c32b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6c19fb70-c5eb-4147-b8d6-33d6200564f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_EarningsPerShareBasic_6c19fb70-c5eb-4147-b8d6-33d6200564f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_287e62e2-ae26-4d44-969d-0d88df7d32e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_287e62e2-ae26-4d44-969d-0d88df7d32e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00064da9-6e43-453b-9233-c9a58b712470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dcb2b519-a251-4ad2-a43e-056b2f01fdc6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00064da9-6e43-453b-9233-c9a58b712470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02c22fd2-a946-4f21-9ec9-d39eaa881914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00064da9-6e43-453b-9233-c9a58b712470" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02c22fd2-a946-4f21-9ec9-d39eaa881914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4163e169-399c-4bbd-9655-f9bae9dafeab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00064da9-6e43-453b-9233-c9a58b712470" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4163e169-399c-4bbd-9655-f9bae9dafeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fdcc9ba-e1dd-4600-9b27-2b29a41e6752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2293cecd-d4b2-492f-b355-739a2e59a0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fdcc9ba-e1dd-4600-9b27-2b29a41e6752" xlink:to="loc_us-gaap_ProfitLoss_2293cecd-d4b2-492f-b355-739a2e59a0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1198c83d-5e8d-494f-8ae5-1892a96f3ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fdcc9ba-e1dd-4600-9b27-2b29a41e6752" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1198c83d-5e8d-494f-8ae5-1892a96f3ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a845dfe7-2bdb-4af5-866c-33a4537ab0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fdcc9ba-e1dd-4600-9b27-2b29a41e6752" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a845dfe7-2bdb-4af5-866c-33a4537ab0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8f3bdd22-49f9-47ef-988b-b2862554ac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fdcc9ba-e1dd-4600-9b27-2b29a41e6752" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8f3bdd22-49f9-47ef-988b-b2862554ac3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_999f2a43-41fd-449d-9681-e555c954a0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fdcc9ba-e1dd-4600-9b27-2b29a41e6752" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_999f2a43-41fd-449d-9681-e555c954a0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a35ea4dd-c494-4f1a-8038-4683bab3883a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fdcc9ba-e1dd-4600-9b27-2b29a41e6752" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a35ea4dd-c494-4f1a-8038-4683bab3883a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7c296ea2-81b7-473f-8527-da7ccfc76db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6f24b149-294a-4c27-bfec-85e8f516303e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7c296ea2-81b7-473f-8527-da7ccfc76db0" xlink:to="loc_us-gaap_StatementTable_6f24b149-294a-4c27-bfec-85e8f516303e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_25bf38ef-42bc-475e-ad21-2e22ac2d5b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6f24b149-294a-4c27-bfec-85e8f516303e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_25bf38ef-42bc-475e-ad21-2e22ac2d5b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9918e186-5dab-4d21-abf7-410e96433dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25bf38ef-42bc-475e-ad21-2e22ac2d5b08" xlink:to="loc_us-gaap_EquityComponentDomain_9918e186-5dab-4d21-abf7-410e96433dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9918e186-5dab-4d21-abf7-410e96433dac" xlink:to="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5b2a3589-08cd-408e-9d65-7f09e83bf715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:to="loc_us-gaap_CommonStockMember_5b2a3589-08cd-408e-9d65-7f09e83bf715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_36180c57-9ef9-45f6-9adf-c87f4e214cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_36180c57-9ef9-45f6-9adf-c87f4e214cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_358ef6e3-2d7a-4017-9746-c5dbe611e4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_358ef6e3-2d7a-4017-9746-c5dbe611e4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_517ec737-cff1-491f-8e7c-504c389c948c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_f2cf9224-22b8-41b0-b036-2371ba83abc0" xlink:to="loc_us-gaap_RetainedEarningsMember_517ec737-cff1-491f-8e7c-504c389c948c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9992076c-f48b-4cce-b5e7-5d787cc0945f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9918e186-5dab-4d21-abf7-410e96433dac" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9992076c-f48b-4cce-b5e7-5d787cc0945f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bab60446-13ea-4351-bea6-83d118abddf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6f24b149-294a-4c27-bfec-85e8f516303e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bab60446-13ea-4351-bea6-83d118abddf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57040d81-ba00-44d6-8fd2-ef63e3577e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bab60446-13ea-4351-bea6-83d118abddf2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57040d81-ba00-44d6-8fd2-ef63e3577e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_105ab3c6-6f86-4407-9591-e2505fa07d1b" xlink:href="rdnt-20220331.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57040d81-ba00-44d6-8fd2-ef63e3577e4b" xlink:to="loc_rdnt_DeepHealthInc.Member_105ab3c6-6f86-4407-9591-e2505fa07d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cccbf66a-8d68-4e6b-b197-b8686c9128d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6f24b149-294a-4c27-bfec-85e8f516303e" xlink:to="loc_us-gaap_StatementLineItems_cccbf66a-8d68-4e6b-b197-b8686c9128d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cccbf66a-8d68-4e6b-b197-b8686c9128d2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1c18dcc9-786d-413f-9cfa-108691ee77e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_SharesOutstanding_1c18dcc9-786d-413f-9cfa-108691ee77e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5d3bdaf-2ceb-4d8a-923e-07c7ec1ced17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5d3bdaf-2ceb-4d8a-923e-07c7ec1ced17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a44b6824-05d3-44f2-9313-0f59be7c577a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a44b6824-05d3-44f2-9313-0f59be7c577a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_866415c8-6b33-4eac-b62b-0bbaeac4bece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_866415c8-6b33-4eac-b62b-0bbaeac4bece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_c99ac0db-611e-4793-89f9-f7652ca4e8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_c99ac0db-611e-4793-89f9-f7652ca4e8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_79f79720-948e-452d-8d45-8bff1bd4a7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_79f79720-948e-452d-8d45-8bff1bd4a7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_79461a6e-eaf6-42fb-89a6-cd24dfbc65b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_79461a6e-eaf6-42fb-89a6-cd24dfbc65b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests_ed2bf835-c01a-4b50-b80c-4661d1196776" xlink:href="rdnt-20220331.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_rdnt_ContributionsFromNoncontrollingInterests_ed2bf835-c01a-4b50-b80c-4661d1196776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_28032968-4f7f-4927-a525-aee060d19cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_28032968-4f7f-4927-a525-aee060d19cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6521fec8-f8e5-4c8f-91b5-2e03c0e965af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6521fec8-f8e5-4c8f-91b5-2e03c0e965af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_a55c5ef5-b4e6-4db3-8315-a29491501c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockholdersEquityOther_a55c5ef5-b4e6-4db3-8315-a29491501c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6ac23167-60f1-4b30-bdba-4bb6d5708239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_ProfitLoss_6ac23167-60f1-4b30-bdba-4bb6d5708239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_83eb497b-d55c-435b-8ef4-b63bcfbc1844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_SharesOutstanding_83eb497b-d55c-435b-8ef4-b63bcfbc1844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b81916bf-4282-419f-a4e5-a81735ee6af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06963aac-493d-4478-a9c0-2c654ebc7102" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b81916bf-4282-419f-a4e5-a81735ee6af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a68e43d6-9540-4b77-a1f4-f5020f6c7225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7ad3ce7f-f6c5-4d12-86c4-2ee984d7c286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a68e43d6-9540-4b77-a1f4-f5020f6c7225" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7ad3ce7f-f6c5-4d12-86c4-2ee984d7c286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e272e61e-7ffd-4638-8855-d5c82a5b9f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7ad3ce7f-f6c5-4d12-86c4-2ee984d7c286" xlink:to="loc_us-gaap_ProfitLoss_e272e61e-7ffd-4638-8855-d5c82a5b9f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7ad3ce7f-f6c5-4d12-86c4-2ee984d7c286" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d30d1dd3-9c5a-4031-8c63-c13615544a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d30d1dd3-9c5a-4031-8c63-c13615544a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_a935916e-c38a-4109-a936-9ec0463c66b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_a935916e-c38a-4109-a936-9ec0463c66b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_83d05e09-455c-4d78-bdd8-1ce202fe02b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_83d05e09-455c-4d78-bdd8-1ce202fe02b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_583ab3ab-1c9f-4676-86bc-45222b288c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_583ab3ab-1c9f-4676-86bc-45222b288c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_ab7dd84d-2e99-4bbc-a74a-dca8786ddebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_ab7dd84d-2e99-4bbc-a74a-dca8786ddebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_77dbf151-c296-4f88-94da-ca39d299a924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_77dbf151-c296-4f88-94da-ca39d299a924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_fc63b6ff-ead5-4ccd-8005-fe62b697723d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_fc63b6ff-ead5-4ccd-8005-fe62b697723d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b6c27478-9a8a-49ef-983b-da9bc61c8f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:to="loc_us-gaap_ShareBasedCompensation_b6c27478-9a8a-49ef-983b-da9bc61c8f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e62f6480-e4d5-472a-bbf5-a510ebf4eb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e62f6480-e4d5-472a-bbf5-a510ebf4eb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_41529a14-46b8-466e-a6d3-d1525763ef42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_880fd139-3092-4ea6-901c-ade3e1dcad76" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_41529a14-46b8-466e-a6d3-d1525763ef42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6a0fa643-db84-4588-9501-6d925b1dcd62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_41529a14-46b8-466e-a6d3-d1525763ef42" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6a0fa643-db84-4588-9501-6d925b1dcd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_ebcc370b-fb27-4315-87a4-ca8eaba78f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_41529a14-46b8-466e-a6d3-d1525763ef42" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_ebcc370b-fb27-4315-87a4-ca8eaba78f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_7e782b64-b96f-4b8f-90bb-9fc6e35f1537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_41529a14-46b8-466e-a6d3-d1525763ef42" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_7e782b64-b96f-4b8f-90bb-9fc6e35f1537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_8f742205-d99d-4f4e-920f-df3c0730e26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_41529a14-46b8-466e-a6d3-d1525763ef42" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_8f742205-d99d-4f4e-920f-df3c0730e26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_98e27bec-cf2b-4068-9a38-04f25e378e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_41529a14-46b8-466e-a6d3-d1525763ef42" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_98e27bec-cf2b-4068-9a38-04f25e378e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_16dbfd0a-aa87-497b-bd22-3c9bc229208e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_41529a14-46b8-466e-a6d3-d1525763ef42" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_16dbfd0a-aa87-497b-bd22-3c9bc229208e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8a00c801-c84b-426d-8924-24af941db1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_41529a14-46b8-466e-a6d3-d1525763ef42" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8a00c801-c84b-426d-8924-24af941db1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6fca8098-460b-42e8-8b98-81083f3a7325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7ad3ce7f-f6c5-4d12-86c4-2ee984d7c286" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6fca8098-460b-42e8-8b98-81083f3a7325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bd098ff-46eb-4b9a-8556-1b296e70a2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a68e43d6-9540-4b77-a1f4-f5020f6c7225" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bd098ff-46eb-4b9a-8556-1b296e70a2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_91470fc0-7829-421e-b746-81e343d732b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bd098ff-46eb-4b9a-8556-1b296e70a2ab" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_91470fc0-7829-421e-b746-81e343d732b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_7ef18faa-3bf9-4f49-b9b4-70b2d6d4076a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bd098ff-46eb-4b9a-8556-1b296e70a2ab" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_7ef18faa-3bf9-4f49-b9b4-70b2d6d4076a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d365c3a8-2b9e-4b75-9aac-fe42181db7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bd098ff-46eb-4b9a-8556-1b296e70a2ab" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d365c3a8-2b9e-4b75-9aac-fe42181db7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16dddee0-7466-4ed8-a4a4-d46584367bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bd098ff-46eb-4b9a-8556-1b296e70a2ab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16dddee0-7466-4ed8-a4a4-d46584367bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9e2651b-bf7d-40ba-ae3c-a7cfcfc3a89a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a68e43d6-9540-4b77-a1f4-f5020f6c7225" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9e2651b-bf7d-40ba-ae3c-a7cfcfc3a89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_1fa6b9a0-2561-4713-84cf-2c604081b3af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9e2651b-bf7d-40ba-ae3c-a7cfcfc3a89a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_1fa6b9a0-2561-4713-84cf-2c604081b3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_1b526e0c-b619-41cf-9ae5-6c68a92d44ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9e2651b-bf7d-40ba-ae3c-a7cfcfc3a89a" xlink:to="loc_us-gaap_RepaymentsOfDebt_1b526e0c-b619-41cf-9ae5-6c68a92d44ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_40de1631-9f7d-40ae-af89-4e907f7a7299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9e2651b-bf7d-40ba-ae3c-a7cfcfc3a89a" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_40de1631-9f7d-40ae-af89-4e907f7a7299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_288b9c84-69a2-48b9-9f55-787a7235cd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9e2651b-bf7d-40ba-ae3c-a7cfcfc3a89a" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_288b9c84-69a2-48b9-9f55-787a7235cd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_68834850-01a6-4072-882d-0adae5c3facd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9e2651b-bf7d-40ba-ae3c-a7cfcfc3a89a" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_68834850-01a6-4072-882d-0adae5c3facd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1286c49b-0c1e-4dc3-9be5-19e345e0c20d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9e2651b-bf7d-40ba-ae3c-a7cfcfc3a89a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1286c49b-0c1e-4dc3-9be5-19e345e0c20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f170d3f7-af30-46c2-8454-06b4b41044e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a68e43d6-9540-4b77-a1f4-f5020f6c7225" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f170d3f7-af30-46c2-8454-06b4b41044e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb86d19c-5aaa-49d7-859d-08173b05cf5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a68e43d6-9540-4b77-a1f4-f5020f6c7225" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb86d19c-5aaa-49d7-859d-08173b05cf5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ebcdbff-63b1-4665-ab21-0fd0b4ad7fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a68e43d6-9540-4b77-a1f4-f5020f6c7225" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ebcdbff-63b1-4665-ab21-0fd0b4ad7fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_00728531-c2cb-4c4e-bd91-936ea498ca83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a68e43d6-9540-4b77-a1f4-f5020f6c7225" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_00728531-c2cb-4c4e-bd91-936ea498ca83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_383040f4-4019-4241-af68-8be4ad12ec47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a68e43d6-9540-4b77-a1f4-f5020f6c7225" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_383040f4-4019-4241-af68-8be4ad12ec47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_6b933502-c9da-4f00-b5a1-24986f6769b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_383040f4-4019-4241-af68-8be4ad12ec47" xlink:to="loc_us-gaap_InterestPaidNet_6b933502-c9da-4f00-b5a1-24986f6769b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_a8c06f48-49b5-4cb5-a79b-b34f61f1abd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_383040f4-4019-4241-af68-8be4ad12ec47" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_a8c06f48-49b5-4cb5-a79b-b34f61f1abd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_825e4fc3-ff1a-43a8-a06e-3092b2a3ae9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3b18c2de-54bc-447d-9184-64335f1dae53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_825e4fc3-ff1a-43a8-a06e-3092b2a3ae9f" xlink:to="loc_us-gaap_StatementTable_3b18c2de-54bc-447d-9184-64335f1dae53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_01b4981a-dab8-4c04-9fe2-5131b5046f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3b18c2de-54bc-447d-9184-64335f1dae53" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_01b4981a-dab8-4c04-9fe2-5131b5046f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f592cdf1-9a9d-4660-8033-14c890c8b53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_01b4981a-dab8-4c04-9fe2-5131b5046f8f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f592cdf1-9a9d-4660-8033-14c890c8b53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_88c8f46e-89d8-4b73-9e5a-53afee3adb6b" xlink:href="rdnt-20220331.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f592cdf1-9a9d-4660-8033-14c890c8b53f" xlink:to="loc_rdnt_AidenceMember_88c8f46e-89d8-4b73-9e5a-53afee3adb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_4c7654bc-222f-4757-b986-f87cadf1e3e9" xlink:href="rdnt-20220331.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f592cdf1-9a9d-4660-8033-14c890c8b53f" xlink:to="loc_rdnt_QuantibMember_4c7654bc-222f-4757-b986-f87cadf1e3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_32548eb2-69b7-444e-9df9-9ce7e072d6ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3b18c2de-54bc-447d-9184-64335f1dae53" xlink:to="loc_dei_LegalEntityAxis_32548eb2-69b7-444e-9df9-9ce7e072d6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3815a56b-2254-4f99-bf11-9b70af13bf95" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_32548eb2-69b7-444e-9df9-9ce7e072d6ac" xlink:to="loc_dei_EntityDomain_3815a56b-2254-4f99-bf11-9b70af13bf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_5866b0a9-5dac-4ee4-b759-eadf6721c744" xlink:href="rdnt-20220331.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3815a56b-2254-4f99-bf11-9b70af13bf95" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_5866b0a9-5dac-4ee4-b759-eadf6721c744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_af70cf5a-e42b-473a-92fb-d623ac67e990" xlink:href="rdnt-20220331.xsd#rdnt_SimiAdventistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3815a56b-2254-4f99-bf11-9b70af13bf95" xlink:to="loc_rdnt_SimiAdventistMember_af70cf5a-e42b-473a-92fb-d623ac67e990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3b18c2de-54bc-447d-9184-64335f1dae53" xlink:to="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_90a8c765-5124-4c34-b624-78e17cb36991" xlink:href="rdnt-20220331.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_90a8c765-5124-4c34-b624-78e17cb36991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_58fdab7c-0f05-48ae-b554-90a8afd86a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_58fdab7c-0f05-48ae-b554-90a8afd86a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_2b6104b5-a520-46d7-b602-6ed8f1be6a49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_2b6104b5-a520-46d7-b602-6ed8f1be6a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_69105774-376c-4bcc-8a4e-f130a22bd657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_69105774-376c-4bcc-8a4e-f130a22bd657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_1e16065b-71e7-4190-b5af-b16fe6a5de66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ed3d714-8912-453e-b551-3709f9881d5b" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_1e16065b-71e7-4190-b5af-b16fe6a5de66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="rdnt-20220331.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cadac9e5-1d55-45ae-b67b-c728fb2854d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1845938b-bfc0-4ce3-889f-63d33573c314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cadac9e5-1d55-45ae-b67b-c728fb2854d4" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1845938b-bfc0-4ce3-889f-63d33573c314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e194c9f8-c8d9-480c-a447-209f6037c5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e194c9f8-c8d9-480c-a447-209f6037c5e1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_59484ea4-03c1-4264-a13e-fc1b498d6ee8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_59484ea4-03c1-4264-a13e-fc1b498d6ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b90a7157-8b55-478e-aedf-a3f07eccdc4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_59484ea4-03c1-4264-a13e-fc1b498d6ee8" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b90a7157-8b55-478e-aedf-a3f07eccdc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_13e48a16-dfb7-4434-8267-3cfb036cb797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b90a7157-8b55-478e-aedf-a3f07eccdc4d" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_13e48a16-dfb7-4434-8267-3cfb036cb797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_15e7b2ad-3fbf-4ee8-944c-7718994efe14" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_15e7b2ad-3fbf-4ee8-944c-7718994efe14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1402a872-941a-4940-87f7-c1ad53905f64" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_15e7b2ad-3fbf-4ee8-944c-7718994efe14" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1402a872-941a-4940-87f7-c1ad53905f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLlcMember_199076ec-23fe-4d39-ba6f-64cac11f9c73" xlink:href="rdnt-20220331.xsd#rdnt_ScriptSenderLlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1402a872-941a-4940-87f7-c1ad53905f64" xlink:to="loc_rdnt_ScriptSenderLlcMember_199076ec-23fe-4d39-ba6f-64cac11f9c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_e7564535-434e-4e67-b626-0355d897333e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_e7564535-434e-4e67-b626-0355d897333e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_905bc40d-61e5-4b4f-802b-8107f77f448d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_e7564535-434e-4e67-b626-0355d897333e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_905bc40d-61e5-4b4f-802b-8107f77f448d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_fbec9ffd-42b7-492f-ae5d-70d4cb91584f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_905bc40d-61e5-4b4f-802b-8107f77f448d" xlink:to="loc_us-gaap_OperatingExpenseMember_fbec9ffd-42b7-492f-ae5d-70d4cb91584f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6046805e-d93f-44b9-bcb5-bb3ef02617c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6046805e-d93f-44b9-bcb5-bb3ef02617c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2866834b-0a10-465d-aff2-b66354cb11f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6046805e-d93f-44b9-bcb5-bb3ef02617c2" xlink:to="loc_us-gaap_RelatedPartyDomain_2866834b-0a10-465d-aff2-b66354cb11f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_2495cdd7-bc91-4191-9380-71f5f68e84a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2866834b-0a10-465d-aff2-b66354cb11f9" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_2495cdd7-bc91-4191-9380-71f5f68e84a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98d08b7e-088b-49eb-a46a-9513275555e7" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_dc8d13c9-8ee9-42fb-91e3-920512f2f137" xlink:href="rdnt-20220331.xsd#rdnt_NumberOfCenters"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_rdnt_NumberOfCenters_dc8d13c9-8ee9-42fb-91e3-920512f2f137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_4bd5cf45-ef69-41f0-9f6b-1a1bb6f82250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_NumberOfReportableSegments_4bd5cf45-ef69-41f0-9f6b-1a1bb6f82250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_3630f918-3ad0-4745-9c35-64d647114d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_3630f918-3ad0-4745-9c35-64d647114d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_9797a7e8-23dd-42f0-986f-b461c6ae3407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_9797a7e8-23dd-42f0-986f-b461c6ae3407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_b5356632-29f5-4e0f-9d2a-c6c516d43f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_b5356632-29f5-4e0f-9d2a-c6c516d43f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e7415022-0efd-4426-8208-c854526d2b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_Assets_e7415022-0efd-4426-8208-c854526d2b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_90e73d01-ea9b-4fe8-8fa6-a3621cadc7de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_Liabilities_90e73d01-ea9b-4fe8-8fa6-a3621cadc7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_05b8a4bf-1c34-474f-82c4-16c1666beb71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_05b8a4bf-1c34-474f-82c4-16c1666beb71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_db05a12a-db5d-490d-8360-a839500aa2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_EquityMethodInvestments_db05a12a-db5d-490d-8360-a839500aa2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_61758de2-ff55-494e-bc9e-af58f3087244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c557c730-9de3-43fc-960c-1a4de23e2de9" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_61758de2-ff55-494e-bc9e-af58f3087244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1313adc3-b474-4f08-a135-c606faffe213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1d5d4bcb-a9a2-435b-ac55-08993d73a924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1313adc3-b474-4f08-a135-c606faffe213" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1d5d4bcb-a9a2-435b-ac55-08993d73a924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_ab1971d2-adee-45a5-a53b-a4f0db69333a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_ab1971d2-adee-45a5-a53b-a4f0db69333a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_ad6d9d36-2447-475e-80a0-d981fe0d12dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_ad6d9d36-2447-475e-80a0-d981fe0d12dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_d83571f8-f2ed-4ca0-b5f5-010332e7f28e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_d83571f8-f2ed-4ca0-b5f5-010332e7f28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8fff9e7d-ab4a-4f81-ba54-585c62ad151a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8fff9e7d-ab4a-4f81-ba54-585c62ad151a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_a1a3b2ad-ce00-45f8-a1ff-35ee33df9cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_a1a3b2ad-ce00-45f8-a1ff-35ee33df9cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_0d43e2c7-e1d5-4c31-9942-c4a5a7e56fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_0d43e2c7-e1d5-4c31-9942-c4a5a7e56fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_0d1a7bf7-53ce-41f3-ad44-60166c5e5c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_0d1a7bf7-53ce-41f3-ad44-60166c5e5c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_204a8916-b909-4b97-8e2c-041c0e88b2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_204a8916-b909-4b97-8e2c-041c0e88b2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_107658ee-bb21-4aa0-86ca-23647f4c554a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_107658ee-bb21-4aa0-86ca-23647f4c554a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_acec1803-f11f-471a-bec2-7539a6e97973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_acec1803-f11f-471a-bec2-7539a6e97973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_3c96d87c-f900-4094-8ed0-b561c4bd61c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_3c96d87c-f900-4094-8ed0-b561c4bd61c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_bfe4cd68-bd13-4ebb-b5cc-936d883fde6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_bfe4cd68-bd13-4ebb-b5cc-936d883fde6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_c977f98f-f3ad-437d-9e26-bf043f13720b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_c977f98f-f3ad-437d-9e26-bf043f13720b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_9f9380f4-155b-4edd-8d03-7976b1de4f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_9f9380f4-155b-4edd-8d03-7976b1de4f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_8afd9172-6c97-4439-a04d-8cbcf400cd16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_8afd9172-6c97-4439-a04d-8cbcf400cd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_8151c223-da8f-4f56-9558-89fe735be538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_8151c223-da8f-4f56-9558-89fe735be538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b63175d8-800e-4842-80da-18605588145d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c05b66be-d23a-45fe-90e7-e3fca1cea0ee" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b63175d8-800e-4842-80da-18605588145d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fcd32ba2-9ef6-42dd-9255-14d9a99ecf92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_4ff877f0-4a94-4dae-acbb-0776c7d94a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fcd32ba2-9ef6-42dd-9255-14d9a99ecf92" xlink:to="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_4ff877f0-4a94-4dae-acbb-0776c7d94a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_80f32177-0248-40f0-b61f-78c2c4eaf523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fcd32ba2-9ef6-42dd-9255-14d9a99ecf92" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_80f32177-0248-40f0-b61f-78c2c4eaf523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_237f9387-6d15-4c28-a074-4cc0db7a2744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fcd32ba2-9ef6-42dd-9255-14d9a99ecf92" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_237f9387-6d15-4c28-a074-4cc0db7a2744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_92d8f5d3-7092-4bb9-926b-6e84470634ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fcd32ba2-9ef6-42dd-9255-14d9a99ecf92" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_92d8f5d3-7092-4bb9-926b-6e84470634ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_c88093bf-c71e-4cfc-b822-845905b63fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fcd32ba2-9ef6-42dd-9255-14d9a99ecf92" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_c88093bf-c71e-4cfc-b822-845905b63fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c238ae56-8887-40b8-a15c-72ebf51dcd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fcd32ba2-9ef6-42dd-9255-14d9a99ecf92" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c238ae56-8887-40b8-a15c-72ebf51dcd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_530b84a3-f6d1-40c9-a54d-415f061e08e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fcd32ba2-9ef6-42dd-9255-14d9a99ecf92" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_530b84a3-f6d1-40c9-a54d-415f061e08e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_fa47be35-3999-4a65-9fc0-f84f71a9bc34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fcd32ba2-9ef6-42dd-9255-14d9a99ecf92" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_fa47be35-3999-4a65-9fc0-f84f71a9bc34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_75197356-f487-4a1a-8bae-23c9fc42dc2e" xlink:href="rdnt-20220331.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fcd32ba2-9ef6-42dd-9255-14d9a99ecf92" xlink:to="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_75197356-f487-4a1a-8bae-23c9fc42dc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f44b8af1-9235-4c4c-8173-7aef5052f6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ed8dc71a-5f0e-4d7f-8f18-fc2b03f9bd80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f44b8af1-9235-4c4c-8173-7aef5052f6e4" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ed8dc71a-5f0e-4d7f-8f18-fc2b03f9bd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c7037f2c-93f2-4a56-8464-201750db5438" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ed8dc71a-5f0e-4d7f-8f18-fc2b03f9bd80" xlink:to="loc_srt_ProductOrServiceAxis_c7037f2c-93f2-4a56-8464-201750db5438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fdbd9936-4358-45ca-9bb1-6baedb092ee5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c7037f2c-93f2-4a56-8464-201750db5438" xlink:to="loc_srt_ProductsAndServicesDomain_fdbd9936-4358-45ca-9bb1-6baedb092ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fdbd9936-4358-45ca-9bb1-6baedb092ee5" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_dbd0a201-5b9f-4b81-b7aa-0fb038bf0b81" xlink:href="rdnt-20220331.xsd#rdnt_CommercialInsurance1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_CommercialInsurance1Member_dbd0a201-5b9f-4b81-b7aa-0fb038bf0b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_7dd3f46e-91fa-46c9-af0b-b67c1a8af7fb" xlink:href="rdnt-20220331.xsd#rdnt_Medicare1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_Medicare1Member_7dd3f46e-91fa-46c9-af0b-b67c1a8af7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_0b1bb17d-1f8a-4f1c-be2f-d7663bcf97c4" xlink:href="rdnt-20220331.xsd#rdnt_Medicaid1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_Medicaid1Member_0b1bb17d-1f8a-4f1c-be2f-d7663bcf97c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_9d0c89fb-4af1-4006-86c1-0409932b6653" xlink:href="rdnt-20220331.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_9d0c89fb-4af1-4006-86c1-0409932b6653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_f923ba52-858d-4dfa-8874-21fcb1f42bc9" xlink:href="rdnt-20220331.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_f923ba52-858d-4dfa-8874-21fcb1f42bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_33a3ad24-367b-45e2-8ffd-f657bc7bcdba" xlink:href="rdnt-20220331.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_HealthCareManagementServiceMember_33a3ad24-367b-45e2-8ffd-f657bc7bcdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SoftwareMember_6fbbf994-f294-4926-8cfc-88bd5fe00b3f" xlink:href="rdnt-20220331.xsd#rdnt_SoftwareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_SoftwareMember_6fbbf994-f294-4926-8cfc-88bd5fe00b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_ecc8b749-f690-44a9-b26a-54c9c27a631b" xlink:href="rdnt-20220331.xsd#rdnt_AIMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_rdnt_AIMember_ecc8b749-f690-44a9-b26a-54c9c27a631b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_efad2e67-dfb2-4d89-806d-288694981228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_3e737445-7b26-4d7d-89ac-4775da416f89" xlink:to="loc_us-gaap_HealthCareOtherMember_efad2e67-dfb2-4d89-806d-288694981228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_def0b508-15bd-4f67-8fba-eb497bd6f231" xlink:href="rdnt-20220331.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fdbd9936-4358-45ca-9bb1-6baedb092ee5" xlink:to="loc_rdnt_CapitationArrangementsMember_def0b508-15bd-4f67-8fba-eb497bd6f231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ba81732e-78b2-41d3-8f12-c66d147e7b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_ed8dc71a-5f0e-4d7f-8f18-fc2b03f9bd80" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ba81732e-78b2-41d3-8f12-c66d147e7b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ed5f7886-fe55-4b01-86e6-b1aea18fb258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ba81732e-78b2-41d3-8f12-c66d147e7b26" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ed5f7886-fe55-4b01-86e6-b1aea18fb258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_06b2d320-433c-434a-8e89-700a87775657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06b2d320-433c-434a-8e89-700a87775657" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_b988b25c-555a-4f4d-9f95-ef4e4a53a3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_b988b25c-555a-4f4d-9f95-ef4e4a53a3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_1f81f706-2acd-4c20-b76b-6c560c89bd33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_b988b25c-555a-4f4d-9f95-ef4e4a53a3c6" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_1f81f706-2acd-4c20-b76b-6c560c89bd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_d5e7d6b2-7ff0-4790-8fe9-72f2d55e5f33" xlink:href="rdnt-20220331.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_1f81f706-2acd-4c20-b76b-6c560c89bd33" xlink:to="loc_rdnt_COVID19PandemicMember_d5e7d6b2-7ff0-4790-8fe9-72f2d55e5f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b3008d0b-066a-4dc8-9a23-478738a91c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_DebtInstrumentAxis_b3008d0b-066a-4dc8-9a23-478738a91c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1969f011-37b8-443e-aa6a-34e29bd8b866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b3008d0b-066a-4dc8-9a23-478738a91c9b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1969f011-37b8-443e-aa6a-34e29bd8b866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_a7be3d82-0c62-4355-9acf-708f08897331" xlink:href="rdnt-20220331.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1969f011-37b8-443e-aa6a-34e29bd8b866" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_a7be3d82-0c62-4355-9acf-708f08897331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_ce575a56-a9a0-43ae-946e-6af2cd305a3e" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1969f011-37b8-443e-aa6a-34e29bd8b866" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_ce575a56-a9a0-43ae-946e-6af2cd305a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bf8b13bf-b8ea-47c1-8773-3395d9a4d58d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_srt_RangeAxis_bf8b13bf-b8ea-47c1-8773-3395d9a4d58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc1119e8-a7a8-402f-b00f-bca619bbbb31" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bf8b13bf-b8ea-47c1-8773-3395d9a4d58d" xlink:to="loc_srt_RangeMember_cc1119e8-a7a8-402f-b00f-bca619bbbb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d707b531-3395-46eb-a2f4-970bda14dd60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cc1119e8-a7a8-402f-b00f-bca619bbbb31" xlink:to="loc_srt_MinimumMember_d707b531-3395-46eb-a2f4-970bda14dd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_36507e78-e2f8-4654-bf93-ba11632c8551" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cc1119e8-a7a8-402f-b00f-bca619bbbb31" xlink:to="loc_srt_MaximumMember_36507e78-e2f8-4654-bf93-ba11632c8551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3161b45e-1fa3-4b1d-af8d-c22ecd8bc706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3161b45e-1fa3-4b1d-af8d-c22ecd8bc706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47e98f12-ce9c-4972-8979-9e46e22adadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3161b45e-1fa3-4b1d-af8d-c22ecd8bc706" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47e98f12-ce9c-4972-8979-9e46e22adadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember_b83949c9-6c3e-4cfe-9b09-3c388f4099b4" xlink:href="rdnt-20220331.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47e98f12-ce9c-4972-8979-9e46e22adadd" xlink:to="loc_rdnt_ProperyAndEquipmentNetMember_b83949c9-6c3e-4cfe-9b09-3c388f4099b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_fd3f534d-2537-4982-925a-cf0d891a99bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47e98f12-ce9c-4972-8979-9e46e22adadd" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_fd3f534d-2537-4982-925a-cf0d891a99bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4b3ef0b3-235c-46ea-813f-634b0b6e402a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_PlanNameAxis_4b3ef0b3-235c-46ea-813f-634b0b6e402a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6fd070b4-b92e-440f-a482-b93389b8fa34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_4b3ef0b3-235c-46ea-813f-634b0b6e402a" xlink:to="loc_us-gaap_PlanNameDomain_6fd070b4-b92e-440f-a482-b93389b8fa34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_8d90a727-4435-4f97-ba3c-1be742b5cbea" xlink:href="rdnt-20220331.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6fd070b4-b92e-440f-a482-b93389b8fa34" xlink:to="loc_rdnt_RestatedPlanMember_8d90a727-4435-4f97-ba3c-1be742b5cbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_68ddb746-922c-4ed2-9fe1-db022f178534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_68ddb746-922c-4ed2-9fe1-db022f178534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_6dfa53d1-8c18-4ead-bb37-61506fe8d1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_68ddb746-922c-4ed2-9fe1-db022f178534" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_6dfa53d1-8c18-4ead-bb37-61506fe8d1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_7e7ee4ec-2753-482b-9895-914cef0fd959" xlink:href="rdnt-20220331.xsd#rdnt_A2019SWAPSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_6dfa53d1-8c18-4ead-bb37-61506fe8d1ff" xlink:to="loc_rdnt_A2019SWAPSMember_7e7ee4ec-2753-482b-9895-914cef0fd959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_4687c2f0-3e6d-4dd0-8c97-ab0051224b10" xlink:href="rdnt-20220331.xsd#rdnt_A2019SWAPS1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_6dfa53d1-8c18-4ead-bb37-61506fe8d1ff" xlink:to="loc_rdnt_A2019SWAPS1Member_4687c2f0-3e6d-4dd0-8c97-ab0051224b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_80dab679-45ed-47c6-8b88-337316f660ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_80dab679-45ed-47c6-8b88-337316f660ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_bca07b64-6a15-4651-9894-3291e4bb8e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_80dab679-45ed-47c6-8b88-337316f660ba" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_bca07b64-6a15-4651-9894-3291e4bb8e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_5674a9c8-050a-4b49-a416-305d1d3c83aa" xlink:href="rdnt-20220331.xsd#rdnt_October2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_bca07b64-6a15-4651-9894-3291e4bb8e47" xlink:to="loc_rdnt_October2023Member_5674a9c8-050a-4b49-a416-305d1d3c83aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_99e8cc84-15a5-4943-8b45-2229bb6004c4" xlink:href="rdnt-20220331.xsd#rdnt_October2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_bca07b64-6a15-4651-9894-3291e4bb8e47" xlink:to="loc_rdnt_October2025Member_99e8cc84-15a5-4943-8b45-2229bb6004c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fa60426a-2905-4d7a-81e2-d0133772acc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fa60426a-2905-4d7a-81e2-d0133772acc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_07c0a416-7cce-4c57-bc19-9c37ecd0f801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fa60426a-2905-4d7a-81e2-d0133772acc6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_07c0a416-7cce-4c57-bc19-9c37ecd0f801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_01eed272-e4a5-49bc-8921-27dd49bf1a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_07c0a416-7cce-4c57-bc19-9c37ecd0f801" xlink:to="loc_us-gaap_InterestRateSwapMember_01eed272-e4a5-49bc-8921-27dd49bf1a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_01e0854e-2687-4461-b433-82dd53c74188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_VariableRateAxis_01e0854e-2687-4461-b433-82dd53c74188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c65fdecd-fde4-47b3-b465-5ec656a40492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_01e0854e-2687-4461-b433-82dd53c74188" xlink:to="loc_us-gaap_VariableRateDomain_c65fdecd-fde4-47b3-b465-5ec656a40492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_5e2409e8-26bc-4957-b1b5-13b18c68db40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c65fdecd-fde4-47b3-b465-5ec656a40492" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_5e2409e8-26bc-4957-b1b5-13b18c68db40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ffb1e653-a823-47e0-8f1e-bb00a20da01c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_srt_StatementScenarioAxis_ffb1e653-a823-47e0-8f1e-bb00a20da01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_da8b43d9-4779-4c43-be8d-16be02fec9ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_ffb1e653-a823-47e0-8f1e-bb00a20da01c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_da8b43d9-4779-4c43-be8d-16be02fec9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_879ea67c-e7ff-43f8-b160-334c9eef684f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_da8b43d9-4779-4c43-be8d-16be02fec9ea" xlink:to="loc_srt_ScenarioForecastMember_879ea67c-e7ff-43f8-b160-334c9eef684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4a122d4f-79dc-4f4e-bad5-8c194a31ba13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_CreditFacilityAxis_4a122d4f-79dc-4f4e-bad5-8c194a31ba13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6298937-b2ce-4b9d-916a-a7303b6b0cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4a122d4f-79dc-4f4e-bad5-8c194a31ba13" xlink:to="loc_us-gaap_CreditFacilityDomain_d6298937-b2ce-4b9d-916a-a7303b6b0cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d25f827e-01b9-43a1-9d55-f3e74b195dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d6298937-b2ce-4b9d-916a-a7303b6b0cae" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d25f827e-01b9-43a1-9d55-f3e74b195dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_4787df01-4bf5-4a3e-a017-f9786ac0aa68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_4787df01-4bf5-4a3e-a017-f9786ac0aa68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_782f8c93-f913-4d0e-9a04-b48b2b29a39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_4787df01-4bf5-4a3e-a017-f9786ac0aa68" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_782f8c93-f913-4d0e-9a04-b48b2b29a39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_584d6a24-2867-43d6-87f6-1ddab7e23865" xlink:href="rdnt-20220331.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_782f8c93-f913-4d0e-9a04-b48b2b29a39e" xlink:to="loc_rdnt_BarclaysMember_584d6a24-2867-43d6-87f6-1ddab7e23865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6eefd33f-4e36-4359-a369-d2f0e2fa4207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6eefd33f-4e36-4359-a369-d2f0e2fa4207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8f9676ea-de88-4306-a2d7-d79cb27a937a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6eefd33f-4e36-4359-a369-d2f0e2fa4207" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8f9676ea-de88-4306-a2d7-d79cb27a937a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d089dd2f-9d8b-40fa-8911-7573c6429f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8f9676ea-de88-4306-a2d7-d79cb27a937a" xlink:to="loc_us-gaap_LineOfCreditMember_d089dd2f-9d8b-40fa-8911-7573c6429f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1c3d6f48-3b0e-4cd8-bf88-045f8e61e440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1c3d6f48-3b0e-4cd8-bf88-045f8e61e440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06f0334b-df5e-4180-bdf7-883ad5fcf44f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1c3d6f48-3b0e-4cd8-bf88-045f8e61e440" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06f0334b-df5e-4180-bdf7-883ad5fcf44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_a960b7a5-d8ae-48af-a335-791d2ec21782" xlink:href="rdnt-20220331.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06f0334b-df5e-4180-bdf7-883ad5fcf44f" xlink:to="loc_rdnt_QuantibMember_a960b7a5-d8ae-48af-a335-791d2ec21782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_412c2ab2-7bce-44d3-9798-6ce7442abb66" xlink:href="rdnt-20220331.xsd#rdnt_AidenceHoldingBVAndQuantibBVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06f0334b-df5e-4180-bdf7-883ad5fcf44f" xlink:to="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_412c2ab2-7bce-44d3-9798-6ce7442abb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_658d9540-3af9-4ef5-9d14-d957512ff357" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_658d9540-3af9-4ef5-9d14-d957512ff357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_91e46695-83d7-44ec-b1f6-a82db52b76c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_658d9540-3af9-4ef5-9d14-d957512ff357" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_91e46695-83d7-44ec-b1f6-a82db52b76c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_11d9cbd5-d12d-4c8d-9b8c-e96b4e273be1" xlink:href="rdnt-20220331.xsd#rdnt_MedicVisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_91e46695-83d7-44ec-b1f6-a82db52b76c0" xlink:to="loc_rdnt_MedicVisionMember_11d9cbd5-d12d-4c8d-9b8c-e96b4e273be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_a3642115-f2cb-46d8-8772-5e97f45c2663" xlink:href="rdnt-20220331.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_91e46695-83d7-44ec-b1f6-a82db52b76c0" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_a3642115-f2cb-46d8-8772-5e97f45c2663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c34c029d-9859-4271-9fd9-ac43c3b9b4d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_srt_CounterpartyNameAxis_c34c029d-9859-4271-9fd9-ac43c3b9b4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e8b4e0b0-93c7-4259-ade3-5b0543af11df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_c34c029d-9859-4271-9fd9-ac43c3b9b4d9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e8b4e0b0-93c7-4259-ade3-5b0543af11df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_4dde5ac1-81e7-4fb6-a8db-de5b7deefd23" xlink:href="rdnt-20220331.xsd#rdnt_DignityHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e8b4e0b0-93c7-4259-ade3-5b0543af11df" xlink:to="loc_rdnt_DignityHealthMember_4dde5ac1-81e7-4fb6-a8db-de5b7deefd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dd14d4c8-c448-4b4a-b45d-e136eeeb1491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dd14d4c8-c448-4b4a-b45d-e136eeeb1491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_64cf8f81-8c36-4898-a2d9-77ab111569e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dd14d4c8-c448-4b4a-b45d-e136eeeb1491" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_64cf8f81-8c36-4898-a2d9-77ab111569e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_4764c3e8-7c57-46c6-bfe2-f85355c2ddc6" xlink:href="rdnt-20220331.xsd#rdnt_JointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_64cf8f81-8c36-4898-a2d9-77ab111569e5" xlink:to="loc_rdnt_JointVentureMember_4764c3e8-7c57-46c6-bfe2-f85355c2ddc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8e6731dd-eb5d-49ee-9e68-b58ed5df85ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_dei_LegalEntityAxis_8e6731dd-eb5d-49ee-9e68-b58ed5df85ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_05abf13c-8599-4a89-b0e9-5fab242a0ee4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8e6731dd-eb5d-49ee-9e68-b58ed5df85ae" xlink:to="loc_dei_EntityDomain_05abf13c-8599-4a89-b0e9-5fab242a0ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_e0781990-4e99-4c49-ae64-1156901f71b8" xlink:href="rdnt-20220331.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_05abf13c-8599-4a89-b0e9-5fab242a0ee4" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_e0781990-4e99-4c49-ae64-1156901f71b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1526dd46-c739-432c-93cb-085531734424" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_ca6256e3-79a6-4fdf-96d9-1a0dd1bd46a4" xlink:href="rdnt-20220331.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_AdvanceMedicarePayments_ca6256e3-79a6-4fdf-96d9-1a0dd1bd46a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans_b2fa0911-4349-4460-93f9-33654adc84bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLoans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_ProceedsFromLoans_b2fa0911-4349-4460-93f9-33654adc84bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_eb32b243-7cb9-4d2f-bbbd-10ef9030b524" xlink:href="rdnt-20220331.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_eb32b243-7cb9-4d2f-bbbd-10ef9030b524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments_22d65d96-1f36-4a3d-995b-2f2cd1ee4700" xlink:href="rdnt-20220331.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_RepaymentOfAdvanceMedicarePayments_22d65d96-1f36-4a3d-995b-2f2cd1ee4700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_7e8a089b-1e80-4569-9472-ddd884725d12" xlink:href="rdnt-20220331.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_7e8a089b-1e80-4569-9472-ddd884725d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage_87464db1-4e66-42fc-beca-32a3cefec3a8" xlink:href="rdnt-20220331.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_CaresActRefundableClaimPercentage_87464db1-4e66-42fc-beca-32a3cefec3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_71b29435-fa42-4067-9446-dfc8cb047bf8" xlink:href="rdnt-20220331.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_71b29435-fa42-4067-9446-dfc8cb047bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_1267ab95-f933-4946-b411-5078a43e4cff" xlink:href="rdnt-20220331.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_1267ab95-f933-4946-b411-5078a43e4cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_a917aaeb-1702-48f9-932a-2c86a30e5bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_a917aaeb-1702-48f9-932a-2c86a30e5bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e921fcd8-ee00-4d6a-8c36-4fdf62cc34f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e921fcd8-ee00-4d6a-8c36-4fdf62cc34f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_acc01d14-6383-4607-a37b-dbe0f1e940d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_Goodwill_acc01d14-6383-4607-a37b-dbe0f1e940d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_87c30b29-efa2-4495-9564-2e5f0934b92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_87c30b29-efa2-4495-9564-2e5f0934b92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b0110c10-f74e-45d8-9f5d-fc53e76b1153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b0110c10-f74e-45d8-9f5d-fc53e76b1153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9b0223d1-d54f-49bb-8d31-bda7ec44191c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9b0223d1-d54f-49bb-8d31-bda7ec44191c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_745e934c-308a-4eca-8a40-df22d736233c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_745e934c-308a-4eca-8a40-df22d736233c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_029c9fe2-8f24-47b0-ba14-7546329538d4" xlink:href="rdnt-20220331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_029c9fe2-8f24-47b0-ba14-7546329538d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_d95164bb-ff55-4e09-aa9d-083b7315cd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_d95164bb-ff55-4e09-aa9d-083b7315cd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_410b78bc-bc88-4152-af83-25f1625742a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_410b78bc-bc88-4152-af83-25f1625742a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_11ef8905-d3c1-466f-85a1-baa9cc6d4bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_11ef8905-d3c1-466f-85a1-baa9cc6d4bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_bf516d91-82eb-4449-a6b8-78c7e679fbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_bf516d91-82eb-4449-a6b8-78c7e679fbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_dd936aab-d2c3-4803-930a-9ab215a39567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_dd936aab-d2c3-4803-930a-9ab215a39567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_64ec9d7b-fe19-45e1-a6a7-f1591726e85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_64ec9d7b-fe19-45e1-a6a7-f1591726e85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_1addb169-7083-42fb-8dfb-62b669585b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_1addb169-7083-42fb-8dfb-62b669585b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_9b520694-4c95-4f23-953d-16bbee3caa51" xlink:href="rdnt-20220331.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_9b520694-4c95-4f23-953d-16bbee3caa51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_1d27644d-2aa2-4e3c-84a4-ffe8a1c4e59a" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_1d27644d-2aa2-4e3c-84a4-ffe8a1c4e59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_88c80b6b-e7bf-4509-8869-372a5f1c1030" xlink:href="rdnt-20220331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_88c80b6b-e7bf-4509-8869-372a5f1c1030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_bb8634f0-e8c4-450e-9bcf-405378471ed4" xlink:href="rdnt-20220331.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_bb8634f0-e8c4-450e-9bcf-405378471ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_6a6133b2-f31c-4049-828f-8e47cfb1abaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_SharePrice_6a6133b2-f31c-4049-828f-8e47cfb1abaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e1fbfea8-2572-441c-8305-fd6bce07606e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_LineOfCredit_e1fbfea8-2572-441c-8305-fd6bce07606e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_5b8fe284-4ab6-4790-83f5-73cb5a016c5d" xlink:href="rdnt-20220331.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities_5b8fe284-4ab6-4790-83f5-73cb5a016c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_65d8aeab-6d47-449d-942b-41f74f3020e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_65d8aeab-6d47-449d-942b-41f74f3020e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1ecd1bf2-351c-4b77-9014-c956cdb1d3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1ecd1bf2-351c-4b77-9014-c956cdb1d3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_66785405-f6cb-4698-aa05-48b1bbfff0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_66785405-f6cb-4698-aa05-48b1bbfff0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_3c172394-178a-43d1-81bd-d1cdce474079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_3c172394-178a-43d1-81bd-d1cdce474079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_d24713cb-336b-4878-bd5e-bfbba698add3" xlink:href="rdnt-20220331.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_d24713cb-336b-4878-bd5e-bfbba698add3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_67c062e0-9add-42c9-88c9-34d8a5556802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_67c062e0-9add-42c9-88c9-34d8a5556802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_bc483d42-d2ac-488b-afcb-4f9b518215be" xlink:href="rdnt-20220331.xsd#rdnt_ManagementServiceFees"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_704cf1da-c03f-49c0-93c6-88fc8879fb6e" xlink:to="loc_rdnt_ManagementServiceFees_bc483d42-d2ac-488b-afcb-4f9b518215be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_288ebea2-0ae7-4490-a927-3f307fc4b944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_fbea7e1c-1da6-4a07-8c2f-63450a7a986b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_288ebea2-0ae7-4490-a927-3f307fc4b944" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_fbea7e1c-1da6-4a07-8c2f-63450a7a986b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_20f42278-a466-422d-b7c3-ad45c2624aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_fbea7e1c-1da6-4a07-8c2f-63450a7a986b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_20f42278-a466-422d-b7c3-ad45c2624aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12e3b2d9-5d97-409b-8735-0aa0254ae7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_20f42278-a466-422d-b7c3-ad45c2624aca" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12e3b2d9-5d97-409b-8735-0aa0254ae7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember_e2ff8cc5-a42d-4f8d-af71-ecfa3070c1c3" xlink:href="rdnt-20220331.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12e3b2d9-5d97-409b-8735-0aa0254ae7ce" xlink:to="loc_rdnt_BusinessAcquisitionsMember_e2ff8cc5-a42d-4f8d-af71-ecfa3070c1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_c4db84a2-ca7d-4bce-ba5e-f8874b945325" xlink:href="rdnt-20220331.xsd#rdnt_AidenceHoldingBVAndQuantibBVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12e3b2d9-5d97-409b-8735-0aa0254ae7ce" xlink:to="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_c4db84a2-ca7d-4bce-ba5e-f8874b945325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_1e6bcecf-7fce-4b16-b128-6952088f5994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_fbea7e1c-1da6-4a07-8c2f-63450a7a986b" xlink:to="loc_us-gaap_GoodwillLineItems_1e6bcecf-7fce-4b16-b128-6952088f5994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1e6bcecf-7fce-4b16-b128-6952088f5994" xlink:to="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3563f806-d410-4750-8286-23ac9f7ae1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:to="loc_us-gaap_Goodwill_3563f806-d410-4750-8286-23ac9f7ae1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_957afadb-48ae-4f6a-9a55-ced84b66fda8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_957afadb-48ae-4f6a-9a55-ced84b66fda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_cfa37406-82e0-4bce-839a-e11c757b5e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_cfa37406-82e0-4bce-839a-e11c757b5e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_891f390f-999c-49f9-afad-4207682508a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_891f390f-999c-49f9-afad-4207682508a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0f345c6b-f336-4054-a482-e42e80c69a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7a6d9b40-548f-4eb1-b0a9-6e65f1d7c00e" xlink:to="loc_us-gaap_Goodwill_0f345c6b-f336-4054-a482-e42e80c69a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f7485892-7b24-40f0-a3f2-8854b7921d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f7485892-7b24-40f0-a3f2-8854b7921d53" xlink:to="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0a927420-5aa1-4e45-b363-d2c6c59fe2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0a927420-5aa1-4e45-b363-d2c6c59fe2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_99189698-3a8d-436c-ae58-3b767e3a1b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0a927420-5aa1-4e45-b363-d2c6c59fe2fe" xlink:to="loc_us-gaap_EquityComponentDomain_99189698-3a8d-436c-ae58-3b767e3a1b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f1f37d4a-88f2-4fc5-a45c-6f2471c57fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_99189698-3a8d-436c-ae58-3b767e3a1b3d" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f1f37d4a-88f2-4fc5-a45c-6f2471c57fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_884e38f0-4ca6-49e7-8a62-7c3834c25e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_884e38f0-4ca6-49e7-8a62-7c3834c25e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ff3e3e78-f636-4952-8933-008dc1d717b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_884e38f0-4ca6-49e7-8a62-7c3834c25e9f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ff3e3e78-f636-4952-8933-008dc1d717b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_e955d70d-9eb4-4349-a641-16967c4c2493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff3e3e78-f636-4952-8933-008dc1d717b8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_e955d70d-9eb4-4349-a641-16967c4c2493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_22c81242-dd00-4b5f-b84d-97307ee8a5de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff3e3e78-f636-4952-8933-008dc1d717b8" xlink:to="loc_us-gaap_InterestExpenseMember_22c81242-dd00-4b5f-b84d-97307ee8a5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_469beb6f-9972-4a03-8ce9-8395de679625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_469beb6f-9972-4a03-8ce9-8395de679625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_23f88e08-e7f7-4256-9743-216a4c219372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_469beb6f-9972-4a03-8ce9-8395de679625" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_23f88e08-e7f7-4256-9743-216a4c219372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c3f1b6ba-b071-43f3-8e4d-8bf1bb011553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_23f88e08-e7f7-4256-9743-216a4c219372" xlink:to="loc_us-gaap_InterestRateSwapMember_c3f1b6ba-b071-43f3-8e4d-8bf1bb011553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_c08a1e90-ab01-497f-b525-c497ffa51909" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58ef43a5-abaf-4591-8e54-b601b69dbeed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58ef43a5-abaf-4591-8e54-b601b69dbeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_23c90ae0-4bdf-4d5f-903c-fc96aa5bf165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_23c90ae0-4bdf-4d5f-903c-fc96aa5bf165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_69c299fa-eda1-417f-89a0-ee5bae5a9b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_69c299fa-eda1-417f-89a0-ee5bae5a9b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6f439622-421e-44d5-aeef-217eff007a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6f439622-421e-44d5-aeef-217eff007a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2e0cdb36-be50-45e7-9718-23444fccc2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0ed80e92-bf4b-4e14-94f1-5f3e0a7a10c7" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2e0cdb36-be50-45e7-9718-23444fccc2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_042f34eb-a01c-4857-bf50-0d18e89f0b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c53bf5f3-0ffe-47fd-930f-bae0d4979ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_042f34eb-a01c-4857-bf50-0d18e89f0b57" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c53bf5f3-0ffe-47fd-930f-bae0d4979ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cf0939bc-fab5-43c5-9bb3-7482771b49a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c53bf5f3-0ffe-47fd-930f-bae0d4979ab9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cf0939bc-fab5-43c5-9bb3-7482771b49a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecb3f70b-c925-4099-8eb8-8322c627933b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cf0939bc-fab5-43c5-9bb3-7482771b49a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecb3f70b-c925-4099-8eb8-8322c627933b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_d14996e5-1eb6-44fe-8724-96029eab2837" xlink:href="rdnt-20220331.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecb3f70b-c925-4099-8eb8-8322c627933b" xlink:to="loc_rdnt_QuantibMember_d14996e5-1eb6-44fe-8724-96029eab2837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3e984d24-5f7b-4c0f-9173-4fdf287f0019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c53bf5f3-0ffe-47fd-930f-bae0d4979ab9" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3e984d24-5f7b-4c0f-9173-4fdf287f0019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_da88a623-026a-49da-9021-ef4c16e3ca35" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e984d24-5f7b-4c0f-9173-4fdf287f0019" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_da88a623-026a-49da-9021-ef4c16e3ca35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7f7274da-3b8e-4535-bbc8-2e45c633025a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_da88a623-026a-49da-9021-ef4c16e3ca35" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7f7274da-3b8e-4535-bbc8-2e45c633025a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_31b25c06-fe78-4fa2-be2a-0a765b6ed4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_da88a623-026a-49da-9021-ef4c16e3ca35" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_31b25c06-fe78-4fa2-be2a-0a765b6ed4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b0c62f57-780f-4ed9-a9e8-d9af2b769008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward_da88a623-026a-49da-9021-ef4c16e3ca35" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b0c62f57-780f-4ed9-a9e8-d9af2b769008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_56dda0b4-e418-4432-bfa0-c20d0b5d6a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56dda0b4-e418-4432-bfa0-c20d0b5d6a24" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5f17527e-989e-4ce4-a7ac-484b60ff2cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5f17527e-989e-4ce4-a7ac-484b60ff2cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c1e3ea55-6bbe-4e27-9d36-378aa66d3849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5f17527e-989e-4ce4-a7ac-484b60ff2cff" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c1e3ea55-6bbe-4e27-9d36-378aa66d3849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c51cd6b0-5730-4a90-9c38-87b2170fa296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c1e3ea55-6bbe-4e27-9d36-378aa66d3849" xlink:to="loc_us-gaap_InterestRateSwapMember_c51cd6b0-5730-4a90-9c38-87b2170fa296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_25c58ff1-d06c-45eb-8f4d-359721c66d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_25c58ff1-d06c-45eb-8f4d-359721c66d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_10f6254c-2a08-4d5b-9c2c-758ff086e125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_25c58ff1-d06c-45eb-8f4d-359721c66d56" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_10f6254c-2a08-4d5b-9c2c-758ff086e125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_2b56f605-a6ea-4737-9e09-92b00e734db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_10f6254c-2a08-4d5b-9c2c-758ff086e125" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_2b56f605-a6ea-4737-9e09-92b00e734db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f6d5eddb-1d17-4c41-9c09-0bcef8441cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_2b56f605-a6ea-4737-9e09-92b00e734db3" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f6d5eddb-1d17-4c41-9c09-0bcef8441cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fd01fe05-478f-4e3e-8486-f692287b8799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fd01fe05-478f-4e3e-8486-f692287b8799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61c022f3-c508-4e08-bdad-7ea123297c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fd01fe05-478f-4e3e-8486-f692287b8799" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61c022f3-c508-4e08-bdad-7ea123297c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7fa6ed4b-66dd-4aa4-9018-d672cb4df9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61c022f3-c508-4e08-bdad-7ea123297c6c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7fa6ed4b-66dd-4aa4-9018-d672cb4df9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f91e509a-ca4c-443b-a3b4-e922cf84020f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61c022f3-c508-4e08-bdad-7ea123297c6c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f91e509a-ca4c-443b-a3b4-e922cf84020f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_87837744-12e5-41e7-adaf-47c973168069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61c022f3-c508-4e08-bdad-7ea123297c6c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_87837744-12e5-41e7-adaf-47c973168069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_67bfb462-f9b6-4701-b4f4-e39d8dddbd83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_67bfb462-f9b6-4701-b4f4-e39d8dddbd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0027a946-3421-4cb2-9bac-25f1baddd350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67bfb462-f9b6-4701-b4f4-e39d8dddbd83" xlink:to="loc_us-gaap_EquityComponentDomain_0027a946-3421-4cb2-9bac-25f1baddd350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2c086b5e-db00-40a4-b9e6-631bd88f34aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0027a946-3421-4cb2-9bac-25f1baddd350" xlink:to="loc_us-gaap_CommonStockMember_2c086b5e-db00-40a4-b9e6-631bd88f34aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c8f4cee6-0eaf-4c15-9ef4-06c7e3964f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c741b7-bd8f-4f86-954b-2c4ee712f771" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c8f4cee6-0eaf-4c15-9ef4-06c7e3964f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_e5ab3ef7-5de4-49ac-9e82-c5d11e2088fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c8f4cee6-0eaf-4c15-9ef4-06c7e3964f98" xlink:to="loc_us-gaap_DerivativeAssets_e5ab3ef7-5de4-49ac-9e82-c5d11e2088fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2d9cdb30-6b5f-4b2f-bfd1-9513711527b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c8f4cee6-0eaf-4c15-9ef4-06c7e3964f98" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2d9cdb30-6b5f-4b2f-bfd1-9513711527b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_c979159f-b47d-4241-bf84-e02802ba9f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c8f4cee6-0eaf-4c15-9ef4-06c7e3964f98" xlink:to="loc_us-gaap_DebtInstrumentFairValue_c979159f-b47d-4241-bf84-e02802ba9f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3b9789c1-f7e4-42b7-a80d-510d20b5f91e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d075223e-d492-4c82-9929-887f619239b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3b9789c1-f7e4-42b7-a80d-510d20b5f91e" xlink:to="loc_us-gaap_NetIncomeLoss_d075223e-d492-4c82-9929-887f619239b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_bc92443d-5e9a-4f5d-9824-de841ff8cd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3b9789c1-f7e4-42b7-a80d-510d20b5f91e" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_bc92443d-5e9a-4f5d-9824-de841ff8cd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6b8143a6-b2b0-4dfe-93e1-03d2130e5ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_bc92443d-5e9a-4f5d-9824-de841ff8cd36" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6b8143a6-b2b0-4dfe-93e1-03d2130e5ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4f274094-0fa9-46ef-a8ea-0f83aa5b9862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_bc92443d-5e9a-4f5d-9824-de841ff8cd36" xlink:to="loc_us-gaap_EarningsPerShareBasic_4f274094-0fa9-46ef-a8ea-0f83aa5b9862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_16ad1fca-7b26-4ff4-95c3-b6cee4a0e90c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_bc92443d-5e9a-4f5d-9824-de841ff8cd36" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_16ad1fca-7b26-4ff4-95c3-b6cee4a0e90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_5cee2732-b77b-4abb-8a06-3ba4c713b139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_bc92443d-5e9a-4f5d-9824-de841ff8cd36" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_5cee2732-b77b-4abb-8a06-3ba4c713b139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_59caeb94-9b4d-4b9c-9e63-d49606e89c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_bc92443d-5e9a-4f5d-9824-de841ff8cd36" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_59caeb94-9b4d-4b9c-9e63-d49606e89c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_817b8b25-b7b0-43fb-945a-ded87e79eed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_bc92443d-5e9a-4f5d-9824-de841ff8cd36" xlink:to="loc_us-gaap_EarningsPerShareDiluted_817b8b25-b7b0-43fb-945a-ded87e79eed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3e1fabda-bfa5-46f1-a03b-16c02fbd8958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3b9789c1-f7e4-42b7-a80d-510d20b5f91e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3e1fabda-bfa5-46f1-a03b-16c02fbd8958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_de797b1f-12f5-44c5-a4f4-5a3d06c5db07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3e1fabda-bfa5-46f1-a03b-16c02fbd8958" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_de797b1f-12f5-44c5-a4f4-5a3d06c5db07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0379c1f9-b659-4898-9492-5eca1c848e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_de797b1f-12f5-44c5-a4f4-5a3d06c5db07" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0379c1f9-b659-4898-9492-5eca1c848e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8893c193-dbd0-4442-b0de-bc65b1168be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0379c1f9-b659-4898-9492-5eca1c848e63" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8893c193-dbd0-4442-b0de-bc65b1168be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_601856f9-ca2a-46ba-a295-0d8001e7988b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3e1fabda-bfa5-46f1-a03b-16c02fbd8958" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_601856f9-ca2a-46ba-a295-0d8001e7988b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d0a401a8-1924-4191-a063-4df95446cdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_601856f9-ca2a-46ba-a295-0d8001e7988b" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d0a401a8-1924-4191-a063-4df95446cdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40185192-9473-4bba-b859-940d90e44ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d0a401a8-1924-4191-a063-4df95446cdbd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40185192-9473-4bba-b859-940d90e44ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6bc4d066-1397-480b-ab41-1ed28fca9831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50a92d26-ae8b-4184-baad-4da93ff3efcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6bc4d066-1397-480b-ab41-1ed28fca9831" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50a92d26-ae8b-4184-baad-4da93ff3efcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_750508b7-414d-4bc2-b8ea-3d326774b6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50a92d26-ae8b-4184-baad-4da93ff3efcc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_750508b7-414d-4bc2-b8ea-3d326774b6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4bbcf22-3c37-4521-8cf9-e227a976994e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_750508b7-414d-4bc2-b8ea-3d326774b6fc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4bbcf22-3c37-4521-8cf9-e227a976994e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCMember_58a80032-b67e-40ea-b460-1f3ab6e98123" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4bbcf22-3c37-4521-8cf9-e227a976994e" xlink:to="loc_rdnt_IFRCLLCMember_58a80032-b67e-40ea-b460-1f3ab6e98123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCAcquisitionsMember_0e171a16-7717-4eb0-b87b-d044add231cb" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLCAcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d4bbcf22-3c37-4521-8cf9-e227a976994e" xlink:to="loc_rdnt_IFRCLLCAcquisitionsMember_0e171a16-7717-4eb0-b87b-d044add231cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50a92d26-ae8b-4184-baad-4da93ff3efcc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d1c6d47-d98d-4bc1-85ab-d43a0f90207a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d1c6d47-d98d-4bc1-85ab-d43a0f90207a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4dd37faa-4581-4590-a1d9-04c56d9e3126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4dd37faa-4581-4590-a1d9-04c56d9e3126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_86a26c62-b5ab-40da-b3ff-e28353f01c32" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_86a26c62-b5ab-40da-b3ff-e28353f01c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_39f05eff-fa53-469f-ac2d-c567604efdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_us-gaap_Goodwill_39f05eff-fa53-469f-ac2d-c567604efdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_59953e76-b7a6-4403-8d5e-95c24e034964" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_59953e76-b7a6-4403-8d5e-95c24e034964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_a58fcabd-bbae-4f95-876b-4f5f7130dee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49288988-13f2-4d20-af9b-e2e68dc7b62c" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_a58fcabd-bbae-4f95-876b-4f5f7130dee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f3fccd12-b8a2-4f52-8761-fea57bae7789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_1e8b829b-62a5-4ae4-b0b6-3feb3b87a417" xlink:href="rdnt-20220331.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3fccd12-b8a2-4f52-8761-fea57bae7789" xlink:to="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_1e8b829b-62a5-4ae4-b0b6-3feb3b87a417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_582dbf9d-7e66-48b6-9801-928f596308ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_1e8b829b-62a5-4ae4-b0b6-3feb3b87a417" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_582dbf9d-7e66-48b6-9801-928f596308ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_693a457d-8d33-428b-920b-34001f995e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_1e8b829b-62a5-4ae4-b0b6-3feb3b87a417" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_693a457d-8d33-428b-920b-34001f995e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c8f9ebf1-d7c6-4631-9be4-cfea1fb66ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_1e8b829b-62a5-4ae4-b0b6-3feb3b87a417" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c8f9ebf1-d7c6-4631-9be4-cfea1fb66ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f7edc8ca-e396-4530-b9e6-35b7b4f178fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_24e3f5e5-f85c-4bd7-b3a4-2e7eb46e862e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f7edc8ca-e396-4530-b9e6-35b7b4f178fd" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_24e3f5e5-f85c-4bd7-b3a4-2e7eb46e862e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0f47839b-3fed-4bf5-9ad4-f00d1d77031e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_24e3f5e5-f85c-4bd7-b3a4-2e7eb46e862e" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0f47839b-3fed-4bf5-9ad4-f00d1d77031e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_6cf95a20-1368-411b-8586-06c575827b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0f47839b-3fed-4bf5-9ad4-f00d1d77031e" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_6cf95a20-1368-411b-8586-06c575827b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_fd0ca2e0-b8fc-445a-8b17-06e5ed9a5be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_6cf95a20-1368-411b-8586-06c575827b66" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_fd0ca2e0-b8fc-445a-8b17-06e5ed9a5be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_24e3f5e5-f85c-4bd7-b3a4-2e7eb46e862e" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fbfbcd00-6785-4d17-886e-a2b00a844200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_AssetsCurrent_fbfbcd00-6785-4d17-886e-a2b00a844200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_5f18d99e-7e9f-4f17-8a80-d83f15e81bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_AssetsNoncurrent_5f18d99e-7e9f-4f17-8a80-d83f15e81bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_651207f9-c55f-4e1c-8ea7-f2d6b384f7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_LiabilitiesCurrent_651207f9-c55f-4e1c-8ea7-f2d6b384f7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_9c99603f-6d89-4bda-a91d-23e8c22be16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_9c99603f-6d89-4bda-a91d-23e8c22be16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_7fd63306-db6b-4171-a700-58134f923d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_7fd63306-db6b-4171-a700-58134f923d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_54df15e0-c5ce-4f14-8c1a-7991bae47654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_EquityMethodInvestments_54df15e0-c5ce-4f14-8c1a-7991bae47654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_79c62385-ca03-4f4e-be89-c05457a08a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_79c62385-ca03-4f4e-be89-c05457a08a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_3088283c-7b42-4f8b-a740-8b6a22a0ecf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_3088283c-7b42-4f8b-a740-8b6a22a0ecf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_193e4723-d11a-44cf-87f5-2bda01124b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_Revenues_193e4723-d11a-44cf-87f5-2bda01124b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6d916c24-7d38-46a7-a7c1-435a8841a303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_99d18ea6-659f-4838-81d5-0b4a8a8dce50" xlink:to="loc_us-gaap_ProfitLoss_6d916c24-7d38-46a7-a7c1-435a8841a303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD" xlink:type="simple" xlink:href="rdnt-20220331.xsd#RECENTACCOUNTINGANDREPORTINGSTANDARD"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_cc84240e-e536-471d-8788-3d51edbed7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_363c29d9-2663-49fc-93f7-de1e4ebab7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_cc84240e-e536-471d-8788-3d51edbed7f7" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_363c29d9-2663-49fc-93f7-de1e4ebab7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY" xlink:type="simple" xlink:href="rdnt-20220331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c86edd07-4d18-4382-9c02-59599eedfe1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_2c64af4d-ed6d-4bed-8df6-ad8248268f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c86edd07-4d18-4382-9c02-59599eedfe1c" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_2c64af4d-ed6d-4bed-8df6-ad8248268f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" xlink:type="simple" xlink:href="rdnt-20220331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_be26e45f-0545-4fc5-97e7-b80da735ce1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_46da62f4-6702-44ac-a903-311ab60e5b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_be26e45f-0545-4fc5-97e7-b80da735ce1e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_46da62f4-6702-44ac-a903-311ab60e5b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20220331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fc222624-1cc0-4a50-9527-9a1318d88ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85df6b4c-65cf-4df8-b1b1-6e871cbc14f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fc222624-1cc0-4a50-9527-9a1318d88ffb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85df6b4c-65cf-4df8-b1b1-6e871cbc14f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8082a522-5be6-4db5-b5dc-2b966544df3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85df6b4c-65cf-4df8-b1b1-6e871cbc14f1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8082a522-5be6-4db5-b5dc-2b966544df3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14607d17-fd0e-40f9-a93b-a7602dca5aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8082a522-5be6-4db5-b5dc-2b966544df3c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14607d17-fd0e-40f9-a93b-a7602dca5aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCAcquisitionsMember_56b8485e-31b9-4072-a95f-2403cab443c2" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLCAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14607d17-fd0e-40f9-a93b-a7602dca5aa4" xlink:to="loc_rdnt_IFRCLLCAcquisitionsMember_56b8485e-31b9-4072-a95f-2403cab443c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLC1Member_8c5a63d6-c785-45d7-af91-59bbda1c27ce" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLC1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_IFRCLLCAcquisitionsMember_56b8485e-31b9-4072-a95f-2403cab443c2" xlink:to="loc_rdnt_IFRCLLC1Member_8c5a63d6-c785-45d7-af91-59bbda1c27ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLC2Member_1f5d5b96-f8a5-4676-8641-76b9ec1d950c" xlink:href="rdnt-20220331.xsd#rdnt_IFRCLLC2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_IFRCLLCAcquisitionsMember_56b8485e-31b9-4072-a95f-2403cab443c2" xlink:to="loc_rdnt_IFRCLLC2Member_1f5d5b96-f8a5-4676-8641-76b9ec1d950c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_85df6b4c-65cf-4df8-b1b1-6e871cbc14f1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fa9098c0-82ff-4753-ae62-6495d7082f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fa9098c0-82ff-4753-ae62-6495d7082f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cc5d10d9-d2e2-40cb-aff5-20337e414fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cc5d10d9-d2e2-40cb-aff5-20337e414fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_7fcd6413-8db7-4336-af28-bd2affe4eeb8" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_7fcd6413-8db7-4336-af28-bd2affe4eeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ca91e80e-0505-4c54-8942-c500a4cb4ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_us-gaap_Goodwill_ca91e80e-0505-4c54-8942-c500a4cb4ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_0c62e606-c91c-4d9d-9235-1f90679a4983" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_0c62e606-c91c-4d9d-9235-1f90679a4983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_2d132a4c-3303-4093-8d06-b71cf47a9b09" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_2d132a4c-3303-4093-8d06-b71cf47a9b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_1d73fa73-1793-4fd0-a325-d224291f1f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e44ff66d-0135-4e34-b4d0-42f342925ebc" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_1d73fa73-1793-4fd0-a325-d224291f1f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d6c0e3e1-69b5-4a23-b9d6-237e8004bc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d6c0e3e1-69b5-4a23-b9d6-237e8004bc85" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b494f2c0-0c00-4242-ba2b-b9cdd27e2e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b494f2c0-0c00-4242-ba2b-b9cdd27e2e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50d6b7dc-d4c6-4c45-896e-b32e9c126e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b494f2c0-0c00-4242-ba2b-b9cdd27e2e16" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50d6b7dc-d4c6-4c45-896e-b32e9c126e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_e0b018e6-bc33-498a-93af-b0b1dd54a51d" xlink:href="rdnt-20220331.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50d6b7dc-d4c6-4c45-896e-b32e9c126e43" xlink:to="loc_rdnt_AidenceMember_e0b018e6-bc33-498a-93af-b0b1dd54a51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_e2264fb2-7f4e-4b7b-8dcd-ebb6802c328c" xlink:href="rdnt-20220331.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50d6b7dc-d4c6-4c45-896e-b32e9c126e43" xlink:to="loc_rdnt_QuantibMember_e2264fb2-7f4e-4b7b-8dcd-ebb6802c328c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_bf92a9d9-c570-4467-b3ee-6401453786d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:to="loc_srt_CounterpartyNameAxis_bf92a9d9-c570-4467-b3ee-6401453786d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8038c35b-b45d-48d5-a823-a2661dc57310" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_bf92a9d9-c570-4467-b3ee-6401453786d4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8038c35b-b45d-48d5-a823-a2661dc57310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CertainSellerMember_282d4e32-c9b5-48cf-a34c-4a27233a4040" xlink:href="rdnt-20220331.xsd#rdnt_CertainSellerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8038c35b-b45d-48d5-a823-a2661dc57310" xlink:to="loc_rdnt_CertainSellerMember_282d4e32-c9b5-48cf-a34c-4a27233a4040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OtherSellersMember_0947b3a4-3165-4197-9d3f-a0a446b0c7c0" xlink:href="rdnt-20220331.xsd#rdnt_OtherSellersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8038c35b-b45d-48d5-a823-a2661dc57310" xlink:to="loc_rdnt_OtherSellersMember_0947b3a4-3165-4197-9d3f-a0a446b0c7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_deb3476b-a50f-4ab7-8d87-21d87e1c8897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_deb3476b-a50f-4ab7-8d87-21d87e1c8897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a4546f63-1401-4a2a-9a17-4b077ec25e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_deb3476b-a50f-4ab7-8d87-21d87e1c8897" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a4546f63-1401-4a2a-9a17-4b077ec25e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_f4e6f3e9-1496-4f09-b3c8-688503b41c96" xlink:href="rdnt-20220331.xsd#rdnt_CashHoldbackMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_a4546f63-1401-4a2a-9a17-4b077ec25e4b" xlink:to="loc_rdnt_CashHoldbackMember_f4e6f3e9-1496-4f09-b3c8-688503b41c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_483765a4-2895-4e0b-a6e3-0fab037e4c56" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2e0d767a-63df-4a65-b07c-18710f81c14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2e0d767a-63df-4a65-b07c-18710f81c14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_12b05854-502a-46bf-bf62-13108f655db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_12b05854-502a-46bf-bf62-13108f655db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_9378e558-c04f-4a87-afc9-52c55b142825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_9378e558-c04f-4a87-afc9-52c55b142825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_906158b6-9286-448a-b111-b0b9766e64f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_906158b6-9286-448a-b111-b0b9766e64f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c0847a21-62a3-4405-80e0-0fc568c84e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c0847a21-62a3-4405-80e0-0fc568c84e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_04f9096c-026a-49f8-acc0-ad2ab69a5aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_04f9096c-026a-49f8-acc0-ad2ab69a5aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c9dfbd1e-2f22-4017-a38d-340fa16ee23a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c9dfbd1e-2f22-4017-a38d-340fa16ee23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_6ef73a15-a9d5-4ec2-968b-c0d2f95f0bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_6ef73a15-a9d5-4ec2-968b-c0d2f95f0bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_22aea4d1-3208-4e84-a08d-8caa4fa839aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_22aea4d1-3208-4e84-a08d-8caa4fa839aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_73ad71fb-9565-4b8b-b3d3-9dd16085529a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_73ad71fb-9565-4b8b-b3d3-9dd16085529a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eca3f16b-6215-4b68-aa9f-43e39f832707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eca3f16b-6215-4b68-aa9f-43e39f832707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_f5392a89-e23e-4043-8d95-4f49988f0fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_f5392a89-e23e-4043-8d95-4f49988f0fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_79e7cde7-84dd-46fb-8896-73c4505b2ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_us-gaap_Goodwill_79e7cde7-84dd-46fb-8896-73c4505b2ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_c1a4808f-b020-441d-b18f-b8f401e0e846" xlink:href="rdnt-20220331.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_57c5e1a3-42d4-467d-8a76-0d3b7e43a43f" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_c1a4808f-b020-441d-b18f-b8f401e0e846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTING" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SEGMENTREPORTING"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a48eb8df-92e6-4194-bc02-b6f7ad39e8be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_df1f5a61-a605-4d4c-aeac-132ac39786b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a48eb8df-92e6-4194-bc02-b6f7ad39e8be" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_df1f5a61-a605-4d4c-aeac-132ac39786b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGTables" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SEGMENTREPORTINGTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_07eaebf4-51f8-451a-bdf6-50939747fd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_81166f46-9016-46c2-b9b3-6b7b9edce4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_07eaebf4-51f8-451a-bdf6-50939747fd3c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_81166f46-9016-46c2-b9b3-6b7b9edce4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SEGMENTREPORTINGDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4ab98466-c9bb-4609-ba70-f3a1febeb731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d081c3fc-108a-4026-a603-754ddb5ca59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4ab98466-c9bb-4609-ba70-f3a1febeb731" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d081c3fc-108a-4026-a603-754ddb5ca59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_abb18ca6-8cdf-4979-8f0e-b0449ec2c0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d081c3fc-108a-4026-a603-754ddb5ca59d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_abb18ca6-8cdf-4979-8f0e-b0449ec2c0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3c830565-b007-4137-baa0-b92184023775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_abb18ca6-8cdf-4979-8f0e-b0449ec2c0d5" xlink:to="loc_us-gaap_SegmentDomain_3c830565-b007-4137-baa0-b92184023775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_0baac765-e865-4e6a-8898-ae5fee066056" xlink:href="rdnt-20220331.xsd#rdnt_ImagingCentersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3c830565-b007-4137-baa0-b92184023775" xlink:to="loc_rdnt_ImagingCentersMember_0baac765-e865-4e6a-8898-ae5fee066056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_ebb95030-17ae-4010-938a-4269a6948dc5" xlink:href="rdnt-20220331.xsd#rdnt_AIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3c830565-b007-4137-baa0-b92184023775" xlink:to="loc_rdnt_AIMember_ebb95030-17ae-4010-938a-4269a6948dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_029d8459-f95d-4e8f-a646-2bc74df3198f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d081c3fc-108a-4026-a603-754ddb5ca59d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_029d8459-f95d-4e8f-a646-2bc74df3198f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_22198f26-9606-4cf3-b84a-f8a47b1d1d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_029d8459-f95d-4e8f-a646-2bc74df3198f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_22198f26-9606-4cf3-b84a-f8a47b1d1d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_c2651d03-9997-4b85-b644-82b594d0caa0" xlink:href="rdnt-20220331.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_22198f26-9606-4cf3-b84a-f8a47b1d1d96" xlink:to="loc_rdnt_COVID19PandemicMember_c2651d03-9997-4b85-b644-82b594d0caa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d081c3fc-108a-4026-a603-754ddb5ca59d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_16492983-2052-45ce-bd96-388a2c380ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_Revenues_16492983-2052-45ce-bd96-388a2c380ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_f4c3c4fa-1d65-4c04-951e-348181b0d6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_f4c3c4fa-1d65-4c04-951e-348181b0d6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e0c5ec93-b7f9-4634-8995-8be73f36f39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e0c5ec93-b7f9-4634-8995-8be73f36f39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_e58f251c-3a51-448c-8a29-c61373a0a401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_e58f251c-3a51-448c-8a29-c61373a0a401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_f5bced7e-4258-43d2-8e59-afef5d16e990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_us-gaap_SeveranceCosts1_f5bced7e-4258-43d2-8e59-afef5d16e990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_a872991d-0abb-4d67-a0c5-44165e053337" xlink:href="rdnt-20220331.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_a872991d-0abb-4d67-a0c5-44165e053337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_a7001da0-fc66-4c59-b5f4-59efd66a0133" xlink:href="rdnt-20220331.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bda5410f-5dcd-44c4-bb85-80c0ec54ba8e" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_a7001da0-fc66-4c59-b5f4-59efd66a0133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITIESANDNOTESPAYABLE"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c621d7e8-b39e-43e1-98b2-ac36ef166909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_168095c9-466a-4e8e-af35-15c764f9ada6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c621d7e8-b39e-43e1-98b2-ac36ef166909" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_168095c9-466a-4e8e-af35-15c764f9ada6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITYANDNOTESPAYABLETables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9b2b078f-bb85-4db9-9f5f-4b228f0f46b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_2a7bd38d-0c54-4961-9276-ec3a944577a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9b2b078f-bb85-4db9-9f5f-4b228f0f46b7" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_2a7bd38d-0c54-4961-9276-ec3a944577a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_aebc3006-1ada-40ae-8fd3-7be6888647f7" xlink:href="rdnt-20220331.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9b2b078f-bb85-4db9-9f5f-4b228f0f46b7" xlink:to="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_aebc3006-1ada-40ae-8fd3-7be6888647f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2842a363-4823-4c71-9abe-280000cfb574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2a39e8e3-83d3-4051-9170-37e56dfc575b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2842a363-4823-4c71-9abe-280000cfb574" xlink:to="loc_us-gaap_DebtInstrumentTable_2a39e8e3-83d3-4051-9170-37e56dfc575b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fac26bae-53b6-4913-a4af-f8a3b62fdaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2a39e8e3-83d3-4051-9170-37e56dfc575b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fac26bae-53b6-4913-a4af-f8a3b62fdaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1705876b-ddc6-4bf2-81ee-ce8220f7bd09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fac26bae-53b6-4913-a4af-f8a3b62fdaa3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1705876b-ddc6-4bf2-81ee-ce8220f7bd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_4eb134b1-aeab-426a-b4b1-cebe39a75b42" xlink:href="rdnt-20220331.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1705876b-ddc6-4bf2-81ee-ce8220f7bd09" xlink:to="loc_rdnt_TermLoanMember_4eb134b1-aeab-426a-b4b1-cebe39a75b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9a441ea6-ff67-4a1c-bec1-03d3d79e8b12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2a39e8e3-83d3-4051-9170-37e56dfc575b" xlink:to="loc_us-gaap_DebtInstrumentAxis_9a441ea6-ff67-4a1c-bec1-03d3d79e8b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95ff090f-0742-40cb-8f7c-dabb60212e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9a441ea6-ff67-4a1c-bec1-03d3d79e8b12" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95ff090f-0742-40cb-8f7c-dabb60212e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_af04b4ef-8618-4e85-897f-c98a6dc94477" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95ff090f-0742-40cb-8f7c-dabb60212e14" xlink:to="loc_rdnt_FirstLienTermLoanMember_af04b4ef-8618-4e85-897f-c98a6dc94477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_f725b364-cd1b-4886-a558-21ca21b6c369" xlink:href="rdnt-20220331.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95ff090f-0742-40cb-8f7c-dabb60212e14" xlink:to="loc_rdnt_RestatedAgreementMember_f725b364-cd1b-4886-a558-21ca21b6c369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2a39e8e3-83d3-4051-9170-37e56dfc575b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_41089ab1-5559-4f6b-8c45-c7f0837f1aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:to="loc_us-gaap_LongTermDebt_41089ab1-5559-4f6b-8c45-c7f0837f1aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_bffab436-a5e6-4378-9eec-6192dd3fed86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_bffab436-a5e6-4378-9eec-6192dd3fed86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8ef8aa1d-b7af-40d4-a1f7-8e6a9ebd1e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:to="loc_us-gaap_LongTermDebt_8ef8aa1d-b7af-40d4-a1f7-8e6a9ebd1e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3a961337-6f83-4509-9763-e8f962e0bae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:to="loc_us-gaap_LongTermDebtCurrent_3a961337-6f83-4509-9763-e8f962e0bae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b8f26e9d-9056-4ad7-ad6d-908d505d4735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_883731b4-37f4-4de2-84d7-a8f6729b2bdb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b8f26e9d-9056-4ad7-ad6d-908d505d4735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c30b2ace-0f65-41d7-a0be-8a5249a659cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c30b2ace-0f65-41d7-a0be-8a5249a659cf" xlink:to="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_79a1c075-54b1-49ca-af6e-9ca8911e8335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_CreditFacilityAxis_79a1c075-54b1-49ca-af6e-9ca8911e8335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8267301c-58fc-409e-babf-e9fb03600bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_79a1c075-54b1-49ca-af6e-9ca8911e8335" xlink:to="loc_us-gaap_CreditFacilityDomain_8267301c-58fc-409e-babf-e9fb03600bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e61f3255-731a-4027-bb55-9dc40248f166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8267301c-58fc-409e-babf-e9fb03600bb1" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e61f3255-731a-4027-bb55-9dc40248f166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_7fed1fe4-afc1-428a-94fc-f98d3041f870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8267301c-58fc-409e-babf-e9fb03600bb1" xlink:to="loc_us-gaap_LetterOfCreditMember_7fed1fe4-afc1-428a-94fc-f98d3041f870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ccec444f-f819-4844-bd66-f89883b50af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_DebtInstrumentAxis_ccec444f-f819-4844-bd66-f89883b50af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ccec444f-f819-4844-bd66-f89883b50af9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_30fcf78e-794b-44a4-8bdb-602c5b927688" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_30fcf78e-794b-44a4-8bdb-602c5b927688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_879d5a91-560b-40c9-8153-542a9b014469" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_879d5a91-560b-40c9-8153-542a9b014469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_3311bfdc-1e0b-43d0-94bd-137226d8af09" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_3311bfdc-1e0b-43d0-94bd-137226d8af09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_bd4df2c5-8ec9-4329-98d3-560bb2b1b356" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:to="loc_rdnt_FirstLienTermLoanMember_bd4df2c5-8ec9-4329-98d3-560bb2b1b356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_870d5351-3481-4d03-8e14-4005378c864d" xlink:href="rdnt-20220331.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb7d1e2d-4e06-4c77-baf2-83e97ffe2f5d" xlink:to="loc_rdnt_RestatedAgreementMember_870d5351-3481-4d03-8e14-4005378c864d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_9d293cd9-5199-4125-9682-8d70d3579a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_9d293cd9-5199-4125-9682-8d70d3579a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_38356050-a513-4998-9e83-96f1a403e8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_9d293cd9-5199-4125-9682-8d70d3579a08" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_38356050-a513-4998-9e83-96f1a403e8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_ab320b23-30a5-42ee-a9c3-df004234c0f0" xlink:href="rdnt-20220331.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_38356050-a513-4998-9e83-96f1a403e8b1" xlink:to="loc_rdnt_BarclaysMember_ab320b23-30a5-42ee-a9c3-df004234c0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_6fcec59d-dee1-4811-a510-cb245963c60c" xlink:href="rdnt-20220331.xsd#rdnt_SunTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_38356050-a513-4998-9e83-96f1a403e8b1" xlink:to="loc_rdnt_SunTrustMember_6fcec59d-dee1-4811-a510-cb245963c60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0d12a072-9d89-41df-b362-6c80757c97b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0d12a072-9d89-41df-b362-6c80757c97b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0d12a072-9d89-41df-b362-6c80757c97b9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_04aec08d-8a92-400c-a5db-dc6e92b9ff5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:to="loc_us-gaap_LineOfCreditMember_04aec08d-8a92-400c-a5db-dc6e92b9ff5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_3589d062-37e6-430f-a64e-35f76d196593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:to="loc_us-gaap_MediumTermNotesMember_3589d062-37e6-430f-a64e-35f76d196593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_cce0096e-b1ae-459d-b93a-a08bc2633e3e" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_cce0096e-b1ae-459d-b93a-a08bc2633e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_e9a4dbc3-c543-4de7-9c12-fb167b953180" xlink:href="rdnt-20220331.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:to="loc_rdnt_TermLoanMember_e9a4dbc3-c543-4de7-9c12-fb167b953180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a0daa255-fca9-44fd-86a1-757088bed38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23c95429-192f-4946-946a-7ece2995a478" xlink:to="loc_us-gaap_LetterOfCreditMember_a0daa255-fca9-44fd-86a1-757088bed38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9edccd2b-979a-43fa-8407-09ca27c24d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_VariableRateAxis_9edccd2b-979a-43fa-8407-09ca27c24d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8de3c52c-6bc9-4288-8783-2dc04a974288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_9edccd2b-979a-43fa-8407-09ca27c24d2c" xlink:to="loc_us-gaap_VariableRateDomain_8de3c52c-6bc9-4288-8783-2dc04a974288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_fadac3db-8aa3-4ab2-8c81-7f11b3b39eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8de3c52c-6bc9-4288-8783-2dc04a974288" xlink:to="loc_us-gaap_EurodollarMember_fadac3db-8aa3-4ab2-8c81-7f11b3b39eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4b1f38e1-07c3-4150-8ce1-d215c0dd3b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8de3c52c-6bc9-4288-8783-2dc04a974288" xlink:to="loc_us-gaap_BaseRateMember_4b1f38e1-07c3-4150-8ce1-d215c0dd3b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_13965a9d-4c4c-4efd-a02c-0546301779b2" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_rdnt_LeverageRatioAxis_13965a9d-4c4c-4efd-a02c-0546301779b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_2be56c80-391b-40ab-ab4a-e71987708e94" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_13965a9d-4c4c-4efd-a02c-0546301779b2" xlink:to="loc_rdnt_LeverageRatioDomain_2be56c80-391b-40ab-ab4a-e71987708e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFiveMember_a8d2b587-f963-4f44-8952-348a5a408f78" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioFiveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_2be56c80-391b-40ab-ab4a-e71987708e94" xlink:to="loc_rdnt_LeverageRatioFiveMember_a8d2b587-f963-4f44-8952-348a5a408f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_5457dfe1-5f27-4567-9b05-e3503510bc23" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_2be56c80-391b-40ab-ab4a-e71987708e94" xlink:to="loc_rdnt_LeverageRatioThreeMember_5457dfe1-5f27-4567-9b05-e3503510bc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_ab58a93e-0128-44b2-bc0f-7471d272d6ab" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_2be56c80-391b-40ab-ab4a-e71987708e94" xlink:to="loc_rdnt_PricingLevelIIIMember_ab58a93e-0128-44b2-bc0f-7471d272d6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ecd15c30-3306-40ea-8b78-86b36a3752cd" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ea384bf8-65d1-4d9a-8a12-4344a7d876d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LineOfCredit_ea384bf8-65d1-4d9a-8a12-4344a7d876d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c2ddb9e2-4344-4058-8736-291af6bbff6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c2ddb9e2-4344-4058-8736-291af6bbff6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_38ff15bd-1d43-47ee-8831-308b756ee011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_38ff15bd-1d43-47ee-8831-308b756ee011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0fd8f22c-b3ce-46d9-bb19-cd92d50a050e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0fd8f22c-b3ce-46d9-bb19-cd92d50a050e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_638be7db-fd93-4dc0-80e1-f9c171f6a8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_638be7db-fd93-4dc0-80e1-f9c171f6a8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_f67e63e0-5362-4d44-866d-ebc9512e65df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_f67e63e0-5362-4d44-866d-ebc9512e65df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_d1b91c89-e9ba-4eb9-8c75-160ce62e813e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_d1b91c89-e9ba-4eb9-8c75-160ce62e813e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_75de4ca6-81b8-4eca-8d5b-9f53c1ac33af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_75de4ca6-81b8-4eca-8d5b-9f53c1ac33af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_6994b9d1-5da2-4d83-80ee-196ba50fa33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_6994b9d1-5da2-4d83-80ee-196ba50fa33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_14398520-4bff-4b13-b9db-0a8ab39c1a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_14398520-4bff-4b13-b9db-0a8ab39c1a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_efa7367c-a96b-4d43-984f-c37f9a2500ff" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_efa7367c-a96b-4d43-984f-c37f9a2500ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c28feb1b-5170-4d46-b6a0-30bfdb1ac4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c28feb1b-5170-4d46-b6a0-30bfdb1ac4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1d3b8176-b238-408d-abb6-ee2a308739cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1d3b8176-b238-408d-abb6-ee2a308739cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_43066008-397b-4e19-b92a-9af52ea0fb9d" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_43066008-397b-4e19-b92a-9af52ea0fb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_ef0e784a-9a5d-4cf4-94f8-7f667bb86026" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_ef0e784a-9a5d-4cf4-94f8-7f667bb86026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_cafccd1f-bbb0-457d-a2f6-cdb233103c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_cafccd1f-bbb0-457d-a2f6-cdb233103c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_d9fbf57b-b60b-46a9-a0ba-570253282f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_d9fbf57b-b60b-46a9-a0ba-570253282f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_333f4a35-67b9-4131-88ce-d2053b6c20a1" xlink:href="rdnt-20220331.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_333f4a35-67b9-4131-88ce-d2053b6c20a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAmendments_d935aaf3-6c43-435b-a78c-12c0d4754123" xlink:href="rdnt-20220331.xsd#rdnt_NumberOfAmendments"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_NumberOfAmendments_d935aaf3-6c43-435b-a78c-12c0d4754123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentExtensionPeriod_8868017a-18cb-4459-a06d-e2b173371e40" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentExtensionPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd312b5b-ef6e-4ed3-9733-0da14b6ed4ce" xlink:to="loc_rdnt_DebtInstrumentExtensionPeriod_8868017a-18cb-4459-a06d-e2b173371e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f1f837b1-5602-4900-b91a-ca3828ffdb66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f1f837b1-5602-4900-b91a-ca3828ffdb66" xlink:to="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_fca15705-3a69-49d4-8c6e-a0c655d58632" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_rdnt_LeverageRatioAxis_fca15705-3a69-49d4-8c6e-a0c655d58632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_fca15705-3a69-49d4-8c6e-a0c655d58632" xlink:to="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_6f9c5bec-32c1-4980-9edc-c672ab18cc69" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:to="loc_rdnt_PricingLevelIMember_6f9c5bec-32c1-4980-9edc-c672ab18cc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_b0650abb-87e1-4cb1-99dc-768bf5f6f767" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:to="loc_rdnt_PricingLevelIIMember_b0650abb-87e1-4cb1-99dc-768bf5f6f767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_7ffc7775-478e-4bcc-a12c-7fa3f9865978" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:to="loc_rdnt_PricingLevelIIIMember_7ffc7775-478e-4bcc-a12c-7fa3f9865978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_b886d671-00b4-48e4-9f16-96cda52edce0" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelIVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:to="loc_rdnt_PricingLevelIVMember_b886d671-00b4-48e4-9f16-96cda52edce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_51c23e55-5d98-4276-82ed-63215d90516b" xlink:href="rdnt-20220331.xsd#rdnt_PricingLevelVMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_06a38b00-3345-4bd3-a584-2bc4199e33ff" xlink:to="loc_rdnt_PricingLevelVMember_51c23e55-5d98-4276-82ed-63215d90516b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d3a859e6-1509-4c2f-80f9-aefe2cf43434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_us-gaap_VariableRateAxis_d3a859e6-1509-4c2f-80f9-aefe2cf43434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d2905496-033c-45ed-8a90-af07a76458c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_d3a859e6-1509-4c2f-80f9-aefe2cf43434" xlink:to="loc_us-gaap_VariableRateDomain_d2905496-033c-45ed-8a90-af07a76458c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_94c1844b-fb44-4ae1-8e6c-78235e267917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d2905496-033c-45ed-8a90-af07a76458c5" xlink:to="loc_us-gaap_EurodollarMember_94c1844b-fb44-4ae1-8e6c-78235e267917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_b385d263-f042-49a1-ad92-49212d22bec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d2905496-033c-45ed-8a90-af07a76458c5" xlink:to="loc_us-gaap_BaseRateMember_b385d263-f042-49a1-ad92-49212d22bec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_35371ded-fce9-499b-98c9-1697577f239d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_us-gaap_DebtInstrumentAxis_35371ded-fce9-499b-98c9-1697577f239d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a0f6aaba-3783-41f1-a6fc-085767084b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_35371ded-fce9-499b-98c9-1697577f239d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a0f6aaba-3783-41f1-a6fc-085767084b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_c4c9e54f-e71c-4dbe-bfe4-adf8f900b443" xlink:href="rdnt-20220331.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a0f6aaba-3783-41f1-a6fc-085767084b1e" xlink:to="loc_rdnt_RestatedAgreementMember_c4c9e54f-e71c-4dbe-bfe4-adf8f900b443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b30161fe-4707-4333-83c6-fd32c4a88961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_us-gaap_CreditFacilityAxis_b30161fe-4707-4333-83c6-fd32c4a88961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_241d27f1-30a2-4a4c-8096-f6c297c8655c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b30161fe-4707-4333-83c6-fd32c4a88961" xlink:to="loc_us-gaap_CreditFacilityDomain_241d27f1-30a2-4a4c-8096-f6c297c8655c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_25bfce3e-5a07-4d88-a2fd-f82b96a5d043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_241d27f1-30a2-4a4c-8096-f6c297c8655c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_25bfce3e-5a07-4d88-a2fd-f82b96a5d043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_17775467-e28e-4ce3-9f22-af9b207d8f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_17775467-e28e-4ce3-9f22-af9b207d8f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9dc77752-4e02-4cb5-b4d9-e9b169a3fd15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17775467-e28e-4ce3-9f22-af9b207d8f4b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9dc77752-4e02-4cb5-b4d9-e9b169a3fd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_b66cf742-9d75-42ec-bed7-018ce9294960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9dc77752-4e02-4cb5-b4d9-e9b169a3fd15" xlink:to="loc_us-gaap_LineOfCreditMember_b66cf742-9d75-42ec-bed7-018ce9294960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5f36c455-0796-498b-a36e-69d8ff48452c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_368379a5-acab-44c6-9019-219639746ea8" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_368379a5-acab-44c6-9019-219639746ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_fc3fcc30-7aab-40b8-946b-f72e9ace77ed" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_fc3fcc30-7aab-40b8-946b-f72e9ace77ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2f043059-10a1-4bbc-98c7-3c0aa18a3bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2f043059-10a1-4bbc-98c7-3c0aa18a3bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_ce411710-51a9-4270-b99a-4aae9f6d8a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_ce411710-51a9-4270-b99a-4aae9f6d8a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_9daf8fb8-519b-4a2e-84fc-72f04e558f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc14080a-c5e9-471a-a005-8509f236677e" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_9daf8fb8-519b-4a2e-84fc-72f04e558f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20220331.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7c1fc3d5-634d-4cbe-8566-c9288dc333eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7c1fc3d5-634d-4cbe-8566-c9288dc333eb" xlink:to="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_dab8c1d7-2e9d-47d2-893f-c9ef10b791e3" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_rdnt_LeverageRatioAxis_dab8c1d7-2e9d-47d2-893f-c9ef10b791e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_a7d303b2-a9de-4d9a-9c27-48a5a1db4cbc" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_dab8c1d7-2e9d-47d2-893f-c9ef10b791e3" xlink:to="loc_rdnt_LeverageRatioDomain_a7d303b2-a9de-4d9a-9c27-48a5a1db4cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_582e09fe-7e80-425b-b9a6-e7640218d47e" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_a7d303b2-a9de-4d9a-9c27-48a5a1db4cbc" xlink:to="loc_rdnt_LeverageRatioOneMember_582e09fe-7e80-425b-b9a6-e7640218d47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_451e081b-4c49-43c2-bfb8-7ec73023c4ed" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_a7d303b2-a9de-4d9a-9c27-48a5a1db4cbc" xlink:to="loc_rdnt_LeverageRatioTwoMember_451e081b-4c49-43c2-bfb8-7ec73023c4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember_3eec2362-9475-4abc-b572-897df0b0f46b" xlink:href="rdnt-20220331.xsd#rdnt_LeverageRatioFourMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_a7d303b2-a9de-4d9a-9c27-48a5a1db4cbc" xlink:to="loc_rdnt_LeverageRatioFourMember_3eec2362-9475-4abc-b572-897df0b0f46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0937ec47-914c-43c1-bfa3-95b59ab92910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_us-gaap_CreditFacilityAxis_0937ec47-914c-43c1-bfa3-95b59ab92910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ebbf773e-a7eb-47f5-989c-266ec5b15364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0937ec47-914c-43c1-bfa3-95b59ab92910" xlink:to="loc_us-gaap_CreditFacilityDomain_ebbf773e-a7eb-47f5-989c-266ec5b15364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9b0e0213-f008-49d7-b877-10efe36c7ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ebbf773e-a7eb-47f5-989c-266ec5b15364" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9b0e0213-f008-49d7-b877-10efe36c7ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f4a2740f-6941-48b8-badb-42d92d8b7894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_us-gaap_DebtInstrumentAxis_f4a2740f-6941-48b8-badb-42d92d8b7894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c4fffe31-7bfb-4a07-aecd-e5c33e2b3ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f4a2740f-6941-48b8-badb-42d92d8b7894" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c4fffe31-7bfb-4a07-aecd-e5c33e2b3ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_135f6890-8466-4dc3-815f-a6e583090de5" xlink:href="rdnt-20220331.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c4fffe31-7bfb-4a07-aecd-e5c33e2b3ae5" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_135f6890-8466-4dc3-815f-a6e583090de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_207756e2-3ddf-4bfb-9c8f-79038a3ed39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_207756e2-3ddf-4bfb-9c8f-79038a3ed39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ec444684-95cf-4385-a561-4ba8adc7efbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_207756e2-3ddf-4bfb-9c8f-79038a3ed39d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ec444684-95cf-4385-a561-4ba8adc7efbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_cf364f1b-bb12-4039-bd1a-79cf2f85ef37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ec444684-95cf-4385-a561-4ba8adc7efbe" xlink:to="loc_us-gaap_LineOfCreditMember_cf364f1b-bb12-4039-bd1a-79cf2f85ef37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f9a4f381-f13f-465c-83e7-fbad41b0a0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_us-gaap_VariableRateAxis_f9a4f381-f13f-465c-83e7-fbad41b0a0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b0927d63-3adc-4fa6-8958-2ee4331b0935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f9a4f381-f13f-465c-83e7-fbad41b0a0ba" xlink:to="loc_us-gaap_VariableRateDomain_b0927d63-3adc-4fa6-8958-2ee4331b0935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_da70e34b-b1d4-49a4-8d90-bc8fef034546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b0927d63-3adc-4fa6-8958-2ee4331b0935" xlink:to="loc_us-gaap_EurodollarMember_da70e34b-b1d4-49a4-8d90-bc8fef034546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_247d3550-cc45-46ba-b560-0cf6fac20739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b0927d63-3adc-4fa6-8958-2ee4331b0935" xlink:to="loc_us-gaap_BaseRateMember_247d3550-cc45-46ba-b560-0cf6fac20739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_65bbb55e-da8e-4024-943a-2246b782deb9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_srt_RangeAxis_65bbb55e-da8e-4024-943a-2246b782deb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f850901-d04e-4e2e-ab42-edef195fe146" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_65bbb55e-da8e-4024-943a-2246b782deb9" xlink:to="loc_srt_RangeMember_6f850901-d04e-4e2e-ab42-edef195fe146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c712498-ae72-4f1c-a6e0-fb9a83bce076" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f850901-d04e-4e2e-ab42-edef195fe146" xlink:to="loc_srt_MaximumMember_0c712498-ae72-4f1c-a6e0-fb9a83bce076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4ecb7c88-0167-4153-8a13-c55b10c4d848" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f850901-d04e-4e2e-ab42-edef195fe146" xlink:to="loc_srt_MinimumMember_4ecb7c88-0167-4153-8a13-c55b10c4d848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_18f0efa7-9964-47a3-94eb-1fab47ef98e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09d2fb8a-6704-4a01-97b7-7de8b935b933" xlink:to="loc_us-gaap_DebtInstrumentLineItems_18f0efa7-9964-47a3-94eb-1fab47ef98e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_78c1c773-ff9f-4fbf-be95-f1e616871a47" xlink:href="rdnt-20220331.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_18f0efa7-9964-47a3-94eb-1fab47ef98e8" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_78c1c773-ff9f-4fbf-be95-f1e616871a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c4e8d277-4cda-44d5-a11b-f5fe90c006a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_18f0efa7-9964-47a3-94eb-1fab47ef98e8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c4e8d277-4cda-44d5-a11b-f5fe90c006a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20220331.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e85bef9a-2de9-41e7-bdaa-e66227899b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4286dc89-5139-40db-b5c8-b0c6ebc88418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e85bef9a-2de9-41e7-bdaa-e66227899b47" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4286dc89-5139-40db-b5c8-b0c6ebc88418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20220331.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a7c3c6f2-7c51-4234-b1f0-af2e4c1462dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_734b503e-50f8-4a29-ac7a-e05712d4035e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a7c3c6f2-7c51-4234-b1f0-af2e4c1462dd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_734b503e-50f8-4a29-ac7a-e05712d4035e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_3806cfe1-a6fe-46ea-8a8b-c71351ef1e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a7c3c6f2-7c51-4234-b1f0-af2e4c1462dd" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_3806cfe1-a6fe-46ea-8a8b-c71351ef1e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20220331.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_18c4cece-cd38-4e8f-aa2a-2fcf4ab80c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_18c4cece-cd38-4e8f-aa2a-2fcf4ab80c88" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d2b90150-b80b-4f73-908c-ce515a8abc20" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:to="loc_srt_RangeAxis_d2b90150-b80b-4f73-908c-ce515a8abc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8fbcac11-8ad2-4b42-a381-6d7a7d1b601b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d2b90150-b80b-4f73-908c-ce515a8abc20" xlink:to="loc_srt_RangeMember_8fbcac11-8ad2-4b42-a381-6d7a7d1b601b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b2495929-8b49-496d-ac94-2f8c77605338" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8fbcac11-8ad2-4b42-a381-6d7a7d1b601b" xlink:to="loc_srt_MinimumMember_b2495929-8b49-496d-ac94-2f8c77605338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f1d47b2d-676f-4d6e-897e-2329f5684ef8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8fbcac11-8ad2-4b42-a381-6d7a7d1b601b" xlink:to="loc_srt_MaximumMember_f1d47b2d-676f-4d6e-897e-2329f5684ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f5d49d2d-4225-40cf-97ea-bd06d2ff7436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:to="loc_us-gaap_AwardTypeAxis_f5d49d2d-4225-40cf-97ea-bd06d2ff7436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f5d49d2d-4225-40cf-97ea-bd06d2ff7436" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_19942fa3-c95c-4aab-a4b3-ba4d118f237e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:to="loc_us-gaap_StockOptionMember_19942fa3-c95c-4aab-a4b3-ba4d118f237e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e341517f-f841-4571-a5da-57379df71b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:to="loc_us-gaap_RestrictedStockMember_e341517f-f841-4571-a5da-57379df71b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_9f1f79ad-022a-468b-8f21-bc4b752dea48" xlink:href="rdnt-20220331.xsd#rdnt_FutureServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:to="loc_rdnt_FutureServiceMember_9f1f79ad-022a-468b-8f21-bc4b752dea48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_7567be1d-df3c-4686-aa84-78c9904310ab" xlink:href="rdnt-20220331.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_7567be1d-df3c-4686-aa84-78c9904310ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_d545d25c-f4a4-483f-a811-ee637676db2f" xlink:href="rdnt-20220331.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95d30910-6c10-42f1-95dc-9954a0e614f5" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_d545d25c-f4a4-483f-a811-ee637676db2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_83f12ca9-976c-4253-b0d6-da6a91e315ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_83f12ca9-976c-4253-b0d6-da6a91e315ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc5aaf9e-d927-4e4a-afd4-a8e04ddbb36e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_83f12ca9-976c-4253-b0d6-da6a91e315ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc5aaf9e-d927-4e4a-afd4-a8e04ddbb36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_dd55db1b-c8f0-49d1-91a6-6e5824795b23" xlink:href="rdnt-20220331.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc5aaf9e-d927-4e4a-afd4-a8e04ddbb36e" xlink:to="loc_rdnt_DeepHealthIncMember_dd55db1b-c8f0-49d1-91a6-6e5824795b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56f753ee-59fe-4ae2-a4cb-aedc932c7725" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_e179b3fd-58c0-43c7-b3e5-19e3449ffa15" xlink:href="rdnt-20220331.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_e179b3fd-58c0-43c7-b3e5-19e3449ffa15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_67e46d12-48fb-454f-a296-c298139f014c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_67e46d12-48fb-454f-a296-c298139f014c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_05da8765-12b5-4088-b55b-0aac0328fbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_05da8765-12b5-4088-b55b-0aac0328fbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_af639ce7-c985-436c-8f2f-b46fe76cd6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_af639ce7-c985-436c-8f2f-b46fe76cd6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8f844acb-e249-44df-a870-f084d4467405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8f844acb-e249-44df-a870-f084d4467405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_53989260-f639-4684-be44-72df3bae78ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_53989260-f639-4684-be44-72df3bae78ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_137b730c-bb1f-4677-b7e1-8c8b449e10b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_137b730c-bb1f-4677-b7e1-8c8b449e10b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d8e3f45-674a-41ef-a7ee-972ae3590f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d8e3f45-674a-41ef-a7ee-972ae3590f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d1c8c06b-5a52-4a6e-8a70-fc67f226fd57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d1c8c06b-5a52-4a6e-8a70-fc67f226fd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0063dae0-8bfc-427c-b6c8-fb63de7c090c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0063dae0-8bfc-427c-b6c8-fb63de7c090c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1e50c94b-befa-43d7-b45a-d5064d5df375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1e50c94b-befa-43d7-b45a-d5064d5df375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dc17a4b0-59d0-4a1b-8ce6-5c9bd4654f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dc17a4b0-59d0-4a1b-8ce6-5c9bd4654f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2c2a95d8-8247-4d17-910a-dd4e86b0f099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2c2a95d8-8247-4d17-910a-dd4e86b0f099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_354d3030-c3ca-489d-8db6-0866fb5c1d63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_354d3030-c3ca-489d-8db6-0866fb5c1d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_207650ee-eb58-45aa-a48c-3e552f6768fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_207650ee-eb58-45aa-a48c-3e552f6768fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d3241c40-f797-4139-800f-8734d39db303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d3241c40-f797-4139-800f-8734d39db303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_5f1868f3-a83c-48b2-a19b-6372639299de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_578931e9-156f-4b03-8707-f7ea3b689500" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_5f1868f3-a83c-48b2-a19b-6372639299de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20220331.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b881807-e113-4902-a0d0-75a380e30649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac1ff9e-f184-4ed2-80d5-e0c167da6799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b881807-e113-4902-a0d0-75a380e30649" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac1ff9e-f184-4ed2-80d5-e0c167da6799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_142e1b8e-9410-4e1e-b364-55436ab11613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac1ff9e-f184-4ed2-80d5-e0c167da6799" xlink:to="loc_us-gaap_AwardTypeAxis_142e1b8e-9410-4e1e-b364-55436ab11613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb9813b7-39bc-4691-901e-56a1658fc599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_142e1b8e-9410-4e1e-b364-55436ab11613" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb9813b7-39bc-4691-901e-56a1658fc599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_2a6e633e-0d82-4e21-938b-22fd5d980397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb9813b7-39bc-4691-901e-56a1658fc599" xlink:to="loc_us-gaap_StockOptionMember_2a6e633e-0d82-4e21-938b-22fd5d980397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_197d21db-aa16-44ab-be96-afc79c5e71a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac1ff9e-f184-4ed2-80d5-e0c167da6799" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_197d21db-aa16-44ab-be96-afc79c5e71a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b4bba07-75d0-433d-aa27-422f67533648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_197d21db-aa16-44ab-be96-afc79c5e71a8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b4bba07-75d0-433d-aa27-422f67533648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_fb31e163-1377-439f-b276-f07fe31682ab" xlink:href="rdnt-20220331.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7b4bba07-75d0-433d-aa27-422f67533648" xlink:to="loc_rdnt_DeepHealthInc.Member_fb31e163-1377-439f-b276-f07fe31682ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac1ff9e-f184-4ed2-80d5-e0c167da6799" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_878729de-a3b7-489e-8ec8-e346c357c9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_878729de-a3b7-489e-8ec8-e346c357c9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_76ad2498-997e-4428-8650-7704fb8758a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_76ad2498-997e-4428-8650-7704fb8758a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cb6cfcb9-5187-4906-91e9-9df013299d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cb6cfcb9-5187-4906-91e9-9df013299d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_46bc877c-49b7-4b4a-ab13-eb57e5a0e02b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a63e7e3-0bc3-48eb-b0fb-8aaf094ac400" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_46bc877c-49b7-4b4a-ab13-eb57e5a0e02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2b19180d-42a2-40ef-ad62-b9a5720ab612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2b19180d-42a2-40ef-ad62-b9a5720ab612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d7dd96a3-a0c9-4bfa-83f2-28d7f0655325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d7dd96a3-a0c9-4bfa-83f2-28d7f0655325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_feb2369b-8e1c-4695-9ecc-980591fce7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d7dd96a3-a0c9-4bfa-83f2-28d7f0655325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_feb2369b-8e1c-4695-9ecc-980591fce7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1a744f92-aa92-46c5-a5f5-10127626ed32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d7dd96a3-a0c9-4bfa-83f2-28d7f0655325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1a744f92-aa92-46c5-a5f5-10127626ed32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_04253071-7c3e-4162-8264-a472ee3109ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d7dd96a3-a0c9-4bfa-83f2-28d7f0655325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_04253071-7c3e-4162-8264-a472ee3109ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d9d165b3-e0d5-4c26-b458-d4a6c388cf15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d9d165b3-e0d5-4c26-b458-d4a6c388cf15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_88de5c15-f504-42cc-9a6b-9693a6422950" xlink:href="rdnt-20220331.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_88de5c15-f504-42cc-9a6b-9693a6422950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_22316704-5125-4eec-a543-6d4350c48678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_88de5c15-f504-42cc-9a6b-9693a6422950" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_22316704-5125-4eec-a543-6d4350c48678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7cd54807-b980-4589-9ca3-72b29af6b595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_88de5c15-f504-42cc-9a6b-9693a6422950" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7cd54807-b980-4589-9ca3-72b29af6b595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_8a83d7a1-f73d-4803-9462-e3f4849d6563" xlink:href="rdnt-20220331.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cbbac57d-57b3-4163-8ecc-c8be4ecc4aa0" xlink:to="loc_rdnt_AggregateIntrinsicValue_8a83d7a1-f73d-4803-9462-e3f4849d6563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5364c0d1-a90c-4c91-b00b-02469653f089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_8a83d7a1-f73d-4803-9462-e3f4849d6563" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5364c0d1-a90c-4c91-b00b-02469653f089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_823c307b-52cb-462a-b83a-4fa66cef7cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_8a83d7a1-f73d-4803-9462-e3f4849d6563" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_823c307b-52cb-462a-b83a-4fa66cef7cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="simple" xlink:href="rdnt-20220331.xsd#STOCKBASEDCOMPENSATIONDetailsRSUs"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08e6a6ce-8777-4b36-89d1-ca53f56f26a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a226620-8f2a-43be-b60d-4c8942659098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08e6a6ce-8777-4b36-89d1-ca53f56f26a2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a226620-8f2a-43be-b60d-4c8942659098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e7e1cb72-fa75-4bc6-8beb-a089e1aab739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a226620-8f2a-43be-b60d-4c8942659098" xlink:to="loc_us-gaap_AwardTypeAxis_e7e1cb72-fa75-4bc6-8beb-a089e1aab739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f2dfd4-8cf3-4a70-8a8c-c3adffc9e0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e7e1cb72-fa75-4bc6-8beb-a089e1aab739" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f2dfd4-8cf3-4a70-8a8c-c3adffc9e0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_572c1cdd-a34f-4b71-a9f3-b87b61f8cfae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f2dfd4-8cf3-4a70-8a8c-c3adffc9e0f9" xlink:to="loc_us-gaap_RestrictedStockMember_572c1cdd-a34f-4b71-a9f3-b87b61f8cfae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0923cebe-f9b6-4a06-bc7c-baa85a3d19f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3a226620-8f2a-43be-b60d-4c8942659098" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0923cebe-f9b6-4a06-bc7c-baa85a3d19f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0923cebe-f9b6-4a06-bc7c-baa85a3d19f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51cbe86d-a8fe-484c-b3ea-6afbb3358789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_51cbe86d-a8fe-484c-b3ea-6afbb3358789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8e4a9436-fe3e-40aa-aece-6c52a56e89f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8e4a9436-fe3e-40aa-aece-6c52a56e89f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_19b9aaee-344d-45e7-ad09-8c0f67a57839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_19b9aaee-344d-45e7-ad09-8c0f67a57839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0da1aea2-b946-4943-8617-01c073d240e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d941e827-d73a-4a30-8b68-5a7267fb046b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0da1aea2-b946-4943-8617-01c073d240e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_02a15805-739a-4d42-ab86-a4ed635a1156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0923cebe-f9b6-4a06-bc7c-baa85a3d19f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_02a15805-739a-4d42-ab86-a4ed635a1156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0923cebe-f9b6-4a06-bc7c-baa85a3d19f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d799be6b-57d4-4b87-b978-e81577af2ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d799be6b-57d4-4b87-b978-e81577af2ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bcc3de1f-c024-4a45-875b-0fcb85676c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bcc3de1f-c024-4a45-875b-0fcb85676c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d67ae66a-8dc9-4f0e-ab4d-2326ce1f67b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d67ae66a-8dc9-4f0e-ab4d-2326ce1f67b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1176e04a-603a-4500-be5a-17d79ded2967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d82effeb-f968-4c27-8585-49589d9c92d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1176e04a-603a-4500-be5a-17d79ded2967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_07bdd597-cab4-4d09-8e05-d9ef1d605982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_cdec3d73-0b80-47cf-8c38-13e3d53b2385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_07bdd597-cab4-4d09-8e05-d9ef1d605982" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_cdec3d73-0b80-47cf-8c38-13e3d53b2385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="rdnt-20220331.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_f0f4135e-fe23-4345-acea-6550c4dcd874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_f0f4135e-fe23-4345-acea-6550c4dcd874" xlink:to="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_aaf5bf9b-a0e6-4e24-ae16-7fc1fa61b7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_aaf5bf9b-a0e6-4e24-ae16-7fc1fa61b7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_64494676-645a-4c70-86c7-bd3b2f7faeef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_aaf5bf9b-a0e6-4e24-ae16-7fc1fa61b7aa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_64494676-645a-4c70-86c7-bd3b2f7faeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6dbda06b-5f7c-42a7-bb8a-41707ddf1d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_64494676-645a-4c70-86c7-bd3b2f7faeef" xlink:to="loc_us-gaap_SubsequentEventMember_6dbda06b-5f7c-42a7-bb8a-41707ddf1d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_636fc50b-79d9-4666-9012-0d6d41b65a5a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:to="loc_dei_LegalEntityAxis_636fc50b-79d9-4666-9012-0d6d41b65a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_46720b2a-29d0-469d-a1d7-c5a94c5908cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_636fc50b-79d9-4666-9012-0d6d41b65a5a" xlink:to="loc_dei_EntityDomain_46720b2a-29d0-469d-a1d7-c5a94c5908cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_1271105d-6604-49d1-9694-4c9dc028d6c5" xlink:href="rdnt-20220331.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_46720b2a-29d0-469d-a1d7-c5a94c5908cd" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_1271105d-6604-49d1-9694-4c9dc028d6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember_98a9ac7b-b288-4255-93f7-71a20ca40870" xlink:href="rdnt-20220331.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_46720b2a-29d0-469d-a1d7-c5a94c5908cd" xlink:to="loc_rdnt_FrederickHealthHospitalIncMember_98a9ac7b-b288-4255-93f7-71a20ca40870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_ae718554-2e00-4d2d-9454-31be894e6759" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:to="loc_srt_OwnershipAxis_ae718554-2e00-4d2d-9454-31be894e6759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_cbc8f4f6-2576-4c14-9e1d-fdd2601fa3d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_ae718554-2e00-4d2d-9454-31be894e6759" xlink:to="loc_srt_OwnershipDomain_cbc8f4f6-2576-4c14-9e1d-fdd2601fa3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_6d2f5283-be78-4c71-a986-084331ca5bc0" xlink:href="rdnt-20220331.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_cbc8f4f6-2576-4c14-9e1d-fdd2601fa3d0" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_6d2f5283-be78-4c71-a986-084331ca5bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_0d970e32-205d-4ab1-b711-f4adb01d9a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2b5af135-1cda-4061-9d02-34b940a483c3" xlink:to="loc_us-gaap_SubsequentEventLineItems_0d970e32-205d-4ab1-b711-f4adb01d9a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_99f7460e-c32a-44c0-9899-42dbb0398af3" xlink:href="rdnt-20220331.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0d970e32-205d-4ab1-b711-f4adb01d9a08" xlink:to="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_99f7460e-c32a-44c0-9899-42dbb0398af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_8814756d-046c-4acc-8bbe-0efb6ec3de34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0d970e32-205d-4ab1-b711-f4adb01d9a08" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_8814756d-046c-4acc-8bbe-0efb6ec3de34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069813827352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>May 05, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,219,473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069815329528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 70,713<span></span>
</td>
<td class="nump">$ 134,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">159,725<span></span>
</td>
<td class="nump">135,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from affiliates</a></td>
<td class="nump">5,783<span></span>
</td>
<td class="nump">5,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">52,475<span></span>
</td>
<td class="nump">49,212<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">288,696<span></span>
</td>
<td class="nump">324,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract', window );"><strong>PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">488,958<span></span>
</td>
<td class="nump">484,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">595,792<span></span>
</td>
<td class="nump">584,291<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets', window );">Total property, equipment and right-of-use assets</a></td>
<td class="nump">1,084,750<span></span>
</td>
<td class="nump">1,068,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">570,188<span></span>
</td>
<td class="nump">513,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">99,339<span></span>
</td>
<td class="nump">56,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Deferred financing costs</a></td>
<td class="nump">2,009<span></span>
</td>
<td class="nump">2,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">44,746<span></span>
</td>
<td class="nump">42,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">12,800<span></span>
</td>
<td class="nump">14,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits and other</a></td>
<td class="nump">38,993<span></span>
</td>
<td class="nump">36,032<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,141,521<span></span>
</td>
<td class="nump">2,058,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable, accrued expenses and other</a></td>
<td class="nump">276,313<span></span>
</td>
<td class="nump">263,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Due to affiliates</a></td>
<td class="nump">21,985<span></span>
</td>
<td class="nump">23,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">6,930<span></span>
</td>
<td class="nump">10,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liability</a></td>
<td class="nump">64,906<span></span>
</td>
<td class="nump">65,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">11,164<span></span>
</td>
<td class="nump">11,164<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">381,298<span></span>
</td>
<td class="nump">374,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">590,665<span></span>
</td>
<td class="nump">577,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">740,707<span></span>
</td>
<td class="nump">743,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">7,401<span></span>
</td>
<td class="nump">16,360<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,720,071<span></span>
</td>
<td class="nump">1,712,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - $0.0001 par value, 200,000,000 shares authorized; 56,197,826 and 53,548,227 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">409,863<span></span>
</td>
<td class="nump">342,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(20,761)<span></span>
</td>
<td class="num">(20,421)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(90,260)<span></span>
</td>
<td class="num">(93,272)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total RadNet, Inc.'s stockholders' equity</a></td>
<td class="nump">298,847<span></span>
</td>
<td class="nump">228,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">122,603<span></span>
</td>
<td class="nump">117,253<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">421,450<span></span>
</td>
<td class="nump">346,157<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 2,141,521<span></span>
</td>
<td class="nump">$ 2,058,474<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property Plant and Equipment Net Including Right of Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069813014520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock - shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock - shares issued (in shares)</a></td>
<td class="nump">56,197,826<span></span>
</td>
<td class="nump">53,548,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock - shares outstanding (in shares)</a></td>
<td class="nump">56,197,826<span></span>
</td>
<td class="nump">53,548,227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069815161400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total service revenue</a></td>
<td class="nump">$ 341,767<span></span>
</td>
<td class="nump">$ 315,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Provider relief funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of operations, excluding depreciation and amortization</a></td>
<td class="nump">315,039<span></span>
</td>
<td class="nump">282,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">27,118<span></span>
</td>
<td class="nump">22,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss (gain) on sale and disposal of equipment and other</a></td>
<td class="nump">1,128<span></span>
</td>
<td class="num">(1,307)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">343,486<span></span>
</td>
<td class="nump">303,914<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(LOSS) INCOME FROM OPERATIONS</a></td>
<td class="num">(1,719)<span></span>
</td>
<td class="nump">17,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>OTHER INCOME AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">11,593<span></span>
</td>
<td class="nump">12,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of joint ventures</a></td>
<td class="num">(2,517)<span></span>
</td>
<td class="num">(2,285)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1', window );">Non-cash change in fair value of interest rate hedge</a></td>
<td class="num">(20,819)<span></span>
</td>
<td class="num">(11,245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="num">(11,578)<span></span>
</td>
<td class="num">(498)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">INCOME BEFORE INCOME TAXES</a></td>
<td class="nump">9,859<span></span>
</td>
<td class="nump">18,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(1,496)<span></span>
</td>
<td class="num">(4,376)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME</a></td>
<td class="nump">8,363<span></span>
</td>
<td class="nump">13,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">5,350<span></span>
</td>
<td class="nump">4,317<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="nump">$ 3,013<span></span>
</td>
<td class="nump">$ 9,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>WEIGHTED AVERAGE SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">55,303,007<span></span>
</td>
<td class="nump">51,951,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">56,362,193<span></span>
</td>
<td class="nump">52,828,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total service revenue</a></td>
<td class="nump">$ 303,276<span></span>
</td>
<td class="nump">$ 279,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total service revenue</a></td>
<td class="nump">$ 38,491<span></span>
</td>
<td class="nump">$ 35,742<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817540136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME</a></td>
<td class="nump">$ 8,363<span></span>
</td>
<td class="nump">$ 13,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(1,264)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</a></td>
<td class="nump">923<span></span>
</td>
<td class="nump">925<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">COMPREHENSIVE INCOME</a></td>
<td class="nump">8,022<span></span>
</td>
<td class="nump">14,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">5,350<span></span>
</td>
<td class="nump">4,317<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="nump">$ 2,672<span></span>
</td>
<td class="nump">$ 10,371<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069810535960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Radnet, Inc.'s Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,640,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 258,303<span></span>
</td>
<td class="nump">$ 165,743<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307,788<span></span>
</td>
<td class="num">$ (24,051)<span></span>
</td>
<td class="num">$ (117,999)<span></span>
</td>
<td class="nump">$ 92,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">699,825<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">8,248<span></span>
</td>
<td class="nump">8,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of noncontorlling interests</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContributionsFromNoncontrollingInterests', window );">Contribution from noncontrolling partner</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in cumulative foreign currency translation adjustment</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</a></td>
<td class="nump">925<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">13,775<span></span>
</td>
<td class="nump">9,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,458<span></span>
</td>
<td class="nump">4,317<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,340,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Mar. 31, 2021</a></td>
<td class="nump">281,358<span></span>
</td>
<td class="nump">184,358<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,032<span></span>
</td>
<td class="num">(23,138)<span></span>
</td>
<td class="num">(108,541)<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,640,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">258,303<span></span>
</td>
<td class="nump">165,743<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,788<span></span>
</td>
<td class="num">(24,051)<span></span>
</td>
<td class="num">(117,999)<span></span>
</td>
<td class="nump">92,560<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,548,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2021</a></td>
<td class="nump">346,157<span></span>
</td>
<td class="nump">228,904<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342,592<span></span>
</td>
<td class="num">(20,421)<span></span>
</td>
<td class="num">(93,272)<span></span>
</td>
<td class="nump">117,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">530,188<span></span>
</td>
<td class="nump">13,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">10,801<span></span>
</td>
<td class="nump">10,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for sale of unregistered securities for acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,106,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock in connection with acquisitions</a></td>
<td class="nump">56,470<span></span>
</td>
<td class="nump">56,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in cumulative foreign currency translation adjustment</a></td>
<td class="num">(1,264)<span></span>
</td>
<td class="num">(1,264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</a></td>
<td class="nump">923<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">8,363<span></span>
</td>
<td class="nump">3,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,013<span></span>
</td>
<td class="nump">5,350<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,197,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Mar. 31, 2022</a></td>
<td class="nump">$ 421,450<span></span>
</td>
<td class="nump">$ 298,847<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 409,863<span></span>
</td>
<td class="num">$ (20,761)<span></span>
</td>
<td class="num">$ (90,260)<span></span>
</td>
<td class="nump">$ 122,603<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContributionsFromNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContributionsFromNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069813322776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">$ 8,363<span></span>
</td>
<td class="nump">$ 13,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">27,118<span></span>
</td>
<td class="nump">22,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">16,802<span></span>
</td>
<td class="nump">17,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in earnings of joint ventures, net of dividends</a></td>
<td class="num">(2,517)<span></span>
</td>
<td class="num">(2,285)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs and loan discount</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">1,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss (gain) on sale and disposal of equipment and other</a></td>
<td class="nump">1,128<span></span>
</td>
<td class="num">(1,307)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredHedgeGains', window );">Amortization of cash flow hedge, net of taxes</a></td>
<td class="nump">923<span></span>
</td>
<td class="nump">925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Non-cash change in fair value of interest rate hedge</a></td>
<td class="num">(20,819)<span></span>
</td>
<td class="num">(11,245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">11,102<span></span>
</td>
<td class="nump">8,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="num">(501)<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(23,904)<span></span>
</td>
<td class="num">(17,493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="num">(4,065)<span></span>
</td>
<td class="num">(4,308)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(1,417)<span></span>
</td>
<td class="num">(3,507)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="nump">1,387<span></span>
</td>
<td class="nump">3,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(15,859)<span></span>
</td>
<td class="num">(18,291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(4,519)<span></span>
</td>
<td class="nump">1,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other</a></td>
<td class="nump">7,031<span></span>
</td>
<td class="nump">17,157<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="nump">901<span></span>
</td>
<td class="nump">28,084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBuildings', window );">Purchase of imaging centers and other acquisitions</a></td>
<td class="num">(25,123)<span></span>
</td>
<td class="num">(57,075)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(36,558)<span></span>
</td>
<td class="num">(30,424)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(61,564)<span></span>
</td>
<td class="num">(87,348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities', window );">Principal payments on notes and leases payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(827)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payments on term loan debt</a></td>
<td class="num">(3,313)<span></span>
</td>
<td class="num">(10,824)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">87,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(87,100)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(3,313)<span></span>
</td>
<td class="num">(11,651)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">EFFECT OF EXCHANGE RATE CHANGES ON CASH</a></td>
<td class="nump">83<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET DECREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(63,893)<span></span>
</td>
<td class="num">(70,927)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">134,606<span></span>
</td>
<td class="nump">102,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="nump">70,713<span></span>
</td>
<td class="nump">31,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest</a></td>
<td class="nump">7,448<span></span>
</td>
<td class="nump">8,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid during the period for income taxes</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of buildings (properties) whether for investment or use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069815147464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 20, 2022</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements', window );">Equipment acquired and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,200<span></span>
</td>
<td class="nump">$ 28,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember', window );">Simi Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_SimiAdventistMember', window );">Simi Adventist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence B.V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">1,141,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Equity interest issued, value assigned</a></td>
<td class="nump">$ 30,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib B.V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">965,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Equity interest issued, value assigned</a></td>
<td class="nump">$ 25,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquipmentAcquiredAndLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiAdventistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiAdventistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817328808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">NATURE OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text">NATURE OF BUSINESS AND BASIS OF PRESENTATION<div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At March&#160;31, 2022, we operated directly or indirectly through joint ventures with hospitals, 351 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group ("the Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $45.7 million and $46.1 million of revenue, net of management services fees to RadNet, for the three months ended March&#160;31, 2022 and 2021, respectively and $45.7 million and $46.1 million of operating expenses for the three months ended March&#160;31, 2022 and 2021, respectively.  RadNet recognized $191.0 million and $179.0 million of total billed net service fee revenue for the three months ended March&#160;31, 2022, and 2021, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying condensed consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our condensed consolidated balance sheets at March&#160;31, 2022 and December&#160;31, 2021, we have included approximately $100.4 million and $89.2 million, respectively, of accounts receivable and approximately $16.9 million and $14.4 million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also own a 49% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender, LLC is dependent on RadNet to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $3.9&#160;million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $0.4&#160;million and $0.6&#160;million for the three months ended March 31, 2022, and March&#160;31, 2021, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended March&#160;31, 2022 and 2021 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817426296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period covered in this report, there have been no material changes to the significant accounting policies we use and have explained, in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2021. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2021.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenues during the three months ended March&#160;31, 2022 and 2021 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.707%"><tr><td style="width:1.0%"/><td style="width:65.631%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.781%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,465&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,096&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,087&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,451&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,775&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,647&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,622&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,491&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,742&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,767&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Beginning in the second quarter of 2020 and through the three months ended March 31, 2022, we received funding from the various programs established by the CARES Act as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$39.6 million total of accelerated Medicare payments received, $39.5 million for the twelve months ended December&#160;31, 2020 and $0.1 million for the twelve months ended December&#160;31, 2021.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$4.0 million from the Paycheck Protection Program through the twelve months ended December 31, 2020.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$35.4 million total Provider Relief Funding, $26.3 million received for the twelve months ended December 31, 2020 and $9.1 million received for the twelve months ended December 31, 2021, with $6.2 million of it received during the three months ended March 31, 2021.  No Provider Relief Funding was received for the three months ended March 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accelerated Medicare and Blue Shield payments were recorded to Deferred Revenue in our consolidated balance sheet and are being applied to revenue as services are performed beginning in 2021. Through the three months ended March 31, 2022, $36.0 million of the accelerated Medicare payments has been applied to revenue. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The $4.0 million secured from the Paycheck Protection Program was accounted for as debt and in December 2020 we met the eligibility requirements under the government guidelines for forgiveness and the loans were written off to gain on extinguishment of debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Provider Relief Funding from 2021 is displayed as such on our condensed consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The CARES Act also provides for the deferral of the employer-paid portion of the social security payroll tax with 50% due by December 31, 2021 and 50% due December 31, 2022. We elected to defer $16.3 million of this tax through December 31, 2020. Additionally, The CARES Act provided a refundable employer tax credit equal to 50% of qualified wages, including </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">certain health insurance costs, that can be used to offset payroll tax liabilities.  In 2021 we qualified for a portion of the credit and recorded a benefit of $7.7&#160;million through a reduction of payroll tax expense.  Our remaining deferred tax liability balance of approximately $8.1&#160;million at March 31, 2022, will be paid by December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  Amounts remaining to be collected on these agreement were $17.0 million and $17.7 million at March&#160;31, 2022 and December&#160;31, 2021, respectively. We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method. Deferred financing costs, net of accumulated amortization, were $2.0 million and $2.1 million, as of March&#160;31, 2022 and December&#160;31, 2021, respectively and related to our Barclays Revolving Credit Facility.  See Note 5, Credit Facilities and Notes Payable for more information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES - Goodwill at March&#160;31, 2022 totaled $570.2 million.  Indefinite lived intangible assets at March&#160;31, 2022 were $13.2 million.  Goodwill and Indefinite Lived Intangibles are recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2021, noting no impairment.  We considered the current and expected future economic and market conditions surrounding COVID-19 pandemic and did not identify an indication of goodwill impairment being more likely than not through March&#160;31, 2022.  Activity in goodwill for the three months ended March&#160;31, 2022 is provided below (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,820&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,188&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill balances at March 31, 2022 reflect additional goodwill arising from deferred tax liabilities recorded on our acquisitions of Aidence Holding B.V. and Quantib B.V. of $7.3 million.  See Note 4, Business Combinations and Related Activity for more information.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded income tax expense of $1.5 million, or an effective tax rate of 15.2%, for the three months ended March 31, 2022 compared to income tax expense of $4.4 million, or an effective tax rate of 24.1% for the three months ended March 31, 2021.  The income tax rates for the three months ended March&#160;31, 2022 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes (iii) effects of foreign income taxes; and (iv) excess tax benefits attributable to share-based compensation.  We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of March&#160;31, 2022.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we have amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric.  We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period.  Stock options generally vest over three years to five years and expire five years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 7, Stock-Based Compensation, for more information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPREHENSIVE INCOME (LOSS) - Accounting guidance establishes rules for reporting and displaying comprehensive income or loss and its components. Our unrealized gains or losses on foreign currency translation adjustments, interest rate cap and swap agreements are included in comprehensive loss and are included in the consolidated statements of comprehensive income (loss) for the three months ended March&#160;31, 2022 and 2021.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS - In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.  The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional.  As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates are above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional are being recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million through October 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:36.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.534%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,886)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,963)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"/><td style="width:35.886%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.706%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.709%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,581)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,695&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,886)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:23.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.114%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,819&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(923)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of the 2019 Swaps at March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONTINGENT CONSIDERATION - On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening, in a combination stock and cash purchase.  As part of the purchase agreement, we will issue 18 months after acquisition, 113,303 shares with an initial fair value at the date of close of $3.0 million subject to adjustment for any indemnification claims and will be marked to market in subsequent periods.  See Note 4, Business Combinations and Related Activity for more information on the Quantib acquisition.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of contingent consideration on our condensed consolidated balance sheet is as follows (amounts in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"/><td style="width:24.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.899%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 20, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of other non operating income recognized on contingent consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Non Operating Income</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of contingent consideration at March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term assets</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarize the estimated fair values of certain of our shares of common stock issued in our Quantib B.V. acquisition on January 20, 2022, and held back for indemnification purposes that are subject to fair value measurements and the classification of these liabilities on our condensed consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,303 shares of RadNet common stock</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 3 inputs. More specifically, the fair value was determined by calculating the value estimated shares issuable as of the reporting date (which was $22.37), the time period related to the contractual settlement term, and the probability of issuing the shares.  As all the inputs are not observable (excluding our closing share price) and cannot be corroborated by observable market data, we employ a Level 3 category.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,769&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,769&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,563&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,875&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and at December&#160;31, 2021 our Barclays revolving credit facility had no balance outstanding. Our SunTrust revolving credit facility relating to our consolidated subsidiary The New Jersey Imaging Network ("NJIN"), had no principal amount outstanding at March&#160;31, 2022 and at December&#160;31, 2021.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt, which is discussed in Note 6, Credit Facilities and Notes Payable, was determined using Level 2 inputs primarily related to comparable market prices.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"/><td style="width:67.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.768%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income  attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,458&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,303,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,951,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,303,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,951,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,911&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,265&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and contingently issuable shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,362,193&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,828,941&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options:</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,912&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,595&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY INVESTMENTS AT FAIR VALUE&#8211;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we have three equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision Imaging Solutions Ltd., based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $1.2 million  represents a 14.21% equity interest in the company.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes, impairment in our investment or impairment of the loan receivable was identified as of March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition by Equity Method Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, our joint venture with Calvert Medical Imaging Center, LLC, completed the acquisition of certain assets to strengthen our presence in the Maryland market.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:17.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.974%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.126%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC *^</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,922</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,295</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,295)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, two of which were purchased separately by wholly owned RadNet subsidiaries.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the three months ended March 31, 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,746&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately $5.5 million and $5.2 million for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2022 and December&#160;31, 2021 and income statement data for the three months ended March 31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,119&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,186&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,722)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,919)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,506&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,489&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,214&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,930&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,746&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,411&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,718&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817425736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING AND REPORTING STANDARD<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING AND REPORTING STANDARD</a></td>
<td class="text">RECENT ACCOUNTING AND REPORTING STANDARD<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#8217;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard was effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-01 clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  The adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  The adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. We do not expect ASU 2021-08 to have a material effect, if any, on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817458984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATIONS AND RELATED ACTIVITY</a></td>
<td class="text">BUSINESS COMBINATIONS AND RELATED ACTIVITY<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Maryland market.  These acquisitions are reported as part of our Imaging Center segment.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"><tr><td style="width:1.0%"/><td style="width:16.890%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.624%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,000</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,013</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,560</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,968</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,560)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening, in an combination stock and cash purchase.  Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $45.2 million including i) 1,117,872 shares issued at $26.80 per share with a fair value of $30.0 million ii) cash of $1.8 million and iii) assuming liabilities of $11.9 million, $7.4 million in milestone contingent consideration and cash holdback of $4.5 million and iv) a settlement of a loan from RadNet of $1.5 million.  In addition we paid certain seller closing costs through the issuance of 23,362 shares at a fair value of $0.6 million.  We preliminarily recorded $1.0 million in current assets, $0.2 million in property plant and equipment, $27.5 million in intangible assets, $3.2 million in liabilities and $19.2 million in goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening, in a combination stock and cash purchase.  Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $42.3 million including i) 965,058 shares issued at $26.80 per share with a fair value of $25.9 million ii) cash of $11.8 million and iii)  113,303 shares with a fair value at the date of close of $3.0 million and cash holdback of $1.6 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods. We preliminarily recorded $2.4 million in current assets, $0.1 million in property plant and equipment, $21.3 million in intangible assets, $3.7 million in liabilities and $22.2 million in goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, our acquisitions of Aidence and Quantib are preliminary.  As we finalize our estimation of the fair value of the assets acquired and liabilities assumed, additional adjustments may be recorded during the measurement period (a period not to exceed 12 months). The initial accounting is preliminary as of March 31, 2022 for the acquired assets and liabilities as we are currently in the process of completing the assessment of valuation inputs and assumptions as well as completing the assessment of the tax attributes of the business combination. The finalization of the acquisition accounting valuation assessment may result in a change in the valuation of the deferred tax assets and liabilities and intangible assets, along with the opening working capital accounts, which could have a material impact on our results of operations and financial position.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817450200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text">SEGMENT REPORTING<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reportable segments are described below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence ("AI")</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):</span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.198%"><tr><td style="width:1.0%"/><td style="width:51.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.103%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.104%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">341,168&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">315,319&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">341,767&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">315,319&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">310,110&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">281,013&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">315,039&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">282,280&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,805&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,569&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">27,118&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,656&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss (Gain) on Disposal of Equipment:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,154&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,307)</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss (gain)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,128&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,307)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">201&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">285&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">201&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">285&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(Loss) Income from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,898&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,759&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,617)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total (loss) income from operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,719)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,405&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For proper comparative purposes, Imaging Center segment revenue in 2021 excludes $6.2 million in Provider Relief Funding, as it represents a form of direct Government stimulus.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817438232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CREDIT FACILITIES AND NOTES PAYABLE</a></td>
<td class="text">CREDIT FACILITIES AND NOTES PAYABLE<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and December&#160;31, 2021 our term loan debt obligations are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:74.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.841%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719,563&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,500&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751,871&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,164)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,164)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,498&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at March&#160;31, 2022 and have reserved $7.8 million for certain letters of credit. The remaining $187.2 million of our Barclays Revolving Credit Facility was available to draw upon as of March&#160;31, 2022.  We had no outstanding balance under our $30.0 million SunTrust Revolving Credit Facility at March&#160;31, 2022.  As of March&#160;31, 2022, we were in compliance with all covenants under our credit facilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $725.0 million of senior secured first lien term loans (the "First Lien Term Loans") and a $195.0 million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $14.9 million segregated as follows: $8.8 million capitalized to discount and deferred finance cost, $4.5 million expensed to debt restructuring costs,  $1.5 million charged to loss on early extinguishment of debt and $0.1 million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Secured Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">First Lien Term Loans:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Lien Term Loans under the Restated Credit Agreement bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable margin for Eurodollar Rate term loans under the Restated Credit Agreement is 3.25% per annum, with a reduction to 3.00% per annum upon delivery by us of financial statements for the period ending March 31, 2021 evidencing a first lien net leverage ratio of 3.50 to 1.00 or less.  Such statements were delivered by us on May 27, 2021. At March&#160;31, 2022 the effective Eurodollar Rate and the Alternate Base Rate for the First Lien Term Loans under the Restated Credit Agreement was 0.75% and 3.50%, respectively and the applicable margin for the Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was 3.00% and 2.00%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $1.8 million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, our SunTrust credit facilities, which relate to our consolidated subsidiary The New Jersey Imaging Network, L.L.C.("NJIN"), were comprised of one term loan in the principal amount described in the table above (the "SunTrust Term Loan") and a revolving credit facility of $30.0 million (the "SunTrust Revolving Credit Facility") both of which are provided pursuant to the Amended and Restated Revolving Credit and Term Loan Agreement dated August 31, 2018, among NJIN, as borrower, with SunTrust Bank, as administrative agent, and the lenders identified therein (as amended, the "SunTrust Credit Agreement").  Our SunTrust Term Loan bears interest at either an Adjusted LIBOR or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans and other obligations outstanding under the SunTrust Credit Agreement currently bear interest at a three month LIBOR election at 0.22% plus an applicable margin and fees based on Pricing Level V described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $0.8 million, representing annual amortization equal to 5.0% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $0.4 million, with the remaining balance to be paid at maturity.  The SunTrust Term Loan will mature on August 31, 2023 unless otherwise accelerated under the terms of the SunTrust Credit Agreement.</span></div><div><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $195.0 million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $2.0 million at March&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Net Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alternate Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.50x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.00x but &#8804; 3.50x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.00x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was 5.25%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently 2.75% and fronting fees accrue at 0.125% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SunTrust Credit Agreement established a $30.0 million revolving credit facility available to NJIN for funding requirements. The SunTrust Revolving Credit Facility terminates on the earliest of (i) August 31, 2023, (ii) the voluntary termination thereof by NJIN pursuant to Section 2.8 of the SunTrust Credit Agreement, or (iii) the date on which all amounts outstanding under the SunTrust Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  As of March&#160;31, 2022, NJIN had no borrowings under the SunTrust Revolving Credit Facility. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent prior amendments to prior credit facilities:</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the "Eighth Amendment").  The Eighth Amendment amended the prior first lien credit agreement to add $57.5 million of revolving commitments to the prior Barclays revolving credit facility increasing the maximum borrowing capacity under the prior Barclays revolving credit facility to $195.0 million while leaving the maturity date of July 1, 2023 unchanged.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019 we entered into the following two amendments to the prior first lien credit agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#8220;Sixth Amendment&#8221;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#8220;Seventh Amendment&#8221;).  Among other things, the Sixth Amendment amended the prior first lien credit agreement to issue $100.0 million in incremental first lien term loans and to add an additional $20.0 million of revolving commitments to the prior Barclays revolving credit facility.  The Seventh Amendment amended the prior first lien credit agreement to extend the maturity date of the prior Barclays revolving credit facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the prior first lien credit agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The prior first lien credit agreement was amended and restated by the Restated Credit Agreement described above, and the prior first lien term loans and prior Barclays revolving credit facility under the prior first lien credit agreement were refinanced and replaced by the First Lien Term Loans and the Barclays Revolving Credit Facility provided under the Restated Credit Agreement described above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817457304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021  (the "Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan 16,500,000 shares of common stock. We can issue options (incentive and nonstatutory), performance based options, stock awards (restricted or unrestricted), stock units, performance based stock units, and stock appreciation rights under the Restated Plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option grants, whether incentive or nonstatutory, generally vest over 3 to 5 years and expire 5 to 10 years from the date of grant.  Under the Restated Plan, stock options may not be granted at a per share exercise price below the fair market value of a share of our common stock on the date of grant, may not be repriced or exchanged without stockholder approval, and the maximum exercisable term of the option may not exceed 10 years.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had outstanding options to acquire 683,914 shares of our common stock, of which options to acquire 508,969 shares were exercisable. The following summarizes all of our option transactions for the three months ended March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,939&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.38&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683,914&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.54&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.49</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,157,802&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.43</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,126,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on March&#160;31, 2022 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on March&#160;31, 2022.  As of March&#160;31, 2022, total unrecognized stock-based compensation expense related to non-vested employee awards was $2.6 million, which is expected to be recognized over a weighted average period of approximately 2.24 years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted options to acquire&#160;412,434&#160;shares at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of March&#160;31, 2022, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $1.6 million, which is expected to be recognized over a weighted average period of approximately 1.23 years</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:48.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,660&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,637)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,023&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.18</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890,475&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,912&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options issued in replacement of original DeepHealth options as a result of our acquisition are not included in the share count under the Restated Plan.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of March&#160;31, 2022, we have issued a total of 7,743,651 RSA&#8217;s of which 438,786 were unvested at March&#160;31, 2022. The following summarizes all unvested RSA&#8217;s activities during the three months ended March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,075&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.06&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,622&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.72&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(517,911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at March 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438,786&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.96&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based on the closing price of our common stock on the award date.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits share awards not subject to any future service period. These are valued and expensed based on the closing price of our common stock on the date of award. During the three months ended March&#160;31, 2022, no such awards were granted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock units ("PSUs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the company granted certain employees PSUs with a target award of 25,683 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock options ("PSOs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the company granted certain employees PSOs with a potential to option a maximum of 111,925 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 111,925 shares) depending upon the extent to which we achieve a performance condition as determined the board of directors over the period from January 1, 2022 through December 31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restated Plan summary</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the 16,500,000 shares of common stock reserved for issuance under the Restated Plan, at March&#160;31, 2022, there remain 2,380,364 shares available under the Restated Plan for future issuance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817326648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTSFormation of majority owned subsidiaryOn April 1, 2022 we entered into Frederick County Radiology, LLC, a partnership with Frederick Health Hospital, Inc. ("Hospital").  The operation will offer multi-modality services out of six locations in Frederick, Maryland.  RadNet will have a 65% economic interest and Hospital will have a 35% economic interest<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069812944552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">REVENUES</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">ACCOUNTS RECEIVABLE</a></td>
<td class="text">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">DEFERRED FINANCING COSTS</a></td>
<td class="text">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">BUSINESS COMBINATION</a></td>
<td class="text">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">GOODWILL AND INDEFINITE LIVED INTANGIBLES</a></td>
<td class="text">GOODWILL AND INDEFINITE LIVED INTANGIBLESGoodwill and Indefinite Lived Intangibles are recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2021, noting no impairment.  We considered the current and expected future economic and market conditions surrounding COVID-19 pandemic and did not identify an indication of goodwill impairment being more likely than not through March&#160;31, 2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">LEASES</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of March&#160;31, 2022.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">EQUITY BASED COMPENSATION</a></td>
<td class="text">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we have amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric.  We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period.  Stock options generally vest over three years to five years and expire five years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 7, Stock-Based Compensation, for more information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text">COMPREHENSIVE INCOME (LOSS) - Accounting guidance establishes rules for reporting and displaying comprehensive income or loss and its components. Our unrealized gains or losses on foreign currency translation adjustments, interest rate cap and swap agreements are included in comprehensive loss and are included in the consolidated statements of comprehensive income (loss) for the three months ended March&#160;31, 2022 and 2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text">DERIVATIVE INSTRUMENTSThe 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional.As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates are above the arranged rates.At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div>The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt, which is discussed in Note 6, Credit Facilities and Notes Payable, was determined using Level 2 inputs primarily related to comparable market prices.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">EQUITY INVESTMENTS AT FAIR VALUE</a></td>
<td class="text">EQUITY INVESTMENTS AT FAIR VALUE&#8211;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">INVESTMENTS IN JOINT VENTURES</a></td>
<td class="text">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of March&#160;31, 2022.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">RECENT ACCOUNTING AND REPORTING STANDARDS</a></td>
<td class="text">RECENT ACCOUNTING AND REPORTING STANDARD<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#8217;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard was effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-01 clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  The adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  The adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. We do not expect ASU 2021-08 to have a material effect, if any, on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069813285112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock', window );">Schedule of Service Fee Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenues during the three months ended March&#160;31, 2022 and 2021 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.707%"><tr><td style="width:1.0%"/><td style="width:65.631%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.781%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,465&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,096&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,087&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,451&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,775&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,647&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,622&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,491&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,742&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,767&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Intangible Assets</a></td>
<td class="text">Activity in goodwill for the three months ended March&#160;31, 2022 is provided below (in thousands):<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,820&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,188&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill balances at March 31, 2022 reflect additional goodwill arising from deferred tax liabilities recorded on our acquisitions of Aidence Holding B.V. and Quantib B.V. of $7.3 million.  See Note 4, Business Combinations and Related Activity for more information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Effect of Derivative Instruments on Comprehensive Loss</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:36.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.534%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,886)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,963)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"/><td style="width:35.886%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.706%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.709%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,581)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,695&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,886)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:23.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.114%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,819&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(923)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of contingent consideration on our condensed consolidated balance sheet is as follows (amounts in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"/><td style="width:24.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.899%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 20, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of other non operating income recognized on contingent consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Non Operating Income</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Fair Value of Assets and Liabilities</a></td>
<td class="text">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term assets</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Swaps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarize the estimated fair values of certain of our shares of common stock issued in our Quantib B.V. acquisition on January 20, 2022, and held back for indemnification purposes that are subject to fair value measurements and the classification of these liabilities on our condensed consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,303 shares of RadNet common stock</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,769&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,769&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,563&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,875&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share</a></td>
<td class="text">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"/><td style="width:67.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.768%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income  attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,458&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,303,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,951,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,303,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,951,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,911&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,265&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and contingently issuable shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,362,193&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,828,941&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options:</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,912&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,595&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions</a></td>
<td class="text">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:17.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.974%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.126%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC *^</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,922</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,295</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,295)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, two of which were purchased separately by wholly owned RadNet subsidiaries.</span></div>We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"><tr><td style="width:1.0%"/><td style="width:16.890%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.624%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,000</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,013</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,560</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,968</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,560)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Investment in Joint Ventures</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the three months ended March 31, 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,746&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock', window );">Schedule of Joint Venture Investment and Financial Information</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2022 and December&#160;31, 2021 and income statement data for the three months ended March 31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,119&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,186&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,722)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,919)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,506&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,489&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,214&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,930&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,746&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,411&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,718&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Joint Venture Investment And Financial Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42567-110969<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817318152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions</a></td>
<td class="text">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:17.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.751%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.974%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.126%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC *^</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,922</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,295</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,295)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, two of which were purchased separately by wholly owned RadNet subsidiaries.</span></div>We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"><tr><td style="width:1.0%"/><td style="width:16.890%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.624%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,000</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,013</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,560</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,968</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,560)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817500744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.198%"><tr><td style="width:1.0%"/><td style="width:51.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.103%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.104%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">341,168&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">315,319&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">341,767&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">315,319&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">310,110&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">281,013&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">315,039&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">282,280&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,805&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,569&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">27,118&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,656&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss (Gain) on Disposal of Equipment:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,154&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,307)</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss (gain)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,128&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,307)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">201&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">285&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">201&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">285&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(Loss) Income from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,898&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,759&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,617)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total (loss) income from operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,719)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,405&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069895599944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Notes Payable, Line of Credit and Capital Lease Obligations</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and December&#160;31, 2021 our term loan debt obligations are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:74.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.841%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719,563&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,500&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751,871&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,164)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,164)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,498&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ScheduleOfLeverageRatioTableTextBlock', window );">Schedule of Leverage Ratio</a></td>
<td class="text">Our SunTrust Term Loan bears interest at either an Adjusted LIBOR or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table>Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Net Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alternate Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.50x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.00x but &#8804; 3.50x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.00x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ScheduleOfLeverageRatioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leverage Ratio [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ScheduleOfLeverageRatioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069816747560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Activity</a></td>
<td class="text">The following summarizes all of our option transactions for the three months ended March&#160;31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,939&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.38&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683,914&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.54&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.49</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,157,802&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.43</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,126,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:48.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,660&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,637)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,023&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.18</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890,475&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,912&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of RSA Activity</a></td>
<td class="text">The following summarizes all unvested RSA&#8217;s activities during the three months ended March&#160;31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,075&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.06&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,622&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.72&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(517,911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at March 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438,786&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.96&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069810426728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>center </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberOfCenters', window );">Number of centers | center</a></td>
<td class="nump">351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues', window );">BRMG and NY Groups revenues</a></td>
<td class="nump">$ 45,700<span></span>
</td>
<td class="nump">$ 46,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense', window );">BRMG and NY Groups operating expenses</a></td>
<td class="nump">45,700<span></span>
</td>
<td class="nump">46,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax', window );">Management services provided to BRMG and NY Groups</a></td>
<td class="nump">191,000<span></span>
</td>
<td class="nump">179,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">2,141,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,058,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 1,720,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,712,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLlcMember', window );">ScriptSender LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLlcMember', window );">ScriptSender LLC | Operating Expense | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">100,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 16,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Centers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069810446072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 341,767<span></span>
</td>
<td class="nump">$ 315,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">303,276<span></span>
</td>
<td class="nump">279,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member', window );">Commercial insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">188,465<span></span>
</td>
<td class="nump">182,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">70,999<span></span>
</td>
<td class="nump">63,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">9,087<span></span>
</td>
<td class="nump">8,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member', window );">Workers' compensation/personal injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">12,449<span></span>
</td>
<td class="nump">10,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember', window );">Other patient revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">7,123<span></span>
</td>
<td class="nump">4,775<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember', window );">Management fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">5,508<span></span>
</td>
<td class="nump">5,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_SoftwareMember', window );">Software revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">3,399<span></span>
</td>
<td class="nump">2,426<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_AIMember', window );">AI revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">599<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">5,647<span></span>
</td>
<td class="nump">2,622<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 38,491<span></span>
</td>
<td class="nump">$ 35,742<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicare1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicaid1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_SoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_SoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_AIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_AIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069802783128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="2">24 Months Ended</th>
<th class="th" colspan="1">27 Months Ended</th>
<th class="th" colspan="1">40 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 20, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 05, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>jointVenture </div>
<div>security </div>
<div>incentivePlan</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>jointVenture </div>
<div>security </div>
<div>incentivePlan</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>incentivePlan </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractsReceivableFactoringReceivable', window );">Contracts receivable, factoring receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,700,000<span></span>
</td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">570,188,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">513,820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">513,820,000<span></span>
</td>
<td class="nump">570,188,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,496,000)<span></span>
</td>
<td class="num">$ (4,376,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.20%<span></span>
</td>
<td class="nump">24.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans', window );">Number of plans | incentivePlan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Amount of loss recognized in income on derivative (current period ineffective portion)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (dollars per share) | $ / shares</a></td>
<td class="nump">$ 22.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities', window );">Number of securities without readily determinable fair value | security</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberofUnconsolidatedJointVentures', window );">Number of unconsolidated joint ventures | jointVenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ManagementServiceFees', window );">Management service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember', window );">Medic Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member', window );">WhiteRabbit.ai Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Payments to fund loan to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib B.V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 22,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Contingent consideration, liability, period</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares', window );">Additional number of shares issued (in shares) | shares</a></td>
<td class="nump">113,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution', window );">Fair value of additional shares issued after execution</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVAndQuantibBVMember', window );">Aidence Holding B.V. and Quantib B.V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 Swaps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 Swaps - Interest Rate Contracts | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.96%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS | 2019 Swaps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS | 2019 Swaps - Interest Rate Contracts | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.05%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Dignity Health | Joint Venture | Glendale Advanced Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Variable interest entity, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Amounts returned to property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Dignity Health | Joint Venture | Glendale Advanced Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Variable interest entity, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Amounts returned to property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">First Lien Credit Agreement | Revolving Credit Facility | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">COVID-19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AdvanceMedicarePayments', window );">Advance medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">$ 39,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsFromProviderReliefFunding', window );">Proceeds from provider relief funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="nump">26,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_RepaymentOfAdvanceMedicarePayments', window );">Repayment of advance medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_SocialSecurityTaxEmployerDeferralCARESAct', window );">Deferred social security taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_CaresActRefundableClaimPercentage', window );">Refundable claim percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct', window );">Reduction in deferred social security taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">COVID-19 Pandemic | Paycheck Protection Program loans at 1% due April 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Proceeds from PPP loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CaresActRefundableClaimPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cares Act, Refundable Claim Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CaresActRefundableClaimPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractsReceivableFactoringReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Factoring Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractsReceivableFactoringReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ManagementServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management service fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ManagementServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly Amortization Of Deferred Hedge Gains</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MonthlyAmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberofUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Unconsolidated Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberofUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromProviderReliefFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Provider Relief Funding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromProviderReliefFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_RepaymentOfAdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment Of Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_RepaymentOfAdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_SocialSecurityTaxEmployerDeferralCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Social Security Tax, Employer, Deferral, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_SocialSecurityTaxEmployerDeferralCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from principal payments made on loans related to operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVAndQuantibBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVAndQuantibBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_DignityHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ProperyAndEquipmentNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ProperyAndEquipmentNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069815403192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">$ 513,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Valuation adjustment</a></td>
<td class="num">(296)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(551)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">570,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember', window );">Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from acquisitions</a></td>
<td class="nump">57,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVAndQuantibBVMember', window );">Aidence Holding B.V. and Quantib B.V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from acquisitions</a></td>
<td class="nump">$ 7,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVAndQuantibBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVAndQuantibBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069802731928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value</a></td>
<td class="nump">$ 346,157<span></span>
</td>
<td class="nump">$ 258,303<span></span>
</td>
<td class="nump">$ 258,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</a></td>
<td class="nump">923<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value</a></td>
<td class="nump">421,450<span></span>
</td>
<td class="nump">281,358<span></span>
</td>
<td class="nump">346,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Amount of comprehensive loss recognized on derivative net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</a></td>
<td class="nump">923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other income (expense) | Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of gain recognized in income on derivative (current period ineffective portion)</a></td>
<td class="nump">20,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest Expense | Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</a></td>
<td class="num">(923)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Other Comprehensive Loss, net of taxes | Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value</a></td>
<td class="num">(18,886)<span></span>
</td>
<td class="num">$ (22,581)<span></span>
</td>
<td class="num">(22,581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value</a></td>
<td class="num">$ (17,963)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,886)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069812939800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details- Contingent Consideration) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Amount of other non operating income recognized on contingent consideration</a></td>
<td class="num">$ (501)<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib B.V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward', window );"><strong>Business Combination, Contingent Consideration, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Accrued expenses at the beginning</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Amount of other non operating income recognized on contingent consideration</a></td>
<td class="num">(501)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Accrued expenses at the end</a></td>
<td class="nump">$ 501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069810843704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and SunTrust Term Loan</a></td>
<td class="nump">$ 764,563<span></span>
</td>
<td class="nump">$ 767,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">2,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and SunTrust Term Loan</a></td>
<td class="nump">753,769<span></span>
</td>
<td class="nump">766,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and SunTrust Term Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and SunTrust Term Loan</a></td>
<td class="nump">753,769<span></span>
</td>
<td class="nump">766,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Milestone contingent consideration</a></td>
<td class="nump">2,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and SunTrust Term Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 Swaps - Interest Rate Contracts | Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">2019 Swaps - Interest Rate Contracts</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">16,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 Swaps - Interest Rate Contracts | Estimate of Fair Value Measurement | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">2019 Swaps - Interest Rate Contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 Swaps - Interest Rate Contracts | Estimate of Fair Value Measurement | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">2019 Swaps - Interest Rate Contracts</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">16,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 Swaps - Interest Rate Contracts | Estimate of Fair Value Measurement | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">2019 Swaps - Interest Rate Contracts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069812929656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to RadNet, Inc.'s common stockholders</a></td>
<td class="nump">$ 3,013<span></span>
</td>
<td class="nump">$ 9,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">55,303,007<span></span>
</td>
<td class="nump">51,951,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Nonvested restricted stock subject only to service vesting (in shares)</a></td>
<td class="nump">197,911<span></span>
</td>
<td class="nump">253,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Additional shares issuable upon exercise of stock options and warrants (in shares)</a></td>
<td class="nump">861,275<span></span>
</td>
<td class="nump">624,170<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares used in calculating diluted net income per share (in shares)</a></td>
<td class="nump">56,362,193<span></span>
</td>
<td class="nump">52,828,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Nonvested restricted stock subject to service vesting</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">46,912<span></span>
</td>
<td class="nump">82,595<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069817514920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details- Schedule of Acquisition)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($) </div>
<div>center</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 570,188<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember', window );">IFRC LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="nump">$ 3,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="nump">2,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="nump">1,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="num">$ (1,295)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCAcquisitionsMember', window );">IFRC LLC Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,560)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | center</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069808852280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward', window );"><strong>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Beginning balance</a></td>
<td class="nump">$ 42,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings in these joint ventures</a></td>
<td class="nump">2,517<span></span>
</td>
<td class="nump">$ 2,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Ending balance</a></td>
<td class="nump">$ 44,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069818268776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 288,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 324,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(381,298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(374,784)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Total value of RadNet joint venture interests</a></td>
<td class="nump">44,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">341,767<span></span>
</td>
<td class="nump">$ 315,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">8,363<span></span>
</td>
<td class="nump">13,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember', window );">Equity Method Investment, Nonconsolidated Investee or Group of Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">37,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">83,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(12,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,919)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(27,298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,370)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="nump">80,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">37,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Cost in excess of book value of acquired joint venture interests and other</a></td>
<td class="nump">7,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,299<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Total value of RadNet joint venture interests</a></td>
<td class="nump">44,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">34,411<span></span>
</td>
<td class="nump">31,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 5,035<span></span>
</td>
<td class="nump">$ 4,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069810447032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets Acquired and Liabilities Assumed)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($) </div>
<div>center</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 570,188<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCAcquisitionsMember', window );">IFRC LLC Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,560)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | center</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLC1Member', window );">IFRC LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="nump">2,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="nump">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="num">(857)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLC2Member', window );">IFRC LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="nump">8,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="nump">2,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLC1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLC1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLC2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLC2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069810379128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jan. 20, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 570,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 570,188<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence B.V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,141,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payment to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Assumed liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities', window );">Loans settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence B.V | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence B.V | Certain Seller</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity issued or issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence B.V | Other Sellers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,117,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Price per share (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity issued or issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib B.V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">113,303<span></span>
</td>
<td class="nump">965,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Price per share (dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity issued or issuable</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 25,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payment to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="nump">501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 501<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Contingent consideration, liability, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib B.V | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Milestone contingent consideration</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_CertainSellerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_CertainSellerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_OtherSellersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_OtherSellersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069809920904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 341,767<span></span>
</td>
<td class="nump">$ 315,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="nump">315,039<span></span>
</td>
<td class="nump">282,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">27,118<span></span>
</td>
<td class="nump">22,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss (gain) on sale and disposal of equipment and other</a></td>
<td class="nump">1,128<span></span>
</td>
<td class="num">(1,307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">(Loss) Income from Operations</a></td>
<td class="num">(1,719)<span></span>
</td>
<td class="nump">11,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">COVID-19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsFromProviderReliefFunding', window );">Proceeds from provider relief funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 35,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember', window );">Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">341,168<span></span>
</td>
<td class="nump">315,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="nump">310,110<span></span>
</td>
<td class="nump">281,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">25,805<span></span>
</td>
<td class="nump">22,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss (gain) on sale and disposal of equipment and other</a></td>
<td class="nump">1,154<span></span>
</td>
<td class="num">(1,307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">(Loss) Income from Operations</a></td>
<td class="nump">3,898<span></span>
</td>
<td class="nump">12,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember', window );">AI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">599<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="nump">4,929<span></span>
</td>
<td class="nump">1,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,313<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss (gain) on sale and disposal of equipment and other</a></td>
<td class="num">(26)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">(Loss) Income from Operations</a></td>
<td class="num">$ (5,617)<span></span>
</td>
<td class="num">$ (1,354)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingIncomeLossExcludingReliefFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Excluding Relief Funding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingIncomeLossExcludingReliefFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromProviderReliefFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Provider Relief Funding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromProviderReliefFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069802773464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">$ 751,871<span></span>
</td>
<td class="nump">$ 754,662<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">751,871<span></span>
</td>
<td class="nump">754,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion</a></td>
<td class="num">(11,164)<span></span>
</td>
<td class="num">(11,164)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term portion debt obligations</a></td>
<td class="nump">740,707<span></span>
</td>
<td class="nump">743,498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loans | First Lien Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">719,563<span></span>
</td>
<td class="nump">721,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on First Lien Term Loans</a></td>
<td class="num">(12,692)<span></span>
</td>
<td class="num">(13,213)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">719,563<span></span>
</td>
<td class="nump">721,375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loans | SunTrust Term Loan collateralized by NJIN's tangible and intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">46,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="nump">$ 46,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069807062600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 23, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 18, 2019 </div>
<div>USD ($) </div>
<div>center</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 28, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt restructuring and extinguishment expenses</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberOfAmendments', window );">Number of amendments | center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember', window );">First Lien Credit Agreement Seventh Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="nump">14,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt discount</a></td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredCharges', window );">Amortization of deferred issuance costs</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember', window );">SunTrust | Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentPercent', window );">Periodic payment, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease', window );">Periodic payment amortization increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember', window );">First Lien Credit Agreement, Sixth Amendment | Term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember', window );">First Lien Term Loan | Barclays | Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit facility, remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | SunTrust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | SunTrust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity', window );">Line of credit facility, increase borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement, Sixth Amendment | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity', window );">Line of credit facility, increase borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentExtensionPeriod', window );">Extension period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Eurodollar Rate Spread | Leverage Ratio Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Eurodollar Rate Spread | Leverage Ratio Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Alternate Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Alternate Base Rate Spread | Leverage Ratio Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | SunTrust Term Loan collateralized by NJIN's tangible and intangible assets | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | SunTrust Term Loan collateralized by NJIN's tangible and intangible assets | Eurodollar Rate Spread | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">0.22%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | SunTrust Term Loan collateralized by NJIN's tangible and intangible assets | Alternate Base Rate Spread | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Barclays | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | First Lien Credit Agreement, Sixth Amendment | Line of Credit | Eurodollar Rate Spread | Leverage Ratio Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Terms, Amortization Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Increase Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LineofCreditFacilityIncreaseBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Amendments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortization of deferred charges applied against earnings during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069810664520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) - SunTrust Term Loan<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage Ratio, greater than</a></td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Applicable Margin for Letter of Credit Fees</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Applicable Percentage for Commitment Fee</a></td>
<td class="nump">0.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I | Eurodollar Rate Spread | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Margin For Loans</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I | Alternate Base Rate Spread | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Margin For Loans</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage Ratio, greater than</a></td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage Ratio, less than</a></td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Applicable Margin for Letter of Credit Fees</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Applicable Percentage for Commitment Fee</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II | Eurodollar Rate Spread | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Margin For Loans</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II | Alternate Base Rate Spread | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Margin For Loans</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage Ratio, greater than</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage Ratio, less than</a></td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Applicable Margin for Letter of Credit Fees</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Applicable Percentage for Commitment Fee</a></td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III | Eurodollar Rate Spread | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Margin For Loans</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">0.22%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III | Alternate Base Rate Spread | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Margin For Loans</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage Ratio, greater than</a></td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage Ratio, less than</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Applicable Margin for Letter of Credit Fees</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Applicable Percentage for Commitment Fee</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV | Eurodollar Rate Spread | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Margin For Loans</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV | Alternate Base Rate Spread | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Margin For Loans</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage Ratio, less than</a></td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Applicable Margin for Letter of Credit Fees</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Applicable Percentage for Commitment Fee</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V | Eurodollar Rate Spread | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Margin For Loans</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V | Alternate Base Rate Spread | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Margin For Loans</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069813332936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio) - Revolving Credit Facility - First Lien Credit Agreement - Line of Credit<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember', window );">&gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember', window );">&gt; 3.50x | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember', window );">&gt; 3.50x | Alternate Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember', window );">&gt; 3.00x but &#8804; 3.50x | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember', window );">&gt; 3.00x but &#8804; 3.50x | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember', window );">&gt; 3.00x but &#8804; 3.50x | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember', window );">&gt; 3.00x but &#8804; 3.50x | Alternate Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember', window );">&#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember', window );">&#8804; 3.00x | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember', window );">&#8804; 3.00x | Alternate Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069810267032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details Narrative)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>incentivePlan </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>incentivePlan </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans', window );">Number of plans | incentivePlan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance', window );">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,380,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 2 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">473,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option | DeepHealth Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Total issued up to date (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,743,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">456,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember', window );">Future Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">25,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="nump">111,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Performance Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Performance Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available in grant (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Performance Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Performance Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available in grant (in shares)</a></td>
<td class="nump">111,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_FutureServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069813031992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) - Equity Option<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares)</a></td>
<td class="nump">473,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">209,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares)</a></td>
<td class="nump">683,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable Shares at the end (in shares)</a></td>
<td class="nump">508,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 9.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share) | $ / shares</a></td>
<td class="nump">29.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">15.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Per Common Share, Exercisable (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">6 years 5 months 26 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">5 years 5 months 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 6,157,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 6,126,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares)</a></td>
<td class="nump">320,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(12,637)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares)</a></td>
<td class="nump">308,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable Shares at the end (in shares)</a></td>
<td class="nump">46,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">7 years 2 months 4 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">7 years 2 months 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 6,890,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 1,049,413<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069809894696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details - RSU's) - Restricted Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>RSA's</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">456,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">500,622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(517,911)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">438,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Term (Years)</a></td>
<td class="text">1 year 1 month 28 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 20.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">28.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">21.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 25.96<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140069818838168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - Subsequent Event - Frederick County Radiology, LLC<br></strong></div></th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>location</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberOfLocationOfferingMultiModalityServices', window );">Number of location offering multi-modality services</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Frederick County Radiology, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Ownership interest</a></td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Frederick Health Hospital, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Ownership interest</a></td>
<td class="nump">35.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfLocationOfferingMultiModalityServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Location Offering Multi-Modality Services</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfLocationOfferingMultiModalityServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_FrederickCountyRadiologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_FrederickCountyRadiologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>rdnt-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rdnt="http://www.radnet.com/20220331"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20220331.xsd" xlink:type="simple"/>
    <context id="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib54bc4806e7a4e68808598eddfb79202_I20220505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2022-05-05</instant>
        </period>
    </context>
    <context id="i2d51580d4825469e821595335785ef53_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i149f4a7d4caa402e82e20e079677076d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2605b786cda241819a617675d3a16552_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i285d42025a684eea9d37aef0f1d14159_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i61b4276af6d44d32ad20efcc3c5b920b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1edab43086bf43f4838cf141ce134cfb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic6c326d52eb544be8bd9b419b21bf661_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92a159e91d424561b526e4f4e0f77d49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie0a062644b1a463b95d9488efe1f1e9d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9902151192a44beaa1c9350219e3f13_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4bb0ae88cb924707aa34148fe232e546_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i520ee3069e394d228388f671ea45af80_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53a301eed9394031a8f0503c15c07855_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ca7e0851947420686d239632088b156_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9029d82f8c0a4ca992f906e0be3c5858_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib19dc048664d4c4fa328399747a3ccfa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4622b4997a4a4eccb0c0fb0915a887af_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia31e62681d3c4358b16ca1844ba3f0b1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibb193f06c3a44c5a8335f469b106c368_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iadec43eade70409e9d0da25233b1dfde_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6075cb3a8ec8490d9a77109346158e64_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic4832576a7844a8596613f578d05549d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iefc7c8c1bcd0401d8a5c82be7e8fe00f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaa990aa527e1441eb4aa259e7c4a4311_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i70baa850fe584a93b43499065527584c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i068b30b1e9cb45efbe0395c727f3bb66_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia524ae0349d841c5bea7e971fafb1f2f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic3ea365926174da78fafa3edf281157f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3bd41347893b42dda87f2f49f1d20d77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i729694f595eb4900a9bbee1a57c1c865_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80d5947f62c845b3b04f76fc1a749fe1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i776431f5daf3445a96806322961098ce_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib6c1a53cb7ec4f729af5315153b1f9ab_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia07ad7db2a1a4923864a30fe3533a635_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia3d203a14a9649c5b4159c9895f003d2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9c8654171884445c860af370f5bfea70_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a645db31d194b07afc404edff2224fc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib15b4952b11a47fb9236321bd4319708_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ice4eb83abe1d4023b624f59e96214964_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9923e7aecddc4104b04852156ffa40cd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i072529ea3a664abaa7cfed01aee70693_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i08eccb87eff3426d8baf820a26ef8096_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i87a8e19419ba4657b804a6671424a127_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i59d4c12a55344278a60a16915110bed1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i193b2936e56f4e0cbc28405f53112fa5_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="ifa15adcb65e94d769e97b210362a1702_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="id4779c75d3584b92a138261c6841bda4_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="id03c7545762c4f66b0e58615ce5345db_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="i92e430343aa64146a7eda3b1524bc877_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="ie4b3b1411401444f9e1598514c6e4f34_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="i10368330403342cab4b72f7c8a363d0b_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i408288df014b467c9d35d6c84ed0afd4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia4121846437d46c897233bae9c9a6bbd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibe76a6a063624942b6870c14878eb85b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i36c0e21c63724ab3a7cb8109c29fb186_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0f9c76414c854366adacd1025313a311_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if0814f8295094f73a07b17a0ea048a22_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if18b633eea03421b8f0beb791427de6a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i63f90bdc631743c984922bdc1021a382_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4a26be7fa427465ea07552ca86911792_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4bd4c2145a8a4cd3863fd3617fbfa90e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5620bbf4e4f84b4c910f4cc3a6fd3e4b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia71163553a4f410787a124d8d66b0e24_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id872fda809f94d66911bf9bed7f149bc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icaf803a00a874891b5809498d753bd6c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i92d49bb958ff4b4c812a88416ba02fa6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i41646490802644a5945209bcc69d3f40_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie16c2fada5f146a28cfdc71179dea43e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id9ebdad869674354bf27b7a86e43d9e3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie38a0f605d3e4c68b25430e65285e3e7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib6e867081801442288b3623055f9b0d6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i041ea1457ed044bcaa322ae1adc5cf1d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i97333ecfd0244f90905767929fe29b00_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iad6312f903a74fa5a463cec7c3aeeef9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifb6fe52c39e2437d8016fabb3cae733e_D20200101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if3550ac82c3f40c19d6f03a23e217852_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b6de56811c743baa555eba8f903a54d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i75d923098e5d4a0ba8b3f7ac2c2de141_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie82ee386e6eb4838b2bc73fbbed35685_D20200101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3be9b88ce86c4744bf9e653fbfd94c90_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if7a4a64a35034275b1c621fed996e4d6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i942d9cebffbb4273877f3ac67a45462f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9b445489971a44ef8c84f8ed64c4e83e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5ee8582ac6274cbd9efd095c7d1133b3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i12c3a8c867b34ac68810453b838a2512_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibe80e0841a2748468587fe41fa4e816d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id6c679f4cdfd406189d36613f3477385_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia604fcc12d02444abd767ce04feff86e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6fefd7d7be254ff5afc618390afc8022_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVAndQuantibBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8c5258f2864b4b36a115d030fd6f6f0c_I20210415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-15</instant>
        </period>
    </context>
    <context id="i1f6c8dad5f1a47f795469ebccd173f1a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i096002072adf4d33b28c2551f1673e8d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3ca7aedbfe5d492cbf2c8002a3274c68_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic89c652d406f400bb6ace78022bdeb15_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6ca7b8d957854f59aa72e2303bda7c43_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i94e159b506e24f2ba312631b9d16e313_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i4a953bd9d4fa4594b4bec67ab351df4a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib3c38d0041d84df692e1f844842547ab_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i1ad404b13b9e47818c995000abcc2af9_D20200701-20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-01</endDate>
        </period>
    </context>
    <context id="idd1aeae2536a41608c3ca6a90e5f158e_D20200701-20231031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="i81fba56dea454c119ee7cf826d420c68_D20231101-20251030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2025-10-30</endDate>
        </period>
    </context>
    <context id="ia5a821e65c2544d5a2b4b289ae3296fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i75a2b41962224ca58c77ef230e603ac4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7ed6eb6d787b4fb6b3d5fbfd38cd9917_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if95355fe5a3242819fcb7d0e02be7ec3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf2ec2ce1cae4a43bed55d993eadf539_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f460fdf9f124cfaa19c7b7e51eaf2f2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9c9a983e6ab54175b3a01c54d524c7a8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i753a81b55a9f4fb484fadfcdc315c4e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc1c497245b149e284139819564e0884_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf6e35695eaa4dd8b7dd11f4cabb0ea7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7b37a6d0909f429ea7e69dfe397ea84b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie1c72c1dc48746639ec661fa2dcd2090_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie348136a7ee3486ca5466e8c06a98ee0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if1b6d8c2e1034d85aab248128f367e1b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia18b8469f0344621a9fe57a2fdd8b537_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2943452c6ebb4be889c458dfb30e5334_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id14ca2ee887945609d66115bf804422c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if42b9c9a847043829b014731da1e39d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9157a041f574895a708682c8fc778d8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id469797c65cf443da10faec1b3088beb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2158c83bdd5247bcb8c21b6f9c1ab650_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib324770e341c43deb03d6adaf27aeb3b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9fb86495a1f749bea1502c1e616f2590_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="ib2cdca6cf3344e588f5fd3a61929ec4a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65afeb72c5874b7dabc692b4b7060cf4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7628b2fb529f4c519168b280f905d875_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fc944cf5d8b4854b25485eed3739509_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i087e463165f046e8819239d70522c4bb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia6e199c650d745829d22ac92ce902098_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i992fabbabab44df7b3b1693d7cbf856c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7037863c1e3e41be9812230db93860cc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id0849868ae3c4ceb92bbeb7de548fba8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4f1f9da235cc407c9377b1b4199f2c94_D20191105-20191105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-05</startDate>
            <endDate>2019-11-05</endDate>
        </period>
    </context>
    <context id="i6eae8a7d772041fd90c955f920bc9ae8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iec48a9056e99437fbf2864df26de0803_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie110fb96d5d244519c0c1cf9826af837_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="i729756c7eae9463bb7f2dc97e4f51489_D20220101-20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="ic67563cef4c9491d9d0dc503a64601b6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie90163b29ad64822a65cf592dbd711ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id06cc52a0f9944378c61c46c035f80f6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia2588fa1944547388e26c3a6dc631651_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i636dd2048c8c4f80b50c95a50ddf044d_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="ideac6fdbbd604859beff580d11ae84b3_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLC2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="ib261e6ac493749b8b10541441e853944_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id0bf43006b8e4c76b133b1590044e764_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="i87b26de1e4b243908f72f164ff3c9086_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="i2031463f67164712a74de886e34783a3_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="i3d27827222204849a68e073722e8fc1d_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:CertainSellerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="i15c67e44f3fc456cab260a3b8f274e7e_D20220331-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ieeafd6bcebca4a6683a7ac275f256f43_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iae865f3f81124444953fdc68855c5377_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia6603de1c39843a99a8e725c3ba62d5d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i733096088bfb4e4593a3c6893d07f184_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibfb1d71aa2ad40129d22f67c28e34718_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i17d341f477874224896da30df2514be5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b2021e8693c43efb8f3683e1a35b4df_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="i4c9e01d6493f43e299012d6df312e4bf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i306b15aed8664de6a18898691aeec87c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i45d5c9e3d43546498d2a26f35f8668b2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2f7f03f2987a4c7fb79e4440534fa07b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i53f75acbd56447d2a0b5536e5817ebbb_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="i808acf82ba384ff191da9c1c7c61d43a_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="i7c887837d9ef4909b82fa07c516cbe5f_D20210423-20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-04-23</startDate>
            <endDate>2021-04-23</endDate>
        </period>
    </context>
    <context id="ia71e051856e14e40b66eb9309af46b02_D20210423-20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-23</startDate>
            <endDate>2021-04-23</endDate>
        </period>
    </context>
    <context id="ieb3b9b1ec109454b8176b9068a603457_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9078e720809546d6aaf957bdefc7dbd7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaf7f88c678b74b4b886228218a5301cd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3a411712fae44141898b470479a1a692_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4bc8bed1e3c54b7ba889d6e0b9d215c5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7b94146cc90742289e03e41f9581f179_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1fb8a36da6224876bbbbb9c7b1e0d449_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2a2d0c6e90f04f8082784ea469840870_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a4c35b6f71f4affa5768a0f639d4a2e_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="ib94c9abf453248efa63db38b503a8c1f_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i14767b8798514b70a2a6a74b9bfa6102_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i6498b4b0455a4c30a9f141fc0c149aa5_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i77287fbd0d0a43c186ef244cf589e396_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i21e6a5f9bcb0473b911a70e52c9e9944_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i0203d30cd0df4077a62703e30f8c9f72_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i66fff8293b844dbb838b2a1631a77770_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i7197db62c8b045d3873fabec7ae0b9bb_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="ib0748b4650f54d66b1525c3d3fd5f155_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i9f32cd9d031641319a66833f52dcf90b_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i4e79888671f849d681c9ca4dc7cbaa90_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i2d79a719943a464f8d6d78268821d707_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i6a23d776eb16471e8f49c42bb87a1e64_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i284b87cc02134d23929b19658a998ad3_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i64766f8ffc80490290a08bed27b2773e_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i788b4cad69a643e098e52cb02eb7e58d_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i216ae89339844560bddb88a4bcab64fb_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i9bdf68a9ef0548fb84d159aeddab27f9_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i5c6b1f79048e42b0884571c09c623080_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ib450abcacaa5468ca7b49d50d7ed31f4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i12925f11ce794cee9ffd477add1fac2e_D20181231-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3adb88ce1adf406397b79615c8b29bf7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6e5edfcb6761487ba2db12d147e1a78a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i944cc9d161d74ab4a23982b4cd8bdde3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifab2cc344a8d437a8e02749427a7acff_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i55945c769c1d4cb2adf73dd4dd33aeb1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5b949300d1bf4eb787b7017dba8800a8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8f737acdac8048f2957feb692e3d8687_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if714085c7d9d491f9c016de58ac30e20_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6f29d5fa82f04e0896fcba4d15e506de_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaf21c52bd3f345188e62a53c44636392_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3c069f2e05fb4ade941f4557b949f231_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ba7bf841c994912865be36c75e38317_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i69b9eb94e2114856a02bf051af39e645_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2c4dd403dd9e4ae1818b1ff441f9d0fd_I20200828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-28</instant>
        </period>
    </context>
    <context id="i0dde26745a6044629a509a83ba660edb_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="i173683f5805b4c458be4a416f552f961_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="ice280dd4e241422aad4acecf0b4651de_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="i6d0fe3c768bd4ce39293d761c41ecb34_D20190418-20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-18</startDate>
            <endDate>2019-04-18</endDate>
        </period>
    </context>
    <context id="i11e3573789424e659f1797ec670783df_I20210415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-04-15</instant>
        </period>
    </context>
    <context id="i5fe72543c2724817acf22b92b9937440_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9212727f374b4ce7870dbc05eb4d8aab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if325d72e03184e4ea6e238d77b34f487_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icf3ba225c36c476084469d9c6670a07a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6bb501a256514bab8c456345170a164f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8e2634a74afe41adab0fab66686d695b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia330bf2f544847c6ba7b2723fd73ac98_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib5e7a1236cb84c87a209ab1daf15ec5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5e5cdfa72e1f434c8006a75f7440ddfa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9638ca6566474cefbd8968ed4929434f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie2d96663c67244b8aed2634eec524266_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i02c8a2af4cae4e6e846dbb7f3b47fdb3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id651533cf9634a93ac70355625b736ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5c138bc3875441b941c772784e63633_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibc2a40dd49e04ddfaf6d85ae95da2eff_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i097c50f9108e4084a44c52e4dd246bee_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i34139941895f4c2b87454e78288b6292_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="id250c206c9c1458d9f1fbcfcdf5640d7_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="id200edd7b27544e283a49fdc5f16ae77_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ie6fa67c017444c96a4b8dc187d33a734_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i05688edf21f347e59b6c396261cdb342_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i5b489515e2944df5827ad37c4f4ac39a_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="ibf0e02f07fbc478f873c7b8dd2a24f2d_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="center">
        <measure>rdnt:center</measure>
    </unit>
    <unit id="segment">
        <measure>rdnt:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="incentiveplan">
        <measure>rdnt:incentivePlan</measure>
    </unit>
    <unit id="agreement">
        <measure>rdnt:agreement</measure>
    </unit>
    <unit id="security">
        <measure>rdnt:security</measure>
    </unit>
    <unit id="jointventure">
        <measure>rdnt:jointVenture</measure>
    </unit>
    <unit id="location">
        <measure>rdnt:location</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80L2ZyYWc6OWM4MTJhNDc3ZWU4NDAxNzljZDYzZmFkZDMzNzBjZTMvdGFibGU6MzMyMjkxYjkzM2ZlNDA0OGJiMjEyYzY2NmE0OTQ5NTEvdGFibGVyYW5nZTozMzIyOTFiOTMzZmU0MDQ4YmIyMTJjNjY2YTQ5NDk1MV8xLTEtMS0xLTE0Mjc5_bff61dc2-0e03-45ce-8503-5248048e6447">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80L2ZyYWc6OWM4MTJhNDc3ZWU4NDAxNzljZDYzZmFkZDMzNzBjZTMvdGFibGU6MzMyMjkxYjkzM2ZlNDA0OGJiMjEyYzY2NmE0OTQ5NTEvdGFibGVyYW5nZTozMzIyOTFiOTMzZmU0MDQ4YmIyMTJjNjY2YTQ5NDk1MV8yLTEtMS0xLTE0Mjc5_67d882ce-7816-486b-8f80-c9fa30a7a395">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80L2ZyYWc6OWM4MTJhNDc3ZWU4NDAxNzljZDYzZmFkZDMzNzBjZTMvdGFibGU6MzMyMjkxYjkzM2ZlNDA0OGJiMjEyYzY2NmE0OTQ5NTEvdGFibGVyYW5nZTozMzIyOTFiOTMzZmU0MDQ4YmIyMTJjNjY2YTQ5NDk1MV8zLTEtMS0xLTE0Mjc5_90099f11-bace-4b90-b162-bafa79a80b31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80L2ZyYWc6OWM4MTJhNDc3ZWU4NDAxNzljZDYzZmFkZDMzNzBjZTMvdGFibGU6MzMyMjkxYjkzM2ZlNDA0OGJiMjEyYzY2NmE0OTQ5NTEvdGFibGVyYW5nZTozMzIyOTFiOTMzZmU0MDQ4YmIyMTJjNjY2YTQ5NDk1MV80LTEtMS0xLTE0Mjc5_9a7c6e00-109a-425f-adce-17ad7775d158">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80L2ZyYWc6OWM4MTJhNDc3ZWU4NDAxNzljZDYzZmFkZDMzNzBjZTMvdGFibGU6MzMyMjkxYjkzM2ZlNDA0OGJiMjEyYzY2NmE0OTQ5NTEvdGFibGVyYW5nZTozMzIyOTFiOTMzZmU0MDQ4YmIyMTJjNjY2YTQ5NDk1MV81LTEtMS0xLTE0Mjc5_7b3394d6-e896-43d1-80c3-d92bb28a9cb1">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentType
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjM5_2cbcf70a-ec94-42ec-93e2-ac0e9ba20196">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjM1_55fbade5-e73b-433b-bcc4-052b1cd6f421">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQ_c1894b9b-34d1-4cb6-9f51-3217f7dedfaa">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjM2_90595e2b-a27e-487e-9cd5-c861ce1fdb25">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQ0_618091fb-d4db-4e66-b164-a61d3a536872">001-33307</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQw_9bfdb962-073c-48b9-83d1-5337de9323d8">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF8wLTAtMS0xLTE0Mjc5_13ed9f23-cb66-4cd2-946f-5bd41555f059">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF8wLTItMS0xLTE0Mjc5_fcebab3b-b2cb-44d8-978b-301eb46a860c">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF8zLTAtMS0xLTE0Mjc5_3eb791c7-cee7-4803-90e4-6e0c4e5b4a6b">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF80LTAtMS0xLTE0Mjc5_e75b0df8-87dc-4fd4-8851-95da0bcb8218">Los Angeles,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF80LTEtMS0xLTE0Mjc5_47786280-22ac-4286-9592-b2045c928664">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZmY0MzVhNzY2NzBmNDZlMzhiMDgwMjk1MGE5MGEzZTAvdGFibGVyYW5nZTpmZjQzNWE3NjY3MGY0NmUzOGIwODAyOTUwYTkwYTNlMF80LTItMS0xLTE0Mjc5_9702910d-f12d-4f07-9211-11d2367032f4">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQx_e9ef9563-578d-4b9e-9219-4777e0dbb2be">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjM3_d080afc7-3737-4d21-8443-9bbf09c87905">478-7808</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZjFjYjFhMmZiOWQxNDEyOWJjM2FhNGZhOWYxNjg5MDQvdGFibGVyYW5nZTpmMWNiMWEyZmI5ZDE0MTI5YmMzYWE0ZmE5ZjE2ODkwNF8xLTAtMS0xLTE0Mjc5_ef6e0ff1-3f90-4cf3-b8d7-47f8f5c097bb">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZjFjYjFhMmZiOWQxNDEyOWJjM2FhNGZhOWYxNjg5MDQvdGFibGVyYW5nZTpmMWNiMWEyZmI5ZDE0MTI5YmMzYWE0ZmE5ZjE2ODkwNF8xLTItMS0xLTE0Mjc5_cb439d47-7cdf-4463-959d-33adf3086960">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6ZjFjYjFhMmZiOWQxNDEyOWJjM2FhNGZhOWYxNjg5MDQvdGFibGVyYW5nZTpmMWNiMWEyZmI5ZDE0MTI5YmMzYWE0ZmE5ZjE2ODkwNF8xLTQtMS0xLTE0Mjc5_521b21f6-b83e-4fce-8af9-0648973369d6">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjM4_44f8d900-d391-4e9c-8194-69bfd4742423">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQy_dc67fd7c-8039-47de-af81-4e8040d14a8e">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6MTk5ZDJhZDYwZmE1NGNkNjhhNmUyZGE2NjA0YmQ0MTgvdGFibGVyYW5nZToxOTlkMmFkNjBmYTU0Y2Q2OGE2ZTJkYTY2MDRiZDQxOF8wLTAtMS0xLTM1NDg0_a9264edf-e76f-4f95-928d-d89414c8b868">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6MTk5ZDJhZDYwZmE1NGNkNjhhNmUyZGE2NjA0YmQ0MTgvdGFibGVyYW5nZToxOTlkMmFkNjBmYTU0Y2Q2OGE2ZTJkYTY2MDRiZDQxOF8xLTMtMS0xLTE0Mjc5_2a55de5f-0a81-4657-bc63-7a5f12208fcb">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGFibGU6MTk5ZDJhZDYwZmE1NGNkNjhhNmUyZGE2NjA0YmQ0MTgvdGFibGVyYW5nZToxOTlkMmFkNjBmYTU0Y2Q2OGE2ZTJkYTY2MDRiZDQxOF8yLTMtMS0xLTE0Mjc5_9c9b5df8-f51c-4a7e-a55f-ca8bec2b2a53">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjQz_75d3fb24-99d6-4df7-8a68-9b3377e65c45">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib54bc4806e7a4e68808598eddfb79202_I20220505"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xL2ZyYWc6ZmUxNDQyYzE4YTE3NDFjMTg0NTMxNjA1NjY3NzIzZjUvdGV4dHJlZ2lvbjpmZTE0NDJjMThhMTc0MWMxODQ1MzE2MDU2Njc3MjNmNV8yMjI2_3e140ec3-b7b1-4286-9f55-e0dda96c8a8c"
      unitRef="shares">56219473</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNC0xLTEtMS0xNDI3OQ_03e9a56b-2d38-428b-b835-d1b8934404e9"
      unitRef="usd">70713000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNC0zLTEtMS0xNDI3OQ_a0fecf5a-507c-4012-ac74-218bf017baa8"
      unitRef="usd">134606000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNS0xLTEtMS0xNDI3OQ_5f8e22dd-8595-42c2-b854-3760b571c7b3"
      unitRef="usd">159725000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNS0zLTEtMS0xNDI3OQ_d1ade471-fdf7-4c99-a307-2bfc816a9672"
      unitRef="usd">135062000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNi0xLTEtMS0xNDI3OQ_ed65408d-2044-477f-81f4-20a5a5c7a9ce"
      unitRef="usd">5783000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNi0zLTEtMS0xNDI3OQ_89d81a46-2c5e-4f24-bc9f-1a8dca04003e"
      unitRef="usd">5384000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNy0xLTEtMS0xNDI3OQ_b48689ea-ce72-4c96-8331-b699471ea67b"
      unitRef="usd">52475000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNy0zLTEtMS0xNDI3OQ_2fd93870-99e3-4e5e-8c36-f1ada6204ad8"
      unitRef="usd">49212000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfOS0xLTEtMS0xNDI3OQ_12b40bcf-63d1-4875-9128-7fe00a6635d6"
      unitRef="usd">288696000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfOS0zLTEtMS0xNDI3OQ_a9b2c2e5-e286-47ff-9d87-901d47547475"
      unitRef="usd">324264000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTEtMS0xLTEtMTQyNzk_1c81b476-68d7-487e-a54d-aa0782529433"
      unitRef="usd">488958000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTEtMy0xLTEtMTQyNzk_e47c0d64-1a1e-4f18-b076-948e4b7ad450"
      unitRef="usd">484247000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTItMS0xLTEtMTQyNzk_95ee0aa4-9f07-49e6-94bb-392897578ed0"
      unitRef="usd">595792000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTItMy0xLTEtMTQyNzk_297aed39-129b-462d-bca1-fdd9b7f12430"
      unitRef="usd">584291000</us-gaap:OperatingLeaseRightOfUseAsset>
    <rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTMtMS0xLTEtMTQyNzk_b3094687-a0e9-42f7-ac3e-6d74e4495033"
      unitRef="usd">1084750000</rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets>
    <rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTMtMy0xLTEtMTQyNzk_9e805ebe-af25-4d28-addb-584c1804ac4f"
      unitRef="usd">1068538000</rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets>
    <us-gaap:Goodwill
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTUtMS0xLTEtMTQyNzk_74e5f79d-93d4-427a-bd5c-5e76448cff59"
      unitRef="usd">570188000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTUtMy0xLTEtMTQyNzk_1b996130-7eae-49b0-b753-5b31db4c6754"
      unitRef="usd">513820000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTYtMS0xLTEtMTQyNzk_a0186e4b-4b94-4e4b-8e53-11300a4e8b14"
      unitRef="usd">99339000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTYtMy0xLTEtMTQyNzk_af68411c-7b7a-471d-aab2-5e9b4eb6d8a3"
      unitRef="usd">56603000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTctMS0xLTEtMTQyNzk_c609c8ed-3831-4b52-9afd-dcf9346ec70e"
      unitRef="usd">2009000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTctMy0xLTEtMTQyNzk_d9e82954-0621-456e-86ec-3b471f00ca7a"
      unitRef="usd">2135000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTgtMS0xLTEtMTQyNzk_663d6e34-74cf-4fd9-a2e5-9a33046db9b7"
      unitRef="usd">44746000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTgtMy0xLTEtMTQyNzk_92f60fc2-ffc0-443a-bb18-dadbc4410ade"
      unitRef="usd">42229000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTktMS0xLTEtMTQyNzk_7e063da3-eeba-4fec-8b68-5ff98ec3dfee"
      unitRef="usd">12800000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMTktMy0xLTEtMTQyNzk_8ee2f20c-be46-4ea7-acbd-7c17eafe8319"
      unitRef="usd">14853000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DepositsAssets
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjAtMS0xLTEtMTQyNzk_8e894f1f-4d58-4517-a917-24923a110e5d"
      unitRef="usd">38993000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjAtMy0xLTEtMTQyNzk_84a845ab-74d9-4f68-b50a-73e47439fcf5"
      unitRef="usd">36032000</us-gaap:DepositsAssets>
    <us-gaap:Assets
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjEtMS0xLTEtMTQyNzk_d09bf0b9-a12b-49c1-861e-c8107bc87293"
      unitRef="usd">2141521000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjEtMy0xLTEtMTQyNzk_12a8f3fa-5d51-4b6c-ae75-d4b7dc1be9f3"
      unitRef="usd">2058474000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjQtMS0xLTEtMTQyNzk_ba98cc97-cc9e-4f5b-8a0d-10b4abe50f22"
      unitRef="usd">276313000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjQtMy0xLTEtMTQyNzk_c1260a90-f32b-46f6-812a-285f9b69f69e"
      unitRef="usd">263937000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjUtMS0xLTEtMTQyNzk_5843d51a-4988-4c69-861d-45d5e8dccde4"
      unitRef="usd">21985000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjUtMy0xLTEtMTQyNzk_1354a784-83b1-4e04-b48c-45bd250992d8"
      unitRef="usd">23530000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DeferredRevenue
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjYtMS0xLTEtMTQyNzk_ee3cf539-8068-4f65-9735-6e13a922932a"
      unitRef="usd">6930000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjYtMy0xLTEtMTQyNzk_226344f7-0df6-4694-9766-7300a893e223"
      unitRef="usd">10701000</us-gaap:DeferredRevenue>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjgtMS0xLTEtMTQyNzk_d494d2f0-f713-45a2-b7ad-14b4a4c21c8e"
      unitRef="usd">64906000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjgtMy0xLTEtMTQyNzk_fe5bd60d-5563-436e-a44d-2cb43ef291b4"
      unitRef="usd">65452000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjktMS0xLTEtMTQyNzk_e58e43a0-8a7f-4232-bb60-c99fa28bab7a"
      unitRef="usd">11164000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMjktMy0xLTEtMTQyNzk_9c6c85f9-48a3-4dc2-9740-886c857be078"
      unitRef="usd">11164000</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzAtMS0xLTEtMTQyNzk_f1fecbbf-4267-4f6e-a814-7d9b7a14d848"
      unitRef="usd">381298000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzAtMy0xLTEtMTQyNzk_71790eac-db68-4093-948e-68e19b498c04"
      unitRef="usd">374784000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzMtMS0xLTEtMTQyNzk_a398b9eb-c035-41f5-b026-2c71fdc49271"
      unitRef="usd">590665000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzMtMy0xLTEtMTQyNzk_a8e4dc4f-3461-4635-8b41-9823ffd0c19d"
      unitRef="usd">577675000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzQtMS0xLTEtMTQyNzk_396057ec-2766-462a-9a11-64977effcca2"
      unitRef="usd">740707000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzQtMy0xLTEtMTQyNzk_b442fdb0-06ef-4ed7-8072-eb969a9a42ff"
      unitRef="usd">743498000</us-gaap:LongTermNotesPayable>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzUtMS0xLTEtMTQyNzk_787d673d-a00b-4328-b067-bdb8e9c3f274"
      unitRef="usd">7401000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzUtMy0xLTEtMTQyNzk_cda9a198-47f3-4ee2-87fc-75370ce5e28c"
      unitRef="usd">16360000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzYtMS0xLTEtMTQyNzk_7a64c68b-188c-4c5d-ac69-716b9b84f91a"
      unitRef="usd">1720071000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzYtMy0xLTEtMTQyNzk_f57b8ae9-3210-4a2f-9522-f674a10eae15"
      unitRef="usd">1712317000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV8xOQ_406b5ec6-a5fa-4662-9db6-5353707806ea"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV8xOQ_f5b86d27-ada6-4313-bbd2-e349418e0650"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV8zMw_60c8d945-93eb-4f13-b146-cfd27f4e158d"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV8zMw_a5c24e22-eee5-47a0-b895-f808cb069063"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV81NQ_6aed3357-15bb-42b5-9dea-48702acad63e"
      unitRef="shares">56197826</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV81NQ_c840d738-fffa-4c4f-b65e-fa912992b08d"
      unitRef="shares">56197826</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV82Mg_b4daad65-dcee-408c-a46b-2c7d4e7f8c84"
      unitRef="shares">53548227</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMC0xLTEtMTQyNzkvdGV4dHJlZ2lvbjo4ZGU1MDlmMDZkNDA0ZGZhOWQ0NDM3MWNlMDgxMWIzNV82Mg_cb74376b-9d1f-4f5e-9c17-9e042e5bcf1b"
      unitRef="shares">53548227</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMS0xLTEtMTQyNzk_1655081f-d7d2-4786-8f06-e54c65bffeeb"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzgtMy0xLTEtMTQyNzk_6a16bccb-e12d-480e-9e84-8443e38b0c77"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzktMS0xLTEtMTQyNzk_36df3923-a6e4-4c35-8441-a32e1d1a19a3"
      unitRef="usd">409863000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfMzktMy0xLTEtMTQyNzk_6f8b358b-f730-4b88-901c-fa5a9b49baeb"
      unitRef="usd">342592000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDAtMS0xLTEtMTQyNzk_e3d731e9-f11d-46f3-a0ec-8d80684644af"
      unitRef="usd">-20761000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDAtMy0xLTEtMTQyNzk_1e2a890a-218b-41ae-a5e1-c8f61d47f6b8"
      unitRef="usd">-20421000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDEtMS0xLTEtMTQyNzk_c30ab2bf-b0dc-42ce-a2ec-c6d5ba450d3b"
      unitRef="usd">-90260000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDEtMy0xLTEtMTQyNzk_52ce09c6-670f-4a88-9414-cbcd93561359"
      unitRef="usd">-93272000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDItMS0xLTEtMTQyNzk_e26fb8fb-8a92-44fb-b81e-f47663d5df96"
      unitRef="usd">298847000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDItMy0xLTEtMTQyNzk_cddbc60f-0e6f-4938-9a46-018d20dd5ef1"
      unitRef="usd">228904000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDMtMS0xLTEtMTQyNzk_3e8f584b-1186-44af-b02d-06dd560497c4"
      unitRef="usd">122603000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDMtMy0xLTEtMTQyNzk_fe6e4428-50e0-4bfe-a281-fc274f1e4771"
      unitRef="usd">117253000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDQtMS0xLTEtMTQyNzk_21ab7623-47de-41f6-bc0f-0e5c6b6a20f7"
      unitRef="usd">421450000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDQtMy0xLTEtMTQyNzk_0e7351f7-faa0-4355-99e6-f411f31bbdd3"
      unitRef="usd">346157000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDUtMS0xLTEtMTQyNzk_6cbc27d5-b4b3-477f-96b1-820d5eefc125"
      unitRef="usd">2141521000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xNi9mcmFnOmZmMDY4NDEzYmM4NzRkZjFhYmNiYzljODg1YzE2NjI4L3RhYmxlOjljNzg1YzZiOTg4MjRlYjZiZDNmNDIxNzU4MDQyYjdjL3RhYmxlcmFuZ2U6OWM3ODVjNmI5ODgyNGViNmJkM2Y0MjE3NTgwNDJiN2NfNDUtMy0xLTEtMTQyNzk_0bb0a813-eab2-4e4b-a633-40a91b20fbe1"
      unitRef="usd">2058474000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2605b786cda241819a617675d3a16552_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMy0xLTEtMS0xNDI3OQ_6743fe6b-048d-4cd1-a3f8-8f3ecc604091"
      unitRef="usd">303276000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i285d42025a684eea9d37aef0f1d14159_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMy0zLTEtMS0xNDI3OQ_d645c49f-02bb-4790-bb4a-cc9df9063779"
      unitRef="usd">279577000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61b4276af6d44d32ad20efcc3c5b920b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNC0xLTEtMS0xNDI3OQ_37dc0d0d-acf5-43ee-bd77-6a9c865b0a61"
      unitRef="usd">38491000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1edab43086bf43f4838cf141ce134cfb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNC0zLTEtMS0xNDI3OQ_009a11f8-4b5a-430e-85b4-8323bb2ab8da"
      unitRef="usd">35742000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNS0xLTEtMS0xNDI3OQ_ac548f13-56dc-460b-8e01-cf17d2e500cd"
      unitRef="usd">341767000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNS0zLTEtMS0xNDI3OQ_00ec7af8-242b-4875-bc25-d3b074997de6"
      unitRef="usd">315319000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNi0xLTEtMS0xNDI3OQ_e3f495e8-cfb0-435a-be95-f327db014c95"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfNi0zLTEtMS0xNDI3OQ_cbb56b6a-2bdb-46e0-8d07-174f97f89363"
      unitRef="usd">6248000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfOC0xLTEtMS0xNDI3OQ_81deff8c-1abf-4516-a552-352cd4da0bfb"
      unitRef="usd">315039000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfOC0zLTEtMS0xNDI3OQ_09286c08-f4ab-474c-9855-ebe27fdd74c2"
      unitRef="usd">282280000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfOS0xLTEtMS0xNDI3OQ_42d0ff66-9be8-41e7-8aaf-7f0a100a6a3d"
      unitRef="usd">27118000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfOS0zLTEtMS0xNDI3OQ_e4543706-6351-4d05-a2f3-60e82063dea3"
      unitRef="usd">22656000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTAtMS0xLTEtMTQyNzk_e1446f35-4eea-4462-ae93-ab43da60fbbd"
      unitRef="usd">-1128000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTAtMy0xLTEtMTQyNzk_6fa9ad07-60b0-4ade-8118-3612a8e2d3ea"
      unitRef="usd">1307000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:SeveranceCosts1
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTEtMS0xLTEtMTQyNzk_5a39a621-42dd-43e2-84da-39602c94f8bc"
      unitRef="usd">201000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTEtMy0xLTEtMTQyNzk_388f3da8-d7aa-4341-bd92-553c81c7758c"
      unitRef="usd">285000</us-gaap:SeveranceCosts1>
    <us-gaap:OperatingExpenses
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTItMS0xLTEtMTQyNzk_a4af68f0-8d59-487c-b9a3-90309ab3021b"
      unitRef="usd">343486000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTItMy0xLTEtMTQyNzk_ecf5bc9f-9c54-4db9-bb96-9a9173267a6f"
      unitRef="usd">303914000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTMtMS0xLTEtMTQyNzk_e517b55f-add1-4ed0-a093-08cc5509902c"
      unitRef="usd">-1719000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTMtMy0xLTEtMTQyNzk_557688bd-8640-4c1f-a7c1-648148886675"
      unitRef="usd">17653000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseDebt
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTYtMS0xLTEtMTQyNzk_d7bc2cb5-335c-43b5-8481-71f650967821"
      unitRef="usd">11593000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTYtMy0xLTEtMTQyNzk_1220af2b-6712-4f92-a3c0-4150dc7c42aa"
      unitRef="usd">12826000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTctMS0xLTEtMTQyNzk_60027d05-5d17-4fb4-8f97-4d8d529f9d62"
      unitRef="usd">2517000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTctMy0xLTEtMTQyNzk_1b61da85-6d31-4d53-96f4-de29c5ce952a"
      unitRef="usd">2285000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTgtMS0xLTEtMTQyNzk_5a96f45d-7ede-495b-bd6e-1202d6087578"
      unitRef="usd">20819000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMTgtMy0xLTEtMTQyNzk_210fdfed-cf4f-4ec1-8c97-08c9fe314c05"
      unitRef="usd">11245000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjAtMS0xLTEtMTQyNzk_69758f31-c104-4921-a6e7-72a395943cb6"
      unitRef="usd">-165000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjAtMy0xLTEtMTQyNzk_c2518227-d584-4aab-a01d-98205c29a1ac"
      unitRef="usd">-206000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjEtMS0xLTEtMTQyNzk_a7046e53-82bd-464a-833a-d54664350df5"
      unitRef="usd">11578000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjEtMy0xLTEtMTQyNzk_8f91beed-58d1-4c02-80aa-3400e921ef89"
      unitRef="usd">498000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjItMS0xLTEtMTQyNzk_7f54abf8-af31-4e8e-b2ce-09bcc8f6352f"
      unitRef="usd">9859000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjItMy0xLTEtMTQyNzk_f2087d16-579f-4720-af86-6914112a03bd"
      unitRef="usd">18151000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjMtMS0xLTEtMTQyNzk_505d17e4-0749-4523-817f-387fbaffd0f9"
      unitRef="usd">1496000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjMtMy0xLTEtMTQyNzk_042ae99b-07ca-44e1-b67b-125df5f304dc"
      unitRef="usd">4376000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjQtMS0xLTEtMTQyNzk_4198d68a-5739-4c32-8047-015112651df7"
      unitRef="usd">8363000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjQtMy0xLTEtMTQyNzk_30dd6cb7-381b-46ad-b5eb-cc6f04377e05"
      unitRef="usd">13775000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjUtMS0xLTEtMTQyNzk_c7be1cd9-a146-4f81-868a-e825f925decb"
      unitRef="usd">5350000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjUtMy0xLTEtMTQyNzk_0e7cfd2b-9530-4585-bd55-8a769143708d"
      unitRef="usd">4317000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjYtMS0xLTEtMTQyNzk_dfc6bc12-7356-4096-8729-fc2b86734a72"
      unitRef="usd">3013000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjYtMy0xLTEtMTQyNzk_84900985-6ee1-4fd4-8400-ee11ea06fbd2"
      unitRef="usd">9458000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjgtMS0xLTEtMTQyNzk_51891c3a-ef15-44d7-af4f-47cd50204dca"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMjgtMy0xLTEtMTQyNzk_9086a115-d101-48d5-bbd0-2414c27dba9b"
      unitRef="usdPerShare">0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzAtMS0xLTEtMTQyNzk_d183191b-7d1e-4258-b435-4c1a3eb03752"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzAtMy0xLTEtMTQyNzk_9c4d4aa2-81df-4676-a8f9-68c371721195"
      unitRef="usdPerShare">0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzItMS0xLTEtMTQyNzk_5c302461-30c3-4215-8445-b41f41e08a93"
      unitRef="shares">55303007</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzItMy0xLTEtMTQyNzk_f26ba4db-8e44-4a57-9983-93ff4b1338fd"
      unitRef="shares">51951506</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzMtMS0xLTEtMTQyNzk_a647d542-e9f6-4459-8d45-21e1f11bc4f9"
      unitRef="shares">56362193</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xOS9mcmFnOmJhNTgxZGVjMzIzZTRjOThhNzM3MWRlOGM0NGVjMTIwL3RhYmxlOjY2NTE3ZTFhZWI0ZjQ2YTZhZDQzMTY3ZGE0NTQ5MmRjL3RhYmxlcmFuZ2U6NjY1MTdlMWFlYjRmNDZhNmFkNDMxNjdkYTQ1NDkyZGNfMzMtMy0xLTEtMTQyNzk_36418344-aeae-400d-b55c-c5c5a011ab19"
      unitRef="shares">52828941</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfMi0xLTEtMS0xNDI3OQ_f494f733-354f-49f5-ad26-609dae716f8e"
      unitRef="usd">8363000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfMi0zLTEtMS0xNDI3OQ_40697341-3c75-4c85-835c-c2e03157ac90"
      unitRef="usd">13775000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfMy0xLTEtMS0xNDI3OQ_fc6aed5d-190d-48f2-949f-6518f864f68e"
      unitRef="usd">-1264000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfMy0zLTEtMS0xNDI3OQ_fd14780e-df3a-4606-9176-6df9c9c2825e"
      unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNS0xLTEtMS0xNDI3OQ_1338fb7a-0043-4785-8114-68ab9925039f"
      unitRef="usd">-923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNS0zLTEtMS0xNDI3OQ_b92f90cf-6a43-4831-846d-f015e47cd26c"
      unitRef="usd">-925000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNi0xLTEtMS0xNDI3OQ_77d4187b-7428-4390-a511-f6180a34fd71"
      unitRef="usd">8022000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNi0zLTEtMS0xNDI3OQ_de5eed07-d878-4b48-a484-9c319f013928"
      unitRef="usd">14688000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNy0xLTEtMS0xNDI3OQ_553f4fda-eed4-4a77-b182-dbf30e078b7e"
      unitRef="usd">5350000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfNy0zLTEtMS0xNDI3OQ_98a7a9d6-2b2a-4a42-85d7-6e63a4c2d45b"
      unitRef="usd">4317000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfOS0xLTEtMS0xNDI3OQ_cfcb3935-24d7-4a75-a9ba-7963304c9a13"
      unitRef="usd">2672000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yMi9mcmFnOmJiY2NkNjJlNDhkODQyOTBiZDUwM2E5MmQwMGRhOGU4L3RhYmxlOjcwNGJjODI3YWU3OTRlMGI4OTA1ZDk4YjllMTY3NGE0L3RhYmxlcmFuZ2U6NzA0YmM4MjdhZTc5NGUwYjg5MDVkOThiOWUxNjc0YTRfOS0zLTEtMS0xNDI3OQ_2df7f3c5-ce22-4371-b838-3ce304dc4cd8"
      unitRef="usd">10371000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="ic6c326d52eb544be8bd9b419b21bf661_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi0xLTEtMS0xNDI3OQ_d282360a-6e75-4921-8ccc-8c0bb8ce4cfa"
      unitRef="shares">53548227</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6c326d52eb544be8bd9b419b21bf661_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi0zLTEtMS0xNDI3OQ_c90f0df3-e944-4bf9-9884-8b1fd18bc86c"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92a159e91d424561b526e4f4e0f77d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi01LTEtMS0xNDI3OQ_9129ddd9-36a3-4b47-82ab-31abe5bbea26"
      unitRef="usd">342592000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0a062644b1a463b95d9488efe1f1e9d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi03LTEtMS0xNDI3OQ_d7f2f55d-a778-42cc-a7a0-abb89f354d49"
      unitRef="usd">-20421000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id9902151192a44beaa1c9350219e3f13_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi05LTEtMS0xNDI3OQ_41a3563a-2d23-4cbd-aedc-18efbeb82553"
      unitRef="usd">-93272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4bb0ae88cb924707aa34148fe232e546_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi0xMS0xLTEtMTQyNzk_005f2163-0e87-43d3-bd09-0b308fbe253b"
      unitRef="usd">228904000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i520ee3069e394d228388f671ea45af80_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi0xMy0xLTEtMTQyNzk_c06e5e98-aea9-49c0-a209-f1dd667b7ffe"
      unitRef="usd">117253000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMi0xNS0xLTEtMTQyNzk_e02e8966-5013-42ed-9772-840aa6ab6fb0"
      unitRef="usd">346157000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i53a301eed9394031a8f0503c15c07855_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNS0xLTEtMS0xNDI3OQ_e81eb2ca-1fff-4051-8fb0-8a23288c2c7b"
      unitRef="shares">530188</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i3ca7e0851947420686d239632088b156_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNi0xLTEtMS0xNDI3OQ_abf74015-452b-4d89-a99c-9d965c97ea41"
      unitRef="shares">13119</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9029d82f8c0a4ca992f906e0be3c5858_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNy01LTEtMS0xNDI3OQ_80bf79c5-2768-426d-97cb-f7db7cb6d943"
      unitRef="usd">10801000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNy0xMS0xLTEtMTQyNzk_17826665-0334-4e52-9178-de9e770c3e22"
      unitRef="usd">10801000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNy0xNS0xLTEtMTQyNzk_345f47bd-5c48-4eed-b7b1-359552e68d16"
      unitRef="usd">10801000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i53a301eed9394031a8f0503c15c07855_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfOS0xLTEtMS0xNDI3OQ_4e3b63f6-d0ab-41b8-94d5-6393b986603b"
      unitRef="shares">2106292</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i9029d82f8c0a4ca992f906e0be3c5858_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfOS01LTEtMS0xNDI3OQ_d1b5ab4d-7c89-4ddf-8267-e428676f1c95"
      unitRef="usd">56470000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfOS0xMS0xLTEtMTQyNzk_7204145f-280a-4f18-8d9d-142b2e1bd816"
      unitRef="usd">56470000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfOS0xNS0xLTEtMTQyNzk_d2e8e453-2b0c-474a-b8e5-1c55aff97357"
      unitRef="usd">56470000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ib19dc048664d4c4fa328399747a3ccfa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTctNy0xLTEtMTQyNzk_1fa2f07e-0c4d-4e7e-8171-fe08a8953314"
      unitRef="usd">-1264000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTctMTEtMS0xLTE0Mjc5_2ea29e36-1946-4a80-9b98-da278a17bc8c"
      unitRef="usd">-1264000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTctMTUtMS0xLTE0Mjc5_a55a2e26-528f-477d-bbbb-13afd04378e2"
      unitRef="usd">-1264000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib19dc048664d4c4fa328399747a3ccfa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTktNy0xLTEtMTQyNzk_19b85285-50bc-41a0-9c5a-0c75a617e057"
      unitRef="usd">-923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTktMTEtMS0xLTE0Mjc5_c63882f4-0ca9-4372-960a-8957f4ed4a06"
      unitRef="usd">-923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMTktMTUtMS0xLTE0Mjc5_0772e1fa-91fb-40d3-b895-8eeac4a3c909"
      unitRef="usd">-923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityOther
      contextRef="ib19dc048664d4c4fa328399747a3ccfa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjAtNy0xLTEtMTQyNzk_e0b0550e-805d-4322-8479-e521a88c4c00"
      unitRef="usd">-1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i4622b4997a4a4eccb0c0fb0915a887af_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjAtOS0xLTEtMTQyNzk_f9c2a6df-dfd7-4d22-8f39-886c8aa12034"
      unitRef="usd">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjAtMTUtMS0xLTE0Mjc5_ffa490cf-8db8-4cad-82ee-f049ed916c3a"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:ProfitLoss
      contextRef="i4622b4997a4a4eccb0c0fb0915a887af_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjEtOS0xLTEtMTQyNzk_74068177-f587-4970-96df-b4b5d29a134a"
      unitRef="usd">3013000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c809df3f85f47ce8d3b9be50f2b0262_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjEtMTEtMS0xLTE0Mjc5_e457ecdc-cbc7-4d19-b421-273dc8cc7f4d"
      unitRef="usd">3013000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia31e62681d3c4358b16ca1844ba3f0b1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjEtMTMtMS0xLTE0Mjc5_dd33b432-5482-4f45-838b-dfd9f8571c09"
      unitRef="usd">5350000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjEtMTUtMS0xLTE0Mjc5_7ed156ec-ee5f-4f8f-bf9a-8075e1d1a539"
      unitRef="usd">8363000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="ibb193f06c3a44c5a8335f469b106c368_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItMS0xLTEtMTQyNzk_1430ebfb-3bda-4706-9387-954cac7012e9"
      unitRef="shares">56197826</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb193f06c3a44c5a8335f469b106c368_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItMy0xLTEtMTQyNzk_fe8b9f0a-1ea8-4ee9-b2ac-4ac119dc95d9"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iadec43eade70409e9d0da25233b1dfde_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItNS0xLTEtMTQyNzk_e40c116b-3fa2-4e07-9642-e3ef14eccb5d"
      unitRef="usd">409863000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6075cb3a8ec8490d9a77109346158e64_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItNy0xLTEtMTQyNzk_8ee5b4b9-134c-4c98-bdf1-2e03abfc65bb"
      unitRef="usd">-20761000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic4832576a7844a8596613f578d05549d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItOS0xLTEtMTQyNzk_5bc07254-00ab-4621-a076-a7b35f1b9c44"
      unitRef="usd">-90260000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iefc7c8c1bcd0401d8a5c82be7e8fe00f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItMTEtMS0xLTE0Mjc5_e89312e7-cdfe-4155-91eb-333696b18be8"
      unitRef="usd">298847000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa990aa527e1441eb4aa259e7c4a4311_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItMTMtMS0xLTE0Mjc5_fd832291-e307-4267-8f14-570247adc050"
      unitRef="usd">122603000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjItMTUtMS0xLTE0Mjc5_809b44a0-277c-4374-bac9-5144ab079cb5"
      unitRef="usd">421450000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i70baa850fe584a93b43499065527584c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtMS0xLTEtMTQyNzk_bbdea9ff-beaf-4cd4-be79-50dfec469014"
      unitRef="shares">51640537</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70baa850fe584a93b43499065527584c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtMy0xLTEtMTQyNzk_82762a22-bede-4741-858a-441da11246e5"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i068b30b1e9cb45efbe0395c727f3bb66_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtNS0xLTEtMTQyNzk_ea43e862-ddc6-4b02-b673-b93ad0904109"
      unitRef="usd">307788000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia524ae0349d841c5bea7e971fafb1f2f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtNy0xLTEtMTQyNzk_1b82e8f8-491c-4b59-81c3-ef9e520d6700"
      unitRef="usd">-24051000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic3ea365926174da78fafa3edf281157f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtOS0xLTEtMTQyNzk_e67e14fe-d8b0-45b1-8700-255209de9abe"
      unitRef="usd">-117999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3bd41347893b42dda87f2f49f1d20d77_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtMTEtMS0xLTE0Mjc5_4b82b150-074f-4cef-86ba-f0d986284371"
      unitRef="usd">165743000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i729694f595eb4900a9bbee1a57c1c865_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtMTMtMS0xLTE0Mjc5_6b6b339a-29e4-4d45-8b3a-8c96a1a66ac8"
      unitRef="usd">92560000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80d5947f62c845b3b04f76fc1a749fe1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjQtMTUtMS0xLTE0Mjc5_ae3659fc-d849-4797-b80b-c0f73d14d604"
      unitRef="usd">258303000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i776431f5daf3445a96806322961098ce_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjYtMS0xLTEtMTQyNzk_29315a62-2929-40b9-bbbd-bf7346b22f36"
      unitRef="shares">699825</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib6c1a53cb7ec4f729af5315153b1f9ab_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjctMS0xLTEtMTQyNzk_63d5ff0c-0c24-4e6f-a70e-e55a264ac5ad"
      unitRef="shares">494</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia07ad7db2a1a4923864a30fe3533a635_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjgtNS0xLTEtMTQyNzk_bee48d86-6136-4ebd-8618-f450451a9f7b"
      unitRef="usd">8248000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjgtMTEtMS0xLTE0Mjc5_4324d120-3672-4104-b7e9-7e44b04c175f"
      unitRef="usd">8248000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjgtMTUtMS0xLTE0Mjc5_a91f64d3-248d-4ed7-9f87-7bc89998266b"
      unitRef="usd">8248000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ia07ad7db2a1a4923864a30fe3533a635_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjktNS0xLTEtMTQyNzk_869a9500-ac74-4ae1-a8d1-a7f6b2767fa9"
      unitRef="usd">4000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjktMTEtMS0xLTE0Mjc5_ac005b2c-ca37-48f8-a074-3e67ffe9f262"
      unitRef="usd">4000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMjktMTUtMS0xLTE0Mjc5_be0095e9-8833-4d30-baa2-e1796bce73d8"
      unitRef="usd">4000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <rdnt:ContributionsFromNoncontrollingInterests
      contextRef="ia3d203a14a9649c5b4159c9895f003d2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzMtMTMtMS0xLTE0Mjc5_93407a75-65e2-4db9-8038-69883e9e4cbf"
      unitRef="usd">123000</rdnt:ContributionsFromNoncontrollingInterests>
    <rdnt:ContributionsFromNoncontrollingInterests
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzMtMTUtMS0xLTE0Mjc5_28e7dae7-0d26-47db-a817-9e824597595f"
      unitRef="usd">123000</rdnt:ContributionsFromNoncontrollingInterests>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i9c8654171884445c860af370f5bfea70_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzUtNy0xLTEtMTQyNzk_3c1a7c12-e2b7-4fd6-9fca-ca05d39960a1"
      unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzUtMTEtMS0xLTE0Mjc5_ec56cb49-64a6-477f-bacf-eb8de0b328bc"
      unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzUtMTUtMS0xLTE0Mjc5_a8c59d6a-ba61-4b37-b260-1af9675c90f2"
      unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9c8654171884445c860af370f5bfea70_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzctNy0xLTEtMTQyNzk_267cbd15-e3be-4752-9a2a-17f6511e556f"
      unitRef="usd">-925000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzctMTEtMS0xLTE0Mjc5_215b9ad4-28eb-45f3-9f13-b1bfcfe65f30"
      unitRef="usd">-925000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzctMTUtMS0xLTE0Mjc5_3812ed11-6ec3-4659-b8c8-ff4119934099"
      unitRef="usd">-925000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="i5a645db31d194b07afc404edff2224fc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzktOS0xLTEtMTQyNzk_280d6c26-46c4-4578-903c-96d89dcae2ea"
      unitRef="usd">9458000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if0f3faa7ef774d10bdf7cfce1bb8e63c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzktMTEtMS0xLTE0Mjc5_b75fe1db-d372-4c99-8326-c1b95e2a7d0f"
      unitRef="usd">9458000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia3d203a14a9649c5b4159c9895f003d2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzktMTMtMS0xLTE0Mjc5_05403efb-35a8-45f4-b08d-803dbb829e52"
      unitRef="usd">4317000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfMzktMTUtMS0xLTE0Mjc5_0a669a43-5205-4642-b03f-26754f93afcf"
      unitRef="usd">13775000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="ib15b4952b11a47fb9236321bd4319708_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtMS0xLTEtMTQyNzk_d65396e3-a74f-4eb5-aa0c-a1858d75f392"
      unitRef="shares">52340856</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib15b4952b11a47fb9236321bd4319708_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtMy0xLTEtMTQyNzk_07df5d32-2516-40fc-957f-51bf9b27b9f4"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice4eb83abe1d4023b624f59e96214964_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtNS0xLTEtMTQyNzk_344ab2f2-2ecf-4e7f-9f4a-ee659578a87b"
      unitRef="usd">316032000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9923e7aecddc4104b04852156ffa40cd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtNy0xLTEtMTQyNzk_8fe3c3ba-edd8-4925-a42f-2ea59c5b5bd2"
      unitRef="usd">-23138000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i072529ea3a664abaa7cfed01aee70693_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtOS0xLTEtMTQyNzk_94b9555c-2004-4fdf-be69-b70d50267946"
      unitRef="usd">-108541000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i08eccb87eff3426d8baf820a26ef8096_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtMTEtMS0xLTE0Mjc5_aad82afc-7d04-4547-a394-cdbd0e41a755"
      unitRef="usd">184358000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87a8e19419ba4657b804a6671424a127_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtMTMtMS0xLTE0Mjc5_ef2cc74a-3303-40e0-972f-80919f13e982"
      unitRef="usd">97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i59d4c12a55344278a60a16915110bed1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8yNS9mcmFnOjMyNWZlYjA2ZGRjMTQwNTE4OTJkNjllMTNkZTExMDEzL3RhYmxlOmNkNDMyOWQ1OWZlNDQwNTk4NzhiZGRkYTUzYjY3MGI2L3RhYmxlcmFuZ2U6Y2Q0MzI5ZDU5ZmU0NDA1OTg3OGJkZGRhNTNiNjcwYjZfNDAtMTUtMS0xLTE0Mjc5_a5ee69cd-9e25-40c9-93ac-8e746496c1db"
      unitRef="usd">281358000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMy0xLTEtMS0xNDI3OQ_d87ed036-1462-4c1f-9f6e-9c7f3bcf1e44"
      unitRef="usd">8363000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMy0zLTEtMS0xNDI3OQ_5c166588-1f01-4e52-97a4-45f2479997a2"
      unitRef="usd">13775000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNS0xLTEtMS0xNDI3OQ_bd2344a9-9c4e-4656-a402-266a9e8b2be6"
      unitRef="usd">27118000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNS0zLTEtMS0xNDI3OQ_a5d2596e-2242-4106-813b-0625aeb68e75"
      unitRef="usd">22656000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNi0xLTEtMS0xNDI3OQ_a1275876-eb0b-4c71-80c4-5554612b7b44"
      unitRef="usd">16802000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNi0zLTEtMS0xNDI3OQ_ab19276b-b9b1-450c-b49c-b6cb28f2195a"
      unitRef="usd">17863000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNy0xLTEtMS0xNDI3OQ_7d2ea010-0071-4f58-8cb1-cf1260f92053"
      unitRef="usd">2517000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNy0zLTEtMS0xNDI3OQ_2499aee2-dec5-4106-8c61-aee353dcd123"
      unitRef="usd">2285000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfOS0xLTEtMS0xNDI3OQ_b8520c2d-b10b-430c-a6ce-660fa755d7be"
      unitRef="usd">648000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfOS0zLTEtMS0xNDI3OQ_9837c0a3-942d-4501-b324-212fd207476e"
      unitRef="usd">1147000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTAtMS0xLTEtMTQyNzk_9154711d-e368-4b8b-b08a-783bf4163474"
      unitRef="usd">-1128000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTAtMy0xLTEtMTQyNzk_51d1d622-1dcc-4382-ad91-fc1fef4f7a38"
      unitRef="usd">1307000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTItMS0xLTEtMTQyNzk_2bef196b-e1f3-42d0-89a8-8b6ae2e43c90"
      unitRef="usd">923000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTItMy0xLTEtMTQyNzk_27f2a177-5501-4782-8a58-f9aacd065012"
      unitRef="usd">925000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTMtMS0xLTEtMTQyNzk_c3bdc80c-1cd1-48e4-b62c-db5aacd7a432"
      unitRef="usd">20819000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTMtMy0xLTEtMTQyNzk_5f4294e0-0aae-4ae2-993a-b3f9c1d4f10c"
      unitRef="usd">11245000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:ShareBasedCompensation
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTQtMS0xLTEtMTQyNzk_6d4e0d0d-bc1d-4ada-bbd1-aebb0eb7ceb2"
      unitRef="usd">11102000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTQtMy0xLTEtMTQyNzk_d173fa20-f014-43dd-b10f-24fa44d77d7c"
      unitRef="usd">8248000</us-gaap:ShareBasedCompensation>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTYtMS0xLTEtMTQyNzk_84e52d26-91e1-4e7b-9502-c7af4ed9004a"
      unitRef="usd">-501000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTYtMy0xLTEtMTQyNzk_c85e17fc-1015-42cc-a533-05c21d053102"
      unitRef="usd">200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTgtMS0xLTEtMTQyNzk_b6eefeaa-bdd2-4287-b2b5-002830ad1235"
      unitRef="usd">23904000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTgtMy0xLTEtMTQyNzk_17b20653-44c2-4e74-a60f-baeb20a607bc"
      unitRef="usd">17493000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTktMS0xLTEtMTQyNzk_baf7eb8f-d54a-494e-ad78-aa486f59569b"
      unitRef="usd">4065000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMTktMy0xLTEtMTQyNzk_223a9fd1-2459-4bdf-9afb-8e812c617f93"
      unitRef="usd">4308000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjAtMS0xLTEtMTQyNzk_ce3e3221-750e-47aa-a7bf-69fc189d406f"
      unitRef="usd">1417000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjAtMy0xLTEtMTQyNzk_fb025881-487a-44aa-8242-5b3779f9b6f2"
      unitRef="usd">3507000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjEtMS0xLTEtMTQyNzk_a0e83d02-0f79-4a11-8d0c-1a6df76b0ebf"
      unitRef="usd">-1387000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjEtMy0xLTEtMTQyNzk_7d30f70b-ff0c-4ddd-a47b-06d8b9af90f2"
      unitRef="usd">-3133000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjItMS0xLTEtMTQyNzk_6650a127-fe98-4e50-85ab-00f184ffe8dd"
      unitRef="usd">-15859000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjItMy0xLTEtMTQyNzk_773b4927-c377-4ccd-a4fd-7bd8365cf7e2"
      unitRef="usd">-18291000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjMtMS0xLTEtMTQyNzk_7acccd4d-a190-4d67-bedd-814994af5ff7"
      unitRef="usd">-4519000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjMtMy0xLTEtMTQyNzk_9d3a7dd6-059e-42b1-88d3-843170743a6a"
      unitRef="usd">1416000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjQtMS0xLTEtMTQyNzk_a0caafa9-b75d-4d7b-b7c1-2c79e9896af7"
      unitRef="usd">7031000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjQtMy0xLTEtMTQyNzk_5776dc39-e1b4-48d4-8281-bc9e4bff87d8"
      unitRef="usd">17157000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjUtMS0xLTEtMTQyNzk_9e84368a-360d-4dbe-be42-f7e791fbec7e"
      unitRef="usd">901000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjUtMy0xLTEtMTQyNzk_282cdc41-9981-41cb-a7dc-78f7f73abcd2"
      unitRef="usd">28084000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjctMS0xLTEtMTQyNzk_1fa060a1-da8c-4bd6-a385-adc0fac401ba"
      unitRef="usd">25123000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjctMy0xLTEtMTQyNzk_9f7ea63b-e916-40f4-9d39-d3842fa0e46b"
      unitRef="usd">57075000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjktMS0xLTEtMTQyNzk_eac8edf2-a640-4a91-b2f8-4bc55b34fee9"
      unitRef="usd">36558000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMjktMy0xLTEtMTQyNzk_49a7f404-9b26-4ede-85e8-6e6948043d5a"
      unitRef="usd">30424000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzAtMS0xLTEtMTQyNzk_437b332b-9c83-40f3-b0d9-3dd9df343650"
      unitRef="usd">117000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzAtMy0xLTEtMTQyNzk_d0a11c5f-a6fe-40a3-a3af-457f29133aee"
      unitRef="usd">151000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzQtMS0xLTEtMTQyNzk_7d238300-a369-4169-ad7a-d852b83a0c23"
      unitRef="usd">-61564000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzQtMy0xLTEtMTQyNzk_d18c53a9-dc89-4dc2-86b1-a94a89264438"
      unitRef="usd">-87348000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzYtMS0xLTEtMTQyNzk_3b582842-f79b-4e34-906e-2d694798c31d"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzYtMy0xLTEtMTQyNzk_bdb7b5ab-4062-431c-b79b-7740708be779"
      unitRef="usd">827000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfDebt
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzctMS0xLTEtMTQyNzk_d1258ecc-d835-40df-856a-6457d6fdf9bf"
      unitRef="usd">3313000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfMzctMy0xLTEtMTQyNzk_bbfebf3f-24ba-47a6-b1e5-dcf28de341fb"
      unitRef="usd">10824000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDUtMS0xLTEtMTQyNzk_e850853e-0805-4bbd-bbed-ee73713edaf9"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDUtMy0xLTEtMTQyNzk_cd43c40b-333a-467a-80c2-1c221174397e"
      unitRef="usd">87100000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDYtMS0xLTEtMTQyNzk_75d3a3c1-0724-4b7d-8016-233b1b612bef"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDYtMy0xLTEtMTQyNzk_c493f145-afb7-4b95-9afa-624f81531b57"
      unitRef="usd">87100000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDgtMS0xLTEtMTQyNzk_dcb13be8-65b8-4362-ba51-419d7db3da80"
      unitRef="usd">-3313000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDgtMy0xLTEtMTQyNzk_c71dc11e-ad26-4415-90cd-e0ae14858769"
      unitRef="usd">-11651000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDktMS0xLTEtMTQyNzk_8bd20e14-8179-4baf-bd76-198278aba2c5"
      unitRef="usd">83000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNDktMy0xLTEtMTQyNzk_b31e3a15-97fe-4813-bdde-16ea4b4986d7"
      unitRef="usd">-12000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTAtMS0xLTEtMTQyNzk_67821609-f967-4f8a-8f2e-6c704f88c9f7"
      unitRef="usd">-63893000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTAtMy0xLTEtMTQyNzk_f3934019-910b-4211-b1c3-5043cfea88da"
      unitRef="usd">-70927000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTEtMS0xLTEtMTQyNzk_c4dd6149-7719-4712-bbf4-27260f72e3ca"
      unitRef="usd">134606000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i80d5947f62c845b3b04f76fc1a749fe1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTEtMy0xLTEtMTQyNzk_0a3a0a4a-1764-42f6-a58c-b3fb3b33868b"
      unitRef="usd">102018000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTItMS0xLTEtMTQyNzk_2d2c6a76-bf1f-41e0-9365-62d28b1c6e30"
      unitRef="usd">70713000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i59d4c12a55344278a60a16915110bed1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTItMy0xLTEtMTQyNzk_6b7112ff-6aaf-4405-9be8-cf344f813440"
      unitRef="usd">31091000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTUtMS0xLTEtMTQyNzk_d3ae0ed8-5bab-40de-8385-5a1707725cbc"
      unitRef="usd">7448000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTUtMy0xLTEtMTQyNzk_882bfe6f-df3f-4608-8cea-3f7923631d9a"
      unitRef="usd">8267000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTYtMS0xLTEtMTQyNzk_89a3b5f7-06c6-4a4b-aa9f-b572dec6049d"
      unitRef="usd">34000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RhYmxlOjhlOTkyYzNiMDBkMDRjYWViNTA3MjM1NDU1OTU5Y2YyL3RhYmxlcmFuZ2U6OGU5OTJjM2IwMGQwNGNhZWI1MDcyMzU0NTU5NTljZjJfNTYtMy0xLTEtMTQyNzk_ed52621b-0cf2-422e-a8f6-7234d2d523c2"
      unitRef="usd">24000</us-gaap:IncomeTaxesPaidNet>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfNDMz_d8aa1727-b6b6-4d2d-a428-bc6a9f139a86"
      unitRef="usd">42200000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfNDQw_344e5ea3-9aaa-435e-ad06-df7588073f15"
      unitRef="usd">28800000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i193b2936e56f4e0cbc28405f53112fa5_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTcwNQ_7ad48ca9-997f-49c2-8163-a5f011bc54e9"
      unitRef="shares">1141234</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTcyMQ_4f7cd3bb-9839-4fbf-bb7f-57b35cb57672"
      unitRef="usd">30600000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTc1Ng_bfff0d9c-a21f-4980-85c6-e2e8e2e627c2"
      unitRef="shares">965058</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTc0Mw_4d7653b7-cffb-4a62-9436-184d809cfdff"
      unitRef="usd">25900000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i92e430343aa64146a7eda3b1524bc877_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTExMw_aa213311-deed-4bce-9879-23de8fadc707"
      unitRef="usd">400000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="ie4b3b1411401444f9e1598514c6e4f34_D20210101-20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTEzNw_f27a8639-fef3-430f-b1d7-4526ebf96b40"
      unitRef="usd">300000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i10368330403342cab4b72f7c8a363d0b_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zMS9mcmFnOmE2M2ViZGY2NDg5YzQ5ZGY5ZmJhMTA3NDM1Y2I3Y2RlL3RleHRyZWdpb246YTYzZWJkZjY0ODljNDlkZjlmYmExMDc0MzVjYjdjZGVfMTA5OTUxMTYzMTE4Ng_5030f077-ed34-4fbe-b803-3408519a6811"
      unitRef="usd">100000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfODk2NQ_9aae7568-d124-4a74-9501-d3a7d4929cef">NATURE OF BUSINESS AND BASIS OF PRESENTATION&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At March&#160;31, 2022, we operated directly or indirectly through joint ventures with hospitals, 351 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#x201c;RadNet&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company&#x201d; in this report&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#x2019;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group ("the Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Group on a combined basis recognized $45.7 million and $46.1 million of revenue, net of management services fees to RadNet, for the three months ended March&#160;31, 2022 and 2021, respectively and $45.7 million and $46.1 million of operating expenses for the three months ended March&#160;31, 2022 and 2021, respectively.  RadNet recognized $191.0 million and $179.0 million of total billed net service fee revenue for the three months ended March&#160;31, 2022, and 2021, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flows of the Group are included in the accompanying condensed consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our condensed consolidated balance sheets at March&#160;31, 2022 and December&#160;31, 2021, we have included approximately $100.4 million and $89.2 million, respectively, of accounts receivable and approximately $16.9 million and $14.4 million of accounts payable and accrued liabilities related to the Group, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also own a 49% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender, LLC is dependent on RadNet to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $3.9&#160;million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $0.4&#160;million and $0.6&#160;million for the three months ended March 31, 2022, and March&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended March&#160;31, 2022 and 2021 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <rdnt:NumberOfCenters
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfMTA5OTUxMTY1MzY5Nw_2c5cb528-6c18-46e4-933a-d6220dfb2acb"
      unitRef="center">351</rdnt:NumberOfCenters>
    <us-gaap:NumberOfReportableSegments
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfMTA5OTUxMTY1ODk2OQ_86ca50c9-50c9-4c0f-9775-d5c96b792a26"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDc1Mw_acb791df-aea7-4d27-a653-7b5969e7a393"
      unitRef="usd">45700000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDc2MA_8a2d674c-7b38-4233-bfe3-0e25afbb78d9"
      unitRef="usd">46100000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDg3Mw_11d29d63-8452-4262-908d-2d68e73abe1d"
      unitRef="usd">45700000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDg4MA_3556c250-16eb-4ae8-b240-59f40f6eec95"
      unitRef="usd">46100000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDk3Ng_20ae9ffa-13cb-4a55-b89a-878420856273"
      unitRef="usd">191000000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNDk4Mw_9caeda5e-6a7e-4b33-a726-2d285a4aee73"
      unitRef="usd">179000000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:Assets
      contextRef="i408288df014b467c9d35d6c84ed0afd4_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNTg5MQ_d003cb0a-15d9-4220-94fa-ab680e712fae"
      unitRef="usd">100400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia4121846437d46c897233bae9c9a6bbd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNTg5OA_981199bc-3b2c-483d-bcfe-db39b06e26e9"
      unitRef="usd">89200000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i408288df014b467c9d35d6c84ed0afd4_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNTk1Nw_2bbcc8af-526c-477d-aa01-b220a1a9de0a"
      unitRef="usd">16900000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia4121846437d46c897233bae9c9a6bbd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNTk2NA_fbb92c45-fe04-401a-8926-bb138b3a6857"
      unitRef="usd">14400000</us-gaap:Liabilities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ibe76a6a063624942b6870c14878eb85b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfNjMzOQ_b88f2ec1-2ed1-4fa8-a3f0-55e2621feaa6"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="ibe76a6a063624942b6870c14878eb85b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfMTA5OTUxMTY1NTczNg_8005e086-0841-48a7-aeb4-e4d73fe429c5"
      unitRef="usd">3900000</us-gaap:EquityMethodInvestments>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i36c0e21c63724ab3a7cb8109c29fb186_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfMTA5OTUxMTY1NTk0Mw_28694ba1-077f-4a8e-b2f5-8a6b89fc0e09"
      unitRef="usd">400000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i0f9c76414c854366adacd1025313a311_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8zNy9mcmFnOmQxYzc1MWUwYjg3MDQyMWFhYzQ0NTY0NmIzZmUzZDI2L3RleHRyZWdpb246ZDFjNzUxZTBiODcwNDIxYWFjNDQ1NjQ2YjNmZTNkMjZfMTA5OTUxMTY1NTkzNQ_93bcac4f-c20c-4116-bc2c-13fc42841f37"
      unitRef="usd">600000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyODQ_fc9303c6-0166-40f1-a837-d93ef97344b3">SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the period covered in this report, there have been no material changes to the significant accounting policies we use and have explained, in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2021. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service revenues during the three months ended March&#160;31, 2022 and 2021 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total service revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Beginning in the second quarter of 2020 and through the three months ended March 31, 2022, we received funding from the various programs established by the CARES Act as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt"&gt;$39.6 million total of accelerated Medicare payments received, $39.5 million for the twelve months ended December&#160;31, 2020 and $0.1 million for the twelve months ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:45pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt"&gt;$4.0 million from the Paycheck Protection Program through the twelve months ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt"&gt;$35.4 million total Provider Relief Funding, $26.3 million received for the twelve months ended December 31, 2020 and $9.1 million received for the twelve months ended December 31, 2021, with $6.2 million of it received during the three months ended March 31, 2021.  No Provider Relief Funding was received for the three months ended March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The accelerated Medicare and Blue Shield payments were recorded to Deferred Revenue in our consolidated balance sheet and are being applied to revenue as services are performed beginning in 2021. Through the three months ended March 31, 2022, $36.0 million of the accelerated Medicare payments has been applied to revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The $4.0 million secured from the Paycheck Protection Program was accounted for as debt and in December 2020 we met the eligibility requirements under the government guidelines for forgiveness and the loans were written off to gain on extinguishment of debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Provider Relief Funding from 2021 is displayed as such on our condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The CARES Act also provides for the deferral of the employer-paid portion of the social security payroll tax with 50% due by December 31, 2021 and 50% due December 31, 2022. We elected to defer $16.3 million of this tax through December 31, 2020. Additionally, The CARES Act provided a refundable employer tax credit equal to 50% of qualified wages, including &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;certain health insurance costs, that can be used to offset payroll tax liabilities.  In 2021 we qualified for a portion of the credit and recorded a benefit of $7.7&#160;million through a reduction of payroll tax expense.  Our remaining deferred tax liability balance of approximately $8.1&#160;million at March 31, 2022, will be paid by December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  Amounts remaining to be collected on these agreement were $17.0 million and $17.7 million at March&#160;31, 2022 and December&#160;31, 2021, respectively. We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method. Deferred financing costs, net of accumulated amortization, were $2.0 million and $2.1 million, as of March&#160;31, 2022 and December&#160;31, 2021, respectively and related to our Barclays Revolving Credit Facility.  See Note 5, Credit Facilities and Notes Payable for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GOODWILL AND INDEFINITE LIVED INTANGIBLES - Goodwill at March&#160;31, 2022 totaled $570.2 million.  Indefinite lived intangible assets at March&#160;31, 2022 were $13.2 million.  Goodwill and Indefinite Lived Intangibles are recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2021, noting no impairment.  We considered the current and expected future economic and market conditions surrounding COVID-19 pandemic and did not identify an indication of goodwill impairment being more likely than not through March&#160;31, 2022.  Activity in goodwill for the three months ended March&#160;31, 2022 is provided below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill from acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill balances at March 31, 2022 reflect additional goodwill arising from deferred tax liabilities recorded on our acquisitions of Aidence Holding B.V. and Quantib B.V. of $7.3 million.  See Note 4, Business Combinations and Related Activity for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded income tax expense of $1.5 million, or an effective tax rate of 15.2%, for the three months ended March 31, 2022 compared to income tax expense of $4.4 million, or an effective tax rate of 24.1% for the three months ended March 31, 2021.  The income tax rates for the three months ended March&#160;31, 2022 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes (iii) effects of foreign income taxes; and (iv) excess tax benefits attributable to share-based compensation.  We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of March&#160;31, 2022.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we have amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, and currently as of April 15, 2021 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric.  We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period.  Stock options generally vest over three years to five years and expire five years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 7, Stock-Based Compensation, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMPREHENSIVE INCOME (LOSS) - Accounting guidance establishes rules for reporting and displaying comprehensive income or loss and its components. Our unrealized gains or losses on foreign currency translation adjustments, interest rate cap and swap agreements are included in comprehensive loss and are included in the consolidated statements of comprehensive income (loss) for the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DERIVATIVE INSTRUMENTS - In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.  The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional.  As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates are above the arranged rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional are being recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million through October 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the twelve months ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ineffective interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(923)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Fair Value Measurements section below for the fair value of the 2019 Swaps at March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CONTINGENT CONSIDERATION - On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening, in a combination stock and cash purchase.  As part of the purchase agreement, we will issue 18 months after acquisition, 113,303 shares with an initial fair value at the date of close of $3.0 million subject to adjustment for any indemnification claims and will be marked to market in subsequent periods.  See Note 4, Business Combinations and Related Activity for more information on the Quantib acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of contingent consideration on our condensed consolidated balance sheet is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.899%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 20, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of other non operating income recognized on contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Non Operating Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Fair Value Measurements section below for the fair value of contingent consideration at March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarize the estimated fair values of certain of our shares of common stock issued in our Quantib B.V. acquisition on January 20, 2022, and held back for indemnification purposes that are subject to fair value measurements and the classification of these liabilities on our condensed consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,303 shares of RadNet common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 3 inputs. More specifically, the fair value was determined by calculating the value estimated shares issuable as of the reporting date (which was $22.37), the time period related to the contractual settlement term, and the probability of issuing the shares.  As all the inputs are not observable (excluding our closing share price) and cannot be corroborated by observable market data, we employ a Level 3 category.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long Term Debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022 and at December&#160;31, 2021 our Barclays revolving credit facility had no balance outstanding. Our SunTrust revolving credit facility relating to our consolidated subsidiary The New Jersey Imaging Network ("NJIN"), had no principal amount outstanding at March&#160;31, 2022 and at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of our long-term debt, which is discussed in Note 6, Credit Facilities and Notes Payable, was determined using Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income  attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,303,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,951,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,303,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,951,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,362,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,828,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY INVESTMENTS AT FAIR VALUE&#x2013;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, we have three equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medic Vision Imaging Solutions Ltd., based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $1.2 million  represents a 14.21% equity interest in the company.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed.  No observable price changes or impairment in our investment was identified as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes, impairment in our investment or impairment of the loan receivable was identified as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisition by Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, our joint venture with Calvert Medical Imaging Center, LLC, completed the acquisition of certain assets to strengthen our presence in the Maryland market.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.862%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC *^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,922&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,121&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,295&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,295)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, two of which were purchased separately by wholly owned RadNet subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment and financial information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the three months ended March 31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We charged management service fees from the centers underlying these joint ventures of approximately $5.5 million and $5.2 million for the three months ended March&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2022 and December&#160;31, 2021 and income statement data for the three months ended March 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement data for the three months ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNTc_a3203be2-7978-444c-bb11-2e98276bc707">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyMzM_d3eec6d9-cdb3-4a2a-b621-83dc101c3726">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service revenues during the three months ended March&#160;31, 2022 and 2021 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total service revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0814f8295094f73a07b17a0ea048a22_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMi0xLTEtMS0xNDI3OQ_0a941d2b-a4ec-48d8-84e7-99cce3162584"
      unitRef="usd">188465000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if18b633eea03421b8f0beb791427de6a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMi0zLTEtMS0xNDI3OQ_033fb4fa-c7b3-4d0f-8eda-741669f3a38d"
      unitRef="usd">182096000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63f90bdc631743c984922bdc1021a382_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMy0xLTEtMS0xNDI3OQ_66517092-21d7-44c6-a020-791cc4fee9e6"
      unitRef="usd">70999000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a26be7fa427465ea07552ca86911792_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMy0zLTEtMS0xNDI3OQ_89f8050d-740b-4a0a-9cc8-dd5d02096fe0"
      unitRef="usd">63589000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bd4c2145a8a4cd3863fd3617fbfa90e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNC0xLTEtMS0xNDI3OQ_1f41d90a-d59a-4d54-b1bd-d9ea5cea9a10"
      unitRef="usd">9087000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5620bbf4e4f84b4c910f4cc3a6fd3e4b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNC0zLTEtMS0xNDI3OQ_d6d31753-6d00-4e74-a4bc-11419e861a1f"
      unitRef="usd">8451000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia71163553a4f410787a124d8d66b0e24_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNS0xLTEtMS0xNDI3OQ_5d19766c-e606-475b-be83-02b72885e9ed"
      unitRef="usd">12449000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id872fda809f94d66911bf9bed7f149bc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNS0zLTEtMS0xNDI3OQ_d75277b9-832c-471a-9085-b67731f835ff"
      unitRef="usd">10399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icaf803a00a874891b5809498d753bd6c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNi0xLTEtMS0xNDI3OQ_7a0d7f3d-2541-4aea-8da6-d51642e87ae7"
      unitRef="usd">7123000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92d49bb958ff4b4c812a88416ba02fa6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNi0zLTEtMS0xNDI3OQ_b489e7f0-8dde-4ad3-a0d6-e0d269bbad1a"
      unitRef="usd">4775000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41646490802644a5945209bcc69d3f40_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNy0xLTEtMS0xNDI3OQ_70e7a744-9174-4203-b659-245b95689d59"
      unitRef="usd">5508000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie16c2fada5f146a28cfdc71179dea43e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfNy0zLTEtMS0xNDI3OQ_167230ca-8fea-424c-a587-f31dcdf6aa92"
      unitRef="usd">5219000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9ebdad869674354bf27b7a86e43d9e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOC0xLTEtMS0zODIxMA_ef45050c-3a83-4dfa-b883-d0aef15e9d03"
      unitRef="usd">3399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie38a0f605d3e4c68b25430e65285e3e7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOC0zLTEtMS0zODIyMg_b1f7049f-49cd-4456-b93d-d88c78bdbeb8"
      unitRef="usd">2426000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6e867081801442288b3623055f9b0d6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOC0xLTEtMS0xNDI3OQ_c9bea4c0-3197-49d6-b439-4a9d6604bbcb"
      unitRef="usd">599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i041ea1457ed044bcaa322ae1adc5cf1d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOC0zLTEtMS0xNDI3OQ_0487221b-5567-4225-8cc0-a204033a88f3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97333ecfd0244f90905767929fe29b00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOS0xLTEtMS0xNDI3OQ_d2523360-4afb-4b27-a188-248c61dd3247"
      unitRef="usd">5647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad6312f903a74fa5a463cec7c3aeeef9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfOS0zLTEtMS0xNDI3OQ_675891cb-ddf9-4ccf-a3eb-03580b918f54"
      unitRef="usd">2622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2605b786cda241819a617675d3a16552_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTAtMS0xLTEtMTQyNzk_f4133d0b-a9de-4732-8ad3-24ebf5461f6c"
      unitRef="usd">303276000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i285d42025a684eea9d37aef0f1d14159_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTAtMy0xLTEtMTQyNzk_41963681-e7b5-4979-bd29-3fa4417a7469"
      unitRef="usd">279577000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61b4276af6d44d32ad20efcc3c5b920b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTEtMS0xLTEtMTQyNzk_4f96f6e0-5832-48b8-ae95-066852efba81"
      unitRef="usd">38491000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1edab43086bf43f4838cf141ce134cfb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTEtMy0xLTEtMTQyNzk_9bed5862-bc99-475e-a5cc-9f8ea1ab4d94"
      unitRef="usd">35742000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTItMS0xLTEtMTQyNzk_fa9b569f-8750-4f86-8ec1-ae9270e93f63"
      unitRef="usd">341767000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjNkYTUzOGYwOGE1ZTRlNGNiM2ZlODI4YjllZTgxMjQ3L3RhYmxlcmFuZ2U6M2RhNTM4ZjA4YTVlNGU0Y2IzZmU4MjhiOWVlODEyNDdfMTItMy0xLTEtMTQyNzk_42ec45f4-78b4-402f-97e9-9f75b18c9901"
      unitRef="usd">315319000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <rdnt:AdvanceMedicarePayments
      contextRef="ifb6fe52c39e2437d8016fabb3cae733e_D20200101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NjEyNg_0201c080-06ea-4568-aa52-b07cad6b1f71"
      unitRef="usd">39600000</rdnt:AdvanceMedicarePayments>
    <rdnt:AdvanceMedicarePayments
      contextRef="if3550ac82c3f40c19d6f03a23e217852_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NzYyMQ_44f14ea1-2776-49c3-8795-d6bcaf96b384"
      unitRef="usd">39500000</rdnt:AdvanceMedicarePayments>
    <rdnt:AdvanceMedicarePayments
      contextRef="i8b6de56811c743baa555eba8f903a54d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NzYyOA_ba05c87a-db1d-4273-8ac9-126e33b57582"
      unitRef="usd">100000</rdnt:AdvanceMedicarePayments>
    <us-gaap:ProceedsFromLoans
      contextRef="i75d923098e5d4a0ba8b3f7ac2c2de141_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NzI4Ng_61744820-b715-479b-bbc0-eb5cb3fcab78"
      unitRef="usd">4000000</us-gaap:ProceedsFromLoans>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="ie82ee386e6eb4838b2bc73fbbed35685_D20200101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODA4Ng_aeca735b-552a-4a89-bec1-870d70cc479c"
      unitRef="usd">35400000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="if3550ac82c3f40c19d6f03a23e217852_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODA5MA_ed5ea287-5c85-4e71-8dd0-a8bcc21b34fd"
      unitRef="usd">26300000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="i8b6de56811c743baa555eba8f903a54d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODA5NA_2b45bde9-e4fe-4329-89d6-02a502d3b4ff"
      unitRef="usd">9100000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="i3be9b88ce86c4744bf9e653fbfd94c90_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODMwMQ_85110032-3a0d-43fd-b577-44a71f0ed49d"
      unitRef="usd">6200000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="if7a4a64a35034275b1c621fed996e4d6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODM5MA_8069aabc-1410-432b-859c-ed54cc93d3ef"
      unitRef="usd">0</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:RepaymentOfAdvanceMedicarePayments
      contextRef="if7a4a64a35034275b1c621fed996e4d6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODE4Mw_53b88f4c-85cb-4027-9666-8dd39492cb01"
      unitRef="usd">36000000</rdnt:RepaymentOfAdvanceMedicarePayments>
    <us-gaap:ProceedsFromLoans
      contextRef="i75d923098e5d4a0ba8b3f7ac2c2de141_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NzI5Mg_61744820-b715-479b-bbc0-eb5cb3fcab78"
      unitRef="usd">4000000</us-gaap:ProceedsFromLoans>
    <rdnt:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i942d9cebffbb4273877f3ac67a45462f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NTAxMA_fc18eaae-262c-4d3c-8e89-48a62b075fa1"
      unitRef="usd">16300000</rdnt:SocialSecurityTaxEmployerDeferralCARESAct>
    <rdnt:CaresActRefundableClaimPercentage
      contextRef="i942d9cebffbb4273877f3ac67a45462f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NTAyMg_e9e27ac8-846c-4b88-819c-3548edbc5c5b"
      unitRef="number">0.50</rdnt:CaresActRefundableClaimPercentage>
    <rdnt:IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i8b6de56811c743baa555eba8f903a54d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NTAyNg_54b79f1e-a8df-4a1c-996e-0856c554a176"
      unitRef="usd">7700000</rdnt:IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct>
    <rdnt:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i9b445489971a44ef8c84f8ed64c4e83e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2NTAzMw_e19651b4-4aae-4e3b-a61c-c43d385f2807"
      unitRef="usd">8100000</rdnt:SocialSecurityTaxEmployerDeferralCARESAct>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNTA_ccb424a3-fc47-4a8a-91d0-f50ec8440ea5">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. We do not utilize factoring arrangements as an integral part of our financing for working capital and assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.</us-gaap:ReceivablesPolicyTextBlock>
    <rdnt:ContractsReceivableFactoringReceivable
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfNzM3Ng_c7b5d5b4-166a-4855-8d66-91f6771ec30b"
      unitRef="usd">17000000</rdnt:ContractsReceivableFactoringReceivable>
    <rdnt:ContractsReceivableFactoringReceivable
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfNzM4Mw_967314e3-eeb1-4586-94e8-c13e280c2986"
      unitRef="usd">17700000</rdnt:ContractsReceivableFactoringReceivable>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyODU_673ed42c-335b-42bc-9807-20561f9aa404">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method.</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfNzkwMQ_865cac27-5cc8-498c-aa84-79c105daaa66"
      unitRef="usd">2000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfNzkwOA_b94b68c1-ad72-40b8-a511-b7704b0f9f2f"
      unitRef="usd">2100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNjQ_cab837e8-d9d9-4668-a404-9d6534186c3d">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5ee8582ac6274cbd9efd095c7d1133b3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfODM0MA_1c06b7a1-2db4-48a6-9e99-8f6a28fd2b95">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i12c3a8c867b34ac68810453b838a2512_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfODM0Ng_6cd57b06-b606-4936-8490-9b754820923e">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ibe80e0841a2748468587fe41fa4e816d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfODQ2NQ_129bf4f3-ec0e-42d3-b185-e7b1210379b5">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id6c679f4cdfd406189d36613f3477385_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfODQ3MQ_531f501f-8bb8-4d6f-9a7d-39a116b787b1">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyMzc_a84599c4-cb14-40b9-8a5b-64d9d53843b1">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyMzQ_0afb67aa-cfc2-412d-98bf-56c4496b3c64">GOODWILL AND INDEFINITE LIVED INTANGIBLESGoodwill and Indefinite Lived Intangibles are recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2021, noting no impairment.  We considered the current and expected future economic and market conditions surrounding COVID-19 pandemic and did not identify an indication of goodwill impairment being more likely than not through March&#160;31, 2022</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:Goodwill
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfOTY4Mw_1c82d49b-6931-4b3f-b443-3332e7c09a32"
      unitRef="usd">570200000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfOTczNA_1fb3157a-4512-4ccb-b006-564865b277b6"
      unitRef="usd">13200000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNzg_f2aeeeb3-33df-4361-925f-54089f5ed45b">Activity in goodwill for the three months ended March&#160;31, 2022 is provided below (in thousands):&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill from acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill balances at March 31, 2022 reflect additional goodwill arising from deferred tax liabilities recorded on our acquisitions of Aidence Holding B.V. and Quantib B.V. of $7.3 million.  See Note 4, Business Combinations and Related Activity for more information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmI3OTc1ZTNlMGFkYTQxYjY5NDdjMDA5Y2Y2ZDFkYmMzL3RhYmxlcmFuZ2U6Yjc5NzVlM2UwYWRhNDFiNjk0N2MwMDljZjZkMWRiYzNfMC0xLTEtMS0xNDI3OQ_34917ab6-5ae8-4dd1-a9fb-accc9f0fdcdb"
      unitRef="usd">513820000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia604fcc12d02444abd767ce04feff86e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmI3OTc1ZTNlMGFkYTQxYjY5NDdjMDA5Y2Y2ZDFkYmMzL3RhYmxlcmFuZ2U6Yjc5NzVlM2UwYWRhNDFiNjk0N2MwMDljZjZkMWRiYzNfMS0xLTEtMS0xNDI3OQ_bcae721e-5ee9-490f-adf0-d440565c6aa4"
      unitRef="usd">57215000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmI3OTc1ZTNlMGFkYTQxYjY5NDdjMDA5Y2Y2ZDFkYmMzL3RhYmxlcmFuZ2U6Yjc5NzVlM2UwYWRhNDFiNjk0N2MwMDljZjZkMWRiYzNfMi0xLTEtMS0xNDI3OQ_1196e1e8-45d7-4755-8187-329cd1a95110"
      unitRef="usd">-296000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmI3OTc1ZTNlMGFkYTQxYjY5NDdjMDA5Y2Y2ZDFkYmMzL3RhYmxlcmFuZ2U6Yjc5NzVlM2UwYWRhNDFiNjk0N2MwMDljZjZkMWRiYzNfMy0xLTEtMS0xNDI3OQ_eefa6612-2c13-4a81-b38f-c1229223affa"
      unitRef="usd">-551000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmI3OTc1ZTNlMGFkYTQxYjY5NDdjMDA5Y2Y2ZDFkYmMzL3RhYmxlcmFuZ2U6Yjc5NzVlM2UwYWRhNDFiNjk0N2MwMDljZjZkMWRiYzNfMTQtMS0xLTEtMTQyNzk_3ad58288-c19e-422d-92e1-b71ab89760ae"
      unitRef="usd">570188000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6fefd7d7be254ff5afc618390afc8022_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjE5OTAyMzMxMDg1NQ_aa5005e8-7b56-4a02-8b1e-864c963aef1c"
      unitRef="usd">7300000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNTE_a11fc5bb-f2ba-4a87-a32d-ec9ce6076b9b">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTE1ODE_4c9e957f-826a-41f5-8a86-ef0768df7d26"
      unitRef="usd">1500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTE2MTM_83e85c86-753c-4ce9-a1eb-0193e26b67bf"
      unitRef="number">0.152</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTE2NjI_b12704b0-0bd5-4a67-879d-77a8fe66fd12"
      unitRef="usd">4400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTE2OTQ_76103854-ae11-4045-b398-ba4c56df90cf"
      unitRef="number">0.241</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNjE_2893dee6-17a0-4362-8468-528f26d11773">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of March&#160;31, 2022.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.&lt;/span&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyMzg_db815701-01ba-423c-98c8-a37e74f4425e">EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we have amended and restated at various points in time: first on April 20, 2015, second on March 9, 2017, and currently as of April 15, 2021 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric.  We evaluate performance-based awards to determine if it is probable that the vesting conditions will be met. We also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period.  Stock options generally vest over three years to five years and expire five years to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 7, Stock-Based Compensation, for more information.</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTQ5MjY_f79458dc-7df6-4fe2-91a9-8a4d87d1e7d4"
      unitRef="incentiveplan">1</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i8c5258f2864b4b36a115d030fd6f6f0c_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTUyNzM_649c7662-d399-47d8-81df-9ce8359099b3"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1f6c8dad5f1a47f795469ebccd173f1a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTU1MzM_e1683e8d-b6a6-4297-893e-f9db2e812307">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTU1Mzk_0d1e5826-7fd9-41b9-bba1-855cf9c13010">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i1f6c8dad5f1a47f795469ebccd173f1a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTU1NTM_a4bf8c2d-8523-4dd8-899c-6b01dea79e65">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTU1NTk_b56f4002-f1bb-4f37-a4e2-790b6617fcde">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNjU_cfebca64-8409-4f53-9640-0c2df3708364">COMPREHENSIVE INCOME (LOSS) - Accounting guidance establishes rules for reporting and displaying comprehensive income or loss and its components. Our unrealized gains or losses on foreign currency translation adjustments, interest rate cap and swap agreements are included in comprehensive loss and are included in the consolidated statements of comprehensive income (loss) for the three months ended March&#160;31, 2022 and 2021</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNjI_27a96608-1da5-49f8-89be-b76c3609de75">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNDA_8c0d9700-8287-4e6a-aee7-6ccbb53ca272">DERIVATIVE INSTRUMENTSThe 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional.As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates are above the arranged rates.At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i096002072adf4d33b28c2551f1673e8d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTc5ODQ_287b4317-1b9e-412b-9714-21c3a5e41a5f"
      unitRef="agreement">4</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i096002072adf4d33b28c2551f1673e8d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTgwODM_a553584a-e791-403f-bca7-9ed0f2ebe1cb"
      unitRef="usd">500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i3ca7aedbfe5d492cbf2c8002a3274c68_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTgxMDE_d0553068-47fb-4a7a-a520-0094b369150c"
      unitRef="agreement">2</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3ca7aedbfe5d492cbf2c8002a3274c68_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTgxMTg_31ee4541-6724-4247-95d7-a5a159140c2a"
      unitRef="usd">50000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i3ca7aedbfe5d492cbf2c8002a3274c68_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTgxMzA_a751e40c-cdb2-4eba-96da-8a357ca8f333"
      unitRef="agreement">2</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ic89c652d406f400bb6ace78022bdeb15_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTgxNDg_37601643-9a3f-41aa-988c-89ff7a8aa83d"
      unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i6ca7b8d957854f59aa72e2303bda7c43_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTg1MDU_b7572978-0e95-466d-a955-eee705c7a343"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i94e159b506e24f2ba312631b9d16e313_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTg1MTY_e7e0c0eb-68a3-4524-8213-90844bb14c1d"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i4a953bd9d4fa4594b4bec67ab351df4a_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTg1MzU_3dfc546b-aab4-4cbc-8a5f-5011ea19e6ae"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib3c38d0041d84df692e1f844842547ab_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTg1NDY_2c0194df-c6a2-4ed0-96b5-b74d6d6db522"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib3c38d0041d84df692e1f844842547ab_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTkyNjY_2c0194df-c6a2-4ed0-96b5-b74d6d6db522"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i4a953bd9d4fa4594b4bec67ab351df4a_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTkzMTk_3dfc546b-aab4-4cbc-8a5f-5011ea19e6ae"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i94e159b506e24f2ba312631b9d16e313_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTkzNDc_e7e0c0eb-68a3-4524-8213-90844bb14c1d"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i6ca7b8d957854f59aa72e2303bda7c43_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk0MDA_b7572978-0e95-466d-a955-eee705c7a343"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib3c38d0041d84df692e1f844842547ab_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk2MTk_2c0194df-c6a2-4ed0-96b5-b74d6d6db522"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i94e159b506e24f2ba312631b9d16e313_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk2NjI_e7e0c0eb-68a3-4524-8213-90844bb14c1d"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i1ad404b13b9e47818c995000abcc2af9_D20200701-20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk4MzQ_6ac2a587-54e4-4b75-997f-034bfd50790a"
      unitRef="usd">24400000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="idd1aeae2536a41608c3ca6a90e5f158e_D20200701-20231031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk5NDE_f674be67-44f1-4679-ae5c-3b7e5f87f801"
      unitRef="usd">400000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="i81fba56dea454c119ee7cf826d420c68_D20231101-20251030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTk5ODY_fde7361b-3ac3-4f5e-98c8-6a2464129ca6"
      unitRef="usd">300000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyODg_a642bab2-8314-4a7a-b28b-45305d62cd56">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the twelve months ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ineffective interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(923)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5a821e65c2544d5a2b4b289ae3296fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmIwMTRkMjQ3NGFkMzQxYTJiM2ZkOTc2NDVmODE4OTdkL3RhYmxlcmFuZ2U6YjAxNGQyNDc0YWQzNDFhMmIzZmQ5NzY0NWY4MTg5N2RfMi0yLTEtMS0xNDI3OQ_8d52e7bf-305a-4c30-b466-b7b2e3bcdb9d"
      unitRef="usd">-18886000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i75a2b41962224ca58c77ef230e603ac4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmIwMTRkMjQ3NGFkMzQxYTJiM2ZkOTc2NDVmODE4OTdkL3RhYmxlcmFuZ2U6YjAxNGQyNDc0YWQzNDFhMmIzZmQ5NzY0NWY4MTg5N2RfMi00LTEtMS0xNDI3OQ_bd3f3618-4c39-43a6-9d55-ec732b0c2396"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i75a2b41962224ca58c77ef230e603ac4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmIwMTRkMjQ3NGFkMzQxYTJiM2ZkOTc2NDVmODE4OTdkL3RhYmxlcmFuZ2U6YjAxNGQyNDc0YWQzNDFhMmIzZmQ5NzY0NWY4MTg5N2RfMi02LTEtMS0xNDI3OQ_d7223baf-2afa-4f62-b5a1-0bba00634ef1"
      unitRef="usd">-923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ed6eb6d787b4fb6b3d5fbfd38cd9917_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmIwMTRkMjQ3NGFkMzQxYTJiM2ZkOTc2NDVmODE4OTdkL3RhYmxlcmFuZ2U6YjAxNGQyNDc0YWQzNDFhMmIzZmQ5NzY0NWY4MTg5N2RfMi04LTEtMS0xNDI3OQ_cf3cd70e-cb66-4255-accf-04fc8c2c8135"
      unitRef="usd">-17963000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if95355fe5a3242819fcb7d0e02be7ec3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjgwMzRiY2Y4ODM1NDQ1OTFiOGU5YWFhNjc2YzU5NzZjL3RhYmxlcmFuZ2U6ODAzNGJjZjg4MzU0NDU5MWI4ZTlhYWE2NzZjNTk3NmNfMi0yLTEtMS0xNDI3OQ_e42d2a7e-897a-43cf-879d-8ef1c5bd1f42"
      unitRef="usd">-22581000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="icf2ec2ce1cae4a43bed55d993eadf539_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjgwMzRiY2Y4ODM1NDQ1OTFiOGU5YWFhNjc2YzU5NzZjL3RhYmxlcmFuZ2U6ODAzNGJjZjg4MzU0NDU5MWI4ZTlhYWE2NzZjNTk3NmNfMi00LTEtMS0xNDI3OQ_b8df3ed0-381c-4dd4-acf0-9896ee3c8a52"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="icf2ec2ce1cae4a43bed55d993eadf539_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjgwMzRiY2Y4ODM1NDQ1OTFiOGU5YWFhNjc2YzU5NzZjL3RhYmxlcmFuZ2U6ODAzNGJjZjg4MzU0NDU5MWI4ZTlhYWE2NzZjNTk3NmNfMi02LTEtMS0xNDI3OQ_46b06173-0a2e-45f0-95a8-bff7f2b1f237"
      unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5a821e65c2544d5a2b4b289ae3296fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjgwMzRiY2Y4ODM1NDQ1OTFiOGU5YWFhNjc2YzU5NzZjL3RhYmxlcmFuZ2U6ODAzNGJjZjg4MzU0NDU5MWI4ZTlhYWE2NzZjNTk3NmNfMi04LTEtMS0xNDI3OQ_faaffee0-42bb-43be-83dd-6198bdc19f31"
      unitRef="usd">-18886000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i3f460fdf9f124cfaa19c7b7e51eaf2f2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJmZDlkNTZiMzk3ZDRiMzE5NDVhYzJkNDRmMDE4NDMwL3RhYmxlcmFuZ2U6MmZkOWQ1NmIzOTdkNGIzMTk0NWFjMmQ0NGYwMTg0MzBfMi0yLTEtMS0xNDI3OQ_7b426209-e85c-4b58-9e81-9b4a5948718b"
      unitRef="usd">-20819000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9c9a983e6ab54175b3a01c54d524c7a8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJmZDlkNTZiMzk3ZDRiMzE5NDVhYzJkNDRmMDE4NDMwL3RhYmxlcmFuZ2U6MmZkOWQ1NmIzOTdkNGIzMTk0NWFjMmQ0NGYwMTg0MzBfMi02LTEtMS0xNDI3OQ_de121cf4-bafe-4d12-9d8a-6559b946e832"
      unitRef="usd">923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod
      contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMzI5ODUzNDkzNzE2Mg_8376e9a1-38cc-444b-8e78-2a283c0bb1fd">P18M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY4MTUyMQ_505466ba-784b-4666-92c4-f87134e2380c"
      unitRef="shares">113303</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY4MTUzOQ_397dc9d2-934d-4e3f-ae4b-e78750e8cc00"
      unitRef="usd">3000000</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMzI5ODUzNDkzNzE2Mw_339ddbf7-8752-4acf-8ff0-a1009a0e56da">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of contingent consideration on our condensed consolidated balance sheet is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.899%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 20, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of other non operating income recognized on contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Non Operating Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i753a81b55a9f4fb484fadfcdc315c4e5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjA3NGJiMjhiN2RkYjQ2YzA5MWQ2ZDEwMTZmMjZhOTVkL3RhYmxlcmFuZ2U6MDc0YmIyOGI3ZGRiNDZjMDkxZDZkMTAxNmYyNmE5NWRfMi0yLTEtMS0zOTI5OA_ba45eecb-5250-4143-a51a-83c15e31462a"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ibc1c497245b149e284139819564e0884_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjA3NGJiMjhiN2RkYjQ2YzA5MWQ2ZDEwMTZmMjZhOTVkL3RhYmxlcmFuZ2U6MDc0YmIyOGI3ZGRiNDZjMDkxZDZkMTAxNmYyNmE5NWRfMi00LTEtMS0zOTI5OA_7914d20a-1076-4497-a7dc-5e635c68fe0c"
      unitRef="usd">-501000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iaf6e35695eaa4dd8b7dd11f4cabb0ea7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjA3NGJiMjhiN2RkYjQ2YzA5MWQ2ZDEwMTZmMjZhOTVkL3RhYmxlcmFuZ2U6MDc0YmIyOGI3ZGRiNDZjMDkxZDZkMTAxNmYyNmE5NWRfMi04LTEtMS0zOTI5OA_69da8cdd-241a-483f-ae03-e453c2f506c9"
      unitRef="usd">501000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNzM_1703cc95-f3a5-416b-80ed-c69158ee4de6">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of our long-term debt, which is discussed in Note 6, Credit Facilities and Notes Payable, was determined using Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNjM_64c9774e-07ff-4da5-8bc6-916923e9f0ba">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarize the estimated fair values of certain of our shares of common stock issued in our Quantib B.V. acquisition on January 20, 2022, and held back for indemnification purposes that are subject to fair value measurements and the classification of these liabilities on our condensed consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,303 shares of RadNet common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="i7b37a6d0909f429ea7e69dfe397ea84b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjYzZTQ3NDQzODVhODQ2ODM5MGUxMTBlNzBmZDMzMTQ5L3RhYmxlcmFuZ2U6NjNlNDc0NDM4NWE4NDY4MzkwZTExMGU3MGZkMzMxNDlfNC0xLTEtMS0xNDI3OQ_90bc3f99-7747-4aad-b425-3478d6345d9c"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie1c72c1dc48746639ec661fa2dcd2090_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjYzZTQ3NDQzODVhODQ2ODM5MGUxMTBlNzBmZDMzMTQ5L3RhYmxlcmFuZ2U6NjNlNDc0NDM4NWE4NDY4MzkwZTExMGU3MGZkMzMxNDlfNC0zLTEtMS0xNDI3OQ_379465a3-df94-46a2-aff1-764369a8ca0f"
      unitRef="usd">4500000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie348136a7ee3486ca5466e8c06a98ee0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjYzZTQ3NDQzODVhODQ2ODM5MGUxMTBlNzBmZDMzMTQ5L3RhYmxlcmFuZ2U6NjNlNDc0NDM4NWE4NDY4MzkwZTExMGU3MGZkMzMxNDlfNC01LTEtMS0xNDI3OQ_94819936-c79b-47c4-b71e-50b531b4f158"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="if1b6d8c2e1034d85aab248128f367e1b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjYzZTQ3NDQzODVhODQ2ODM5MGUxMTBlNzBmZDMzMTQ5L3RhYmxlcmFuZ2U6NjNlNDc0NDM4NWE4NDY4MzkwZTExMGU3MGZkMzMxNDlfNC03LTEtMS0xNDI3OQ_56298835-6776-4634-98f7-b5d8ec549e91"
      unitRef="usd">4500000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia18b8469f0344621a9fe57a2fdd8b537_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjZmNTRkMDEyNjYzMDQ0N2E4ZjM3ZjA2Yzg4NTU4ZDIwL3RhYmxlcmFuZ2U6NmY1NGQwMTI2NjMwNDQ3YThmMzdmMDZjODg1NThkMjBfNC0xLTEtMS0xNDI3OQ_9e905569-667d-4da2-aeb7-a00fe37cbc0c"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2943452c6ebb4be889c458dfb30e5334_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjZmNTRkMDEyNjYzMDQ0N2E4ZjM3ZjA2Yzg4NTU4ZDIwL3RhYmxlcmFuZ2U6NmY1NGQwMTI2NjMwNDQ3YThmMzdmMDZjODg1NThkMjBfNC0zLTEtMS0xNDI3OQ_fc48d67b-5084-46fe-b637-5dffd4ffa2fb"
      unitRef="usd">16319000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id14ca2ee887945609d66115bf804422c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjZmNTRkMDEyNjYzMDQ0N2E4ZjM3ZjA2Yzg4NTU4ZDIwL3RhYmxlcmFuZ2U6NmY1NGQwMTI2NjMwNDQ3YThmMzdmMDZjODg1NThkMjBfNC01LTEtMS0xNDI3OQ_ed40b7db-3651-41ad-b6e6-5402518f9674"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="if42b9c9a847043829b014731da1e39d0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjZmNTRkMDEyNjYzMDQ0N2E4ZjM3ZjA2Yzg4NTU4ZDIwL3RhYmxlcmFuZ2U6NmY1NGQwMTI2NjMwNDQ3YThmMzdmMDZjODg1NThkMjBfNC03LTEtMS0xNDI3OQ_f18a418f-becd-4f4d-b98b-d9c6050b21a8"
      unitRef="usd">16319000</us-gaap:DerivativeAssets>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmE5MmZlNzc5NjJiZjRiMWU4MmQzOTZiMzBlNjVkNDYyL3RhYmxlcmFuZ2U6YTkyZmU3Nzk2MmJmNGIxZTgyZDM5NmIzMGU2NWQ0NjJfNC0wLTEtMS0zOTYxNC90ZXh0cmVnaW9uOjFlOTg0MDY1NmQ1ZDQxMTg4YmYxNDE1NjYxOGQ2ZDY3XzE2NDkyNjc0NDE3MTM_505466ba-784b-4666-92c4-f87134e2380c"
      unitRef="shares">113303</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ic9157a041f574895a708682c8fc778d8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmE5MmZlNzc5NjJiZjRiMWU4MmQzOTZiMzBlNjVkNDYyL3RhYmxlcmFuZ2U6YTkyZmU3Nzk2MmJmNGIxZTgyZDM5NmIzMGU2NWQ0NjJfNC0xLTEtMS0zOTA5NQ_27c68808-98b5-4f78-946b-95386b0e5af4"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="id469797c65cf443da10faec1b3088beb_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmE5MmZlNzc5NjJiZjRiMWU4MmQzOTZiMzBlNjVkNDYyL3RhYmxlcmFuZ2U6YTkyZmU3Nzk2MmJmNGIxZTgyZDM5NmIzMGU2NWQ0NjJfNC0zLTEtMS0zOTA5NQ_18c7ec9a-7ab7-450d-960e-ee978be45010"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i2158c83bdd5247bcb8c21b6f9c1ab650_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmE5MmZlNzc5NjJiZjRiMWU4MmQzOTZiMzBlNjVkNDYyL3RhYmxlcmFuZ2U6YTkyZmU3Nzk2MmJmNGIxZTgyZDM5NmIzMGU2NWQ0NjJfNC01LTEtMS0zOTA5NQ_81c6493d-fb03-4837-b651-0e87d5812c51"
      unitRef="usd">2535000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ib324770e341c43deb03d6adaf27aeb3b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmE5MmZlNzc5NjJiZjRiMWU4MmQzOTZiMzBlNjVkNDYyL3RhYmxlcmFuZ2U6YTkyZmU3Nzk2MmJmNGIxZTgyZDM5NmIzMGU2NWQ0NjJfNC03LTEtMS0zOTA5NQ_1ac46b6b-bf6e-48b7-992d-c8179c72461b"
      unitRef="usd">2535000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:SharePrice
      contextRef="i9fb86495a1f749bea1502c1e616f2590_I20220120"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY4MzMyNw_8994963f-fc07-40b2-8df2-9befd02c8eca"
      unitRef="usdPerShare">22.37</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic9157a041f574895a708682c8fc778d8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjk5Yzk2ZmVjMThlNDRjZmM5NmVkMzBiOTY0NDU0OTlmL3RhYmxlcmFuZ2U6OTljOTZmZWMxOGU0NGNmYzk2ZWQzMGI5NjQ0NTQ5OWZfMi0xLTEtMS0xNDI3OQ_beda4210-4aab-4c51-b5e1-37961339f967"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id469797c65cf443da10faec1b3088beb_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjk5Yzk2ZmVjMThlNDRjZmM5NmVkMzBiOTY0NDU0OTlmL3RhYmxlcmFuZ2U6OTljOTZmZWMxOGU0NGNmYzk2ZWQzMGI5NjQ0NTQ5OWZfMi0zLTEtMS0xNDI3OQ_022db19d-d296-4a7e-bb25-073e22e2f048"
      unitRef="usd">753769000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2158c83bdd5247bcb8c21b6f9c1ab650_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjk5Yzk2ZmVjMThlNDRjZmM5NmVkMzBiOTY0NDU0OTlmL3RhYmxlcmFuZ2U6OTljOTZmZWMxOGU0NGNmYzk2ZWQzMGI5NjQ0NTQ5OWZfMi01LTEtMS0xNDI3OQ_6cf572c5-d8ba-46bc-8c5f-8b6a4cb0c50b"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib324770e341c43deb03d6adaf27aeb3b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjk5Yzk2ZmVjMThlNDRjZmM5NmVkMzBiOTY0NDU0OTlmL3RhYmxlcmFuZ2U6OTljOTZmZWMxOGU0NGNmYzk2ZWQzMGI5NjQ0NTQ5OWZfMi03LTEtMS0xNDI3OQ_160f240d-82f9-4a44-9362-b20952b58c1e"
      unitRef="usd">753769000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjk5Yzk2ZmVjMThlNDRjZmM5NmVkMzBiOTY0NDU0OTlmL3RhYmxlcmFuZ2U6OTljOTZmZWMxOGU0NGNmYzk2ZWQzMGI5NjQ0NTQ5OWZfMi05LTEtMS0xNDI3OQ_80890b8d-7346-40c5-9947-6d09ab7d58c4"
      unitRef="usd">764563000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib2cdca6cf3344e588f5fd3a61929ec4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJiYmNlYjY3NjNiZTRhOGY5NGRlMjdlZDNjOWQzNTk2L3RhYmxlcmFuZ2U6MmJiY2ViNjc2M2JlNGE4Zjk0ZGUyN2VkM2M5ZDM1OTZfMi0xLTEtMS0xNDI3OQ_428db72c-7ed8-47ac-9bcc-1d4e3943d2ee"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i65afeb72c5874b7dabc692b4b7060cf4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJiYmNlYjY3NjNiZTRhOGY5NGRlMjdlZDNjOWQzNTk2L3RhYmxlcmFuZ2U6MmJiY2ViNjc2M2JlNGE4Zjk0ZGUyN2VkM2M5ZDM1OTZfMi0zLTEtMS0xNDI3OQ_823cd004-3b72-48d5-a660-0762a383fcd8"
      unitRef="usd">766973000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7628b2fb529f4c519168b280f905d875_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJiYmNlYjY3NjNiZTRhOGY5NGRlMjdlZDNjOWQzNTk2L3RhYmxlcmFuZ2U6MmJiY2ViNjc2M2JlNGE4Zjk0ZGUyN2VkM2M5ZDM1OTZfMi01LTEtMS0xNDI3OQ_ec449e8d-2e93-476c-8e72-e7b10473bfc7"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8fc944cf5d8b4854b25485eed3739509_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJiYmNlYjY3NjNiZTRhOGY5NGRlMjdlZDNjOWQzNTk2L3RhYmxlcmFuZ2U6MmJiY2ViNjc2M2JlNGE4Zjk0ZGUyN2VkM2M5ZDM1OTZfMi03LTEtMS0xNDI3OQ_4024dbbe-4387-428e-bdba-8108ca40e007"
      unitRef="usd">766973000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjJiYmNlYjY3NjNiZTRhOGY5NGRlMjdlZDNjOWQzNTk2L3RhYmxlcmFuZ2U6MmJiY2ViNjc2M2JlNGE4Zjk0ZGUyN2VkM2M5ZDM1OTZfMi05LTEtMS0xNDI3OQ_9ef1df05-738b-4dff-a02b-fb54f5a792f6"
      unitRef="usd">767875000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LineOfCredit
      contextRef="i087e463165f046e8819239d70522c4bb_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjI2MzA_40b0875a-d4d1-43a5-a79f-aa8652f3e672"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ia6e199c650d745829d22ac92ce902098_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjI2MzA_c3fa8075-c212-4967-8582-562d03d093c2"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjI3Nzg_751bc152-cfc2-4c21-9f8e-1cfc046a9996"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjI3Nzg_b2725c9b-0946-4a76-a2e5-5ea677d6b481"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNTU_d2864375-2505-4b1b-bccd-1d11827f43e7">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyODI_65e9366b-eccc-4108-b7fa-c1793c1fd015">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income  attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,303,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,951,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,303,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,951,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,362,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,828,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMi0xLTEtMS0xNDI3OQ_dd15cd64-da20-495a-9462-51c015956b7f"
      unitRef="usd">3013000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMi0zLTEtMS0xNDI3OQ_d9c5414d-6517-45d1-bdf1-440226e33b4d"
      unitRef="usd">9458000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfNS0xLTEtMS0xNDI3OQ_da1a683b-ae38-4a66-b4cc-965645188363"
      unitRef="shares">55303007</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfNS0zLTEtMS0xNDI3OQ_3493ba89-6d53-478e-842c-f92033c9162a"
      unitRef="shares">51951506</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfNi0xLTEtMS0xNDI3OQ_295e8c84-33a1-4cad-976d-f3119db1d15e"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfNi0zLTEtMS0xNDI3OQ_89f1d033-6635-4f78-acac-474d49ff6c51"
      unitRef="usdPerShare">0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfOS0xLTEtMS0xNDI3OQ_63e98820-2c92-494f-89b7-cff2113d2613"
      unitRef="shares">55303007</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfOS0zLTEtMS0xNDI3OQ_136de271-a66e-47a4-afc2-199f9f083073"
      unitRef="shares">51951506</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTAtMS0xLTEtMTQyNzk_eb7ab237-2199-4857-b50d-47b8972a7a57"
      unitRef="shares">197911</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTAtMy0xLTEtMTQyNzk_5767e399-253a-425d-ba55-519a4afdfe05"
      unitRef="shares">253265</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTEtMS0xLTEtMTQyNzk_775bf995-bc76-46c3-84ee-c53721c9f2af"
      unitRef="shares">861275</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTEtMy0xLTEtMTQyNzk_575948df-f20b-41e9-975b-158ff3028389"
      unitRef="shares">624170</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTItMS0xLTEtMTQyNzk_adf9bf68-a8f4-455f-9e21-1cd77f056002"
      unitRef="shares">56362193</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTItMy0xLTEtMTQyNzk_4f9b3a0d-868f-4a72-8134-26fce0a7a8dd"
      unitRef="shares">52828941</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTMtMS0xLTEtMTQyNzk_82c548e5-0c56-4ead-9a96-a620a511f45a"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTMtMy0xLTEtMTQyNzk_b051bbb9-efc7-4955-b6e5-18815a38da9e"
      unitRef="usdPerShare">0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i992fabbabab44df7b3b1693d7cbf856c_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTctMS0xLTEtMTQyNzk_2b3c0db7-6c63-4ba4-b4a9-013b46bba064"
      unitRef="shares">46912</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7037863c1e3e41be9812230db93860cc_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjRmNDZiMDE1ZjRlYjQ1NzlhNTBkYWI5ZTMxMmVmOGY3L3RhYmxlcmFuZ2U6NGY0NmIwMTVmNGViNDU3OWE1MGRhYjllMzEyZWY4ZjdfMTctMy0xLTEtMTQyNzk_ce292ffb-7adf-4f00-ab10-04fe5fef50e6"
      unitRef="shares">82595</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNzU_cb385a56-2776-4fcb-ba88-63d48de39af9">EQUITY INVESTMENTS AT FAIR VALUE&#x2013;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.</us-gaap:EquityMethodInvestmentsPolicy>
    <rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjQyMjA_830cf82c-97a6-47e8-ba94-37add25c17bd"
      unitRef="security">3</rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="id0849868ae3c4ceb92bbeb7de548fba8_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjQ1ODI_54270d60-f071-4a6b-8172-8ff0defdc6b5"
      unitRef="usd">1200000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="id0849868ae3c4ceb92bbeb7de548fba8_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjQ1OTk_47640089-2181-4b5b-aa4f-f28b78b667e8"
      unitRef="number">0.1421</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i4f1f9da235cc407c9377b1b4199f2c94_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjU1MDY_e3785ff0-7265-4f27-96c3-15da2dad7ac0"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="i4f1f9da235cc407c9377b1b4199f2c94_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjU1Mzc_34481872-d16c-4c61-8ece-7e3d239fbef6"
      unitRef="usd">2500000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyODM_a36b997a-42c3-40e2-afcd-1961d7475dcc">INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of March&#160;31, 2022.</us-gaap:InvestmentPolicyTextBlock>
    <rdnt:NumberofUnconsolidatedJointVentures
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjU3MzA_889a55f8-c291-4b07-8687-3105c8d37a60"
      unitRef="jointventure">13</rdnt:NumberofUnconsolidatedJointVentures>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i6eae8a7d772041fd90c955f920bc9ae8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjU4MDE_bc0d4fd0-3398-470c-a522-7f6539812e04"
      unitRef="number">0.35</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="iec48a9056e99437fbf2864df26de0803_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjU4MDc_98482a17-1910-44a1-9041-d81038bec166"
      unitRef="number">0.55</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfNDM5ODA0NjUzOTg4Nw_0becb54e-5683-4dd3-89db-3a154c3f5ad4">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.862%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.751%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC *^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,922&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,121&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,295&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,295)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, two of which were purchased separately by wholly owned RadNet subsidiaries.&lt;/span&gt;&lt;/div&gt;We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,103&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,697&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(857)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,200&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,271&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,560&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,968&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,560)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ie110fb96d5d244519c0c1cf9826af837_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjQ5OTg2ZDIzMmUwYzQ0ODE5NGJhOTc5ZTUxMDdkZjQxL3RhYmxlcmFuZ2U6NDk5ODZkMjMyZTBjNDQ4MTk0YmE5NzllNTEwN2RmNDFfMS0yLTEtMS0zMDQzMw_2b04a46c-42e7-451d-a1ad-6cf90c2b3299"
      unitRef="usd">3922000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ie110fb96d5d244519c0c1cf9826af837_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjQ5OTg2ZDIzMmUwYzQ0ODE5NGJhOTc5ZTUxMDdkZjQxL3RhYmxlcmFuZ2U6NDk5ODZkMjMyZTBjNDQ4MTk0YmE5NzllNTEwN2RmNDFfMS0zLTEtMS0zMDQzMw_85b6cc74-c0d3-474a-8e12-806333c7dea1"
      unitRef="usd">2121000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ie110fb96d5d244519c0c1cf9826af837_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjQ5OTg2ZDIzMmUwYzQ0ODE5NGJhOTc5ZTUxMDdkZjQxL3RhYmxlcmFuZ2U6NDk5ODZkMjMyZTBjNDQ4MTk0YmE5NzllNTEwN2RmNDFfMS00LTEtMS0zMDQzMw_6d65b723-3c5d-44e5-965c-bd12a15e712c"
      unitRef="usd">1295000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ie110fb96d5d244519c0c1cf9826af837_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjQ5OTg2ZDIzMmUwYzQ0ODE5NGJhOTc5ZTUxMDdkZjQxL3RhYmxlcmFuZ2U6NDk5ODZkMjMyZTBjNDQ4MTk0YmE5NzllNTEwN2RmNDFfMS01LTEtMS0zMDQzMw_f9d6a993-26df-4969-87fc-db024b451562"
      unitRef="usd">1801000</us-gaap:Goodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ie110fb96d5d244519c0c1cf9826af837_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjQ5OTg2ZDIzMmUwYzQ0ODE5NGJhOTc5ZTUxMDdkZjQxL3RhYmxlcmFuZ2U6NDk5ODZkMjMyZTBjNDQ4MTk0YmE5NzllNTEwN2RmNDFfMS04LTEtMS0zMDQzMw_d4da1c5e-16a6-4816-a433-d20d2ef4758f"
      unitRef="usd">1295000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i729756c7eae9463bb7f2dc97e4f51489_D20220101-20220101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMTA5OTUxMTY2ODQ1Nw_30322cfc-0dd5-436c-b86e-d54236e2f2be"
      unitRef="center">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNDk_cfe01ffc-950f-422d-b0ca-2bf477d582f6">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the three months ended March 31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmNmMjFkYzUzNmViYTQ5YTJhZGQ0MDk3OTE4NDIyNzI1L3RhYmxlcmFuZ2U6Y2YyMWRjNTM2ZWJhNDlhMmFkZDQwOTc5MTg0MjI3MjVfMC0xLTEtMS0xNDI3OQ_751474af-687d-4c34-9ee5-b56cb3ed88c2"
      unitRef="usd">42229000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmNmMjFkYzUzNmViYTQ5YTJhZGQ0MDk3OTE4NDIyNzI1L3RhYmxlcmFuZ2U6Y2YyMWRjNTM2ZWJhNDlhMmFkZDQwOTc5MTg0MjI3MjVfMS0xLTEtMS0xNDI3OQ_c821536b-91b8-4142-9968-da7b26748d3b"
      unitRef="usd">2517000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmNmMjFkYzUzNmViYTQ5YTJhZGQ0MDk3OTE4NDIyNzI1L3RhYmxlcmFuZ2U6Y2YyMWRjNTM2ZWJhNDlhMmFkZDQwOTc5MTg0MjI3MjVfNy0xLTEtMS0xNDI3OQ_2cd18a7a-d066-4c9f-be6d-9a1b4b8d6c48"
      unitRef="usd">44746000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:ManagementServiceFees
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjY4MDA_be3c108f-01ba-4e8e-a6e3-1ce07b8294ae"
      unitRef="usd">5500000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjY4MDc_240d99be-6c5f-4f22-bc9e-eb0802e0434c"
      unitRef="usd">5200000</rdnt:ManagementServiceFees>
    <rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RleHRyZWdpb246Y2NlZGE5YWZjZWQ3NDliZGI2ZDUyYTJlZWQ4ZjViNWNfMjcyNDM_f9771e7a-a58d-4e2a-bf4b-1f1f74eddb7f">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key balance sheet data for these joint ventures as of March&#160;31, 2022 and December&#160;31, 2021 and income statement data for the three months ended March 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement data for the three months ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMS0xLTEtMS0xNDI3OQ_b295c706-9646-49f1-9d1d-252ce628a271"
      unitRef="usd">37119000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMS0zLTEtMS0xNDI3OQ_fecf3b06-8170-4f55-a0fd-b4d7623f59e0"
      unitRef="usd">37186000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMi0xLTEtMS0xNDI3OQ_4981cd39-9aa6-493b-a061-ee97d7542ed4"
      unitRef="usd">83407000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMi0zLTEtMS0xNDI3OQ_0f98256d-6134-490d-b1a3-9bbf7456224e"
      unitRef="usd">73592000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMy0xLTEtMS0xNDI3OQ_24a3db8c-84ee-4fff-afa0-0ec9ab822a87"
      unitRef="usd">12722000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfMy0zLTEtMS0xNDI3OQ_78e4524f-26df-439b-b5ae-273e7a84f556"
      unitRef="usd">12919000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNC0xLTEtMS0xNDI3OQ_0cc2d1d7-74a2-4f6a-b19b-1fd0339a496f"
      unitRef="usd">27298000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNC0zLTEtMS0xNDI3OQ_f58c263f-b9fe-4183-a0e5-65d468594840"
      unitRef="usd">22370000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNS0xLTEtMS0xNDI3OQ_dd52e07b-ff8c-4670-8654-217129819e40"
      unitRef="usd">80506000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNS0zLTEtMS0xNDI3OQ_d789ab1c-d4d2-463a-bd55-93f07a5ef26f"
      unitRef="usd">75489000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestments
      contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNy0xLTEtMS0xNDI3OQ_5b424380-b716-4f45-ba5e-ed6d053121a1"
      unitRef="usd">37214000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfNy0zLTEtMS0xNDI3OQ_f45200b6-c86c-4b70-8b97-feea918382b5"
      unitRef="usd">34930000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfOC0xLTEtMS0xNDI3OQ_ef600a51-eb50-49e4-9314-da7b58307f21"
      unitRef="usd">7532000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfOC0zLTEtMS0xNDI3OQ_ddb6e503-2d14-4c79-bfcf-38b521977ad9"
      unitRef="usd">7299000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ic67563cef4c9491d9d0dc503a64601b6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfOS0xLTEtMS0xNDI3OQ_4a393b59-bb2f-4540-9707-b202b6c9d0cd"
      unitRef="usd">44746000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ie90163b29ad64822a65cf592dbd711ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOmRmNmU1OGY1YWU1ODRkN2U4NDVjMmUwM2M2ZTE4N2YzL3RhYmxlcmFuZ2U6ZGY2ZTU4ZjVhZTU4NGQ3ZTg0NWMyZTAzYzZlMTg3ZjNfOS0zLTEtMS0xNDI3OQ_6e493e60-9af1-4a02-ba71-c81cc21560f6"
      unitRef="usd">42229000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Revenues
      contextRef="id06cc52a0f9944378c61c46c035f80f6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjEyNTQ3ZWQzYTM2NTRiMmY4OGQyODE3ZTg0YjU3NzYzL3RhYmxlcmFuZ2U6MTI1NDdlZDNhMzY1NGIyZjg4ZDI4MTdlODRiNTc3NjNfMS0xLTEtMS0xNDI3OQ_676a14be-38a3-4cca-8086-75c5780924ab"
      unitRef="usd">34411000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia2588fa1944547388e26c3a6dc631651_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjEyNTQ3ZWQzYTM2NTRiMmY4OGQyODE3ZTg0YjU3NzYzL3RhYmxlcmFuZ2U6MTI1NDdlZDNhMzY1NGIyZjg4ZDI4MTdlODRiNTc3NjNfMS0zLTEtMS0xNDI3OQ_f6477fde-c4d5-464e-be03-95c50347f8bb"
      unitRef="usd">31718000</us-gaap:Revenues>
    <us-gaap:ProfitLoss
      contextRef="id06cc52a0f9944378c61c46c035f80f6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjEyNTQ3ZWQzYTM2NTRiMmY4OGQyODE3ZTg0YjU3NzYzL3RhYmxlcmFuZ2U6MTI1NDdlZDNhMzY1NGIyZjg4ZDI4MTdlODRiNTc3NjNfMi0xLTEtMS0xNDI3OQ_1bc148ad-5f1d-4e31-84ae-3437f8caeae0"
      unitRef="usd">5035000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia2588fa1944547388e26c3a6dc631651_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80MC9mcmFnOmNjZWRhOWFmY2VkNzQ5YmRiNmQ1MmEyZWVkOGY1YjVjL3RhYmxlOjEyNTQ3ZWQzYTM2NTRiMmY4OGQyODE3ZTg0YjU3NzYzL3RhYmxlcmFuZ2U6MTI1NDdlZDNhMzY1NGIyZjg4ZDI4MTdlODRiNTc3NjNfMi0zLTEtMS0xNDI3OQ_2416f2da-5467-4d90-8ccd-926d1425a1cf"
      unitRef="usd">4803000</us-gaap:ProfitLoss>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80My9mcmFnOjc1N2Q0OTViMGNhMzRmZjhiYjk3ZDBlY2E5NjY3N2Q4L3RleHRyZWdpb246NzU3ZDQ5NWIwY2EzNGZmOGJiOTdkMGVjYTk2Njc3ZDhfMjIzMQ_92ce3bfe-bb33-43d7-883b-60dd87d66ca2">RECENT ACCOUNTING AND REPORTING STANDARD&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#x2019;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard was effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption did not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2021-01 clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  The adoption did not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  The adoption did not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. We do not expect ASU 2021-08 to have a material effect, if any, on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80My9mcmFnOjc1N2Q0OTViMGNhMzRmZjhiYjk3ZDBlY2E5NjY3N2Q4L3RleHRyZWdpb246NzU3ZDQ5NWIwY2EzNGZmOGJiOTdkMGVjYTk2Njc3ZDhfMjIzNA_3c356eed-ddb7-4b31-b0b6-b8a089c02287">RECENT ACCOUNTING AND REPORTING STANDARD&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#x2019;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard was effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption did not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2021-01 clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  The adoption did not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  The adoption did not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. We do not expect ASU 2021-08 to have a material effect, if any, on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTgxOQ_f8504ed1-7fe2-4553-8714-9bc6d5e6c384">BUSINESS COMBINATIONS AND RELATED ACTIVITY&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Imaging Center&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Maryland market.  These acquisitions are reported as part of our Imaging Center segment.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,103&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,697&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(857)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,200&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,271&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,560&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,968&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,560)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Artificial Intelligence&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Aidence Holding B.V.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening, in an combination stock and cash purchase.  Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $45.2 million including i) 1,117,872 shares issued at $26.80 per share with a fair value of $30.0 million ii) cash of $1.8 million and iii) assuming liabilities of $11.9 million, $7.4 million in milestone contingent consideration and cash holdback of $4.5 million and iv) a settlement of a loan from RadNet of $1.5 million.  In addition we paid certain seller closing costs through the issuance of 23,362 shares at a fair value of $0.6 million.  We preliminarily recorded $1.0 million in current assets, $0.2 million in property plant and equipment, $27.5 million in intangible assets, $3.2 million in liabilities and $19.2 million in goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Quantib B.V.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening, in a combination stock and cash purchase.  Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.  The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $42.3 million including i) 965,058 shares issued at $26.80 per share with a fair value of $25.9 million ii) cash of $11.8 million and iii)  113,303 shares with a fair value at the date of close of $3.0 million and cash holdback of $1.6 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods. We preliminarily recorded $2.4 million in current assets, $0.1 million in property plant and equipment, $21.3 million in intangible assets, $3.7 million in liabilities and $22.2 million in goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As noted above, our acquisitions of Aidence and Quantib are preliminary.  As we finalize our estimation of the fair value of the assets acquired and liabilities assumed, additional adjustments may be recorded during the measurement period (a period not to exceed 12 months). The initial accounting is preliminary as of March 31, 2022 for the acquired assets and liabilities as we are currently in the process of completing the assessment of valuation inputs and assumptions as well as completing the assessment of the tax attributes of the business combination. The finalization of the acquisition accounting valuation assessment may result in a change in the valuation of the deferred tax assets and liabilities and intangible assets, along with the opening working capital accounts, which could have a material impact on our results of operations and financial position.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS0yLTEtMS0xNDI3OQ_e8b5b262-2fad-4753-ab44-eef326da1c33"
      unitRef="usd">4800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS0zLTEtMS0xNDI3OQ_58c1f77e-e06e-414b-aac6-4ddcfe2dab22"
      unitRef="usd">2103000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS00LTEtMS0xNDI3OQ_cac5d17f-cd6b-488a-973f-f77826879031"
      unitRef="usd">857000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS01LTEtMS0xNDI3OQ_274ac6d2-8097-42b0-89aa-9db8de4e2971"
      unitRef="usd">2697000</us-gaap:Goodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS03LTEtMS0xNDI3OQ_cec36195-dee5-4691-b416-98de93e62c32"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i636dd2048c8c4f80b50c95a50ddf044d_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMS04LTEtMS0xNDI3OQ_8cb01583-1b37-44a9-9645-1540812a41b6"
      unitRef="usd">857000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi0yLTEtMS0xNDI3OQ_a0c49be4-1e51-4aa5-accb-8e1ef1b84116"
      unitRef="usd">8200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi0zLTEtMS0xNDI3OQ_5fad21d4-1aec-419b-8bd7-b8c7a93d97d9"
      unitRef="usd">2910000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi00LTEtMS0xNDI3OQ_99ceb28d-ab25-49f1-893f-3f3c8e50308b"
      unitRef="usd">1703000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi01LTEtMS0xNDI3OQ_4cf9d5a0-ce9a-40fa-a180-23360bd53ede"
      unitRef="usd">5271000</us-gaap:Goodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi03LTEtMS0xNDI3OQ_eb05f1fc-70b4-4d9a-960e-9e7e89220a90"
      unitRef="usd">19000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ideac6fdbbd604859beff580d11ae84b3_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMi04LTEtMS0xNDI3OQ_ab3d55c9-f8cd-4983-b6ec-e1a27d090e63"
      unitRef="usd">1703000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ib261e6ac493749b8b10541441e853944_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctMi0xLTEtMTQyNzk_8b5db959-8c12-4e58-80c6-6378fcd93e33"
      unitRef="usd">13000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ib261e6ac493749b8b10541441e853944_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctMy0xLTEtMTQyNzk_982d96ff-9822-4a76-85c5-806862194cb0"
      unitRef="usd">5013000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ib261e6ac493749b8b10541441e853944_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctNC0xLTEtMTQyNzk_0cea6562-f7ea-4554-9f6d-01de57ffeb4b"
      unitRef="usd">2560000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ib261e6ac493749b8b10541441e853944_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctNS0xLTEtMTQyNzk_6466da4b-a2c9-492e-9323-45cf8a5d34b2"
      unitRef="usd">7968000</us-gaap:Goodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="ib261e6ac493749b8b10541441e853944_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctNy0xLTEtMTQyNzk_dc9852c3-f285-4e9d-a177-482b085ae4bf"
      unitRef="usd">19000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ib261e6ac493749b8b10541441e853944_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RhYmxlOjU0MTg5OGVhODZmMDQ0NmU5Njg1YzBkNDc5MDE0YmUzL3RhYmxlcmFuZ2U6NTQxODk4ZWE4NmYwNDQ2ZTk2ODVjMGQ0NzkwMTRiZTNfMTctOC0xLTEtMTQyNzk_a37e183e-4c4e-46e1-8241-830370cbf283"
      unitRef="usd">2560000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i729756c7eae9463bb7f2dc97e4f51489_D20220101-20220101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTYzNDgwNg_8b4b41f2-ff56-4b5e-9fea-21d2608ce09e"
      unitRef="center">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i193b2936e56f4e0cbc28405f53112fa5_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjE3Nw_2e3f0b21-c3b1-47eb-8cce-952459b20da4"
      unitRef="usd">45200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="id0bf43006b8e4c76b133b1590044e764_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjQ2NA_c11128e2-ff78-4880-b73c-477cd9cba4a4"
      unitRef="shares">1117872</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjIxNg_4797db09-4426-4246-9986-f37607c181c9"
      unitRef="usdPerShare">26.80</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i87b26de1e4b243908f72f164ff3c9086_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjIxNg_aab5bcb0-b683-44fe-9de3-4a8f8d56d1ee"
      unitRef="usdPerShare">26.80</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="id0bf43006b8e4c76b133b1590044e764_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjQ2OA_d09502af-b839-41d8-a3cb-a0c3850e6b5f"
      unitRef="usd">30000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i193b2936e56f4e0cbc28405f53112fa5_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjI2Nw_4bff6b0a-1716-45bb-a6ed-9a3f4a00c0aa"
      unitRef="usd">1800000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjI5NQ_b7035510-654d-4270-980e-2e19d2698269"
      unitRef="usd">11900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjMwMA_b802d2d7-7cc2-458a-8f63-27b8fa5ca694"
      unitRef="usd">7400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2031463f67164712a74de886e34783a3_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjM4NA_67d01419-c11a-406d-b214-f7bed35e76f7"
      unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities
      contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MjQzOA_10b80234-1c01-4107-b426-cad191537e43"
      unitRef="usd">1500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i3d27827222204849a68e073722e8fc1d_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1Mjk3MA_900fbc29-4141-4791-a9bc-067ccc0e6de8"
      unitRef="shares">23362</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i3d27827222204849a68e073722e8fc1d_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MzA4NA_0b0106d2-e24c-4074-9af7-1104e8467c45"
      unitRef="usd">600000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MTAyMw_8f3041f6-83bb-4b6a-969c-613095575d22"
      unitRef="usd">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MTAzOQ_510eaecb-2a12-47fe-a620-f9e6f5b60bec"
      unitRef="usd">200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MTA1MQ_886f45f8-d6b0-4d02-b076-1103a3cd1561"
      unitRef="usd">27500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MTMwNw_d5ac2591-5576-4c56-b1a9-bf391fea2dfd"
      unitRef="usd">3200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:Goodwill
      contextRef="ifa15adcb65e94d769e97b210362a1702_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY1MTA0NQ_1f965840-e5be-44ed-b819-e53c140dfa75"
      unitRef="usd">19200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0MzIxMA_f39ba270-71a5-4acb-8b93-f820881d0564"
      unitRef="usd">42300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTc5NQ_0574c655-d1f0-4bf0-bf9a-b4753162831e"
      unitRef="shares">965058</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NDM1OA_4797db09-4426-4246-9986-f37607c181c9"
      unitRef="usdPerShare">26.80</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i87b26de1e4b243908f72f164ff3c9086_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NDM1OA_aab5bcb0-b683-44fe-9de3-4a8f8d56d1ee"
      unitRef="usdPerShare">26.80</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0MzIzNQ_574f4886-d385-4ceb-b1eb-167d1e9d3c61"
      unitRef="usd">25900000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="id4779c75d3584b92a138261c6841bda4_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NDk2NQ_1fad84b7-cd58-450d-b6fb-0040c39f7cfa"
      unitRef="usd">11800000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i15c67e44f3fc456cab260a3b8f274e7e_D20220331-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0MzI1OA_df51bea4-1f5e-445c-ac12-f0e36cd4f24c"
      unitRef="shares">113303</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i15c67e44f3fc456cab260a3b8f274e7e_D20220331-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0MzI3Mw_fc08b1c8-2730-481b-8e3f-a5e8bbbfdf34"
      unitRef="usd">3000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ieeafd6bcebca4a6683a7ac275f256f43_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTAwNA_3a17f478-46a6-4dd0-966f-dfb6804e3717"
      unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod
      contextRef="ibc1c497245b149e284139819564e0884_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMzI5ODUzNDkxMDEyNw_c9444196-860a-4657-8692-9c5bf374f5b5">P18M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTMzOQ_342c3831-d4df-4a46-a36b-620a68010e62"
      unitRef="usd">2400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTM0Mg_dad8f1ca-5350-42d8-ace9-022d9e85b2c4"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTM4Mw_ef2c3fe6-1774-4e3c-86d6-307ccb30ba29"
      unitRef="usd">21300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTQwOQ_a52aa5bd-8dee-4236-8490-60f6212ab00f"
      unitRef="usd">3700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:Goodwill
      contextRef="id03c7545762c4f66b0e58615ce5345db_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80Ni9mcmFnOjc5OWEyZGE2OGIxYjQ0OTk4ZjYyMjg3YjU4OWRiZWM4L3RleHRyZWdpb246Nzk5YTJkYTY4YjFiNDQ5OThmNjIyODdiNTg5ZGJlYzhfMTA5OTUxMTY0NTQzMg_4ae0127e-6321-4e1f-a04c-7763bedf44a4"
      unitRef="usd">22200000</us-gaap:Goodwill>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGV4dHJlZ2lvbjo0ZTEyOWUwYTE1MTc0YThkODhiYTNhOTA5MDBmM2RjMV8zMjk4NTM0OTA1MTQ3_54a4c7c7-5a90-4388-9669-64c6ad093876">SEGMENT REPORTING&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our reportable segments are described below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Imaging Center&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Artificial Intelligence ("AI")&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.103%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;341,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;315,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;341,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;315,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cost of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;310,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;281,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cost of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;315,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;282,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Depreciation and Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;25,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;27,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Loss (Gain) on Disposal of Equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;(Loss) Income from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(5,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total (loss) income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For proper comparative purposes, Imaging Center segment revenue in 2021 excludes $6.2 million in Provider Relief Funding, as it represents a form of direct Government stimulus.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGV4dHJlZ2lvbjo0ZTEyOWUwYTE1MTc0YThkODhiYTNhOTA5MDBmM2RjMV8zMjk4NTM0OTA1MTQ4_937e7e27-f0b0-4be6-8b61-f1327eb6759c">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.103%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;341,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;315,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;341,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;315,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cost of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;310,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;281,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cost of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;315,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;282,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Depreciation and Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;25,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;27,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Loss (Gain) on Disposal of Equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;(Loss) Income from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(5,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total (loss) income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8zLTEtMS0xLTMwNDg3_4f81c467-8268-4586-908f-cf80f8435645"
      unitRef="usd">341168000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8zLTMtMS0xLTMwNDg3_3b5137ce-cb9f-4bf7-a8d9-39b5ed92d91a"
      unitRef="usd">315319000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV80LTEtMS0xLTMwNDg3_6819768f-9ba8-45b7-9f44-82e55c631823"
      unitRef="usd">599000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV80LTMtMS0xLTMwNDg3_175d9fe2-76c8-4ba5-92da-7e9a88936e43"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV81LTEtMS0xLTMwNDg3_1c428699-7bba-448c-b58b-9d42ef0969db"
      unitRef="usd">341767000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV81LTMtMS0xLTMwNDg3_c9837f80-807c-49f4-979b-4d20f90d16ac"
      unitRef="usd">315319000</us-gaap:Revenues>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV84LTEtMS0xLTMwNDg3_d7aa9608-6333-4f83-b7aa-faff7a3d1848"
      unitRef="usd">310110000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV84LTMtMS0xLTMwNDg3_2f42f908-a6a1-4d28-ae56-115c207c4709"
      unitRef="usd">281013000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV85LTEtMS0xLTMwNDg3_17467aa6-9889-4045-9f37-e75086f7ed2b"
      unitRef="usd">4929000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV85LTMtMS0xLTMwNDg3_bb0903fb-421e-454c-81fc-7a3b0e024ce3"
      unitRef="usd">1267000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xMC0xLTEtMS0zMDQ4Nw_7a871762-e65d-400f-badb-02d954fcd16d"
      unitRef="usd">315039000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xMC0zLTEtMS0zMDQ4Nw_1f678462-c744-4051-8d47-4c91cf343300"
      unitRef="usd">282280000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xMy0xLTEtMS0zMDQ4Nw_7f4933d0-80b0-41c0-8dba-17667800d4f4"
      unitRef="usd">25805000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xMy0zLTEtMS0zMDQ4Nw_a279fb13-5f27-4b28-9879-99178dd32f08"
      unitRef="usd">22569000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xNC0xLTEtMS0zMDQ4Nw_e664c277-cbc6-4d79-8985-032ef0194142"
      unitRef="usd">1313000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xNC0zLTEtMS0zMDQ4Nw_d8630146-c1ef-4f80-ab69-e9badaa9dcad"
      unitRef="usd">87000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xNS0xLTEtMS0zMDQ4Nw_0dc44c7f-4513-4181-86f9-d7520cb50ba9"
      unitRef="usd">27118000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xNS0zLTEtMS0zMDQ4Nw_b5ac55bb-466a-4d05-be3a-7ae42bdc5f2f"
      unitRef="usd">22656000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xOC0xLTEtMS0zMDQ4Nw_70748690-5f7c-4cef-ab78-647a9e3c7ef2"
      unitRef="usd">-1154000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xOC0zLTEtMS0zMDQ4Nw_c3bde0a9-af54-4684-955b-547ce8992629"
      unitRef="usd">1307000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xOS0xLTEtMS0zMDQ4Nw_e9f51ea6-11d7-4e80-8dde-1e789f33a5e5"
      unitRef="usd">26000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8xOS0zLTEtMS0zMDQ4Nw_6cad91df-c640-4ced-ad7e-cca9827fec54"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yMC0xLTEtMS0zMDQ4Nw_e6b10979-724e-4eb2-ab1a-eb0ca9e3cb02"
      unitRef="usd">-1128000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yMC0zLTEtMS0zMDQ4Nw_abc24239-8f9d-486e-b2ab-901a232e9a0d"
      unitRef="usd">1307000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:SeveranceCosts1
      contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yMy0xLTEtMS0zMDQ4Nw_9a9b13a5-bbdd-4526-bca2-5fa94e9cc416"
      unitRef="usd">201000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yMy0zLTEtMS0zMDQ4Nw_346294df-66bf-4028-a703-85604b6620fc"
      unitRef="usd">285000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yNC0xLTEtMS0zMDQ4Nw_c6f65cb4-9777-4a51-9cf6-789f57b04d30"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yNC0zLTEtMS0zMDQ4Nw_7290d7d1-02d9-43a5-90f7-6eefef4c3567"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yNS0xLTEtMS0zMDQ4Nw_dace7161-8c70-49fb-adf7-05f8035ffe63"
      unitRef="usd">201000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yNS0zLTEtMS0zMDQ4Nw_c0aecdd7-4389-4fc9-81ef-61de6fb9593d"
      unitRef="usd">285000</us-gaap:SeveranceCosts1>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i523b034a1ea64cdbb823cb87c63c25c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yOC0xLTEtMS0zMDQ4Nw_712a1d66-5a82-4ecd-9c02-4a3a28c84774"
      unitRef="usd">3898000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="iae865f3f81124444953fdc68855c5377_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yOC0zLTEtMS0zMDQ4Nw_361b895a-4767-4f1b-a461-b0b8a49225bc"
      unitRef="usd">12759000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i3ccbc9b8209a4d9999dfedf12d83764d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yOS0xLTEtMS0zMDQ4Nw_5c3c805c-3569-43d2-a5f9-b1183e4242f5"
      unitRef="usd">-5617000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i39566436adc04db69a318bf75e1aa4b4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8yOS0zLTEtMS0zMDQ4Nw_4bb4757f-5cb7-4a7b-a4c7-57360e83b9c3"
      unitRef="usd">-1354000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8zMC0xLTEtMS0zMDQ4Nw_71f15b80-f5a1-4e27-b30b-876a32f5ed46"
      unitRef="usd">-1719000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="if96d9d3f8ac64a29bcf200cffad4ca6d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGFibGU6MDE5ZDRkZDc2YzJjNGI5MmFkZDYyZDRiZTVkNTgwOWEvdGFibGVyYW5nZTowMTlkNGRkNzZjMmM0YjkyYWRkNjJkNGJlNWQ1ODA5YV8zMC0zLTEtMS0zMDQ4Nw_236d62b2-aa69-40ea-81ca-1e47e12b8377"
      unitRef="usd">11405000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="i3be9b88ce86c4744bf9e653fbfd94c90_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF8xMDk5NTExNjI4ODEwL2ZyYWc6NGUxMjllMGExNTE3NGE4ZDg4YmEzYTkwOTAwZjNkYzEvdGV4dHJlZ2lvbjo0ZTEyOWUwYTE1MTc0YThkODhiYTNhOTA5MDBmM2RjMV8xNjQ5MjY3NDY5NzE0_85110032-3a0d-43fd-b577-44a71f0ed49d"
      unitRef="usd">6200000</rdnt:ProceedsFromProviderReliefFunding>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfODE0OA_92d6747e-c756-4875-89fc-1de5119211fe">CREDIT FACILITIES AND NOTES PAYABLE&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022 and December&#160;31, 2021 our term loan debt obligations are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="12" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at March&#160;31, 2022 and have reserved $7.8 million for certain letters of credit. The remaining $187.2 million of our Barclays Revolving Credit Facility was available to draw upon as of March&#160;31, 2022.  We had no outstanding balance under our $30.0 million SunTrust Revolving Credit Facility at March&#160;31, 2022.  As of March&#160;31, 2022, we were in compliance with all covenants under our credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Second Amended and Restated First Lien Credit and Guaranty Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $725.0 million of senior secured first lien term loans (the "First Lien Term Loans") and a $195.0 million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $14.9 million segregated as follows: $8.8 million capitalized to discount and deferred finance cost, $4.5 million expensed to debt restructuring costs,  $1.5 million charged to loss on early extinguishment of debt and $0.1 million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"&gt;First Lien Term Loans:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The First Lien Term Loans under the Restated Credit Agreement bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable margin for Eurodollar Rate term loans under the Restated Credit Agreement is 3.25% per annum, with a reduction to 3.00% per annum upon delivery by us of financial statements for the period ending March 31, 2021 evidencing a first lien net leverage ratio of 3.50 to 1.00 or less.  Such statements were delivered by us on May 27, 2021. At March&#160;31, 2022 the effective Eurodollar Rate and the Alternate Base Rate for the First Lien Term Loans under the Restated Credit Agreement was 0.75% and 3.50%, respectively and the applicable margin for the Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was 3.00% and 2.00%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $1.8 million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;SunTrust Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022, our SunTrust credit facilities, which relate to our consolidated subsidiary The New Jersey Imaging Network, L.L.C.("NJIN"), were comprised of one term loan in the principal amount described in the table above (the "SunTrust Term Loan") and a revolving credit facility of $30.0 million (the "SunTrust Revolving Credit Facility") both of which are provided pursuant to the Amended and Restated Revolving Credit and Term Loan Agreement dated August 31, 2018, among NJIN, as borrower, with SunTrust Bank, as administrative agent, and the lenders identified therein (as amended, the "SunTrust Credit Agreement").  Our SunTrust Term Loan bears interest at either an Adjusted LIBOR or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Eurodollar Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loans and other obligations outstanding under the SunTrust Credit Agreement currently bear interest at a three month LIBOR election at 0.22% plus an applicable margin and fees based on Pricing Level V described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $0.8 million, representing annual amortization equal to 5.0% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $0.4 million, with the remaining balance to be paid at maturity.  The SunTrust Term Loan will mature on August 31, 2023 unless otherwise accelerated under the terms of the SunTrust Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revolving Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $195.0 million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $2.0 million at March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Net Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eurodollar Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Alternate Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.00x but &#x2264; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.00x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was 5.25%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently 2.75% and fronting fees accrue at 0.125% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;SunTrust Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The SunTrust Credit Agreement established a $30.0 million revolving credit facility available to NJIN for funding requirements. The SunTrust Revolving Credit Facility terminates on the earliest of (i) August 31, 2023, (ii) the voluntary termination thereof by NJIN pursuant to Section 2.8 of the SunTrust Credit Agreement, or (iii) the date on which all amounts outstanding under the SunTrust Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  As of March&#160;31, 2022, NJIN had no borrowings under the SunTrust Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recent prior amendments to prior credit facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the "Eighth Amendment").  The Eighth Amendment amended the prior first lien credit agreement to add $57.5 million of revolving commitments to the prior Barclays revolving credit facility increasing the maximum borrowing capacity under the prior Barclays revolving credit facility to $195.0 million while leaving the maturity date of July 1, 2023 unchanged.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 18, 2019 we entered into the following two amendments to the prior first lien credit agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#x201c;Sixth Amendment&#x201d;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#x201c;Seventh Amendment&#x201d;).  Among other things, the Sixth Amendment amended the prior first lien credit agreement to issue $100.0 million in incremental first lien term loans and to add an additional $20.0 million of revolving commitments to the prior Barclays revolving credit facility.  The Seventh Amendment amended the prior first lien credit agreement to extend the maturity date of the prior Barclays revolving credit facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the prior first lien credit agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The prior first lien credit agreement was amended and restated by the Restated Credit Agreement described above, and the prior first lien term loans and prior Barclays revolving credit facility under the prior first lien credit agreement were refinanced and replaced by the First Lien Term Loans and the Barclays Revolving Credit Facility provided under the Restated Credit Agreement described above.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfODE0OQ_c6323d09-97d6-4f76-b29e-124e64137cc3">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022 and December&#160;31, 2021 our term loan debt obligations are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="12" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ia6603de1c39843a99a8e725c3ba62d5d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMi0xLTEtMS0xNDI3OQ_9121669e-14ba-4796-a732-c03857182997"
      unitRef="usd">719563000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i733096088bfb4e4593a3c6893d07f184_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMi0zLTEtMS0xNDI3OQ_c1a88288-6f93-4817-8474-8133f1ba8838"
      unitRef="usd">721375000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ia6603de1c39843a99a8e725c3ba62d5d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMy0xLTEtMS0xNDI3OQ_adce833b-93aa-467f-8a17-4b54b3811fc8"
      unitRef="usd">12692000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i733096088bfb4e4593a3c6893d07f184_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMy0zLTEtMS0xNDI3OQ_137b991b-48c5-4fbe-926d-d8b3bd16dbea"
      unitRef="usd">13213000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="ibfb1d71aa2ad40129d22f67c28e34718_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfNC0xLTEtMS0xNDI3OQ_70779f3f-d265-40c9-a729-17fdfe130b51"
      unitRef="usd">45000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i17d341f477874224896da30df2514be5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfNC0zLTEtMS0xNDI3OQ_07e64140-da3b-47f0-af2a-2c52b47faf3b"
      unitRef="usd">46500000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfOC0xLTEtMS0xNDI3OQ_24835c36-e206-41f4-a361-fd3f17fa385f"
      unitRef="usd">751871000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfOC0zLTEtMS0xNDI3OQ_bfc28c52-1b62-4be6-b173-a06350807780"
      unitRef="usd">754662000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfOS0xLTEtMS0xNDI3OQ_0dff8170-f7cd-4e72-8769-f6391dae6290"
      unitRef="usd">11164000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfOS0zLTEtMS0xNDI3OQ_4f9d35ce-dd6d-442c-ac8d-d29fcf46ef29"
      unitRef="usd">11164000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMTAtMS0xLTEtMTQyNzk_99d0e24b-050b-4cc2-867c-8f747fe73df4"
      unitRef="usd">740707000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i149f4a7d4caa402e82e20e079677076d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOmZlMjMxY2RkZDg5ZjQxNGNiN2VlMjkwOGIwMWYzM2E0L3RhYmxlcmFuZ2U6ZmUyMzFjZGRkODlmNDE0Y2I3ZWUyOTA4YjAxZjMzYTRfMTAtMy0xLTEtMTQyNzk_975ac29f-c8b9-4299-bbed-9f3862d5b276"
      unitRef="usd">743498000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCredit
      contextRef="i087e463165f046e8819239d70522c4bb_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTM3_40b0875a-d4d1-43a5-a79f-aa8652f3e672"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ia6e199c650d745829d22ac92ce902098_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTM3_c3fa8075-c212-4967-8582-562d03d093c2"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4b2021e8693c43efb8f3683e1a35b4df_I20210423"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTcw_806bb614-a15f-4bba-911b-89786b2b44d4"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i4c9e01d6493f43e299012d6df312e4bf_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjMy_8cac2f52-e71c-473f-b281-bfa481d9553f"
      unitRef="usd">7800000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i306b15aed8664de6a18898691aeec87c_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjgw_d971c0b1-cd1b-4c97-b043-658b69f420bc"
      unitRef="usd">187200000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i45d5c9e3d43546498d2a26f35f8668b2_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMzcw_227322bd-89f1-47aa-b08e-8a03cacee279"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2f7f03f2987a4c7fb79e4440534fa07b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNDAz_da19a20d-7c79-4fa3-ae2e-68fcdc0ae4da"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i53f75acbd56447d2a0b5536e5817ebbb_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNzYw_ec4cd18c-3ea3-4ee3-aea6-deaebd557d8b"
      unitRef="usd">725000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4b2021e8693c43efb8f3683e1a35b4df_I20210423"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfODM5_806bb614-a15f-4bba-911b-89786b2b44d4"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i808acf82ba384ff191da9c1c7c61d43a_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTE4MA_e358e6d9-1f54-4ca2-8374-3d661059d320"
      unitRef="usd">14900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="i808acf82ba384ff191da9c1c7c61d43a_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTIwNg_701749f1-620c-48ed-aa00-4fac6cedd679"
      unitRef="usd">8800000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i808acf82ba384ff191da9c1c7c61d43a_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTI2MA_3fa237a5-66a6-416c-8a1b-1b10813b28fb"
      unitRef="usd">4500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7c887837d9ef4909b82fa07c516cbe5f_D20210423-20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTMwMg_fa03d0a0-c4ce-4468-b5bd-d6e6a092e31c"
      unitRef="usd">1500000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AmortizationOfDeferredCharges
      contextRef="ia71e051856e14e40b66eb9309af46b02_D20210423-20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTM1Nw_7cb30f19-c00e-468d-940c-ce5169a5c7e6"
      unitRef="usd">100000</us-gaap:AmortizationOfDeferredCharges>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ieb3b9b1ec109454b8176b9068a603457_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTg5OA_19e1292d-b5f6-4c0c-919e-9a44ee38b438"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9078e720809546d6aaf957bdefc7dbd7_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMTkzMg_72d2dc99-68fc-428c-b314-f91dc4f98065"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="iaf7f88c678b74b4b886228218a5301cd_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjA3Mg_0f70ecb7-7598-4d6e-b634-e5deb0e0abbb"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i3a411712fae44141898b470479a1a692_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjI3OQ_ba460654-82d2-4d2a-9a3d-34c428e781e9"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i4bc8bed1e3c54b7ba889d6e0b9d215c5_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjI4Ng_37a762a6-8258-46d2-86bb-3386012be8b4"
      unitRef="number">0.0350</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7b94146cc90742289e03e41f9581f179_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjQzOQ_6bf92397-713a-4503-b02b-7431a7de1bfd"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1fb8a36da6224876bbbbb9c7b1e0d449_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjQ0Ng_1b65aa8a-1fa8-4ae0-bcab-279a33e6b9de"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i2a2d0c6e90f04f8082784ea469840870_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMjYwMA_57ccc2cd-dc01-419e-84e4-a0ce80ee307b"
      unitRef="usd">1800000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2f7f03f2987a4c7fb79e4440534fa07b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMzA0Ng_da19a20d-7c79-4fa3-ae2e-68fcdc0ae4da"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:ScheduleOfLeverageRatioTableTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfODE1MQ_13798acf-f268-4640-91c0-9e9b33e2ed3e">Our SunTrust Term Loan bears interest at either an Adjusted LIBOR or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Eurodollar Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Net Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eurodollar Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Alternate Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.00x but &#x2264; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.00x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</rdnt:ScheduleOfLeverageRatioTableTextBlock>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i6a4c35b6f71f4affa5768a0f639d4a2e_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMS0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjgwNTZjYTQ0NWU4MjQ2MWE4ZjNiMmYxNmVhNGM0NzE1XzI5_5932e248-d623-406d-87ef-68f595c6ec85"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib94c9abf453248efa63db38b503a8c1f_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMS0yLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjVmYWZkMmYxYzY3YzQ2NWI5NTg1MjdlYzJlMTRkOGE2XzU_aef539f0-d905-4713-8613-22df37c39128"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i14767b8798514b70a2a6a74b9bfa6102_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMS0zLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjViMTNlYWRlZTk0MjQ0ZjBiZTNhZDA2OTQ1NDcyODBmXzU_510b4ee0-9e6b-4c5f-86b7-a89cfc7c18cd"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i6498b4b0455a4c30a9f141fc0c149aa5_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMS00LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjQ2MTgzMmE4MGMyYjQyMGE4M2E2YTZkNjIyYTA0NGFiXzU_f9f8bc6c-323d-4ef9-b019-e380bfa54869"
      unitRef="number">0.0275</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i6498b4b0455a4c30a9f141fc0c149aa5_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMS01LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjcwMzA4YTE0YzM1YzQyNDI5MTQ2MzQzZGUwMGQ1YTY5XzU_b1184bb7-e1ba-49e5-bb75-336eeba4297d"
      unitRef="number">0.0045</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i77287fbd0d0a43c186ef244cf589e396_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjU1OTJlM2NkMTU4ZTRlMmNhMzc5ZDIwMjc4YjJlMzZiXzE0_ea39a0d2-76e0-4fd0-9f1e-e494019ae5b8"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i77287fbd0d0a43c186ef244cf589e396_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjU1OTJlM2NkMTU4ZTRlMmNhMzc5ZDIwMjc4YjJlMzZiXzUx_cb978cb5-b3a6-44f9-aca7-ee5cc93ea6cd"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i21e6a5f9bcb0473b911a70e52c9e9944_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi0yLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmVhNGU1YzQ5MmI3MDRjMDZiOTRkZjY5N2VhMjFlZTNjXzU_b08fc110-c15a-4e39-8f09-7f99a27409e0"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0203d30cd0df4077a62703e30f8c9f72_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi0zLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjllZjMzZmIwZmY5YzQxMDRiY2E1YTk0MzI5YzYyMTg1XzU_0f92e885-8c9b-4a1e-bd0c-4438b43d4c6f"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i66fff8293b844dbb838b2a1631a77770_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi00LTEtMS0xNDI3OS90ZXh0cmVnaW9uOmMyYTcxYzE4NDE1OTQ5NjI5ZmYwNDg1NTFjNzJiYWUyXzU_a3486d1c-dbe7-4ce3-ae89-6f1fd7c1454b"
      unitRef="number">0.0225</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i66fff8293b844dbb838b2a1631a77770_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMi01LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjhjNzY2MjhlZjM2MjQzMGE5M2FmZGExY2RhNTdiMTFiXzU_f47e3aa0-fbdb-4b4a-9d28-146d52b6faa0"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i7197db62c8b045d3873fabec7ae0b9bb_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmZkMmEzNzBiZDc5MDQwMzg5NGFjMDNmODE5ZDQ0OGUzXzE1_31a6acab-bc69-4052-a460-75ac5171c71d"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i7197db62c8b045d3873fabec7ae0b9bb_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmZkMmEzNzBiZDc5MDQwMzg5NGFjMDNmODE5ZDQ0OGUzXzUy_d51579a0-8716-4461-b549-07d5ada7aec2"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib0748b4650f54d66b1525c3d3fd5f155_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy0yLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmNiYmI4ZmI3Yjg0YzRmZTI4Nzc4ZjFjODU1YTNmMTAzXzU_7a79bb0a-e45a-41bc-b72d-2017f3c1a12b"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9f32cd9d031641319a66833f52dcf90b_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy0zLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjBlNjhjNTI3MjZlYTRkNzM5YmJlNDliNDZiYTg4YWI3XzU_2cbc21c1-7069-484c-981e-afff973cf5f6"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i4e79888671f849d681c9ca4dc7cbaa90_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy00LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjc3Y2VkNmU2M2Y5NjRiNDJiM2UyMzIxZWFlZDBjYzNiXzU_341c6c45-80b3-4299-b968-0c002df4c105"
      unitRef="number">0.0200</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i4e79888671f849d681c9ca4dc7cbaa90_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfMy01LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjMxMDRhYmNjNzQzOTRmMjZhZmU1MWYwMTIzYmI2MDM1XzU_2693a8ea-c43b-445d-94c4-f2b478508170"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i2d79a719943a464f8d6d78268821d707_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjQ4YTdjYTU4MTIyZjQ3NWI4ZDIwOWIyNTA0Y2FmMzkwXzE0_411b4889-0983-4352-b0fc-df43f203cd14"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i2d79a719943a464f8d6d78268821d707_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjQ4YTdjYTU4MTIyZjQ3NWI4ZDIwOWIyNTA0Y2FmMzkwXzUx_4610a5fe-2e58-455e-9683-7c63cc34a643"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6a23d776eb16471e8f49c42bb87a1e64_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC0yLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjg2ODk3ZjNhYjZlNjQwZjg5ZWU5MTZhMzAwODc0NjRhXzU_3609be58-fd2f-4722-b5fb-dc00bd4e3a5c"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i284b87cc02134d23929b19658a998ad3_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC0zLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmU2ZTY1ZmU5MmJhNTQzZDM5ZWUzMWEyNzEzMmVlNTljXzU_cd6709fa-a743-488b-b868-ea17820d408a"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i64766f8ffc80490290a08bed27b2773e_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC00LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjhmMTI2YjhmMjNkYTRjZDJhMzI4N2IyZDE3NDcyOTVjXzU_78f9b19a-ca72-4097-895a-c6955d6c55c6"
      unitRef="number">0.0175</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i64766f8ffc80490290a08bed27b2773e_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNC01LTEtMS0xNDI3OS90ZXh0cmVnaW9uOmE3ZjcxYjRiNjRkZTRhMTJiYjY0MmFiNmNmMGEyY2E5XzU_9882dcb9-d9e9-4430-8804-cfd4ed6bf640"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i788b4cad69a643e098e52cb02eb7e58d_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNS0xLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjEwMmE3YmViZDZkMzQzMzViZTE0NzY4NTQ3ZTljZjhjXzE0_e9256885-1e87-4b3b-9de0-3b3acd81008c"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i216ae89339844560bddb88a4bcab64fb_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNS0yLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmY4NzIwNzU2Mzc0OTQwNDdiNDI1OWZmNjAxMmJjMDZmXzU_80a7ff73-60ef-454a-8afe-5fe1fa6a0610"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9bdf68a9ef0548fb84d159aeddab27f9_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNS0zLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjBjMzNhMjMzODhiNTRiNjk4ZDM4MWExYTIzYTgzN2MxXzU_0dd74bb2-17ab-4511-b132-124f4ec86989"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i5c6b1f79048e42b0884571c09c623080_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNS00LTEtMS0xNDI3OS90ZXh0cmVnaW9uOjE0MTJmODlhYmMwMjRjNTViYjg4NThjN2ExM2MzODQ0XzU_243dbd2c-d8ce-43b4-bee4-eef232fa34ee"
      unitRef="number">0.0150</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i5c6b1f79048e42b0884571c09c623080_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjE5N2Y1MDE5ODQzMjRkODI4YmY2NTE2ZTlmOTczNWM1L3RhYmxlcmFuZ2U6MTk3ZjUwMTk4NDMyNGQ4MjhiZjY1MTZlOWY5NzM1YzVfNS01LTEtMS0xNDI3OS90ZXh0cmVnaW9uOmJlM2U2MTM0ZWFlZDQ0NDdhNDc2ZGRiNzQ5OWYxOGRlXzU_52781483-d9d2-48bd-8f71-ea8e32fe5acb"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib450abcacaa5468ca7b49d50d7ed31f4_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMzcxMg_ee94925e-85ce-47f5-bf1c-0681a4218a69"
      unitRef="number">0.0022</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i12925f11ce794cee9ffd477add1fac2e_D20181231-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMzg5Nw_92ce7a81-7e5a-4fce-baae-56ffc34a9798"
      unitRef="usd">800000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <rdnt:DebtInstrumentPeriodicPaymentPercent
      contextRef="i12925f11ce794cee9ffd477add1fac2e_D20181231-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfMzk0Mw_f412e665-db95-48ba-8acd-70c56eb96a80"
      unitRef="number">0.050</rdnt:DebtInstrumentPeriodicPaymentPercent>
    <rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease
      contextRef="i3adb88ce1adf406397b79615c8b29bf7_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNDA3MA_1393b313-e501-45c8-8d79-3d41c9abf41d"
      unitRef="usd">400000</rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4b2021e8693c43efb8f3683e1a35b4df_I20210423"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNDQwNA_806bb614-a15f-4bba-911b-89786b2b44d4"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i4c9e01d6493f43e299012d6df312e4bf_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNDU3MA_34b2bd3f-2a87-4314-8682-6a70a849a959"
      unitRef="usd">2000000</us-gaap:DeferredFinanceCostsNet>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i6e5edfcb6761487ba2db12d147e1a78a_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMS0wLTEtMS0xNDI3OS90ZXh0cmVnaW9uOjhlNjExZTJiZjk4MjQ5MmE5MDIwZjA5NjU2Y2Q4OTdjXzY_ee1c03a1-22a2-4e04-b03c-b3871a4fbc8e"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i944cc9d161d74ab4a23982b4cd8bdde3_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMS0xLTEtMS0xNDI3OQ_35707668-31c3-4b3f-83f3-97ede0d7db47"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ifab2cc344a8d437a8e02749427a7acff_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMS0yLTEtMS0xNDI3OQ_6a0536b1-ae76-4e7f-ba08-35d89e66ca07"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i55945c769c1d4cb2adf73dd4dd33aeb1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMi0wLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmUyYjUwYjZlM2I2OTQ3OTI5M2RmMzFjNGUzOTljMDhlXzY_d5117274-43fc-43b0-93df-0ed7340f3f69"
      unitRef="number">3.00</rdnt:DebtInstrumentLeverageRatio>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i5b949300d1bf4eb787b7017dba8800a8_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMi0wLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmUyYjUwYjZlM2I2OTQ3OTI5M2RmMzFjNGUzOTljMDhlXzE2_4aaaafa6-eca4-4cc5-92de-23768e63c354"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8f737acdac8048f2957feb692e3d8687_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMi0xLTEtMS0xNDI3OQ_509d7451-0f32-4021-9440-77a2bdd8b345"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if714085c7d9d491f9c016de58ac30e20_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMi0yLTEtMS0xNDI3OQ_a8480453-71a4-4863-8960-dbeac0f7b588"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i6f29d5fa82f04e0896fcba4d15e506de_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMy0wLTEtMS0xNDI3OS90ZXh0cmVnaW9uOmNjZWQxNzFjOWYxYTRjNWJhNWU5ZDFjMzRmNjU3NmQ1XzY_8ec7ab32-6f11-4217-be58-43887099ed4e"
      unitRef="number">3.00</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iaf21c52bd3f345188e62a53c44636392_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMy0xLTEtMS0xNDI3OQ_7aee6163-6108-462b-a372-b5de76489509"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i3c069f2e05fb4ade941f4557b949f231_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RhYmxlOjg1NGY3ZTljYjMyZjRlZTJhZGJhMTQ5MDJhYmFhYzhjL3RhYmxlcmFuZ2U6ODU0ZjdlOWNiMzJmNGVlMmFkYmExNDkwMmFiYWFjOGNfMy0yLTEtMS0xNDI3OQ_1a63a9a6-360e-4a95-9d2d-f953456bc2ff"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i4c9e01d6493f43e299012d6df312e4bf_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNTAyMg_3075c3d0-d1ff-4612-9ef4-ba23037799c7"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9ba7bf841c994912865be36c75e38317_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNTIxMQ_f68ac3ac-ea45-4e48-945b-88aed78b1abb"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i69b9eb94e2114856a02bf051af39e645_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNTI0Mg_94faa2de-1f68-4e30-87ac-4ae4887f7a74"
      unitRef="number">0.00125</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i69b9eb94e2114856a02bf051af39e645_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNTQ0Mg_f6735989-3822-4912-9cf4-bce9a5e499aa"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2f7f03f2987a4c7fb79e4440534fa07b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNTc5Mg_fcd7dd84-bf4d-4f49-984e-b661755ed6c9"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i2c4dd403dd9e4ae1818b1ff441f9d0fd_I20200828"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNjY4Mg_f3495d1d-c24c-4aba-82a7-942379d4942c"
      unitRef="usd">57500000</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4b2021e8693c43efb8f3683e1a35b4df_I20210423"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNjg1NA_806bb614-a15f-4bba-911b-89786b2b44d4"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:NumberOfAmendments
      contextRef="i0dde26745a6044629a509a83ba660edb_I20190418"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNjk2NQ_81344636-6d6e-4334-8e58-76edfd268832"
      unitRef="center">2</rdnt:NumberOfAmendments>
    <us-gaap:LineOfCredit
      contextRef="i173683f5805b4c458be4a416f552f961_I20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNzMyMw_650b1920-8dd7-4de9-a85f-2badcdbdf302"
      unitRef="usd">100000000</us-gaap:LineOfCredit>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="ice280dd4e241422aad4acecf0b4651de_I20190418"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNzM4OA_187fa84a-cfb0-4435-b233-b117b75a01d5"
      unitRef="usd">20000000</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <rdnt:DebtInstrumentExtensionPeriod
      contextRef="i6d0fe3c768bd4ce39293d761c41ecb34_D20190418-20190418"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF80OS9mcmFnOmY4MGU5YWM3OGU0ZjRhODZiNWI2ZDQzZGY4OTYxNTkzL3RleHRyZWdpb246ZjgwZTlhYzc4ZTRmNGE4NmI1YjZkNDNkZjg5NjE1OTNfNzYyNw_99448021-ab0f-42d5-84e6-d102ced40b63">P2Y</rdnt:DebtInstrumentExtensionPeriod>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMzcxOQ_049a44ee-88e4-4a09-9cd7-793ccfcf25b1">STOCK-BASED COMPENSATION&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021  (the "Restated Plan&#x201d;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan 16,500,000 shares of common stock. We can issue options (incentive and nonstatutory), performance based options, stock awards (restricted or unrestricted), stock units, performance based stock units, and stock appreciation rights under the Restated Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option grants, whether incentive or nonstatutory, generally vest over 3 to 5 years and expire 5 to 10 years from the date of grant.  Under the Restated Plan, stock options may not be granted at a per share exercise price below the fair market value of a share of our common stock on the date of grant, may not be repriced or exchanged without stockholder approval, and the maximum exercisable term of the option may not exceed 10 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, we had outstanding options to acquire 683,914 shares of our common stock, of which options to acquire 508,969 shares were exercisable. The following summarizes all of our option transactions for the three months ended March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,157,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,126,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on March&#160;31, 2022 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on March&#160;31, 2022.  As of March&#160;31, 2022, total unrecognized stock-based compensation expense related to non-vested employee awards was $2.6 million, which is expected to be recognized over a weighted average period of approximately 2.24 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%"&gt;DeepHealth Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted options to acquire&#160;412,434&#160;shares at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of March&#160;31, 2022, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $1.6 million, which is expected to be recognized over a weighted average period of approximately 1.23 years&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,890,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options issued in replacement of original DeepHealth options as a result of our acquisition are not included in the share count under the Restated Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan permits the award of restricted stock awards (&#x201c;RSA&#x2019;s&#x201d;). As of March&#160;31, 2022, we have issued a total of 7,743,651 RSA&#x2019;s of which 438,786 were unvested at March&#160;31, 2022. The following summarizes all unvested RSA&#x2019;s activities during the three months ended March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(517,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the fair value of all RSA&#x2019;s based on the closing price of our common stock on the award date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other stock bonus awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan also permits share awards not subject to any future service period. These are valued and expensed based on the closing price of our common stock on the date of award. During the three months ended March&#160;31, 2022, no such awards were granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance based stock units ("PSUs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, the company granted certain employees PSUs with a target award of 25,683 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance based stock options ("PSOs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, the company granted certain employees PSOs with a potential to option a maximum of 111,925 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 111,925 shares) depending upon the extent to which we achieve a performance condition as determined the board of directors over the period from January 1, 2022 through December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restated Plan summary&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In summary, of the 16,500,000 shares of common stock reserved for issuance under the Restated Plan, at March&#160;31, 2022, there remain 2,380,364 shares available under the Restated Plan for future issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
      contextRef="i11e3573789424e659f1797ec670783df_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNjk_26ad1308-c3e3-4bb4-a1e9-d21d27103691"
      unitRef="incentiveplan">1</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i11e3573789424e659f1797ec670783df_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNDUx_d4eb6a5e-edf8-4360-91e0-705654f7d480"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1f6c8dad5f1a47f795469ebccd173f1a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNzI0_db37cde9-aff9-4574-9a80-71b5f02be6b3">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNzMw_ae8c0c63-1461-42cf-8fc0-2f3fbd288cd8">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i1f6c8dad5f1a47f795469ebccd173f1a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNzUw_b99b60e4-a65f-4319-abcc-f3bbe0389526">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNzU2_2b773c42-067f-426e-8abc-aa8a4f7d5789">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i8a4ed362f73c443f9c6eadaae3d7ae28_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA4NA_7d1e9ae4-0764-4e14-9cc8-4c70510e97f1">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5fe72543c2724817acf22b92b9937440_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTE0Mg_8f4bebb1-cdda-40ff-9ae5-d70bf8cbd9f8"
      unitRef="shares">683914</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i5fe72543c2724817acf22b92b9937440_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTIwMQ_48641de6-1966-49e1-90c0-318015378434"
      unitRef="shares">508969</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMzcyMQ_0885bba8-bf46-42b4-9e54-dc48220fcbc3">The following summarizes all of our option transactions for the three months ended March&#160;31, 2022:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,157,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,126,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,890,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9212727f374b4ce7870dbc05eb4d8aab_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfMS0yLTEtMS0xNDI3OQ_fbc5943f-32b5-42c2-b10a-38d28e620cbc"
      unitRef="shares">473939</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9212727f374b4ce7870dbc05eb4d8aab_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfMS00LTEtMS0xNDI3OQ_d217e871-f399-4ada-98f0-eb633fb0eaef"
      unitRef="usdPerShare">9.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="if325d72e03184e4ea6e238d77b34f487_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfMi0yLTEtMS0xNDI3OQ_feb2df58-05e4-463c-871f-45cab696c9ad"
      unitRef="shares">209975</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="if325d72e03184e4ea6e238d77b34f487_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfMi00LTEtMS0xNDI3OQ_3396ef88-f466-4ae0-aebe-05abfbc4e822"
      unitRef="usdPerShare">29.44</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5fe72543c2724817acf22b92b9937440_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNS0yLTEtMS0xNDI3OQ_ed7fbdba-cfaf-4a7b-87bf-2df241399dcc"
      unitRef="shares">683914</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5fe72543c2724817acf22b92b9937440_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNS00LTEtMS0xNDI3OQ_e45bca62-a5da-44fc-b538-17747438786d"
      unitRef="usdPerShare">15.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="if325d72e03184e4ea6e238d77b34f487_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNS02LTEtMS0xNDI3OQ_9c5e0095-c617-45e7-b148-21d18c212efd">P6Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i5fe72543c2724817acf22b92b9937440_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNS04LTEtMS0xNDI3OQ_88938eab-b58c-43df-802b-3c537d42b01c"
      unitRef="usd">6157802000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i5fe72543c2724817acf22b92b9937440_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNi0yLTEtMS0xNDI3OQ_db159cf7-075d-4e26-ad76-f0ac2b364a48"
      unitRef="shares">508969</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i5fe72543c2724817acf22b92b9937440_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNi00LTEtMS0xNDI3OQ_98e35efb-4758-4f60-b489-c80995df785e"
      unitRef="usdPerShare">11.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="if325d72e03184e4ea6e238d77b34f487_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNi02LTEtMS0xNDI3OQ_b19148c2-0d1f-4467-bed2-16cdeb5e441b">P5Y5M4D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i5fe72543c2724817acf22b92b9937440_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjY5NTYzYzY5ZjY5YTRlNDM4N2RkNjIzNGUwMWIzM2YzL3RhYmxlcmFuZ2U6Njk1NjNjNjlmNjlhNGU0Mzg3ZGQ2MjM0ZTAxYjMzZjNfNi04LTEtMS0xNDI3OQ_15ca3f05-9042-4d5b-8ba1-71e40cce2989"
      unitRef="usd">6126246000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzMjYwOA_a4f4ffe2-8a62-4d8b-8f54-9b86ad790215"
      unitRef="usd">2600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTkxNw_14c5d4aa-332d-4935-bed6-7f03bfb10d96">P2Y2M26D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="icf3ba225c36c476084469d9c6670a07a_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjA3Nw_35dfad2e-ed0a-4a17-9b57-4eede73940f1"
      unitRef="shares">412434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6bb501a256514bab8c456345170a164f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjExNw_c7ed90f2-b6ad-432b-a0c6-260a72316d4b"
      unitRef="usdPerShare">16.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i8e2634a74afe41adab0fab66686d695b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjM2NQ_3fb29d89-34a5-43fe-bdb0-b0f2a7ff12fb"
      unitRef="usd">1600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia330bf2f544847c6ba7b2723fd73ac98_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjQ1Mg_33bbbd86-0b80-4f90-b294-1ba5da11a232">P1Y2M23D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib5e7a1236cb84c87a209ab1daf15ec5d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfMS0yLTEtMS0xNDI3OQ_1761a507-d29c-41be-915e-c7e5308802db"
      unitRef="shares">320660</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5e5cdfa72e1f434c8006a75f7440ddfa_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfMi0yLTEtMS0xNDI3OQ_20192704-86ce-4b1b-825d-21ec89309198"
      unitRef="shares">12637</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9638ca6566474cefbd8968ed4929434f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfMy0yLTEtMS0xNDI3OQ_e0cd33f1-2190-4f3f-bfd8-083bc163a5b5"
      unitRef="shares">308023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i5e5cdfa72e1f434c8006a75f7440ddfa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfMy02LTEtMS0xNDI3OQ_a0fbf8ab-562e-45be-bdd5-5e02f2c6c38e">P7Y2M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i9638ca6566474cefbd8968ed4929434f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfMy04LTEtMS0xNDI3OQ_8ece2a87-a6ac-4bbb-b84b-b75fa0f45c36"
      unitRef="usd">6890475000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i9638ca6566474cefbd8968ed4929434f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfNC0yLTEtMS0xNDI3OQ_696248fa-3596-4492-b695-a60c0480c6e3"
      unitRef="shares">46912</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i5e5cdfa72e1f434c8006a75f7440ddfa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfNC02LTEtMS0xNDI3OQ_8df234c2-ebe3-4d3e-ac17-1f6f008a1278">P7Y2M4D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i9638ca6566474cefbd8968ed4929434f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjA1MThjYzkzMGVmMzQ0MTlhYzNkOGZhNjIyMjZmOWM5L3RhYmxlcmFuZ2U6MDUxOGNjOTMwZWYzNDQxOWFjM2Q4ZmE2MjIyNmY5YzlfNC04LTEtMS0xNDI3OQ_d7b389f3-402f-4261-896a-e743163c3765"
      unitRef="usd">1049413000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjc0NA_2258ed5d-803b-485e-8c73-a10b07f633d6"
      unitRef="shares">7743651</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i02c8a2af4cae4e6e846dbb7f3b47fdb3_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMjc2Mg_a646c2cd-8bf1-4290-b2ae-56d830d7e715"
      unitRef="shares">438786</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMzcxNw_39cf7d59-4737-4404-9112-a770516af0a9">The following summarizes all unvested RSA&#x2019;s activities during the three months ended March&#160;31, 2022:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(517,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id651533cf9634a93ac70355625b736ef_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfMS0xLTEtMS0xNDI3OQ_ec803e09-eac1-4ec7-97ea-feccd1662ff0"
      unitRef="shares">456075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id651533cf9634a93ac70355625b736ef_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfMS01LTEtMS0xNDI3OQ_7bba8ff7-611e-4adc-a69b-6164f6887604"
      unitRef="usdPerShare">20.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfMy0xLTEtMS0xNDI3OQ_c50b2499-77c5-4759-8765-19b5088f3148"
      unitRef="shares">500622</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfMy01LTEtMS0xNDI3OQ_c3bd500e-2fa3-40f9-964f-b69ca1c75843"
      unitRef="usdPerShare">28.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfNC0xLTEtMS0xNDI3OQ_4112d3b7-a651-4cd3-8be7-552dd1475dca"
      unitRef="shares">517911</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfNC01LTEtMS0xNDI3OQ_fc467c85-6704-411b-b1e0-e50a92894dd4"
      unitRef="usdPerShare">21.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i02c8a2af4cae4e6e846dbb7f3b47fdb3_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfNi0xLTEtMS0xNDI3OQ_5741743a-2348-4bd0-8f76-5f20c53ad90b"
      unitRef="shares">438786</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="ie2d96663c67244b8aed2634eec524266_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfNi0zLTEtMS0xNDI3OQ_1808b9dd-142c-420d-a06d-9ec7f7ca89ff">P1Y1M28D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i02c8a2af4cae4e6e846dbb7f3b47fdb3_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RhYmxlOjYxZWUxM2M4ZmQ4NDRhNDZhMzQwNTYyZjEyZDZkODRmL3RhYmxlcmFuZ2U6NjFlZTEzYzhmZDg0NGE0NmEzNDA1NjJmMTJkNmQ4NGZfNi01LTEtMS0xNDI3OQ_ad8492e2-0634-49bb-b333-bde4fe8b68c0"
      unitRef="usdPerShare">25.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia5c138bc3875441b941c772784e63633_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfNjU5NzA2OTc3MTQ5Mw_b83c7e39-fa74-4ea8-998f-96bfc4667b6d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ibc2a40dd49e04ddfaf6d85ae95da2eff_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNjk5OQ_6fb06a46-a34a-4417-901d-29df5616c420"
      unitRef="shares">25683</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i097c50f9108e4084a44c52e4dd246bee_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNzAwMw_394b1ee3-d668-488d-9632-43590f10fbbe"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i34139941895f4c2b87454e78288b6292_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNzAwOA_3390dc50-2ced-4b23-8271-ef1e7adc5a30"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="id250c206c9c1458d9f1fbcfcdf5640d7_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNzA0Nw_7f0543db-2d96-4b9f-9e07-442208c86c04"
      unitRef="shares">111925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="id200edd7b27544e283a49fdc5f16ae77_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNzA1MQ_bda63507-24e1-4533-ac65-a823318e1f15"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ie6fa67c017444c96a4b8dc187d33a734_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMTA5OTUxMTYzNzA1NQ_72eda54b-ea1e-4d06-bc27-4fb0bd672158"
      unitRef="shares">111925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i11e3573789424e659f1797ec670783df_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMzM5NA_d4eb6a5e-edf8-4360-91e0-705654f7d480"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
      contextRef="i2d51580d4825469e821595335785ef53_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81Mi9mcmFnOjQxNGM5MjQ5ZTc3NjRlNmQ4ZGUwNzlkY2MxODcyMTk3L3RleHRyZWdpb246NDE0YzkyNDllNzc2NGU2ZDhkZTA3OWRjYzE4NzIxOTdfMzY1MQ_c1ff5a37-1ae6-4a06-b869-029ef7fa74a9"
      unitRef="shares">2380364</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81NS9mcmFnOjY0NzczMzQzZThkMTQyZTI5ZmZhZjg3OTc5MjE5ZDU5L3RleHRyZWdpb246NjQ3NzMzNDNlOGQxNDJlMjlmZmFmODc5NzkyMTlkNTlfMzM_5d165f5d-a7fb-4012-a505-d8914b861641">SUBSEQUENT EVENTSFormation of majority owned subsidiaryOn April 1, 2022 we entered into Frederick County Radiology, LLC, a partnership with Frederick Health Hospital, Inc. ("Hospital").  The operation will offer multi-modality services out of six locations in Frederick, Maryland.  RadNet will have a 65% economic interest and Hospital will have a 35% economic interest</us-gaap:SubsequentEventsTextBlock>
    <rdnt:NumberOfLocationOfferingMultiModalityServices
      contextRef="i05688edf21f347e59b6c396261cdb342_I20220401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81NS9mcmFnOjY0NzczMzQzZThkMTQyZTI5ZmZhZjg3OTc5MjE5ZDU5L3RleHRyZWdpb246NjQ3NzMzNDNlOGQxNDJlMjlmZmFmODc5NzkyMTlkNTlfMTY0OTI2NzQ0NDIxMA_29d4c3eb-b1b0-469a-8988-72fe2cefc970"
      unitRef="location">6</rdnt:NumberOfLocationOfferingMultiModalityServices>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="i5b489515e2944df5827ad37c4f4ac39a_D20220401-20220401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81NS9mcmFnOjY0NzczMzQzZThkMTQyZTI5ZmZhZjg3OTc5MjE5ZDU5L3RleHRyZWdpb246NjQ3NzMzNDNlOGQxNDJlMjlmZmFmODc5NzkyMTlkNTlfMTA5OTUxMTYzMDMxNA_c7a64c6d-67bf-42c5-913f-b1cc35eabf21"
      unitRef="number">0.65</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="ibf0e02f07fbc478f873c7b8dd2a24f2d_D20220401-20220401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNmNTBjMzU0ZDNkMTRmOWVhZWI2ODNiYzE1YWQ0MzI4L3NlYzpjZjUwYzM1NGQzZDE0ZjllYWViNjgzYmMxNWFkNDMyOF81NS9mcmFnOjY0NzczMzQzZThkMTQyZTI5ZmZhZjg3OTc5MjE5ZDU5L3RleHRyZWdpb246NjQ3NzMzNDNlOGQxNDJlMjlmZmFmODc5NzkyMTlkNTlfMTA5OTUxMTYzMDMxOA_9629b765-d748-4ba7-8774-f6ab69764d78"
      unitRef="number">0.35</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>56
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M?\6;\_,#5[QR7=K'V*KZX.&VGG=C  O6\RBX@.^Y&$A5##S<P1]E"#F9K:7
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M#:M2N1"OG_EA05X]7RS2LOF/7@]89X#BJI0B.PP&!EF2[S_9]X,AC@9@US"
M' :0<P?0PP#:+'3/K%G6A$EV?5F(5U34:)BMOFALTXR&U21YO8U+6<"O"8R3
MU[?W\\ETOIQ.$%PM[^]FDYL5W'R\N;N9WT[1\O-TNEJB$7I<3M#/'WY!'U"2
MH]565"7+U^7E6 *'>J9Q?'C>Q_WSB.%Y7UAQ@2@>(N(0HAE^:Q\^X7$['+\?
M/H:5M\LG[?)),Q\U+?]QL9C.5^AFN81U6B:D[82TF= U3<C*+0+3H+B^X-^J
MY(6E/)=:4^VG\INIZGA[N0Z< -/+\<NQ1504IJ[O^"WL'5&W)>I:B=[$L:B
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MN=QR!GY; ^#WC8 BY'!3OVUJWRY>_P=02P,$%     @ >8JJ5"<U[(N4 @
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M$"B;@/>74IK'P,ZX]I.6_@502P,$%     @ >8JJ5.$= 2Q9!@  TA<  !@
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M.!#]*U8TAUVIIT,22& $2#1DU&@::!%F]K#:@TDJQ#N)S=H&>O[]EI-TEH:
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M82&OZNY_,-5? #ZE.\85R2%%R,YC@ &4566M!EKLR^*T%1I+7=G-\&<$I#'
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MHT!)4@#7%U4E7D[D][WM5^_3/P%02P,$%     @ >8JJ5*)!51[E!P  G!X
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M"I'>.]*!;.,DDC3B@[=?4<1%W"VV%/+D5Q<5# [9]SOR;R=U-[EC[$*%>L2
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MD0W(UE)VA<[[6K-G+2$U3\ZB6R$6IHN>S8@R6;P2QL#-R+9@;J]1X6'\W*.
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M'L?J9O)IC%\\CFY_GH!3A\K:,=R.[43Q3%CHU?"LZ^*$Z"//D%3B4I,,).\
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M(^*3)I"*\C#P*AQLG8E^8OH)<'86M6L;QB:9'*(K/Q--@*':]1I-\GU2 WC
MAQTK6Y'8\4=O.M#9I!*$.6V(+BYJVIJWZX7Z?83@ -0OSJ7@V6E?I&\Z6#I/
MAFH;.C=.0GMV'CK<+)-A*$TE9PHT8)0@Y>.6FB(TR)/[5B#?H!5-3=QZ>CG>
MY1[DWI[+"5,P%NMJ=E@!1_:&G?YWP3>(9(H(YXSP/8N?N/SL\XOW3SJ][UZ\
MMNV;<$Q#9_!RV&< 0&Y<1F)1C5X+1VFJ,@,^)M PB [;.XR/,$HJT<:$DXP<
M)"G,&%N"C'$TCJ>G.J?R^Q]@ IB!MTZD0M:CMP$ 'H;4Q\!N=+Q(:Z-^("%P
M&#\=&:?+XU94)&4>3RNN3L*>$;"4]#&SKU^/0Y0SQ73<$\:U:OTP7FDSE<>F
MGGE56XSX,T/WB1P!&9_J+Z7J]07['74S'CV0=/_--P;C.0ER%]U##@[%\P=1
M8(-O'75G8Z[TJ_&HJ-:9\J!9?8#**;R1S8_1"3RD8H'N#_=W'^E3[X<CX;+
M&E;-"3P9RQ4J+HJZ;^CVZ[EMP,6[F ,1>S;2'LAQ<,[]Q]W2#L9C@G'/L!=!
M"&@R0BC74O5&3Q%2J6J2^J(X<Y"0+<]"U4:<7?"&P&IBM#&O:XO!R5?A9S.#
M:U'PS1V[P@Y=^*#O^*MYW4DHN4 7-DZD1Z$'J^.X]HXAM&Y* R8;S'"[):^=
MFFHD)"V'+*%M4^3(G@S7M.;&$S?1"B &UN0@B*;@4F<42,YWP/,;QIQ*;MU6
M0_N\8',D&Q BKM7W8.6V*.R.Q7);ZYK#VO2,D#+PB VN@"S0&'*1)39B"I"V
M#K$@< H3F8"(29:17-%?L#*1H A+F5+BB5;#(,DU#J9>A$JA\WK D^+G[>?W
MCO+,MD&C6;,:<H12(,)A #2&$KYHKPC&MER(*$MGE%[COU $9RFW8)FLH)?]
MESBAR_78X>QT(QLD!F;[(X7.UW@498DVP;LLKXL RMI+1-\JY]3;OB<B:NA[
M-C?@&=Q^>-K$:"PW?O.1@/MNZO3V1*3GNA8<5#N2IR;'J$^0W?>&4PY**(KS
MJ%IA8IV[,18+W!N=<"U>(18RAMFL1<I%MT3]6#/@+4GF(4N"N20<FGD 'ICM
M:*^"BKFP@HBJBP#CI&'1S#(Y^7F,?7CS),NX(TU:;R@E3@3+V6;:IS;N!>;,
M$ P13CY^6KQ5WI&%7429A*DE2FUSY5Z'@^V?9<:A. RA"4;_CI4 X0JKE"6>
M-K?Y%I(?=D(;4B)BRZNUI(G-,E1FCY,F&4>=[0-BBH4.]"D<TXK#+.FQC=*!
M?)7B79$]-3K@W;O#\M2UZ3T&QVE#UHN<[&YI!:. X;1)!^YT(47 [65YK7$&
M0,?N'J9[E\A)L=B4<N44705K/^]0LNGQO]0E6%?7F*#X,+Y]X P%%3?W?K!5
M!!@.=M8!6E8I]Q5AC;T1NN$,9"R;(7CE 8%JQ1]-$Z[8DN8LBDMBV;K7+):B
M 6!8_89CK$CAHW4>)S KDE9O&)AZ7%NZ>T$_G+$9([8.YO4X3$$/XV,4Q#E$
MU!B3S@#Q 39BC#OV#&H_<27=FO)/='*<K<^BSYB9PB:RL/0;J&L_K30W*0&T
MOU: R%[7>" &O:A-<YRY=QH,N]V@V^VRW2T)D=4**T5P3I8_!=:T1-HKQFM
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MD1[ESBD.SU$;1'.336[C:N?"6&,H+^F<))B:?G:M5,Q0?F;*&+2V9&-@NFP
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M%(998V_72F)5_9QIA<^P]\/ NA8%'^R LX?;H.$5N= 1:H^07#DIDO#:,6R
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M?'C>E2K8:CV$@%OHJ%S!7;>S4VZPI4O6P%"T04)):6'/;3;-^&:RJ8] H]=
M_H?F0 ??>J#VO*K4FYGK6<N=Q6LK?BR\M(],)V\7J#.'UP*-Z/V]FBVX"?+:
M!4;?D!0J^4(6%K?\CAWLCZ\7B#:ZQTV)1_V*$'?2=H=?EZ*!32ONWL(J@7I7
MT/E"55P$-4W<T,"CMAY"PUG"H^9HY7+1*Z]/U'4L"&">L7OLS.E[M+2N/'/<
MJ<L3+&9K^6:TI[WRC\#F\]DW ]@[I>M26[YZW$,5[K2\,LVPQ@7, F8/3+L=
M]1[-.7/9$U^PUM CC6F (V!<5)D0HFE:-^K%]0C6KOSE6O*ZSRI/[#JRKGF0
M[U;*J3A :H$*FPSD#!#)#U'HNS](03Z5]=<T"%O_TR2.?"EJ"OR028U[V-Z2
MT#I%APY4+*,KWS+R>/U/L?J>\DM73(F#:DY7S5EK<^\H48B2>!J:0LZ&IP%>
MTCHK]#?)E:^*%9]#_B]ERTTKSS8\.YCT/IS=ZK*.=I]#W:=^,!P,[;]_$<L.
M_@:6=6#)-JF"5VXH$^YTE0/DNQZZ&XM?@74_.#N2=$.\LE>B-^XH\V_&!X%=
MFC<] 7A.^31*4Q$0>ZT/P<97ATBD032O2?%X6OQ0?W$5<#GYV711_)*OT8OQ
MHGP."Z32[? R8X/K$JC6#ZQ><R1B08,_051$&:IK/2V?X?9B+[O7NDZEB< 3
MKM1X96O=.<7_ES*"YQ":+V!]_F)_&NZA2A]S,-S=]S5>.!L.@K/3BSW?G9V"
MYCT=_$'-^_< ?'H:7)P-]GQW=GH6G)\-,<7>4O 6MN52:K=VY?;6+KGETW9S
M+$,T/]WMFZY\DTL++=C[I_#S>KMYJ&H*VBA&T8^T>:LWZE>LV=FJB;Q, :0;
MWBZG#@]N?YW<'AP%!B9@&[ NU]X=(UYM:?O->&V8Z#PK"G?)VUP Q%?H1E4A
M/@<%KDY?=+59\!(CR'O/AB>YF!E],<"N5>T:D[9.*E;.&'6TX4>,4<!&V=SV
M;F$,6B]$=%VQ22.68\),);\)R5[[Z.4Y=S/54QV%E75;A$CH>CEJ1_->O48R
MW#?:LCQ>U"\H*NJ9$I'>>(F9N2-!+APP/J'4KC0O\=T\C\.Z8V/ZWQIOK'O1
MKG'R#;WB$\,H\BJ)NL5IHCAHY;G;_W=.U5NNL"<DI"&%-^/1_>WD]N<']6%\
MKQY^&=WC[;9C2=53IIKU4%PTWY.S V):$>]@/WV[Q<?9;N\+C\A\!K69M-I@
MLO=09>1DLFWW&U54K+@N!7)J\[+[0,78_B:.AD@@07A+\6B*/S:;^=FVXI+Q
M[XL:J*9;";-]W1[*X(O@9'B.W6&3*W4[?C3%WP[GH\?'^\GEQT>Z7OCQ3MV/
MKF%<@ ,[W].5=^_O;M7#X]W5/WZYN[D>WS\ 3^_%OP%&CL$3?;LO5QP.T6@,
MNMTS->P%%_#?L'N*M;C@(J1N^PZ#?P@1W4YW2/_TSM7UY.;CX_CZ_P<B0 9@
MD/R)6U:;G5K6J;"O!96F#]/XT[LX"RYZ/=4'^Z%_.J3IO.:$I@U+S&6;K>EF
M"K]AR)6++*2TRCPH$YV?]H(^Z/K3_DG0.^N^'#4F..8;W>" TDT_K50P!.?^
MM!_T+@9JV _.^^?!Q4E/73_WR)\FG(<=9&#Z8O=HI.6#S6KM7?#/EQ=9Y6 V
MZ(%H!&=A= 3G>^SE9NBDTF.@CMZHA[;C(UMYWQ&^42=@E_7ZZAP\K8NAZ1N=
MW'X:/YB&@T<O_R 9A[;F$'M-)89,2=]B#HW=69?71.S8ETLZ91.8Q-_6+QFK
M%5SY^7)WGATU(:W**B'-6B\@J"V$^+! ARRN'<A8"^HN_C7@-^#FFUEMM)T*
M[9S+(R\CDVU0\X3M*B]DH^;7_=MJ\S[<O0"<>FO!JGM98BVQ(-<PM2)'+!"N
MT/<*WUSV3TBZ[:*,HOZR&GH'AOK$+Q(T5O%#ELBUXS?EK&,NC,*RAR(/\<6%
MY(E3TP\=>V'>U;0.H\_AP@1-3&\T)=)CC!!C9QUSSPPCZFA4125=/5KO2=+I
M$D][1B\],Q>3RZ57_.C5HRHB^X8PAU"Y)*GOO=)%TK!8SMH[Z?1[WS63]JZ*
M%>_$WU(#V%[R:-PYD,I-'W9]-+[]J^%;V_$?JSP%F6'QO87CPB8?B^B/9;@,
M3%N-N<R>(W:()X+K/X_S<.M>"\=SU#$?HES.FTPB]VMZ$VCI7C77KF-CCI:N
M1*DJU7J&'0Y_.VI^6\:EO@^GT[CLA#')=@\O5U@WG8%Q&5*YL*MS%529*^7V
M5%D454SWGA"[82%!F9FKC#GLLM92H<WWR$9;=FRH]@)YT%YQCY2<)=EB:^0%
MS6%?[@8HZV!AR2U>DCREEY)Q2'RC_7M8OT*))!R FNL7;5-J"M_AHF>UP:_Z
MWONBJ ABS:\.GU/?GG^GZ3.G&#Q_AHU[,.>2/ U3S\=[V4$[E04?U:]W$_CP
M"?[ZB*\Y:5YZ $9PE=9\^]_Q?@*%%VM4M@PEV\@575X]#K8)V/N&!L/OZ&TH
MP^_,NPT:T[C;C/P+O^3=%%E!]\\#BN0E*8;GL*?2TL,:XW[\'@SD)%1T<FNW
MJ2N0T#(Y?)O4R#Q71='RTD=Y+RZ]X<"]]M>].HDK;6J;>6::YJN6MC9>20T5
MNSNAJW1V?Q!A0RU7\9J<1"'@&B0[,CHV;R1H8#]NOB+)-=D*HYAK'0ML]C#A
MZ5FF65M*+YU_KYM+$_H\1@E:L^S;U^5/;U_'!?PO@O_R; /_I[C[-?AZ/[U=
MX=5R5R!$"D[-_'C0._"^Q<L]?SP8]=Z,^@>OX4DW_*>W:Q"M0/<+;(M-]!P>
M[7;.A@=\]8+YH\S6."6V,939BCX"?<'&<0#\/L^RTOR!"V# BL#[Z7\!4$L#
M!!0    ( 'F*JE3=!<=YLP4  # /   9    >&PO=V]R:W-H965T<R]S:&5E
M=#$Q+GAM;-5746_;-A#^*P</&%H@M64G:8,N"6 [29>A30([61^&/5#262(J
MD2I)Q?%^_>Y(298W)^W#^K 76R3OCM_=?7<D3]?:?+$YHH.GLE#V;) [5[T?
MC6R28RGL4%>H:&6E32D<#4TVLI5!D7JELAA-HNCMJ!12#<Y/_=R=.3_5M2ND
MPCL#MBY+838S+/3Z;# >M!,+F>6.)T;GIY7(<(GNH;HS-!IU5E)9HK)2*S"X
M.AM,Q^]G1RSO!7Z7N+:];V!/8JV_\. Z/1M$# @+3!Q;$/3WB',L"C9$,+XV
M-@?=EJS8_VZM7WG?R9=86)SKXK-,77XV.!E BBM1%VZAU[]BX\\QVTMT8?TO
MK(/LNZ,!)+5UNFR4"4$I5?@73TT<>@HGT3,*DT9AXG&'C3S*"^'$^:G1:S L
M3=;XP[OJM0F<5)R4I3.T*DG/G2\NYY<W]S"=SV\?;NZO;S[ ].8"%I=WMPL_
M6M[3>+JX.!TYVHUU1DEC>18L3YZQ? B?M'*YA4N58KJK/R*4'=1)"W4V>='@
M)V&&<#@^@$DTF;Q@[[!S_=#;.WS&WC1)=*V<5!DLG5"I,*F%ARH5#H&&,,^%
MRA"D@I[DG9$JD56!\,<TMLX0J_Y\ <M1A^7(8SGZ 6GX;RSWG;1=.$2J*X<I
M7"NXT8]8QF@X_)0$ER-<39<SD-;6)#%=/OB5-^,(7@UZH\'K _A ND91+3N8
M6BO9?H+PZEY7,H&3PPF)7$B;%-K6!BW$&YC5EARQS!XGG:1)$5-/V6]IN+.[
MP:^U9#/8JCH-E=&/,D5(>]M04Z"R1B-% =G6KM@BI/PJ*WS_L$ =D'BA:I(V
M6&GC0U61ND[M$.[S7>-$DZ).F3ZA<_H69"C"J0^=$H[$0*_\:+ME"*S!0G#8
MQ38GE2YDPL[4EA;(HV;-P]J+/IC"U8H:(&^TWT6"Y<4X5IN??SJ9C-_]0KY*
M1:L<&!)SR$KVP%>%4!NP,E-R)1-!IBA^I?4KB5:I#*%JW<H,MKHA'NQ)HLM2
M.C_=ZK&'J-B]$$A%W;PE(:R%;;R@_NW=W8>NY>%+68(8,ZD4SX@5 8<+3 *G
MQ\>^K8R)27:'3%H5&Y!E122PK=T]V].VVBGM=C@0$N!+B+.?RA1(!')!;H@M
M]=H,*="UX6A82G7J\[_/T2$7XV^"D)C-MVHQ&O=K,1IS+2YPA08Y]0ON=#0D
M?G:U>'1"(LN$#GT8[MA)"F$HYUQ-M)OU$I3F3@VLIA7AZ$@T\E%PKBA@WC5"
M1!7MF@)I">UK2S9U001\JIC@CL*-A<QD7(1<)V@<W2V@"2*)82H[[N!3@E7@
M',ET8 *+LIK"R([*/H'JBLQPH/P2&R'JH1$%[4R,)HZ J @+5UE.!9OE6YJT
MIT^P_T,R2Z=<DO,FT;-YC=Y$1]N\\N@[\WHE$EE(%YI14Z.7'J,OV?T62/2J
M [OH2FJX@Z9IK[9)$_O^;*)\A5*$-VQF&WOJ9UC]L^FUIZWOX2T5N&'PP0NE
M3GT;"G9YFQS3C!5] ^797%8V\-)TWGVD1D5>72M*TYM8J"]PN^*U-/C]ZN/U
M[';Q&GPCT10CT],U+,&^>5H3J+AA-0.F'/U?F;?W]&?+&WH8]&X!MXG3WW$)
MB$YV&@^3KSO1Y[J,"4-(6LO/Z)A$>B"8)/,VSW328\.C;NZC%#&3F3O2RNBR
M6[%T@W8YS/W=&8T=[J#J+@>"7P3^VW#K$!"W^)(M/DZPP433<?=7R%B)@GO[
MEH-BBZV;*WK8V#:Y90(?/+2]%\]YC\M-(WL;O=T%+_]]$-J$$KE!8;Y]N$U"
M(0K#Q=82B$S2X4CGL6/N?B8R:Y_V0/&=W2D6^VE&A_N*[P4'W\^W?5?F4>\5
M0XG+_%N-TT&Q"@^:;K9[#D[#*V@K'MZ2U$0I%A8*7)%J-'QW/  3WF=AX'3E
MWT2Q=L02_YG3DQ8-"] Z'^?M@#?H'LGG?P-02P,$%     @ >8JJ5'!&='GV
M!P  S10  !D   !X;"]W;W)K<VAE971S+W-H965T,3(N>&ULU5AK;]LX%OTK
MA#<8) -!EF0[=CI) .?1F2S:M).D+1:+'8"6:)L-):HD%2?[Z^=<2I;EU EV
MBYT/"P2Q1/&^SKWW\'&\TN;>+H5P[#%7A3WI+9TKW_3[-EV*G-M0EZ+ E[DV
M.7=X-8N^+8W@F1?*53^)HL-^SF71.SWV8Q_-Z;&NG)*%^&B8K?*<FZ<SH?3J
MI!?WU@,W<K%T-- _/2[Y0MP*]ZG\:/#6;[5D,A>%E;I@1LQ/>M/XS=F0YOL)
MGZ58V<XSHTAF6M_3RU5VTHO((:%$ZD@#Q\^#.!=*D2*X\:W1V6M-DF#W>:W]
MK8\=L<RX%>=:?9&96Y[T)CV6B3FOE+O1J]]$$\^(]*5:6?^?K>JYHV&/I95U
M.F^$X4$NB_J7/S8X= 0FT0L"22.0>+]K0][+"^[XZ;'1*V9H-K31@P_52\,Y
M65!2;IW!5PDY=WKVZ?;J^O+VEIU_>']V=3V]N_IP?<NFUQ?LYO+=].[R@DW/
M[ZX^7]W]X[CO8(^D^FFC^ZS6G;R@>\#>Z\(M+;LL,I%MR_?A9^MLLG;V+'E5
MX7MN0C:( Y9$2?**OD$;_,#K&[P4?&4Q8BT[U_E,%KRNDR)C4VO1#]/T6R6M
M]*/_G,ZL,ZBA?[UB=]C:'7J[P[\$]/^5[FY\EEWE?"&+!3L7A1.&752&WMQ2
ML+DTUK%O%3?T0<\]^@%;"9;JO%3"B<S/XQVX,"L5QH$4&"<L+8UX95J!!T@U
M[&"NL-"TE.F2"8GO!L,+D '+I$'?JB<&#217$O8R%:3'\$QJI1=/3!M2KU/)
MR8E9DTYA0W;G9201#;B#6_@$!B-5=LM3RU;<,J<9L@O3^ [G*P-93"Q@K[&/
MTGM25!K0>"^<-_!<$S<"MDIMR!EH+8$8^4OZGL%KQ0+,!C5?!#1F4,3F7!KV
MP%6%X(&IR=<%V2#G31FOV0-*SN"QRC&D))])Y>'TX]M(KX1W+-4&;<CV?42Z
MLIAH#]Z@.9&')P;V$'5%D(T[[;A"6X!\,V%J/SX:+ 4&4W_B>?D+N\34DH)@
MGLG)S4] 9%I[]ZO6V4HJQ3[XK#:C6S/?=9R^>GMSSMZ].__Y#Q;WXSY5&!L&
MDRAB21!' S89C?%T>#1F/_UMDL3)+VP?0P<[Y29!XN6.XHC%P1C2HR 9QRP^
M8OO^_: )+QX$$6:.@B@>8/[H,&+CX.APXF?Z]P/V\UM*RV>?EHNMM$C+WN)9
ML3]:+[;+(27T+-6"SZ 1 DO?#(!*;BAFC))@P'3AR[IN RK'LC+I$DM-ACI!
M$2$S:(39$XKDJY8 _ &H5\CI"BW#SKEZ0%K8>Y')%.YL5QK:"XZ%;&J<G$LT
M"B9@7"FY\.4]17[I]S>M,I(Z"S^'[$/!_LZ+BGHGB8)=_4XE_:S?.9)-=2<P
MZJAO85W8NO-W6MGO-<.] Q0MNJ?U4'8]]&&@E5$QJ7\F\P53%?2D'#/032G
M+: XH':%KK3#YUA"TWO?%2FWRQ;;L'4*B7RI:U_RJ6E?KY42UO8FB$042_+*
MRT^O8+1LR[RF)2PCA>7UIJ063G55D/6YYS,/QC-L6VZKV]N7[SJ2NM#:-B65
M:P*I/9J!/,K2Z$?0H2^EO>$H3+";0#Q4R$6J*I\6>8"&B>-Q,!DGS"[!9Q;H
MV(J <6PO.0PG$2L)</I6E]\6<<'5O4$41AO=4.EAIR]Q.&D_4!B2OGH*(^-=
M#O.SX_!H/3U@>^-PV/&8'E%<U#F(WD&>TK$-1)OR):INQE$$I'88CK:=>( /
M2*AS2OB<>KB51A+F1N?LAF?7PC7^MZ(ANHCQ+*LSA-8HN<S:)0^;3@644J4M
M199J:@,P@*X62]\C!&I=)%A-!\'@L(4;.'^':!0>;NQ^H75-*$D\9*1ZVA [
M_(NZ$*65,;Y(/?<&I*>;=*AI^+S$PE;7LEAS.F8GXPY2DOX<+Q9RIL1&XV!;
MX_-E:"\^VIZP:%:%D/V.^)V<_45\LZ5]O]>\_A#/ "7K:&W<S37_&=6L_?EQ
MJ@G^?[DF"0>[N>;H$$OO:/+#3).,-@SQC&EV4DV,!7^ [4!C[WNE,$T5E5&Z
M:0>+_FTXK=-9NVDEWO1H T,33@Q'ZE,0G]/.KXLVM@-?L<LE 9Y]Q6'/$Y#/
M3$$5G8F\H**HP4X5EWF=%+^SFHEZ,^IQK[>E5)*TQT!/D"8 *'5F7R6-9)M7
M=Y!&_-^01KR5[!=(8_PJ:23)2Z0QM:S0OG=F^D$$SUEA:ZM!JM9M1R6TB?_)
M*UK1P0;;-_GONGU '52RG0WW=K7Y+7BS\VYWXL6SK7>]'0_:E0&=LTFL19*>
M*&LM^-GFD)7CC((M7;Y)&]OGZR<$[;O],15444E340=UC\L"MLA2W=N^N6PW
M7NIS1( C#/:7Z^/S^CBT\URQ'11A11 VM=$]E.F4>()ZI:;J=3BDR]KU>DH@
M-IOFHJRZ9Y>R.3F1#90TMZ\KHA''']&HSLA9Y41[KFPYJ\/'-3Q-EK\_2S5-
MV(%MXV?'+"4-=%$IUQ ^*'?1G@LW(HWJ3,R%\?1,?KX *3'2]YW!E:;3&M$2
M::*+-W]\T^;>;R-X*=TFS^W!&6\J8TO^0*=(8EWC%Y&\!._3"D;570?@T:+^
MY0WL\(/@*?RR4^H:D7#7#4>_<\64"[/P%VF$-CRI;YO:T?:N;EI?46VFUQ=]
MJ$,<4"Q38@[1*!R/>LS4EV?UB].EO["::>=T[A^7 H=D0Q/P?:Y! LT+&6AO
M,$__!%!+ P04    " !YBJI4&=34A,D&  "6#@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q,RYX;6RE5VUOXS82_BN$KRAL0+4M^27V-@G@S6;3 $T3)&E[
M0-$/M#2V>$N)*DDE\?WZ>X:4'>\VNX?#?;$ED3/SS#-OY.FSL9]<2>3%2Z5K
M=]8KO6_>C48N+ZF2;F@:JK&R,;:2'J]V.W*-)5D$H4J/LO%X/JJDJGOGI^';
MG3T_-:W7JJ8[*UQ;5=+NWI,VSV>]M+?_<*^VI></H_/31F[I@?ROS9W%V^B@
MI5 5U4Z96EC:G/56Z;OW4]X?-ORFZ-D=/0OV9&W,)WZY+LYZ8P9$FG+/&B3^
MGNB"M&9%@/%7I[-W,,F"Q\][[1^#[_!E+1U=&/V[*GQYUEOT1$$;V6I_;YY_
MHLZ?&>O+C7;A5SS'O=FR)_+6>5-UPD!0J3K^RY>.AR.!Q?@K EDGD 7<T5!
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MWF!X(NZSZ+N!*U6[.HBZ_3R]?9ZDT=CI]_MB=.:,\>=[G,IP6WKGXX%S<3[
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MFF3(!.7F(1?Y(!$=@0;\E41;BKR=IX;&90 "--T'1+E\:+Q^@ CW-)E3^$J
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MBZ,I$]/2):=U&DTJTIE(IR<2^&TVK)XB _0T(4-XJM'YNJ*3C$8\'E1<*%N
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MZ@68KN!LX!/XNA;.>E[H<'ILS^6)[=JJ=?88W)I8.& B[!8VO>-?O?&&)4B
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M=*I+E"S^)*D[]$+)MYAQA-WR!XH3"/MBS@V9S0S<2Z&F.T@!)75]I2++9Y.
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M.2.7PK\D$5&H' Q<TDPN\QC>@AD09"I#[7VKC"A;Q_E"35IA"> #8+[F7*/
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MX$SDN5BJQP5'N9?1!'R_%2*O7@A!?8GTU?\ 4$L#!!0    ( 'F*JE1GD6T
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MA"I$&FU+JH\S9?&0UCKZ8&IIA3KC2=9P5U8JR6B6I*"Q9$0'B@TL-V1"'&]
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MLVGL@6HON79B9.TNEHTT=$VY84[_!:BL >UOI32'B770_VDLOP%02P,$%
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MGF>>F=EA&&ZY^"9+1 5/3=W*D54JM;YT79F7V##I\#6V=+/DHF&*MF+ERK5
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MJ'N_/OO79>S2\>!53GN1VG9G,Y6(1I:BS&8&%&RNB&1D,O#(=/<<LS1;\*5
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MHED\;-"UT>%+0OL]A$Z3@+%95MZ.$/P3%X7$?2_.YL4=L*Y!Z?4-IXNJ2-U
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M@(79H-?GG*O-Q!"4_QB]OU!+ P04    " !YBJI4O %XEST$   ($   &0
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ME@E-<536@.['4IK%Q@8H_Q=T_@)02P,$%     @ >8JJ5.(4H'T.!   4!4
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MW8>#,!OT]PWGZF%B&K>RLQ_] E!+ P04    " !YBJI44X?/1+X"  ""!@
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M=0 N W [P.X)L,H JQW01\DN ^Q3*SAE@'-J!;<,<//>%\W*.SWSA3\9,WI
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MQ)??OAE /E]3*EYOL@+5@>SD/U!+ P04    " !YBJI4V4*I]F4#  !O"P
M&0   'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6RU5FV/VC@0_BNCJ-*U4KN)
M\P:L (F%796*VULM]$[5J1\,&+":Q-1VENVI/[[C$ (+)KNMKE_ =N89/_-X
M/)[V1L@O:L68AL<TR53'66F]OG1=-5NQE*H+L689?ED(F5*-4[ETU5HR.B]
M:>+ZGA>[*>69TVT7:W>RVQ:Y3GC&[B2H/$VI_';%$K'I.,39+=SSY4J;!;?;
M7M,E&S/]<7TG<>967N8\99GB(@/)%AVG1R[[)#* PN)OSC;J8 PFE*D07\QD
M..\XGF'$$C;3Q@7%OP?69TEB/"&/KZ53I]K3  _'.^\W1? 8S)0JUA?)/WRN
M5QVGZ<"<+6B>Z'NQ><_*@ J",Y&HXA<VI:WGP"Q76J0E&!FD/-O^T\=2B ,
M"<\ _!+@OQ00E("@"'3+K AK0#7MMJ78@#36Z,T,"FT*-$;#,W.,8RWQ*T><
M[O;OKP?#"=ST^L/1</()>K<#N/UK<CV&N]ZGWM7H&EX/F*8\4? .QIA$\SQA
M(!8HU52_P;6/XP&\?O4&7@'/8+(2N:+97+5=C>3,%NZL)'*U)>*?(?(GE1<0
MD+?@>[YO@??KX0,VJ^#D*=Q%22I=_$H7O_ 7G/4WU3#,E)8Y)JV&?T=H $/-
M4O6YQGU0N0\*]V&->YM&6U1<H,P-?.@V(M)L8$0/AUK8S,(X]BNS)Z3"BE18
M2VHB-$V*@P4Q3?B2FHMF/<JMG^@YFC:S\S2CBF942W/$E+K$NR&E.9BUD(:F
MC65TLOT[0D@<'K%\UNP)R[AB&=>S%-D2-)/ICN&+A(U/%0N]AM<XHFPS"\)6
MTTZY45%NU)^_83L2-%/P'6ZX5!I&G.&MWJW7)'ZSVJ/Y.^Y5JW+?^J5[U3H5
MC+2B.#C2U6+FDZ 1V74EWK[(>O6TN)J)',/%-+ ):Z^7GB4Q_;CE'Y&VV@7(
M^PSK@Z>!_$_UH'3TK+XVNSJ!]]6:^"]/W7&>320^G7M] 9_)A.)MI G_C\UA
M^@UN/PQO_U"@:;;D4WS2\-7"%VP_58II59.19%_J2? [4I[LRS:IK]OGDIZ<
MUM\P\CSO^% L9G%T8/:4UKY,D_HZ_1/I$YV\9U:B%C,+4?>@&S*M*'862XZ)
MD; %XKR+!KJ1V^YN.]%B731(4Z&QW2J&*^R(F30&^'TAA-Y-3,]5]=C='U!+
M P04    " !YBJI4@9FO%DP(  #;,P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970S."YX;6S-F_]OZC@2P/\5"]WJ]J0*$N<KJ[824-C'4U^W:OONM#K=#VXP
MU-I\86U#V]7]\6>'@$,)DX":VWT_O/(E,Q[/C#\S=L+E:\9_$R^42O26Q*FX
MZKQ(N?RIUQ/1"TV(Z&9+FJIOYAE/B%1O^:(GEIR262Z4Q#UL67XO(2SM7%_F
MG]WSZ\ML)6.6TGN.Q"I)"'\?TCA[O>K8G>T'#VSQ(O4'O>O+)5G01RJ_+^^Y
M>M?;:9FQA*:"92GB='[5&=@_?0T]+9!?\4]&7T7I-=)3><ZRW_2;Z>RJ8VF+
M:$PCJ540]6=-1S2.M29EQ^^%TLYN3"U8?KW5/LDGKR;S3 0=9?&_V$R^7'7"
M#IK1.5G%\B%[_4*+">4&1EDL\O_1:W&MU4'12L@L*825!0E+-W_)6^&(D@"V
MCPC@0@!_% B."#B%@--T!+<0<#\(V.X1 :\0\)J.X!<"?M,1@D(@:"H0%@)A
M4Y/ZA4"_J8!M;2-GY1FT"7F>+S=$DNM+GKTBKJ]7^O2+/.ER>94F+-7KXU%R
M]2U3<O)Z]#"^F3ZAR6 TO9T^_8H&=S?H[I>G\2.Z'_PZ&-Z.T8\W5!(6"W1'
M."<ZF_]QV9-J:*V@%Q7###?#X"/##):\B[!S@;"%[>^/-^C'OU5I&3708H=:
MB]TOM$0TE917Z+J!==W0J(L<.]<5'K=H7&/1:F&T5(A/8/%OA&_%,3YNQ,_-
MM=@5XE\:>P);%>+3YN) :+\V<"0.-T94:NFIS-ZE-]ZE-\[5.D>->Y9HF@K)
M5PKJ$OW[5EV II(FXC^ >F>GWLG5NT?4/V62Q"CB=,8DFI.(Q4PR*I J1$*2
M=,;21552;)3ZN5)=P-;7RN_KLLNA*_8L=7>6NJ"E-W1.N;(3S5E*TD@9AJ),
M2'&!4E6$L[DJ5-$J6<5$JFM(DG')_B"Z@E79OQG**UFGRK'^]V$6%=?9^]?M
MS<7;S<6KF8L**J<ZJ)%<<3T7Y6M$WZ1ZN6+B)0\U?5,]A*"B"E;>@7MM#S#,
MWQGF@X;=K9)GRG-O*A-FV@R!_HN.(FKD'SJHVH)@9T$ )R3E"8HSD@+)'>YT
MA6VLG?Y.?;^%M3/L'[@LP)X%!,^V3"FT0(LFC N);AE-T6ACUF#!*<TG_TC7
MZL\+&FP#"WC +A5?NPT7VP9_-JY?*DR(E5KS=+/B*XLW/O"J[?8AIQI"VC B
M<PMF3$39ZJ/3BK&=@['#$!K:(,_^_S%O:!_"S(6881N:V3#.!J61M56SK=D-
MXN8=Q@VRR8#,ADGVN$J?N.H_%;URI-PJI @H(PV@[*"5E#?4LD/0]'O*639C
M$5J2=SW"!5JJ$A&Q)8DKN\3PH!: V6?P9L-\J["#\NB '(45L"ZO:UD_0.V0
M81R&&??1JKV\1\I/:I,M:)6)A>*RHUS 4=A $-OG8O<"/;*W,G6W^5A3XG"I
M/VRE0<2&?[B-%G&$#SO S<H^[G##10QSL>3PW>)6CAT2'L7D731=\]@0#GNM
M.-G@"L.X.FW-3_!AWV5#BQX;NF&X_WJ@ZRQ>ZTI3I/)D$_%W:)H&;;B5C@P;
M9F&8,[=4JDY5Z"I49&S-3@97M&.0)QT#*@<&U:=N6)Q#=GW<L>R;:>#EP/ :
MS^<T/^)3[%2N4YL2Q)5)E4; FKPN]B#&.X9I#MST'4W"TB*'!BKM?IU6=M>&
M5 Y,JER?2<8"G^\7:O>GSW[U%)\SKM3FZ4&6ZON/2ZWPO7N(TS# 4 H8NCEP
M_P:YN]1';>>RN0ARC\&>X[?B?X,S!\;9-_+&DE72U,G! 0P<L&0YAGP.W-1!
M/H:V;7M5K7D$##"=?AL1< T&71B#9YXP%5K+H3@XG#EDXK$S)D-#%V;8^6$Z
M9Z&XAHAN*UV>:TCHMG(0Z#8_YRL=],',/#<&8WTG:;_5/F?MN(:;;BM=H6OP
MZ,)=X4GT&A;*]DI$'SQ9<@U'79BC1^O8=L/5S,:OQ3!E&[T .H5P#6'=5@A;
MM4-KGBN&LVXKG/4,9SV8L[=T33E94-V]L:SJ'DRAH%^N;EWOR$FV(:8'$_.3
M,F-4#%/1X1X[;#?P].!V<OPFB_OARWR;53D\K *C=THXU'1Z!K4>C-K6$E5]
M,%[Q;);%,>'H077QZ#%_Y@ RVV#9<UO)X-)-$;@-'1+!!-H\)8%4L-:$,_(<
MTV/[D2\U^IR:_8AG..S!'#YACU2CR>H&L$V&R-Z9&_76LDA?N87,@X:,&F=-
MH<D8=GNMG MX!K\>?"YP:F[]7*//J3G/] VW?9C;?X4X/KTHK=!L3#7P6[D?
MY!N6^S"(3PWDI$9?;2 -UOT_#^N#6&$GU2$<ZHK:#.V^0;O?"MI]@W8?1O$)
M *W1I#H6.%ZE6]TPBO^<>)VQ^$Q)\%NY,^4;3/MPBWWZXH/UX;K%9_CNPSQN
M=(1E[A5$&HHJ1"1F?] 9>GY'=U^G=W\72&UU%TS/2#^/H7)U]U8(FC\*<<]9
M?I2K@QBCZ70*F!^8(A!8;40N,%P.X"Y]E"4)D[GN.:7;&WDJ":N>&*O151>U
MP, \@.'[/5T)Y?[MMN!"Q>44,V'E5M<!6ZW D#TXG^R?FEQ'Z_5)66>P'[2"
M_<!@/_C<CGY<HZ\B\S:<J9&SNAB#J6"*1G!^T?C45  KR$GI4'KRJI7R$9CR
M$7QN^1C7Z+/K0&3*1]#DMN%>"2\?'7[X%GHTS2 _; 7YH4%^^'G(G]3HLKHV
MO)<.#?/#%ID_J5%NU72'H6%^"#._(B/^*KNQT  ^; 7PH0%\^+F G]3HP\>.
M1WJE'PCHG[U\(WS!4H%B.E>*]*E*!_'-+TDV;V2VS'\S\)Q)F27YRQ=E).7Z
M O7]/,OD]HW^&<+N]SS7_P-02P,$%     @ >8JJ5"YW8=-B!0  /R4  !D
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M!\#8P(FQSR;1QH6_3C : $8#,^B<+RV&__,G?,J? H!D8":9DT566BT\.@
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MXQH]5 ,9(I<9N@1SI#$O<P7>_-3M1FT'_@X_T31/?4,Y-X%Q(Y2=P\#V=WI
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MQ2W;?*:F0UCYF[$XT__!QMSK=< LSP1+C+%4D$1I\4D>32 J!K#) !H#^,(
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M;].^CC>J^*,RGQ=V.]+-H5?8K68%7[KYLF@%8.Q=G)U6E5A]$GPF2^8W?W#
MT8"N_:*YTOS)1H-6F5H#TR1Z9-KPZ;;EEZ;5/5N:=3LM"UQS[PUJ_KMYGC')
M-!7;HFWO'W.67ZTXN?I7DMU_E5W!08W-07CL(B_?@LCT^$4FV?%K;%Y&CDYD
MW!R-6^?OL].WM4;PEC,DW^%]2FR"1I,%%X;+9C;G><[DBT/8TALZL:_#S_CM
M^IP5="',?0L.R6;\C>5\46;MJEM(1+-J,_X*V^NF[2N6C<5ESI8L'S=3/9NX
M860'-FIS@<,N<N.N,(+Y>"R, (;%P11@/MX+B_,_[:>/[L=CF+9^$.FC/GW4
MQWN%D+'[8''"/IF]PCO-LB1)4RRCXW%0P1C+6YK"-\R&:0,/+ Y$^K-<X]7&
M.V1_'V UW=<AV$[Q3L1VBN<:D'#>P"/+PM7&XH '5@6L=R!^. [T5-@G2:"J
MF#;L"<:1+,,0Z,5PCZ8IDIT4/N'Z8$])DF19& $LK"!), 2>1AS!%( &#$D2
M=P[NG$?Q^IR*-[\1C7X#4$L#!!0    ( 'F*JE27BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ >8JJ5)UCZ\"P P
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M+GAM;%!+ 0(4 Q0    ( 'F*JE2SL@9S[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( 'F*JE297)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ >8JJ5#OA.X\:!0  0Q4  !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( 'F*JE0E&-7-00<
M &D<   8              " @5X-  !X;"]W;W)K<VAE971S+W-H965T,BYX
M;6Q02P$"% ,4    " !YBJI4)S7LBY0"  #>!@  &               @('5
M%   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ >8JJ5.$=
M 2Q9!@  TA<  !@              ("!GQ<  'AL+W=O<FMS:&5E=',O<VAE
M970T+GAM;%!+ 0(4 Q0    ( 'F*JE3;Z8B2:0,  .H(   8
M  " @2X>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !Y
MBJI4,[\T0P8'   !'P  &               @('-(0  >&PO=V]R:W-H965T
M<R]S:&5E=#8N>&UL4$L! A0#%     @ >8JJ5*)!51[E!P  G!X  !@
M         ("!"2D  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0
M   ( 'F*JE1(D-LV3@,  *(*   8              " @20Q  !X;"]W;W)K
M<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !YBJI42.TL9# .   G)@
M&               @(&H-   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!
M A0#%     @ >8JJ5#\&J#?O*@  $(4  !D              ("!#D,  'AL
M+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !YBJI4W07'>;,%
M   P#P  &0              @($T;@  >&PO=V]R:W-H965T<R]S:&5E=#$Q
M+GAM;%!+ 0(4 Q0    ( 'F*JE1P1G1Y]@<  ,T4   9              "
M@1YT  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ >8JJ
M5!G4U(3)!@  E@X  !D              ("!2WP  'AL+W=O<FMS:&5E=',O
M<VAE970Q,RYX;6Q02P$"% ,4    " !YBJI4/7O^V_@,  #D*@  &0
M        @(%+@P  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0
M   ( 'F*JE3$Z_<61@D  (D9   9              " @7J0  !X;"]W;W)K
M<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ >8JJ5%S9EPJE @  L 4
M !D              ("!]YD  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q0
M2P$"% ,4    " !YBJI41:'CB&0?  !N7P  &0              @('3G
M>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( 'F*JE2*H6Z[
MZ P  % J   9              " @6Z\  !X;"]W;W)K<VAE971S+W-H965T
M,3@N>&UL4$L! A0#%     @ >8JJ5&>1;0"U P  3@@  !D
M ("!C<D  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " !Y
MBJI4.+P?<-$#  !U"   &0              @(%YS0  >&PO=V]R:W-H965T
M<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( 'F*JE1/(_HEJ 0  (D+   9
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M970R-2YX;6Q02P$"% ,4    " !YBJI4/9&;H/$"  !O"   &0
M    @($P\   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (
M 'F*JE2\ 7B7/00   @0   9              " @5CS  !X;"]W;W)K<VAE
M971S+W-H965T,C<N>&UL4$L! A0#%     @ >8JJ5&2GP1?H @  (P@  !D
M             ("!S/<  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"
M% ,4    " !YBJI4XA2@?0X$  !0%0  &0              @('K^@  >&PO
M=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( 'F*JE00?B[1A@0
M %H-   9              " @3#_  !X;"]W;W)K<VAE971S+W-H965T,S N
M>&UL4$L! A0#%     @ >8JJ5 *KHLQN P  Y0L  !D              ("!
M[0,! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " !YBJI4
M4X?/1+X"  ""!@  &0              @(&2!P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,R+GAM;%!+ 0(4 Q0    ( 'F*JE3U,=P":00  "40   9
M      " @8<* 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%
M  @ >8JJ5"75Z5X1!   AA   !D              ("!)P\! 'AL+W=O<FMS
M:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !YBJI4R;C11*$%  ".&@
M&0              @(%O$P$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+
M 0(4 Q0    ( 'F*JE03S0Y)[@0  )P5   9              " @4<9 0!X
M;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ >8JJ5-E"J?9E
M P  ;PL  !D              ("!;!X! 'AL+W=O<FMS:&5E=',O<VAE970S
M-RYX;6Q02P$"% ,4    " !YBJI4@9FO%DP(  #;,P  &0
M@($((@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( 'F*
MJE0N=V'38@4  #\E   9              " @8LJ 0!X;"]W;W)K<VAE971S
M+W-H965T,SDN>&UL4$L! A0#%     @ >8JJ5,A%\7C& P  -Q$  !D
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M=#0T+GAM;%!+ 0(4 Q0    ( 'F*JE0OZEJ"'@,  # 2   -
M  "  0-& 0!X;"]S='EL97,N>&UL4$L! A0#%     @ >8JJ5)>*NQS
M$P(   L              ( !3$D! %]R96QS+RYR96QS4$L! A0#%     @
M>8JJ5)UCZ\"P P  ]!T   \              ( !-4H! 'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( 'F*JE1''&"YI $  )L:   :              "
M 1). 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( 'F*
MJE0NTOC K@$  ,H:   3              "  >Y/ 0!;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     T #0 (PX  ,U1 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>246</ContextCount>
  <ElementCount>298</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>101</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION</Role>
      <ShortName>NATURE OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2116103 - Disclosure - RECENT ACCOUNTING AND REPORTING STANDARD</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD</Role>
      <ShortName>RECENT ACCOUNTING AND REPORTING STANDARD</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117104 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121105 - Disclosure - SEGMENT REPORTING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTING</Role>
      <ShortName>SEGMENT REPORTING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124106 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2130107 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2135108 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2318302 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2322303 - Disclosure - SEGMENT REPORTING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTINGTables</Role>
      <ShortName>SEGMENT REPORTING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SEGMENTREPORTING</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2325304 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2331305 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative</Role>
      <ShortName>NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2410406 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details- Contingent Consideration)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details- Contingent Consideration)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2411407 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2412408 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2413409 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details- Schedule of Acquisition)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details- Schedule of Acquisition)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2414410 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2415411 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2419412 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets Acquired and Liabilities Assumed)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets Acquired and Liabilities Assumed)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2420413 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2423414 - Disclosure - SEGMENT REPORTING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTINGDetails</Role>
      <ShortName>SEGMENT REPORTING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SEGMENTREPORTINGTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2426415 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2427416 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2428417 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2429418 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2432419 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2433420 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2434421 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details - RSU's)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="rdnt-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2436422 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>44</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="rdnt-20220331.htm">rdnt-20220331.htm</File>
    <File>q12022exhibit311.htm</File>
    <File>q12022exhibit312.htm</File>
    <File>q12022exhibit321.htm</File>
    <File>q12022exhibit322.htm</File>
    <File>rdnt-20220331.xsd</File>
    <File>rdnt-20220331_cal.xml</File>
    <File>rdnt-20220331_def.xml</File>
    <File>rdnt-20220331_lab.xml</File>
    <File>rdnt-20220331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="684">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>61
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rdnt-20220331.htm": {
   "axisCustom": 1,
   "axisStandard": 33,
   "contextCount": 246,
   "dts": {
    "calculationLink": {
     "local": [
      "rdnt-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rdnt-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "rdnt-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 536,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 5
   },
   "keyCustom": 34,
   "keyStandard": 264,
   "memberCustom": 63,
   "memberStandard": 35,
   "nsprefix": "rdnt",
   "nsuri": "http://www.radnet.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.radnet.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116103 - Disclosure - RECENT ACCOUNTING AND REPORTING STANDARD",
     "role": "http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD",
     "shortName": "RECENT ACCOUNTING AND REPORTING STANDARD",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117104 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121105 - Disclosure - SEGMENT REPORTING",
     "role": "http://www.radnet.com/role/SEGMENTREPORTING",
     "shortName": "SEGMENT REPORTING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124106 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130107 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135108 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318302 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322303 - Disclosure - SEGMENT REPORTING (Tables)",
     "role": "http://www.radnet.com/role/SEGMENTREPORTINGTables",
     "shortName": "SEGMENT REPORTING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325304 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Tables)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331305 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative",
     "shortName": "NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "if0814f8295094f73a07b17a0ea048a22_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:ContractsReceivableFactoringReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i149f4a7d4caa402e82e20e079677076d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i149f4a7d4caa402e82e20e079677076d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i75a2b41962224ca58c77ef230e603ac4_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410406 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details- Contingent Consideration)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details- Contingent Consideration)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "ibc1c497245b149e284139819564e0884_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411407 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412408 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413409 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details- Schedule of Acquisition)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details- Schedule of Acquisition)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "ie110fb96d5d244519c0c1cf9826af837_I20220101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i149f4a7d4caa402e82e20e079677076d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414410 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415411 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "ic67563cef4c9491d9d0dc503a64601b6_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419412 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets Acquired and Liabilities Assumed)",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets Acquired and Liabilities Assumed)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "ib261e6ac493749b8b10541441e853944_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420413 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details Narrative)",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i193b2936e56f4e0cbc28405f53112fa5_D20220120-20220120",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423414 - Disclosure - SEGMENT REPORTING (Details)",
     "role": "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
     "shortName": "SEGMENT REPORTING (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:OperatingIncomeLossExcludingReliefFunding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426415 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LineOfCredit",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427416 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i7c887837d9ef4909b82fa07c516cbe5f_D20210423-20210423",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i6a4c35b6f71f4affa5768a0f639d4a2e_I20180831",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428417 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i6a4c35b6f71f4affa5768a0f639d4a2e_I20180831",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueNotFromContractWithCustomer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i6e5edfcb6761487ba2db12d147e1a78a_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429418 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i6e5edfcb6761487ba2db12d147e1a78a_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CompensationRelatedCostsPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans",
      "reportCount": 1,
      "unitRef": "incentiveplan",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432419 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
     "shortName": "STOCK-BASED COMPENSATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i2d51580d4825469e821595335785ef53_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9212727f374b4ce7870dbc05eb4d8aab_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433420 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
     "shortName": "STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9212727f374b4ce7870dbc05eb4d8aab_I20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "id651533cf9634a93ac70355625b736ef_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434421 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
     "shortName": "STOCK-BASED COMPENSATION (Details - RSU's)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "ie2d96663c67244b8aed2634eec524266_D20220101-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i05688edf21f347e59b6c396261cdb342_I20220401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfLocationOfferingMultiModalityServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "location",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436422 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i05688edf21f347e59b6c396261cdb342_I20220401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfLocationOfferingMultiModalityServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "location",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i70baa850fe584a93b43499065527584c_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i776431f5daf3445a96806322961098ce_D20210101-20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:EquipmentAcquiredAndLeaseholdImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:EquipmentAcquiredAndLeaseholdImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION",
     "shortName": "NATURE OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20220331.htm",
      "contextRef": "i9f5cf97ca0244adaa2d333473a5f39d1_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 101,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Current"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "rdnt_A2019SWAPS1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 SWAPS1 [Member]",
        "label": "2019 SWAPS1 [Member]",
        "terseLabel": "2019 SWAPS"
       }
      }
     },
     "localname": "A2019SWAPS1Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A2019SWAPSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 SWAPS [Member]",
        "label": "2019 SWAPS [Member]",
        "terseLabel": "2019 SWAPS"
       }
      }
     },
     "localname": "A2019SWAPSMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AI",
        "label": "AI [Member]",
        "terseLabel": "AI",
        "verboseLabel": "AI revenue"
       }
      }
     },
     "localname": "AIMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AdvanceMedicarePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance Medicare Payments",
        "label": "Advance Medicare Payments",
        "terseLabel": "Advance medicare payments"
       }
      }
     },
     "localname": "AdvanceMedicarePayments",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AggregateIntrinsicValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value",
        "label": "Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValue",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_AidenceHoldingBVAndQuantibBVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aidence Holding B.V. and Quantib B.V",
        "label": "Aidence Holding B.V. and Quantib B.V [Member]",
        "terseLabel": "Aidence Holding B.V. and Quantib B.V"
       }
      }
     },
     "localname": "AidenceHoldingBVAndQuantibBVMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AidenceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aidence",
        "label": "Aidence [Member]",
        "terseLabel": "Aidence B.V"
       }
      }
     },
     "localname": "AidenceMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BarclaysMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barclays [Member]",
        "label": "Barclays [Member]",
        "terseLabel": "Barclays"
       }
      }
     },
     "localname": "BarclaysMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares",
        "terseLabel": "Additional number of shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution",
        "terseLabel": "Fair value of additional shares issued after execution"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisitions",
        "label": "Business Acquisitions [Member]",
        "terseLabel": "Business Acquisitions"
       }
      }
     },
     "localname": "BusinessAcquisitionsMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Period",
        "label": "Business Combination, Contingent Consideration, Liability, Period",
        "terseLabel": "Contingent consideration, liability, period"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPeriod",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability",
        "label": "Business Combination, Contingent Consideration, Liability [Roll Forward]",
        "terseLabel": "Business Combination, Contingent Consideration, Liability [Roll Forward]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityRollForward",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "negatedTerseLabel": "Right of Use Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "terseLabel": "Right of Use Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_COVID19PandemicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Pandemic [Member]",
        "label": "COVID-19 Pandemic [Member]",
        "terseLabel": "COVID-19 Pandemic"
       }
      }
     },
     "localname": "COVID19PandemicMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CapitationArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitation Arrangements [Member]",
        "label": "Capitation Arrangements [Member]",
        "terseLabel": "Revenue under capitation arrangements",
        "verboseLabel": "Revenue under capitation arrangements"
       }
      }
     },
     "localname": "CapitationArrangementsMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CaresActRefundableClaimPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cares Act, Refundable Claim Percentage",
        "label": "Cares Act, Refundable Claim Percentage",
        "terseLabel": "Refundable claim percentage"
       }
      }
     },
     "localname": "CaresActRefundableClaimPercentage",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_CashHoldbackMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Holdback",
        "label": "Cash Holdback [Member]",
        "terseLabel": "Cash Holdback"
       }
      }
     },
     "localname": "CashHoldbackMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CertainSellerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain Seller",
        "label": "Certain Seller [Member]",
        "terseLabel": "Certain Seller"
       }
      }
     },
     "localname": "CertainSellerMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CommercialInsurance1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Insurance1 [Member]",
        "label": "Commercial Insurance1 [Member]",
        "terseLabel": "Commercial insurance"
       }
      }
     },
     "localname": "CommercialInsurance1Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ContractsReceivableFactoringReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts Receivable, Factoring Receivable",
        "label": "Contracts Receivable, Factoring Receivable",
        "terseLabel": "Contracts receivable, factoring receivable"
       }
      }
     },
     "localname": "ContractsReceivableFactoringReceivable",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ContributionsFromNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contributions From Noncontrolling Interests",
        "terseLabel": "Contribution from noncontrolling partner"
       }
      }
     },
     "localname": "ContributionsFromNoncontrollingInterests",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DebtInstrumentCovenantLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Leverage Ratio, less than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "label": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "terseLabel": "Leverage Ratio, greater than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Period",
        "label": "Debt Instrument, Extension Period",
        "terseLabel": "Extension period"
       }
      }
     },
     "localname": "DebtInstrumentExtensionPeriod",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_DebtInstrumentLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Leverage Ratio",
        "label": "Debt Instrument, Leverage Ratio",
        "terseLabel": "Leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentLeverageRatio",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Percent",
        "label": "Debt Instrument, Periodic Payment, Percent",
        "terseLabel": "Periodic payment, percent"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPercent",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "label": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "terseLabel": "Periodic payment amortization increase"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsAmortizationIncrease",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeepHealthInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DeepHealth, Inc. [Member]",
        "label": "DeepHealth, Inc. [Member]",
        "terseLabel": "DeepHealth, Inc."
       }
      }
     },
     "localname": "DeepHealthInc.Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DeepHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deep Health, Inc. [Member]",
        "label": "Deep Health Inc [Member]",
        "terseLabel": "DeepHealth Inc."
       }
      }
     },
     "localname": "DeepHealthIncMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DignityHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dignity Health [Member]",
        "terseLabel": "Dignity Health"
       }
      }
     },
     "localname": "DignityHealthMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_EquipmentAcquiredAndLeaseholdImprovements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment Acquired and Leasehold Improvements",
        "terseLabel": "Equipment acquired and leasehold improvements"
       }
      }
     },
     "localname": "EquipmentAcquiredAndLeaseholdImprovements",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Securities",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Securities",
        "terseLabel": "Number of securities without readily determinable fair value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_FirstLienCreditAgreementEighthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Eighth Amendment",
        "label": "First Lien Credit Agreement Eighth Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement Eighth Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementEighthAmendmentMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Lien Credit Agreement [Member]",
        "terseLabel": "First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSeventhAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Seventh Amendment [Member]",
        "label": "First Lien Credit Agreement Seventh Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement Seventh Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSeventhAmendmentMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSixthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Sixth Amendment [Member]",
        "label": "First Lien Credit Agreement Sixth Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement, Sixth Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSixthAmendmentMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Lien Term Loan [Member]",
        "terseLabel": "First Lien Term Loan"
       }
      }
     },
     "localname": "FirstLienTermLoanMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FrederickCountyRadiologyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frederick County Radiology, LLC",
        "label": "Frederick County Radiology, LLC [Member]",
        "terseLabel": "Frederick County Radiology, LLC"
       }
      }
     },
     "localname": "FrederickCountyRadiologyLLCMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FrederickHealthHospitalIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frederick Health Hospital, Inc.",
        "label": "Frederick Health Hospital, Inc. [Member]",
        "terseLabel": "Frederick Health Hospital, Inc."
       }
      }
     },
     "localname": "FrederickHealthHospitalIncMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FutureServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future Services [Member]",
        "label": "Future Service [Member]",
        "terseLabel": "Future Service"
       }
      }
     },
     "localname": "FutureServiceMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_GlendaleAdvancedImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Glendale Advanced Imaging [Member]",
        "terseLabel": "Glendale Advanced Imaging"
       }
      }
     },
     "localname": "GlendaleAdvancedImagingMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthCareManagementServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Management Service [Member]",
        "label": "Health Care, Management Service [Member]",
        "terseLabel": "Management fee revenue"
       }
      }
     },
     "localname": "HealthCareManagementServiceMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthCarePatientServiceOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Patient Service Other [Member]",
        "label": "Health Care, Patient Service Other [Member]",
        "terseLabel": "Other patient revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceOtherMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IFRCLLC1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IFRC LLC 1",
        "label": "IFRC LLC 1 [Member]",
        "terseLabel": "IFRC LLC"
       }
      }
     },
     "localname": "IFRCLLC1Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IFRCLLC2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IFRC LLC2",
        "label": "IFRC LLC2 [Member]",
        "terseLabel": "IFRC LLC"
       }
      }
     },
     "localname": "IFRCLLC2Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IFRCLLCAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IFRC LLC Acquisitions",
        "label": "IFRC LLC Acquisitions [Member]",
        "terseLabel": "IFRC LLC Acquisitions"
       }
      }
     },
     "localname": "IFRCLLCAcquisitionsMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IFRCLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IFRC LLC",
        "label": "IFRC LLC [Member]",
        "terseLabel": "IFRC LLC"
       }
      }
     },
     "localname": "IFRCLLCMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ImagingCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Imaging Centers",
        "label": "Imaging Centers [Member]",
        "terseLabel": "Imaging Centers"
       }
      }
     },
     "localname": "ImagingCentersMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act",
        "label": "Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act",
        "terseLabel": "Reduction in deferred social security taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]",
        "terseLabel": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Venture Investment And Financial Information",
        "label": "Joint Venture Investment And Financial Information [Table Text Block]",
        "terseLabel": "Schedule of Joint Venture Investment and Financial Information"
       }
      }
     },
     "localname": "JointVentureInvestmentAndFinancialInformationTableTextBlock",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_JointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Venture [Member]",
        "terseLabel": "Joint Venture"
       }
      }
     },
     "localname": "JointVentureMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Axis]",
        "terseLabel": "Leverage Ratio [Axis]"
       }
      }
     },
     "localname": "LeverageRatioAxis",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LeverageRatioDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Domain]",
        "terseLabel": "Leverage Ratio [Domain]"
       }
      }
     },
     "localname": "LeverageRatioDomain",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Five",
        "label": "Leverage Ratio Five [Member]",
        "terseLabel": "Leverage Ratio Five"
       }
      }
     },
     "localname": "LeverageRatioFiveMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Four [Member]",
        "label": "Leverage Ratio Four [Member]",
        "terseLabel": "\u2264 3.00x"
       }
      }
     },
     "localname": "LeverageRatioFourMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio One [Member]",
        "label": "Leverage Ratio One [Member]",
        "terseLabel": "> 3.50x"
       }
      }
     },
     "localname": "LeverageRatioOneMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Three [Member]",
        "label": "Leverage Ratio Three [Member]",
        "terseLabel": "Leverage Ratio Three"
       }
      }
     },
     "localname": "LeverageRatioThreeMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Two [Member]",
        "label": "Leverage Ratio Two [Member]",
        "terseLabel": "> 3.00x but \u2264 3.50x"
       }
      }
     },
     "localname": "LeverageRatioTwoMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LineofCreditFacilityIncreaseBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Increase Borrowing Capacity",
        "label": "Line of Credit Facility, Increase Borrowing Capacity",
        "terseLabel": "Line of credit facility, increase borrowing capacity"
       }
      }
     },
     "localname": "LineofCreditFacilityIncreaseBorrowingCapacity",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ManagementServiceFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management service fees.",
        "label": "Management Service Fees",
        "terseLabel": "Management service fees"
       }
      }
     },
     "localname": "ManagementServiceFees",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_MedicVisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medic Vision [Member]",
        "terseLabel": "Medic Vision"
       }
      }
     },
     "localname": "MedicVisionMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Medicaid1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid1 [Member]",
        "label": "Medicaid1 [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "Medicaid1Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Medicare1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare1 [Member]",
        "label": "Medicare1 [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "Medicare1Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MonthlyAmortizationOfDeferredHedgeGains": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly Amortization Of Deferred Hedge Gains",
        "label": "Monthly Amortization Of Deferred Hedge Gains",
        "terseLabel": "Monthly amortization of deferred hedge gains"
       }
      }
     },
     "localname": "MonthlyAmortizationOfDeferredHedgeGains",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NumberOfAmendments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Amendments",
        "label": "Number Of Amendments",
        "terseLabel": "Number of amendments"
       }
      }
     },
     "localname": "NumberOfAmendments",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberOfCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Centers",
        "label": "Number Of Centers",
        "terseLabel": "Number of centers"
       }
      }
     },
     "localname": "NumberOfCenters",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberOfLocationOfferingMultiModalityServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Location Offering Multi-Modality Services",
        "label": "Number Of Location Offering Multi-Modality Services",
        "terseLabel": "Number of location offering multi-modality services"
       }
      }
     },
     "localname": "NumberOfLocationOfferingMultiModalityServices",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberofUnconsolidatedJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Unconsolidated Joint Ventures",
        "label": "Number of Unconsolidated Joint Ventures",
        "terseLabel": "Number of unconsolidated joint ventures"
       }
      }
     },
     "localname": "NumberofUnconsolidatedJointVentures",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_October2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2023 [Member]",
        "label": "October 2023 [Member]",
        "terseLabel": "October 2023"
       }
      }
     },
     "localname": "October2023Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_October2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2025 [Member]",
        "label": "October 2025 [Member]",
        "terseLabel": "October 2025"
       }
      }
     },
     "localname": "October2025Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_OperatingIncomeLossExcludingReliefFunding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss) Excluding Relief Funding",
        "label": "Operating Income (Loss) Excluding Relief Funding",
        "terseLabel": "(Loss) Income from Operations"
       }
      }
     },
     "localname": "OperatingIncomeLossExcludingReliefFunding",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_OtherSellersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Sellers",
        "label": "Other Sellers [Member]",
        "terseLabel": "Other Sellers"
       }
      }
     },
     "localname": "OtherSellersMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PaycheckProtectionProgramLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paycheck Protection Program Loans [Member]",
        "label": "Paycheck Protection Program Loans [Member]",
        "terseLabel": "Paycheck Protection Program loans at 1% due April 2022"
       }
      }
     },
     "localname": "PaycheckProtectionProgramLoansMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PerformanceBasedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Stock Options",
        "label": "Performance Based Stock Options [Member]",
        "terseLabel": "Performance Based Stock Options"
       }
      }
     },
     "localname": "PerformanceBasedStockOptionsMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PerformanceBasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Stock Units",
        "label": "Performance Based Stock Units [Member]",
        "terseLabel": "Performance Based Stock Units"
       }
      }
     },
     "localname": "PerformanceBasedStockUnitsMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level III [Member]",
        "label": "Pricing Level III [Member]",
        "terseLabel": "Pricing Level III"
       }
      }
     },
     "localname": "PricingLevelIIIMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level II [Member]",
        "label": "Pricing Level II [Member]",
        "terseLabel": "Pricing Level II"
       }
      }
     },
     "localname": "PricingLevelIIMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level I [Member]",
        "label": "Pricing Level I [Member]",
        "terseLabel": "Pricing Level I"
       }
      }
     },
     "localname": "PricingLevelIMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level IV [Member]",
        "label": "Pricing Level IV [Member]",
        "terseLabel": "Pricing Level IV"
       }
      }
     },
     "localname": "PricingLevelIVMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level V [Member]",
        "label": "Pricing Level V [Member]",
        "terseLabel": "Pricing Level V"
       }
      }
     },
     "localname": "PricingLevelVMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ProceedsFromProviderReliefFunding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Provider Relief Funding",
        "label": "Proceeds From Provider Relief Funding",
        "terseLabel": "Proceeds from provider relief funding"
       }
      }
     },
     "localname": "ProceedsFromProviderReliefFunding",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property Plant and Equipment Net Including Right of Use Assets",
        "label": "Property Plant and Equipment Net Including Right of Use Assets",
        "totalLabel": "Total property, equipment and right-of-use assets"
       }
      }
     },
     "localname": "PropertyPlantandEquipmentNetIncludingRightofUseAssets",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProperyAndEquipmentNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Propery and Equipment, Net [Member]",
        "terseLabel": "Amounts returned to property and equipment"
       }
      }
     },
     "localname": "ProperyAndEquipmentNetMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_QuantibMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quantib",
        "label": "Quantib [Member]",
        "terseLabel": "Quantib B.V"
       }
      }
     },
     "localname": "QuantibMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RepaymentOfAdvanceMedicarePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment Of Advance Medicare Payments",
        "label": "Repayment Of Advance Medicare Payments",
        "terseLabel": "Repayment of advance medicare payments"
       }
      }
     },
     "localname": "RepaymentOfAdvanceMedicarePayments",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_RestatedAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restated Agreement [Member]",
        "label": "Restated Agreement [Member]",
        "terseLabel": "SunTrust Term Loan collateralized by NJIN's tangible and intangible assets",
        "verboseLabel": "SunTrust Term Loan"
       }
      }
     },
     "localname": "RestatedAgreementMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RestatedPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restated Plan [Member]",
        "terseLabel": "Restated Plan"
       }
      }
     },
     "localname": "RestatedPlanMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ScheduleOfLeverageRatioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Leverage Ratio [Table Text Block]",
        "label": "Schedule Of Leverage Ratio [Table Text Block]",
        "terseLabel": "Schedule of Leverage Ratio"
       }
      }
     },
     "localname": "ScheduleOfLeverageRatioTableTextBlock",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_ScriptSenderLlcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScriptSender LLC [Member]",
        "terseLabel": "ScriptSender LLC"
       }
      }
     },
     "localname": "ScriptSenderLlcMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans",
        "terseLabel": "Number of plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_SimiAdventistMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simi Adventist",
        "label": "Simi Adventist [Member]",
        "terseLabel": "Simi Adventist"
       }
      }
     },
     "localname": "SimiAdventistMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SimiValleyImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simi Valley Imaging Group, LLC",
        "label": "Simi Valley Imaging Group, LLC [Member]",
        "terseLabel": "Simi Valley Imaging Group, LLC"
       }
      }
     },
     "localname": "SimiValleyImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SocialSecurityTaxEmployerDeferralCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Social Security Tax, Employer, Deferral, CARES Act",
        "label": "Social Security Tax, Employer, Deferral, CARES Act",
        "terseLabel": "Deferred social security taxes"
       }
      }
     },
     "localname": "SocialSecurityTaxEmployerDeferralCARESAct",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_SoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software",
        "label": "Software [Member]",
        "terseLabel": "Software revenue"
       }
      }
     },
     "localname": "SoftwareMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SunTrustMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SunTrust [Member]",
        "label": "SunTrust [Member]",
        "terseLabel": "SunTrust"
       }
      }
     },
     "localname": "SunTrustMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loans"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WeightedAverageRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Life abstract",
        "label": "Weighted Average Remaining Contractual Life",
        "terseLabel": "Weighted Average Remaining Contractual Life (in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLife",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_WhiteRabbit.aiInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "WhiteRabbit.ai Inc. [Member]",
        "label": "WhiteRabbit.ai Inc. [Member]",
        "terseLabel": "WhiteRabbit.ai Inc."
       }
      }
     },
     "localname": "WhiteRabbit.aiInc.Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WorkersCompensationPersonalInjury1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers' Compensation/Personal Injury1 [Member]",
        "label": "Workers' Compensation/Personal Injury1 [Member]",
        "terseLabel": "Workers' compensation/personal injury"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjury1Member",
     "nsuri": "http://www.radnet.com/20220331",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r128",
      "r246",
      "r251",
      "r257",
      "r403",
      "r404",
      "r410",
      "r411",
      "r472",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r128",
      "r246",
      "r251",
      "r257",
      "r403",
      "r404",
      "r410",
      "r411",
      "r472",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r59",
      "r61",
      "r125",
      "r126",
      "r263",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r262",
      "r297",
      "r323",
      "r326",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r543",
      "r545",
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r262",
      "r297",
      "r323",
      "r326",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r543",
      "r545",
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r199",
      "r306",
      "r307",
      "r491",
      "r542",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r199",
      "r306",
      "r307",
      "r491",
      "r542",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r262",
      "r297",
      "r312",
      "r323",
      "r326",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r543",
      "r545",
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r262",
      "r297",
      "r312",
      "r323",
      "r326",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r543",
      "r545",
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r60",
      "r61",
      "r125",
      "r126",
      "r263",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r142",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r142",
      "r147",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r142",
      "r147",
      "r243",
      "r324",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable, accrued expenses and other"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r7",
      "r30",
      "r204",
      "r205"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r67",
      "r75",
      "r76",
      "r77",
      "r78",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss, net of taxes"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r33",
      "r65",
      "r66",
      "r67",
      "r528",
      "r550",
      "r553"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r64",
      "r67",
      "r75",
      "r76",
      "r77",
      "r130",
      "r131",
      "r132",
      "r409",
      "r546",
      "r547",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r31",
      "r357",
      "r475"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r353",
      "r354",
      "r355",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r327",
      "r329",
      "r358",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDeferredCharges": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of amortization of deferred charges applied against earnings during the period.",
        "label": "Amortization of Deferred Charges",
        "terseLabel": "Amortization of deferred issuance costs"
       }
      }
     },
     "localname": "AmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredHedgeGains": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.",
        "label": "Amortization of Deferred Hedge Gains",
        "verboseLabel": "Amortization of cash flow hedge, net of taxes"
       }
      }
     },
     "localname": "AmortizationOfDeferredHedgeGains",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r87",
      "r109",
      "r282",
      "r461"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred financing costs and loan discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r122",
      "r181",
      "r188",
      "r195",
      "r219",
      "r246",
      "r247",
      "r248",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r403",
      "r410",
      "r447",
      "r473",
      "r475",
      "r510",
      "r526"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "BRMG and NY Groups accounts receivable",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r54",
      "r122",
      "r219",
      "r246",
      "r247",
      "r248",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r403",
      "r410",
      "r447",
      "r473",
      "r475"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 3.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r122",
      "r219",
      "r246",
      "r247",
      "r248",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r403",
      "r410",
      "r447",
      "r473"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 4.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r330",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Alternate Base Rate Spread"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r322",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r322",
      "r325",
      "r381",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Equity interest issued, value assigned"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Price per share (dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r386",
      "r387",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r386",
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Equity issued or issuable"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r108",
      "r394"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent consideration",
        "verboseLabel": "Amount of other non operating income recognized on contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r385",
      "r388",
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Accrued expenses at the end",
        "periodStartLabel": "Accrued expenses at the beginning",
        "terseLabel": "Milestone contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r385",
      "r389"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Milestone contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS COMBINATIONS AND RELATED ACTIVITY"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities",
        "terseLabel": "Loans settled"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Assumed liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property &amp; Equipment",
        "verboseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total Consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Axis]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Domain]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Domain]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r5",
      "r129",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "NATURE OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r40",
      "r111"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r104",
      "r111",
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of period",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r104",
      "r451"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET DECREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r244",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock - par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock - shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock - shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r28",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock - shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r28",
      "r475"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock - $0.0001 par value, 200,000,000 shares authorized; 56,197,826 and 53,548,227 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "EQUITY BASED COMPENSATION"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r70",
      "r72",
      "r73",
      "r85",
      "r520",
      "r537"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r72",
      "r84",
      "r399",
      "r400",
      "r417",
      "r519",
      "r536"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r72",
      "r83",
      "r398",
      "r417",
      "r518",
      "r535"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "COMPREHENSIVE INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditDerivativesByContractTypeAxis": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type of contract of credit derivatives.",
        "label": "Credit Derivatives Contract Type [Axis]",
        "terseLabel": "Credit Derivatives Contract Type [Axis]"
       }
      }
     },
     "localname": "CreditDerivativesByContractTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditDerivativesContractTypeDomain": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents major types of credit derivative contracts.",
        "label": "Credit Derivatives Contract Type [Domain]",
        "terseLabel": "Credit Derivatives Contract Type [Domain]"
       }
      }
     },
     "localname": "CreditDerivativesContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r276",
      "r283",
      "r284",
      "r286",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "CREDIT FACILITIES AND NOTES PAYABLE"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r121",
      "r128",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r290",
      "r291",
      "r292",
      "r293",
      "r462",
      "r511",
      "r512",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate",
        "verboseLabel": "Applicable Margin For Loans"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r274",
      "r290",
      "r291",
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "First Lien Term Loans and SunTrust Term Loan"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r49",
      "r288",
      "r460",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r50",
      "r121",
      "r128",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r290",
      "r291",
      "r292",
      "r293",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment, principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r50",
      "r121",
      "r128",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r285",
      "r290",
      "r291",
      "r292",
      "r293",
      "r300",
      "r301",
      "r302",
      "r303",
      "r459",
      "r460",
      "r462",
      "r463",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r272",
      "r459",
      "r463"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Discount on First Lien Term Loans"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "auth_ref": [
      "r459",
      "r463"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
        "label": "Debt Instrument, Unamortized Discount, Current",
        "terseLabel": "Debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "DEFERRED FINANCING COSTS"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.",
        "label": "Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance",
        "terseLabel": "Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r44",
      "r272",
      "r461"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Deferred financing costs, net of accumulated amortization"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r44",
      "r461"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r363",
      "r364"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssets": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.",
        "label": "Deposits Assets",
        "terseLabel": "Deposits and other"
       }
      }
     },
     "localname": "DepositsAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r109",
      "r176"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r419",
      "r420",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r420",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.",
        "label": "Derivative Asset, Number of Instruments Held",
        "terseLabel": "Number of forward interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssetNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r55",
      "r58",
      "r61",
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "2019 Swaps - Interest Rate Contracts"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedLabel": "Amount of gain recognized in income on derivative (current period ineffective portion)"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r61",
      "r425",
      "r427",
      "r430",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r127",
      "r418",
      "r421",
      "r423",
      "r424",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r8",
      "r15",
      "r29",
      "r124",
      "r249",
      "r251",
      "r252",
      "r256",
      "r257",
      "r258",
      "r470"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Due from affiliates"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r22",
      "r124",
      "r470",
      "r554"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Due to affiliates"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r86",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r150",
      "r153",
      "r158",
      "r159",
      "r160",
      "r163",
      "r164",
      "r438",
      "r439",
      "r521",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)",
        "verboseLabel": "BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r86",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r153",
      "r158",
      "r159",
      "r160",
      "r163",
      "r164",
      "r438",
      "r439",
      "r521",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)",
        "verboseLabel": "Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Nonvested restricted stock subject to service vesting"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r161",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "EFFECT OF EXCHANGE RATE CHANGES ON CASH"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized expense weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r75",
      "r76",
      "r77",
      "r130",
      "r131",
      "r132",
      "r136",
      "r144",
      "r146",
      "r165",
      "r221",
      "r299",
      "r304",
      "r353",
      "r354",
      "r355",
      "r371",
      "r372",
      "r437",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r546",
      "r547",
      "r548",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r213",
      "r496",
      "r498",
      "r500",
      "r502",
      "r504",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Equity Method Investee"
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Total net assets",
        "totalLabel": "Total net assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Cost in excess of book value of acquired joint venture interests and other"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r4",
      "r122",
      "r219",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r4",
      "r122",
      "r219",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": {
     "auth_ref": [
      "r4",
      "r122",
      "r219",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee or Group of Investees"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r41",
      "r182",
      "r214"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Book value of RadNet joint venture interests"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r41",
      "r103",
      "r216",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "EQUITY INVESTMENTS AT FAIR VALUE"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "verboseLabel": "Schedule of Investment in Joint Ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r274",
      "r290",
      "r291",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar Rate Spread"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r440",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r440",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets and Liabilities"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r274",
      "r290",
      "r291",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r321",
      "r441",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r274",
      "r290",
      "r291",
      "r440",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r274",
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r274",
      "r313",
      "r314",
      "r319",
      "r321",
      "r441",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r274",
      "r290",
      "r291",
      "r313",
      "r314",
      "r319",
      "r321",
      "r441",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r274",
      "r290",
      "r291",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r321",
      "r441",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r274",
      "r290",
      "r291",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r321",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r109",
      "r234",
      "r237"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss (gain) on sale and disposal of equipment and other",
        "negatedTerseLabel": "Loss (gain) on sale and disposal of equipment and other"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "terseLabel": "Amount of loss recognized in income on derivative (current period ineffective portion)"
       }
      }
     },
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r109",
      "r294",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Debt restructuring and extinguishment expenses"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r224",
      "r225",
      "r475",
      "r509"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending Balance",
        "periodStartLabel": "Goodwill, Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill from acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "terseLabel": "GOODWILL AND INDEFINITE LIVED INTANGIBLES"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r228",
      "r379"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Valuation adjustment"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOtherMember": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other.",
        "label": "Health Care, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "HealthCareOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility.",
        "label": "Health Care, Patient Service [Member]",
        "terseLabel": "Service fee revenue",
        "verboseLabel": "Service fee revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r80",
      "r181",
      "r187",
      "r191",
      "r194",
      "r197",
      "r507",
      "r516",
      "r522",
      "r540"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "INCOME BEFORE INCOME TAXES"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r81",
      "r109",
      "r178",
      "r214",
      "r515",
      "r533"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity in earnings of joint ventures",
        "terseLabel": "Equity in earnings in these joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedLabel": "Equity in earnings of joint ventures, net of dividends"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r238",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r145",
      "r146",
      "r179",
      "r365",
      "r376",
      "r377",
      "r541"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "negatedTerseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r74",
      "r361",
      "r362",
      "r367",
      "r368",
      "r369",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid during the period for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable, accrued expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1": {
     "auth_ref": [
      "r425",
      "r428"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.",
        "label": "Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge",
        "negatedTerseLabel": "Non-cash change in fair value of interest rate hedge"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r108",
      "r467"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r160"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Additional shares issuable upon exercise of stock options and warrants (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r233"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r231",
      "r232"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r90",
      "r280",
      "r289",
      "r292",
      "r293"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r101",
      "r106",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the period for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "2019 Swaps - Interest Rate Contracts",
        "verboseLabel": "Interest rate contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r216",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "INVESTMENTS IN JOINT VENTURES"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Investment in joint ventures",
        "totalLabel": "Total value of RadNet joint venture interests"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r47",
      "r122",
      "r189",
      "r219",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r404",
      "r410",
      "r411",
      "r447",
      "r473",
      "r474"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "BRMG and NY Groups accounts payable",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r36",
      "r122",
      "r219",
      "r447",
      "r475",
      "r514",
      "r531"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r48",
      "r122",
      "r219",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r404",
      "r410",
      "r411",
      "r447",
      "r473",
      "r474",
      "r475"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 2.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "negatedLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r25",
      "r26",
      "r122",
      "r219",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r404",
      "r410",
      "r411",
      "r447",
      "r473",
      "r474"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 1.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "negatedLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "LONG-TERM LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).",
        "label": "Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r25",
      "r512",
      "r525"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Total credit facilities outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r45",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage",
        "verboseLabel": "Applicable Margin for Letter of Credit Fees"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r45",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of credit facility, remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Unused capacity, commitment fee percentage",
        "verboseLabel": "Applicable Percentage for Commitment Fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r25",
      "r273",
      "r287",
      "r290",
      "r291",
      "r512",
      "r527"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Debt",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedLabel": "Less: current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long term portion debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes payable, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r50",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Term loan"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r53",
      "r122",
      "r219",
      "r246",
      "r251",
      "r252",
      "r253",
      "r257",
      "r258",
      "r447",
      "r513",
      "r530"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r304",
      "r401",
      "r402"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Purchase of noncontorlling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r104",
      "r107",
      "r110"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r4",
      "r69",
      "r71",
      "r77",
      "r82",
      "r110",
      "r122",
      "r135",
      "r139",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r157",
      "r181",
      "r187",
      "r191",
      "r194",
      "r197",
      "r219",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r439",
      "r447",
      "r517",
      "r534"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to RadNet, Inc.'s common stockholders",
        "totalLabel": "NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r69",
      "r71",
      "r77",
      "r145",
      "r146",
      "r406",
      "r416"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r2",
      "r133",
      "r134",
      "r137",
      "r138",
      "r147",
      "r148",
      "r149",
      "r211",
      "r212",
      "r222",
      "r223",
      "r308",
      "r309",
      "r310",
      "r311",
      "r356",
      "r373",
      "r374",
      "r375",
      "r436",
      "r448",
      "r449",
      "r450",
      "r468",
      "r492",
      "r493",
      "r494",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "RECENT ACCOUNTING AND REPORTING STANDARD"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARD"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "RECENT ACCOUNTING AND REPORTING STANDARDS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": {
     "auth_ref": [
      "r113",
      "r114",
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r304",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTotalLabel": "Total other income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Current portion of notes payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Assets [Line Items]",
        "terseLabel": "Offsetting Assets [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r56",
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]",
        "terseLabel": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "terseLabel": "Cost of operations, excluding depreciation and amortization",
        "verboseLabel": "Cost of Operations"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "terseLabel": "Operating Expense"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r181",
      "r187",
      "r191",
      "r194",
      "r197"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "(LOSS) INCOME FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r465"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r465"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r464"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets [Abstract]",
        "terseLabel": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r63",
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "netLabel": "Amount of comprehensive loss recognized on derivative net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r65",
      "r68"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedLabel": "Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes",
        "negatedNetLabel": "Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes",
        "negatedTerseLabel": "Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r62",
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Change in cumulative foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses [Abstract]",
        "terseLabel": "OTHER INCOME AND EXPENSES"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other expenses"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Radnet, Inc.'s Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Additional deferred finance costs on revolving loan amendment"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBuildings": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for acquisition of buildings (properties) whether for investment or use.",
        "label": "Payments to Acquire Buildings",
        "negatedTerseLabel": "Purchase of imaging centers and other acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBuildings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r95",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash payment to acquire business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Payments to acquire equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Payments to Acquire Other Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r94",
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.",
        "label": "Payments to Fund Long-term Loans to Related Parties",
        "terseLabel": "Payments to fund loan to related parties"
       }
      }
     },
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r330",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r9",
      "r38",
      "r39"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r97",
      "r121"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLoans": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from principal payments made on loans related to operating activities.",
        "label": "Proceeds from Loans",
        "terseLabel": "Proceeds from PPP loans"
       }
      }
     },
     "localname": "ProceedsFromLoans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r69",
      "r71",
      "r77",
      "r102",
      "r122",
      "r135",
      "r145",
      "r146",
      "r181",
      "r187",
      "r191",
      "r194",
      "r197",
      "r219",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r398",
      "r405",
      "r407",
      "r416",
      "r417",
      "r439",
      "r447",
      "r522"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Net (loss) income",
        "terseLabel": "Net income",
        "totalLabel": "NET INCOME",
        "verboseLabel": "NET INCOME"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r43",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r236",
      "r475",
      "r523",
      "r532"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]",
        "terseLabel": "PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r42",
      "r236",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r17",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "PPE estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r206",
      "r208",
      "r209",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "ACCOUNTS RECEIVABLE"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r320",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r320",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r469"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r320",
      "r469",
      "r471",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedLabel": "Payments on term loan debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r99",
      "r121"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Payments on revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.",
        "label": "Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security",
        "negatedLabel": "Principal payments on notes and leases payable"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r32",
      "r304",
      "r357",
      "r475",
      "r529",
      "r549",
      "r553"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r130",
      "r131",
      "r132",
      "r136",
      "r144",
      "r146",
      "r221",
      "r353",
      "r354",
      "r355",
      "r371",
      "r372",
      "r437",
      "r546",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r172",
      "r173",
      "r186",
      "r192",
      "r193",
      "r199",
      "r200",
      "r202",
      "r305",
      "r306",
      "r491"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Total service revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue that is not accounted for under Topic 606.",
        "label": "Revenue Not from Contract with Customer",
        "terseLabel": "Provider relief funding"
       }
      }
     },
     "localname": "RevenueNotFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r118",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "REVENUES"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r79",
      "r122",
      "r172",
      "r173",
      "r186",
      "r192",
      "r193",
      "r199",
      "r200",
      "r202",
      "r219",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r447",
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "netLabel": "Revenue",
        "terseLabel": "Net revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r381",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsAcquiredandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsScheduleofAcquisition"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r381",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Effect of Derivative Instruments on Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Notes Payable, Line of Credit and Capital Lease Obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r4",
      "r122",
      "r218",
      "r219",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of RSA Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.",
        "label": "Schedule of Principal Transactions Revenue [Table Text Block]",
        "terseLabel": "Schedule of Service Fee Revenue"
       }
      }
     },
     "localname": "ScheduleOfPrincipalTransactionsRevenueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r43",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r181",
      "r184",
      "r190",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r181",
      "r184",
      "r190",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r330",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r336",
      "r345",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.",
        "label": "Securities Financing Transaction [Axis]",
        "terseLabel": "Securities Financing Transaction [Axis]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement of financing transaction securities held.",
        "label": "Securities Financing Transaction [Domain]",
        "terseLabel": "Securities Financing Transaction [Domain]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r168",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r197",
      "r202",
      "r241",
      "r242",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r168",
      "r170",
      "r171",
      "r181",
      "r185",
      "r191",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT REPORTING"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTING"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance costs",
        "verboseLabel": "Severance"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based payment award, award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)",
        "terseLabel": "RSA's unvested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted-Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "RSA's"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available in grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Exercisable Shares at the end (in shares)",
        "terseLabel": "Exercisable shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price Per Common Share, Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Issuance of common stock upon exercise of options (in shares)",
        "verboseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate value outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r338",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending Balance (in dollars per share)",
        "periodStartLabel": "Beginning Balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise price Per Common Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Total issued up to date (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r328",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting rights, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Share-based payment award, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "periodEndLabel": "Aggregate value exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balance at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at the end"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r117",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r168",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r197",
      "r202",
      "r229",
      "r239",
      "r241",
      "r242",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r52",
      "r75",
      "r76",
      "r77",
      "r130",
      "r131",
      "r132",
      "r136",
      "r144",
      "r146",
      "r165",
      "r221",
      "r299",
      "r304",
      "r353",
      "r354",
      "r355",
      "r371",
      "r372",
      "r437",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r546",
      "r547",
      "r548",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r165",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r27",
      "r28",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of common stock for sale of unregistered securities for acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r27",
      "r28",
      "r299",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under the equity compensation plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r27",
      "r28",
      "r299",
      "r304",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r52",
      "r299",
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock in connection with acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Equity Option"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r28",
      "r34",
      "r35",
      "r122",
      "r207",
      "r219",
      "r447",
      "r475"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total RadNet, Inc.'s stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r76",
      "r122",
      "r130",
      "r131",
      "r132",
      "r136",
      "r144",
      "r219",
      "r221",
      "r304",
      "r353",
      "r354",
      "r355",
      "r371",
      "r372",
      "r396",
      "r397",
      "r415",
      "r437",
      "r447",
      "r452",
      "r453",
      "r457",
      "r547",
      "r548",
      "r567"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r458",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r458",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r458",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r458",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r476",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedLabel": "Non-cash change in fair value of interest rate hedge"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Expense",
        "terseLabel": "BRMG and NY Groups operating expenses"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Income or Loss before Tax",
        "terseLabel": "Management services provided to BRMG and NY Groups"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Revenues",
        "terseLabel": "BRMG and NY Groups revenues"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityRevenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Variable interest entity, ownership percentage"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r403",
      "r404",
      "r410",
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r152",
      "r160"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of common shares used in calculating diluted net income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r150",
      "r160"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding during the period (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "WEIGHTED AVERAGE SHARES OUTSTANDING"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "terseLabel": "Nonvested restricted stock subject only to service vesting (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1828-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=125513658&loc=d3e32014-111567"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "d",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r561": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r562": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r563": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r564": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r565": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r566": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>62
<FILENAME>0000790526-22-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000790526-22-000010-xbrl.zip
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M%3O(Z4!&T[/3B(\)C]Z4>-@*ZD$M;!XU6J^/@D:5UJ.0130,Z\U@T'P=_3L
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MB>X!$2[Z_Y7@_FO#V7\!4$L#!!0    ( 'F*JE3_NP#*,@4  +X:   4
M<3$R,#(R97AH:6)I=#,R,2YH=&WM66USVC@0_GZ_8DOGVG3&^ V2$*"9(4 O
MS#0A!7?:?KH1E@RZ&LN51 CWZV\EVWDI2=L/]P)SS60\V%JMGMUGM=)*W6>#
M<3_Z=#6$A5ZF</7^[.VH#[6ZYWUH]#UO$ W@/+IX"TW7#R"2)%-<<Y&1U/.&
MES6H+;3.VYZW7J_==<,5<NY%$\^H:GJI$(JY5-/::==\P2<C]/27[K-Z'08B
M7BU9IB&6C&A&8:5X-H</E*G/4*^74GV1;R2?+S2$?AC"!R$_\VM2M&NN4W9:
MZ>EZQ7O7LX-T9X)N3KN47P.GKVN\27SF^ZT@9K-6\XCZ)PF9M<A1X[B94+\Q
M._H]0) >BA=]E-ZD['5MR;/Z@IGQV\W0/3[,=6?-J5ZT ]__M69%3[N)R#2.
M)[%_\;-0LZ5,LQM=)RF?9VUK4JWH6C7'(A6R_=RW?QW34D_(DJ>;]LN(+YF"
M2[:&B5B2[*6CD(:Z8I(GA:#B?S+$A/#LZ[J ?(QZ4IZQRH0@-*"''\]'9Z,(
M&J$;/$3\.-88G<OD?P3VQ?/@R._L/,S^<!*-WHSZO6@TOL0Y-)F^[UU&$(UW
M'GG0@O?NU.V[,!WV+?J@<>CO/.S>%'J#\54T'.R5MRL?G_A','X#T?D0IKW)
M6>]R.*V//[X=?H)>/S(MH>^'.V_-CT_./U9*\V33L9]X1A%U.PQ=S*?_./3F
MH]!'&<0BRUALUC)8<[T O6#P;D4D^C/=P(3E0FH0"4P(O63:@5$6NW!@I%X\
M;X6AW^F+94ZRC7T+.J\ %;T1<@F!7W\'B9!6XY=;C3DB%1086D_A@LAX 8W
ML>N: T1!PE-LN(4R9?%*XE*+-I.,PO F7I!LSG!%7"ZY4@8V_E^0#8Y7:'D
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M)A5,=%&FZGP";:50%GP(D6J.ORV ]/Y:[IY!=(Y@BR7-@Q \V:# 1>> 1^V
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M"TF- <6<Y$$(Q16W;($,40T/:TE;%EO$ U$V,2 R>>$B6$&3D#(?#H,_<[I
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M:C:)3)+ B HV4"%-M(DF'U*(22HT&5=6 ^>036Y-S)%[N:3D) 1BS.%G1&K
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M01\W7IQ%(*OSD]K?P)"U4IB7L=R.S+52J+GEAMRB<M%=O+&3%R;P4P4"JWR
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MZ_;[UR3G]S/8FPWH&T#.7 ?D>MW/H\]L@0OIFQ_)505/SBI%5, R5XNXGX.
M%V(RSI=HG<P'O<DI ]]S!VYT=,!"3,]OPXX;QG( \??I,LGR3-$H1G@=RWSS
MW5WX>-#K(B(NQF.$ZM^\O/>/[7/UXJN[NQOG#GCY#JU_XGU[^4%S=?S(-73^
MR=>]B7@LZY3=6C12]>][[_W=8-HL!&/M[<[.1G.O<0<!^?%;+P2U?_)U?TI
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M?ZB!)[6-B'%)$)=)J;7C!!E-68P!>V)"[IBN.E(U29_7BT0OQD.Z5P\A.]4
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MJ,4T:W'O&"KK<]:<'7S.IZ2#NM>M':67!_61Z=M1G<@_JGO>3HYA#%7L#^S
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MJ.W3*ONC/-+O*#Q\B>G/O=]V#R]I>.Y66;*@VP)#)4ZT?MS+;=Y@/+GTYY<
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MYYMVP/:WE8EQ ?$U">JNB4/]*9R[S;G^WL"?G.<)>SD<U2D^D\FH[\XGUIU
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M0Q./$16;@C #JL@QSK(TQK9IZWSY7Y>![Q]WK!GX^S'P8J^T6%*J4P=V@[/
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MOP8:<($L^Z')Z-F@9Z+R?#@:? J:TCLWY!"^^ P0<FQ[E]%__D ;.6W@ZLC
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M@&XI?98 'H2 17WJS]I_V]C>W_@=1P#K4,_'F\#XFO (U (P9W\^@B.R_;-
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M<21CV<ATG!*&*$4.=.)4?(:W^M/V:<Y12RS/$V\%2'P47HF H16(!>LPJ98
M2MBKX/;"0<Y>L'HJ<X.J WTU/+Y$03H_8C/PZ6Q^%S$!"WUFC<^JQIKUK<'S
M>>8#A7T27.VPDJ,1>M<"0;3TH'?'69@./J[1K'T0)F>RYQ9&^#?@ ""7:6S:
MN?2Z<V3K;&!4";446$:EWNKPQ :0=+;+T\POD 9 GYZ:7.OW>D&OJ;/Q!%3
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M/JJ D2%8.>,R[%STVX$_G?!E$?RGTG1J,P8-!M01H2D-R/3&C!B<@UBK:[Z
M./6+$,S,<B'OW=_C2T#ZPX%918'ZH;/[[>=:Z_S>I)JW(Y#10M,MO^)RP'GP
M439'&?[,8U;EI%VZJ)EO\ -,IPP/7BQ+\BVK$'8-ECB<V+2SY&L[8V$C5LSM
MPDZI<J%DPXS3+H=XM(0D-;0:Y$WS2A]4T#19;=$4UMG JK]R9'P=IJ8PYHPV
MIZGV,)SIPY2LFI.D(=92F1[X8(G."LEW)=5[9J@\8D"Y82V!IY+F*'P4:@8?
MS$ZV&F 7Q-&GTEZT"@[5U(_-T6O-[\,<JKKK65,QQ\=(- 5) )D,C1\B.LCE
M16.ZS2IL-<3FL-Q NUPH,E*; -IC"%05+%1?! DE8G,!?-]0TO0-^-4%\.*O
MX%;:KD*AD5ZSKJU / \Q5T5'U(Z<:D922%^^S-12Y,7LO'0NU*5Y5"N)+L3H
MG+>+_XU;;.==!WBZ$4I5>._>7 BA5T*>WALML5B9MM,JKX)=P.2HOU!8)01@
MS*^(?V$UBVRY>EDJ_\B6<)P?SB2T[L-QK@CSF87 -%3L[ZX:!]$TN6:FAF8+
M-7M1N\I,^^C:G^_"E;J'('9U21K@_&K0[]M>!S9S\/&CM4/_R-5'U!V?V]-<
MT-340:?5W, ; O 'J%C2S@8H[[5+9362!!HJ'7]8-IQZ!+W":*K[MU[JXYUL
M.+]M/3Z@A.8\VX F!JWLRZ&':E3-.&%LYX.Z1M[L]/E78.4Y)(A"KB7G_2EA
MD+6H7FM5<N'-.W\6/T!'FC^1[ 5N:JJD>6DX5V!Y6=MM1GOULT-:4DNX2BPW
M%_*0 GJ<$\-7JMY:,R]/HI$&06@'/5G.<J@:<3 WA%8=I"FP;,F-2=^_MZV)
MP[BF"M\7$_)A8#Z:N5Z]H%/K.T*MO4]3:%%K&2!#F*TO@N-_;11HA9D//1SX
M;[/7MW[LST]AV64XYU%91T7/<X)81T4_C+%\I\Y**[V&-WH!%UP%PCA**5>I
MY(Z[!)-9,IWHP@J62V-P(5='3=_D8KBC^OA)/#(5-J&(JC<M@PYM*8KR?(AN
MP7&PV' !=0!V5?1;$,RS)&!8'P!&XT% %S,XX%7,J,1JL+^O%KO3?)'Q= B5
M[3E0,9<MA3:^C1*K7_LKJ/,WP=DBAV4-F9?MSL9MTS9G.U-DZQT1Q/9]K<9&
M;<%/@ /]D7J=]^V+]\U"O*]K$X,5$@%OXGNBYKF-7O>6W<K!3K5NXS^Z8DKS
M5<IJA5[[4A;+^=9>FOEZ<NUQKASC0F3_JN6[\73N.Y]FZ3, &CV+7:S\*;;L
MM2-3ZH5\RI[A@R\')X99JS-3$&T4(UPFDJ@LH40PHV%U-<N3[-?P]"*F#[4@
MIGZ61B"VO*%W+&CC.:@.0)AQVCA$*?KSER#;O2'F$;R>BU.8R> EI][LW+UQ
M.:M05F2N"FWSF^[)JO*'4<WCV\ZW&CO_YL<'? K#KW[_XS:2/?7[%28T1;/8
MRX>@?I##RO[1?/@3]" P_N4?9=^OOK^IZ6]>0V $?=Z>!,56DXDGC_!SC0=S
MOIG'.4+"\0C^;YH7UVAQTZ/%?XW-\F]9NIDQ>N7/\>;5OUWW6,HWTS3]JL=>
M_UN>BT<T6''K.X$DD+3^OPVVT5S7$ =(?/L]K_R7IYFI:=*TT*6!CN<?,QI<
MA,_)QLR4,;Y@>#+\'-%Y>=:S;HEX ]W^>(D6K^AWLKA.Q6TF%8S+'S,M<5.T
M2QRB\U "'P0)O(<2V.=(3:,5KYPO6YIO'(5MOQ<2HLDJ$FIDHM0?,8VL;TB]
M3,[_Y\]'M?2HVFZQO#=.]A;K_LLL&/W^]/@=Q>3MM\?Z_URW/0]./NZL<(<N
M[M9-\ZW!CL>WPW'DXQ^C9NCMQ8BCQ[ D__G]YM^>MV\0\J F?I=B@;&@W(FD
M2..".S YXUS17,96QES()+DIR89=$96$N1$[M=F,>1$[8!\-@$#W/M=A 5A2
M"?YG;ET9D#U.H_7LW?GGWN&'[L=WQV^^P/<7AW_MT??'KWO=O[KE0?*^=[B[
MS]_!>]\?GWX^^/"*-?? NR;ODS?90?+ZK'M\ ,;L-G]W_ _<]R9^E_A<#'[P
MX:R$.<(S]BZ[N\8=E/'G%\=[XX.C^'-W=Y\=OCJ)9<&I2121W&)=)B.(X#8G
M1:&U931+4L$WMJ@0'9ZE5^17?#<^PE_OR$]W4K,+<GQ1):WEX5H>+LI#*E3&
MF 7YQWA"E7"QLE@DGR>YL9F\*8=L+0\?F#S\LB@/&7,*"P_J''V )G9$6"-)
MSFF6%8Y))@S*PZ03%U?EF_VJ\O Q0?2;+:@')W^;H,,KC:CD;O-=J74>M?3-
MF"MB973&:,Z9+@0ODD2A<SZAP)AK-/JXI._E$AK-LI3F<9&0A)J<<*XS(N,D
M)J!@M>;.VL)F&UMYW"F*JPHGW%KXKI80WU6^WM8U].09G<LD4S9W$F 5V!V
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MG&L5<:.*.-[&=@I.4V&EM"3)L+^R88"TK"@(%S)+5)RG3@*^HM>Z&#WY@51
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ML5, &B,_MZG!/)R,J@E,V0,=H/Q+*T>MP7N_S_P[O7NO\AZ=>@\&DPH>>3X
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M[1W\]?SCN^-7G]]]>)=V=\V'@]WM]%WR#E08?']^\&6Q*^6[#SKM?OFG=Y#
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MIL7HE7XXM'OZJ%N'@,OO)>YTO_M\OELY.C&>(81L$\#VS!)[=CF[Y&5 ,MO
MVZ;K782'#BMG5\LULON3\PM@18"34^==_-1HY_A5>O#AW8G+"YX*HTEN7$:X
MLPDIJ,3"P]R(W%";&[ZQ!7AMV8L[L^*FE! A*4P!L32 ?X.YF,1QYD7H%)EZ
MVH*M]HZZ4&M[U@:DZ5<[')1UFUG 4O:/4!$55?#V<%3VX*FH]6C: 1F.=;;P
ME^ T+/P/>3 W:YL4V_&$($M_,]Z&?L7H-Q39C>G=# (IIS'"P\G^W$^@02H\
M0L>> 5ZCA/ZN((.PFX =^>A1'^ 9PAWF?CH'^]5K@W[T[PG@2!HW'LZ&Y]#4
M&>&3KV0^[]^K%KA.:,"'PB4BXXHKEDE*4Q.SV)G,92[6H<9)S&EZ!==-ZW1]
M*^/Y7ZOM"4#M$<+GVQVE/#TF?'/9_7)PDO%"YUF6$,.*@O#<""*H<:305K"T
MB(M"L8TMFG72..Z (E_FQ4 .H;;U^3DV]D:""_"YPA;DNFGE/%XFY8!VX).R
MH>VWF4;*#-"/Y%H,#OST+]_HN3_SEX=WU>:S;X U!A 0@GW\U>@0GG[GK^[4
M-R$]UXZK\ 7RU+25C_?>(*8[!BD3(%BKG![&QR#-5<W80Y?VZ!2A717YEN=-
MH(P^*ZUOM26;%D!^2< 6A%$%#&M#((MM7U [T.O7 ,2;\PH&CP#( !6\[HT-
M\@E-/]]'<#K6$%GN7^BY'!AO, M;"8\(J-=W',313F.(V@-N/Q*=$FTG26,B
MUT9K\#P\KVW,>@H76.)[.L#6Z#L>M(XO5QP9+!K"C;W;]#5KGA:J8F-0<IL>
MHE/;Q_,5K%R.EIJ__=I&.B[3PDB3.BIY#OK) PBEM:$Y@^]N4V;P:\67_^.?
M,)\0SDY7=MB8HH>G)J[H 8@K2S,,'#!$91(P0U+D1!3,$E<8E5A!$Q;G&UOA
M/,XWUKAK[Q0 ']:P+'$YTYPS5^C,HN%@F<FE3<2:!'XN"7P\B0$9IB+)2.ZP
M,QQ5!5%*4B)2M/4T93%6F7"H,5930%T^%9T2/T(8J)LI02U2PAX.SU^\(K-E
M30;=XX,3R943.C&P[PG#.FT 7(I"DTS%U%B9%S9+KR6#'R0(UMO_';;_XXE*
M,\?C."&.*@7&(\L);%A"\B)6649SIXT%10 X9?7NAURY.M['P[8 Q18*5;>Q
M2/L,Q0)0F@.? >6TW/_/>A)^/-)@>>%I MQ3E><ENNYF4<OG V-[/KAD4-GP
MKYG#-)SB3-#5UY?UZ:\_[6N\C[.(8VP98D<>B?EFZP[5WUP/ZH!@/PTP(ZHY
MY?21*R/ID_W +-6V\?:V<7PP0%>N0PN8X9)(/()J [D:]UT!X<*OWN.3_SEU
MA 8@![A[[SI(J'NRJDI7+AYLUR.KVA$>%;!DY,],RK$];QKR>,]RC7F#[[XZ
MFW_-4):AX=;YL#>XM-Z_N]_'I>[;8!#[YBX+F92AT*L=_FUE#W[=[P/"G]K:
MWM2._3%6TR &WSV[OA-N0/=!O0#X16W^H,'4J4\,O0D_&:/G.7RN 6]C+?C3
MMF"9-*>"89.6MQ?/#UI)I0U8KXT&SQEXCC0UX.XPVG:28-X)V)QXU!.U!6+G
MJIS 7RZB_0>XJD<6;+-J&CP8O-1K7W7WPYL3[0"]R8P3P6, CBYE_S][;]K5
M1K*TB_Z56NQSW]-]%DE7CI79O2]K80M[T]>2VB#;![ZP<BH0"(FMP1A^_8W,
MTBQA!H,M0>VA&Y"J*BLSXLD8GHQ 2K 4I6!%P/Z12BH6ZI2'\/3^[G]V:P=[
MGW>3X3&EWS[4#PY^3U RJ2*7G R:+KK)(;YA6LW>:<A]#48M "9'>8I:^[&R
M2.&H3ZW9B'77&2:I8G>!?F\JJ;T5<TPAJ%$<_$A.8D)]>(&/.<(1A<\NJ?<U
MW<)I<W:+ ,"X+*(A5^&'$]A#)IV>IODWLT,>#W3^:T-JXFT-H9:^^&_A;K\_
ME%<9GEX4U)Y%C#N/%;_V0\2X/$2\&F/YJ8>([SH4/'^64V(N/),I3P$M0W@_
M4Y2G8&ACN%*EMQXB?O6;\46S -J=MBO8^R< Q\V2FANVX[UCDFDE1"H1=IHC
MIO+@P!N FDQ8*E+E?,:7;,?5O49UM]8XB W7WM9KC;W:^]W:V[T1>39L0X$&
M?QV,]U$RK^5/P+:]['9"'R!8A\!J;>GFQ3#^7Y J0D)A,Y+&8?LY"8Y*>TBD
M" Y9<^A#-=LQZ'PRK'$13>U N/2C/0_<\F8['/\%VZ!;G# :,4VVDB_!9PB=
M((=-+>&"X/GI/@!K07 ;YP**(ZM??:MS.=PTV['C4L'_* A@<=^UMCN(5+LQ
M)>UJV'5IQ)G7Q2X]G3$8'3<><I6&SL(4Q7#,(=M*WHQR&2.&[929'L<\9&R.
M'C?LGC2^%>R,O=C,K-.=#&!HKX CU DYEU&S3/ *7$%OFENQ(3'(-R-]*70F
M^MIT@QC<#YFF8N[U"9@M)Y$D6B1YP]2">@?'QL&"]D:TO%$1G#$':)C@F5@K
MDY/:$[ME*_E/YRITR=PL5GK0+\RU?'8=PT0OZV@:?6D ^DX@9#7SV(9TY/DL
MW".V=@-)Z;1",E9'.Z\?6%31UXZK%K/3D]:RDSC!_^X-#V'K85XL\I'C&?6Y
M9ISQO2>O.L[Q3#N:H15K5*FFC:(WL66'S4C'K,^B7:@]'<],Y%'Y.;$K)"LF
M?NRH=]=HF4*BO%BH\%-<JK+!]2-VGPK<]6LT7,O=YKI6V3F6-G4J2U,DB<P0
M\T(C[7V&A+7&<&HUR<B\Y>.IMQ+L5\M4RBS3VGIF4L-Y:G"FM)O?G2J[^WN?
M=QJ%IWC0V/\4-ZHEC3_WAJ&I@CGRWX$>D7=A456Q"T3/++:2Z]S.Q!@[:7-D
MC%2)-"5I1K3+P92DADA+.,<Y%EG(G@4R!E:IH.D=9(R)&,56:2.*Q1Y 47<0
M(?$_OK4D/%VRG/)JP_)ZY>,QB)MA%&<(FU!8#Q.#5(89(MB"/GN&0:DWMG-
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M1DYOC"S-6+KSP:$0=QCR;T-((X3W8EAA>."W?0X"9XJ"@$7\9[K"RXCM,6[
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M";,#&Z^)9YV&E?]GRK2/3I#E4PF/F:1%9TD'B9FDP))$PO#>TTR?>*2J2!#
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MY;,>R^9X , _86;TK@1HB4 O%(&>BG5V+P1ZD2G.GP=#\[5$86&<P<HA1Y0
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M'"-O>(J8\@PIBEFL^,DE3;.<@"F6;7*Z2J3<,KN]5J9+J?._5.<7@H_." ^
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M8]'9'VUU*X$3<6V&%E=OJ+!!"6Y5V;AI@ZZ%0^536@@FCK^<MX/&H:E@!(U
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ME?Y,=BU^BDC^U-CI&EG]D<.:>IU.[RA?>AQWAROMM,&/C^W28XK[VW8[NT9
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M#11F$8L9:1YU5NB36O.5!EE?KK-"G\]2SF]6Z".RAWI#Z![(Q2D8![ -B6M
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MC7S?D7B <8C@I$Q4!O/$<Z,H%XYP$RE0&&8T,4+RB+7FDU6 2L&XNBC8=7(
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MH8)VN?['E3X;(-8@[K=[N6"\'V:I2Z5 =;) G96V'%32LS"S6@4(3A8Y6P<
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ME[>(B80:FKL3)B"^'@R4@=\A8WF.8FK'<^%BMD2G2<W_%KD!IMV')5T<[9^
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MC>]?3\K4%L:U#,2CX*)"W)=]AK1!,I$4E">Y>FI-C>X3CNK]F_F'JGK_YB&
MZYK]FQT I@T*W\]\BN:29HWWJZ)!WW4WWZ\>;]#/.\U6:#=:HXUGKB*S%J/D
M O HQRTR@6I$N R".IG@O7+_9D8%K.</7/7!AVOV;Y[@T8>96&YFRNC9KRIC
M\YCP_LN[/,2HX"3U.F_6!Z852]9%KVPN85KUFZQW>1X+S$^N";%W<W+UZFGS
M]$U[<\6+QLJGH\;IMFB^?[?;6&EVUV%\\ P8GNOT/S!?6V"^I<T%#)V7!G$L
M*,K5<E%N.2J((EZ1*T/L5^[RW 3NGX FS9'^U'M5<ZE(7T^V@B!"&:!%6I&\
M5R4)<H(;A%40-EA8?4\O*0SZ_,X:S5;I)Z&^#BNN'9<")\&#E(X(*CP++ 61
MB/B%/+4Z//Q "GS-5A7,0W>-;W;7V,;N-MXX_=S=;*WQ9J[PM?MN=WWE*]EH
M-;N-UG)6X"UE%8 SMBCRO%5%G$=.T9 7627FB27475;8]_F[-344/0(4F<2H
M#R9@1B0GC!@KI68L"1I\,MC54#0W4'3-3M6;3C-'65IKK+&[V=EH?=Z#[XJ-
M[H=.<Z73;L)S;+2V^<;W-9:AB'KG*?$$*9PYN>8>&4TBLBDEHYA/(LF\4U5#
M40U%OPF*>%1&:RT529J;(#7QQEL>O/+.6E-O5,T5&EUST,BS#?IMK]G]2AL4
MOK?[&1#H0[M!OY[ O!QO?G_7V5QYL[MQVBSCO8P3+ST72&/'$*?&(&>D1MAC
M3$/BGF!1$Z/G=="H1JIZG^H1<.N:?:I&SN^!ZS=WFZ>?3M=ACH!-[6QVOY+&
M]PVXQQH\]QIMK#3*?!\J#;,Z6N0Y<XASD;LV>XX2=5QI@351Y3X5>Y$;[/4Y
MHZOWJ;X]O7-&3VN;B09EK"+&<&:YY$D'&92F4FM*@L*JWF9Z1"QNOKWN),<G
MOM$*NQNMKQQP]V1S]Q.#<?-\BF/]^]I)L[6,-^B[;N-T[Z@\3,0)<5QK@[#1
M0"*9H,CAY!'P1Y8H9CX0?E5T_#X/$SVHY-4;-',I@E^/M[@DV(H4$8VY/Z00
M$8$;PY#RDGG/N)6<Y:C*BSA,](0)OK24!:5D=$1R1:).W'A.G=/*DBCKLT3S
MH\#7U(+;AKG(UVON;.QN=IJ[GXYRFY7-[U\%7&NG<;I\M+[B<1.>J8Q#2&Q<
M5MT4:$)<49H[W;O<^@V[P".SPM^E_M+O5XHYSY>MD>@Z(J$Y@([WF!+& V6&
M&D>,%-H:HVU@-1+-#1)=O3_3_0KWVB";74">[H>=9BL_=R,CT6GC^^I)\W3U
MM-']UFFV.N6I1A^DPB999!4',JNU0TY+C:(EP"-QX%C;R_J)UTA4(]%#%%=2
M4B:=DM>8&TP-MCCWH*?*4:58K+=GY@F,KMF>V>F"/T,W\K^[S;V-UN?=S94/
M.WE.FA3\G)555I:E;'TKP4CIE*V.1=XJBC@V"FDCX$=IA C2"^%E38N>U3&B
M&JCJW9E'@*VK=V>ZJW M?[R1=Y-A#)NMSSN-UH?VQNX&;G3?M6$&NXWWJR<;
M=+6L F>TIL$[@X*))I_!QDB#2""?P)4+TB7)J]V97]Q5?M*P=<=#1*.V=K,A
MZKGOW/S:QLV<3N"3V]51X QQ;X,T.9P:L=&YR(_#-#H5A0[UKLYC8OBU_556
MCQJ XQO=;^W-E<V]7+VS<0JO6ZNX>;K!P2]F,!:8EYW=JD2<R;U"M4 D:H6X
M8PZ9$#%BCED?-(B2]@\44I]?A9T+8W2OM;MD+DS F-&<"XE="$YKRYVW3O)4
M9R'/CW9?<R "-/AT[:AY^I4V3CU>;WTZ:JZ$-GR6K'_?[#9WEX\;W0^YGE?9
M[T!CJU)2#$D<$^*"6Z1MBDBD2)*5%DN"+U'NY\_0:IB:-Y@R+B2IK8D)"ZZ3
MTSP086P,P8)KF4P-4W,#4]<=EH#Y:>XTX._UE9UVLY4=RCV^N=+@C>^KQQLY
MS:^U?=JDC>.RK%<(BCM'$5'6 4P1@AQA\"/EB4>OI=$F.Y(U3-4P-0<P);QT
M)"F#N8Z<.JPU%XIX;+RD#.OZ(,5<(=4UD?I5W&A]Z*ZO=. >C2,8QVZS]:V]
ML;L-KM+.;I.N'C=H1K%/N$Q(YBRX0#T*VD?$F>/(Q<A1C(DRFBSC,=:$ZG<A
M51W&GWL4J\/X#X%IUX3Q<WEV<!!;#5P=!/N$P4G<::YXNOD>F-CI)P'7.UY_
M_[E3-L6C2A.N&0HF4,2U"T@G15"T.@*F16&]>]EA_'\=9D?A=?GX68?:^T-;
M/O_T<U_:(.3UOUW_7Z\OG:^;%<_Y:_KRU:_:^P%4Z14CCP,_-$]C:R<6G1Y<
M "8S%+W#'9C6GH.QEG,U*'K#P\$AO 7/!- 4RB3P6'P9[K?Z\"A%A1O%\G8_
MQK(?O1_V^_!OYZ1PT?:+-F!7/\('+?P/O@H?*[HPJ)WBX]J;]<]%[,0*]N#]
M6Y8+X0);YZVW5G"IO56.FR!P4#$PDLIL5 H8B#,2P@M6NYUCX.O$__M\LOD]
M'#C*Y>;N]A& W,Y&+L\!XVN^7^7-[AK9V-V$^S3W<F9H<S>756VFQJD_;FQO
MQ6BXH2(B+3*?4DD@EXA'6&IB.27:RM+SHW0:>XJ#SC#+6F$/#D#1\Z06%>R4
M I@BB+:S8'T*D("_^VV?!2]O0'2*;[!\ ]]O.WC3NMZ/N/0[%?-E0,' [\0P
M[.09[O: 59V6,%#TTD6U;\5^M_@(L %:O@U_KT0?LXX6C"P6F7@41VW0\?\.
M;1_T'\#@P)YDI1KD*_W/I8H^'(3)GK\4!"T1XJ,RW(/@I12X4C"S)%E/1VD+
MA([X3GYQ7LN1N%K)@<VT>Z'M_ZZ&!_*V[]L'MK-0I%Z_:P]A!,>'KP!_4.@=
MHM%US_1?OCCUA]='6X;":EA-D(JY8$\"#'#61B1D2ODXAU%&9_774]I?@-1V
MX,5BT8^ K(.8K?)V:<9MYZ+$_>(1HSO*R]7[H9/24E'AEVP.]G#C:"MQ0J.4
M @5G1*:B>;_"!Z2P%S(Z(ZW&"Z_%T@PF.@:6'F!D>Q\6_&"L@5D:AL G+D6>
MI6+Y\!Q<E43C!RSB8OGYG\AS0:K@XF#0!]G&G-P*AYC->V\^$IM[5TAFE%-&
M$N&UH\:ET=&UR^'G>FG*#S98/C?8M=%8:RR:)7O-E6766-XBS##'"$-1 -'C
ML!Y(!V40"YQX8QW(9M73\@HL*DU5%II^[-KV?D8D9SMVW\>,/RZ"\6J'3%!A
M$89]<(B7BJ(UVQH>P36KC\7,7Y:'V_G]RBA2!@+6R>D=)<L^:@]B8;T'!MP'
M5AG.L>O#+ I3DC])M:?9S\,2E4=A)=4X0-A[_5(I7I6SE#^U\/IS_-'K_,C+
M-9J:4?BB'0<W\7#+^U_'Q^1\>+S7S,0;V_<=>S(H+IN2DTLGY.83<(U</>I,
M7C9OA(YX[?4S=$[_/H/#6JKDE'?;!M?E5G:#.U!\$K4TS',6D].)2<W CC#A
M>$C9;E"".66_$*8;I6*]Z?7[O2-XI'' KK88LRW&IZ/F\I;&TCE).+)$),0=
ML!5#B$/:*"T==9P'OO":F%E\96PS"F"N[5X?_O& ] $,QUBH?"4Q:;1"0%(&
M@YYOE])T9F=N((P6#$B(*?;SY1-0H_W2$?:]P2$PG/U8$B.P'L/NL%->_#S-
M6;RME\6]B9@$R0U+(*74&$QHD"$Q8';<55(Z%4*9Y5Q5(WY7#CB^S:-MQL-:
M'F?+X]?,8!A A LL(6IS*A\#R=124R2MPE9S8XTP98&&RZ41J$D#1&KGG_\@
M$O\U8AOT\NC(\\9\.MY5.1_TK43+<Z(T![ U2O(4O"::F6B=]-9107FE%O"=
M&):SM&I-.$F!<.H3CU$::;#SR5&;G$I&G><@51#5E5A\@<W=0-NG0J6Q709B
M;;$Z[/="K].!]W/L,1??@,E<[L!']_//;\!!J-[YHPU.L_4[A8=?+19VD/$#
MYB6[1E=;M3^OB,D=[;3ADC;DY<U7/(A5*#C'A(9]0*8^#+C3COLE)G5&B<)%
M25$6,T#U^N7G@4CG,21XE-)4G7ENKV;%Y^=#;F>*T/4B\>]RW^%L([7:V/1Y
M#0\&\=7XQ5^A/3@ L7C5WB^EM_S27R-Z.MI=S3Q\8F^S'&;U]E]'[7"X\TJ;
M)7 \L\B/SBV,;ER]2Y9*;1CO]%YXCY$E+2Y_&R^12]^[\K)TB7'Z$)<56-_H
MLM>=XGB0?)H<"HK]1SJ1H69ND;TKM?-CUDZPPL4XC;\H\_AO<EKCI4S4),I6
MVS[W-4/WFO PA[,WRQK-F,$GU*!IMJFHIOZ1TD3^N7WXURUCX3**&))W4H&[
MHY6S-#B@]80K<#^5MK-9_=4A\ M'@9[)&:!MN,=&>;YF8[=Q M_I;+8^[&R^
M_[#3:'T2C94/\+EW0.EW=B<30-97\CU"9_U[L]TX_0!T_UNGT7VWM]%=/6ZN
M[!WE\Y<;W]_MKK]OIL87?'3-\?,.N ;'<._VYNX>;^SF3M^K</^UH\W=97 ;
MOM(-^@G&'W;_<[JQ%2/QF%F"*+44\8@Y<IAYY)A6Q/+DO(X+K]FLI+;C>2WN
M_:C@=B^Y\)Q[;P*1)"AN';?@:FCJN _:A1!9G90P-\IX\4#>IRTF%%92:L2(
M9_E(74*:)8:,BB'BH(+C*NO3E6UAGT1AZB>O90F\]5PXD%L=.%-61TP5-YPJ
MJZQ/J=:RN=&RDPDMDQ8+)AU!-BH)5DLEY"P&I1-!FRBEMUA=VWSYT7R\%T :
MA3!<>"6-)X%[1VU(BH7 0V#,1D=JTOA;-:A]#6GL?CW9R,^\N]EI4)B7UB>V
MWEH3#?JYVSA]M]M\__5T'<;86-GI9-(8!"$*L!)QEGP^"8&182$A'(-B'">6
M<N8>FU4-^+BL!/S/?^1B(;<6*F>X81@'XA*/3H$SHC !DVKA:MCJ6JB>KE"M
MTBUNX4^R$D5O0;2\%\C0$!%E2NHHF6>"W]T5J3V.6:JE 9Z!] 2;ZSKI1(U0
M*3II:&1!2ZUJ+C0W2C?I<0ALP$L4! 'NY@)RE"#P'S%2RE+P%K5C7%P"QC?R
M.&K'XM:.A2(<:Z _P01N2#(>$QFBT-8S'"FNE6ENE&G2L;": P *AG+P"W$M
M&=)&8A1<M!XGY836US;+JL/4=_8X?HD?2K!;022K:<(\8EBXY)W-=22BP*"
M-3_\K=IU<AT_;.YN?O]TW 0NF(\DYD*IS>\?=IK?OXK-E7<P=Y_A$U]9L_N)
M9*=#YQ;L#DR<3(0@3HE"93EYSK16V)@8>+S,Z:@CU0]DZFRBQ(LR\PAH!M'
MT^G_S]Z7-K>-)&G_%82F9]?> -BX#WM>1Z@MV:/>EM2VY.ZUOS@*0$&$31(<
M@)0L__HW,ZL @J=(ZN*!F5V/)() (2N/)[/R8(X5V;9KN59@-J9N8X1Q$C=Z
MC'/7  /G&CI(D6N&&K,\',H0<\^U_0" )9JZA8V'FTCU4TB9%>END)A<=Y+0
M9C$/;".Q'<?#>$AB6D8C91LC99. TF"NQ0+F:I:K<\UF@:,%L1EK2>" PG3#
MR$R2.]M[UP!ER:@E-XDZSX6NVV)YT5%:#I9Q 9_A/G=4X#]'2JBRA6FLAU0&
M-".Y5U2Y\23!\OEK/DH>Q5HBK+:E'$303_E$@NI*>:DWK%@1R:^726XOUG(G
M\N50L1V7K[Q#C4C63R&_/+P]O?IJZ9X363$XNT:2 " P3"W@B:V%S+1TR_."
M(/*P '/6H=I>9XF_RW*EPP? 721GLG@C+8KABAG<JKQ-[2[4R8!%43[DF-&-
M]YE.KTY@ ;7D0Q+>28D5*=AI46NML6J#1N:%B8\%D0 [#--WG9!;;N0YW/(M
MHPD1/XIDGOPX_? 5&V-&%HLTSFQ'L[GM:X'MA)KO,QY[?FBP,)P'U44_C#P3
M-?(3[+1B?"4( PZ8DYN&8?N.RW0S3'3'8(D5<-=V5N> ?>I]=Q\FT$$]!W;"
M&)Z'&< .P 0X<<$#GK 9\(/O)1[S;*Q1-F;I9Z7J<Z0J]0H/M.VD4V1.-[NZ
MROD5ZH^8@:($!4.U@649/;N&OY+F$27-<<YN>E+%L4YG&2TXMWZDI9ST% 2!
MHO:, >^5C(!LB_?<1';=CR9G]V#>#\B\B>M93N 'FN6;IH;F0PLBQ!81#YC#
M[2!@;%Z7UQ'O2LU5E%P[)-I+4P<7C3AF-83Z$.CER?V0;71$EJRAIOX'V+X@
MI7H ;('0S]..8EKDMKB+.R!@#RBJ&*/>"U6Y[%@[A/E::")4/.5S/@:TE32R
MT8)C(X6L("7X*N<=ADZ*K-&2H:/:%V6%ES[Z"@O!K1X.YG]E XYXB!5,8X+2
MM7_;59BC#\I3"P$3?M=8 HM]Q3HWP#L'OXZW8TA[V@0-)U]_[DLFR;-TG?@7
MVYBU*.T<[>4_TBAQ=$RRB:W8L). ,QZZOA5&AL-BVS+]KZ8)(BQ" HGR%FTM
M:-I__<K>S-K*F76/21CJ,;8>3?383F(G=)B!,TC0S6>AX<SEU2UNJU&U7GG&
MMAKK-)%[7C,QOS<DJNZPDQ9M[%>P4H,"$_G.2LP @+,=>4GH!=RV;=VQ %OK
M7GCG 7'31N/A<&'D("Z,8B^.?0""B1UK=F('6N#;H/)=U_ <A\=NA)FD^J*^
M!7/;9HR[*V>_GYQ1I"09BN+SG/]GF.;$4T5KO!73?&A2H9(*A'(&<HXQ4]")
M+]*7D]V:5/@C_!6OA'N"$\7RT5U2<8^<PW?#6['$_C OA@SX'-9\(=N:FBW_
MSD9.*E;UP[/DPV*)G&3I?:=LA;9Z+]8V.(?@[/$>RD2'82L1>!+]E0T!?C Z
M5:-6K0# X<D86^C%5?CXQ4V;4Q\">,,*IU$[R'R$X%ZV%&5!F)HHTV:QTLMD
M<P18?3%K^?-!_BJ ^9D4GWCMO6BZA> 3^_1A*PI@LUAX;<#SXF_CH@SR]6KI
M9EP/U$-U.\!%Y4U--2_;+8(M%)OSJD>>Z9/&T%7E(XNQ6\$IZX$+(?3C22]J
MD682G\D_D!,D6C]FRF')BLI9UE+@9H!RL;\H?8U:*>*'K*/\GJ6D>T9J$KXM
M]P"O?3]D.2CQV]H%+U!/'1SCNMNC!QV\E'T )S\08@$+PZ\)H:CU29'RP>J/
MASU;#0Y%=AS;NA7' (,8-WS#!VB>V+:1!+&>T+!'4]=]TU^4+X=8*)O 0F73
MR08,+0>&OL%S  Q9=N#$1JQ%IHUQ7>R :C)/"VS3\C"5V#:C@S>.UYH.\%9@
M" QH#0_5XF&R=8Y@I$IKS,=.LL<I==UI\RH07!E?)9);6C/"2]\<%M.TO]M2
M5KTR'JK]'4!3@(<=SJY'7"9:HTKTFBB_#P%7COJ>1FW6N^+Q7I\VGY?14(-L
MG1$H-WS<B(VWR)HK9S+\-RYJ>AQST_5LA[FZ;;MFP!P]8+X5,M?5>4PNLA'H
MMK'0)IS1><QY4AFS8DR:X-4CE*B;+(_!NFY[6O4]A.F[>?;AJV]8E"^KN;&+
M@Z4L6_,QL]ES>9S$INO[EGGP9G"338O2.'1>"BF\$E[J&-!Q'Q[H_-<_?-/4
M7U_ =M= #?W5>/WR-7V7/./QE7@KWIY?\]ZL!Z [V<VPQ1RYGH,V^HLBW6EB
M2:OC+#K37&W^@(?V*G%\'>Q59#M^"(#+-MS$<<PD<(W94C7=&;-NOQK[-%.D
M?I[>GMY\=1T]- )3U_PX]C0[YH'&?+!49LCB* [CQ-)!I Q]86 IE9W>I234
MN +C-[5Y-Q)[L]'Y-5R^"G]$W/1!\]K<M W;-!F+;1;Q*-%#VW4,4;ERM]9M
MD/A#L(]]?OC5\+V$^3;3HB34-=NV'"TT+4L+#<,+/8?I1NP<O#$7<L]#(?&R
M3?RDIEM=;P&[\5X\&VBM!-\QD#?&ZY+5P>P#IHDFTC# E>16Y+E^&-L1MP(S
ML&+/-2+;X%%HT80EP=O:B,GGUF,=XSL4\%0Q]V :5L3#O((5>\:ZGV]QK$I@
MVSX6 ;-0!V1NQH[FV]S58D,W(P[N?NA:!":46\[RHN1?N75OD$_JH%LMS]J+
M+.NA(2WCW\N=L]_)E_L*Y:N6\G=++J9/E[*.UB8O<Q= #!?WF9\8=*4*8S7K
MH1,&;6E-,.G[+WP/\%#@5J(->?4N_0Z+1N]2ZS5:C<,HJF4OD3K2S[/K-%XN
MX^R.06 +<S_6GP QCUM%:^F[CN =\^#NB.[3=_ DS_3L_/(8 #Q"<,-XO= H
M!(D3)8$7,=VT;19C8J,%?H]G,2>Q@GAV1=-$]G!:1)VL&.:(B+-N'\P";=-'
M3JWLJ6O\19OE'-N)QG(\3G$)2_BMDT7?G]<Z&*>IM [?/OPX>W_J8)_&+Y>1
M=?;M8^>L^\'^\O[3S=G/SO?/YNF/\Z/H%H>$3EJ',WC&YY_?;\^..IVSGY%Y
M]OX36)3V]R^7A];YWQ^_P1KMLY\G/\XO8YJY=_[AJVX'S+8YUWR?VYK-]$ +
M(D#(7F!%41(EIA,:D^W+$QULM6D[@>N%=NQZS+  1(>>$3BZ%436@0)BQ/JH
M:?,AYCM<GK_]7^VWPXOC(^7M^>F?QV<7AY<GYV>3IF9<!&:GB]SYZ/&E L*
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MLTZ,:?-L0'^3@PS'/NIR/I 3$WX?]KABZ&))+:64,QR$F..=,<<%0U0$RV?
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M1. !  XY9L['4>1.IB!<C@\)'W;!'H--+*@.6FHAZ2$-0*@+P4L%'9U1#AL
M$?"Q8 WM0A$GBC,LY*O%&0VSX8 S?RCXW6\YD9CA, ^H9@:!']H^ PA#)[*(
M3BR?A_S)AX@'0<MQUQHB;ONMP+/6FO:]^#/'LA]\AKBAMUS;:Q;;+-9=<O#]
M'=- -J1WN;_4G.X:<%;*PT?,:!Q%X$Q==RGZMD2;^!7:1V\5E42>PAX3X&_Z
M!;-O1&M)XI'CL> J_>E/8)JWPB$@FC4D&R?91]YE:0_>@7[#4 <B7\P/^B--
MQ"4OTIZ(]+W<8^(=EIU+B20G0*:T5Z01_?87ANL?<CS3PPY@>HX!%+^Q#B;.
MJ,H1CSBZJ&7#(F,)'II+GCN9RWQ $NO*#$)3>L]&47JU&$9@&J9G>HGEV:$=
M<<_W]#B,=(>'=NPS)EJ4&8;9Q,<>U*F58T(^.V>7GW_"?YTO\//G2_C.T:E]
M9G[\?O;MY"<XMS>G?Y_\/#4__YP<$W+V[;MQ]@W_V^G"_[?A6GB'*^O+^P_F
MZ;=3'1SB'Y_AK;]\FSG0.@DC)["M1+/,T,$D"%,+#9UIEA^;.%-)!Z_XX(WM
M66I@3<= )MI&C:/1!]%E)&KZ\H+VD,KC<17&QFGF7QYM'U?8OXU2E,,B!I1(
MVNI!M*7YB+JRQ' 2PI6 ]T_$NXV27$U)ZA-*,C8-C_N>H256$&@8MM4"/]$U
M'KJ6E80Z9SPY>!.T+'_/-.2#(]C[/.!Y%KDRH$_H/UN%V=^+C*6U /K$ZZX%
MT&>0;"<Q>&*93NR97+<,W^8V9RXW 8AY7FC9B;W.,/3[&AC:^>)$9D>]S[.B
M:.#X@UF:Z3'0"0_-.'%\#:"$K=FN%6E@=Q+-=B(6NH$;!2S&_A^!&LR8N;.B
ML9FMB1[5GC3:8$6@>4^5L#KB+%;2" WJ?#A=,(DZ+2MP>>+[6F)C>@+CNL9X
MR$$UL!#<=IO[F(QF!BU[.O%E=S3!MM_C#GQ8GH##YO'%CVVN7/?*9@N>_<IU
MCSVVR4NJ3C9$=7^9K+.QQQH[A: V.R^S.=-X-.!T-GVFP6,O">,0FR@R<)V8
M%X(3%28:>%:F;5A!$$?1_)SA!X[8;62X;@FUL4O*8;Y[M9Z&:.+XVZ$8)CTJ
M;CMAQ%Q38PX6$]A)I(6.Y6N&Y]F>;?F>[\8';PRGY3R46MA$X;\?[-I8L9^9
M;K]6^.2!:DOOE.TJPZJ67(7-)\T=JT)]:K$W)\0^B!RNZX&C1:[A:;;#/2TT
M;%\SC=CP(],P>0)B[[;L8&Y>_1-F%>Q!XL".Y 8\");0K$<$$U4V(B4B+N=T
M6(V264;)V!-*QO<#R^<L!$3A1YIMQ8GFZV:H69%C>;%MAKJ!3H=J.)X*'VP0
MOMB'$^Q:823VW7B ",T#GF1)WU$6/%FPC7$VQ)66=-GOS-2-B>+L5W7MTRK4
MZ:/P.#2<($H\3?><6+.YZ6HL]EPMT5EDAI9K,]N?7YV[W@'8PTGBIAR?-0?I
MFQ7IJ>F0)M+S<,IC,M(3^-QR>!)JMN?XFIVXNA;:?J!%OAX$3IQXOL,/WAA&
M2]_E+)K[@;B-%?NGC?1,-GZF<M-:CP5JU3XFO!]1%]0$78I^$_UY$E4P&?T)
MC<"P_<C4]!@3Z6S7TT(>FYKA1C$/'6[;1@@XHF5/-7=];K]@QPSS8X9+[A&?
MK0GJ>+C$:.(E#RB6D_$2PXF8E>B.%NBVJ=FQ$VI^R S-,[BM1Q$W ^S'Z:J&
MZ:JF[6Z0E:9XR:_4JV164\,[>K!L<D>VLI(9I_D*09 -1U/1450T=:&15=1#
ME!=BKB!^E.&D2OC3@/V8^CH-KXC3).$YIZ;Y?'##>4_TY.ID-.M;M"X5O4_+
M"1GC76^J%J3CG5)5I3OL#-)^)QU-\^J1>XX-=Y#P;:YULQZ_K1I]X5RS/GPA
MPO=Y"=]@ ^4F&W9B,= BQ+7AX(ST>G1+V1 5^])A+Y]R/$:Y%EI9FE>/F/T*
M.!QV?ML[04.</!!E5SW$&H(JFA@R$-74&[:>AI]Q&VCH%/8N ^G0L!$]_,:[
M_4YVRWDYW #'@:PR%M2,'</Q]=CV3>I7[9O@BSN6Y2!N3AQKCFZ>&AM[+-=Q
MP?-KV*K9SM-9UA/+)JU<7"(5ZI_C0*VS;/"9P^)*PM1[7&W%0-'GZ.#JG%]^
M^G$*ZOWTV^>;\\.O#( PR*"I^7@&;L<^J-S$L;4@]%T6>X$.NWSPQFQ-*]MR
MMF@Y]B8MB $CR7G44KCB69J#P)2;LJD$$W@76QVG64S-B[&K\ _8G@'OW#YV
MN[1'XT&1 ?\NR^6?\+JFPW[%?M]_G-U\->S(B6W&-,LR8\T.<)XMCUW-2W0K
M3$)#CP,76<ZTEVHAO-EC43QL]73$>?_?G'4&;65W)J0<#7.TT6@'@:4SL,/_
M&;)\($QLDJ**11NFJX@4X/,>%R:FFLV*MJO#!W(\,?ZE1B=JNBF:-U/OU[)!
M^G1?3@GZ5CH^B!(K9*;I1)8;V9ZK^^ "!G$0N:ZG,]T3$QATW18J1-==2V^*
MZC9$B7P[M$")6$Z<L-C$>5(ZTVQF>&"R'$^S.8^Y9P6VCEW(;<-4;6M>XI9L
MUDD]]XF_1'M\ZJU?-=5?")'FQ)7=,'1T@YF.ZQAVR$(_LAW7LAT#N,MP[>0.
M]GKP //"^BSZ\ A>_!V\M\P)V%O>.D8#%7D\#O3$U$* 0)IMF:'&],C53%=G
MGFD9;FR'.*NL%5AS.&LTP0&Y!9553;650+Q Q2AG#M,$8*$%4SF';Z3JR!7!
MCK+UYM>L&FM=>DO(O.LY$\K*SD3M=<IEW@@/J@;B5O$N?&Z"A##/9@FW#4!U
MH9ZPT'5=WXW=P D;[V(+I.?4//OPU4I",XC]0(/M=$!Z$JZ%<:AKL*$F\Y+$
M,!.4GDWR*)AEZ6%B@M]C^[87N2'S0A,D/8G!J8B"9::--![%\[#<!^/TZJME
MA6$8^ZZFA[ZNV4D W&8&MF:$F-1M@"6V3&0Y<WI6&WD42[9*GM%S< 86GST[
M>N.Z(YLMWW+7[([LZ.YCM,7UUVNV>T=;7,]8=T'-8G=JL<MU]+XK\W$L&VBE
MMIN;UZ;T[N[)B/,4"?0>OHGR(F)N%R4?H\/R3K':9G1@WAV&V[3VS#O%K$W[
MYG6:'&Q1]^:=2J.9&>$.'>XQP[3<*/3MR/>8J0<L-&*6& Z/G+AIW?R8&32'
MQNEE&SS5[S]/W__5/?T)Z[CLM#__//M^_OY+^^S;R>WIMR^PWE-G,H/F].C3
MC_/W9]_.+T]OOOP-WSCZ\./\[W??3DUX9O?8/(7OGG4_.Y]_=F:U;C8\UV".
M[FFQ&42:;81<"V##M<CCCJ7[OF[&X<$;R]15U]7WJ<W!@RGC'2V_W)6^S?_U
M#]\TS-=-B]WEI;/IK[N)$ESZ1DV'W=5I]V+%8D+N1''"/),;B6T!6M)UEWE.
M@AG',7RP1HM=/"PZ*8HACT6:A(CBBRA!_22IVN4&%3T8*IHN&X2]"TQ/MS7?
MC;AFAT:H^:83:Z;!(S^P], (_(,WAJFZEC<%BJ8<Y6VL^ME-.5_/V&_P-FW[
M/9J6CDVLXQG&5+F6'S'7<5W;LR.>A+$?N#Z/[< ,P)XG34O'';#JM],M'?4H
MMJP$0)D1X*F_E6AA$ON:[EMA9+@6<T+GX(VE^ZINSDO4VLE8QXZW=+R7B[^)
MV[1/S??6\K6:YGO;K;DGRZ^9GH2)ST+-<4WPQYP04P1C1W.X;B9FY$:6SP_>
M>"W#;YKO-<WWUJXF7P\7-LWWME/)3#7?XQ$WF>]IS&619H=AJ(6^#?^ M0$%
M9&/Q#Q:3^X&NVO<?G-0TWVN:[RUY6KA%2G6S_>V];+[W- KU[.V4O^T&KFG[
M"=,L)W U&W9;"]W  ?VJ1[KMZY'+K8,WMJL&QKU;F3:]][9*?^QS('XK-NA9
M7/*F2]IV*?Q)-]V/$Q/XP=1XR"W-CBVNL<CP-"-Q$UWWF6%Z_@.ZZ?NM0I_+
MKVVZI&VZ6$XZMK$76GZ0@$3J9J+9IFMHL/],XYYM&:X569[K'+PQ5-T.5-NX
M]\G'9G1)V_!F*%(BE)1R?F84]H,%A%=AG5F5\U@X#]<7PXZX=)C7VY\HV$:@
MEPW@IE%G&(N[4]<5:C 0P5X-0%N4%5L?>3&@@GVTKDNURG$VHU,.T1%7#P8$
MUT] 01&5TCO0+N=R<F^P4KV;RE9YU),--S\?$4"T9I#=VEX@Q#;UUQ\O#@EL
M>Z\+^HOQ^F5K4<N'&R[ZUTG&9+('!%R^FL_/S3AP7= NKF?:=N@S'F/#!LXC
MQP05Y#[A&'H!*T5V7=G39*<=_WN4QT?ZV>%7TW0 '3BQYNM6J-F^PS4_\BR-
M&7JH>XEK6;$+.$X%^Z&ZCC'=EZ'&=,@YHCO#:ORCFY'/3);8$>,V=[EONW$8
M>HD5VEX2AW.Z!SXDVQR#1AW<GO1 OH8TU/P<!"^_;+.>5-Y5=X8]B"7=AZ7,
MTZNOS+7=R(R I<+$  Q"'1<8UQPW]BT]]KB';0-MRU<]?T:C#^IF,Y3DKN*_
MDWTQ'[D)X$74YO$0G,RDVOF1^2'K\PE8NCB$-5\#YUPB;+F$!?S6@8_V;=M_
M1M@9R<+A&[$3:$!H3[-MW=8"PS UYGFZ8[@LT5D@!!]0'?CK*#R6EP2FH[O,
M3CRP%%'H!Z87NAYXDI'G)]&!PD&6^K Q()A<&,HDZW2R&VH!.^R"C0<[6U"+
MU8IGZBJ)B1U*X9IXU)1NT,XY5[JPEG:A\!X"IQE<]FJNZWHG8IK9Z./.MWWR
M1A]!R].]=1I]N-B"<;FF"2OV8G"M^1_?HW&$U2S6M99;T!U'C)MYDCB[6'NV
M.[O:2VU>"3KHM_]^X'X26_7^9<A76ZJ_ ?V.(6#EQ>=':&ZP_93#WH[*P[4N
MV$S],#NP2I(T!C:7[U-PG[S[O4@%B,%?!%,&4!R[-P86BSS=<AS7=$+/<GGR
M^&T&&K=NQ@"/'U_^_O3CU#RUO\"U9T<?VV='7]JG/S_<G%U^OOWR[?CVR]&7
M[^=''[O3 SS>=;Y<'O_\_+/=_7)TI9^]/];/NL<_SXX.C;-OOW=/+W__CL\_
M>_\%VP_\F$S)CWS=XGJ@<1:!6\@C3PL\SK2$1U%LN*Z9)#JXA8ZKZ@^6<;4Q
M*0!;7[3=]$C8CQX):W2T7D_//UPCZ^6U_,YWMWYJ'6],Z'@O#)F?))[F&@;7
M;!9'&G.#$'YU[<3U?<_5[8,WIM[2[SV@Z:DT_#XDW+YMHXR-1<A$J^1'S=5H
M[O%@3I:PJ<&&L]E[,:?C/A[5SCM-&W26>J=='1\=T3A/#V98;Z><I\C10],.
M LWS(@>'% <:&%-',X+0T7T_L0PQW%Q77?/>"=:[40[['%[0'C@ZN^W+W%/]
M/J%3LV=S>YY: 4]Z-I$5QJ!>N68F#+,KDT +P*?!*I>(&9'G^+8%GHW?\C9)
M_3Z0\[(=\/(O\O'70I?;FQJ^8CN[;8*78C\;>/G0VNWL[12\M W#C*T0ZZ$=
M0[.CV-+\D'N:XYAQ; #<C",&\-+PU,"8S@'<B2YXSWR/>ZNFC5/'RR/+6:^X
MV5IWIY'EN-YMD.4#Z]Y)9)E$MNM%OJ.YV(44-'&HA0;7->[H+##]P(YCC)D;
M+7?CRG7F(\LR0Q$6RQ=KRFV^<C]39);LQ[%\?LP:)?S;"-6;HHC&2BQI)=(I
MA.YXMN'9%M-,R_8U.XQUS4\\5W,24X\<B\6!'LXOJKC7V>I]Q7.+8L=WOO'.
M-'98"XX^E6)9O0MCL9OM'9Y,W?R<G!7DZWX8Q+%FV&:DV:8>:TQW8RW@D9=X
M$?.#),&IN8:["5T85Q+;7?.>UZ+!5BBN5=SK]>!2DX2V [IKTJ%FL6\')C<U
M'0R:9@?8W-&R+"V,N9UP/W3]2 >'VFD%3P:4GKE!QL1\\@WK?O W!XD<8,.#
M'J?<LP0+4JY1%+"B'$L[ZQ6=U'%&R42?BZB3%9BR1D-BRP89D9@1*WHDR M%
M$X48Y&RB[\4T)6LTE.NTS9:'-.QGHNW&JYQWX.)K_KHLKB.M5?NB9 5]]!46
M CP>#N9_9:IPZ)FV _OACQ&H]F\['Y4]77$MS#G[KK$$%ON*=6[8;7'PZS@/
M @-.T'#R]>>^9)(\VDL*S@<SD.6TYZ^H10I>!6MB&[,6I9VC;?M'&B6.'EF.
M'5NQ82<!9QR4& XR<%AL6Z;_U30/WE -.HH 0F.T0/_ZE;V9M94S:Y--[KN)
M9>L\-AP[<.PP3/30U$%C MI+F'ZPJ+7*QK2((:,K!3_,>L-"MDC9R1XQ@&"R
MJE&,:/@C&\)@1Z!B&'[CT4 99 KKW2K)<#"$"^#AUZ@I17IO2X&[%IRZ")&^
MC>':6.$_$/G +^NI6E2RI+AQ,2WE:-6R>W7%]B',B0S+#R/+]QS;-L+ -B+/
M,ST?<*#E6M83GFG/S,UYGV?%N'_Z*DE_\%C[R?-LV\'>VETCSKY]<LY^'IKG
M\(S3RP_.Z<W7T+<BCUL!") 'P(TS7PL"/]$"-\1#$M<+W?C@32^;[AE2#*-V
MR?S4/^1*I!HOU>-JCN!OC%(#+B+>P3':0B*%N*%4%,J+@S\O/A4'+W= Q9WT
ME-\96*7\5NH!4CL@@:C Y(XJ$6!DEO84WNUWLEL.3\?W5V[201L[6,'+\L&H
M9=:*@[$CDV%?4SO@NHWM31,W]AW& R=F)D^224UB-,G7&ZUC3B\/G?-+<$(O
M/_\\^_;=P4;528@-6%R-63;3P%QX6J ;L68&<>*XAAO9)CF'*@"L&7J&N&:6
M\2-36K(B>"SHZU,SOIM,X?\9LH[29_F@4.%J^%]A$-$88HBR4)(\ZQ*W$Y<+
M"UH97PG6,D STGRK@MWQ"STZ>L$5R;7!_7KPO?EY83UY6#,>/@F\R-&3P-!]
M;NN^S6P[<DP.0@ D#SE?D_/7:2!*_V . A#I(VJ' E@</2+P."I.ULQ]9N6?
MAS>GV'#)#@W.+2UV75^S?3\&2VF9FFTY@9X8>A*&X,],3W+_)V+"U=C#L@TK
M %SE!TYB1V;H>[9C<\\W?3]TS<!LV&/#V./\\*ME!7H,0JV9$6!-.S0MS3<]
M0^.)P3T&GS +-9T^BT% G1!>KUG3E["?L$\8QE*&?0GU@4&PARGPD^C[=P.^
M1-1.^37\+_H8%6X!;HIEQ])B%.T!#^.6[A-FTE[':0Y.2P8J,;N634N%JR)4
M9 D/I*> .C0;7K6GNG:8.PW\RMZP"/W.]QSZG5?0KY\A+Z9@:8$=!8G@KUWV
M(^T.NZMCP=AT],C4W2B(#-OQXR QDC!*(H0)@!&])\2"RWJ5#>R;J0SULYNO
M7J([MA6'&AY[@S(,P*OD.K8IA*WS(]^-L##=, PU,*>;CRR!^\XG<1^AN\U"
M?G/X7-=Y''NAB=$3;OH6LX,$S$-BN(Q[GCPX>T3V%ME#YXD<"7'-T@Z&,M]E
M.7%\P\:"C8W3#U_#F+F6 WQKVMS0;,>R-!:YCL9\T[(,GQL)ME:=MN@EBRP"
M?K/K1=R$N5ZD&YX-'D$ GE/HQY'A>[%E,<^R-X [&@UX-^N<??CJF3QFCAUJ
MG&%KCEAWM3 R00."0QS&KF<:CG^G!GP<$/B\"'!CX-YX=%\TM[V]ZRWD02,]
M=*O@GGP_M?0U5M-+AL$MQ[,\/[!!%;H.H#,O\'CD>KKG6['L.:3;H Z?1B]5
M@XP:A32[1_2I<W;X-;9YZ#*':SQ.?,VV7%T+L-;!TQW7L1,OMGWP20U7Q4X&
M^@S7M(;$QHZ>X&\ D$!V@/@TSX 4SIS)%^J<KN+D=>0<;H9)ABMRI!D[H$%U
M> /3L=V ^Z!0 S#0CN<[/'&6S]<^X@G/\[G\^#?@OQ/0H]=I#-CR+1&!&I)_
ME"0 R_B.#OM.)!D:CIS-D9\1445&DCC,\C2#<7 ,&)I%WPTTW0QXXN%!% L.
MWIBJY>NJY=IS&9*5P&0>TQ%GRE/8DD&72D6A7;DS \!Q#FI&XLF[+9-6/SN_
M/%9\A3)UC->/WJ)_&!;@7X%('%_C <FFM-\_NR@9^;,.3/CS]"=\Y[(-S_EP
M^^7RQ/G2_=+^\NW*.K^,@,F/G2]'GYPI1O[VP3J#;YX=G77.WX- '/W>.?W6
MZ7[IONL"\SMGP.2GEYWO9Y<=5*U?G=APG<2)->8EH6;KV';?T1TM]@,#$#NV
M7S,F>^^;MF, E@]"[NJVXQJA%]F)&V,K3A9ZOC?9>__BTV\7QQ\^'9]=*L=_
MP;\7ZW3'W_20VYSDF#M)-4Y:/W$<\(E</3(C._:X'_N.%3 ]-'PGMLWPX,T[
MTLCX +!D7?8-L,/@5LEN$ X7P-AIG!+XFT[SV_I0WVP2WTVR\YYRV,_33@7]
MP<^@/#F:>@7>QSOX"1GQN_(6YU[=*A]9G,)+70'(_../MRIZ(RP?]'A>M-.^
M"*2,OB/G;OT[*_K(+:IRTHM:RHN#\@\'+UL*Q7HR<$?$PBG@DR5@KI7NL#-(
MM6X6 \GAR3): SAE.%@8>@1]1?>:/(YS7-\'C&0:"2A%[@2A&UF!:[I&%(>6
M;4HP 8(^!TSD,6QR"5'_D \YQZ6"ZW:*BSV5:[V02YTNH "D<)/E<<%[&P,2
MGERW7G[6SR]/S+.?'_2SHY,?IX=?S2"V(XMCD6ZH:X#TF.8'OJ]Y9L+-B"=1
MX &$+=(?TU"AW.P" X05YZD(16\!(<3 8,"R9WP@.(MF<[$53^J<T/8#0*+<
M#&P[3AS?]%ALH;ZR&;!0.;#5+@WK?!8J[>P?:3<%$/-'RL(4&>:MB,J#1)WG
M\K,_1V+UQY^GK,>ND,O('S_/WW/XB'7D-><W\L(3$MUBL#EG=D_/7*,@S>D1
MK.7P:^0QUX[<6'.]$,<W1@[X1U8"O!8!^N,L!(UP\,:=CL_\4^' !ED7<%8J
M"4NI?*7VN@='A8G.=3/1 5E$MN<GOF=%7NC'L<E,.S'CAJ,VEJ/.#[^"T0A"
M[!08>U0WRCS-]SQ;2P"YN('G@JWU#]Y82W'4-!R9$61;TEWQ#]:*:3W]'!D1
MK[H\/E7,E@@7B'^)*<DCKRH3CM(B&A8%!3A!]@Y[K'-;I!2L>)?VP.'#P\FW
MHR H7/.1)GO2)><EKK@S6WEC8WYSP?9L)/@Y&X+[G T[L9)S)N+ H^E>\3@U
M68V:> B75!2-QBB:CRA:(34RN'#9MV$ODL@-1ZS"788]-HQ3.ES.D$*%^(DJ
MF<EU'SV&?'E*Q:/G]+(!+T3 "+!G??XJZB7E!  D7*X8(KX)Z_XPA+_SO .X
ME/<SN 36@6Z 8NC:![IEM:K:FE9>"889D)!XO"ASK*=FFHPM%Q]XV.OA0>7T
MPOZWNE^2HE9=?-LD[?!X=$+YJ7714BYX-,S% #9<[/&/B)I-*QBY2L7VOK@X
M?OL2GRHZ2\P/X"^G6UQC@6YY9D6R :<2"]<'^X[!;>V/+/N.0GA1L=H.>)Z7
M*(;_J<0PGR&&:-U8"@I#CM1-)#TZDAXCT9,3=HG;Y=#E+F=8FHX2#UQ/BL;T
M#LL#CIH@'$;D%1J!9:DTX;DK).H%7B>?/'YY.<^79*BZN7$\X^:5A(V>8M>?
MTE+>S7TIH$G2P:H1N%N.AWK7*;^!;X;HQ\K@);^N- _6C53)"I09(;X&Q!W%
M0RN]I8X0!7X9LWOX(,4R.DQ[8/1'3'J0CPZ'!>Q@42A]\(V*%KX.ZBCY>-!*
MI:;OLELP%L(-AQ?)X5&P@-%!)=PS3XOO8LE@ 406$=%JT&8#^CZ#KR.YX!U&
M5D.%C_+OG'(WI)>LBO(7<:^,JHT21L>5]\DXVQ0!P6.YK,N5"/847O46['/$
M,$"#B57)K3)?&BB1C\YS*> B"S(J,0(2JZ7 R#^A0S+Y-P$&)O^*Y4C18/*O
M"$I[4]<BKTS^C<'BH[0/2YW\).0=/*:>>B!L2G?&Y7UPV=/IE52)9Y,?E$'!
MJ045Q;!+.5WE!]+&]O@5E95*J2XXT9287? :9<3E)%8U:B^4:-)-L_2>Q "@
M&KH92@D^0&0IE5^] 97&ON-YV!7<'.N7E^9Q6?"L85^%5YYY-]=KS\CVM MN
M5?7]]$L8)Y=EMFB([(AO 1J#2HR+$J[EJ 2'**)26<'^R:(]8I:(":>?_@90
M$M0V7$LJ:PPY7PT!6X)"?-WLZQ/NJ]!GB.B%015&1F%1Q/L#.K=&S(T[U<^S
M>!@):S>R0+B/5-)>XP^X<B!1 9@R;$= N=4R6[&RLP7RT1567Y:011@X%'4Z
M/9[/"7-,U!L:(3GW6WM90&\W!?2;L9;E"^B]%>KG:]O3J,/[J\-:WG[:14N&
M^BT%G"/<ETC.I@*%!3ADV"D#.G0!P7O0<:6O,%]]C3_:76*G#']9)==PP?VY
M (T1P- ,=[3<_-[8W@(T'?;[ -@1I?;9;8;_&P%UP6/!'W/*F\+P&'Q+N&KR
M$ %_ G>O]%I'Y2/2>7Y[_M?)D68$<!GL#_BGKY6&C[:8C^K B$O'/BDC- 6"
M8<I1SK' C=RE08;!A'Z&P"J;S1(-0VPI0U \79PSXN860X#919$,,4;$HO\,
M4VR;TJ,4$GZ58_E-#Q8#_O\5&9<J&-3HA*UE@2@K!DK!KN$#L 6@$4 [</"
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MWYWQOULTQ->RS85R\'@CXN\8(]UPPW-P@^$\.C>,3\A=QF_?V)AW>822%C(
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M+01@LB_H0T7%=J[A@6ZIIK>J&[,J,38%(.SA!IM>H#K>JK9L6S=X"W3H%B+
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M-&  BB3($N 'WNX[!VU#<^21.#0O<S1L3<YA'-.13!D6LJ,P&\VX)ER5UV^
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M&*0-*$<!5OJ4(":N,Q)VH,#VXQU"_']S :2%O%;\$&/@&H.6@QE??B$H#1^
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M"]DW@\"9PO^,XK'WZ_\'4$L#!!0    ( 'F*JE1ZYU$GJ1$  +JT   1
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M5? DO)2!GTB$ZGO_!!U;F(*YSTD7%.'\0ST4=UV[4(,6Z.LO_P]02P,$%
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M&RFKT\*Z$G;_0MA13J76=CA(NJ8X>,[@,G=@D8PXYE*RZ;/1^4U80W"U'XE
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M!J*^M^%+C1UJJCZE^0GF<\*O:EHEVFA9HH!"K_HL! B\7B0:E52*S&R)?4Y
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MY<F'5R\O/N"?O[QZ^^'B_/7YNU?O3SZ<X;\^#GV4A@4?YU3,7O%_W^3C;ZT
MJ=(?]HOU>8/?SI]1\-99"_PQ@6&"]/UW_?3W[_O90(B122M%D#Z Q25Y3T/B
M 8)1H;?)@\JB%LL:-/'.<P?%Q#8WG!C@LP;3G_:NQ^32^T^]BPGN=F7C0SG
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M\B&7.0TE#))")%\G$WR/A%A3#7 H/FPB\@H\>(>NW7 R3UG./&;'N22<!]Q
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M+]HWPJ/57E!083DSIZ-8<@V@H^%&EX*O<(^Q=M6_CG$_'+SI9^B!*Y?5R1(
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M%4LH:$@07A(.!H+48#6O<[_<#M^^,J3V1(\*2GDJ65*K%U0.'9KAN!GT$VZ
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MD@+DQ8++!GVN\.ZLS9"NW<? L!6M407/)'K#I;1@BI.@-//@K9% 'J4W(K.
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MN+^YYR6/6]2CLG!+^FODXIM7%6\C+R^JVKTH)<=ZX_ N+R+]CD@^B\*5''@
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M<;E!=>AMBM:M'%UH:CM:>PM51YJF/5!B]RK  '8?2A6<,%8R'D&[$DG;?8:
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MA6?#C;/\3K]EIY[M+;HZA9:V/F*]ITE[?Q8V"&\Z=P%'E1U%>!2!Q82@5-*
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MSB=P*1A@SI@2=.3)3.Q:^+[E/$WM/ZI2;%'UX]T7]]S3#T=$@EFC6<Z0@W9
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M+  3RGBC96%N8N,B'EK2@<^_432F719V@+@/YB-T=XMNG-VW%\;/G)!1,AM
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MH*"ELS]$ RZ044#F?.:(P3:ZP3NQGM9>FG!O3VL?B3R6;L N:_K9T]JIHV*
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MY@9LB;R@X<$B'D15CIU+&RSH!S1G'X8?X+R@_VT=5'0AK&V6:Q=IQTE5C2+
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M7!/G'7J,-D 0SI%UUQJ\+!8L1\$B*N9LMUF%#[WI4<MV#.Z-N'&7BXNS'VG
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MJRAWETD6!B*&$GM,64-(NY<C 4-?!A)A1UE&5B>!EN,/S2[:2+ZN#G#!)R%
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M,V/A2MDE-[)R^'PBK&P-KS1Z3LK$CT]"%VQ@VCG]**;(IUCX3$(GB#V('.I
M*F(!_2CV'48X<AUILYQ;C#VT!7<E)I!"Z+6V%M1NK;5!'P>1\"77F7DQTFUQ
M0T@=[D'&/4_-#"%>3.UR9#K"OZ=TF9>76<+*L.C/)'M4"Y!V:%V)HJB*"M>.
M9Z6%Y4FJS9R862@=X=RQ#:&E7@>R%ES'/RW??9T+<'OZW;=>TQL@UNJJ:S-^
MK^MB V"V5ZXFCSCOG&=]BZOC7"03A),PA@X)D4[YD\H$=0/H4\_%$6&(4L]F
M'3DPSM#6C.5!S^:1CGTLT2%<[0[*SD"KKQ,Q"Z :GWL=@*&3 Z[ML=[E).N
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M/OJ- DEH'+G0#7P)E0&BK!,WPA#SB.*0>)(S\ZRU/0,,[>/6(H*EC!:'Y?O
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MK7-T/4\A(_D38$_ZH$[7RY#Z0WHK/Z2Y5#^H]Q&9D@8\"6Y;ZO[4))B141O
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MR;<]E#KFS[T -:G ?1@IB\#:5A#K*9C6[M6R"YH]B</10-G#=_<7''M2@XV
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MIVOUM)K'*CRW4SAD>3"A:\*O&.A.E,4QRH(#.P24KX[*0L_'L=(9JL]=T4"
M",1<J*TQC]T@((%T'+NCR//D&1IGW#_<7/XW_#"Z'W\$ES>?;\?7]Z.'R<VU
MY3GEF9-D>)[9'_0]FHE+\V_-0NSH'+0=_-H]+SU3IG[/5=L!<.?\M:7'-B/8
M3R3)RB#>2?KR6N17XDW,_-H$\%P:(3>4,! A4384BB#UD0]#RF,68^:1P"KB
M]LA80R/&4C;@V_'@,2S-.*XEA#KF+RWE(H"_$O0"U(!U8&098-(J)QT;KU>^
M,5!\FTM,;FD0<:N?H_=L=YJ8/LZ?29).:>2)$"$)'4I\W3DGAL3Q*?0)#2-?
M[;5X3(S#;O<,,$1&*(]>2AG![Y64-C&H^U \3@MM8-/U'JL36"SB<\^$IZ<@
MW04N0,XSL(W9Z&N2MQ6U>P2.HZ&[^^[K+W[WB-0;0;S'KFMX="3R7(@R+";?
M#C6-18 EXQ0&*'1T9@&".(@X9(QYON\Q$MC%L1P9:W!L-U9[0MLLHR-0&IXF
MM0-0YY2GI;RHHN+R;L-V#1!I]ZCIR'C]GCF=5GSG\,G@EH8U:?[^FA3?/HOB
M:<XG97T5O61\3*04F5#J?!#%%R'22Y)EWY+TL6IB.$KYKZD:8Z9_5#UA&CN<
M.B[#T'-]':GAQA [+(#,<W&$0TX44E;%:EH2;&CTHS>].@15?&6Z;\)< CJ?
M_VW5)+G,RM;5#?ZW+-OT5I=M6O9**!M5E6UT+4O;M#719GSW'M/7,3E6 H%*
M)[!22I?$6:@%:KW 0K%%[UH]:RO=0/6L%JODM QWN^5SVA*NW[HZ+4.Z4W"G
M[><WV/TN.MKNZ=?D,L=A81#!T'-BB&+LPYA[ ?0Q<R6//.)B\WJ!A\<9&CTO
M.U8W;!5V!%&##7$[.'7,@WLA:I*Y>@0KBUUR.YCUM%FV>[WL]L>G@3BZ33YR
M>W^[Y=,Z;&R:#2YO9A:/&--TJXN!:',[6:OYQZC$0< $Q(@*B 1V84R0"R.&
M,1:$2$=R&T/W\%!#X\:5I& AJDD1"EN S0S,=F#KF"H;(F9M_IT&HU6#[LAP
MO9IHI]7>-KH,[CC7B?!)O3WU*B8#Z8:".I"YS-5EV!F,A;*FPDC$KH]%++V&
MCH35($,CB7_YYSAVT+\!_T?'^=KTK'P-0ULW0C-D^G4E:!F;&$R',&KJ4VB&
M54^F4B/,SO H[()A[E58N_>=/ N[TA_V+NRY]HQL#GHZA)8>"*%=RRO9"J&]
M$]H!HGY^J=L+*GI^);,'D3U[4TP8=ARJ>^*($"+L:TX-N?HG)9)[H8-=JZ+8
M[Z##T"C[0YUD1@H@].&B!%5>28,,C9Y?!C-3<>!3W/':TV;FQAH2>S(WEFB
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MB*0N"P4D@3[/#[AN>1\I+G"]@/BA+US/J-W;L4&&]MDOY 0K06LKV[PU]4%
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M,ZILU;LTGYF%CJI#'6R)^O5'$ZV1)K8K=(:CU):ZR"'/<D-HBB6$Z!RSQ*L
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M)-,)T9HEY@>_%[^3W/%Y XV28&7UNS2+ZAC4;H01#KXWS9A:PUG75GML135
MCE0+2CUG1AV3_,;Y4"U@G,^":KNY&Q55N52?]>K[W#SU52]7UNNIBGXNY]-"
MV?E=?:"K[A%4IPRQF,*<V>CBB E(;:H$YBI+6)++./-JP.&MP=C\F3KGL+(
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M;?6O2WM].@V5VVN_?_A[II(3W4#7PU&;48)?&Q+V@#8,DCUW#'52Y8U;B/K
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M.15.'20\9(Z->[Y\N05F35K\*'/X7DH]P;1X]5V!NL#M>'H:%L2^CU%K;:]
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MDS1/(!*9AI0;!S1.DD02+!A)W-M;M\L:F]M8:@NLNDW3@;7"'M&$9_!M9X3
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MZ6P,:%H$\RWU;=+I;'=17'3<1/ >(\>=A3Z1[WN[P8!>*=^T#+[>P_[$AD3
M?8BN\(7=G/#68M@=BZX@'6QC='Y0-V+<JD)BGU^5)IFDW'P=::RA4HDA/YZ;
M%8[Q7*!0*N8HQIK(R*]9^E$Y3A-MT ;I&]W M&L)J>.0NG%5=YB&X:,M_:[
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M[ZETUGN_!GZYISW,36,6:Y?C]Y</VP.*6YFU?8S7=D>AU=P,=?6=S;^I17'
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M]FPE.=@0'5C9P2__J=C<-U=^4.B['@$/2>8!?68*I2&W6A]/TS=?GLWK*GA
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M%R.%L$@XPS"2MCZX2I39F\:)V9:R6"G.4XJ\CDG/D&5HY'TI91& ;8-D"B7
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M-()^F1N&Z_7C?%KMW>^SPQUM[?;Y^ >S.=*7BX5:&H.=FD\QERG$L= 0,91
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MHH/Y32I$5,8'Q4GV ??_5%*LF%<D,0P@;- RZ>?N"G='TW-4#=/4HQZ:>M-
M VCZ,(,KWZ4W7ZY@,@<TO:>+3QC/WI;9R"5A@I&!J) 8.I48?UHA-7'*::]!
M^\1S%5!M0=PPG4'J8:MO?30 L;O$!V$S-=H0&I%DF6PBW@1/D!5NE:0IB3K^
MU,MAT_O%4\4-;F<9[PZ0Z<*/>[)!TRN8+;Y^&'L4QR05S^^J1+JX29],XOBZ
MW+.6[W]9?S[V5UUY.?@YI"7K-T*40D8#N#8\599((SAQX"/1R3,;:1 IU#DJ
MZ)&)%KRO7L+$H13;@-%[CO61XEXD$3)1VJ!,-=/H;&9/&$3I?#),RN?R@>N
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MWO71 ,9>KU^[NNZ'X^D<^9I.XNJ4IP0DT<80D1DB?%DJO-0K* !B@C*>2Y&
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M+79?0^YBMQA%$;W2R Q+N?11ATR\ 4ZTIC(9$[6HU"#A^[0-ZZI70ES/*FD
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M'''W%0>9(O$,5X<<*>%]R04.@.Z9R(C.$(AE,A!ME60T!V<KI=,>8J3$K5-
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M$1$;2DMKBYRX0,M<FB!IIM)Y6J>$[CXEC?BY.VKV03[<'F)N!R9E2N5Q24M
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M*$6L%1;_<#YSS:V@M4:@5V-JZ*Y4O8:SK2B_@:.4&Q;7R_D53"!WBU&@UM+
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MW  >&O!*GY/"L9]_>CN>_K',!MM4E)U!'/OYO,M=7(D@(S&%<6^E2AF*\%/
M&#8K8K6.1 B/_I3Q@:9*5>U]L=!(I<7 V*^G]29NC1_A>K-V=YJD8[,(*?&R
M!69'I(%,G+6!!&XU5TKZ*+;JT_ABV/?,2",E(P< _Y (:.#FZ1GVMV+7.9>Y
M+U$RRRAZZ4KX:AD!I51TR"Y-U6:1[$-X(TEDPP*\=PTWX,(\P^[("P5>H@0C
M>F)$9N:)+<DL4EL1?!#65IJ3^ Q1C623#0O$%VGF!QH*=G-*=/KV_./I\?_Z
MZ^F[UV_.SM_\]V\G'_]/_V=@C[ZE^@G8]WGK__SKN>%UD3L-GA/+@L$-6&#(
MI1"BR9L8<S0ZA3I'0%N1U_-\ 9VY#$PZPIWT1$;D,V2(R'&94<JTH)7\S9;F
M"_2/B^],&WB)U!O8$F^H7TFDV.'II)0F+KNH<Q6RL.BF2AXBRD4!\0EUSH%S
M7YHT!EJI>\IS9#6"J!WT_11T]A9^ TBZQ\.Z.[9SS *SFJA4"EP+_3[DTI^*
M@M-2B.3K=#MXE)Q&D+._NN\G'>TM^P8 M!HANNY_GGG,CG-). _HZK% 2:!"
M$RX,"QX]OA K7=;<HF)8N/2@U/N7,KM*N %TW)HHMF9 !8ZA@76$VHCQ!K5E
M$K%6Q&3J $.#;%B=\5 /2!D6)[MK]>FA;3N(N &,'*6T;%_GQQ]\ETXFJPD+
MXS4S0C-+HS+$03E]*V6@SJ=,HC59 F<R5KIV>):L8:_1>L-.?Z)O 4<Q7E]>
MC\M-PE/W'QO&%.[8&@3AR:#W1QFR:*0F4:4 FC&0E0+*K4D<]JJJ/WQ544D#
M6#N#!6[KD#9YXQO+RPQ$(PR).;/2'Q\CTM)]4U$9A77125O';WZ<GF'O?'I#
M40_";@ RCQ_&KWEQSG%J="19VC*.* ()"@RZB\::&*E#ZUL%.,]1->PFU[\C
MW9L&&D#3J^LY+HGY_"BBF-8C@$L\&GS05*+A9 +0C@K%2 "OB16),>M#2KF.
MN_0$08WD&^U_ZM.'P!O%3?DX UBO,&6HI,DB&W[912_I,H.1$]R>!0AE#&[%
M!T/0'=*&#=AZ < 6H-I=&P/":SD:[S7 U6IT(KIV/Z_M*J/*!Q$UT1FMMI1E
MJHMRC !75&5/36+WX/3$A,''GMX>(O;0WK1/439@:AZI@XLQAJRU)S9I] )!
MA]*ALY3D:JNC8]Q6"N9WG"U8/QFPQ^N(W<3< % >]C)\>.EWAD[;V^GL#S]+
M(ZJ=%MY']/G+)$9I+/$N4L*C5A)"-(S60=$+"6WDWF)'7'RWX61_2FH @P_+
MN%ADMJ3&$&,U,E"FVKN8/6'4:L< T'A7ND7=J0*O&HZJ*OZ^+=M+"SO#Z IF
MW33A@IDM>MKY[@MHI\33K)((R6<47>E=D:PO18M J(D&(HN06)U,S'[H'S;T
M.RAL#Z_OMK!^,I]?0WI]/2L<KUZP7,F;1BRP3$&$R7PU],I+&;3EDE#D&&6=
M.7&""4*S<@%,1,>X3M;F#L0.ZR<>',45-=G +O^MGFO^<?K$Y=>2TW"?TS-8
MQ7BPGB._DLT9Q.G%9/F495_MD=5:,A4MT4&(TO8XDJ!Y(#0$CU_( +%.]EYM
MSH:]2CCD,F@*(PVLF5^[R72VW-)6V]1&!Z6[[1DDN+Q:-K4=1>=\I"F0<EM'
MI'&"V%(PDXU6/'H)-M1)[-B2P&'K0PZ)X!H::Z?]_[/;U*VCN/G(N&R<X90X
M:4O'6YXP\)6*V) S"TEZXVNE4F])XK"E(LTX%SMKK0'S^ 1C2U-_CR^I6>E=
M";ZTLN>YS-_SFL3$9<H!91@J1G-;4#ALA^,&P+B?SH:^?2F=YI<Q9J&\F/K'
MH\SY"!(/V0I%(F6^-)&G)%B*@M2:)<:<-N9>J]HG;F2V?>.P?8T/ :QZ"FC
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M8=ECZ!58(C[;1"+G$-%EBH;6"5.W(&[8DHB#'(#TK:*645<86GOJTH!;)06
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M(K1I[1J3BXF;+GH%_*'Z[@7K\>>\Q_N\4SHPOPR_KK)+SK&XNA<YR\1!&5/
MZ4 ) 1WUE$Q6L;2Y<1J-A8GKOH^!\J-KN@.(WVQBWERZ;;W4S7[O];_A69[%
M0DXJ>PY.8 2E:HN%B0ZL2Q9-E6UN<ULUC+YAQ<*G^J330$<=(F]9U17.7GRK
MXQYF.7MI0HB019*@'),D+Q; ARBX#M)KTV8]P+-D#</9J;[_C*>1KN!%D<E\
M_8GH"/G]XO;"WIE1F'RV%'HC]Z T<CHQP4+AVG,K#)+E;@RR)XD;!K53??H9
M6SL= .Z/,%^\7:[7[Q>OPWSUMW!V@?^&^0NN;YKEWRQ>A=6"XN'UC(><(S<>
M+*M/K*+4&V+ZQ8A8!Z\Y'=F@>6*[/__L0N8P$)[L>U SC4U]C?J7Y>+\Z]D/
MLMRK\_E_;Q3VOFS+CS8\5M[7,Q^U8,8K4,EK4$603==RLPHV(LH4@AXXY'+8
M%P[#TZF]!C43^=0P>F0&R.4+PQ>L8[D6Z]J3M/GCMV2V-_NNMEE0%M8HE4&$
M^E*/M>=;!06EH L\*=0^# +6WB0,@]JI/?\<42V]@._6-/?+J:5OZC0X7)^_
M6:\O,+]?U?^M0<.+G.>7$>O=N]:9<\FQ:"*@C21HS3S)F RYM"+HPA-G<EAC
MV6@D#0/G23X(3:.VDP/K=<11^_2V KAD_/*?OBCT'[[Z!Z:+^G>S&)V1JC!
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M-+Y4>H*T::M^VR!Q7'T<:CFG+ E^8G%/J\K@I[[N2 7"@[AM7R?,E"A2883
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M&7 :RGWJ6Z8/JV5"S.O7)$WZ_?=:$7Z/&\L8SX%!2:;>N]#!B+K67WDLV9C
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M T_,:M#U04SY%" 4@T"_<9YS=+*1ZWI(R_2(.4B]RU%EW1U:KJY%G3!6,IY
MNY)()!XAAE@ ?8E,&L9B;%/O^Q@UTR+F4 T_"Y@]Q-T!9#[B]^79]SH?X0XS
MVREWAA<IM :* S=S7RS$2#_ZG.@'Y6KW11/L/$M63R#:1^L/9YR,I((.\/06
MS^G#WI=+7JYXL 4S+ZCH:"4Z9,(%\(KD5+S+DBE>G&W3S?T8-=/>!HZ.GH,%
MW@%H'GGH3PF34JK6C'$/RBD%,1M#/WI*2Z-FH;1K .R]?.:0*.= 67>'EEL/
MP"7:S%'408F;N7BV3G6M%6@2O2T%1=''2*8Z+I_92=-#RV=V$?O4)1/791^7
MYO+^B[]D)17K$*Q7$90*B@Y6CF"82#K6'BWG=JNB>?1[>L+%OHI\M)CF<*GV
M"I!7\R]?S[^^H-_F6YPYZ[,.GH,V+-:2$P^.:TG)A @^,J[4P$J;G;ZV)X?4
M$CZ'R[Q7-'V:_^,A8P0('DM.P+$R)C.CH"UFX-(*8;(+Y?ZCYXY@>NQ;>WKD
M;(FE@R7>#93N%2S&K'(A.PH.ZS@#*3S4(']S.J*(/,J!.QD.*?P\TKOFJ  Y
M0(Y38^&I@D7*ZK*6FF]F6(*J,YT=<D5&DFEI77)&Y4%8.*3P\TC/E&-@80PY
M=I 0U1?;[07 G<M-GX67*7O0W!.FN=#@C2/!9&)0:NL#NQ?.CG7O\@1%/7F;
MPU/I4>3>*7[>UG?=U79=BB/CQS2#H+D$Y7TM)G.2F"H\*"9KV\71<'2;LHE[
MX$;1_P!0[:V,J1W5;_359^''=A%2B%*P*"1(%C0H@0C!)PFY,*:$5(F582L;
M[GYN?RC87V'+<:0WM>(_72P^KR[66X=J2L*D?8:,2 [5<5Z%P2!%H;0W,AF6
M!BG^[N=.FPBW4_P!TNO!G3S6$LXR%X%9 3Z[:A)S 7*P DQRS&J;O(W':9H?
M'(8<*:<9(0PY5-X=8F:[Z48FKQ6E8MR+NGNQ+IY6)H#%A,)['91M%,">RJB%
MG?0\;-3"+D+O 3JWS/!VX:(*F)C+X(*OG8 LD<',$7(RZ$7TI=5#T$-:^H+,
M/AI^)C[=0]P= .8O1/K%MWK]\VYYCMOH2FKG,Z.3(^VF889M5JTA2%VLR=P;
M[=O, GJ4G(DCF_%A<[C0IPYIG[Q9KBN*'MXMIX2,>8,0>5T06L.WZ&4 2OUB
M$D9*E#\M!=_C>Z>]81D1.*UE/C6<[ET_HP\J1\KFDE:R]EI8\(D+*)$;<N%:
M<C<L->[I]GYL.!P@LP[\SJ.56H'E$&IY7TF!XC=5R(N:P(%B-^9<Q"Q=Z*LT
MKMG]?HM@Y5"1=P";OX75O.:('\/Y9<CO,:>4101O?2"G62A75,P"\RD(FX3*
M(C6!S'U*>GH..CR-/DC.G>%D6U>:42;B&4RL;YK"D21LW:&8$\7LWM8_:8Z4
M'E+GPW3[#%#V$'0'4'EUL5KFY=E96&TGW80<DJ24S85 GC1$ 2XY,HF%\RCK
MW@5LLS7P/B7]P&0?S2Y'%',',/DMK#>BV,YDC+Q(AZ1&2S&7XIH1]?1C%F1S
M6<XRVC:W*G?IF#8U'ADB!XAXZ@3FSK#ZC5'EDA+V0$F72BJ!0@JL B.Y,*V,
M9-Q:'X<-.GWPT=-N4QLKTAA!;%TI?1N@1]3UNAFDKV/26(@0H@J EGMG*:9&
MKW97^Y1APQB*>E+G>TBM*ZV_GG_?FJO@*(32SD+Q=;!\4767K1:U;"I07L9<
MN?\\,T3S-U_0B_;W4=F3^M]3?EUAX#-I<\N$5MKF0DY*%V%!:6/!1Z8!I692
M<Q:3&+85\:EOF,;A-T;!OA*<&@8?5O,T7WRIO)R]>?/FNC1%N^ E4O F'"A%
M@6U,K(!5EF=A138A#L+ HQ\_S9WV^  X7'8=) 5/#0N*67(R9A&PML\KS))R
M:RF!Y<!5-)A5:K5X?O\IH\U6J+;MVMQ/ZAV Y^VMQ^,9!NE4+ Z,SK7*VI,\
M A>@I%+!9F=-;K-T[S85/;7B[:G69Q[H=Y)Q9_BXGH,0_C'_=O'MM^5JM?Q[
MG9(0_J2_.?\Q2R+GZ/&2F3JUM^;=TH#P/!038Z%?CE:5_!25/?7JC8^O4774
M _XV[T7K+7OO+\[7YV&SE/K%M\U85>E*X;JVB.7ZY&@1P3E)"&%DRK5!9+Q1
M)?Q/*.NILV(DG(VIBQZP]<BY^8@UHB26'IX<5K(K0B2(,I'H3/80(_>0LA=9
ML\ T:Q-/[49G3Z6T[>S;2'KJ (6_7WWMZ_DB+!*^7*[/UW^LENOUS$@7T>8(
M)?M:39$8.$9):?&)6UY,<(V&OC])4D_OR^-@:QSI=P&CGPP@WPX,+L:BD<A
MUZIDE>L5ES$9,":ON4"*2]O-\!Q"84]/"V.!K(%NNL#<P\/S#L]GF4?/D_.
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M7<3< 4SNC4"-TNDLC(3"5+U6#1Q"KFMEO. B"T'I<YORD,ZGS!X"D0-$W %
M[KK@C6&56EJ>200E8;V-\Q&\2QZX\59;6X2\7W7;Y'&BSY6VAX0G!\JZ.[3<
MVA(=6#$AQ "R#F=6O!#J34G G+;&,J<B/T9#R@U%/3UL[*[I9X&SI]BGSG^?
MV@>>5/*H5:DC'LGVYH@0"R7R(1=7?$WLU; RGT/VJA\)"?NJ;LA>]5WDN#<6
M**^/RY&,R2.[G:-DW/""H"RSH*24X&0R4+(4207GO&DS 6S/;>I'76-ZB.LY
M4-8=N)Z['&RGQ:HZQ;74L62UXSRH1#D@":>8)+Q-SFC=IH[B,6JF-32':OA9
MP.PA[@X@\Q&_+\^^UXK8N_,4+^VET)%<L430H4HG.U=[ L@_.Q&]"3JS^WYG
M).P\2U9/(-I'Z\M6*N@ 3X_N".;UZ4D9"RCJZQ.Q [X(0:FCCX)9,LVJT:#4
M?7=O'W5IV"%.ZV!Y=XB9JS/E\^;)DHX3UOJV%#5$E3>SGB@A"+)DWN9:]V1V
M;^^DYV&[MW<1>@_0>;@,.AJ3BE5U(7E][Q:8(&*VI&='6:7PRAO6!C:GL7M[
M)PW_?/?V+N+N #!/]1"4Q!5S+$#2]>K!\KJTEVEPFM&1DL98V]_V@*,NG!KO
M5F\_J4]]-W.7AY?+[[@(E9?_NICG.J&W*N<CTD]$UU_FBSJ.?":-D]8'#2&%
MVD)"B85GW(/@WDAOE<$PK&1ICR_OZ4YG3XT_W:LSOO@[A=?M*I&K(?<D0UE2
MW>-A0V6+15<7$D<H5J /"4F$^XS\>.X[>ZJ!: >F0X7=G7][9B:<*)0X,NV!
ML\!!Q9CJ7;L%F5@(W 49XPD,[#OZB*)](-=4-UU<4[_=9<X$*LXM9Z!YW7XN
M;&U;JCN00T!?3'9!M=^Z,\8HD*./.3H$>ZTTU"W\A@V3\#D45\BF:^[)N@>!
MX%1)8.L11*U=N=\U=A*S0(X^*FEL:(ZOO1&!VEV/]ET>C]>5W4L?]EW^VW9>
MV\0I),P:C%1U2%<DS&EC('GA7$Y22FQSEWV\SFOFLZ!3%<!85NOWB!9OHP6;
MT44O-?W_-J\^I])YO0L&AG1>[R+PJ?/4AYVI.427>+9 "1%)PV8!SLM"TL#"
M6;2>XQ[[=_OLO-Y)4\]W7N\BMJZ4OBW.L5DR&04$G_%RLZ-/=7UP71W-<Z1C
MD797>X>=USLIZF>=U[M(K2NMOU]<;XMV BFJ0[#H&*4'.E)Z$ R@-8KLNLOJ
M_E7Y$,5??WXONM]'84]J?S_I=06 SW]?7K&@-$?FZNKII"C8ETE K%&XQ60E
M$S*I@?>/CW]^9VW8XP!@/^EU!8#7RXMMAX=$3*+N[/*J/OJ%F"!J6^VBS85%
M5M3 GLPGOJ"S9NQQ(+"G_#JX5'ZD;HYY28!5%CQ7J:*8$XJ#!*^C]B%ZX7F;
M5_8]JU"/VI^Y3Y0XDJR[0\O5$<(8B[42(5@DTV>+!N]\ F$,)AVYEJ9--^])
M5*'NI.$A5:B[B+L#R#Q? NDC0U)N;1=CKHX^LA"=M< 942M-LIC;7-*>6A7J
M3EK?J0IU%Q5T@*='>HN*"L(J5L!XQ<ES4\050R8IB;HGV47K?!L#= H=>X<X
MK -EW1U:;O4?)54*P9N#I0B]BL5"P)0!=9(2190!VU2@GDS'WDZ:'MJQMXO8
MI\Z07L]7Z_.W<UQ<FLW[#6=<ZF*<9^"4,76KM@3'=8%@4#O)/,OW$?1$HO3\
M]_2$BWT5N6PCU0[LRZ.UVX)9JPT*D#G7G8PD()]< >N9=$%B;M5!OG=/Q%$;
M^0[Q2 ?+NT/,;".\I)0R3E%FD(@+Z30$;6J-4' A4QA68ILRY9/IB=A)S\-Z
M(G81>@_0>5BDGPI%_H5'B)$+4$QZB)D'$DHJHCB-1;:ON>K!58VAX9_W1.PB
M[@X \V!L5/%!%>DX%"Y)'$8G<!(M%(KM%(^L[MMI I>]1J\=M5?O$+]TD)P[
MP\G5P8G,"YN-!$G'!%0)!IS7#@2BHOB5_EK^DXY>VTFW/Q^]MHN@.X#*@YE@
M.5B&4I%)Y%G5D4\*7*8(/I)OQL*DTJK-PHKN1Z_MI-F?C5[;1<P=P.3>7#"A
M;)9:,TBISC\U,4#4A@%+Q920*+23_Y2CUPZ!R $BGA @Z]7Y[&-8?+FTI4;'
M&+5&R*'V.3-1%Z/* $(0 ]:)C'$0+NA3;V&"?KJ/ASM?VU\+YC[!Q_Z2[$']
MUWL+:B$YL9N9JAN^!$*(2@!F+-SK@GR8]Q@.@"F=Q0$JNZ_T/>0WL=JO^NZN
M"&?)<J&\@X"6,JG"4[WD8Q1%^>!D3,CL>(J_\]43JWX?Q2W'D.+4ZK]LW=W6
M2F&*-CE'BC(6%-<27. 2DM:1LZ2R4VX\]=_^ZFEB@-'4O[<4.P@*G^HQXJXP
M+,&"]X:\GZWU$0HC\$(RL5B\PT%@..J(AB,M91[[&7<_J4_]&'>/A]O%=S/K
M$D_62BC%4SY>8H&(7E-ZCH8;9_F#MM-!3?./]$/U\0RWIP:?[I+?7YS=V91G
M6J^30I>%)3.9<@"ELH; >81"QM:SQ)BY/[&CQ[;XHT]BV =C3773YT+>3Y_?
MO_S?O[WX].KWE^__\N'5NT\O/K]Y_^XNS</:-Y_XI!$:,H?0.%:+Y75KW?OR
M<OGM3URL-^1^Q+,ZO??E<GV^_O25@!EKT^>'\&.SMONZ#0^=C@0M2H5R;3KF
M:"'F$ "-$<(Z[V.C20*'T7VP+1OZ[;_=_O;/I+/?Z&/^<Z:$,SDY#YI+$AO+
M$:).#B)+!B/%B8HW,G&'$3ZQ=ST>5A\8R",J_)3LYB;H78]G/:\^KYD-?8S>
M/BQIL$DF4P38I#DH(15$7NIN#X$J49(I<J-U%I-:TD_I*^:+,_KNF^-SFXI/
MYW1\WO]9?[M^D<[GW^?G/S9*O#E;5JJH61W/RXJK(R@\A&3I7#-MN<B*2=VF
M(.=PVD_:GNZ"V/OV],AJ[R#]N>'XW7+Q'=<DX+HB835/]+L-NW]=S,^?8E8Z
M9E+!S?(%A#HU#UQP$9+E4G.DE(^WL0X'D3UQHM0#O%LK^Y2"A:M1,N_":D6?
M_QW'"QL>?'*S .)Y'OH();A+*F%"2%F29417( 1!<6])187H&,6;_X2AQ M2
MV>++IHA]_=N/!]'ZB[^'5;Z:LVN*U1+)M=0I 2J@@*!2A( Y>2F2M:)-2=5H
M+)QT8+$+?G<-+-J H(=W^LM!*2)ZQC4#DE($5:P$SUR"A)KKX$),8E!/>(,R
MC69HFTCECQ9W["+_'D!S]3SI2DPA<4YQ1A:@ZOMFJ(63)MM@,X^&\4$3U4ZQ
MN&,GE3U1W+&+_+IZW8]">>TI=7*Q3D+Q)E,2Y1696D=H-TQ+.>7K?O/BCIT4
M]^3K_BY2G%K]=ZI2"L_*1I'!6%- 98-U_@F"D,(7;9S",J+Z=Z[M:5[<L;?Z
M]Y9B!S<1EPYOVZQ5=%8^$_%*" V*I0)$>X"8F<FB%*MDFZKP.V1,>U,P;01Q
MN%XZ -7^@KMA>Y$_G(7%K>9EK[-DGC,PB==!;84#_5$"[[4*# U7I5$>UH";
M:8/D \!U/\.:6M,]H/WF>GK;#^\]41TD)*]3'=-.9UY%"3&HS+DK0C9:7O2
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MG;VO[,?HL)=(]J^#=714G?*ANWR5>K->7V#>2F?&4;/DZYH=+.2195V'K72
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M7!=T7FN.:"LBCRD!2E4%E6W=EU)W@K/!\$)=PS:I< \VI_/KG<U1LAA[R#K
MW0AQ2.9IHYAI72H^&+(A,Q!BK3F)Z#3*Q'WAT_C4<61B#D!:;1>2L&<$'#+F
M?UJLRYI\6O;DX:3!Y!7/3EA(M@9.4-::K,:!1BN,+8$ITUE.Y] N=KXFC(S=
MT:IZM 32(<^PP94G-;'.[ PMMZYD4$[1R,F,8+"$(*5VMK>CFC8U3+N;86TA
M/EFETR%X.YQLFK'J5+JLT"MIH.1Z@YK5ZETY9C!1"]0F.U\:B37OJ8<'FD=S
M))-Q![0=]:+XV\I#_5OPW >/F#-(I6@/H+,%3,S3'I<58U%;UR@ NZ\>'FCV
MS)',PAW0MJM^3^?S<),LL(0<,U;A"45["_)5X RW-',BLS()Q7)G63--R&E_
M>3-',A-WP5M/EY>:&&?XK?:;"R:0:\<T6.EIF),2@,$90)63D1HYU^; )NP6
M9CA0DCMQ3&=R0!XUQ?WHZIXM(7W/;3N12\F!@$#.6D5RX$X[3:Y1.Y]\]"(=
MVGYT*T,<*&'N?4:W!^67.7U[1399[T,V ;1-"E1P-;7%.LB.:VNQ"(P-LQ4G
M[OV!1H![F#X=NH)!6/[L0LC/FR_$*%/F!2(39#Y4&IS5 5B)P6EC3;2=2<.,
M;8(#Y>>?E3]HB>JC)@7WHXLO\*;&8C8&P:4J+%18IAV22B"D,)$,:FPXM"W[
M0!,<*+G_K-Q!2U0?M3L8P*LXMR8SA6!8C=%JQB!DC< M,:Z4D_#F>#?[!QJ(
M_ZR<0",L=YQ[^?:[\Y-?WI[\].O);_3G?*M4R\UGC)%9^62[1DJD/'\7;O+?
M[ZA])^_SO10S&U+2WD(DEPYJ=5::F8;D<^'),.U=([W91UJTL_??>.ZO9,'O
MZ =_7,24B=;:6C2CZI#86,!%Z8#++).604C7Z #TL29-'$L9 Q.?.*Q1S#\:
MBVCJ0=;9SV,XDG\>U<"?/-C*UFZEL**XU!E*%A*4I!TDQGHS45<]KA23L^J0
MW<IMIH,(&@MU$WA,M# RP\$G)D"JX!5#Y61L)*'_0&LZ=29#D/",,QEN]!YV
M(QM]^"='$;'H4'Q-2LP&5!8*,',#MD1>T/!@$?>"G3Y2E'<>Z6>@LXW9^T3/
M.EG0*.65L0:,(BJN8DT6--%"2+24%ELPY[(O_/20 3S*@#\/HBVLWQ^,UMFA
M)H6$K)[]E%J\32"U/SCJ#K?,IK3B>ON 4!<)O>,,]=, VL+N$X(GY=G%:;[$
MJY/Y<K;\L)I-1IH2-0M &W\/RA@#GG$!+)FD># :]5.KUDV.7U\NWO^''KU"
MR]^J?H3;CRN(//#2B4^8QEJ9=C7GQ$BX;?5Z3M!\$"P(!$'=KF5\$B!/M&'4
MZ%74GKGXU+'GRV!P]XW3.(>=AVPQ@OVFED3]+[TO7\_B']\OWLV7']Y@FBVN
M%I<?3D^_7_LS+BSG3"<PIHK45H4B;[RJ@H4I,N&2B1N!E4?$49]]U70PV'[X
M%LULV0TR?LQXM?S]Q\7-7[,E7KV:QW5GO$./T08(PCE:Z+0&+XL%RU&PB(HY
M^[):!,^]:9HEH@$NQK#DA+"XN5Y>G/UO3L_Y??;7+?W.ECNM%8C,R"1))/"*
M_I4\9.=5-E:_*/V+GGR'7])_F]SRDU=/?!(]%FW8S:2]8&$]06*(KJAB0&@B
MU"IR!3[S!"4E81CMQV1ZT8YC&!JFI! [#M]#(-C"EMVL%(^N>R:)HH63$+*M
MAZ0KI2)G@#E%*T%$'>+ I:(O#K'S" ZC$4/,V5]\XO3?J_;)6Y:EH($F3J0P
M< A$D* H3('QY)$UNFK]2(LFOMK0.$RZG>&G]BZW"8=GY;3^C$;BK% ;9O/+
MU^^NEK/7BX171-'.\_7[6<PW%]X7JPS+$&65IU*1@7>>MG(BA< D,:W-NL>/
M>)I!K^TJNK7E,"_V8O,.W-'I[,]93?">89C5?M2[-SBO[O7L>OW=SWB]7'OS
MTY]?XQPO:^=7SO?L^H=,7^'5^C<?W?ZK.34QWRPOG./*:I. *1/)ZC&""R$#
MRR68>DJ>99O3T<8=ZRI2MQO(>X1"^UL1ZR_JGZI(_<U7_P=02P$"% ,4
M" !YBJI4F)L<J-((  #C/P  %               @ $     <3$R,#(R97AH
M:6)I=#,Q,2YH=&U02P$"% ,4    " !YBJI4!%ERN_0(   00@  %
M        @ $$"0  <3$R,#(R97AH:6)I=#,Q,BYH=&U02P$"% ,4    " !Y
MBJI4_[L RC(%  "^&@  %               @ $J$@  <3$R,#(R97AH:6)I
M=#,R,2YH=&U02P$"% ,4    " !YBJI4AU:2KA %  ##&0  %
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H="TR,#(R,#,S,5]P<F4N>&UL4$L%!@     *  H D@(  ,F1!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
